Citrus Sinensis ID: 046097
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 603 | 2.2.26 [Sep-21-2011] | |||||||
| O64639 | 683 | Receptor-like serine/thre | yes | no | 0.981 | 0.866 | 0.608 | 0.0 | |
| Q9STJ8 | 651 | Receptor-like serine/thre | no | no | 0.956 | 0.886 | 0.476 | 1e-134 | |
| Q9SAH3 | 692 | Putative receptor-like pr | no | no | 0.933 | 0.813 | 0.343 | 1e-81 | |
| Q9FHG4 | 681 | Probable L-type lectin-do | no | no | 0.510 | 0.452 | 0.331 | 3e-34 | |
| Q9XI96 | 699 | Proline-rich receptor-lik | no | no | 0.275 | 0.237 | 0.464 | 6e-34 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.271 | 0.251 | 0.461 | 2e-33 | |
| O64776 | 792 | G-type lectin S-receptor- | no | no | 0.338 | 0.257 | 0.425 | 2e-33 | |
| O64780 | 814 | G-type lectin S-receptor- | no | no | 0.343 | 0.254 | 0.422 | 2e-33 | |
| Q9LFV3 | 436 | Probable leucine-rich rep | no | no | 0.281 | 0.389 | 0.431 | 3e-33 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.301 | 0.439 | 0.419 | 4e-33 |
| >sp|O64639|Y2559_ARATH Receptor-like serine/threonine-protein kinase At2g45590 OS=Arabidopsis thaliana GN=At2g45590 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/694 (60%), Positives = 495/694 (71%), Gaps = 102/694 (14%)
Query: 1 MPSMMAPPVIHHRR-------HNHQAHFLPAILAGTLVLTCFILIIITIFTYRKLYRNRT 53
MPS ++PP I + +H+ LP I+AG+L LT +LI++T+ YR+LYRNRT
Sbjct: 1 MPSRLSPPDIPPLQPTPTVSDGHHRFQTLPLIIAGSLTLTGVLLILVTLLIYRRLYRNRT 60
Query: 54 APSDL----KSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAV 109
APSDL KSP H CRRFSY+ +RRAT SFS S LGHGGFGSVYKA PS LAV
Sbjct: 61 APSDLISNSKSPQHYQCRRFSYSQLRRATNSFSESTHLGHGGFGSVYKADFPSGGDSLAV 120
Query: 110 KILDSS-GSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQ 167
K++D+S GSLQGEREFHNELSL+S L PH+VSLLGF+SDRRGR+L+L+YELM NRSLQ
Sbjct: 121 KVMDTSAGSLQGEREFHNELSLSSHLIGSPHVVSLLGFSSDRRGRKLILVYELMANRSLQ 180
Query: 168 DALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227
DALLDRKC ELM+WNKRFEIA DIAKG+E+LHH C+P +IHGDIKPSNILLD DFKAKIG
Sbjct: 181 DALLDRKCVELMDWNKRFEIATDIAKGIEFLHHCCDPIIIHGDIKPSNILLDSDFKAKIG 240
Query: 228 DFGLARLKTED----LMIEGECVKKRDVNEDNGSILEETESVVTAYEE------------ 271
DFGLAR+K+ED ++IE E K +DV EDNGSILEETESV+T +EE
Sbjct: 241 DFGLARVKSEDFDTRILIEEE-DKSKDVVEDNGSILEETESVITVFEEGNNVVNLSPETC 299
Query: 272 ----------SAGGGNGVDR-----------------------SPESCVVRVFDAEG--- 295
S G +G+ SPE+C + V G
Sbjct: 300 GISVLTETVASPGEKSGLSPENCAVSILTVEVGAASPAMASIPSPETCAISVLTDTGLSP 359
Query: 296 -------GSRRDWWWKQDNGAGS----ESGRVKDYVMEWIGSEIKKERPKN--EWVASPS 342
GS+RDWWWKQDN GS ESG VKDYVMEWIGSEIKKERP N EW+
Sbjct: 360 ESSKLKVGSKRDWWWKQDNNGGSRGGIESGSVKDYVMEWIGSEIKKERPSNNKEWI---- 415
Query: 343 STENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKR------GLNSSNVG 396
NNG S KK +KKEK RKPREWWKEEFCEELT+KK+K+ GL+S +
Sbjct: 416 ---NNGDGSSSVSKK---KKKEKKRKPREWWKEEFCEELTRKKRKKKKKKKRGLSSISSI 469
Query: 397 EMWWQKDEEV--VVQERKKRKNKTSRGSIDWWLDGFSGELRT--GRRSSQD---WASGDI 449
+ W+ +D+ V + R SIDWW+DG SGEL++ G+++SQD W ++
Sbjct: 470 DSWFHRDDGASSVHDHNLNPTKRKKRNSIDWWVDGLSGELKSVMGKKNSQDSGLWCDVNV 529
Query: 450 PKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMS 509
KSGG+SSTPSMRGTVCYIAPE GGGG+LSEKCDVYSFGVL+LVL+SGRRPLQVTASPMS
Sbjct: 530 QKSGGVSSTPSMRGTVCYIAPECGGGGVLSEKCDVYSFGVLLLVLVSGRRPLQVTASPMS 589
Query: 510 EFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
EFERANLISWA+QLA NGKLL+LVD SIHSL+K+QA+LCITIALLCLQRSP KR TMK+I
Sbjct: 590 EFERANLISWAKQLACNGKLLELVDKSIHSLEKEQAVLCITIALLCLQRSPVKRPTMKEI 649
Query: 570 VEMLTGEAEPPHLPFEFSPSPPSNFPFKSQKKAR 603
VEML+G +EPPHLPFEFSPSPP FPFKS+KKAR
Sbjct: 650 VEMLSGVSEPPHLPFEFSPSPPMGFPFKSRKKAR 683
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9STJ8|Y4539_ARATH Receptor-like serine/threonine-protein kinase At4g25390 OS=Arabidopsis thaliana GN=At4g25390 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1231), Expect = e-134, Method: Compositional matrix adjust.
Identities = 312/655 (47%), Positives = 410/655 (62%), Gaps = 78/655 (11%)
Query: 3 SMMAPPVIHHRRHNHQAHFLPAILAGTLVLTCFILIIITIFTYRKLYRNRTAP---SDLK 59
S + P ++ F P ++AG F L I + K R R++P +
Sbjct: 20 SSLVPAAPSGHQNKTTRIFPPFVVAGAG--AGFSLFITLSVCFCKFSRKRSSPPAENASS 77
Query: 60 SPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ 119
SP R FSY+ +RRAT SFS +NRLG GGFG V++ + S + +AVK++DS GSLQ
Sbjct: 78 SPRRPSPREFSYSSLRRATGSFSQANRLGQGGFGVVFRGTI-SGGENVAVKVMDS-GSLQ 135
Query: 120 GEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELM 179
GE EF NEL A+ LD PH+V ++GF+ DR+ RRL+L+Y+LM+N +LQDALL R+C ELM
Sbjct: 136 GEGEFQNELFFAAKLDSPHVVPVIGFSHDRKRRRLLLVYKLMDNGNLQDALLHRRCPELM 195
Query: 180 EWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
+WN+RF +A++IA G+++L HS EPPVIHGDIKPSN+LLD F AKI DFGLARLK E
Sbjct: 196 DWNRRFLVAVNIADGIKHL-HSLEPPVIHGDIKPSNVLLDSLFSAKIADFGLARLKAEQ- 253
Query: 240 MIEGECVKKRDVNEDNGSILEETESV---VTAYEESAGGGNGVDRSPESC---------- 286
+E +RD +GS++EE ESV VT YE+ G VD+SPES
Sbjct: 254 -VEISVAPERD---GDGSMVEEVESVVTTVTGYEDFNFG--LVDQSPESVAKVPGSVSAS 307
Query: 287 -----VVRV-------FDAEGGS-----------RRDWWWKQDNGAGSESGRVKDYVMEW 323
VV V D +GGS +DWWWKQ++ E GRVK+YVM+W
Sbjct: 308 PEATTVVSVSPEMGEKTDEDGGSVVVMKKGKESESKDWWWKQESNV--ERGRVKEYVMQW 365
Query: 324 IGSEIKKERP-KNEWVASPSSTENNGSSSKLE-----------MKKDRIRKKEKNRKPRE 371
IGSE+KKERP +++W+ + + + ++ + + ++D +KK+K R RE
Sbjct: 366 IGSEVKKERPSRSDWIEAAALSSSSSKKLEKKTSKRLDWWLSLEEEDENKKKKKRRMVRE 425
Query: 372 WWKEEFCEELTKKKKKRGLNSSNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFS 431
WWK+E+ EL KK+KK+ + E V Q R+ S SIDWWLDG S
Sbjct: 426 WWKDEYRRELAKKRKKKKKMTLE-AEFCSDDGSSSVSQ---WRRGSGSGSSIDWWLDGLS 481
Query: 432 GE--LRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGG-GGLLSEKCDVYSFG 488
GE LR R +S D SG+I KS GISSTPSMRGTVCY APEY +SEKCDVYS+G
Sbjct: 482 GERWLR-ARGNSHDSVSGEIAKSCGISSTPSMRGTVCYAAPEYCNLDNNVSEKCDVYSYG 540
Query: 489 VLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLC 548
VL+LVLISGRRPL++T S SE +RANL+SWAR+LA GKL+DLVD + +LD++QA+LC
Sbjct: 541 VLLLVLISGRRPLEMTGS-ASEIQRANLMSWARKLARRGKLVDLVDQKLQNLDQEQAVLC 599
Query: 549 ITIALLCLQRSPSKRLTMKDIVEMLTGEAEPPHLPFEFSPSPPSNFPFKSQKKAR 603
I +ALLCLQR P R +MK+++ ML GE P LP EFSPSP P K+ +K R
Sbjct: 600 IKVALLCLQRLPISRPSMKEVLGMLKGEVNLPELPSEFSPSP----PLKTTRKQR 650
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SAH3|Y1887_ARATH Putative receptor-like protein kinase At1g80870 OS=Arabidopsis thaliana GN=At1g80870 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (779), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 243/708 (34%), Positives = 343/708 (48%), Gaps = 145/708 (20%)
Query: 1 MPSMMAP--PVIHHRRHNHQAHFLPAILAGTLVLTCFILIIITIFTYRKLYRNRTAPSDL 58
MPS P P + H R + FL ++ +LV+ IL I L R+RT P D+
Sbjct: 1 MPSRPNPTRPKLFHNRT--KTLFLILTISSSLVIFFAILYFIYHLWISLLNRSRTIPFDV 58
Query: 59 KSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL 118
+ + + F+Y ++ AT F SN +G GG G+V++ + + AVK LD+ S+
Sbjct: 59 AAASPLKLQLFTYKELKLATNDFDESNVIGKGGSGTVFRGIT-RDGKLFAVKRLDNL-SI 116
Query: 119 QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL 178
Q E EF NEL + L +V+LLG+ ++ R LIYE M N+SLQ+ L + +
Sbjct: 117 QTETEFQNELQILGGLKSSFLVTLLGYCVEKNHR--FLIYEYMPNKSLQELLFNEDGDSC 174
Query: 179 MEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNIL--------------------- 217
+ W +RF I +D+AK LE++H C+PPVIHGDIKPSN+L
Sbjct: 175 LNWERRFGIILDVAKALEFMHFGCDPPVIHGDIKPSNVLLDSEFRAKISDFGLSRVKVEG 234
Query: 218 ----------LDGDF------KAKIG-------DFGLA-------------------RLK 235
L G+F + IG DF LA L
Sbjct: 235 GYGVDLFSQELSGNFGGESTPQTAIGTPTHHEVDFALALQASSSSKNSRTSRNIKEMSLN 294
Query: 236 TEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDR-SPESCVVRVFDAE 294
+ L ++GE K ++V+ D V++ + G ++ SP S V D
Sbjct: 295 SMSLAMDGE-TKGKEVSND---------VVLSCEDHEFDQGKEMNLLSPNS----VLDLG 340
Query: 295 GGSR---RDWWWKQDNGAGSESGRVKDYVMEWIGSEIKKERPKNEW------VASPS--- 342
GS+ RDWWWKQ+ GS KDYV EWIGS+I P +W + +P
Sbjct: 341 KGSKQWGRDWWWKQE---GSGELCSKDYVREWIGSQIDTANP--DWDDDKKVITTPELGV 395
Query: 343 ----------STENNGSSSKLEMKKDRIRKKEKNRKP--------------REWWKEEFC 378
E+ + S+ + +++ K+E + + EWWKEE
Sbjct: 396 STRTIDKAEHRDESGLNESRFDTLEEKFAKEEISERKNKRSKNKKKKHRNMEEWWKEEEH 455
Query: 379 EELTKKKKKRG---------LNSSNVGEMWWQKDEEVVVQERKKRKNKTS--RG--SIDW 425
+E KKK G L + + QK E V + + S RG
Sbjct: 456 QEEMNNKKKIGVLRIKFKNHLKFPHFRYCFRQKGENSVHDREGEAAGEFSFRRGWRRKSN 515
Query: 426 WLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGG-LLSEKCDV 484
+ G S+ W SGD+ S +SST SMRGT+CYIAPEYGGG L EK D+
Sbjct: 516 SSSKKKKKNNNGSMGSEMW-SGDL-FSRELSSTTSMRGTLCYIAPEYGGGCCYLMEKGDI 573
Query: 485 YSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHS-LDKD 543
YSFGVLILV++SGRRPL V ASPM + E+ANL+SW RQLA +G +L+LVD + +K+
Sbjct: 574 YSFGVLILVIVSGRRPLHVLASPM-KLEKANLVSWCRQLAQSGNVLELVDEKLKDGYNKE 632
Query: 544 QALLCITIALLCLQRSPSKRLTMKDIVEMLTGEAEPPHLPFEFSPSPP 591
+A LCI +AL CLQ++P R + ++V +L GE + FEFSPSPP
Sbjct: 633 EAGLCINLALACLQKAPELRPDVSEVVRILRGEMDISSTAFEFSPSPP 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 147 bits (370), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 113/341 (33%), Positives = 167/341 (48%), Gaps = 33/341 (9%)
Query: 7 PPVIHHRRHNHQAHFLPAILAGTLVLTCFILIIITIFTYRKLYRNRTAPSDLKSPNHNHC 66
P VI ++ H+ + + VL C L + FT +K +++ A +LK+
Sbjct: 292 PVVIPSKKRRHRHNLAIGLGISCPVLICLALFVFGYFTLKK-WKSVKAEKELKTELITGL 350
Query: 67 RRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN 126
R FSY + AT F S +G G FG+VY+A+ SS AVK S +G+ EF
Sbjct: 351 REFSYKELYTATKGFHSSRVIGRGAFGNVYRAMFVSSGTISAVK-RSRHNSTEGKTEFLA 409
Query: 127 ELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEE---LMEWNK 183
ELS+ + L ++V L G+ +++ L+L+YE M N SL D +L ++ + ++W+
Sbjct: 410 ELSIIACLRHKNLVQLQGWCNEKG--ELLLVYEFMPNGSL-DKILYQESQTGAVALDWSH 466
Query: 184 RFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED----- 238
R IAI +A L YLHH CE V+H DIK SNI+LD +F A++GDFGLARL D
Sbjct: 467 RLNIAIGLASALSYLHHECEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVS 526
Query: 239 LMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSR 298
+ G G + E TA E++ GV +C R D E S+
Sbjct: 527 TLTAGTM----------GYLAPEYLQYGTATEKTDAFSYGVVILEVACGRRPIDKEPESQ 576
Query: 299 R-----DWWWKQDNGAGSESGRVKDYVMEWIGSEIKKERPK 334
+ DW W+ + GRV + V E + E +E K
Sbjct: 577 KTVNLVDWVWRLHS-----EGRVLEAVDERLKGEFDEEMMK 612
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 145 bits (367), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 79/170 (46%), Positives = 111/170 (65%), Gaps = 4/170 (2%)
Query: 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNEL 128
F+Y + AT FS LG GGFG V+K ++P+ + +AVK L +GS QGEREF E+
Sbjct: 324 FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKE-IAVKSL-KAGSGQGEREFQAEV 381
Query: 129 SLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIA 188
+ S + H+VSL+G+ S+ G+RL L+YE + N +L+ L K +M+W R +IA
Sbjct: 382 EIISRVHHRHLVSLVGYCSNAGGQRL-LVYEFLPNDTLE-FHLHGKSGTVMDWPTRLKIA 439
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ AKGL YLH C P +IH DIK SNILLD +F+AK+ DFGLA+L ++
Sbjct: 440 LGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDN 489
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 144 bits (363), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 78/169 (46%), Positives = 110/169 (65%), Gaps = 5/169 (2%)
Query: 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNEL 128
F+Y + RAT FS +N LG GGFG V+K ++PS + +AVK L +GS QGEREF E+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKE-VAVKQL-KAGSGQGEREFQAEV 325
Query: 129 SLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIA 188
+ S + H+VSL+G+ G + +L+YE + N +L+ L K MEW+ R +IA
Sbjct: 326 EIISRVHHRHLVSLIGYC--MAGVQRLLVYEFVPNNNLE-FHLHGKGRPTMEWSTRLKIA 382
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
+ AKGL YLH C P +IH DIK SNIL+D F+AK+ DFGLA++ ++
Sbjct: 383 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASD 431
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64776|Y1144_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61440 OS=Arabidopsis thaliana GN=At1g61440 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 144 bits (362), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 92/216 (42%), Positives = 127/216 (58%), Gaps = 12/216 (5%)
Query: 24 AILAGTLVLTCFILIIITIFTYRKLYRNRTAP-----SDLKSPNHNHCRRFSYNLIRRAT 78
I+A T+ LT F+++ F + +RNR +DL+S + F N I+ AT
Sbjct: 419 TIVASTVSLTLFVILGFATFGF---WRNRVKHHDAWRNDLQSQDVPGLEFFEMNTIQTAT 475
Query: 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH 138
++FS SN+LGHGGFGSVYK + + +AVK L SS S QG++EF NE+ L S L +
Sbjct: 476 SNFSLSNKLGHGGFGSVYKGKLQDGRE-IAVKRLSSS-SEQGKQEFMNEIVLISKLQHRN 533
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+V +LG + G+ +LIYE M+N+SL + + ++W KRF+I I +GL YL
Sbjct: 534 LVRVLGCCVE--GKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRFDIIQGIVRGLLYL 591
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
H VIH D+K SNILLD KI DFGLARL
Sbjct: 592 HRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARL 627
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64780|Y1614_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61400 OS=Arabidopsis thaliana GN=At1g61400 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 144 bits (362), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 92/218 (42%), Positives = 129/218 (59%), Gaps = 11/218 (5%)
Query: 24 AILAGTLVLTCFILIIITIFTY--RKLYRNRTAP-----SDLKSPNHNHCRRFSYNLIRR 76
I+A T+ LT F+++ T F + R++ +N +DL++ + F N I+
Sbjct: 436 TIIAITVSLTLFVILGFTAFGFWRRRVEQNALISEDAWRNDLQTQDVPGLEYFEMNTIQT 495
Query: 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC 136
AT +FS SN+LGHGGFGSVYK + + +AVK L SS S QG++EF NE+ L S L
Sbjct: 496 ATNNFSLSNKLGHGGFGSVYKGKLQDGRE-IAVKRLSSS-SEQGKQEFMNEIVLISKLQH 553
Query: 137 PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLE 196
++V +LG + G +LIYE M+N+SL + D K ++W KRF+I IA+GL
Sbjct: 554 RNLVRVLGCCVE--GTEKLLIYEFMKNKSLDTFVFDSKKRLEIDWPKRFDIIQGIARGLL 611
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
YLH +IH D+K SNILLD KI DFGLAR+
Sbjct: 612 YLHRDSRLRIIHRDLKVSNILLDEKMNPKISDFGLARM 649
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFV3|Y5157_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730 OS=Arabidopsis thaliana GN=At5g15730 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 144 bits (362), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 76/176 (43%), Positives = 110/176 (62%), Gaps = 6/176 (3%)
Query: 68 RFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNE 127
R++Y I++AT +F+ LG G FG VYKAV+P+ LA + S S QG+REF E
Sbjct: 103 RYNYKDIQKATQNFTTV--LGQGSFGPVYKAVMPNGE--LAAAKVHGSNSSQGDREFQTE 158
Query: 128 LSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEI 187
+SL L ++V+L G+ D+ R +LIYE M N SL++ L + +++ W +R +I
Sbjct: 159 VSLLGRLHHRNLVNLTGYCVDKSHR--MLIYEFMSNGSLENLLYGGEGMQVLNWEERLQI 216
Query: 188 AIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEG 243
A+DI+ G+EYLH PPVIH D+K +NILLD +AK+ DFGL++ D M G
Sbjct: 217 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHSMRAKVADFGLSKEMVLDRMTSG 272
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 143 bits (361), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 78/186 (41%), Positives = 116/186 (62%), Gaps = 4/186 (2%)
Query: 50 RNRTAPSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAV 109
+N+ D + N+ + FS+ + AT +F +G GGFG VYK + + +AV
Sbjct: 48 QNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAV 107
Query: 110 KILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDA 169
K LD +G LQG +EF E+ + S L H+V+L+G+ +D G + +L+YE M SL+D
Sbjct: 108 KQLDRNG-LQGNKEFIVEVLMLSLLHHKHLVNLIGYCAD--GDQRLLVYEYMSRGSLEDH 164
Query: 170 LLDRKCEEL-MEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228
LLD +++ ++W+ R IA+ A GLEYLH PPVI+ D+K +NILLDG+F AK+ D
Sbjct: 165 LLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSD 224
Query: 229 FGLARL 234
FGLA+L
Sbjct: 225 FGLAKL 230
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 603 | ||||||
| 255541374 | 681 | ATP binding protein, putative [Ricinus c | 0.985 | 0.872 | 0.693 | 0.0 | |
| 224063935 | 636 | predicted protein [Populus trichocarpa] | 0.948 | 0.899 | 0.685 | 0.0 | |
| 224127450 | 635 | predicted protein [Populus trichocarpa] | 0.910 | 0.864 | 0.678 | 0.0 | |
| 359489512 | 664 | PREDICTED: receptor-like serine/threonin | 0.976 | 0.887 | 0.635 | 0.0 | |
| 317106640 | 548 | JHL05D22.17 [Jatropha curcas] | 0.805 | 0.886 | 0.715 | 0.0 | |
| 449454626 | 654 | PREDICTED: receptor-like serine/threonin | 0.943 | 0.870 | 0.663 | 0.0 | |
| 449521812 | 654 | PREDICTED: LOW QUALITY PROTEIN: receptor | 0.943 | 0.870 | 0.663 | 0.0 | |
| 15225518 | 683 | protein kinase-like protein [Arabidopsis | 0.981 | 0.866 | 0.608 | 0.0 | |
| 297824605 | 681 | kinase family protein [Arabidopsis lyrat | 0.978 | 0.866 | 0.589 | 0.0 | |
| 357514725 | 702 | Cysteine-rich receptor-like protein kina | 0.953 | 0.819 | 0.616 | 0.0 |
| >gi|255541374|ref|XP_002511751.1| ATP binding protein, putative [Ricinus communis] gi|223548931|gb|EEF50420.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2362), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/685 (69%), Positives = 531/685 (77%), Gaps = 91/685 (13%)
Query: 1 MPSMMAPPVIHHRRHNHQAHFL----PAILAGTLVLTCFILIIITIFTYRKLYRNRTAPS 56
+PS+ A P +++ H P+ILAG L T F L+++ F YRKL R RTAPS
Sbjct: 6 LPSLPASPPLNNNHRYHHHRLRHHLLPSILAGALSFTIFCLVVLVFFFYRKLSRKRTAPS 65
Query: 57 DLKSPNHNH-----------CRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQ 105
DLKSP HNH CRRFSY+L+R ATASFS SNRLGHGGFGSVYKA++PS++Q
Sbjct: 66 DLKSPTHNHNSSSSSNQQQQCRRFSYSLLRSATASFSTSNRLGHGGFGSVYKAIIPSTNQ 125
Query: 106 PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRS 165
PLAVK++D +GSLQGEREFHNELSLASSLD PHIVSLLGF+SDRR ++L+L+YELMENRS
Sbjct: 126 PLAVKLMDPNGSLQGEREFHNELSLASSLDSPHIVSLLGFSSDRRRKKLILVYELMENRS 185
Query: 166 LQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAK 225
LQDALLDRKCEELM W KRF+I D+AKG+EYLHH C PPV HGDIKPSNILLD DF AK
Sbjct: 186 LQDALLDRKCEELMNWRKRFDIVSDVAKGIEYLHHFCNPPVTHGDIKPSNILLDADFNAK 245
Query: 226 IGDFGLARLKTEDLMIEGECVKKRD-----VNEDNGSILEETESVVTAYEESAGGGNGVD 280
IGDFGLARLKTE E V+K++ V EDNGSILEETESVVTAYE+S+ G+D
Sbjct: 246 IGDFGLARLKTE------ETVEKKEASFVVVAEDNGSILEETESVVTAYEDSSTVA-GID 298
Query: 281 RSPESCVVRVFDAE--------------------------------------------GG 296
RSPES VRV D++ GG
Sbjct: 299 RSPESFAVRVLDSDASPEMATAAVVSPEMGMDKGSISEMGFDKVSVDSGKDLVNGGKKGG 358
Query: 297 SRRDWWWKQDNGAGSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNG----SSSK 352
SRRDWWWKQDNG GSESGRVKDYVMEWIGSEIKKERPKNEW+ASPSS +N+ S
Sbjct: 359 SRRDWWWKQDNGGGSESGRVKDYVMEWIGSEIKKERPKNEWIASPSSVDNSNVLRTKSLS 418
Query: 353 LEMKK--------------DRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNVGEM 398
+E +K +R++KK+K RKPREWWKEEFCEELTKKKKKRGLNSSN G+
Sbjct: 419 IEPRKKHKKRLDWWASLDEERMQKKDKYRKPREWWKEEFCEELTKKKKKRGLNSSNGGDS 478
Query: 399 WWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISST 458
WWQKD+ +VQE KK KNK SRGSIDWWLDGFSGELR GRR+SQDW SG+IPKSGG+SST
Sbjct: 479 WWQKDDN-LVQETKK-KNKRSRGSIDWWLDGFSGELRNGRRNSQDWLSGEIPKSGGVSST 536
Query: 459 PSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLIS 518
PSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVL+LV++SGRRPLQVTASPMSEFERANLIS
Sbjct: 537 PSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLLLVVVSGRRPLQVTASPMSEFERANLIS 596
Query: 519 WARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTGEAE 578
WARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSP+KR TMK+IV ML+GE E
Sbjct: 597 WARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPTKRPTMKEIVGMLSGETE 656
Query: 579 PPHLPFEFSPSPPSNFPFKSQKKAR 603
PPHLPFEFSPSPPSNFPFKS+KKAR
Sbjct: 657 PPHLPFEFSPSPPSNFPFKSRKKAR 681
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224063935|ref|XP_002301309.1| predicted protein [Populus trichocarpa] gi|222843035|gb|EEE80582.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2152), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/635 (68%), Positives = 493/635 (77%), Gaps = 63/635 (9%)
Query: 16 NHQAHFLPAILAGTLVLTCFILIIITIFTYRKLYRNRTAPSDLKSPNHNH---CRRFSYN 72
+H LP +LAGTL L LI++ + YRK+ RNRTAP +SPNH+H CR +SY+
Sbjct: 18 HHHIRLLPPLLAGTLTLILIFLIVLVVLLYRKITRNRTAPIT-RSPNHHHHHQCRCYSYS 76
Query: 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLAS 132
L+RRAT+SFSPSNRLGHGGFGSVYKA +P+++Q LAVK++D +GSLQGEREFHNELS+AS
Sbjct: 77 LLRRATSSFSPSNRLGHGGFGSVYKATLPNTNQHLAVKLMDQNGSLQGEREFHNELSIAS 136
Query: 133 SLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIA 192
LD P+IVSLLG++ R+ ++LVL+YELMENRSLQ+AL DRKCEELM W RFE+ I +A
Sbjct: 137 CLDSPNIVSLLGYSCSRK-KKLVLVYELMENRSLQEALFDRKCEELMNWKVRFELVIGVA 195
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDVN 252
KGLEYLHH C PPVIHGDIKP NILLD F AKIGDFGLARLK E+ G KK
Sbjct: 196 KGLEYLHHFCSPPVIHGDIKPGNILLDSCFNAKIGDFGLARLKIEE--SNGFLEKKEGFG 253
Query: 253 EDNGSILEETESVVTAYEESA-GGGNGVDRSPESCVVRVFDAEG---------------- 295
EDNGSILEETESV + ES GV RSPES VRV D++
Sbjct: 254 EDNGSILEETESVASGCGESGILDVGGVVRSPESFGVRVLDSDASPEMFSVVSPEVGVDK 313
Query: 296 --------------------------GSRRDWWWKQDNGAGSESGRVKDYVMEWIGSEIK 329
GSRRDWWWKQDNG GSESGRVKDYVMEWIGSEI
Sbjct: 314 GSVSEAGFDKMSVDSGRDLIGGGKKSGSRRDWWWKQDNGGGSESGRVKDYVMEWIGSEIN 373
Query: 330 KERPKNEW-VASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKR 388
KERPK EW ASP S E +R++KKEKNRKPREWWKEEFCEELTKKKKKR
Sbjct: 374 KERPKQEWNAASPISNE------------ERMKKKEKNRKPREWWKEEFCEELTKKKKKR 421
Query: 389 GLNSSNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGD 448
GL+SSN G++WWQKD++ V + +KKRK+K SRGS+D WLDGFSGE R GRR+SQDWASG+
Sbjct: 422 GLSSSNSGDLWWQKDDDGVQERKKKRKSKGSRGSMDRWLDGFSGEFRNGRRNSQDWASGE 481
Query: 449 IPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPM 508
IPKSGGISSTPSMRGTVCYIAPEYGGG LLSEKCDVYSFGVL+LV++SGRRPLQVTASPM
Sbjct: 482 IPKSGGISSTPSMRGTVCYIAPEYGGGSLLSEKCDVYSFGVLLLVVVSGRRPLQVTASPM 541
Query: 509 SEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKD 568
SEFERANLISWARQLAYNGKLLD+VD S+HSLDKDQALLCITI LLCLQ+SPSKR TMK+
Sbjct: 542 SEFERANLISWARQLAYNGKLLDIVDTSVHSLDKDQALLCITIGLLCLQKSPSKRPTMKE 601
Query: 569 IVEMLTGEAEPPHLPFEFSPSPPSNFPFKSQKKAR 603
IV ML+GEAEPPHLPFEFSPSPPSNFPFKS++KAR
Sbjct: 602 IVGMLSGEAEPPHLPFEFSPSPPSNFPFKSRRKAR 636
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127450|ref|XP_002320077.1| predicted protein [Populus trichocarpa] gi|222860850|gb|EEE98392.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 786 bits (2030), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/616 (67%), Positives = 479/616 (77%), Gaps = 67/616 (10%)
Query: 35 FILIIITIFTYRKLYRNRTAPSDLKSPNHNH--CRRFSYNLIRRATASFSPSNRLGHGGF 92
++I+ I YRK+ RNRTAP KSPNH+H CR +SY+L+RRAT+SFSPSNRLGHGGF
Sbjct: 28 IFIVILVILLYRKITRNRTAPIT-KSPNHHHQQCRCYSYSLLRRATSSFSPSNRLGHGGF 86
Query: 93 GSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152
GSVYKA +P+++Q LAVK++D +GSLQGEREFHNELS+AS LD P+IVSLLG++ R+ +
Sbjct: 87 GSVYKATLPNTNQHLAVKLMDQNGSLQGEREFHNELSIASCLDSPNIVSLLGYSCSRK-K 145
Query: 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIK 212
+L+L+YELMENRSLQ+AL DRKCEELM W RF++ I +AKGLEYLHHSC PPVIHGDIK
Sbjct: 146 KLILVYELMENRSLQEALFDRKCEELMNWKVRFDLVIGVAKGLEYLHHSCNPPVIHGDIK 205
Query: 213 PSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEES 272
PSNILLD F AKIGDFGLARLK E+ G KK + E+NGSILEETESV + ES
Sbjct: 206 PSNILLDSFFNAKIGDFGLARLKIEE--SNGVVEKKEGLGEENGSILEETESVGSVCGES 263
Query: 273 AG-GGNGVDRSPESCVVRVFDAEGG----------------------------------- 296
GV+RSPES RV D++
Sbjct: 264 GIIAVGGVERSPESFGGRVLDSDASPEMVSPEVGVDKGSVSEAGFDKMSVDSGRDLIGGG 323
Query: 297 ----SRRDWWWKQDNGAGSESGRVKDYVMEWIGSEIKKER-PKNEW-VASPSSTEN---N 347
SRRDWWWKQDNG GSESGRVKDYVMEWIGSEI KER PK EW V SP S++N +
Sbjct: 324 KKGGSRRDWWWKQDNGGGSESGRVKDYVMEWIGSEINKERRPKQEWNVVSPVSSDNKLLS 383
Query: 348 GSSSKLEMKKDRIR------------KKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNV 395
S K+E KK + R KKEKNRKPREWWKEEFCEELTKKKK RGL+SSN
Sbjct: 384 TESLKIEPKKHKKRLEWWASLDEGRMKKEKNRKPREWWKEEFCEELTKKKK-RGLSSSNS 442
Query: 396 GEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGI 455
G++WWQKD+++V ++++K + S+GSIDWWLDGFSGE R GRR+SQDWASG+IPKSGGI
Sbjct: 443 GDLWWQKDDDLV---QERKKKRKSKGSIDWWLDGFSGEFRNGRRNSQDWASGEIPKSGGI 499
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVL+LV++SGRRPLQVTASPMSEFERAN
Sbjct: 500 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLLLVVVSGRRPLQVTASPMSEFERAN 559
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTG 575
LISWARQLAYNGKLLDLVDPSI SLDKDQALLCITI LLCLQRSPSKR T+K+IV ML+G
Sbjct: 560 LISWARQLAYNGKLLDLVDPSILSLDKDQALLCITIGLLCLQRSPSKRPTVKEIVGMLSG 619
Query: 576 EAEPPHLPFEFSPSPP 591
EAEPPHLPFEFSPSPP
Sbjct: 620 EAEPPHLPFEFSPSPP 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489512|ref|XP_002272077.2| PREDICTED: receptor-like serine/threonine-protein kinase At2g45590-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1985), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/673 (63%), Positives = 491/673 (72%), Gaps = 84/673 (12%)
Query: 1 MPSMMAP--PVIHHRRHNHQAHFLPAILAGTLVLTCFILIIITIFTYRKLYRNRTAPSDL 58
MPS P P H H+ + +P ++ GT+ L+ +L + + YRKL R+RT P+DL
Sbjct: 1 MPSRQPPFSPAPSPVTHRHRPNLVPPVVGGTVALS--LLAFLVVILYRKLSRSRTVPADL 58
Query: 59 KSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL 118
K P+ RFSY+L+RRAT+SFSPSNRLG GGFGSVYK V+PS Q +AVK++DS GSL
Sbjct: 59 KPPH-----RFSYSLLRRATSSFSPSNRLGQGGFGSVYKGVLPSG-QEVAVKLMDS-GSL 111
Query: 119 QGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEE 177
QGEREF+NELSLA + DC ++V + GF+SDRR RRLVL+YELM NRSLQDALLDRKC E
Sbjct: 112 QGEREFNNELSLAGKVVDCEYVVRIQGFSSDRRRRRLVLVYELMTNRSLQDALLDRKCVE 171
Query: 178 LMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
LM+W KRF IAIDIAKGL+YLH C+P +IHGDIKPSNILLDGDF AKI DFGLAR
Sbjct: 172 LMQWKKRFAIAIDIAKGLQYLHSYCDPSIIHGDIKPSNILLDGDFNAKIADFGLARCTGV 231
Query: 238 D----LMIEGECVKKRDVN----EDNGSILEETESVVTAYEESAGGGNG-VDRSPESCVV 288
D ++EGE KK ++ EDNGSILEETESV+T E G G G D SPESC V
Sbjct: 232 DGDLEGLVEGERKKKEGLDAVGVEDNGSILEETESVLTVGIEDGGAGAGDPDPSPESC-V 290
Query: 289 RVFDAEGGS--------------------------------------------RRDWWWK 304
R D E + RDWWW+
Sbjct: 291 RAQDVETATSPEIDMGLDKASTLESCFDKMSVDSGKEIIGCGKGKGGRKKGDSGRDWWWR 350
Query: 305 QDNGAGSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKK------- 357
QD+G GSESGRVKDYVMEWIGSEI+KERPKNEWV S E++G S+K E KK
Sbjct: 351 QDSGWGSESGRVKDYVMEWIGSEIRKERPKNEWVESSGPLEDHGLSTKNEPKKRKKRLEW 410
Query: 358 ------DRIRKKEKNRKPREWWKEEFCEELTKK-KKKRGLNSS--NVGEMWWQKDEEVVV 408
D+IRKKEKNRKPREWWKEEFCEEL++K KKKR L SS GE+WWQ+DEE V
Sbjct: 411 WASLDEDKIRKKEKNRKPREWWKEEFCEELSRKNKKKRTLKSSIGGDGELWWQRDEESV- 469
Query: 409 QERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYI 468
E +K++ S SIDWWLDG SGELR GRR+SQDW SG+IPKSGG+SSTPSMRGT+CYI
Sbjct: 470 -ETRKKRKSRSSRSIDWWLDGLSGELRNGRRNSQDWMSGEIPKSGGVSSTPSMRGTMCYI 528
Query: 469 APEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGK 528
APEYGGGG LSEKCDVYSFGVL+LVLISGRRPLQVTASPMSEFERANLISWARQLA NGK
Sbjct: 529 APEYGGGGQLSEKCDVYSFGVLLLVLISGRRPLQVTASPMSEFERANLISWARQLARNGK 588
Query: 529 LLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTGEAEPPHLPFEFSP 588
LLDLVD SI SLD++Q LLCITIALLCLQRSP+KR +M +IV ML+GE EPPHLPFEFSP
Sbjct: 589 LLDLVDTSIQSLDREQGLLCITIALLCLQRSPAKRPSMNEIVGMLSGETEPPHLPFEFSP 648
Query: 589 SPPSNFPFKSQKK 601
SPPSNFPFKS+KK
Sbjct: 649 SPPSNFPFKSRKK 661
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|317106640|dbj|BAJ53146.1| JHL05D22.17 [Jatropha curcas] | Back alignment and taxonomy information |
|---|
Score = 765 bits (1976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/556 (71%), Positives = 445/556 (80%), Gaps = 70/556 (12%)
Query: 110 KILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDA 169
K++D +GSLQGEREF NELSLASSL+ P+IV+LLGF+SDRR R+L+L+YELMENRSLQ+A
Sbjct: 1 KLMDPNGSLQGEREFQNELSLASSLNSPYIVTLLGFSSDRRRRKLILVYELMENRSLQEA 60
Query: 170 LLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229
LLDRKCEELM W KRF++ D+AKGLEYLH+ C PPVIHGDIKPSNILLD DF AKIGDF
Sbjct: 61 LLDRKCEELMNWGKRFDLVTDVAKGLEYLHYYCNPPVIHGDIKPSNILLDADFNAKIGDF 120
Query: 230 GLARLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVR 289
GLARLKTE+ ++E + + V EDNGSILEETESVVT YE+S G+DRSPES VR
Sbjct: 121 GLARLKTEENVVEKK--EAFVVGEDNGSILEETESVVTGYEDST-TAVGIDRSPESFAVR 177
Query: 290 VFDAE------------------------------------------GGSRRDWWWKQDN 307
V D++ GGSRRDWWWKQDN
Sbjct: 178 VVDSDASPEMAAAVSPEMGVDKGSVSETAFDKVSIDSGKDLVNGGKKGGSRRDWWWKQDN 237
Query: 308 GAGSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENN---GSSSKLEMKK------- 357
G GSESGRVKDYVMEWIGSEIKKERPK+EW+ASPSS +NN S +E KK
Sbjct: 238 GGGSESGRVKDYVMEWIGSEIKKERPKSEWIASPSSVDNNLLRPQSLTIEPKKKHKKRLE 297
Query: 358 -------DRIRKKEKNRKPREWWKEEFCEELT---KKKKKRGLNSSNVGEMWWQKDEEVV 407
+R++KKEKNRKP+EWWKEEFC+ELT KKKKKRGLNSSN G+ WWQKD++ V
Sbjct: 298 WWASLDEERMQKKEKNRKPKEWWKEEFCDELTKKKKKKKKRGLNSSNGGDSWWQKDDD-V 356
Query: 408 VQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCY 467
VQERKKR SRGSIDWWLDG+SGELR GRR+SQDWASG+IPKSGG+SSTPSMRGTVCY
Sbjct: 357 VQERKKR----SRGSIDWWLDGYSGELRNGRRNSQDWASGEIPKSGGVSSTPSMRGTVCY 412
Query: 468 IAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNG 527
IAPEYGGGG LSEKCDVYSFGVL+LV++SGRRPLQVTASPMSEFERANLISWARQLAYNG
Sbjct: 413 IAPEYGGGGQLSEKCDVYSFGVLLLVMVSGRRPLQVTASPMSEFERANLISWARQLAYNG 472
Query: 528 KLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTGEAEPPHLPFEFS 587
KLLDLVDP IHSLDKDQALLCITIALLCLQRSP+KR TM +IV ML+GEAEPPHLPFEFS
Sbjct: 473 KLLDLVDPLIHSLDKDQALLCITIALLCLQRSPTKRPTMNEIVGMLSGEAEPPHLPFEFS 532
Query: 588 PSPPSNFPFKSQKKAR 603
PSPPSNFPFKS+KKAR
Sbjct: 533 PSPPSNFPFKSRKKAR 548
|
Source: Jatropha curcas Species: Jatropha curcas Genus: Jatropha Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454626|ref|XP_004145055.1| PREDICTED: receptor-like serine/threonine-protein kinase At2g45590-like [Cucumis sativus] gi|449474838|ref|XP_004154299.1| PREDICTED: receptor-like serine/threonine-protein kinase At2g45590-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1959), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/633 (66%), Positives = 480/633 (75%), Gaps = 64/633 (10%)
Query: 25 ILAGTLVLTCFILIIITIFTYRKLYRNRTAPSDLKSPN-HNHCRRFSYNLIRRATASFSP 83
ILA +L + IL+ I YRKL RNRTAPS+ N H RRFSY+L+RRATASFSP
Sbjct: 29 ILATSLTASLLILLFIVFLLYRKLSRNRTAPSETHQENPHKLPRRFSYSLLRRATASFSP 88
Query: 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
SNRLGHGGFGSVYKAV+PS +AVKI+DS GSLQGEREFHNELS+AS LD P+IVSLL
Sbjct: 89 SNRLGHGGFGSVYKAVLPSGLS-VAVKIMDSPGSLQGEREFHNELSIASVLDNPNIVSLL 147
Query: 144 GFASDRRGRR--LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
G +SDRR R L+L+YELM NRSLQDAL DRKC ELM W KRFEI++ IA L+YLHH
Sbjct: 148 GHSSDRR--RRRLILVYELMPNRSLQDALFDRKCPELMPWRKRFEISLRIASALQYLHHF 205
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT---EDLMIEGECVKKRDVNEDNGSI 258
C PPVIHGDIKPSNILLD DF+AKIGDFGLARLK+ + + + R+V DNGSI
Sbjct: 206 CNPPVIHGDIKPSNILLDADFEAKIGDFGLARLKSEEEDCGGGGDDGGRVREVIGDNGSI 265
Query: 259 LEETESVVTA-YEESAGGGNGVDRSPESCVVRVFDA------------------------ 293
LEETESV+T+ +EE+ G+DR P+SCVV V D+
Sbjct: 266 LEETESVLTSGFEENI----GMDRLPDSCVVTVLDSPEMVATLGTDKVSLSEGNFDRISV 321
Query: 294 -------EGGSRRDWWWKQDNGA-GSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTE 345
+GGS RDWWWKQ+ GSESGRVKDYVMEWIG+EIKK+RPK+EWV S +
Sbjct: 322 ESGKERKKGGSGRDWWWKQETAVDGSESGRVKDYVMEWIGNEIKKDRPKSEWVE--SESS 379
Query: 346 NNGSSSKLEMKKD-------------RIRKKEKNR-KPREWWKEEFCEELTKKKKKRGLN 391
SS K+E KK R+RKKEK+R KPREWWKEEFCEEL +KKKK+ L
Sbjct: 380 VASSSGKMEQKKQKRRLEWWASLDEGRMRKKEKSRKKPREWWKEEFCEELARKKKKKELA 439
Query: 392 SSNVGEMWWQKDEEVVVQER--KKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDI 449
SS+ E+WWQ+DE+ + R K NK S+GSIDWWLDG SG+LR G+R+S D A+ DI
Sbjct: 440 SSSCRELWWQRDEDSTKERRKKKVNNNKNSKGSIDWWLDGLSGDLRNGKRNSIDGATNDI 499
Query: 450 PKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMS 509
PKSGGISSTPSMRGTVCYIAPEYGGGG +SEKCDVYSFGVL+LVL+SGRRPLQV ASP+S
Sbjct: 500 PKSGGISSTPSMRGTVCYIAPEYGGGGQISEKCDVYSFGVLLLVLVSGRRPLQVMASPIS 559
Query: 510 EFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
EFERANLISWARQLA NGKLLDLVDPSIHSLDK+QALLCITIALLCLQRSPSKR MK+I
Sbjct: 560 EFERANLISWARQLARNGKLLDLVDPSIHSLDKEQALLCITIALLCLQRSPSKRPNMKEI 619
Query: 570 VEMLTGEAEPPHLPFEFSPSPPSNFPFKSQKKA 602
V +L+GEAEPPHLPFEFSPSPPSNF FKSQ+KA
Sbjct: 620 VAVLSGEAEPPHLPFEFSPSPPSNFLFKSQRKA 652
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521812|ref|XP_004167923.1| PREDICTED: LOW QUALITY PROTEIN: receptor-like serine/threonine-protein kinase At2g45590-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1957), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/633 (66%), Positives = 479/633 (75%), Gaps = 64/633 (10%)
Query: 25 ILAGTLVLTCFILIIITIFTYRKLYRNRTAPSDLKSPN-HNHCRRFSYNLIRRATASFSP 83
ILA +L + IL+ I YRKL RNRTAPS+ N H RRFSY+L+RRATASFSP
Sbjct: 29 ILATSLTASLLILLFIVFLLYRKLSRNRTAPSETHQENPHKLPRRFSYSLLRRATASFSP 88
Query: 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
SNRLGHGGFGSVYKAV+PS +AVKI+DS GSLQGEREFHNELS+AS LD P+IVSLL
Sbjct: 89 SNRLGHGGFGSVYKAVLPSGLS-VAVKIMDSPGSLQGEREFHNELSIASVLDNPNIVSLL 147
Query: 144 GFASDRRGRR--LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
G +SDRR R L+L+YELM NRSLQDAL DRKC ELM W KRFEI++ IA L+YLHH
Sbjct: 148 GHSSDRR--RRRLILVYELMPNRSLQDALFDRKCPELMPWRKRFEISLRIASALQYLHHF 205
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT---EDLMIEGECVKKRDVNEDNGSI 258
C PPVIHGDIKPSNILLD DF+AKIGDFGLARLK+ + + + R+V DNGSI
Sbjct: 206 CNPPVIHGDIKPSNILLDADFEAKIGDFGLARLKSEEEDCGGGGDDGGRVREVIGDNGSI 265
Query: 259 LEETESVVTA-YEESAGGGNGVDRSPESCVVRVFDA------------------------ 293
LEETESV+T+ +EE+ G+DR P+SCVV V D+
Sbjct: 266 LEETESVLTSGFEENI----GMDRLPDSCVVTVLDSPEMVATLGTDKVSLSEGNFDRISV 321
Query: 294 -------EGGSRRDWWWKQDNGA-GSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTE 345
+GGS RDWWWKQ+ GSESGRVKDYVMEWIG+EIKK RPK+EWV S +
Sbjct: 322 ESGKERKKGGSGRDWWWKQETAVDGSESGRVKDYVMEWIGNEIKKXRPKSEWVE--SESS 379
Query: 346 NNGSSSKLEMKKD-------------RIRKKEKNR-KPREWWKEEFCEELTKKKKKRGLN 391
SS K+E KK R+RKKEK+R KPREWWKEEFCEEL +KKKK+ L
Sbjct: 380 VASSSGKMEQKKQKRRLEWWASLDEGRMRKKEKSRKKPREWWKEEFCEELARKKKKKELA 439
Query: 392 SSNVGEMWWQKDEEVVVQER--KKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDI 449
SS+ E+WWQ+DE+ + R K NK S+GSIDWWLDG SG+LR G+R+S D A+ DI
Sbjct: 440 SSSCRELWWQRDEDSTKERRKKKVNNNKNSKGSIDWWLDGLSGDLRNGKRNSIDGATNDI 499
Query: 450 PKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMS 509
PKSGGISSTPSMRGTVCYIAPEYGGGG +SEKCDVYSFGVL+LVL+SGRRPLQV ASP+S
Sbjct: 500 PKSGGISSTPSMRGTVCYIAPEYGGGGQISEKCDVYSFGVLLLVLVSGRRPLQVMASPIS 559
Query: 510 EFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
EFERANLISWARQLA NGKLLDLVDPSIHSLDK+QALLCITIALLCLQRSPSKR MK+I
Sbjct: 560 EFERANLISWARQLARNGKLLDLVDPSIHSLDKEQALLCITIALLCLQRSPSKRPNMKEI 619
Query: 570 VEMLTGEAEPPHLPFEFSPSPPSNFPFKSQKKA 602
V +L+GEAEPPHLPFEFSPSPPSNF FKSQ+KA
Sbjct: 620 VAVLSGEAEPPHLPFEFSPSPPSNFLFKSQRKA 652
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225518|ref|NP_182083.1| protein kinase-like protein [Arabidopsis thaliana] gi|75318484|sp|O64639.1|Y2559_ARATH RecName: Full=Receptor-like serine/threonine-protein kinase At2g45590 gi|2979551|gb|AAC06160.1| putative protein kinase [Arabidopsis thaliana] gi|27754326|gb|AAO22616.1| putative protein kinase [Arabidopsis thaliana] gi|28827626|gb|AAO50657.1| putative protein kinase [Arabidopsis thaliana] gi|330255480|gb|AEC10574.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/694 (60%), Positives = 495/694 (71%), Gaps = 102/694 (14%)
Query: 1 MPSMMAPPVIHHRR-------HNHQAHFLPAILAGTLVLTCFILIIITIFTYRKLYRNRT 53
MPS ++PP I + +H+ LP I+AG+L LT +LI++T+ YR+LYRNRT
Sbjct: 1 MPSRLSPPDIPPLQPTPTVSDGHHRFQTLPLIIAGSLTLTGVLLILVTLLIYRRLYRNRT 60
Query: 54 APSDL----KSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAV 109
APSDL KSP H CRRFSY+ +RRAT SFS S LGHGGFGSVYKA PS LAV
Sbjct: 61 APSDLISNSKSPQHYQCRRFSYSQLRRATNSFSESTHLGHGGFGSVYKADFPSGGDSLAV 120
Query: 110 KILDSS-GSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQ 167
K++D+S GSLQGEREFHNELSL+S L PH+VSLLGF+SDRRGR+L+L+YELM NRSLQ
Sbjct: 121 KVMDTSAGSLQGEREFHNELSLSSHLIGSPHVVSLLGFSSDRRGRKLILVYELMANRSLQ 180
Query: 168 DALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227
DALLDRKC ELM+WNKRFEIA DIAKG+E+LHH C+P +IHGDIKPSNILLD DFKAKIG
Sbjct: 181 DALLDRKCVELMDWNKRFEIATDIAKGIEFLHHCCDPIIIHGDIKPSNILLDSDFKAKIG 240
Query: 228 DFGLARLKTED----LMIEGECVKKRDVNEDNGSILEETESVVTAYEE------------ 271
DFGLAR+K+ED ++IE E K +DV EDNGSILEETESV+T +EE
Sbjct: 241 DFGLARVKSEDFDTRILIEEE-DKSKDVVEDNGSILEETESVITVFEEGNNVVNLSPETC 299
Query: 272 ----------SAGGGNGVDR-----------------------SPESCVVRVFDAEG--- 295
S G +G+ SPE+C + V G
Sbjct: 300 GISVLTETVASPGEKSGLSPENCAVSILTVEVGAASPAMASIPSPETCAISVLTDTGLSP 359
Query: 296 -------GSRRDWWWKQDNGAGS----ESGRVKDYVMEWIGSEIKKERPKN--EWVASPS 342
GS+RDWWWKQDN GS ESG VKDYVMEWIGSEIKKERP N EW+
Sbjct: 360 ESSKLKVGSKRDWWWKQDNNGGSRGGIESGSVKDYVMEWIGSEIKKERPSNNKEWI---- 415
Query: 343 STENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKR------GLNSSNVG 396
NNG S KK +KKEK RKPREWWKEEFCEELT+KK+K+ GL+S +
Sbjct: 416 ---NNGDGSSSVSKK---KKKEKKRKPREWWKEEFCEELTRKKRKKKKKKKRGLSSISSI 469
Query: 397 EMWWQKDEEV--VVQERKKRKNKTSRGSIDWWLDGFSGELRT--GRRSSQD---WASGDI 449
+ W+ +D+ V + R SIDWW+DG SGEL++ G+++SQD W ++
Sbjct: 470 DSWFHRDDGASSVHDHNLNPTKRKKRNSIDWWVDGLSGELKSVMGKKNSQDSGLWCDVNV 529
Query: 450 PKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMS 509
KSGG+SSTPSMRGTVCYIAPE GGGG+LSEKCDVYSFGVL+LVL+SGRRPLQVTASPMS
Sbjct: 530 QKSGGVSSTPSMRGTVCYIAPECGGGGVLSEKCDVYSFGVLLLVLVSGRRPLQVTASPMS 589
Query: 510 EFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
EFERANLISWA+QLA NGKLL+LVD SIHSL+K+QA+LCITIALLCLQRSP KR TMK+I
Sbjct: 590 EFERANLISWAKQLACNGKLLELVDKSIHSLEKEQAVLCITIALLCLQRSPVKRPTMKEI 649
Query: 570 VEMLTGEAEPPHLPFEFSPSPPSNFPFKSQKKAR 603
VEML+G +EPPHLPFEFSPSPP FPFKS+KKAR
Sbjct: 650 VEMLSGVSEPPHLPFEFSPSPPMGFPFKSRKKAR 683
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297824605|ref|XP_002880185.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297326024|gb|EFH56444.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/694 (58%), Positives = 484/694 (69%), Gaps = 104/694 (14%)
Query: 1 MPSMMA--PPVIHHRRHNHQAHFLPAILAGTLVLTCFILIIITIFTYRKLYRNRTAPSDL 58
MPS PP +H LP I+AG+L LT +LI+ T+ YR+LYRNRTAPSDL
Sbjct: 1 MPSRQPDFPPTPTVSDGHHHFQTLPLIIAGSLTLTGVLLILFTLLIYRRLYRNRTAPSDL 60
Query: 59 ----KSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDS 114
KSP CRRFS++ +RRAT SFS S +LGHGGFGSVYKA PS LAVK++D+
Sbjct: 61 ISNSKSPQQYQCRRFSFSQLRRATNSFSESTQLGHGGFGSVYKADFPSGGDSLAVKVMDT 120
Query: 115 S-GSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLD 172
S GSLQGEREFHNELSL+S L PH+VSLLGF+SDRRGR+L+L+YELM NRSLQDALLD
Sbjct: 121 SAGSLQGEREFHNELSLSSPLIGSPHVVSLLGFSSDRRGRKLILVYELMANRSLQDALLD 180
Query: 173 RKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
RKCEELM+WNKRFEIA DIAKG+E+LHH C+P +IHGDIKPSNILLD DFKAKIGDFGLA
Sbjct: 181 RKCEELMDWNKRFEIATDIAKGIEFLHHCCDPIIIHGDIKPSNILLDSDFKAKIGDFGLA 240
Query: 233 RLKTEDL----MIEGECVKKRDVNEDNGSILEETESVVTAYEE----------------- 271
R+K+EDL +IE E K++DV EDNGSILEETESV+T +EE
Sbjct: 241 RVKSEDLDTRILIE-EDEKRKDVVEDNGSILEETESVITVFEEGNNVANLSPENCGISVL 299
Query: 272 -----------------------------SAGGGNGVDRSPESCVVRVFDAEG------- 295
+A G SPE+C + V G
Sbjct: 300 TETAVASPDEKSGLSPENCAVSVLTVEVGAASPGLTSITSPETCAISVLTETGLSPGAAS 359
Query: 296 -----------GSRRDWWWKQDNGAGS----ESGRVKDYVMEWIGSEIKKERPKNEWVAS 340
GS+RDWWWKQDN GS ESG VKDYVMEWIGSEIKKE EW+
Sbjct: 360 GLSPESGKLKVGSKRDWWWKQDNNGGSRGGIESGSVKDYVMEWIGSEIKKENNNKEWI-- 417
Query: 341 PSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKR----GLNSSNVG 396
NNGSSS + KK ++K + EWWKEEFCEELT+KK+K+ GL+S +
Sbjct: 418 -----NNGSSSVFKKKKKEKKRKPR-----EWWKEEFCEELTRKKRKKKKKRGLSSISSI 467
Query: 397 EMWWQKDEEV--VVQERKKRKNKTSRGSIDWWLDGFSGELRT--GRRSSQD---WASGDI 449
+ W+ +D++ V + R SIDWW+DG SG+L++ G+++SQD W ++
Sbjct: 468 DSWFHRDDDASSVHDHNLNPTKRKKRNSIDWWVDGLSGDLKSVIGKKNSQDSGLWCDVNV 527
Query: 450 PKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMS 509
KSGG+SSTPSMRGTVCYIAPE GGGG+LSEKCDVYSFGVL+LVL+SGRRPLQVTASPMS
Sbjct: 528 QKSGGVSSTPSMRGTVCYIAPECGGGGVLSEKCDVYSFGVLLLVLVSGRRPLQVTASPMS 587
Query: 510 EFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
EFERANLISWA+QLA N KLL+LVD SIHSL+K+QA+LCITIALLCLQRSP KR TMK+I
Sbjct: 588 EFERANLISWAKQLACNDKLLELVDKSIHSLEKEQAVLCITIALLCLQRSPVKRPTMKEI 647
Query: 570 VEMLTGEAEPPHLPFEFSPSPPSNFPFKSQKKAR 603
V+ML+G +EPPHLPFEFSPSPP FPFKS+KKAR
Sbjct: 648 VQMLSGASEPPHLPFEFSPSPPMGFPFKSRKKAR 681
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357514725|ref|XP_003627651.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355521673|gb|AET02127.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/667 (61%), Positives = 489/667 (73%), Gaps = 92/667 (13%)
Query: 20 HFLPAILAGTLVLTCFILIIITIFTYRKLYRNRTAPSDLKSPNHNHCRRFSYNLIRRATA 79
FL L ++ +I +TIF YRKL NRT P D NH RRFSY+++RRA+
Sbjct: 28 EFLIGGLIAAVIFLTAAIISLTIFLYRKLSHNRTTPVD-----QNH-RRFSYSVLRRASN 81
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
SFS S RLGHGGFGSV+KA +PS + +A+K++DS GS+QGEREFHNELSL S+L P I
Sbjct: 82 SFSTSTRLGHGGFGSVHKATLPSG-ETVALKVMDSPGSIQGEREFHNELSLCSNLRSPFI 140
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
+SLLG++SDR GR+LVL+YELM NRSLQDALLDR+C+ELM W+ RF++ + +AKGLEYLH
Sbjct: 141 LSLLGYSSDRSGRKLVLVYELMSNRSLQDALLDRRCDELMVWSNRFDVVVSVAKGLEYLH 200
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT-ED----LMIE----------GE 244
H C PPVIHGDIKPSN+LLD +F+AKIGDFGLAR+K ED +M+E +
Sbjct: 201 HECNPPVIHGDIKPSNVLLDREFRAKIGDFGLARVKCLEDSGMEMMVEEINHHHHHHEKK 260
Query: 245 CVKKRDVNED--NGSILEETESVVTAYEESAGGGNGVDRSPESCVVRV------------ 290
K V ED + S++EE ES V+ +AG N +DRSPESC VRV
Sbjct: 261 KKKDDFVVEDCSSVSVVEEFESAVSVTNTTAG--NDIDRSPESCNVRVLVDSDASPEVAV 318
Query: 291 --------------FDAEGGSRR------------DWWWKQ-DNGAGSESGRVKDYVMEW 323
F + G++R DWWWKQ +NG GSESGRVKDYVMEW
Sbjct: 319 VSQSSVVSDGCFDKFSIDSGNQRKRGGGGGGGSGRDWWWKQENNGGGSESGRVKDYVMEW 378
Query: 324 IGSEIKKERPKN-EWVASPSSTENN------GSSSKLEMKKDRIRKKE------------ 364
IGSEIKKERPK+ EWV S SS + + SK+E KK + +K E
Sbjct: 379 IGSEIKKERPKSSEWVGSGSSICSGGGGDVVAAQSKVEGKKKQRKKLEWWASLDEEKVKG 438
Query: 365 -KNRKPREWWKEEFCEELTKKKKKRGLN---SSNVGEMWWQKDEEV---VVQERKKRKNK 417
KNRKPREWWKEEFCEEL+KK +K+ + N GE WWQ+D++V ++++KKRK+K
Sbjct: 439 KKNRKPREWWKEEFCEELSKKSRKKKRSLDCRGNGGESWWQRDKDVGGPPLEKKKKRKSK 498
Query: 418 TSRGSIDWWLDGFSGELRT-GRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGG 476
+SRGSIDWWLDG SGELRT GRR+SQDW +GDIPKSGGISSTPSMRGTVCYIAPEYGGGG
Sbjct: 499 SSRGSIDWWLDGLSGELRTNGRRNSQDWGNGDIPKSGGISSTPSMRGTVCYIAPEYGGGG 558
Query: 477 LLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPS 536
LSEKCDVYSFGVL+LVL++GRRPLQVTASP+SEFERANLISWARQLA+NGKLLDLVD S
Sbjct: 559 QLSEKCDVYSFGVLLLVLVAGRRPLQVTASPISEFERANLISWARQLAHNGKLLDLVDSS 618
Query: 537 IHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTGEAEPPHLPFEFSPSPPSNFPF 596
IHSLDK+QALLCITIALLCLQRSP KR +MK+IV ML+GEA+PPHLPFEFSPSPPSNFPF
Sbjct: 619 IHSLDKEQALLCITIALLCLQRSPGKRPSMKEIVGMLSGEADPPHLPFEFSPSPPSNFPF 678
Query: 597 KSQKKAR 603
KS+KKAR
Sbjct: 679 KSRKKAR 685
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 603 | ||||||
| TAIR|locus:2165301 | 654 | AT5G51770 [Arabidopsis thalian | 0.381 | 0.351 | 0.560 | 3e-110 | |
| TAIR|locus:2043629 | 683 | AT2G45590 [Arabidopsis thalian | 0.729 | 0.644 | 0.476 | 2.6e-95 | |
| TAIR|locus:2025742 | 692 | AT1G80870 [Arabidopsis thalian | 0.308 | 0.268 | 0.442 | 2.2e-74 | |
| TAIR|locus:2138014 | 651 | AT4G25390 [Arabidopsis thalian | 0.674 | 0.625 | 0.399 | 5.8e-66 | |
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.276 | 0.424 | 0.476 | 8.7e-51 | |
| TAIR|locus:2099009 | 400 | AT3G58690 [Arabidopsis thalian | 0.281 | 0.425 | 0.432 | 5.9e-48 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.301 | 0.439 | 0.419 | 6.9e-47 | |
| TAIR|locus:2091980 | 432 | CDG1 "CONSTITUTIVE DIFFERENTIA | 0.283 | 0.395 | 0.431 | 9.7e-47 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.270 | 0.422 | 0.446 | 5e-46 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.275 | 0.237 | 0.464 | 5.7e-46 |
| TAIR|locus:2165301 AT5G51770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 606 (218.4 bits), Expect = 3.0e-110, Sum P(2) = 3.0e-110
Identities = 138/246 (56%), Positives = 172/246 (69%)
Query: 47 KLYRNRTAPSDLKS----PNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVV-P 101
K R R +P+ + S P FSY+ +R+ATASFSP NRLG GGFGSV++ + P
Sbjct: 52 KFNRKRRSPAAVASSSTPPQKQPLHEFSYSSLRKATASFSPENRLGQGGFGSVFRGTLSP 111
Query: 102 SSSQP-LAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYEL 160
SS +AVK++DS GSLQGEREF NEL A LD PH+VS++GF S RR RL+L+YEL
Sbjct: 112 SSGGGNVAVKVMDS-GSLQGEREFQNELFFAGKLDSPHVVSVIGF-SRRRRSRLILVYEL 169
Query: 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG 220
M+ +LQDALL R+ ELM WN+RF +AIDIAKG+E+LH S P VIHGD+KPSN+LLD
Sbjct: 170 MDIGNLQDALLHRRSPELMIWNRRFLVAIDIAKGIEHLH-SLNPCVIHGDLKPSNVLLDR 228
Query: 221 DFKAKIGDFGLARLKTEDLMIEGECVKKRDVNEDNGSILEETESVVT---AYEESAGGGN 277
F AKI DFGLARLK+E +E + V + DV ED GS++EE ESVVT +ES G
Sbjct: 229 FFSAKISDFGLARLKSEH--VEVKVVSESDVVEDYGSVVEEVESVVTNTTGCDESNFGFT 286
Query: 278 GVDRSP 283
D+SP
Sbjct: 287 --DQSP 290
|
|
| TAIR|locus:2043629 AT2G45590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 948 (338.8 bits), Expect = 2.6e-95, P = 2.6e-95
Identities = 229/481 (47%), Positives = 287/481 (59%)
Query: 1 MPSMMAPPVIHHRRHNHQAHFLPAILAGXXXXXXXXXXXXXXXXYRKLYRNRTAPSDL-- 58
+P + P + H Q LP I+AG YR+LYRNRTAPSDL
Sbjct: 10 IPPLQPTPTVSDGHHRFQT--LPLIIAGSLTLTGVLLILVTLLIYRRLYRNRTAPSDLIS 67
Query: 59 --KSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS- 115
KSP H CRRFSY+ +RRAT SFS S LGHGGFGSVYKA PS LAVK++D+S
Sbjct: 68 NSKSPQHYQCRRFSYSQLRRATNSFSESTHLGHGGFGSVYKADFPSGGDSLAVKVMDTSA 127
Query: 116 GSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRK 174
GSLQGEREFHNELSL+S L PH+VSLLGF+SDRRGR+L+L+YELM NRSLQDALLDRK
Sbjct: 128 GSLQGEREFHNELSLSSHLIGSPHVVSLLGFSSDRRGRKLILVYELMANRSLQDALLDRK 187
Query: 175 CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
C ELM+WNKRFEIA DIAKG+E+LHH C+P +IHGDIKPSNILLD DFKAKIGDFGLAR+
Sbjct: 188 CVELMDWNKRFEIATDIAKGIEFLHHCCDPIIIHGDIKPSNILLDSDFKAKIGDFGLARV 247
Query: 235 KTED----LMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRV 290
K+ED ++IE E K +DV EDNGSILEETESV+T +EE G N V+ SPE+C + V
Sbjct: 248 KSEDFDTRILIEEED-KSKDVVEDNGSILEETESVITVFEE---GNNVVNLSPETCGISV 303
Query: 291 FDAEGGSRRDWWWKQDNGAGSESGRVKDYVMEWIG--SEIKKERPKNEWVAXXXXXXXXX 348
S + +G E+ V +E +G S P E A
Sbjct: 304 LTETVASPGE-----KSGLSPENCAVSILTVE-VGAASPAMASIPSPETCAISVLTDTGL 357
Query: 349 X--XXKLEM--KKDRIRKKEKNRKPREWWK----EEFCEELTKKKKKRGLNSSNVGEMWW 400
KL++ K+D K++ N R + +++ E + K+ S+N + W
Sbjct: 358 SPESSKLKVGSKRDWWWKQDNNGGSRGGIESGSVKDYVMEWIGSEIKKERPSNN--KEWI 415
Query: 401 QKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPS 460
+ +KK+K K R +WW + F EL +R + K G+SS S
Sbjct: 416 NNGDGSSSVSKKKKKEK-KRKPREWWKEEFCEELTRKKRKKKK------KKKRGLSSISS 468
Query: 461 M 461
+
Sbjct: 469 I 469
|
|
| TAIR|locus:2025742 AT1G80870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 417 (151.9 bits), Expect = 2.2e-74, Sum P(2) = 2.2e-74
Identities = 84/190 (44%), Positives = 122/190 (64%)
Query: 48 LYRNRTAPSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPL 107
L R+RT P D+ + + + F+Y ++ AT F SN +G GG G+V++ + +
Sbjct: 48 LNRSRTIPFDVAAASPLKLQLFTYKELKLATNDFDESNVIGKGGSGTVFRGIT-RDGKLF 106
Query: 108 AVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQ 167
AVK LD+ S+Q E EF NEL + L +V+LLG+ ++ R LIYE M N+SLQ
Sbjct: 107 AVKRLDNL-SIQTETEFQNELQILGGLKSSFLVTLLGYCVEKNHR--FLIYEYMPNKSLQ 163
Query: 168 DALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227
+ L + + + W +RF I +D+AK LE++H C+PPVIHGDIKPSN+LLD +F+AKI
Sbjct: 164 ELLFNEDGDSCLNWERRFGIILDVAKALEFMHFGCDPPVIHGDIKPSNVLLDSEFRAKIS 223
Query: 228 DFGLARLKTE 237
DFGL+R+K E
Sbjct: 224 DFGLSRVKVE 233
|
|
| TAIR|locus:2138014 AT4G25390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 671 (241.3 bits), Expect = 5.8e-66, P = 5.8e-66
Identities = 183/458 (39%), Positives = 252/458 (55%)
Query: 21 FLPAILAGXXXXXXXXXXXXXXXXYRKLYRNRTAP---SDLKSPNHNHCRRFSYNLIRRA 77
F P ++AG + K R R++P + SP R FSY+ +RRA
Sbjct: 38 FPPFVVAGAGAGFSLFITLSVC--FCKFSRKRSSPPAENASSSPRRPSPREFSYSSLRRA 95
Query: 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCP 137
T SFS +NRLG GGFG V++ + S + +AVK++DS GSLQGE EF NEL A+ LD P
Sbjct: 96 TGSFSQANRLGQGGFGVVFRGTI-SGGENVAVKVMDS-GSLQGEGEFQNELFFAAKLDSP 153
Query: 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
H+V ++GF+ DR+ RRL+L+Y+LM+N +LQDALL R+C ELM+WN+RF +A++IA G+++
Sbjct: 154 HVVPVIGFSHDRKRRRLLLVYKLMDNGNLQDALLHRRCPELMDWNRRFLVAVNIADGIKH 213
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDVNEDNGS 257
LH S EPPVIHGDIKPSN+LLD F AKI DFGLARLK E +E +RD +GS
Sbjct: 214 LH-SLEPPVIHGDIKPSNVLLDSLFSAKIADFGLARLKAEQ--VEISVAPERD---GDGS 267
Query: 258 ILEETESVVTA---YEESAGGGNGVDRSPESCVVRVFDAEGGSRR---------DWWWKQ 305
++EE ESVVT YE+ G VD+SPES V +V + S + K
Sbjct: 268 MVEEVESVVTTVTGYEDFNFGL--VDQSPES-VAKVPGSVSASPEATTVVSVSPEMGEKT 324
Query: 306 DNGAGS----ESGRVKDYVMEWIGSE--IKKERPKN---EWVAXXXXXXXXXXXXKLE-- 354
D GS + G+ + W E +++ R K +W+ +E
Sbjct: 325 DEDGGSVVVMKKGKESESKDWWWKQESNVERGRVKEYVMQWIGSEVKKERPSRSDWIEAA 384
Query: 355 -MKKDRIRKKEKNRKPR-EWWKEEFCEELTKKKKKRGLNSSNVGEMWWQKDE--EVVVQE 410
+ +K EK R +WW E+ KKKKKR + V E WW KDE + ++
Sbjct: 385 ALSSSSSKKLEKKTSKRLDWWLSLEEEDENKKKKKRRM----VRE-WW-KDEYRRELAKK 438
Query: 411 RKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGD 448
RKK+K T ++ D S + RR S +S D
Sbjct: 439 RKKKKKMTLEA--EFCSDDGSSSVSQWRRGSGSGSSID 474
|
|
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 384 (140.2 bits), Expect = 8.7e-51, Sum P(2) = 8.7e-51
Identities = 82/172 (47%), Positives = 113/172 (65%)
Query: 64 NHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE 123
N+ R FSYN +R AT SF P+NR+G GG+G V+K V+ +Q +AVK L S+ S QG RE
Sbjct: 29 NNVRVFSYNSLRSATDSFHPTNRIGGGGYGVVFKGVLRDGTQ-VAVKSL-SAESKQGTRE 86
Query: 124 FHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL-MEWN 182
F E++L S++ P++V L+G + G +L+YE +EN SL LL + + ++W+
Sbjct: 87 FLTEINLISNIHHPNLVKLIGCCIE--GNNRILVYEYLENNSLASVLLGSRSRYVPLDWS 144
Query: 183 KRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
KR I + A GL +LH EP V+H DIK SNILLD +F KIGDFGLA+L
Sbjct: 145 KRAAICVGTASGLAFLHEEVEPHVVHRDIKASNILLDSNFSPKIGDFGLAKL 196
|
|
| TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 368 (134.6 bits), Expect = 5.9e-48, Sum P(2) = 5.9e-48
Identities = 77/178 (43%), Positives = 114/178 (64%)
Query: 64 NHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE 123
N + F++ + AT FS SN +G+GGFG VY+ V+ + + +A+K++D +G QGE E
Sbjct: 70 NGLQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVL-NDGRKVAIKLMDHAGK-QGEEE 127
Query: 124 FHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDAL-LDRKCEEL---M 179
F E+ L S L P++++LLG+ SD + +L+YE M N LQ+ L L + + +
Sbjct: 128 FKMEVELLSRLRSPYLLALLGYCSDNSHK--LLVYEFMANGGLQEHLYLPNRSGSVPPRL 185
Query: 180 EWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
+W R IA++ AKGLEYLH PPVIH D K SNILLD +F AK+ DFGLA++ ++
Sbjct: 186 DWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKVGSD 243
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 367 (134.2 bits), Expect = 6.9e-47, Sum P(2) = 6.9e-47
Identities = 78/186 (41%), Positives = 116/186 (62%)
Query: 50 RNRTAPSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAV 109
+N+ D + N+ + FS+ + AT +F +G GGFG VYK + + +AV
Sbjct: 48 QNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAV 107
Query: 110 KILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDA 169
K LD +G LQG +EF E+ + S L H+V+L+G+ +D G + +L+YE M SL+D
Sbjct: 108 KQLDRNG-LQGNKEFIVEVLMLSLLHHKHLVNLIGYCAD--GDQRLLVYEYMSRGSLEDH 164
Query: 170 LLDRKCEEL-MEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228
LLD +++ ++W+ R IA+ A GLEYLH PPVI+ D+K +NILLDG+F AK+ D
Sbjct: 165 LLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSD 224
Query: 229 FGLARL 234
FGLA+L
Sbjct: 225 FGLAKL 230
|
|
| TAIR|locus:2091980 CDG1 "CONSTITUTIVE DIFFERENTIAL GROWTH 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 351 (128.6 bits), Expect = 9.7e-47, Sum P(2) = 9.7e-47
Identities = 76/176 (43%), Positives = 115/176 (65%)
Query: 66 CRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH 125
C+ FSY + AT SF + +G GGFG+VYK + S+ Q +AVK+LD SG +QG++EF
Sbjct: 59 CQIFSYRELAIATNSFRNESLIGRGGFGTVYKGRL-STGQNIAVKMLDQSG-IQGDKEFL 116
Query: 126 NELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLD-RKCEELMEWNKR 184
E+ + S L ++V L G+ ++ G + +++YE M S++D L D + +E ++W R
Sbjct: 117 VEVLMLSLLHHRNLVHLFGYCAE--GDQRLVVYEYMPLGSVEDHLYDLSEGQEALDWKTR 174
Query: 185 FEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLM 240
+IA+ AKGL +LH+ +PPVI+ D+K SNILLD D+K K+ DFGLA+ D M
Sbjct: 175 MKIALGAAKGLAFLHNEAQPPVIYRDLKTSNILLDHDYKPKLSDFGLAKFGPSDDM 230
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 366 (133.9 bits), Expect = 5.0e-46, Sum P(2) = 5.0e-46
Identities = 75/168 (44%), Positives = 114/168 (67%)
Query: 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNEL 128
F++ + AT +F+P N+LG GGFG VYK + + Q +AVK LD +G QG REF E+
Sbjct: 70 FTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNG-YQGNREFLVEV 128
Query: 129 SLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLD--RKCEELMEWNKRFE 186
+ S L ++V+L+G+ +D G + +L+YE M+N SL+D LL+ R ++ ++W+ R +
Sbjct: 129 MMLSLLHHQNLVNLVGYCAD--GDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMK 186
Query: 187 IAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+A A+GLEYLH + +PPVI+ D K SNILLD +F K+ DFGLA++
Sbjct: 187 VAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKV 234
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 372 (136.0 bits), Expect = 5.7e-46, Sum P(2) = 5.7e-46
Identities = 79/170 (46%), Positives = 111/170 (65%)
Query: 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNEL 128
F+Y + AT FS LG GGFG V+K ++P+ + +AVK L +GS QGEREF E+
Sbjct: 324 FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKE-IAVKSL-KAGSGQGEREFQAEV 381
Query: 129 SLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIA 188
+ S + H+VSL+G+ S+ G+RL L+YE + N +L+ L K +M+W R +IA
Sbjct: 382 EIISRVHHRHLVSLVGYCSNAGGQRL-LVYEFLPNDTLEFHL-HGKSGTVMDWPTRLKIA 439
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ AKGL YLH C P +IH DIK SNILLD +F+AK+ DFGLA+L ++
Sbjct: 440 LGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDN 489
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O64639 | Y2559_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6080 | 0.9817 | 0.8667 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_II000698 | hypothetical protein (636 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 603 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-36 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-32 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-07 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-06 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-06 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-05 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-05 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-04 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-04 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.002 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.002 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 0.003 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.003 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 59/161 (36%), Positives = 86/161 (53%), Gaps = 8/161 (4%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG GGFG+VY A + + +A+KI+ S E E+ + L+ P+IV L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206
D L L+ E E SL+D L ++ E + ++ I + I +GLEYLH + +
Sbjct: 61 ED--ENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 207 IHGDIKPSNILLD-GDFKAKIGDFGLARLKTEDLMIEGECV 246
IH D+KP NILLD + K K+ DFGL++L T D + V
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 53/156 (33%), Positives = 72/156 (46%), Gaps = 10/156 (6%)
Query: 87 LGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG VYK +AVK L S Q EF E + LD P+IV L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
LG ++ L+++ E M L D L + +EL + A+ IA+G+EYL
Sbjct: 67 LGVCTE--EEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLLSFALQIARGMEYLESK- 122
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ N L+ + KI DFGL+R +D
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 52/156 (33%), Positives = 70/156 (44%), Gaps = 11/156 (7%)
Query: 87 LGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG VYK +AVK L S Q EF E + LD P++V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
LG ++ L ++ E ME L L RK + + A+ IA+G+EYL
Sbjct: 67 LGVCTE--EEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ N L+ + KI DFGL+R +D
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 155
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 52/160 (32%), Positives = 69/160 (43%), Gaps = 8/160 (5%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G FG VY A + + +A+K++ + E+ + L P+IV L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206
D +L L+ E E L D L R L E RF I LEYLH +
Sbjct: 67 EDE--DKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARF-YLRQILSALEYLHSKG---I 118
Query: 207 IHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECV 246
+H D+KP NILLD D K+ DFGLAR +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVG 158
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 50/158 (31%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 85 NRLGHGGFGSVYKAVV---PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
+LG G FG VYK + + +AVK L S + ++F E + L P++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAKGL 195
LLG ++ L L+ E ME L D L + AI IAKG+
Sbjct: 61 LLGVCTEEE--PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
EYL +H D+ N L+ D KI DFGL+R
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 55/156 (35%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 87 LGHGGFGSVYKAVV----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG VYK + + +AVK L S + EF E S+ L P+IV L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
LG + G L ++ E M L D L RK E + ++A+ IAKG+EYL
Sbjct: 67 LGVCTQ--GEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE--- 119
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ N L+ + KI DFGL+R ED
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 53/153 (34%), Positives = 77/153 (50%), Gaps = 9/153 (5%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLG 144
+LG G FG+VYKA + + +AVKIL + ++ E+ + L P+IV L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
L L+ E E L D L + ++ +IA+ I +GLEYLH
Sbjct: 66 A--FEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLH---SN 117
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
+IH D+KP NILLD + KI DFGLA+ +
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLK 150
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 19/171 (11%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE-REFHNELSLASSLDCPH 138
++ LG G FGSVY A+ + + +AVK ++ SG + E E+ + SSL P+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEI------AIDIA 192
IV G D L + E + SL L++ + I
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSS---------LLKKFGKLPEPVIRKYTRQIL 111
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEG 243
+GL YLH + ++H DIK +NIL+D D K+ DFG A+ + EG
Sbjct: 112 EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 4e-23
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREF-HNELSLASSLDCPHIVSLLGF 145
+G G FG VY S + +K +D S + ERE NE+ + L+ P+I+ +
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY--Y 65
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKC-------EELMEWNKRFEIAIDIAKGLEYL 198
S +L ++ E + L + +K E++++W F + + L+YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---F---VQLCLALKYL 119
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
H ++H DIKP NI L + K+GDFG++++ + +
Sbjct: 120 H---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 8/152 (5%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
F ++G GGFG VYKA + + +A+K++ S + + + NE+ + P+IV
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE-SKEKKEKIINEIQILKKCKHPNIV 60
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
G S + L ++ E SL+D LL + L E + + ++ KGLEYLH
Sbjct: 61 KYYG--SYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCKELLKGLEYLH- 115
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+IH DIK +NILL D + K+ DFGL+
Sbjct: 116 --SNGIIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 8e-23
Identities = 49/150 (32%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G G VYK + + A+K + G + ++ EL S + P++V G A
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG-A 67
Query: 147 SDRRGR-RLVLIYELMENRSLQDALLDRKCEELMEWNKRF--EIAIDIAKGLEYLHHSCE 203
+ G +VL E M+ SL D L + IA I KGL+YLH
Sbjct: 68 FYKEGEISIVL--EYMDGGSLADLLKKVGK-----IPEPVLAYIARQILKGLDYLHTKRH 120
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+IH DIKPSN+L++ + KI DFG+++
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISK 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 87 LGHGGFGSVYKAVV-----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LG G FG VY+ + +A+K ++ + S++ EF NE S+ +C H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWN---------KRFEIAIDIA 192
LLG S G+ +++ ELM L+ L R E N K ++A +IA
Sbjct: 74 LLGVVS--TGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
G+ YL +H D+ N ++ D KIGDFG+ R
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 51/159 (32%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 84 SNRLGHGGFGSVYKAVV-PSSSQP---LAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
+LG G FG V P +AVK L+ SG Q +F E+ + +LD +I
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
V G GR L LI E + + SL+D L ++ + + + + I KG++YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ NIL++ + KI DFGLA++ ED
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE-REFHNELSLASSLDCPHI 139
+ + +G G FG VYK + + +A+K + + + E+ L +L P+I
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIA- 192
V +G L +I E EN SL+ + K+F +A+ +
Sbjct: 62 VKYIGSIET--SDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQ 107
Query: 193 --KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+GL YLH E VIH DIK +NIL D K+ DFG+A
Sbjct: 108 VLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA 146
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 92.1 bits (227), Expect = 5e-20
Identities = 55/163 (33%), Positives = 80/163 (49%), Gaps = 12/163 (7%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--REFHNELSLASSLD-C 136
S+ +LG G FG VY A + +A+K+L + + F E+ + +SL+
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 137 PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLE 196
P+IV L F D L L+ E ++ SL+D L + + ++ I I LE
Sbjct: 58 PNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGLARLKTED 238
YLH +IH DIKP NILLD D K+ DFGLA+L +
Sbjct: 116 YLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 52/149 (34%), Positives = 77/149 (51%), Gaps = 16/149 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G +GSVYKA+ + Q +A+K++ LQ E E+S+ D P+IV +
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKY--YG 65
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGLEYLHHSCE 203
S + L ++ E S+ D ++ + L E EIA KGLEYLH +
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEE----EIAAILYQTLKGLEYLHSN-- 118
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
IH DIK NILL+ + +AK+ DFG++
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 15/155 (9%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
F+ +G G FG VYKA+ ++Q +A+K++D + + E+ S P+I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGLEY 197
G S +G +L +I E S D L K +E IA ++ GLEY
Sbjct: 63 KYYG--SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE-------TYIAFILREVLLGLEY 113
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
LH E IH DIK +NILL + K+ DFG++
Sbjct: 114 LH---EEGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 54/155 (34%), Positives = 74/155 (47%), Gaps = 18/155 (11%)
Query: 85 NRLGHGGFGSVYKAV--VPSSSQ-PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LGHG FGSV K V + S + +AVK L G++EF E S+ + LD P IV
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDR---KCEELMEWNKRFEIAIDIAKGLEYL 198
L+G +G L+L+ EL L L R +L E A +A G+ YL
Sbjct: 61 LIGVC---KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYL 111
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+H D+ N+LL +AKI DFG++R
Sbjct: 112 E---SKHFVHRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 56/197 (28%), Positives = 77/197 (39%), Gaps = 22/197 (11%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS--------GSLQGEREFHNELSLAS 132
F +G G F +V A +++ A+KILD ++ E+E L
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE-----VLTR 57
Query: 133 SLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIA 192
P I+ L D L + E N L + L E RF A +I
Sbjct: 58 LNGHPGIIKLYYTFQDEE--NLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAA-EIL 112
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDVN 252
LEYLH S +IH D+KP NILLD D KI DFG A++ + E +++
Sbjct: 113 LALEYLH-SKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 253 EDNGSILEETESVV-TA 268
S V TA
Sbjct: 170 SQIEKNRRRFASFVGTA 186
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (205), Expect = 2e-17
Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 29/164 (17%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVK--ILD------SSGSLQGEREFHNELSLAS 132
+ +LG G +G VYKA + + +A+K LD S +L+ E+SL
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLK 53
Query: 133 SLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQD--ALLDRKCEEL-MEWNKRFEIAI 189
L P+IV LL R +L L++E + D LD++ L K I
Sbjct: 54 ELKHPNIVKLLDVIHTER--KLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKS--IMY 105
Query: 190 DIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ +GL Y H ++H D+KP NIL++ D K+ DFGLAR
Sbjct: 106 QLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 46/154 (29%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-----FHNELSLASSLDCPHI 139
++G G +G VYKA + + +A+K + ++ E+E E+ L L P+I
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR----MENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
V L + + + +++E M++ L LLD + E + + +GL+YLH
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLT-GLLDSPEVKFTESQIKC-YMKQLLEGLQYLH 117
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ ++H DIK SNIL++ D K+ DFGLAR
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 53/161 (32%), Positives = 82/161 (50%), Gaps = 8/161 (4%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
F+ +LG G FG V++ + + +A+KIL S L +++F E+ L H++
Sbjct: 8 FTLERKLGSGYFGEVWEGLW-KNRVRVAIKIL-KSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
SL S G + +I ELME SL A L +++ ++A +A+G+ YL
Sbjct: 66 SLFAVCS--VGEPVYIITELMEKGSLL-AFLRSPEGQVLPVASLIDMACQVAEGMAYLE- 121
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMI 241
E IH D+ NIL+ D K+ DFGLARL ED+ +
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 53/156 (33%), Positives = 80/156 (51%), Gaps = 20/156 (12%)
Query: 87 LGHGGFGSVYKAV-VPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG+VYK V +P + P+A+K+L S + +E +E + +S+D PH+V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCE----ELMEWNKRFEIAIDIAKGLEYL 198
LG ++ LI +LM L D + + K L+ W + IAKG+ YL
Sbjct: 75 LGICL---SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
E ++H D+ N+L+ KI DFGLA+L
Sbjct: 126 E---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 7/155 (4%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER-EFHNELSLASSLDCPHI 139
F N++G G FG V+K V + + A+K +D S + ER E +E + + LD +I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
+ + S +L ++ E EN L L ++ L E ++ + I I GL +LH
Sbjct: 62 IRY--YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPE-DQVWRFFIQILLGLAHLH 118
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
++H DIK N+ LD KIGD G+A+L
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLL 143
+G G FG+V K S + L K +D + E++ +E+++ L P+IV
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------IAIDIAKGLEY 197
DR + L ++ E E L L +KC++ K E I + L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQ--LIQKCKKE---RKYIEEEFIWRILTQLLLALYE 120
Query: 198 LHHSCEPP--VIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECV 246
H+ +P V+H D+KP+NI LD + K+GDFGLA++ D V
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 52/159 (32%), Positives = 82/159 (51%), Gaps = 15/159 (9%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH-NELSLASSLDCPHIVSLLGF 145
LG G +GSVYK S +Q A+K +D Q ERE NE+ + +S++ P+I+S
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKC-----EELMEWNKRFEIAIDIAKGLEYLHH 200
D G +L ++ E L A+ RK E W I I + +GL+ LH
Sbjct: 68 FLD--GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGLQALH- 120
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
E ++H D+K +NILL + KIGD G++++ +++
Sbjct: 121 --EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 50/151 (33%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
+LG G FG V + +S P+AVK L S +F E ++ SLD +++ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
G L+++ EL SL D L + + + A+ IA G+ YL
Sbjct: 62 YGVVLTHP---LMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLESK- 116
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IH D+ NILL D K KIGDFGL R
Sbjct: 117 --RFIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 54/152 (35%), Positives = 83/152 (54%), Gaps = 12/152 (7%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQ-GEREFHNELSLASSL-DCPHIVS 141
+LG G +G V+KA+ + + +A+K I D+ + +R F E+ L D P+IV
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
LL + + L++E ME L + + L + +KR+ I + K L+Y+H S
Sbjct: 72 LLNVIKAENDKDIYLVFEYMET-DLHAVI---RANILEDVHKRY-IMYQLLKALKYIH-S 125
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
VIH D+KPSNILL+ D + K+ DFGLAR
Sbjct: 126 GN--VIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 55/161 (34%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 87 LGHGGFGSVYKAVV-----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LGHG FG VY+ + + +AVK L S S Q E +F E + S + +IV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCE------ELMEWNKRFEIAIDIAKGL 195
L+G + +R R ++L ELM L+ L R+ + A D+AKG
Sbjct: 74 LIGVSFERLPRFILL--ELMAGGDLKSFL--RENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDG---DFKAKIGDFGLAR 233
+YL E IH DI N LL AKI DFG+AR
Sbjct: 130 KYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 53/162 (32%), Positives = 83/162 (51%), Gaps = 17/162 (10%)
Query: 84 SNRLGHGGFGSVY----KAVVPSSSQP-LAVKILDSSGSLQGEREFHNELSLASSLDCPH 138
S LG G FG VY K VV + +A+K ++ + S++ EF NE S+ +C H
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 139 IVSLLGFASDRRGRRLVLIYELMEN-------RSLQDALLDRKCEELMEWNKRFEIAIDI 191
+V LLG S +G+ ++I ELM RSL+ + + + K ++A +I
Sbjct: 71 VVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
A G+ YL+ + +H D+ N ++ DF KIGDFG+ R
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 27/168 (16%)
Query: 87 LGHGGFGSVYKA--VVPS---SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LG G FG VYK P+ S+ +A+K L + + ++EF E L S L P+IV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALL-------------DRKCEELMEWNKRFEIA 188
LLG + + + +++E + + L + L+ D + ++ + IA
Sbjct: 73 LLGVCT--KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 189 IDIAKGLEYL--HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
I IA G+EYL HH +H D+ N L+ KI DFGL+R
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRD 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 6/149 (4%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG G G V K + + + +AVK + + +++ EL + + P+IV G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
A G + + E M+ SL D +L + + +IA+ + KGL YLH +
Sbjct: 67 -AFYNNGD-ISICMEYMDGGSL-DKILKE-VQGRIPERILGKIAVAVLKGLTYLHEKHK- 121
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+IH D+KPSNIL++ + K+ DFG++
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 48/167 (28%), Positives = 72/167 (43%), Gaps = 35/167 (20%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVK-----ILDSSGSLQGEREFHNELSLASSLDCPHIV 140
R+G G G V+KA + + +A+K L+ Q RE + + P++V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVV 62
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDR---------KCEELMEWNKRFEIAIDI 191
LL G VL+ E M L + L D K M +
Sbjct: 63 KLL--DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM-----------L 108
Query: 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
KG+ Y+H ++H D+KP+N+L+ D KI DFGLARL +E+
Sbjct: 109 LKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 48/171 (28%), Positives = 73/171 (42%), Gaps = 29/171 (16%)
Query: 87 LGHGGFGSVYKA----VVPSSSQPL-AVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
+G G FG V++A ++P + AVK+L S + +F E +L + D P+IV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRK---CEELMEWNKR-------------- 184
LLG + G+ + L++E M L + L R L
Sbjct: 73 LLGVCAV--GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 185 --FEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IA +A G+ YL E +H D+ N L+ + KI DFGL+R
Sbjct: 131 EQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 32/161 (19%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN-----ELSLASSLDCPHIVS 141
LG G + VYKA + + +A+K + G + ++ N E+ L L P+I+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKI-KLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 142 LLG-FASDRRGRRLVLIYELME--------NRSLQDALLDRKCEELMEWNKRFEIAIDIA 192
LL F + L++E ME ++S+ D K LM
Sbjct: 67 LLDVFGHKSN---INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLM-----------TL 112
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+GLEYLH + ++H D+KP+N+L+ D K+ DFGLAR
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 59/180 (32%), Positives = 92/180 (51%), Gaps = 29/180 (16%)
Query: 87 LGHGGFGSVYKAV-VPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG+VYK + VP P+A+KIL+ + + EF +E + +S+D PH+V L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRK----CEELMEWNKRFEIAIDIAKGLEYL 198
LG + L+ +LM + L D + + K + L+ W + IAKG+ YL
Sbjct: 75 LGVC---LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDVNEDNGSI 258
E ++H D+ N+L+ KI DFGLARL +EG+ +++ N D G +
Sbjct: 126 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL------LEGD---EKEYNADGGKM 173
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 17/153 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLA-SSLDCPHIVSLLGF 145
LG G +G V K + +AVK + ++ + Q ++ +L ++ S+DCP+ V+ G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG- 67
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAKGLEYLH 199
A R G V I ME + D LD+ +++ + +IA+ I K LEYLH
Sbjct: 68 ALFREGD--VWIC--ME---VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
VIH D+KPSN+L++ + + K+ DFG++
Sbjct: 121 SKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 27/166 (16%)
Query: 87 LGHGGFGSVYKA----VVPSSSQPL-AVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LG G FG V+ + P + + L AVK L + S ++F E L ++ +IV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDAL------------LDRKCEELMEWNKRFEIAI 189
G + G ++++E ME+ L L D EL ++ +IA+
Sbjct: 73 FYGVCT--EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL-SQLLQIAV 129
Query: 190 DIAKGLEYL--HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IA G+ YL H +H D+ N L+ D KIGDFG++R
Sbjct: 130 QIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 19/155 (12%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN-----ELSLASSLDCPHIV 140
++G G +G VYKA + + +A+K + L+ E E E+ L L+ P+I+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKI----KLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH- 199
LL R L L++E M+ + L+ + L E + + +GL + H
Sbjct: 62 KLL--DVFRHKGDLYLVFEFMDTDLYK--LIKDRQRGLPESLIKS-YLYQLLQGLAFCHS 116
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
H +H D+KP N+L++ + K+ DFGLAR
Sbjct: 117 HGI----LHRDLKPENLLINTEGVLKLADFGLARS 147
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 10/150 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQP---LAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
+G G FG V + + + +A+K L + S + +F E S+ D P+I+ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
G + + R +++I E MEN SL D L R+ + + + IA G++YL
Sbjct: 72 GVVT--KSRPVMIITEYMENGSL-DKFL-RENDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+H D+ NIL++ + K+ DFGL+R
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 22/164 (13%)
Query: 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGEREFHNELSLASSLDCP 137
+ + P +G G +G V A+ S + +A+K I + + EL +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 138 HIVSLLGF--ASDRRGRRLVLIYELMEN------RSLQDALLDRKCEELMEWNKRFEIAI 189
+I+++ + + ++ +LME+ S Q L E + R+
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP---------LTEEHIRY-FLY 114
Query: 190 DIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ +GL+Y+H + VIH D+KPSN+L++ D + +IGDFG+AR
Sbjct: 115 QLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 61/177 (34%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 85 NRLGHGGFGSVYKAV------VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH 138
N LG G FG VY+ S +AVK L + Q ++EF E L S+ + P+
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEE----LMEWNKRFEIAIDIAKG 194
IV LLG + +++ ELME L L D + E L+ + +I +D+AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIM--ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 195 LEYLHHSCEPPVIHGDIKPSNILL-----DGDFKAKIGDFGLAR--LKTEDLMIEGE 244
YL IH D+ N L+ D D KIGDFGLAR K++ EGE
Sbjct: 119 CVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 51/160 (31%), Positives = 72/160 (45%), Gaps = 32/160 (20%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKIL-----DSSGSLQGEREFHNELSLASSLDCPH- 138
R+G G +G VYKA ++ + +A+K++ D +Q E E C H
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE--------CRHP 60
Query: 139 -IVSLLGFASDRRGRRLVLIYELMENRSLQDAL--LDRKCEELMEWNKRFEIAI---DIA 192
IV+ G S R +L ++ E SLQD EL +IA +
Sbjct: 61 NIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-------QIAYVCRETL 111
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
KGL YLH + IH DIK +NILL D K+ DFG++
Sbjct: 112 KGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 87 LGHGGFGSVYKAVVPS--SSQP---LAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LG G FG VY+ + +AVK ++ S SL+ EF NE S+ C H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 142 LLGFASDRRGRRLVLIYELMEN-------RSLQDALLDRKCEELMEWNKRFEIAIDIAKG 194
LLG S +G+ +++ ELM + RSL+ + + ++A +IA G
Sbjct: 74 LLGVVS--KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 195 LEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ YL+ +H D+ N ++ DF KIGDFG+ R
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 5e-14
Identities = 48/150 (32%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLL- 143
LG G FG V + + A+K+L ++ + H E ++ S ++ P IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
F ++ + L L+ E L L E RF A +I LEYLH
Sbjct: 61 AFQTEEK---LYLVLEYAPGGELFSHLSKEGR--FSEERARFYAA-EIVLALEYLH---S 111
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+I+ D+KP NILLD D K+ DFGLA+
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAK 141
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 51/153 (33%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVK---ILDSSGSLQGE-REFHNELSLASSLDCPHIVSL 142
LG G FGSVY+ + AVK + D + Q ++ E++L S L P+IV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDAL--LDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
LG ++R L + EL+ SL L E ++ R I GLEYLH
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLHD 120
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+H DIK +NIL+D + K+ DFG+A+
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 46/148 (31%), Positives = 72/148 (48%), Gaps = 6/148 (4%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+RLG G GSV K + ++ A+K + + + +++ EL + S P+IV G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF--EIAIDIAKGLEYLHHSC 202
D + + E E SL D++ + + ++ +IA + KGL YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--- 122
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFG 230
+IH DIKPSNILL + K+ DFG
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 54/158 (34%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 87 LGHGGFGSV----YKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FGSV Y + ++ + +AVK L S + R+F E+ + SL +IV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH-LRDFEREIEILKSLQHDNIVKY 70
Query: 143 LG--FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
G +++ RR RLV+ E + SL+D L +K E ++ K A I KG+EYL
Sbjct: 71 KGVCYSAGRRNLRLVM--EYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYLG- 125
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ NIL++ + + KIGDFGL ++ +D
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 50/148 (33%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL-DSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+G G FG V Q +AVK L D S + Q F E S+ ++L P++V LLG
Sbjct: 14 IGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLLGV 68
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
G L ++ E M SL D L R ++ ++ A+D+ +G+EYL E
Sbjct: 69 VLQ--GNPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLE---EKN 122
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+H D+ N+L+ D AK+ DFGLA+
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
++G G G VYKA ++ + +A+K + Q + NE+ + P+IV
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHPNIVDYYD- 82
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGLEYLHHSC 202
S G L ++ E M+ SL D ++ + + E +IA ++ +GLEYLH
Sbjct: 83 -SYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNE----PQIAYVCREVLQGLEYLHSQ- 135
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
VIH DIK NILL D K+ DFG A
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 57/199 (28%), Positives = 80/199 (40%), Gaps = 55/199 (27%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---------ELSLASSLDCP 137
+G G +G V AV + + +A+K + F + E+ L L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI--------SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 138 HIVSLLG-FASDRRG--RRLVLIYELMEN------RSLQDALLDRKCEELMEWNKRFEIA 188
+I+ LL + ++ ELME +S Q L D + +
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQP-LTDDHIQYFL--------- 109
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKK 248
I +GL+YLH S VIH D+KPSNIL++ + KI DFGLAR D
Sbjct: 110 YQILRGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD---------- 156
Query: 249 RDVNEDNGSILEETESVVT 267
ED L TE VVT
Sbjct: 157 ----EDEKGFL--TEYVVT 169
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 46/148 (31%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
++G G FG VYK V+ +++ +AVK S+ +R+F E + D P+IV L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
++ + ++ EL+ SL L RK + + K ++++D A G+EYL
Sbjct: 61 CVQKQ--PIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN--- 113
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IH D+ N L+ + KI DFG++R
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 20/160 (12%)
Query: 87 LGHGGFGSVYKAV-VPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG+VYK + +P + P+A+K L + S + +E +E + +S+D PH+ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRK----CEELMEWNKRFEIAIDIAKGLEYL 198
LG + LI +LM L D + + K + L+ W + IAKG+ YL
Sbjct: 75 LGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 125
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
E ++H D+ N+L+ KI DFGLA+L D
Sbjct: 126 E---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 32/161 (19%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN--------EL-SLASSLDC 136
+LG G FGSVY A + + +A+K + +++F++ E+ SL +
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM--------KKKFYSWEECMNLREVKSLRKLNEH 57
Query: 137 PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLE 196
P+IV L + L ++E ME +L + DRK + E + I I +GL
Sbjct: 58 PNIVKLKEVFREND--ELYFVFEYMEG-NLYQLMKDRKGKPFSE-SVIRSIIYQILQGLA 113
Query: 197 YLHHSCEPPVIHG----DIKPSNILLDGDFKAKIGDFGLAR 233
++H HG D+KP N+L+ G KI DFGLAR
Sbjct: 114 HIHK-------HGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 50/155 (32%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
F+ R+G G FG V+K + + Q +A+KI+D + + E+++ S D P++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGLEY 197
G S +G +L +I E + S D L +E F+IA +I KGL+Y
Sbjct: 66 KYYG--SYLKGTKLWIIMEYLGGGSALDLLRAGPFDE-------FQIATMLKEILKGLDY 116
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
LH + IH DIK +N+LL K+ DFG+A
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
F+ R+G G FG VYK + + + +A+KI+D + + E+++ S D P+I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
G S +G +L +I E + S D L EE I +I KGL+YLH
Sbjct: 66 RYYG--SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT----ILREILKGLDYLHS 119
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+ IH DIK +N+LL K+ DFG+A
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER-----EFHNELSLASSLDCPH 138
N++G G FG VY AV + + +AVK + +Q E +E+ + L P+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEI----RIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+V G R ++ + E +L++ LL+ + + + + +GL YL
Sbjct: 61 LVKYYGVEVHRE--KVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVY--TLQLLEGLAYL 115
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
H ++H DIKP+NI LD + K+GDFG A
Sbjct: 116 H---SHGIVHRDIKPANIFLDHNGVIKLGDFGCA 146
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 87 LGHGGFGSVYKAV-VPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG+V+K + +P P+A+K + Q +E + + SLD +IV L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRK----CEELMEWNKRFEIAIDIAKGLEYL 198
LG G L L+ +L SL D + + + L+ W + IAKG+ YL
Sbjct: 75 LGICP---GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYL 125
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
++H ++ NILL D +I DFG+A L D
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 24/171 (14%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE-----REFHNELSLASSLD 135
+ +G G +G+VYKA ++ + +A+K + S +G RE ++L L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE----IALLKQLE 56
Query: 136 ---CPHIVSLLG-FASDRRGRRLV--LIYELMENRSLQD--ALLDRKCEELMEWNKRFEI 187
P+IV LL R R L L++E ++ QD L + + + ++
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDL 112
Query: 188 AIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ +G+++LH ++H D+KP NIL+ D + KI DFGLAR+ + +
Sbjct: 113 MRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 11/151 (7%)
Query: 87 LGHGGFGSV----YKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG V Y + + +AVK L Q + E+++ +L +IV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
G S++ G+ L LI E + SL+D L K + + A I +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IH D+ N+LLD D KIGDFGLA+
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 8e-13
Identities = 50/149 (33%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
LG G FG V S + A+KIL + ++ ++ H NE + S+ P +V+L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
D L L+ E + L L RK E RF A + LEYLH +
Sbjct: 69 SFQD--DSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAA-QVVLALEYLHS-LD- 121
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+++ D+KP N+LLD D KI DFG A+
Sbjct: 122 -IVYRDLKPENLLLDSDGYIKITDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 44/149 (29%), Positives = 79/149 (53%), Gaps = 16/149 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG-- 144
LGHG G+VYKA + + LAVK++ +++ +++ +EL + D P+I+ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F + R+ + E M+ SL + + E ++ IA+ + KGL YL
Sbjct: 69 FVEN----RISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYL---WSL 114
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
++H D+KPSN+L++ + K+ DFG++
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 87 LGHGGFGSVYKAVVP---SSSQPLAVKILDSSGSLQGE-REFHNELSLASSLDCPHIVSL 142
LG G FGSV + + S +AVK + E EF +E + D P+++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 143 LG--FASDRRGR--RLVLIYELMENRSLQDALLDRKCEELMEW---NKRFEIAIDIAKGL 195
+G F + + + ++I M++ L LL + L E + +DIA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
EYL + IH D+ N +L D + DFGL++
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G FG V+ +A+K++ G++ E +F E + L P++V L G
Sbjct: 12 LGSGQFGVVHLGKWRGKID-VAIKMI-REGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206
+ +R + ++ E M N L + L +RK + EW ++ D+ + +EYL +
Sbjct: 69 TKQR--PIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---F 121
Query: 207 IHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ N L+ D K+ DFGLAR +D
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 47/153 (30%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+LG G FG V+ + + +AVK L G++ E F E + L +V L
Sbjct: 13 KLGAGQFGEVWMGTW-NGTTKVAVKTL-KPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAV 69
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
S + ++ E M SL D L + ++L + ++A IA+G+ YL
Sbjct: 70 CS--EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL-PQLVDMAAQIAEGMAYLE---SRN 123
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ NIL+ + KI DFGLARL +D
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
NR+G G G+VYK + + + A+K++ + R+ E+ + ++ P++V
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF--EIAIDIAKGLEYLHHSC 202
D G VL+ E M+ SL+ + +++F ++A I G+ YLH
Sbjct: 140 M-FDHNGEIQVLL-EFMDGGSLEGTHI---------ADEQFLADVARQILSGIAYLHRR- 187
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
++H DIKPSN+L++ KI DFG++R+
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
|
Length = 353 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 52/151 (34%), Positives = 74/151 (49%), Gaps = 16/151 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLAS-SLDCPHIVSLLG- 144
+G G G VYK + +AVK + +G+ + + +L + S DCP+IV G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 145 FASDRRGRRLVLI-YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL--HHS 201
F +D V I ELM + D LL R + E + ++ + I K L YL H
Sbjct: 83 FITDSD----VFICMELMS--TCLDKLLKRIQGPIPE-DILGKMTVAIVKALHYLKEKHG 135
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
VIH D+KPSNILLD K+ DFG++
Sbjct: 136 ----VIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 52/157 (33%), Positives = 74/157 (47%), Gaps = 20/157 (12%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGERE-------FHNELSLASSLDCPH 138
+G G FGSVY + SS + +AVK + S S + E++L L +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDR--KCEELMEWNKRFEIAIDIAKGLE 196
IV LG + D L + E + S+ ALL+ EE + N I KGL
Sbjct: 68 IVQYLGSSLD--ADHLNIFLEYVPGGSVA-ALLNNYGAFEETLVRN----FVRQILKGLN 120
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
YLH+ +IH DIK +NIL+D KI DFG+++
Sbjct: 121 YLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 9/153 (5%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+LG G FG V++ + +++ P+AVK L G++ + +F E + L P ++ L +
Sbjct: 13 KLGAGQFGEVWEGLW-NNTTPVAVKTL-KPGTMDPK-DFLAEAQIMKKLRHPKLIQL--Y 67
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
A + ++ ELM+ SL + L L + + ++A +A G+ YL
Sbjct: 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLE---AQN 123
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ N+L+ + K+ DFGLAR+ ED
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKED 156
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 28/166 (16%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---------ELSLASSLDCP 137
+G G +G V A + + +A+K L R F + EL L +D
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS--------RPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 138 HIVSLLG-FASDRRGRRLVLIYELMENRSLQDALLDR--KCEELMEWNKRFEIAIDIAKG 194
+++ LL F +Y + L A L+ KC++L + + +F + I +G
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTH---LMGADLNNIVKCQKLSDDHIQF-LVYQILRG 130
Query: 195 LEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLM 240
L+Y+H S +IH D+KPSNI ++ D + KI DFGLAR T+D M
Sbjct: 131 LKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEM 172
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 20/156 (12%)
Query: 87 LGHGGFGSVYKAV-VPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG+VYK + +P P+A+K+L + S + +E +E + + + P++ L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRK----CEELMEWNKRFEIAIDIAKGLEYL 198
LG + L+ +LM L D + + K ++L+ W + IAKG+ YL
Sbjct: 75 LGICLTST---VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
E ++H D+ N+L+ KI DFGLARL
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 39/175 (22%)
Query: 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-----FHNELSL 130
R+ F NR+G G +G VY+A +S + +A+K + + ER+ E++L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV----RMDNERDGIPISSLREITL 59
Query: 131 ASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQD--ALLDR----------KCEEL 178
+L P+IV L + + L+ E E QD +LLD KC
Sbjct: 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE----QDLASLLDNMPTPFSESQVKC--- 112
Query: 179 MEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ + + +GL+YLH + +IH D+K SN+LL KI DFGLAR
Sbjct: 113 --------LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
LG GGFG V V S ++ A+K + ++ ++ H +E + + P IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ + + + + ++ E L L DR E+ RF IA + EYLH+
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIAC-VVLAFEYLHNR--- 112
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+I+ D+KP N+LLD + K+ DFG A+
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK 141
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 55/152 (36%), Positives = 73/152 (48%), Gaps = 15/152 (9%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNE---LSLASSLDCPHIVS 141
+G GGFG VY + + A+K LD QGE NE LSL S+ DCP IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 142 L-LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
+ F + + L I +LM L L E RF A +I GLE++H+
Sbjct: 62 MTYAFHTPDK---LCFILDLMNGGDLHYHLSQHGV--FSEKEMRF-YATEIILGLEHMHN 115
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
V++ D+KP+NILLD +I D GLA
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 55/152 (36%), Positives = 73/152 (48%), Gaps = 15/152 (9%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNE---LSLASSLDCPHIVS 141
+G GGFG VY + + A+K LD QGE NE LSL S+ DCP IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 142 L-LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
+ F + + L I +LM L L E RF A +I GLE++H+
Sbjct: 62 MSYAFHTPDK---LSFILDLMNGGDLHYHLSQHGV--FSEAEMRF-YAAEIILGLEHMHN 115
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
V++ D+KP+NILLD +I D GLA
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 43/154 (27%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
++G G +G V+K + Q +A+K ++S ++ E+ + L P++V+L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 145 -FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH-HSC 202
F RR R+L L++E ++ L + L++ + E + +I + + + H H+C
Sbjct: 68 VF---RRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIK-KIIWQTLQAVNFCHKHNC 121
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236
IH D+KP NIL+ + K+ DFG AR+ T
Sbjct: 122 ----IHRDVKPENILITKQGQIKLCDFGFARILT 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+G G +G V K ++ + +A+K +S ++ E+ + L +IV+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH-HSCE 203
RR RL L++E +E L+ LL+ L R + + + Y H H+
Sbjct: 68 AF--RRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVR-SYIWQLLQAIAYCHSHNI- 121
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
IH DIKP NIL+ K+ DFG AR
Sbjct: 122 ---IHRDIKPENILVSESGVLKLCDFGFARALRA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 87 LGHGGFGSVYKAVVPSSSQP-LAVKILD----SSGSLQGERE-----FHNELS-LASSLD 135
LG G FG VYK ++ Q LA+K ++ + G + ER+ +E++ + L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 136 CPHIVSLLGFASDRRGRRLVLIYELMENRSLQDAL--LDRKCEELME---WNKRFEIAID 190
P+IV + + RL ++ +L+E L + L K + E WN I +
Sbjct: 68 HPNIVRY--YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN----IFVQ 121
Query: 191 IAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ L YLH E ++H D+ P+NI+L D K I DFGLA+ K +
Sbjct: 122 MVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE 167
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 51/155 (32%), Positives = 69/155 (44%), Gaps = 13/155 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVK---ILDSSGSLQGE-REFHNELSLASSLDCPHIVSL 142
LG G FG VY + + LAVK S + E E+ L +L IV
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
G D L + E M S++D L L E R + I +G+EYLH +
Sbjct: 70 YGCLRDDE--TLSIFMEYMPGGSVKDQLKAYGA--LTETVTR-KYTRQILEGVEYLHSN- 123
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLA-RLKT 236
++H DIK +NIL D K+GDFG + RL+T
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 14/166 (8%)
Query: 90 GGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---ELSLASSLDCPHIVSLLGFA 146
G +G V+ A S+ A+K++ + + + + E + S P++V L +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKA-DMIRKNQVDQVLTERDILSQAQSPYVVKL--YY 60
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH-HSCEPP 205
S + + L L+ E + L +LL+ L E R IA +I LEYLH +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLA-SLLE-NVGSLDEDVARIYIA-EIVLALEYLHSNGI--- 114
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDV 251
IH D+KP NIL+D + K+ DFGL+++ I +K D
Sbjct: 115 -IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
++LG G +G VY+ V S +AVK L EF E ++ + P++V LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCE 203
+ R +I E M +L D L R+C + + +A I+ +EYL
Sbjct: 70 VCT--REPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK-- 123
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ N L+ + K+ DFGL+RL T D
Sbjct: 124 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 10/160 (6%)
Query: 88 GHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--REFHNELSLASSLDCPHIVSLLGF 145
G G FG V + + A+K ++ ++ R NE + L+ P +V+L +
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL--W 66
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
S + + L+ +L+ L+ L + + E +F I +I LEYLH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWIC-EIVLALEYLH---SKG 120
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGEC 245
+IH DIKP NILLD I DF +A T D +
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 47/148 (31%), Positives = 69/148 (46%), Gaps = 8/148 (5%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG GGFG V V ++ + A K LD +GE+ NE + + IVSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+A + + L L+ LM L+ + + E F A I GLE+LH +
Sbjct: 60 YAFETKDD-LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLH---QR 114
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+++ D+KP N+LLD +I D GLA
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
F+ ++G G FG V+K + + + +A+KI+D + + E+++ S D P++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
G S + +L +I E + S D L +E + I +I KGL+YLH
Sbjct: 66 KYYG--SYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATILREILKGLDYLHS 119
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+ IH DIK +N+LL + K+ DFG+A
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 51/155 (32%), Positives = 75/155 (48%), Gaps = 20/155 (12%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNEL-SLASSLDCPHIVSLLGF 145
+G G FG+V K + S +AVK + S+ + ++ +L + S DCP+IV G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG- 70
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEI--------AIDIAKGLEY 197
A R G + + ELM D LD K + + + I A+ K L Y
Sbjct: 71 ALFREGDCWICM-ELM------DISLD-KFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
L E +IH D+KPSNILLD + K+ DFG++
Sbjct: 123 LKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 46/173 (26%)
Query: 88 GHGGFGSVYKAVV--PSSSQPLAVKILDSSG------SLQGEREFHNELSLASSLDCPHI 139
G G +G VYKA + A+K S RE ++L L ++
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHENV 64
Query: 140 VSLLGFASDRRGRRLVLIYELME--------------NRSLQDALLDRKCEELMEWNKRF 185
VSL+ + + + L+++ E S+ +++
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS------------ 112
Query: 186 EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKA----KIGDFGLARL 234
+ I G+ YLH + V+H D+KP+NIL+ G+ KIGD GLARL
Sbjct: 113 -LLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL-GF 145
LG G FG VYKA + A KI+ + E +F E+ + S P+IV L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMVEIDILSECKHPNIVGLYEAY 71
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
+ + L ++ E + +L D+++ L E R+ + + + L +LH
Sbjct: 72 FYENK---LWILIEFCDGGAL-DSIMLELERGLTEPQIRY-VCRQMLEALNFLH---SHK 123
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGL-ARLKTED 238
VIH D+K NILL D K+ DFG+ A+ K+
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 10/155 (6%)
Query: 87 LGHGGFGSVYKA---VVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
+G G FG V + + +A+K L S + + R+F +E S+ D P+I+ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
G + + R +++I E MEN +L D+ L R+ + + + IA G++YL E
Sbjct: 72 GVVT--KSRPVMIITEFMENGAL-DSFL-RQNDGQFTVIQLVGMLRGIAAGMKYL---SE 124
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ NIL++ + K+ DFGL+R +D
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 54/170 (31%), Positives = 76/170 (44%), Gaps = 20/170 (11%)
Query: 87 LGHGGFGSVYKAVV--PSSSQP---LAVKILDSSGSLQGEREFHNELSLASSLDCPH--I 139
LG G FG V +A S S +AVK+L + +EL + S L H I
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-NHENI 101
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL- 198
V+LLG + G +++I E L + L RK E + + +AKG+ +L
Sbjct: 102 VNLLGACT--IGGPILVITEYCCYGDLLN-FLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKK 248
+C IH D+ N+LL KI DFGLAR D+M + V K
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDSNYVVK 200
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLA---VKILDSSGSLQGEREFHNELSLASSL 134
+F ++G G F VYKA+ + +A V+I + + + E+ L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL-KEIDLLKQL 59
Query: 135 DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALL-----DRKCEELMEWNKRFEIAI 189
D P+++ L AS L ++ EL + L + R E W K F +
Sbjct: 60 DHPNVIKYL--ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW-KYF---V 113
Query: 190 DIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ LE++H ++H DIKP+N+ + K+GD GL R
Sbjct: 114 QLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 47/155 (30%), Positives = 83/155 (53%), Gaps = 10/155 (6%)
Query: 87 LGHGGFGSVY--KAVVPSSSQ-PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
+G G FG V + +P + P+A+K L + + + R+F +E S+ D P+I+ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
G + + + ++++ E MEN SL DA L RK + + + IA G++YL +
Sbjct: 72 GVVT--KSKPVMIVTEYMENGSL-DAFL-RKHDGQFTVIQLVGMLRGIASGMKYL---SD 124
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ NIL++ + K+ DFGL+R+ +D
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 50/149 (33%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+LG G FG V+ + +A+K L GS+ E F E +L L P +V L
Sbjct: 13 KLGAGQFGEVWMGYY-NGHTKVAIKSL-KQGSMSPE-AFLAEANLMKQLQHPRLVRLYAV 69
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
+ + +I E MEN SL D L + +L NK ++A IA+G+ ++
Sbjct: 70 VTQEP---IYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE---RKN 122
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARL 234
IH D++ +NIL+ KI DFGLARL
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 13/142 (9%)
Query: 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH 138
+S N + G G+ YK + VK ++ S+ +E++ L P+
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPN 744
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
IV L+G +G LI+E +E ++L + L + + W +R +IAI IAK L +L
Sbjct: 745 IVKLIGLCRSEKGA--YLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFL 796
Query: 199 HHSCEPPVIHGDIKPSNILLDG 220
H C P V+ G++ P I++DG
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDG 818
|
Length = 968 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 48/154 (31%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILD--SSGSLQGEREFHN--ELSLASSLDCPHIVS 141
RLG G FG+VY + +K+L G L E L S LD P IV
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLD-RKCEELMEWNKRFEIAIDIAKGLEYLHH 200
AS +I E E R L L + + + + N+ E I + G+ Y+H
Sbjct: 67 F--HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH- 123
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+ ++H D+K NI L + KIGDFG++RL
Sbjct: 124 --QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 49/184 (26%), Positives = 85/184 (46%), Gaps = 39/184 (21%)
Query: 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK--------ILDSSGSLQGEREFHNELS 129
+ P +G G +G V A +++ +A+K +D+ +L+ E+
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-------EIK 56
Query: 130 LASSLDCPHIVSL---LGFASDRRGRRLVLIYELMEN------RSLQDALLDRKCEELME 180
L LD +++++ + + ++YELM+ RS Q L D C+ +
Sbjct: 57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQ-TLSDDHCQYFL- 114
Query: 181 WNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE--D 238
+ +GL+Y+H + V+H D+KPSN+LL+ + KI DFGLAR +E D
Sbjct: 115 --------YQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163
Query: 239 LMIE 242
M E
Sbjct: 164 FMTE 167
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 49/168 (29%), Positives = 86/168 (51%), Gaps = 20/168 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREF-HNELSLASSLDCPHIVSLLGF 145
+G G FG +Y A S S+ +K +D + E+E E+ L + + P+IV+ F
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF--F 65
Query: 146 ASDRRGRRLVLIYE------LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
AS + RL ++ E LM+ + Q +L + ++++ W + I+ GL+++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSW------FVQISLGLKHIH 118
Query: 200 HSCEPPVIHGDIKPSNILLDGDFK-AKIGDFGLARLKTEDLMIEGECV 246
+ ++H DIK NI L + AK+GDFG+AR + + + CV
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 49/163 (30%), Positives = 83/163 (50%), Gaps = 16/163 (9%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG-EREFHNELSLASSL---DC 136
+ P +G G +G+VYKA P S +A+K + + G E++L L D
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 137 PHIVSLLGF-ASDRRGR--RLVLIYELMENRSLQD--ALLDRKCEELMEWNKRFEIAIDI 191
P+IV L+ A+ R R ++ L++E ++ QD LD+ + ++
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVD----QDLRTYLDKVPPPGLPAETIKDLMRQF 117
Query: 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+GL++LH +C ++H D+KP NIL+ + K+ DFGLAR+
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 26/164 (15%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG-EREFHNELSLASSLDCPH 138
+F ++G G +G VYKA + + +A+K + +G E+SL L+ P+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK----- 193
IV LL +L L++E + QD ++ M+ + I + + K
Sbjct: 61 IVKLLDVIHTEN--KLYLVFEFLH----QD------LKKFMDASPLSGIPLPLIKSYLFQ 108
Query: 194 ---GLEYLH-HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
GL + H H V+H D+KP N+L++ + K+ DFGLAR
Sbjct: 109 LLQGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 14/164 (8%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPS---SSQPLAVKILDSSGSLQGE-REFHNELSLASSLDC 136
F+ LG G FGSV +A + S S Q +AVK+L + + EF E + D
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 137 PHIVSLLGFASDRRGR-RL---VLIYELMENRSLQDALLDRKCEE---LMEWNKRFEIAI 189
P+++ L+G + R + RL ++I M++ L LL + E + I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 190 DIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
DIA G+EYL IH D+ N +L+ + + DFGL++
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 53/184 (28%), Positives = 80/184 (43%), Gaps = 43/184 (23%)
Query: 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGERE-FH----NELSL 130
+ +LG G FG VYKA + + +A+K IL + E++ F E+ +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-----EKDGFPITALREIKI 60
Query: 131 ASSLDCPHIVSLLGFA---SDRRGRRLVLIYE-----------LMENRSLQDALLDRKC- 175
L P++V L+ A D+ R+ +Y L+EN S++ KC
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 176 -EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+L+E G+ YLH E ++H DIK +NIL+D KI DFGLAR
Sbjct: 121 MLQLLE-------------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARP 164
Query: 235 KTED 238
Sbjct: 165 YDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 5/146 (3%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
+G G VY A+ +++ +A+K +D E E+ S + P++V +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY--YT 66
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206
S G L L+ + SL D + ++ + ++ KGLEYLH + +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 207 IHGDIKPSNILLDGDFKAKIGDFGLA 232
IH DIK NILL D KI DFG++
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 24/165 (14%)
Query: 87 LGHGGFGSVYKA----VVPSSSQPL-AVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LG G FG V+ A + P+ + L AVK L +L ++F E L ++L HIV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 71
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQ--------DALL-----DRKCEELMEWNKRFEIA 188
G D G L++++E M++ L DA++ R+ + + ++ IA
Sbjct: 72 FYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IA G+ YL +H D+ N L+ + KIGDFG++R
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 50/163 (30%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVK--ILDSSGSLQGEREF---HNELSLASSLDCPHI 139
LG G +G+VY + + Q +AVK LD+S L E+E+ E+ L SL +I
Sbjct: 6 EVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF----EIAI-----D 190
V LG D + + E + S+ L RF E
Sbjct: 65 VQYLGTCLDDN--TISIFMEFVPGGSISSIL------------NRFGPLPEPVFCKYTKQ 110
Query: 191 IAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
I G+ YLH++C V+H DIK +N++L + K+ DFG AR
Sbjct: 111 ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 137 PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLE 196
P+I+ L+ DR+ RL L++ELM+ +L + + RK L E + + K L+
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRK-RPLPE-KRVKSYMYQLLKSLD 114
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
++H + + H DIKP NIL+ D K+ DFG R
Sbjct: 115 HMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 54/166 (32%), Positives = 80/166 (48%), Gaps = 27/166 (16%)
Query: 87 LGHGGFGSVYKAVVPSSSQPL--AVKILDSSGSLQGEREFHNELSLASSLDC-PHIVSLL 143
+G G FG V KA + + A+K + S R+F EL + L P+I++LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIA--------------- 188
G A + RG L L E + +L D L RK ++E + F IA
Sbjct: 75 G-ACEHRGY-LYLAIEYAPHGNLLDFL--RK-SRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 189 -IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
D+A+G++YL + IH D+ NIL+ ++ AKI DFGL+R
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGEREFHNELSLASSLDC 136
T + +G G FG V A + Q +A+K I+ + + + EL L L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 137 PHIVSLLG-FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGL 195
+I+SL F S + + EL+ L L R E+ ++ + F I +GL
Sbjct: 69 ENIISLSDIFISPLED--IYFVTELLGT-DLHRLLTSRPLEK--QFIQYF--LYQILRGL 121
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235
+Y+H + V+H D+KPSNIL++ + KI DFGLAR++
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ 158
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 87 LGHGGFGSVYKAVVPSSSQPL--AVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLL 143
+G G FG V +A++ + A+K+L S R+F EL + L P+I++LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL-------------MEWNKRFEIAID 190
G A + RG + I E +L D L + E + + + A D
Sbjct: 70 G-ACENRGYLYIAI-EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 191 IAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+A G++YL E IH D+ N+L+ + +KI DFGL+R
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 49/155 (31%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL----DSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG VY + + LAVK + +S + + E+ L +L IV
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
G D R L + E M S++D L K + N + I +G+ YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLA-RLKT 236
++H DIK +NIL D K+GDFG + RL+T
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 52/180 (28%), Positives = 75/180 (41%), Gaps = 37/180 (20%)
Query: 86 RLGHGGFGSVYKAVV------PSSSQPL----------AVKILDSSGSLQGEREFHNELS 129
+LG G FG V+ V P+ P AVKIL + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 130 LASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDAL----LDRKCEE-------- 177
+ S L P+I+ LLG D L +I E MEN L L LD K E
Sbjct: 72 ILSRLKDPNIIRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 178 ----LMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ ++ +A+ IA G++YL +H D+ N L+ + KI DFG++R
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 23/165 (13%)
Query: 87 LGHGGFGSVYKA--VVP--SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG FG +YK +P +Q +A+K L + Q EF E SL + L P+IV L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALL--------------DRKCEELMEWNKRFEIA 188
LG + + + +++E + L + L+ D + ++ IA
Sbjct: 73 LGVVTQE--QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
I IA G+EYL +H D+ NIL+ KI D GL+R
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
+G G FG V+ + +A+K + G++ E +F E + L P +V L
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRK-VAIKTI-REGAMS-EEDFIEEAQVMMKLSHPKLVQLY 65
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
G ++R + L++E ME+ L D L R + +D+ +G+ YL S
Sbjct: 66 GVCTERS--PICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN- 120
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
VIH D+ N L+ + K+ DFG+ R +D
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 21/158 (13%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELS-LASSLDCPHIVSLLG- 144
+G G +G VYKA + Q +A+KI+D E E E + L + P+I + G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE--EEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 145 -FASDRRGRR--LVLIYELMENRSLQD---ALLD---RKCEELMEWNKRFEIAIDIAKGL 195
+ G L L+ EL S+ D L R EE + + I + +GL
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-----ILRETLRGL 126
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
YLH E VIH DIK NILL + + K+ DFG++
Sbjct: 127 AYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 48/167 (28%), Positives = 71/167 (42%), Gaps = 27/167 (16%)
Query: 87 LGHGGFGSVYKA----VVPSS-SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LG FG VYK P +Q +A+K L EF +E + S L P+IV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALL-------------DRKCEELMEWNKRFEIA 188
LLG + + + L +I+ + L + L+ D+ + +E I
Sbjct: 73 LLGVVT--KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 189 IDIAKGLEYL--HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IA G+E+L HH V+H D+ N+L+ KI D GL R
Sbjct: 131 TQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 12/162 (7%)
Query: 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDC 136
+ F LG G FG V A + + A+K L L+ ++ H E S+ L
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 137 PHIVSLL-GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGL 195
P IV+++ F + R + + E + L L RK +F A ++
Sbjct: 78 PFIVNMMCSFQDENR---VYFLLEFVVGGELFTHL--RKAGRFPNDVAKFYHA-ELVLAF 131
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
EYLH S + +I+ D+KP N+LLD K+ DFG A+ +
Sbjct: 132 EYLH-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170
|
Length = 329 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSS-GSLQGEREFHNELSLASSLDCPHIVSLLG- 144
+G G +GSV A Q +AVK L SL R + EL L + +++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDR--KCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
F +Y L+ N L A L+ KC++L + + +F I + +GL+Y+H +
Sbjct: 83 FTPATSIENFNEVY-LVTN--LMGADLNNIVKCQKLSDEHVQFLI-YQLLRGLKYIHSA- 137
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLM 240
+IH D+KPSN+ ++ D + +I DFGLAR + +D M
Sbjct: 138 --GIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEM 172
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 87 LGHGGFGSVYKAV--VPSSSQPLAVKILDSSGSLQGER-EFHNELSLASSLDCPHIVSLL 143
LG G FG+V K + + S + +AVKIL + + + E E ++ LD P+IV ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
G +L+ EL E L L +K + + E N E+ ++ G++YL E
Sbjct: 63 GIC---EAESWMLVMELAELGPLNKFL--QKNKHVTEKNIT-ELVHQVSMGMKYLE---E 113
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ N+LL AKI DFGL++ D
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 50/160 (31%), Positives = 70/160 (43%), Gaps = 16/160 (10%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER--EFHNELSLASSLDCPH 138
F+ +GHG FG+VY A +++ +A+K + SG E+ + E+ L P+
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGL 195
+ G LV+ Y L S D +L+ + L E EIA +GL
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL---GSASD-ILEVHKKPLQE----VEIAAICHGALQGL 128
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235
YLH IH DIK NILL K+ DFG A L
Sbjct: 129 AYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 50/162 (30%), Positives = 76/162 (46%), Gaps = 21/162 (12%)
Query: 87 LGHGGFGSVYKA----VVPSSSQPL-AVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LG G FG V+ A + P + L AVK L + S ++FH E L ++L HIV
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVK 71
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQ--------DALLDRKCEELMEW--NKRFEIAIDI 191
G + G L++++E M++ L DA+L + E ++ IA I
Sbjct: 72 FYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
A G+ YL +H D+ N L+ + KIGDFG++R
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 52/165 (31%), Positives = 76/165 (46%), Gaps = 25/165 (15%)
Query: 87 LGHGGFGSVYKA----VVPSSSQPL-AVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LG G FG V+ A ++P + L AVK L + S ++F E L + L HIV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71
Query: 142 LLGFASDRRGRRLVLIYELME----NRSLQ----DALL-----DRKCEELMEWNKRFEIA 188
G ++ GR L++++E M NR L+ DA + D +L + IA
Sbjct: 72 FYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT-LGQMLAIA 128
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IA G+ YL +H D+ N L+ KIGDFG++R
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 46/149 (30%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLG 144
+G G FG V+ S A+K++ L+ E+ HNE + + P I+ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F ++ R L ++ E + L L R F A +I LEYLH S E
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLF-YASEIVCALEYLH-SKE- 121
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+++ D+KP NILLD + K+ DFG A+
Sbjct: 122 -IVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 48/150 (32%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G FG V+K + + P+AVK + + +F +E + D P+IV L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKT-PVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 147 SDRRGRRLVLIYELMENRSLQDAL--LDRKCEELMEWNKRFEIAIDIAKGLEYLH-HSCE 203
+ R+ IY +ME D L L +K +EL + + + A+D A G+ YL +C
Sbjct: 62 TQRQP-----IYIVMELVPGGDFLSFLRKKKDEL-KTKQLVKFALDAAAGMAYLESKNC- 114
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IH D+ N L+ + KI DFG++R
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 34/162 (20%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-----FHNELSLASSLDCPHIV 140
++G G +G VYKA + + +A+K + L+ E E E+SL L+ P+IV
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI----RLETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK------- 193
LL +L L++E LD ++ M+ + + + K
Sbjct: 62 RLLDVVHS--ENKLYLVFEF----------LDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 194 -GLEYLH-HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
G+ Y H H V+H D+KP N+L+D + K+ DFGLAR
Sbjct: 110 QGIAYCHSHR----VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 47/154 (30%), Positives = 70/154 (45%), Gaps = 10/154 (6%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE--FHNELSLASSLDCPH 138
F +G G FG V+ + Q A+K+L S ++ + E + + D P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
IV L + S + L L+ E M L + L+ + E RF IA ++ L+ +
Sbjct: 63 IVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV--FPEETARFYIA-ELVLALDSV 117
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
H + IH DIKP NIL+D D K+ DFGL
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 47/171 (27%), Positives = 71/171 (41%), Gaps = 28/171 (16%)
Query: 86 RLGHGGFGSVY------------KAVVPSSSQP--LAVKILDSSGSLQGEREFHNELSLA 131
+LG G FG V+ + QP +AVK+L + + +F E+ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 132 SSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELM---------EWN 182
S L P+I+ LLG L +I E MEN L L R+ E
Sbjct: 72 SRLKNPNIIRLLGVCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 183 KRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+A+ IA G++YL +H D+ N L+ + KI DFG++R
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 24/163 (14%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKI--LDS-----SGSLQGEREFHNELSLAS 132
+F +LG G + +VYK ++ + +A+K LD+ S +++ E+SL
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-------EISLMK 53
Query: 133 SLDCPHIVSLLGFASDRRGRRLVLIYELMEN--RSLQDALLDRKCEELMEWNKRFEIAID 190
L +IV L +L+L++E M+ + D R + K F
Sbjct: 54 ELKHENIVRLHDVIHTEN--KLMLVFEYMDKDLKKYMDTHGVRGALDPNT-VKSF--TYQ 108
Query: 191 IAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ KG+ + H E V+H D+KP N+L++ + K+ DFGLAR
Sbjct: 109 LLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 11/165 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL----DSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG VY + + LAVK + DS + + E+ L +L IV
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
G D ++L + E M S++D L K + N I +G+ YLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLHSNM 126
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVK 247
++H DIK +NIL D K+GDFG ++ + + + + G +K
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIK 167
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPL--AVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLL 143
+G G FG V KA + + A+K + S R+F EL + L P+I++LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 144 GFASDRRGRRLVLIYE--------LMENRSLQ-DALLDRK--CEELMEWNKRFEIAIDIA 192
G R L + Y L ++R L+ D + + A D+A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+G++YL + IH D+ NIL+ ++ AKI DFGL+R
Sbjct: 123 RGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 9/153 (5%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+LG G FG V+ +S++ +AVK L G++ + F E +L +L +V L +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTK-VAVKTL-KPGTMSVQ-AFLEEANLMKTLQHDKLVRL--Y 67
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
A + + +I E M SL D L + +++ K + + IA+G+ Y+
Sbjct: 68 AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKN 123
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D++ +N+L+ KI DFGLAR+ ++
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 87 LGHGGFGSVYKAVVPS--SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+G+G FG V V S + + VK L S S+Q + +F E SL +++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF--EIAIDIAKGLEYLHHSC 202
++ +L+ E L+ L + ELM + +A +IA GL +LH +
Sbjct: 63 QCTEVT--PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK-TEDLMI 241
IH D+ N LL D KIGD+GL+ K ED +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSS-GSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+G G +GSV A + +AVK L S+ + + EL L + +++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 146 ASDRRGRR----LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
+ R + L+ LM L + + KC++L + + +F I I +GL+Y+H +
Sbjct: 85 FTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
+IH D+KPSN+ ++ D + KI DFGLAR +++
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 174
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 41/155 (26%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 87 LGHGGFGSVYKAV--VPSSSQ-PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
+G G FG V++ + +P + +A+K L + + ++F +E S+ +I+ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
G + + + ++I E MEN +L L D E + + IA G++YL +
Sbjct: 73 GVVT--KFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---SD 125
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ NIL++ + + K+ DFGL+R+ +D
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKI-LDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+G G +G V K + Q +A+K L+S ++ E+ + L ++V+L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
RR +RL L++E +++ L D L++ L E R + I +G+E+ H
Sbjct: 69 F--RRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVR-KYLFQILRGIEFCHSH---N 120
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+IH DIKP NIL+ K+ DFG AR
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 17/154 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQP---LAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
+G G FG VY + S AVK L+ L+ +F E + P+++SLL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRK----CEELMEWNKRFEIAIDIAKGLEYLH 199
G G LV++ M++ L++ + ++L+ + + +AKG+EYL
Sbjct: 63 GICLPSEGSPLVVL-PYMKHGDLRNFIRSETHNPTVKDLIGF------GLQVAKGMEYL- 114
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+H D+ N +LD F K+ DFGLAR
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 49/155 (31%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL----DSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG VY + + LA K + +S + + E+ L +L IV
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
G DR + L + E M S++D L + L E R + I +G+ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGMSYLHSNM 126
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLA-RLKT 236
++H DIK +NIL D K+GDFG + RL+T
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+G G FG+V + + Q +AVK + + Q F E ++ + L ++V LLG
Sbjct: 13 IIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGV 67
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
L ++ ELM +L + L R L+ + + ++D+A+G+EYL
Sbjct: 68 ILHNG---LYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---K 120
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLAR 233
++H D+ NIL+ D AK+ DFGLAR
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL-GF 145
LG G FG VYKA + A K++D+ + E ++ E+ + +S D P+IV LL F
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 71
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
+ L ++ E ++ +L EL +I + + LE L++ E
Sbjct: 72 YYENN---LWILIEFCAGGAVDAVML-----ELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
+IH D+K NIL D K+ DFG++ T +
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 53/196 (27%), Positives = 82/196 (41%), Gaps = 27/196 (13%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLA---VKILDSSGSLQGEREF------H----NELSLA 131
LG G +G V KA + + +A VKI++ S + +R+ H EL +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 132 SSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDI 191
+ + +I+ L+ + LV+ ++M S ++DRK L E + I + I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVM--DIMA--SDLKKVVDRKIR-LTESQVKC-ILLQI 128
Query: 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDV 251
GL LH +H D+ P+NI ++ KI DFGLAR + K
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR-RYGYPPYSDTLSKD--- 181
Query: 252 NEDNGSILEETESVVT 267
E E T VVT
Sbjct: 182 -ETMQRREEMTSKVVT 196
|
Length = 335 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 28/163 (17%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G FG VYKA + A K++++ + E ++ E+ + ++ + P+IV LLG A
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYMVEIEILATCNHPYIVKLLG-A 77
Query: 147 SDRRGRRLVLI----------YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLE 196
G+ ++I L +R L + + C +++E L+
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE-------------ALQ 124
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
YLH +IH D+K N+LL D K+ DFG++ + L
Sbjct: 125 YLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 49/159 (30%), Positives = 65/159 (40%), Gaps = 20/159 (12%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCP 137
F +G G FG V + A+K L S L+ E+ H E + + D P
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP 61
Query: 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEI-----AIDIA 192
+V L + S + L LI E + + L+ K + E RF I AID
Sbjct: 62 WVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSI 117
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231
L Y IH DIKP N+LLD K+ DFGL
Sbjct: 118 HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH-NELSLASSLDCPHIVSLLG 144
++G G G+VY A+ ++ Q +A+K ++ Q ++E NE+ + P+IV+ L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLD 83
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
S G L ++ E + SL D + E M+ + + + + LE+LH +
Sbjct: 84 --SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN--- 134
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGL 231
VIH DIK NILL D K+ DFG
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 20/153 (13%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL---DCPHIVSLL 143
+G G +G+VY+ + + +A+KI++ + E++L S L P+I
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 144 GFASDRRGRRLVLIYELMENRSLQDAL----LDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
G S +G RL +I E E S++ + + K + I ++ L+Y+H
Sbjct: 69 G--SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV--------IIREVLVALKYIH 118
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
VIH DIK +NIL+ K+ DFG+A
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVA 148
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVK-------ILDSSGSLQGE--REFHNELSLASSLDCP 137
+G G +G VY A+ ++ + +AVK I S Q + + +E+ LD
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
+IV LGF + L + E + S+ L R E RF + +GL Y
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRF-FTEQVLEGLAY 123
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
LH ++H D+K N+L+D D KI DFG+++ K++D+
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISK-KSDDI 161
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREF-HNELSLASSLDCPHIVSLL 143
++G G G V A S+ + +AVK +D Q RE NE+ + P+IV +
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEM- 81
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
++S G L ++ E +E +L D + + E + + + + K L +LH
Sbjct: 82 -YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIATVCLAVLKALSFLHAQ-- 134
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
VIH DIK +ILL D + K+ DFG ++++
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 24/157 (15%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER--EFHNELSLASSLDCPHIVSL 142
+ +GHG FG+VY A +++ +AVK + SG E+ + E+ L P+ +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIA-------KGL 195
G LV+ Y L +L+E +K+ ++IA +GL
Sbjct: 87 KGCYLKEHTAWLVMEYCL------------GSASDLLEVHKKPLQEVEIAAITHGALQGL 134
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
YLH +IH DIK NILL + K+ DFG A
Sbjct: 135 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 48/154 (31%), Positives = 72/154 (46%), Gaps = 16/154 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG-- 144
+G G +G V+K + + AVKILD + E E + A S D P++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-DHPNVVKFYGMY 84
Query: 145 FASDRR-GRRLVLIYELMENRSLQD---ALLDR--KCEELMEWNKRFEIAIDIAKGLEYL 198
+ D + G +L L+ EL S+ D L R + EE + IA + + L L
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-------IAYILHEALMGL 137
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
H IH D+K +NILL + K+ DFG++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH 138
S +LG G FG V+ A ++ +AVK + GS+ E F E ++ +L
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTM-KPGSMSVE-AFLAEANVMKTLQHDK 62
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEE--LMEWNKRFEIAIDIAKGLE 196
+V L + + +I E M SL D L K +E K + + IA+G+
Sbjct: 63 LVKLHAVVTKEP---IYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
++ + IH D++ +NIL+ KI DFGLAR+
Sbjct: 117 FIE---QRNYIHRDLRAANILVSASLVCKIADFGLARV 151
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 11/156 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+G G +G V A+ + + +A+K I D + E+ L L P IV +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 146 ---ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
S R + + +++ELME+ Q + + ++L + +F + + L+Y+H +
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQ---VIKANDDLTPEHHQF-FLYQLLRALKYIHTA- 122
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
V H D+KP NIL + D K KI DFGLAR+ D
Sbjct: 123 --NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 34/174 (19%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-----FHNELSLASSLDCPHIVS 141
LG G F S Y+A + +AVK + + E+E E+ L + L+ PHI+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 142 LLGFASDRRGRRLVLIYELMENRSL----------QDALLDRKCEELMEWNKRFEIAIDI 191
+LG + L E M S+ ++A++ E+L+
Sbjct: 68 MLG--ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL------------ 113
Query: 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK-AKIGDFGLARLKTEDLMIEGE 244
+GL YLH E +IH D+K +N+L+D + +I DFG A GE
Sbjct: 114 -RGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 29/172 (16%)
Query: 86 RLGHGGFGSVYK--------------AVVPSSSQPL--AVKILDSSGSLQGEREFHNELS 129
+LG G FG V+ ++ S +QP+ AVK+L + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 130 LASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEE-LMEWNKRF--- 185
+ S L P+I+ LL L +I E MEN L L + +E + +
Sbjct: 72 IMSRLKDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 186 ----EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+A IA G++YL +H D+ N L+ ++ KI DFG++R
Sbjct: 130 STLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 29/77 (37%), Positives = 39/77 (50%), Gaps = 19/77 (24%)
Query: 191 IAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRD 250
I +GL+Y+H S V+H D+KPSN+LL+ + KI DFGLAR+
Sbjct: 115 ILRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADP------------- 158
Query: 251 VNEDNGSILEETESVVT 267
D+ L TE V T
Sbjct: 159 -EHDHTGFL--TEYVAT 172
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 19/152 (12%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKI--LDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG G GSV K + +A K+ + + S++ ++ EL + P+IVS G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRSPYIVSFYG 70
Query: 145 -FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL---HH 200
F ++ + + E M+ SL D + +K + +IA+ + +GL YL H
Sbjct: 71 AFLNENN---ICMCMEFMDCGSL-DRIY-KKGGPIPV-EILGKIAVAVVEGLTYLYNVHR 124
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
++H DIKPSNIL++ + K+ DFG++
Sbjct: 125 -----IMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 10/149 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPL--AVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG G FG V K V + + A+K+L + E E + LD P+IV ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
L+L+ E+ L L +K +E+ N E+ ++ G++YL
Sbjct: 63 VC---EAEALMLVMEMASGGPLNKFLSGKK-DEITVSNV-VELMHQVSMGMKYLE---GK 114
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+H D+ N+LL AKI DFGL++
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 11/160 (6%)
Query: 82 SPSNRLGHGGFGSVYKAVVPSSSQP---LAVKILDSSGSLQGEREFHNELSLASSLDCPH 138
+ +G G FG VY+ V S +AVK + S +F E + D PH
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
IV L+G ++ + ++ EL L+ L K ++ + ++ L YL
Sbjct: 69 IVKLIGVITENP---VWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYL 123
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H DI N+L+ K+GDFGL+R ++
Sbjct: 124 ESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 20/170 (11%)
Query: 81 FSPSNRLGHGGFGS--VYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH 138
+ P LG G FG +Y+ S + ++ + S + R+ NE+ + S L P+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 139 IVSLLG-FASDRRGRRLVLIYELMENRSLQDALLDRKC----EELMEWNKRFEIAIDIAK 193
I++ F D L++ E +L D ++ +K EE++ W I
Sbjct: 61 IIAYYNHFMDDNT---LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVS 112
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR-LKTEDLMIE 242
+ Y+H + ++H DIK NI L K+GDFG+++ L +E M E
Sbjct: 113 AVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
++LG G + +V+K + +A+K + E+SL +L +IV+L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
R L L++E +++ Q LD C LM + + +GL Y H
Sbjct: 71 IIHTERC--LTLVFEYLDSDLKQ--YLD-NCGNLMSMHNVKIFMFQLLRGLSYCHKR--- 122
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236
++H D+KP N+L++ + K+ DFGLAR K+
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKS 154
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 10/151 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLL-G 144
+G G FG V+ + + + +K + + ER NE + L P+I+
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F D+ L+++ E +L + + ++C L++ + + I L LHH
Sbjct: 68 FLEDKA---LMIVMEYAPGGTLAE-YIQKRCNSLLDEDTILHFFVQI---LLALHHVHTK 120
Query: 205 PVIHGDIKPSNILLDG-DFKAKIGDFGLARL 234
++H D+K NILLD KIGDFG++++
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 29/180 (16%)
Query: 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH-----NELS 129
+R F ++G G +G VYKA + + +A+K + L E+E E+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV----RLDNEKEGFPITAIREIK 58
Query: 130 LASSLDCPHIVSLLGFASD--------RRGRRLVLIYELMENR---SLQDALLDRKCEEL 178
+ L+ +IV+L +D + L++E M++ L+ L+ + +
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 179 MEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ K+ + +GL Y H +H DIK SNILL+ + K+ DFGLARL +
Sbjct: 119 KSFMKQ------LLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 40/164 (24%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK------ILDSSGSLQGEREFHNELSLAS 132
A+F ++G G F VY+A +P+A+K ++D+ + ++ E+ L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA----KARQDCVKEIDLLK 57
Query: 133 SLDCPHIVSLL-GFASDRRGRRLVLIYELMENRSLQDALLD-RKCEELMEWNKRFEIAID 190
L+ P+++ L F D L ++ EL + L + +K + L+ ++ +
Sbjct: 58 QLNHPNVIKYLDSFIEDNE---LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 191 IAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+ +E++H V+H DIKP+N+ + K+GD GL R
Sbjct: 115 LCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+LG+G FG V+ +++ +AVK L G++ E F E + L +V L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTK-VAVKTL-KPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAV 69
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
S+ + ++ E M SL D L D + L + ++A +A G+ Y+
Sbjct: 70 VSEEP---IYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIERM---N 122
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARL 234
IH D++ +NIL+ KI DFGLARL
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 27/176 (15%)
Query: 87 LGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LG G FG V KA + +AVK+L + S R+ +E +L ++ PH++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 142 LLGFASDRRGRRLVLIYE--------LMENR-----------SLQDALLDRKCEELMEWN 182
L G S L++ Y L E+R + + LD E +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 183 KRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
A I++G++YL E ++H D+ N+L+ K KI DFGL+R E+
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 14/166 (8%)
Query: 87 LGHGGFGSVYKAVVPS--SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+G+G FG V S + VK L +S + + F E+ L+ P+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKR----FEIAIDIAKGLEYLHH 200
+ +L+ E L++ L R ++ + +A ++A GL +LH
Sbjct: 63 QCIE--SIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK-TEDLMIEGEC 245
+ IH D+ N L D KIGD+GLA + ED I +C
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC 161
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 36/152 (23%), Positives = 59/152 (38%), Gaps = 25/152 (16%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD----SSGSLQGEREFHNELSLASSLDCPHIVSL 142
+ K ++ +AVK ++ S L+ E+ + L P+I+
Sbjct: 10 FEDLMIVHLAKHK--PTNTLVAVKKINLDSCSKEDLK---LLQQEIITSRQLQHPNILPY 64
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI-----DIAKGLEY 197
+ S L ++ LM S +D LL E + E+AI D+ L+Y
Sbjct: 65 V--TSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLP-----ELAIAFILKDVLNALDY 116
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229
+H IH +K S+ILL GD K +
Sbjct: 117 IHSK---GFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 44/149 (29%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 90 GGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELS----LASSLDCPHIVSLLGF 145
G FGSVY A S+ A+K+L S + + + N + + + P++ L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKS-DMIAKNQVTNVKAERAIMMIQGESPYVAKL--Y 63
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELME-WNKRFEIAIDIAKGLEYLHHSCEP 204
S + L L+ E + A L + L E W K++ ++ G+E LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDC--ASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQR--- 116
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+IH DIKP N+L+D K+ DFGL+R
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 40/155 (25%), Positives = 63/155 (40%), Gaps = 17/155 (10%)
Query: 90 GGFGSVYKAVV----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
G FG ++ ++ P + + VK + S E L L +I+ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKR-------FEIAIDIAKGLEYL 198
+ VL Y M +L+ L ++C N + +AI IA G+ YL
Sbjct: 77 CIEDGEPPFVL-YPYMNWGNLKLFL--QQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
H VIH DI N ++D + + KI D L+R
Sbjct: 134 HKR---GVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 24/163 (14%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER--EFHNELSLASSLDCPH 138
FS +GHG FG+VY A +S+ +A+K + SG E+ + E+ L P+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIA------ 192
+ G LV+ Y L +L+E +K+ ++IA
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL------------GSASDLLEVHKKPLQEVEIAAVTHGA 124
Query: 193 -KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+GL YLH +IH D+K NILL K+GDFG A +
Sbjct: 125 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 22/162 (13%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---ELSLASSLDC 136
F LG G G V+ + + + A+K+LD + + E + ++LD
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKK-EMIKRNKVKRVLTEQEILATLDH 60
Query: 137 PHIVSLLG-FASDRRGRRLVLIYELMENRSLQD--ALLDR---KCEELMEWNKRFEIAID 190
P + +L F ++ + +M+ + LL R KC L E RF A +
Sbjct: 61 PFLPTLYASFQTET------YLCLVMDYCPGGELFRLLQRQPGKC--LSEEVARFYAA-E 111
Query: 191 IAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+ LEYLH +++ D+KP NILL + DF L+
Sbjct: 112 VLLALEYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
+G G FG V + +AVK + + + Q F E S+ + L ++V LLG
Sbjct: 14 IGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206
+ +G L ++ E M SL D L R ++ + + ++D+ + +EYL +
Sbjct: 69 VEEKGG-LYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 207 IHGDIKPSNILLDGDFKAKIGDFGLAR 233
+H D+ N+L+ D AK+ DFGL +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 9/151 (5%)
Query: 87 LGHGGFGSV----YKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG V Y ++ + +AVK L + E+ + +L +IV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
G ++ G + LI E + + SL++ L K + + ++ + A+ I KG++YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGSR- 128
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+H D+ N+L++ + + KIGDFGL +
Sbjct: 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 30/173 (17%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---------ELSLASSLDCP 137
+G G G V A + Q +A+K L R F N EL L ++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKL--------SRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 138 HIVSLLG-FASDRRGRRLVLIYELMENRSLQDALLDRKCEEL-MEWN-KRFEIAI-DIAK 193
+I+ LL F + +Y +ME L DA L C+ + M+ + +R + +
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVME---LMDANL---CQVIQMDLDHERMSYLLYQMLC 129
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECV 246
G+++LH + +IH D+KPSNI++ D KI DFGLAR M+ V
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 179
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 47/175 (26%), Positives = 74/175 (42%), Gaps = 40/175 (22%)
Query: 86 RLGHGGFGSVYKA-----VVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC---- 136
LG G FG V KA P+ + +AVK+L + E++ L S ++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT---EKDL---SDLVSEMEMMKMI 72
Query: 137 ---PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEI------ 187
+I++LLG + G L ++ E + +L+D L R+ +
Sbjct: 73 GKHKNIINLLG-VCTQEGP-LYVVVEYAAHGNLRDFLRARRPPG-EYASPDDPRPPEETL 129
Query: 188 --------AIDIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
A +A+G+E+L C IH D+ N+L+ D KI DFGLAR
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKC----IHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 7e-07
Identities = 26/114 (22%), Positives = 46/114 (40%), Gaps = 18/114 (15%)
Query: 460 SMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISW 519
+ GT Y+APE G + D++S GV++ L++G+ P F + +
Sbjct: 155 TFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP----------FPGDDQLLE 204
Query: 520 ARQLAYNGKLLDLVDPSIHSLD-KDQALLCITIALLCLQRSPSKRLTMKDIVEM 572
+ K S + KD L+ L + P KRLT ++ ++
Sbjct: 205 LFKKIGKPKPPFPPPEWDISPEAKD--LIR-----KLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 22/48 (45%), Positives = 33/48 (68%), Gaps = 3/48 (6%)
Query: 191 IAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
I +GL+YLH + ++H DIKP N+L++ + KI DFGLAR++ D
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK---ILDSSGSLQGEREFHNELSLASSLD 135
A+F ++G G F VY+A P+A+K I D + + + E+ L L+
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA-KARADCIKEIDLLKQLN 60
Query: 136 CPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLD-RKCEELMEWNKRFEIAIDIAKG 194
P+++ +AS L ++ EL + L + +K + L+ ++ + +
Sbjct: 61 HPNVIKY--YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 195 LEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
LE++H V+H DIKP+N+ + K+GD GL R
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 29/115 (25%), Positives = 52/115 (45%), Gaps = 7/115 (6%)
Query: 122 REFHNELSLASSLDCPHIVSLLGFASDRRGR--RLVLIYELMENRSLQDALLDRKCEELM 179
NE+ +D +I+ + GF D RL LI E L++ L E+ +
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDL 119
Query: 180 EWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+ + ++AID KGL L+ P + ++ + L+ ++K KI GL ++
Sbjct: 120 SFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKI 172
|
Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 50/166 (30%), Positives = 73/166 (43%), Gaps = 8/166 (4%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCP 137
+F LG GGFG V V ++ + A K L+ +GE NE + ++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
+VSL +A + + L L+ LM L+ + E F A +I GLE
Sbjct: 61 FVVSL-AYAYETKDA-LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLED 117
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEG 243
LH +++ D+KP NILLD +I D GLA E I+G
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 48/174 (27%), Positives = 70/174 (40%), Gaps = 33/174 (18%)
Query: 86 RLGHGGFGSVY--KAVVPS------------SSQPL--AVKILDSSGSLQGEREFHNELS 129
+LG G FG V+ +A + P+ AVK+L S +F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 130 LASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELME---WNKRF- 185
+ S L P+I LLG L +I E MEN L L +K N +
Sbjct: 72 ILSRLSDPNIARLLGVC--TVDPPLCMIMEYMENGDLNQFL--QKHVAETSGLACNSKSL 127
Query: 186 ------EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+A IA G+ YL +H D+ N L+ ++ KI DFG++R
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 8/157 (5%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE-REFHNELSLASSLDCPHIVSLLG- 144
+G G G V A +AVK L Q + + EL L ++ +I+SLL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F + +Y +ME L DA L + ++ + + + G+++LH +
Sbjct: 89 FTPQKSLEEFQDVYLVME---LMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA--- 142
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMI 241
+IH D+KPSNI++ D KI DFGLAR + M+
Sbjct: 143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM 179
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 16/153 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE---REFHNELSLASSLDCPHIVSLL 143
+G G +GSV A+ + + +A+K L S Q E + + EL+L + +++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 144 G-FASDRRGRRLVLIYELME--NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
F S G Y +M LQ + E+ +++ + + GL+Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIHS 135
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ +IH D+KP N+ ++ D + KI DFGLAR
Sbjct: 136 A---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 8/152 (5%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
++LG G + +VYK + +A+K + E+SL L +IV+L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ L L++E ++ + L+ L D C + + + +GL Y H
Sbjct: 72 IIHTEKS--LTLVFEYLD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRR--- 123
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236
V+H D+KP N+L++ + K+ DFGLAR K+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKS 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 10/146 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
++G G G+VY A+ ++ Q +A++ ++ + E NE+ + P+IV+ L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLD- 84
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
S G L ++ E + SL D + E M+ + + + + LE+LH +
Sbjct: 85 -SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGL 231
VIH DIK NILL D K+ DFG
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 22/154 (14%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
LG G FG V A + + A+K L D SL E+ A+S P
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRI---FETANSERHPF 63
Query: 139 IVSLLG-FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
+V+L F ++ + +ME + D ++ + E F A + GL+Y
Sbjct: 64 LVNLFACFQTEDH------VCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAA-CVVLGLQY 116
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231
LH E +++ D+K N+LLD + KI DFGL
Sbjct: 117 LH---ENKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-----FHNELSLASSLD 135
++ ++G G +G VYK + Q +A+K + L+ E E E+SL L
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQ 57
Query: 136 CPHIVSLLGFASDRRGRRLVLIYEL--MENRSLQDALLDRKCEELMEWNKRFEIAIDIAK 193
P+IV L RL LI+E M+ + D+L + M+ I +
Sbjct: 58 HPNIVCLQDVLMQES--RLYLIFEFLSMDLKKYLDSL---PKGQYMDAELVKSYLYQILQ 112
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
G+ + H V+H D+KP N+L+D K+ DFGLAR
Sbjct: 113 GILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH----NELSLAS 132
A S+ +LG G + +VYK + + Q +A+K++ S++ E E SL
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLK 58
Query: 133 SLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIA 192
L +IV L + L ++E M Q + + L +N R +
Sbjct: 59 GLKHANIVLLHDIIHTKE--TLTFVFEYMHTDLAQ--YMIQHPGGLHPYNVRL-FMFQLL 113
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236
+GL Y+H ++H D+KP N+L+ + K+ DFGLAR K+
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS 154
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 24/163 (14%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER--EFHNELSLASSLDCPH 138
F+ +GHG FG+VY A +++ +A+K + SG E+ + E+ + P+
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIA------ 192
+ G LV+ Y L +L+E +K+ ++IA
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL------------GSASDLLEVHKKPLQEVEIAAITHGA 134
Query: 193 -KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+GL YLH +IH DIK NILL + K+ DFG A +
Sbjct: 135 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 41/153 (26%), Positives = 73/153 (47%), Gaps = 17/153 (11%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH-NELSLASSLDCPHIVSLLG 144
++G G +G+V+KA + + +A+K + +G E+ L L +IV L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 145 -FASDRRGRRLVLIYELMENRSLQDALLDRKCEEL---MEWNKRFEIAIDIAKGLEYLHH 200
SD++ L L++E + QD L + + ++ + KGL + H
Sbjct: 67 VLHSDKK---LTLVFEYCD----QD--LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH- 116
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
V+H D+KP N+L++ + + K+ DFGLAR
Sbjct: 117 --SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
R+G G FG V+ + + + P+AVK + + +F E + P+IV L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDR----KCEELMEWNKRFEIAIDIAKGLEYLHHS 201
+ + + + ++ EL++ L K +EL+ ++ + A G+EYL
Sbjct: 62 CTQK--QPIYIVMELVQGGDFLTFLRTEGPRLKVKELI------QMVENAAAGMEYLESK 113
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IH D+ N L+ KI DFG++R
Sbjct: 114 H---CIHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 87 LGHGGFGSVY---KAVVPSSSQPLAVKIL-DSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG V+ K P + Q A+K+L ++ ++ E + + ++ P IV L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELM--EWNKRFEIAIDIAKGLEYLHH 200
+A G+ L LI + + L R +E+M E + +F +A ++A L++LH
Sbjct: 64 -HYAFQTEGK-LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLA-ELALALDHLH- 115
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+I+ D+KP NILLD + K+ DFGL++
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 21/156 (13%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ--------GEREFHNELSLASSLDCPH 138
+G G FG VY+ + + A+K+L + GER N L + P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGER---NILVRTLLDESPF 57
Query: 139 IVSL-LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
IV L F +D L L+ + M L L +K E +F IA ++ LE+
Sbjct: 58 IVGLKFSFQTDSD---LYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIA-ELVLALEH 111
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
LH + +++ D+KP NILLD + DFGL++
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 8/148 (5%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG GGFG V V ++ + A K LD GE+ E + ++ P IV+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+A + + L L+ LM L+ + + E +E + + I G+ +LH
Sbjct: 60 YAFESK-THLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+++ D+KP N+LLD ++ D GLA
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 10/146 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
++G G G+VY A+ ++ Q +A+K ++ + E NE+ + P+IV+ L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII-NEILVMRENKNPNIVNYLD- 83
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
S G L ++ E + SL D + E M+ + + + + L++LH +
Sbjct: 84 -SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---Q 135
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGL 231
VIH DIK NILL D K+ DFG
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
++ ++G G G+V+ A+ ++ Q +A+K ++ + E NE+ + L P+IV
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII-NEILVMKELKNPNIV 79
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
+ L S G L ++ E + SL D + E M+ + + + + LE+LH
Sbjct: 80 NFLD--SFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHA 133
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231
+ VIH DIK N+LL D K+ DFG
Sbjct: 134 N---QVIHRDIKSDNVLLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 8/164 (4%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE-REFHNELSLASSLDCPHIVSLLG- 144
+G G G V A + +A+K L Q + + EL L ++ +I+ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F + +Y +ME L DA L + + ++ + + + G+++LH +
Sbjct: 92 FTPQKSLEEFQDVYIVME---LMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA--- 145
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKK 248
+IH D+KPSNI++ D KI DFGLAR M+ V +
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 8/152 (5%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+LG G + +V+K + +A+K + E+SL L +IV+L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ L L++E ++ + L+ + D C +M + I +GL Y H
Sbjct: 72 IV--HTDKSLTLVFEYLD-KDLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRR--- 123
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236
V+H D+KP N+L++ + K+ DFGLAR K+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKS 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+LG G FG V+ +++ +A+K L G++ E F E + L +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTL-KPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 69
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
S+ + ++ E M SL D L + + + + ++A IA G+ Y+
Sbjct: 70 VSEEP---IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+H D++ +NIL+ + K+ DFGLARL
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 17/151 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN----ELSLASSLDCPHIVSL 142
LG G G V K + S +A K++ L+ + N EL + + P+IV
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLI----HLEIKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 143 LG-FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
G F SD + + E M+ SL D +L +K + E N +I+I + +GL YL
Sbjct: 65 YGAFYSDGE---ISICMEHMDGGSL-DQVL-KKAGRIPE-NILGKISIAVLRGLTYLRE- 117
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+ ++H D+KPSNIL++ + K+ DFG++
Sbjct: 118 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG-EREFHNELSLASSL-DCPHIVSLL 143
++G G +G VYKA ++ + +A+K +G E+SL L + +IV LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 144 GFAS--DRRGR-RLVLIYELMEN--RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
++ G+ L L++E +++ + D R + + KG+ +
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMD-SNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 199 H-HSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGLAR 233
H H V+H D+KP N+L+D KI D GL R
Sbjct: 127 HKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G FG V K +A+K++ GS+ E EF E + L +V L G
Sbjct: 12 LGTGQFG-VVKYGKWRGQYDVAIKMI-KEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206
+ +R + ++ E M N L + L R+ + + ++ E+ D+ +G+ YL
Sbjct: 69 TKQR--PIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 207 IHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ N L+D K+ DFGL+R +D
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 48/166 (28%), Positives = 72/166 (43%), Gaps = 8/166 (4%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCP 137
+F LG GGFG V V ++ + A K L+ +GE NE + ++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
+V+L +A + + L L+ +M L+ + + E F A +I GLE
Sbjct: 61 FVVNL-AYAYETKDA-LCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-YAAEILCGLED 117
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEG 243
LH ++ D+KP NILLD +I D GLA E I G
Sbjct: 118 LHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 14/153 (9%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLG- 144
+G G +G VYK AVKILD + + E E ++ SL + P++V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDV--DEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 145 -FASDR-RGRRLVLIYELMENRSLQD---ALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
+ +D+ G +L L+ EL S+ + LL C + ++ I GL++LH
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLL--ICGQRLDEAMISYILYGALLGLQHLH 145
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
++ +IH D+K +NILL + K+ DFG++
Sbjct: 146 NN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 191 IAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
I GL+Y+H + V+H D+KP N+L++ D + KI DFGLAR
Sbjct: 114 ILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 28/169 (16%)
Query: 87 LGHGGFGSVYKAVV-------PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPH 138
LG G FG V +A P + +AVK+L + + + + +E+ L + +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRK-------------CEELMEWNKRF 185
I++LLG + + L +I E +L++ L R+ EE + +
Sbjct: 80 IINLLGVCT--QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 186 EIAIDIAKGLEYLH-HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
A +A+G+EYL C IH D+ N+L+ D KI DFGLAR
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE-REFHNELSLASSLDCPHIVSLLG- 144
+G G G V A + +A+K L Q + + EL L ++ +I+SLL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F + +Y +ME L DA L + + ++ + + + G+++LH +
Sbjct: 85 FTPQKSLEEFQDVYLVME---LMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA--- 138
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMI 241
+IH D+KPSNI++ D KI DFGLAR M+
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
F + LG G G V K S +A K++ + EL + + P+IV
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 141 SLLG-FASDRRGRRLVLIYELMENRSLQDALLD--RKCEELMEWNKRFEIAIDIAKGLEY 197
G F SD + + E M+ SL L + R EE++ +++I + +GL Y
Sbjct: 67 GFYGAFYSDGE---ISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAY 118
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
L + ++H D+KPSNIL++ + K+ DFG++
Sbjct: 119 LREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH---NELSLASSLDCPHIVSLL 143
+G G FG V A + + AVK+L L+ + E H L ++ P +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
S + +L + + + L L +C +E RF A +IA L YLH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARF-YAAEIASALGYLH---S 114
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
+++ D+KP NILLD + DFGL + E
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 45/147 (30%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
+G G FG V + A+KIL + L+ E+ H E + D +V +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM-- 66
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F S + R L LI E + + L+ K + L E +F IA + ++ +H +
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIA-ETVLAIDAIH---QL 120
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGL 231
IH DIKP N+LLD K+ DFGL
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 81 FSPSNRLGHGGFGSVYKAV-VPSSSQPLAVKILDSSGSLQGE-----REFHNELSLASSL 134
+ +G G +G V+KA + + + +A+K + +G RE L +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETF 61
Query: 135 DCPHIVSLLGFASDRRGRR---LVLIYELMENRSLQD--ALLDRKCEELMEWNKRFEIAI 189
+ P++V L + R R L L++E ++ QD LD+ E + ++
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 190 DIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+ +GL++LH V+H D+KP NIL+ + K+ DFGLAR+
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 6e-06
Identities = 27/121 (22%), Positives = 49/121 (40%), Gaps = 17/121 (14%)
Query: 445 ASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVT 504
+ + T S+RGT ++APE G D++S G ++ + +G+ P
Sbjct: 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206
Query: 505 ASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRL 564
+PM+ + + +G+ P I ++A + CL+R P KR
Sbjct: 207 GNPMAALYK---------IGSSGEP-----PEIPEHLSEEAKDFL---RKCLRRDPKKRP 249
Query: 565 T 565
T
Sbjct: 250 T 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 48.6 bits (114), Expect = 6e-06
Identities = 23/131 (17%), Positives = 43/131 (32%), Gaps = 10/131 (7%)
Query: 444 WASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLL---SEKCDVYSFGVLILVLISGRRP 500
S + + GT Y+APE G L S D++S G+ + L++G P
Sbjct: 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
Query: 501 LQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSP 560
+ + + + +L P S + + + L + P
Sbjct: 211 FE---GEKNSSATSQTLKIILELPTPSLAS----PLSPSNPELISKAASDLLKKLLAKDP 263
Query: 561 SKRLTMKDIVE 571
RL+ +
Sbjct: 264 KNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 31/111 (27%), Positives = 59/111 (53%), Gaps = 10/111 (9%)
Query: 467 YIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFE-RANLISWARQLAY 525
Y+APE ++EK D+Y FG++++ L++G+ P EF +++ WAR
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA------EFGVHGSIVEWARYCYS 897
Query: 526 NGKLLDLVDPSIH---SLDKDQALLCITIALLCLQRSPSKRLTMKDIVEML 573
+ L +DPSI S+++++ + + +AL C P+ R D+++ L
Sbjct: 898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G FG V+ + + +A+K ++ G++ E +F E + L P +V L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-VAIKAINE-GAMS-EEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206
+ ++ L ++ E MEN L + L R+ + + + + D+ +G+EYL +
Sbjct: 69 TQQK--PLYIVTEFMENGCLLNYLRQRQGK--LSKDMLLSMCQDVCEGMEYLERN---SF 121
Query: 207 IHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ N L+ K+ DFG+ R +D
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 15/161 (9%)
Query: 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREF---HNELSLA 131
R F R+G G +G VYKA ++ + A+K++ L+ +F E+ +
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI----KLEPGEDFAVVQQEIIMM 60
Query: 132 SSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDI 191
DC H + F S R +L + E SLQD + L E + ++ +
Sbjct: 61 K--DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD--IYHVTGPLSESQIAY-VSRET 115
Query: 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+GL YLH + +H DIK +NILL + K+ DFG++
Sbjct: 116 LQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+LG G FG V+ +++ +A+K L G++ E F E + L +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTL-KPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAV 69
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
S+ + ++ E M SL D L + + L + + ++A IA G+ Y+
Sbjct: 70 VSEEP---IYIVTEFMGKGSLLDFLKEGDGKYL-KLPQLVDMAAQIADGMAYIERM---N 122
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARL 234
IH D++ +NIL+ + KI DFGLARL
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 50/153 (32%), Positives = 72/153 (47%), Gaps = 17/153 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G +G VY A S+ +A+K + S + + H E++L S L +IV LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLG-- 72
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI-----DIAKGLEYLHHS 201
SD + E + SL ALL K L K E I I +GL+YLH
Sbjct: 73 SDSENGFFKIFMEQVPGGSLS-ALLRSKWGPL----KDNEQTIIFYTKQILEGLKYLH-- 125
Query: 202 CEPPVIHGDIKPSNILLDG-DFKAKIGDFGLAR 233
+ ++H DIK N+L++ KI DFG ++
Sbjct: 126 -DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
++G G G V A + + +AVK +D + E F NE+ + ++V + +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDM--Y 85
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
S G L ++ E +E +L D + + E + + + + + L YLH+
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIATVCLSVLRALSYLHNQ---G 138
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGL 231
VIH DIK +ILL D + K+ DFG
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 30/165 (18%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI------- 139
+G GGFG VY+ +S + + + +L+ E L + D I
Sbjct: 20 IGCGGFGCVYE-TQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 140 -VSLLG---------FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF--EI 187
+ LG F R R +L+ +L+EN + R + NK+ I
Sbjct: 79 NIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVEN---TKEIFKR----IKCKNKKLIKNI 131
Query: 188 AIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
D+ LEY+H E + HGDIKP NI++DG+ + I D+G+A
Sbjct: 132 MKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 6/147 (4%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G +GSVYK + + +A+K + + EL + P+IV G A
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG-A 67
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCE-ELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
G + + E M+ SL D L E + + I + KGL++L E
Sbjct: 68 FFIEGAVYMCM-EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLA 232
+IH D+KP+N+L++G+ + K+ DFG++
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 8e-06
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASS 133
+R F +G+G +G VYK + Q A+K++D +G E E E+++
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKK 58
Query: 134 LDCPHIVSLLGFASDRRG-----RRLVLIYELMENRSLQDALLDRKCEELME-WNKRFEI 187
++ A ++ +L L+ E S+ D + + K L E W I
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--I 116
Query: 188 AIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+I +GL +LH + VIH DIK N+LL + + K+ DFG++
Sbjct: 117 CREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 13/151 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLAS----SLDCPHIVSL 142
LG G FG V A + S + AVK+L LQ + E ++ SL H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDD---DVECTMTEKRILSLARNHPFLT 59
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
+ + RL + E + L + +K E RF A +I L +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARF-YAAEITSALMFLH--- 113
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ +I+ D+K N+LLD + K+ DFG+ +
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
++G G G V A V SS + +AVK +D + E F NE+ + ++V + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--Y 83
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
S G L ++ E +E +L D + + E + + + + K L LH
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----EQIAAVCLAVLKALSVLHAQ---G 136
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGL 231
VIH DIK +ILL D + K+ DFG
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 8e-06
Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 41/167 (24%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG-----EREFHNELSLASSLDCPHI 139
NR+ G +G VY+A + + +A+K L +G RE ++ L P+I
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI----NILLKLQHPNI 66
Query: 140 VSLLGFASDRRGRRLVL------IYELMENRSLQDALLDRKCEELMEWNK-RFEIA---- 188
V++ + +V+ IY +ME ++ + LME K F +
Sbjct: 67 VTV---------KEVVVGSNLDKIYMVME-------YVEHDLKSLMETMKQPFLQSEVKC 110
Query: 189 --IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ + G+ +LH + ++H D+K SN+LL+ KI DFGLAR
Sbjct: 111 LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 36/168 (21%), Positives = 66/168 (39%), Gaps = 20/168 (11%)
Query: 79 ASFSPSNRLGHGGFGSVYKAVVPSSS-----QPLAVKILDSSGSLQGEREFHNELSLASS 133
++ LG G FG V+ A + VK L + + EF EL +
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 134 LDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNK--------RF 185
L ++V LLG + ++L E + L+ L K ++ E K +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMIL--EYTDLGDLKQFLRATKSKD--EKLKPPPLSTKQKV 120
Query: 186 EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ IA G+++L ++ +H D+ N L+ + K+ L++
Sbjct: 121 ALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
S+ +LG G + +VYK + + +A+K++ E SL L +I
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
V L + L L++E + Q +D+ L N + + +GL Y+H
Sbjct: 66 VLLHDIIHTKE--TLTLVFEYVHTDLCQ--YMDKHPGGLHPENVKL-FLFQLLRGLSYIH 120
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236
++H D+KP N+L+ + K+ DFGLAR K+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 16/158 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVK--ILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG G G V+ AV + +AVK +L S+ + E+ + LD +IV +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV---KHALREIKIIRRLDHDNIVKVYE 69
Query: 145 FASDRRGRRLVLIYELMENRSLQ--DALLDRKCEELMEWNKRFE-----IAIDIAKGLEY 197
+ L E S+ ++ ++E E + +GL+Y
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKY 129
Query: 198 LHHSCEPPVIHGDIKPSNILLDG-DFKAKIGDFGLARL 234
+H + V+H D+KP+N+ ++ D KIGDFGLAR+
Sbjct: 130 IHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 6/149 (4%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREF-HNELSLASSLDCPHIVSLLGF 145
+G G +G V + + +K L+ + + ER+ E L S L P+IV+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
G L ++ E L L ++K + L E N+ E + IA L+YLH E
Sbjct: 68 WEGEDGL-LYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLH---EKH 122
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARL 234
++H D+K N+ L K+GD G+AR+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARV 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 29/165 (17%)
Query: 84 SNRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGERE-FH----NELSLASSLDCP 137
++G G FG V+KA + Q +A+K +L ++ E+E F E+ + L
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVL-----MENEKEGFPITALREIKILQLLKHE 71
Query: 138 HIVSLL------GFASDRRGRRLVLIYELMEN---RSLQDALLDRKCEELMEWNKRFEIA 188
++V+L+ +R L++E E+ L + + E+ + K
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM---- 127
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ GL Y+H + ++H D+K +NIL+ D K+ DFGLAR
Sbjct: 128 --LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 26/168 (15%)
Query: 87 LGHGGFGSVYKAVV-------PSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPH 138
LG G FG V A P+ +AVK+L S + + + +E+ + + +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRK------C-------EELMEWNKRF 185
I++LLG A + G L +I E +L++ L R+ C EE + +
Sbjct: 86 IINLLG-ACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 186 EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
A +A+G+EYL IH D+ N+L+ D KI DFGLAR
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 27/115 (23%), Positives = 40/115 (34%), Gaps = 52/115 (45%)
Query: 460 SMRGTVCYIAPE-YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLIS 518
++ GT Y+APE G G SEK D++S GV++ + E +LI
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE--------------LPEL--KDLIR 195
Query: 519 WARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEML 573
LQ+ P KR + K+I+E L
Sbjct: 196 K-----------------------------------MLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 32/122 (26%), Positives = 54/122 (44%), Gaps = 14/122 (11%)
Query: 451 KSGGISSTPSMRGTVCYIAPE-YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMS 509
SS + GT Y+APE GG K DV+S GV++ L++G+ P + +
Sbjct: 148 LLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFS-GENILD 206
Query: 510 EFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
+ + I G L+ +P S ++ + CL + PSKR T ++I
Sbjct: 207 QLQLIRRIL--------GPPLEFDEPKWSSGSEE----AKDLIKKCLNKDPSKRPTAEEI 254
Query: 570 VE 571
++
Sbjct: 255 LQ 256
|
Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
F + LG G G V+K S +A K++ + EL + + P+IV
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 141 SLLG-FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
G F SD + + E M+ SL L +K + E +++I + KGL YL
Sbjct: 67 GFYGAFYSDGE---ISICMEHMDGGSLDQVL--KKAGRIPE-QILGKVSIAVIKGLTYLR 120
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+ ++H D+KPSNIL++ + K+ DFG++
Sbjct: 121 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL-DSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+G G +G V K + + +A+K DS + + + EL + +L +IV L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE- 67
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
A RRG+ L L++E +E L+ LL EE+ ++ I + ++ +H +
Sbjct: 68 AFRRRGK-LYLVFEYVEKNMLE--LL----EEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
++H DIKP N+L+ + K+ DFG AR +E
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 34/160 (21%)
Query: 90 GGFGSVYKAVVPSSSQPLAVKILDSS--------GSLQGEREFHNELSLASSLDCPHIVS 141
G FG VY ++S+ AVK++ + +Q ER + L+L+ S P IV
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAER---DALALSKS---PFIVH 68
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDAL-----LDRKCEELMEWNKRFEIAIDIAKGLE 196
L + S + + L+ E + ++ L D EE+ I+ ++A L+
Sbjct: 69 L--YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD---EEM----AVKYIS-EVALALD 118
Query: 197 YLH-HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235
YLH H +IH D+KP N+L+ + K+ DFGL+++
Sbjct: 119 YLHRHG----IIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG GGFG V V ++ + A K L+ +GE NE + ++ +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+A + + L L+ LM L+ + + E F A +I GLE LH
Sbjct: 67 YAYETKDA-LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-YAAEITCGLEDLHRE--- 121
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEG 243
+++ D+KP NILLD +I D GLA E I G
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 37/151 (24%), Positives = 56/151 (37%), Gaps = 19/151 (12%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSS-GSLQGEREFHNELSLAS-SLDCPHIVSLL 143
L G VY + + + +KI S ERE LA L P ++
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVL--- 59
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
AS L+ E +E +L + ++ +IA +A+ L LH
Sbjct: 60 --ASGESDGWSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPL 107
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+ HGD+ P NIL+D I D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 24/159 (15%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--------REFHNELSLASSLDCP 137
+LG G + +VYK + Q +A+K + L+ E RE SL L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI----RLEHEEGAPFTAIRE----ASLLKDLKHA 63
Query: 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
+IV+L ++ L L++E ++ L+ + C + + + +GL Y
Sbjct: 64 NIVTLHDIIHTKK--TLTLVFEYLD-TDLKQYM--DDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236
H V+H D+KP N+L+ + K+ DFGLAR K+
Sbjct: 119 CHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS 154
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 37/146 (25%), Positives = 66/146 (45%), Gaps = 30/146 (20%)
Query: 103 SSQPLAVKILDSSGSLQGERE---FHNELSLASSLDCPHIVSLL--GFASDRRGRRLVLI 157
+ +A+K+L + + + E + F E +L + L P+IV+LL G A L +
Sbjct: 2 TGHEVAIKLLRTD-APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAV 57
Query: 158 YELMENRSLQD------ALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDI 211
+E + R+L++ AL + LM + L+ L + ++H D+
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRLM------------LQVLDALACAHNQGIVHRDL 105
Query: 212 KPSNILL---DGDFKAKIGDFGLARL 234
KP NI++ AK+ DFG+ L
Sbjct: 106 KPQNIMVSQTGVRPHAKVLDFGIGTL 131
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 9/150 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDS--SGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+G G +G+V A+ + +A+K L L +R + EL L + +++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81
Query: 145 -FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
F D R Y +M L K E+L E +F + + KGL+Y+H +
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKL-MKHEKLSEDRIQF-LVYQMLKGLKYIHAA-- 137
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+IH D+KP N+ ++ D + KI DFGLAR
Sbjct: 138 -GIIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 21/155 (13%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
LG G FG V A + + + AVK+L D E+ L+LA P
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRV---LALAG--KHPF 57
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+ L + + RL + E + L + + E RF A +I GL++L
Sbjct: 58 LTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARF-YAAEIVLGLQFL 112
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
H E +I+ D+K N+LLD + KI DFG+ +
Sbjct: 113 H---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 87 LGHGGFGSVYKAVV--PSSSQ-PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
LG G FG + + + PS + P+A+ L + S + R F E D +IV L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
G + RG ++++ E M N +L D+ L RK E + + + +A G++YL E
Sbjct: 73 GVIT--RGNTMMIVTEYMSNGAL-DSFL-RKHEGQLVAGQLMGMLPGLASGMKYL---SE 125
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFG-LARLKTE 237
+H + +L++ D KI F L K+E
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 48/154 (31%), Positives = 70/154 (45%), Gaps = 22/154 (14%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
+G G FG V + + A+K L D ++ ER+ LA S D P
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV-----LAES-DSPW 62
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+VSL + S + + L LI E + L L+ K + E RF +A + +E +
Sbjct: 63 VVSL--YYSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMA-ECVLAIEAV 117
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
H + IH DIKP NIL+D K+ DFGL+
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 26/168 (15%)
Query: 87 LGHGGFGSVYKAVV-------PSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPH 138
LG G FG V A P+ +AVK+L + + + +E+ + + +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRK----------C---EELMEWNKRF 185
I++LLG + + L ++ E +L++ L R+ C EE + +
Sbjct: 80 IINLLGACT--QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 186 EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
A +A+G+EYL IH D+ N+L+ D KI DFGLAR
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 56/188 (29%), Positives = 81/188 (43%), Gaps = 39/188 (20%)
Query: 71 YNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKIL--DSSGSLQGEREFHNEL 128
Y++IR +G GG G VY A P S+ +A+K + D S + ++ F E
Sbjct: 4 YDIIRL----------IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREA 53
Query: 129 SLASSLDCPHIVSLLGFASDRRGRRLVLIYELM---ENRSLQDALLD-RKCE----ELME 180
+A+ L P IV + SD +Y M E +L+ L + E EL E
Sbjct: 54 KIAADLIHPGIVPVYSICSDGD-----PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE 108
Query: 181 WN--KRF-EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-KAKIGDFGLARLKT 236
F I I +EY+H V+H D+KP NILL G F + I D+G A
Sbjct: 109 KTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILL-GLFGEVVILDWGAA---- 160
Query: 237 EDLMIEGE 244
+ + E
Sbjct: 161 --IFKKLE 166
|
Length = 932 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 44/147 (29%), Positives = 66/147 (44%), Gaps = 10/147 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
+G G FG V + A+KIL + L+ E+ H E + D +V +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM-- 66
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F S + L LI E + + L+ K + L E +F IA + ++ +H +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIA-ETVLAIDSIH---QL 120
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGL 231
IH DIKP N+LLD K+ DFGL
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 13/157 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPL--AVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLL 143
LG G FGSV + + L AVK + + + E E F +E D P+++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 144 GF---ASDRRGR-RLVLIYELMENRSLQDALLDRK---CEELMEWNKRFEIAIDIAKGLE 196
G + G V+I M++ L LL + C + + + DIA G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
YL IH D+ N +L+ + + DFGL++
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 11/150 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELS-LASSLDCPHIVSLL 143
+G G FG V A + + AVK+L L+ + + H E + L ++ P +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
S + +L + + + L L + E RF A +IA L YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARF-YAAEIASALGYLH---S 114
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+I+ D+KP NILLD + DFGL +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 16/154 (10%)
Query: 87 LGHGGFGSVY---KAVVPSSSQPLAVKILDSSGSLQGEREFHN---ELSLASSLDCPHIV 140
LG GG+G V+ K + + A+K+L + ++ +++ + E ++ ++ P IV
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 141 SLL-GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
L+ F + G +L LI E + L L+R+ ME F ++ +I+ LE+LH
Sbjct: 64 DLIYAFQT---GGKLYLILEYLSGGELF-MHLERE-GIFMEDTACFYLS-EISLALEHLH 117
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+I+ D+KP NILLD K+ DFGL +
Sbjct: 118 QQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 44/151 (29%), Positives = 64/151 (42%), Gaps = 18/151 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
+G G FG V ++ A+K L + L + H E + + D +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 145 FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
D+ V+ Y ++M +LL R E RF IA ++ +E +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMM-------SLLIRL-GIFEEDLARFYIA-ELTCAIESVHK 119
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231
IH DIKP NIL+D D K+ DFGL
Sbjct: 120 M---GFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN--ELSLASSLDCPHIVSL-L 143
+G G FG V + + + A+K + + + H E ++ + ++CP IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
F S + L L+ + L L + RF A ++ LE LH +
Sbjct: 61 SFQSPEK---LYLVLAFINGGELFHHLQREGRFD--LSRARFYTA-ELLCALENLH---K 111
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
VI+ D+KP NILLD + DFGL +L +D
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 11/150 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG---EREFHNELSLASSLDCPHIVSLL 143
LG G FG V A + + + A+K+L LQ + + LA + P + +L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL- 61
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
+ RL + E + L + ++ + E RF A ++ L +LH
Sbjct: 62 -HCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRF-YAAEVTLALMFLHRH-- 115
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
VI+ D+K NILLD + K+ DFG+ +
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 15/150 (10%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREF---HNELSLASSLDCPHIVSL 142
R+G G +G VYKA + + AVKI+ L+ +F E+ + +C H +
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKII----KLEPGDDFSLIQQEIFMVK--ECKHCNIV 69
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
F S +L + E SLQD + L E + + + +GL YLH
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLSELQIAY-VCRETLQGLAYLHSKG 126
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+ +H DIK +NILL + K+ DFG+A
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 44/150 (29%), Positives = 66/150 (44%), Gaps = 11/150 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH---NELSLASSLDCPHIVSLL 143
+G G FG V A S AVK+L L+ + + H L +L P +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
S + +L + + + L L +C +E RF A ++A + YLH
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARF-YAAEVASAIGYLH---S 114
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+I+ D+KP NILLD + DFGL +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 27/165 (16%)
Query: 86 RLGHGGFGSVYKAVVP--SSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSL 142
++G G +G VYKA + A+K ++ +G S+ RE ++L L P+++SL
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNVISL 63
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKR---------FEIAIDIAK 193
R++ L+++ E+ D K + NK+ + I
Sbjct: 64 QKVFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGD----FKAKIGDFGLARL 234
G+ YLH + V+H D+KP+NIL+ G+ + KI D G ARL
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 8/151 (5%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL-GF 145
+G G FG +S Q A+K + S + E L + + P+IV+ F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
+D L ++ E + L + ++ + E + + + + G++++H E
Sbjct: 68 EADGH---LYIVMEYCDGGDLMQKIKLQRGKLFPE-DTILQWFVQMCLGVQHIH---EKR 120
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236
V+H DIK NI L + K K+GDFG ARL T
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 86 RLGHGGFGSVYKAVVP--SSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSL 142
++G G +G VYKA + A+K ++ +G S+ RE ++L L P++++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIAL 63
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCE---ELMEWNKRF--EIAIDIAKGLEY 197
R++ L+++ E+ R + + M+ + + I G+ Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 198 LHHSCEPPVIHGDIKPSNILLDGD----FKAKIGDFGLARL 234
LH + V+H D+KP+NIL+ G+ + KI D G ARL
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 26/168 (15%)
Query: 87 LGHGGFGSVYKAVV-------PSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPH 138
LG G FG V A P + +AVK+L + + + +E+ + + +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDAL-------------LDRKCEELMEWNKRF 185
I++LLG + + L +I E +L++ L + R +E M +
Sbjct: 83 IINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 186 EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+A+G+EYL IH D+ N+L+ + KI DFGLAR
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 24/156 (15%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCPHIVSLL 143
++G GG+G V+ A + + +A+K + S L R E + ++ +V LL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 144 -GFASDRRGRRLVLIYELMEN------RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLE 196
F D +Y ME R+L + L L E + RF +A ++ + ++
Sbjct: 68 YAFQDDEY------LYLAMEYVPGGDFRTLLNNL-----GVLSEDHARFYMA-EMFEAVD 115
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
LH E IH D+KP N L+D K+ DFGL+
Sbjct: 116 ALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 44/149 (29%), Positives = 65/149 (43%), Gaps = 10/149 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN--ELSLASSLDCPHIVSLLG 144
LG G FG V ++ + A+KIL + + H E + + P + +L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK- 61
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
S + RL + E L L + E RF A +I L YLH SC+
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGA-EIVSALGYLH-SCD- 115
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
V++ D+K N++LD D KI DFGL +
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 17/167 (10%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER--EFHNELSLASSLDCPH 138
F + +G G FG V ++ A+K++ S L E F E + S + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 139 IVSLLGFASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKG 194
I L D+ LV+ Y +L+ +LL+R ++ E +F +A ++
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLL-------SLLNRYEDQFDEDMAQFYLA-ELVLA 114
Query: 195 LEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMI 241
+ +H + +H DIKP N+L+D K+ DFG A T + M+
Sbjct: 115 IHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 87 LGHGGFGSVY---KAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD----CPHI 139
LG G +G V+ K + + A+K+L + +Q + + + L+ CP +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 140 VSL-LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
V+L F +D + L LI + + L L R E E R IA +I L++L
Sbjct: 68 VTLHYAFQTDTK---LHLILDYVNGGELFTHLYQR--EHFTESEVRVYIA-EIVLALDHL 121
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
H + +I+ DIK NILLD + + DFGL++
Sbjct: 122 H---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 25/158 (15%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-----FHNELSLASSLDCPHIV 140
++G G +G VYKA +++ +A+K + L+ E E E+SL + +IV
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKI----RLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIA----IDIAKGLE 196
L + RL L++E + D L + + ++ K + I +G+
Sbjct: 65 RLQDVVHSEK--RLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKA-KIGDFGLAR 233
Y H V+H D+KP N+L+D A K+ DFGLAR
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 44/156 (28%), Positives = 67/156 (42%), Gaps = 21/156 (13%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
LG G FG V A + +++ A+K L D ER L+LA + P
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRV---LALAW--EHPF 57
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+ L F + + L + E + L + + E RF A +I GL++L
Sbjct: 58 LTHL--FCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARF-YAAEIICGLQFL 112
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
H +I+ D+K N+LLD D KI DFG+ +
Sbjct: 113 HKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE 145
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 33/197 (16%)
Query: 47 KLYRNRTAPSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSS-Q 105
+L++ + + S + N + +N IR LG G FG V A +
Sbjct: 8 QLHKKKDSDSTKEPKRKNKMKYEDFNFIRT----------LGTGSFGRVILATYKNEDFP 57
Query: 106 PLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMEN 163
P+A+K + S ++ ++ H +E + + ++ P V+L G D LVL +
Sbjct: 58 PVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF----- 112
Query: 164 RSLQDALLDRKCEELMEWNKRFE------IAIDIAKGLEYLHHSCEPPVIHGDIKPSNIL 217
++ + + NKRF A I EYL +++ D+KP N+L
Sbjct: 113 ------VIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLL 163
Query: 218 LDGDFKAKIGDFGLARL 234
LD D K+ DFG A++
Sbjct: 164 LDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 48/165 (29%), Positives = 74/165 (44%), Gaps = 13/165 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG GGFG V V ++ + A K L+ +GE NE + ++ +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+A + + L L+ +M L+ + + E F A ++ GLE L
Sbjct: 67 YAYETKDA-LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-YAAELCCGLEDLQRE--- 121
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKR 249
+++ D+KP NILLD +I D GLA + EGE V+ R
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAV-----QIPEGETVRGR 161
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
++G G G V A S + +AVK++D + E F NE+ + ++V + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHQNVVEM--Y 84
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
S G L ++ E ++ +L D + + E + + + + L YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTRLNE----EQIATVCESVLQALCYLHSQ---G 137
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
VIH DIK +ILL D + K+ DFG ++D+
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 11/150 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG---EREFHNELSLASSLDCPHIVSLL 143
LG G FG V+ A + ++Q A+K L L E + L+ + + P + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
+ + + L + E + L + + C + F A +I GL++LH
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATF-YAAEIICGLQFLHSK-- 115
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+++ D+K NILLD D KI DFG+ +
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 40/173 (23%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL 134
R S+ N +G+G FG VY+A+ +S+ +A+K + LQ + + EL + +L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-----LQDPQYKNRELLIMKNL 116
Query: 135 DCPHIVSLLGF---ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI-- 189
+ +I+ L + ++ + + + +ME + + + M+ R A+
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVME-------FIPQTVHKYMKHYARNNHALPL 169
Query: 190 --------DIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKA-KIGDFGLAR 233
+ + L Y+H + H D+KP N+L+D + K+ DFG A+
Sbjct: 170 FLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH---IVSLL 143
LG GGFG V + ++ + A K L+ L+ + + + L H IVSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKK-RLKKRKGYEGAMVEKRILAKVHSRFIVSL- 58
Query: 144 GFASDRRGRRLVLIYELMENRSLQDAL--LDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
+A + L L+ +M L+ + +D + E F A I GLE+LH
Sbjct: 59 AYAFQTKTD-LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA-QIISGLEHLHQR 116
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+I+ D+KP N+LLD D +I D GLA
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 11/146 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE--FHNELSLASSLDCPHIVSLLG 144
+G G FG V SS + A+K+L ++ F E + + + P +V L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-- 108
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F + + + L ++ E M L + + + E +W K + + +A L+ +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFYTAEVVLA--LDAIHSM--- 161
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFG 230
+IH D+KP N+LLD K+ DFG
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 7e-04
Identities = 26/105 (24%), Positives = 41/105 (39%), Gaps = 19/105 (18%)
Query: 463 GTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQ 522
GTV Y++PE G S D++S G+ +L G+ P P S+
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----------SFFEL 211
Query: 523 LAYNGKLLDLVDPSIHSLDKDQAL--LCITIALLCLQRSPSKRLT 565
+ + D SL ++ I+ CLQ+ P KR +
Sbjct: 212 MQA------ICDGPPPSLPAEEFSPEFRDFIS-ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 28/107 (26%), Positives = 39/107 (36%), Gaps = 19/107 (17%)
Query: 463 GTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQ 522
GT Y+APE G S K D++S G L+ + + P + A M + R
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE--ARSMQDL---------RY 211
Query: 523 LAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
GK + P I+S D + LQ P R I
Sbjct: 212 KVQRGKYPPI--PPIYSQDLQNFI------RSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 19/49 (38%), Positives = 29/49 (59%), Gaps = 6/49 (12%)
Query: 456 SSTPSMRGTVCYIAPE----YGGGGLLSEKCDVYSFGVLILVLISGRRP 500
SM+G+V ++APE Y G S K D++S G ++L + +GRRP
Sbjct: 165 DQNMSMQGSVFWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 39/166 (23%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER-EFHNELSLASSLDCPHIVSLLG 144
++G G FG + +K ++ S ER E E+++ S++ P+IV
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 145 FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
+ +V+ Y +L + + Q +L + +++++W + I L+++H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE-DQILDW------FVQICLALKHVH- 118
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECV 246
+ ++H DIK NI L D K+GDFG+AR+ + + C+
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 43/171 (25%), Positives = 75/171 (43%), Gaps = 15/171 (8%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN--ELSLASSLDCP 137
F+ LG G FG V A + + A+KIL +Q + E + + D P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLD-RKCEELMEWNKRFEIAIDIAKGLE 196
++ L R +Y +ME + D + ++ + E F A +I+ GL
Sbjct: 61 PFLTQLHSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-YAAEISVGLF 115
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVK 247
+LH +I+ D+K N++LD + KI DFG+ + + M++G +
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTR 159
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 9/146 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE--FHNELSLASSLDCPHIVSLLG 144
+G G FG V + + + A+KIL+ L+ F E ++ + DC I +L
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
D LV+ Y + + LL + + L E RF IA ++ + +H +
Sbjct: 69 AFQDENYLYLVMDYYVGGDLL---TLLSKFEDRLPEDMARFYIA-EMVLAIHSIH---QL 121
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFG 230
+H DIKP N+LLD + ++ DFG
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 11/157 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE--FHNELSLASSLDCPHIVSLLG 144
+G G FG V S+ + A+K+L ++ F E + + + P +V L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-- 108
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F + + R L ++ E M L + + + E +W RF A ++ L+ +H
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KW-ARFYTA-EVVLALDAIHSM--- 161
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMI 241
IH D+KP N+LLD K+ DFG ++ M+
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 13/165 (7%)
Query: 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASS 133
+R F +G+G +G VYK + Q A+K++D + E E E+++
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKK 68
Query: 134 LDCPHIVSLLGFASDRRG-----RRLVLIYELMENRSLQDALLDRKCEELME-WNKRFEI 187
++ A ++ +L L+ E S+ D + + K L E W I
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--I 126
Query: 188 AIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+I +GL +LH VIH DIK N+LL + + K+ DFG++
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 13/181 (7%)
Query: 66 CRRFSYNLIRRATASFSPSNR------LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ 119
CR F + + + + LG G G+V A S +P AVK++D G +
Sbjct: 13 CRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE 72
Query: 120 GER-EFHNELSLASSLDCPHIVSLL-GFA-SDRRGRRLVLIYELMENRSLQDALLDRKCE 176
++ E+ + D IV FA D R VL+ L+ + + L ++ +
Sbjct: 73 ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYA-NAGDLRQEIK 131
Query: 177 ELMEWNKRF---EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ N+ F E + + L +HH +IH DIK +NILL + K+GDFG ++
Sbjct: 132 SRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191
Query: 234 L 234
+
Sbjct: 192 M 192
|
Length = 496 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.003
Identities = 30/110 (27%), Positives = 42/110 (38%), Gaps = 21/110 (19%)
Query: 460 SMRGTVCYIAPEYGGGGLLSEK---CDVYSFGVLILVLISGRRPLQVTASPMSEFERANL 516
S+ GT Y+APE GG D++S G ++L + +G+RP SE + N
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-------WSELD--NE 212
Query: 517 ISWARQLAYNGKLLDLVDPSIHSLDKDQA-LLCITIALLCLQRSPSKRLT 565
+ K P I D Q CL+ P KR T
Sbjct: 213 FQIMFHVGAGHK------PPIP--DSLQLSPEGKDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 13/160 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE--FHNELSLASSLDCPHIVSLLG 144
+G G FG V + ++ + A+KIL+ L+ F E + + D I +L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 145 FASDRRGRRLVLIYELMENR-SLQDALLDRKCEELMEWN-KRFEIAIDIAKGLEYLHHSC 202
D LV+ Y + + +L DR E++ + IAID L Y+H
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR-- 126
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIE 242
DIKP NIL+D + ++ DFG ED ++
Sbjct: 127 -------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 29/78 (37%), Positives = 41/78 (52%), Gaps = 9/78 (11%)
Query: 161 MENRSLQDALLDRKCEELMEWNKRFEIAI----DIAKGLEYL-HHSCEPPVIHGDIKPSN 215
+E++SL D D + +EL + E I +A+G+E+L C IH D+ N
Sbjct: 148 IEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC----IHRDLAARN 203
Query: 216 ILLDGDFKAKIGDFGLAR 233
ILL + KI DFGLAR
Sbjct: 204 ILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 23/156 (14%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG---EREFHNELSLASSLDCPHIVSLL 143
LG G FG V A + + AVK L L E + LA + + P + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEI------AIDIAKGLEY 197
+ + + L + E + L + D+ RF++ A +I GL++
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQF 111
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
LH +I+ D+K N++LD D KI DFG+ +
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 17/43 (39%), Positives = 24/43 (55%), Gaps = 3/43 (6%)
Query: 191 IAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
I +GL YLH +IH D+K NI ++ + IGD G A+
Sbjct: 166 ILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 603 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.96 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.74 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.39 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.26 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.24 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.17 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.13 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.05 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.94 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.83 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.82 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.72 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.72 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.6 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.52 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.49 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.41 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.37 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.35 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.25 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.15 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.13 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.12 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.01 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.97 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.84 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.79 | |
| PLN02236 | 344 | choline kinase | 96.16 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.16 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.14 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.92 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.68 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.46 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.45 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.34 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.95 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.92 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.62 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.45 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.32 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.21 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.7 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.66 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.15 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.84 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.7 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.57 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.15 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 90.31 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=414.38 Aligned_cols=289 Identities=45% Similarity=0.770 Sum_probs=250.1
Q ss_pred ccccccHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEe
Q 046097 65 HCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144 (603)
Q Consensus 65 ~~~~~~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g 144 (603)
....|+++++..+|++|...+.||+|+||.||+|.... +..||||.+....... ..+|.+|+.++.+++|||+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEE
Confidence 56679999999999999999999999999999999954 4899999887644332 556999999999999999999999
Q ss_pred EEecCCCC-eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc
Q 046097 145 FASDRRGR-RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 145 ~~~~~~~~-~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~ 223 (603)
||.+. + ..+||+||+++|+|.++|...... .++|..+++|+.++|+||+|||..+.+.|||||||++|||+|++++
T Consensus 139 yC~e~--~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEG--GEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecC--CceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 99987 5 599999999999999999876543 6899999999999999999999998888999999999999999999
Q ss_pred EEEEeeccceeccc-ccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCccccc
Q 046097 224 AKIGDFGLARLKTE-DLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWW 302 (603)
Q Consensus 224 vKL~DFGlA~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (603)
+||+|||+|+.... ..
T Consensus 216 aKlsDFGLa~~~~~~~~--------------------------------------------------------------- 232 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDT--------------------------------------------------------------- 232 (361)
T ss_pred EEccCccCcccCCcccc---------------------------------------------------------------
Confidence 99999999965432 10
Q ss_pred ccccCCCCCCCcchhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHH
Q 046097 303 WKQDNGAGSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELT 382 (603)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (603)
T Consensus 233 -------------------------------------------------------------------------------- 232 (361)
T KOG1187|consen 233 -------------------------------------------------------------------------------- 232 (361)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HhhhhcCCCCCCcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCc-
Q 046097 383 KKKKKRGLNSSNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSM- 461 (603)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~- 461 (603)
.....
T Consensus 233 --------------------------------------------------------------------------~~~~~~ 238 (361)
T KOG1187|consen 233 --------------------------------------------------------------------------SVSTTV 238 (361)
T ss_pred --------------------------------------------------------------------------ceeeec
Confidence 00011
Q ss_pred ccccCccCccccCCCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCC--C
Q 046097 462 RGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIH--S 539 (603)
Q Consensus 462 ~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 539 (603)
.||.+|+||||+..+..|.|+|||||||+|+||+||+.+.+..... ....+.+|++.....+.+.+++|+.+. .
T Consensus 239 ~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~----~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~ 314 (361)
T KOG1187|consen 239 MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR----GELSLVEWAKPLLEEGKLREIVDPRLKEGE 314 (361)
T ss_pred CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc----ccccHHHHHHHHHHCcchhheeCCCccCCC
Confidence 6999999999999999999999999999999999999988765421 223489999998888899999999985 4
Q ss_pred CCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 046097 540 LDK-DQALLCITIALLCLQRSPSKRLTMKDIVEMLTGEAEP 579 (603)
Q Consensus 540 ~~~-~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~l~~~~~~ 579 (603)
... .+...+..++..|++.+|.+||+|.||+++|+.....
T Consensus 315 ~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 315 YPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 443 6788899999999999999999999999999655543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=378.34 Aligned_cols=149 Identities=29% Similarity=0.396 Sum_probs=136.8
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC-eEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR-RLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~-~~~LVm 158 (603)
+.+.++.||+|..|+||+++++.|++.+|+|++.........+++.+|++++..++||+||.+||.|... . .++++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~--~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN--GEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC--CceEEeeh
Confidence 4455688999999999999999999999999997777777789999999999999999999999999987 4 699999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||++|+|.+++... +.+++...-.++.+|++||.|||. + +||||||||+||||+..|.+||||||.+....
T Consensus 158 EYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred hhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 999999999999765 338999999999999999999996 6 99999999999999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=392.31 Aligned_cols=263 Identities=27% Similarity=0.429 Sum_probs=221.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
.+|...++||+|+|+.||.+++..+|+.||+|++.+.. .....+.+.+|+++.++|+|||||+++++|++. +++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs--~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS--NNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC--CceEE
Confidence 67999999999999999999999999999999997632 334567899999999999999999999999998 89999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|+|+|..++|..+++... .+++.++..++.||+.||.|||++ +|+|||||..|+|++++.++||+|||+|....
T Consensus 96 vLELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999999998543 499999999999999999999999 99999999999999999999999999998876
Q ss_pred cccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcch
Q 046097 237 EDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGRV 316 (603)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (603)
.+.
T Consensus 170 ~~~----------------------------------------------------------------------------- 172 (592)
T KOG0575|consen 170 YDG----------------------------------------------------------------------------- 172 (592)
T ss_pred Ccc-----------------------------------------------------------------------------
Confidence 441
Q ss_pred hhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCcC
Q 046097 317 KDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNVG 396 (603)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (603)
T Consensus 173 -------------------------------------------------------------------------------- 172 (592)
T KOG0575|consen 173 -------------------------------------------------------------------------------- 172 (592)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCCC
Q 046097 397 EMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGG 476 (603)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 476 (603)
-...+++||+.|+|||++...
T Consensus 173 -----------------------------------------------------------Erk~TlCGTPNYIAPEVl~k~ 193 (592)
T KOG0575|consen 173 -----------------------------------------------------------ERKKTLCGTPNYIAPEVLNKS 193 (592)
T ss_pred -----------------------------------------------------------cccceecCCCcccChhHhccC
Confidence 012468999999999999999
Q ss_pred CCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhhcc
Q 046097 477 LLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCL 556 (603)
Q Consensus 477 ~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 556 (603)
..+..+||||+|||||-|++|++||+..+ +.+....+... +. .++...+....+||..+|
T Consensus 194 gHsfEvDiWSlGcvmYtLL~G~PPFetk~----------vkety~~Ik~~----~Y------~~P~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 194 GHSFEVDIWSLGCVMYTLLVGRPPFETKT----------VKETYNKIKLN----EY------SMPSHLSAEAKDLIRKLL 253 (592)
T ss_pred CCCCchhhhhhhhHHHhhhhCCCCcccch----------HHHHHHHHHhc----Cc------ccccccCHHHHHHHHHHh
Confidence 99999999999999999999999998543 22222222111 11 233355667889999999
Q ss_pred CCCCCCCCCHHHHHHH--hcCCCCCCCCCCc
Q 046097 557 QRSPSKRLTMKDIVEM--LTGEAEPPHLPFE 585 (603)
Q Consensus 557 ~~dP~~Rpt~~evl~~--l~~~~~~~~~~~~ 585 (603)
++||++|||+.+|+.. +..-.-|...|..
T Consensus 254 ~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~ 284 (592)
T KOG0575|consen 254 RPNPSERPSLDEVLDHPFFKSGFTPARLPSS 284 (592)
T ss_pred cCCcccCCCHHHHhcCHhhhCCCcCCCCCcc
Confidence 9999999999999975 4455555556653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=374.04 Aligned_cols=152 Identities=30% Similarity=0.456 Sum_probs=134.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh------hHHHHHHHHHHhccCCCCceeEEEeEEecCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ------GEREFHNELSLASSLDCPHIVSLLGFASDRR 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~------~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~ 150 (603)
..+.|.+.+.||+|+||.|-+|..+.+++.||||+++++.... ....+.+|+++|++++|||||+++++|...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~- 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP- 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-
Confidence 4566788899999999999999999999999999997754322 223467999999999999999999999987
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC---CcEEEE
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD---FKAKIG 227 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~---~~vKL~ 227 (603)
...|+||||++||.|.+++..+.. +.+.....+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+
T Consensus 249 -ds~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 249 -DSSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred -CceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence 788999999999999999987654 77788889999999999999999 99999999999999755 789999
Q ss_pred eeccceecc
Q 046097 228 DFGLARLKT 236 (603)
Q Consensus 228 DFGlA~~~~ 236 (603)
|||+|+...
T Consensus 322 DFGlAK~~g 330 (475)
T KOG0615|consen 322 DFGLAKVSG 330 (475)
T ss_pred ccchhhccc
Confidence 999998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=367.29 Aligned_cols=276 Identities=24% Similarity=0.350 Sum_probs=228.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh--hHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ--GEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~--~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|+++++||+|+||+||+++.+.+++.+|+|++++..... ......+|..+|.+++||+||.++-.|++. ..+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~--~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE--EKL 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC--CeE
Confidence 3567999999999999999999999999999999998764333 357789999999999999999999999997 899
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|+|+||+.||.|..+|.++.. +++..+.-++..|+.||.|||++ +||||||||+|||+|++|.++|+|||+++.
T Consensus 101 ylVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchh
Confidence 999999999999999976543 89999999999999999999999 999999999999999999999999999975
Q ss_pred cccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCc
Q 046097 235 KTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESG 314 (603)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (603)
....
T Consensus 175 ~~~~---------------------------------------------------------------------------- 178 (357)
T KOG0598|consen 175 DLKD---------------------------------------------------------------------------- 178 (357)
T ss_pred cccC----------------------------------------------------------------------------
Confidence 4332
Q ss_pred chhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCC
Q 046097 315 RVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSN 394 (603)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (603)
T Consensus 179 -------------------------------------------------------------------------------- 178 (357)
T KOG0598|consen 179 -------------------------------------------------------------------------------- 178 (357)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccC
Q 046097 395 VGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGG 474 (603)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 474 (603)
...+.+++||+.|||||++.
T Consensus 179 ------------------------------------------------------------~~~t~tfcGT~eYmAPEil~ 198 (357)
T KOG0598|consen 179 ------------------------------------------------------------GDATRTFCGTPEYMAPEILL 198 (357)
T ss_pred ------------------------------------------------------------CCccccccCCccccChHHHh
Confidence 01245589999999999999
Q ss_pred CCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhh
Q 046097 475 GGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALL 554 (603)
Q Consensus 475 ~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 554 (603)
+..|+..+|+|||||+||||++|.+||...+. ..+........ +...+.-.+.+.++|+..
T Consensus 199 ~~gy~~~vDWWsLGillYeML~G~pPF~~~~~----------~~~~~~I~~~k---------~~~~p~~ls~~ardll~~ 259 (357)
T KOG0598|consen 199 GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV----------KKMYDKILKGK---------LPLPPGYLSEEARDLLKK 259 (357)
T ss_pred cCCCCcccchHhHHHHHHHHhhCCCCCcCccH----------HHHHHHHhcCc---------CCCCCccCCHHHHHHHHH
Confidence 99999999999999999999999999986542 22222222221 122222244567889999
Q ss_pred ccCCCCCCCC----CHHHHH-----------HHhcCCCCCCCCCCccCCCCCCCCC
Q 046097 555 CLQRSPSKRL----TMKDIV-----------EMLTGEAEPPHLPFEFSPSPPSNFP 595 (603)
Q Consensus 555 cl~~dP~~Rp----t~~evl-----------~~l~~~~~~~~~~~~~~~~~~~~~~ 595 (603)
+|+.||.+|. ++.+|- +.+.+...||+.|....+-+.++|.
T Consensus 260 LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd 315 (357)
T KOG0598|consen 260 LLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFD 315 (357)
T ss_pred HhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCcccccccc
Confidence 9999999996 344443 2346778899999888888888775
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=371.91 Aligned_cols=150 Identities=37% Similarity=0.570 Sum_probs=129.7
Q ss_pred CCCCceeeccCceEEEEEEEcCCCce-EEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQP-LAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~-VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+.+.+.||.|+||+||+|.++ |.. ||||++.... .....+.|.+|+.+|.+++|||||+++|+|.+..+ .+++||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVt 119 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVT 119 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEE
Confidence 344566999999999999994 555 9999997643 22226789999999999999999999999998621 689999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeccCCCCCeEEcCCC-cEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP-VIHGDIKPSNILLDGDF-KAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g-IVHrDLKp~NILld~~~-~vKL~DFGlA~~~~ 236 (603)
||+++|+|..++... ....+++..++.++.|||.||.|||++ + ||||||||+|||++.++ ++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999874 234599999999999999999999999 7 99999999999999998 99999999998754
Q ss_pred c
Q 046097 237 E 237 (603)
Q Consensus 237 ~ 237 (603)
.
T Consensus 196 ~ 196 (362)
T KOG0192|consen 196 I 196 (362)
T ss_pred c
Confidence 3
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=357.98 Aligned_cols=153 Identities=28% Similarity=0.428 Sum_probs=138.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
...+|...+.||.|+||+||+|+++.++..||||.+.+.. .....+.+..|+.+|+.++|||||.+++++.+. +.+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--DFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--CeEE
Confidence 4568999999999999999999999999999999997753 445567789999999999999999999999997 8999
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC------CcEEEEee
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD------FKAKIGDF 229 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~------~~vKL~DF 229 (603)
+|||||.||+|.+++..... +++..+..++.||+.||++||++ +||||||||+||||+.. -.+||+||
T Consensus 86 lVMEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 99999999999999987653 89999999999999999999999 99999999999999764 46899999
Q ss_pred ccceeccc
Q 046097 230 GLARLKTE 237 (603)
Q Consensus 230 GlA~~~~~ 237 (603)
|+|+....
T Consensus 160 GfAR~L~~ 167 (429)
T KOG0595|consen 160 GFARFLQP 167 (429)
T ss_pred chhhhCCc
Confidence 99987653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=362.13 Aligned_cols=324 Identities=24% Similarity=0.332 Sum_probs=234.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|+++..||+|+||.||+|+-+.||..+|+|++++... ......+..|-.+|....+++||+|+-.|++. .++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~--~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK--EYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--Cee
Confidence 56789999999999999999999999999999999987532 23346788999999999999999999999997 999
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||||++||++..+|..... +++..+..++.+++.||.-||+. |+|||||||+|+|||..|++||+|||++.-
T Consensus 217 YLiMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 999999999999999987644 89999999999999999999999 999999999999999999999999999965
Q ss_pred cccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCc
Q 046097 235 KTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESG 314 (603)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (603)
......... |.
T Consensus 291 l~~~~~~~~-------------------------~~-------------------------------------------- 301 (550)
T KOG0605|consen 291 LDKKHRIES-------------------------YR-------------------------------------------- 301 (550)
T ss_pred hhhhhhhhh-------------------------hc--------------------------------------------
Confidence 443311000 00
Q ss_pred chhhhHHhh-hhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCC
Q 046097 315 RVKDYVMEW-IGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSS 393 (603)
Q Consensus 315 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (603)
.+..++. .......++++. .-++++....=--+
T Consensus 302 --~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~------------- 335 (550)
T KOG0605|consen 302 --LDEQMQINLSEAKPSDFPKF-------------------------------NTPRSTMSRREQLQ------------- 335 (550)
T ss_pred --chhhhhhhhccCCCcccccc-------------------------------ccccchhhHHHHHH-------------
Confidence 0000000 000000011100 00000000000000
Q ss_pred CcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCcccc
Q 046097 394 NVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYG 473 (603)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 473 (603)
.|+++.- ....+.+|||.|||||++
T Consensus 336 -----~w~~nrr--------------------------------------------------~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 336 -----TWKRNRR--------------------------------------------------QLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred -----HHHhhhh--------------------------------------------------hhhhcccCCccccchHHH
Confidence 0110000 012347899999999999
Q ss_pred CCCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHh
Q 046097 474 GGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIAL 553 (603)
Q Consensus 474 ~~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 553 (603)
.+..|+..+|+||||||||||+.|.+||+..... .-...+..|-..+.... ....+.+..+||.
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~---~T~rkI~nwr~~l~fP~-------------~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ---ETYRKIVNWRETLKFPE-------------EVDLSDEAKDLIT 424 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhhhccCCC-------------cCcccHHHHHHHH
Confidence 9999999999999999999999999999866532 23345555543332211 1122367888999
Q ss_pred hccCCCCCCCCC---HHHHHHHh---------cCCCCCCCCCCccCCCCCCCCC
Q 046097 554 LCLQRSPSKRLT---MKDIVEML---------TGEAEPPHLPFEFSPSPPSNFP 595 (603)
Q Consensus 554 ~cl~~dP~~Rpt---~~evl~~l---------~~~~~~~~~~~~~~~~~~~~~~ 595 (603)
.||. ||.+|.. +.||-++- -...+||++|-..++.+..||+
T Consensus 425 rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFd 477 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFD 477 (550)
T ss_pred HHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCCCcccccccc
Confidence 9999 9999986 66666553 1344689999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.09 Aligned_cols=265 Identities=23% Similarity=0.359 Sum_probs=216.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..+|++++.||.|+||.||++....+|..||.|.++-.. .....+.+..|+.+|++++|||||+++++.......-++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 346888899999999999999999999999999987543 3344577899999999999999999999654443455899
Q ss_pred EEEccCCCCHHHHHhhccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCEP-PVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~-gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|||||..|+|...+...+. ...+++..+++++.|+|.||.++|..... -|+||||||.||+++.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999876432 34589999999999999999999984221 399999999999999999999999999987
Q ss_pred cccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCc
Q 046097 235 KTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESG 314 (603)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (603)
.....
T Consensus 178 l~s~~--------------------------------------------------------------------------- 182 (375)
T KOG0591|consen 178 LSSKT--------------------------------------------------------------------------- 182 (375)
T ss_pred hcchh---------------------------------------------------------------------------
Confidence 65441
Q ss_pred chhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCC
Q 046097 315 RVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSN 394 (603)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (603)
T Consensus 183 -------------------------------------------------------------------------------- 182 (375)
T KOG0591|consen 183 -------------------------------------------------------------------------------- 182 (375)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccC
Q 046097 395 VGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGG 474 (603)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 474 (603)
....+.+||+.||+||.+.
T Consensus 183 -------------------------------------------------------------tfA~S~VGTPyYMSPE~i~ 201 (375)
T KOG0591|consen 183 -------------------------------------------------------------TFAHSLVGTPYYMSPERIH 201 (375)
T ss_pred -------------------------------------------------------------HHHHhhcCCCcccCHHHHh
Confidence 0124578999999999999
Q ss_pred CCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCC-HHHHHHHHHHHh
Q 046097 475 GGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLD-KDQALLCITIAL 553 (603)
Q Consensus 475 ~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~ 553 (603)
+.+|+.|+||||+||++|||..-+.||.+.+ +......+.. ......+ ...+..+..|+.
T Consensus 202 ~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n----------~~~L~~KI~q---------gd~~~~p~~~YS~~l~~li~ 262 (375)
T KOG0591|consen 202 ESGYNFKSDIWSLGCLLYEMCALQSPFYGDN----------LLSLCKKIEQ---------GDYPPLPDEHYSTDLRELIN 262 (375)
T ss_pred cCCCCcchhHHHHHHHHHHHHhcCCCccccc----------HHHHHHHHHc---------CCCCCCcHHHhhhHHHHHHH
Confidence 9999999999999999999999999998653 3333322221 2233334 567788999999
Q ss_pred hccCCCCCCCCCHHHHHHHhcCCC
Q 046097 554 LCLQRSPSKRLTMKDIVEMLTGEA 577 (603)
Q Consensus 554 ~cl~~dP~~Rpt~~evl~~l~~~~ 577 (603)
.|+..||..||+...+++.+....
T Consensus 263 ~ci~vd~~~RP~t~~~v~di~~~l 286 (375)
T KOG0591|consen 263 MCIAVDPEQRPDTVPYVQDIQSEL 286 (375)
T ss_pred HHccCCcccCCCcchHHHHHHHHh
Confidence 999999999999777777776543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=359.84 Aligned_cols=156 Identities=29% Similarity=0.397 Sum_probs=140.6
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh--hHHHHHHHHHHhccC-CCCceeEEEeEEecCCC
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ--GEREFHNELSLASSL-DCPHIVSLLGFASDRRG 151 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~--~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~ 151 (603)
.+..++|..++.||+|+|++|++|+.+.+++.||||++.+..... ..+.+..|-..|.+| .||.|++|+..|+|.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-- 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-- 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--
Confidence 456678999999999999999999999999999999997653222 235578899999999 799999999999997
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
..+|+|+||+++|+|.++|.... .+++.....++.+|+.||+|||++ |||||||||+|||+|.+|++||.|||.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccc
Confidence 88999999999999999998764 389999999999999999999999 999999999999999999999999999
Q ss_pred ceecccc
Q 046097 232 ARLKTED 238 (603)
Q Consensus 232 A~~~~~~ 238 (603)
|+...+.
T Consensus 221 AK~l~~~ 227 (604)
T KOG0592|consen 221 AKILSPS 227 (604)
T ss_pred cccCChh
Confidence 9988765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=336.02 Aligned_cols=274 Identities=27% Similarity=0.360 Sum_probs=226.7
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|+.+..||.|+||+|.+++.+.++..+|+|++.++.. ....+...+|..+|+.+.||+++++++.|.+. +.+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SNLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC--CeEE
Confidence 3568889999999999999999999999999999977532 23446788999999999999999999999987 8999
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||.+||.|..+++... .+++..++-++.||+.||.|||++ +|++|||||+|||+|.+|.+||.|||+|+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999999999997654 389999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcc
Q 046097 236 TEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGR 315 (603)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (603)
...
T Consensus 195 ~~r----------------------------------------------------------------------------- 197 (355)
T KOG0616|consen 195 SGR----------------------------------------------------------------------------- 197 (355)
T ss_pred cCc-----------------------------------------------------------------------------
Confidence 433
Q ss_pred hhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCc
Q 046097 316 VKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNV 395 (603)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (603)
T Consensus 198 -------------------------------------------------------------------------------- 197 (355)
T KOG0616|consen 198 -------------------------------------------------------------------------------- 197 (355)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCC
Q 046097 396 GEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGG 475 (603)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 475 (603)
+-+.+||+.|+|||.+..
T Consensus 198 --------------------------------------------------------------T~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 198 --------------------------------------------------------------TWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred --------------------------------------------------------------EEEecCCccccChHHhhc
Confidence 346899999999999999
Q ss_pred CCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhhc
Q 046097 476 GLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLC 555 (603)
Q Consensus 476 ~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 555 (603)
.+++.++|.|||||++|||+.|.+||...+.. ..+ ..+ +...+ .++.-....+.+|+...
T Consensus 216 k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-~iY---------~KI---------~~~~v-~fP~~fs~~~kdLl~~L 275 (355)
T KOG0616|consen 216 KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-QIY---------EKI---------LEGKV-KFPSYFSSDAKDLLKKL 275 (355)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-HHH---------HHH---------HhCcc-cCCcccCHHHHHHHHHH
Confidence 99999999999999999999999999876631 111 111 11111 23334455688899999
Q ss_pred cCCCCCCCCC-HH---------------HHHHHhcCCCCCCCCC-CccCCCCCCCCCccc
Q 046097 556 LQRSPSKRLT-MK---------------DIVEMLTGEAEPPHLP-FEFSPSPPSNFPFKS 598 (603)
Q Consensus 556 l~~dP~~Rpt-~~---------------evl~~l~~~~~~~~~~-~~~~~~~~~~~~~~~ 598 (603)
|+.|-++|.. +. +..+.+.+..++|..| ....|...+||.-..
T Consensus 276 L~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y~ 335 (355)
T KOG0616|consen 276 LQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDYE 335 (355)
T ss_pred HhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCcccccccccc
Confidence 9999999942 22 3345567788888765 777788888886443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=360.37 Aligned_cols=148 Identities=32% Similarity=0.501 Sum_probs=130.7
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEc
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
+..++.||+|.||.||.|.+. ....||+|.++.. ....+.|.+|+++|++++|+|||+++++|... ..+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~--~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ--EPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecC--CceEEEEEe
Confidence 345578999999999999994 3447999999763 34457889999999999999999999999986 579999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
|+.|+|.++|.... ...+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+....
T Consensus 283 m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 283 MPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred cccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999998733 34488999999999999999999999 999999999999999999999999999995443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.61 Aligned_cols=155 Identities=28% Similarity=0.441 Sum_probs=132.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~ 150 (603)
..++|++.+.||+|+||.||+|.+. .++..||||+++..........+.+|+.++..+ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 3568999999999999999999752 345789999997644444556799999999999 899999999998764
Q ss_pred CCeEEEEEEccCCCCHHHHHhhccc-------------------------------------------------------
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKC------------------------------------------------------- 175 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~------------------------------------------------------- 175 (603)
+..+++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 3568999999999999999875321
Q ss_pred ----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 176 ----EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 176 ----~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~ 224 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 224 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeeccccccc
Confidence 12377888999999999999999999 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=343.78 Aligned_cols=153 Identities=25% Similarity=0.350 Sum_probs=142.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..+.|++.+.||.|..++||+|+..-++..||||++..+........+.+|+..|+.++||||++++..|... ..+|+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~--~~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD--SELWV 101 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec--ceeEE
Confidence 4567999999999999999999999999999999998887777788999999999999999999999999986 89999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||.||.+|++.++++..-..+ +++..+..|++++++||.|||++ |.||||||+.||||+.+|.+||+|||.+...
T Consensus 102 VmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred eehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999999998876655 89999999999999999999999 9999999999999999999999999987654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=336.48 Aligned_cols=151 Identities=24% Similarity=0.363 Sum_probs=132.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
+.|+.+.++|+|+||+||+|+++.||+.||||++...... ...+-.++|+.+|++++|+|+|.++.+|... ..+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk--rklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK--RKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc--ceeEEE
Confidence 3578889999999999999999999999999999765443 3345678999999999999999999999987 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
+|||+..-|.+ |..... -++...+.+++.|++.|+.|+|++ ++|||||||+||||+.+|.+||||||+|+...+
T Consensus 80 FE~~dhTvL~e-Le~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 80 FEYCDHTVLHE-LERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eeecchHHHHH-HHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99998755544 444332 288999999999999999999999 999999999999999999999999999998764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=354.10 Aligned_cols=152 Identities=25% Similarity=0.442 Sum_probs=136.4
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC----hhhHHHHHHHHHHhccCC-CCceeEEEeEEecCC
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS----LQGEREFHNELSLASSLD-CPHIVSLLGFASDRR 150 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~----~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~ 150 (603)
...+.|.+.+.||+|+||+|+.|.+..+++.||+|++..... ....+.+.+|+.+++++. ||||++++.++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 456789999999999999999999999999999998766411 123456778999999999 99999999999997
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC-CcEEEEee
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKIGDF 229 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~-~~vKL~DF 229 (603)
..+++||||+.+|+|.+++... +.+.+..+..++.|++.|++|||++ ||+||||||+|||++.+ +++||+||
T Consensus 93 -~~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 93 -TKIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred -CeEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecc
Confidence 7799999999999999999873 3388899999999999999999999 99999999999999999 99999999
Q ss_pred ccceec
Q 046097 230 GLARLK 235 (603)
Q Consensus 230 GlA~~~ 235 (603)
|++...
T Consensus 166 G~s~~~ 171 (370)
T KOG0583|consen 166 GLSAIS 171 (370)
T ss_pred cccccc
Confidence 999865
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=364.40 Aligned_cols=275 Identities=24% Similarity=0.366 Sum_probs=227.9
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCC
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGR 152 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~ 152 (603)
...++|.++++||+|+||+|+++..+.+++.+|||+++++.. ..+.+..+.|..++.... ||+++.++..|++. .
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~--~ 442 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK--E 442 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC--C
Confidence 355789999999999999999999999999999999988642 344577888888888775 99999999999997 9
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
++|+||||+.||++..+.+ ...+++..+.-++..|+.||.|||++ +||+||||.+|||+|.+|.+||+|||++
T Consensus 443 ~l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred eEEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 9999999999999544333 23489999999999999999999999 9999999999999999999999999999
Q ss_pred eecccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCC
Q 046097 233 RLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSE 312 (603)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (603)
+..-..
T Consensus 516 Ke~m~~-------------------------------------------------------------------------- 521 (694)
T KOG0694|consen 516 KEGMGQ-------------------------------------------------------------------------- 521 (694)
T ss_pred cccCCC--------------------------------------------------------------------------
Confidence 753211
Q ss_pred CcchhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCC
Q 046097 313 SGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNS 392 (603)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (603)
T Consensus 522 -------------------------------------------------------------------------------- 521 (694)
T KOG0694|consen 522 -------------------------------------------------------------------------------- 521 (694)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccc
Q 046097 393 SNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEY 472 (603)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 472 (603)
-..+.+++||+.|||||+
T Consensus 522 --------------------------------------------------------------g~~TsTfCGTpey~aPEi 539 (694)
T KOG0694|consen 522 --------------------------------------------------------------GDRTSTFCGTPEFLAPEV 539 (694)
T ss_pred --------------------------------------------------------------CCccccccCChhhcChhh
Confidence 013567999999999999
Q ss_pred cCCCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHH
Q 046097 473 GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIA 552 (603)
Q Consensus 473 ~~~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 552 (603)
+.+..|+.++|.|||||+||||+.|..||.+.+.. .+.+ .+. ..-...+...+.+.+.++
T Consensus 540 l~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------e~Fd---sI~----------~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 540 LTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------EVFD---SIV----------NDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred hccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHH---HHh----------cCCCCCCCcccHHHHHHH
Confidence 99999999999999999999999999999866521 1110 111 111134455667788999
Q ss_pred hhccCCCCCCCCCH-----HHHH-----------HHhcCCCCCCCCCCccCCCCCCCCC
Q 046097 553 LLCLQRSPSKRLTM-----KDIV-----------EMLTGEAEPPHLPFEFSPSPPSNFP 595 (603)
Q Consensus 553 ~~cl~~dP~~Rpt~-----~evl-----------~~l~~~~~~~~~~~~~~~~~~~~~~ 595 (603)
..+|..||++|..+ .+|. +.+.+.++||+.|-.-+|.+-+||.
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd 658 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFD 658 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccc
Confidence 99999999999976 3443 2357889999999999999999996
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=339.16 Aligned_cols=153 Identities=32% Similarity=0.465 Sum_probs=134.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
..++...+.||+|+||.||++....+|...|||.+....... .+.+.+|+.+|.+++|||||+++|......+..++++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 345677889999999999999999889999999987653333 6778999999999999999999998555422378999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-CCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-DFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~-~~~vKL~DFGlA~~~~ 236 (603)
|||+++|+|.+++..... .+++..+..++.||+.||.|||++ |+|||||||+|||++. ++.+||+|||++....
T Consensus 95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999987653 489999999999999999999999 9999999999999999 7999999999987654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=342.17 Aligned_cols=148 Identities=28% Similarity=0.405 Sum_probs=132.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++++.+. ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--CeEEE
Confidence 46889999999999999999999899999999986532 122345688999999999999999999998876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 79 LMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred EEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 999999999999987643 388899999999999999999999 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=342.89 Aligned_cols=142 Identities=25% Similarity=0.319 Sum_probs=126.6
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
+.||+|+||.||+|.+..+++.||||+++... .......+.+|+.++.+++||||+++++++... ...|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCCC
Confidence 46999999999999999999999999997532 122345678899999999999999999999886 88999999999
Q ss_pred CCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 163 NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 163 ~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 144 (323)
T cd05571 79 GGELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence 999999887543 388999999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=345.97 Aligned_cols=149 Identities=26% Similarity=0.386 Sum_probs=133.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||+|+++.+++.||+|++.... .......+.+|+.++.+++||||+++++++.+. +..++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 95 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYF 95 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEEE
Confidence 57889999999999999999999999999999996532 122345688999999999999999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 96 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 999999999999987643 378899999999999999999999 9999999999999999999999999998653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=359.23 Aligned_cols=152 Identities=26% Similarity=0.400 Sum_probs=138.0
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
+-|++++.||.|+.|.|-+|++..||+.+|||++.+.. .......+.+|+.+|+-+.||||+++|+++++. .++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~--~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK--QHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC--ceEEE
Confidence 45788899999999999999999999999999997742 223346688999999999999999999999997 89999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|+||+++|-|++++..+.. +++.++.+++.||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|....
T Consensus 90 vlEyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEEecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 9999999999999987654 89999999999999999999999 99999999999999999999999999998766
Q ss_pred cc
Q 046097 237 ED 238 (603)
Q Consensus 237 ~~ 238 (603)
++
T Consensus 164 ~g 165 (786)
T KOG0588|consen 164 PG 165 (786)
T ss_pred CC
Confidence 54
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=353.02 Aligned_cols=154 Identities=31% Similarity=0.446 Sum_probs=137.6
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~L 156 (603)
-++|.++++||.|+||.||+|+.+.++..||||.++.....-++..-++|+..|++|+ |||||++..++.+.. ..+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~-~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND-RILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC-ceEee
Confidence 4578888999999999999999999999999999977544444455678999999999 999999999999873 28999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||||+. +|.++++++ +..+++..+..|+.||++||+|+|.+ |+.||||||+|||+..+..+||+|||+|+...
T Consensus 88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 9999965 999999876 46799999999999999999999999 99999999999999999999999999998765
Q ss_pred cc
Q 046097 237 ED 238 (603)
Q Consensus 237 ~~ 238 (603)
..
T Consensus 162 Sk 163 (538)
T KOG0661|consen 162 SK 163 (538)
T ss_pred cC
Confidence 43
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.01 Aligned_cols=150 Identities=27% Similarity=0.370 Sum_probs=131.0
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++.+++|+||+++++++.+. +..++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEE
Confidence 36778999999999999999999999999999865321 12234678899999999999999999999876 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 79 ~e~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI 152 (285)
T ss_pred EEecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence 999999999988764332 2478999999999999999999999 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=369.41 Aligned_cols=266 Identities=27% Similarity=0.416 Sum_probs=220.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
...+....+.||+|+||+||+|+... ....||||.++.....+...+|++|++++..++|||||+|+|+|.+.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-- 561 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG-- 561 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--
Confidence 34455666889999999999998743 34679999999877777889999999999999999999999999986
Q ss_pred CeEEEEEEccCCCCHHHHHhhccc-----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC
Q 046097 152 RRLVLIYELMENRSLQDALLDRKC-----------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG 220 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~-----------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~ 220 (603)
+.+|+|+|||..|+|.+||....+ ..+++..+.+.|+.|||.||.||-++ ..|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 889999999999999999986432 12388999999999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccceecccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCccc
Q 046097 221 DFKAKIGDFGLARLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRD 300 (603)
Q Consensus 221 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (603)
+..|||+|||+++..+...
T Consensus 639 ~l~VKIsDfGLsRdiYssD------------------------------------------------------------- 657 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSD------------------------------------------------------------- 657 (774)
T ss_pred ceEEEecccccchhhhhhh-------------------------------------------------------------
Confidence 9999999999999876541
Q ss_pred ccccccCCCCCCCcchhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHH
Q 046097 301 WWWKQDNGAGSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEE 380 (603)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (603)
|-+-
T Consensus 658 ------------------YYk~---------------------------------------------------------- 661 (774)
T KOG1026|consen 658 ------------------YYKV---------------------------------------------------------- 661 (774)
T ss_pred ------------------hhcc----------------------------------------------------------
Confidence 1100
Q ss_pred HHHhhhhcCCCCCCcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCC
Q 046097 381 LTKKKKKRGLNSSNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPS 460 (603)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 460 (603)
...
T Consensus 662 -----------------------------------------------------------------------------~~~ 664 (774)
T KOG1026|consen 662 -----------------------------------------------------------------------------RGN 664 (774)
T ss_pred -----------------------------------------------------------------------------cCC
Confidence 000
Q ss_pred cccccCccCccccCCCCCCccCCccchhheeeehcc-CCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCC
Q 046097 461 MRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLIS-GRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHS 539 (603)
Q Consensus 461 ~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
..-...|||||.+.-+.+|++||||||||||||+++ |+.||..... ++.++ .... ..+-.
T Consensus 665 t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------~EVIe----~i~~--------g~lL~ 725 (774)
T KOG1026|consen 665 TLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------QEVIE----CIRA--------GQLLS 725 (774)
T ss_pred ceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------HHHHH----HHHc--------CCccc
Confidence 112456999999999999999999999999999999 9999986542 22222 2223 33345
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 046097 540 LDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTGEAEPP 580 (603)
Q Consensus 540 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~l~~~~~~~ 580 (603)
.++.++..+..|+..||+.+|.+||+++||-..|+...+.+
T Consensus 726 ~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 726 CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 56778889999999999999999999999999998776543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=355.76 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=213.9
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+.. ...+.+.+.+|+++++.++|||||.++++|+.. .++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~--~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS--AHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc--ceEEEE
Confidence 46888899999999999999999999999999997643 444567899999999999999999999999997 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
+||+.| +|..++..... ++++.+..++.+++.||.|||++ +|+|||+||.|||++..+.+|+||||+|+....
T Consensus 80 te~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred ehhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 999977 99999987654 99999999999999999999999 999999999999999999999999999986543
Q ss_pred ccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcchh
Q 046097 238 DLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGRVK 317 (603)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (603)
.
T Consensus 153 ~------------------------------------------------------------------------------- 153 (808)
T KOG0597|consen 153 N------------------------------------------------------------------------------- 153 (808)
T ss_pred C-------------------------------------------------------------------------------
Confidence 2
Q ss_pred hhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCcCc
Q 046097 318 DYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNVGE 397 (603)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (603)
T Consensus 154 -------------------------------------------------------------------------------- 153 (808)
T KOG0597|consen 154 -------------------------------------------------------------------------------- 153 (808)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCCCC
Q 046097 398 MWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGL 477 (603)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 477 (603)
.+..+.+.||+.|||||.+.+.+
T Consensus 154 ---------------------------------------------------------t~vltsikGtPlYmAPElv~e~p 176 (808)
T KOG0597|consen 154 ---------------------------------------------------------TSVLTSIKGTPLYMAPELVEEQP 176 (808)
T ss_pred ---------------------------------------------------------ceeeeeccCcccccCHHHHcCCC
Confidence 01124567999999999999999
Q ss_pred CCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhhccC
Q 046097 478 LSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQ 557 (603)
Q Consensus 478 ~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 557 (603)
|+..+|.||+||||||+++|++||... .+...++.+..+. ...+...+..+..++...|+
T Consensus 177 yd~~sDlWslGcilYE~~~G~PPF~a~----------si~~Lv~~I~~d~----------v~~p~~~S~~f~nfl~gLL~ 236 (808)
T KOG0597|consen 177 YDHTSDLWSLGCILYELYVGQPPFYAR----------SITQLVKSILKDP----------VKPPSTASSSFVNFLQGLLI 236 (808)
T ss_pred ccchhhHHHHHHHHHHHhcCCCCchHH----------HHHHHHHHHhcCC----------CCCcccccHHHHHHHHHHhh
Confidence 999999999999999999999998743 3344444443321 12334667789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 046097 558 RSPSKRLTMKDIVEM 572 (603)
Q Consensus 558 ~dP~~Rpt~~evl~~ 572 (603)
.||.+|.|..+++..
T Consensus 237 kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 237 KDPAQRLTWTDLLGH 251 (808)
T ss_pred cChhhcccHHHHhcC
Confidence 999999999999875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=337.94 Aligned_cols=148 Identities=24% Similarity=0.356 Sum_probs=132.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||+|++..+++.||||+++... .......+.+|+.++..++||||+++++++.+. ...|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CEEEE
Confidence 46899999999999999999999899999999997532 122345688999999999999999999999886 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 v~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred EEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 999999999999996543 378999999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=338.27 Aligned_cols=142 Identities=26% Similarity=0.343 Sum_probs=126.8
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
+.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+. ...++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCCC
Confidence 36999999999999999999999999997532 223346788899999999999999999999886 88999999999
Q ss_pred CCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 163 NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 163 ~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~ 144 (328)
T cd05593 79 GGELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (328)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence 999998886543 388999999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.29 Aligned_cols=156 Identities=29% Similarity=0.412 Sum_probs=138.0
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
-.+.|+.+++||+|.||.||+|++..+|+.||+|.+..+... ....-..+|+.+|++|+||||++|.+...+...+.+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 445678888999999999999999999999999999875432 3345678999999999999999999999887678999
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|+|||+. +|..++..... .+++.++.+++.|++.||.|+|.+ +|+|||||.+|||||.+|.+||+|||+|+..
T Consensus 195 lVFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 99999976 88888865432 389999999999999999999999 9999999999999999999999999999977
Q ss_pred ccc
Q 046097 236 TED 238 (603)
Q Consensus 236 ~~~ 238 (603)
...
T Consensus 269 ~~~ 271 (560)
T KOG0600|consen 269 TPS 271 (560)
T ss_pred cCC
Confidence 654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=358.40 Aligned_cols=152 Identities=28% Similarity=0.468 Sum_probs=139.3
Q ss_pred CCCCCceeeccCceEEEEEEEcCCC---ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSS---QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg---~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
...+.++||.|.||.|++|+++..+ ..||||.++.......+..|+.|..||.++.||||++|.|+.... ..++|
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks--~PvMI 707 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS--KPVMI 707 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC--ceeEE
Confidence 3466789999999999999997655 479999999988888889999999999999999999999999886 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|+|||++|+|..||+.+.. .++..+...|+++|+.||.||-.+ ++|||||..+||||+.+..+|++|||+++..+
T Consensus 708 iTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999988763 388999999999999999999999 99999999999999999999999999999776
Q ss_pred cc
Q 046097 237 ED 238 (603)
Q Consensus 237 ~~ 238 (603)
.+
T Consensus 783 dd 784 (996)
T KOG0196|consen 783 DD 784 (996)
T ss_pred cC
Confidence 55
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.57 Aligned_cols=142 Identities=25% Similarity=0.324 Sum_probs=125.8
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
+.||+|+||.||++.+..+++.||+|++.... .......+..|+.++..++||||+++++++.+. ..+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCCC
Confidence 46999999999999999999999999997532 122345678899999999999999999999886 88999999999
Q ss_pred CCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 163 NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 163 ~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+|+|..++.... .+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 79 GGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 999998886543 38999999999999999999997 6 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.58 Aligned_cols=284 Identities=25% Similarity=0.374 Sum_probs=225.8
Q ss_pred cHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEec
Q 046097 70 SYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASD 148 (603)
Q Consensus 70 ~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~ 148 (603)
+.++++...+.+.+...||+|+||+||+|.+. -.||||+++.... ....+.|.+|+..+++-+|.||+-++|+|..
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 34566667777888899999999999999994 3599999977543 3445789999999999999999999999998
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEe
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~D 228 (603)
+ .. .||+.+|+|.+|+.+++.... .++....+.|+.|||+||.|||.+ +|||||||..|||+.++++|||+|
T Consensus 460 p--~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 460 P--PL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred C--ce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEec
Confidence 6 44 899999999999999987653 388899999999999999999999 999999999999999999999999
Q ss_pred eccceecccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCC
Q 046097 229 FGLARLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNG 308 (603)
Q Consensus 229 FGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (603)
||++....-- ++..+
T Consensus 532 FGLatvk~~w-----------------------------------------------------------------~g~~q 546 (678)
T KOG0193|consen 532 FGLATVKTRW-----------------------------------------------------------------SGEQQ 546 (678)
T ss_pred ccceeeeeee-----------------------------------------------------------------ccccc
Confidence 9998754211 00000
Q ss_pred CCCCCcchhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhc
Q 046097 309 AGSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKR 388 (603)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (603)
T Consensus 547 -------------------------------------------------------------------------------- 546 (678)
T KOG0193|consen 547 -------------------------------------------------------------------------------- 546 (678)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCCcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCcc
Q 046097 389 GLNSSNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYI 468 (603)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~ 468 (603)
.....|...||
T Consensus 547 ---------------------------------------------------------------------~~qp~gsilwm 557 (678)
T KOG0193|consen 547 ---------------------------------------------------------------------LEQPHGSLLWM 557 (678)
T ss_pred ---------------------------------------------------------------------cCCCccchhhh
Confidence 01234677899
Q ss_pred CccccCC---CCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHH
Q 046097 469 APEYGGG---GLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQA 545 (603)
Q Consensus 469 aPE~~~~---~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
|||++.. .+|+..+||||||||+|||+||..||...+.... +++.. ...+.+.+.....++.
T Consensus 558 APEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI----------ifmVG-----rG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 558 APEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI----------IFMVG-----RGYLMPDLSKIRSNCP 622 (678)
T ss_pred cHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----------EEEec-----ccccCccchhhhccCH
Confidence 9998874 5789999999999999999999999984442200 00111 1122344445556677
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCCccCCCCCCCC
Q 046097 546 LLCITIALLCLQRSPSKRLTMKDIVEMLTGEAEPPHLPFEFSPSPPSNF 594 (603)
Q Consensus 546 ~~l~~l~~~cl~~dP~~Rpt~~evl~~l~~~~~~~~~~~~~~~~~~~~~ 594 (603)
+++.+|+..||..++++||.+.+|+..|+..... -|....|++-|..+
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~-~pki~RS~S~P~~~ 670 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS-LPKINRSASEPVLL 670 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc-ccccccCcCccchh
Confidence 8899999999999999999999999998877654 45566777777654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=335.34 Aligned_cols=140 Identities=26% Similarity=0.377 Sum_probs=125.4
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++.+++||||+++++++.+. ...++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCCC
Confidence 799999999999999999999999986532 223346678899999999999999999999876 8899999999999
Q ss_pred CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 165 SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 165 sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 79 ELFHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 9999987643 388999999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.27 Aligned_cols=153 Identities=30% Similarity=0.488 Sum_probs=132.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcC----------------CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPS----------------SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~----------------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~ 141 (603)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++...........+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3678899999999999999998632 344799999977545555678999999999999999999
Q ss_pred EEeEEecCCCCeEEEEEEccCCCCHHHHHhhccc----------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 046097 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKC----------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205 (603)
Q Consensus 142 l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~----------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g 205 (603)
+++++.+. ...++||||+++++|.+++..... ...+++..++.++.||+.||.|||+. +
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 84 LLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred EEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 99999886 779999999999999999865321 12367788999999999999999999 9
Q ss_pred eEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 206 IVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|+||||||+|||++.++.+||+|||++...
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~ 188 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNL 188 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceec
Confidence 999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=340.70 Aligned_cols=150 Identities=27% Similarity=0.369 Sum_probs=131.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCC-ceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSS-QPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg-~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++..++||||+++++++.+. ...
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 106 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SYL 106 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CEE
Confidence 456999999999999999999876554 689999986432 122345688999999999999999999999886 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999997643 388999999999999999999999 999999999999999999999999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 181 ~ 181 (340)
T PTZ00426 181 V 181 (340)
T ss_pred c
Confidence 3
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.45 Aligned_cols=149 Identities=25% Similarity=0.335 Sum_probs=130.0
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||+|+||.||+|+++.+++.||+|++..... ......+.+|+.+++.++|+||+++++++... +..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEEEE
Confidence 478999999999999999999999999999999876432 22346688999999999999999999999876 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||++++.+..+.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 79 FEYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred EecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999987666544322 2388999999999999999999999 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=335.67 Aligned_cols=142 Identities=27% Similarity=0.327 Sum_probs=126.3
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
+.||+|+||.||++.+..+++.||+|+++... .......+.+|+.++..++||||+++++++... ..+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCCC
Confidence 46999999999999999999999999997532 122345677899999999999999999999886 78999999999
Q ss_pred CCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 163 NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 163 ~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 144 (323)
T cd05595 79 GGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence 999998886543 388999999999999999999999 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=335.40 Aligned_cols=145 Identities=26% Similarity=0.358 Sum_probs=125.2
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHH---hccCCCCceeEEEeEEecCCCCeEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSL---ASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~i---L~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
|++.+.||+|+||.||+|.+..+++.||||+++... .....+.+.+|..+ +..++||||+++++++.+. ...|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEEE
Confidence 677899999999999999999999999999997532 11223456666554 4567899999999999886 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+||||+++++|...+... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 lv~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 999999999999887542 389999999999999999999999 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=346.69 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=212.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
...|....+||+|+.|.||.|....+++.||||.+... .....+-+.+|+.+|+..+|+|||.+++.|... +.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec-cCCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEE
Confidence 44577778999999999999999999999999999774 344556789999999999999999999988876 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
|||+++|+|.+.+.... +++.++..|+.+++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999886543 89999999999999999999999 999999999999999999999999999877654
Q ss_pred ccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcchh
Q 046097 238 DLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGRVK 317 (603)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (603)
..
T Consensus 422 ~~------------------------------------------------------------------------------ 423 (550)
T KOG0578|consen 422 EQ------------------------------------------------------------------------------ 423 (550)
T ss_pred cc------------------------------------------------------------------------------
Confidence 31
Q ss_pred hhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCcCc
Q 046097 318 DYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNVGE 397 (603)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (603)
T Consensus 424 -------------------------------------------------------------------------------- 423 (550)
T KOG0578|consen 424 -------------------------------------------------------------------------------- 423 (550)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCCCC
Q 046097 398 MWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGL 477 (603)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 477 (603)
....+++||+.|||||++....
T Consensus 424 ----------------------------------------------------------~KR~TmVGTPYWMAPEVvtrk~ 445 (550)
T KOG0578|consen 424 ----------------------------------------------------------SKRSTMVGTPYWMAPEVVTRKP 445 (550)
T ss_pred ----------------------------------------------------------CccccccCCCCccchhhhhhcc
Confidence 0134689999999999999999
Q ss_pred CCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhhccC
Q 046097 478 LSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQ 557 (603)
Q Consensus 478 ~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 557 (603)
|++|+||||||++++||+-|.+||-..+.- .-.+.+..++. +.+ ..+...+..|.+++.+||+
T Consensus 446 YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl----------rAlyLIa~ng~------P~l-k~~~klS~~~kdFL~~cL~ 508 (550)
T KOG0578|consen 446 YGPKVDIWSLGIMAIEMVEGEPPYLNENPL----------RALYLIATNGT------PKL-KNPEKLSPELKDFLDRCLV 508 (550)
T ss_pred cCccccchhhhhHHHHHhcCCCCccCCChH----------HHHHHHhhcCC------CCc-CCccccCHHHHHHHHHHhh
Confidence 999999999999999999999999753311 11111111111 111 3345567789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 046097 558 RSPSKRLTMKDIVEM 572 (603)
Q Consensus 558 ~dP~~Rpt~~evl~~ 572 (603)
.|+.+|+++.|+|+.
T Consensus 509 ~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 509 VDVEQRASAKELLEH 523 (550)
T ss_pred cchhcCCCHHHHhcC
Confidence 999999999999975
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.94 Aligned_cols=151 Identities=26% Similarity=0.354 Sum_probs=135.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||++++..++..+|+|++...........+.+|++++.+++||||+++++++.+. +..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEEE
Confidence 468999999999999999999999999999999997654444557799999999999999999999999886 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++...
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 82 MEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred eecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 99999999999997643 3789999999999999999999852 6999999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=370.39 Aligned_cols=263 Identities=27% Similarity=0.522 Sum_probs=211.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
....|...+.||+|+||.||+|....++..||||.+..... ....|++.+++++||||++++++|.+. ...++
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~l 760 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYL 760 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcC--CCCEE
Confidence 34567888999999999999999988999999999865322 112458889999999999999999886 77899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++|+|.+++.. +++..+..++.|++.||+|||..+.++|+||||||+||+++.++..++. ||.+....
T Consensus 761 v~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 9999999999999952 7899999999999999999996656699999999999999988887775 44332110
Q ss_pred cccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcch
Q 046097 237 EDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGRV 316 (603)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (603)
.
T Consensus 834 ~------------------------------------------------------------------------------- 834 (968)
T PLN00113 834 T------------------------------------------------------------------------------- 834 (968)
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred hhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCcC
Q 046097 317 KDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNVG 396 (603)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (603)
T Consensus 835 -------------------------------------------------------------------------------- 834 (968)
T PLN00113 835 -------------------------------------------------------------------------------- 834 (968)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCCC
Q 046097 397 EMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGG 476 (603)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 476 (603)
.....||..|+|||++.+.
T Consensus 835 -------------------------------------------------------------~~~~~~t~~y~aPE~~~~~ 853 (968)
T PLN00113 835 -------------------------------------------------------------DTKCFISSAYVAPETRETK 853 (968)
T ss_pred -------------------------------------------------------------CCCccccccccCcccccCC
Confidence 0112478889999999999
Q ss_pred CCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCC---CCCHHHHHHHHHHHh
Q 046097 477 LLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIH---SLDKDQALLCITIAL 553 (603)
Q Consensus 477 ~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~ 553 (603)
.++.++|||||||++|||+||+.||+.... ....+..|++..........++++.+. .....+...+.+++.
T Consensus 854 ~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 928 (968)
T PLN00113 854 DITEKSDIYGFGLILIELLTGKSPADAEFG-----VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLAL 928 (968)
T ss_pred CCCcccchhhHHHHHHHHHhCCCCCCcccC-----CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHH
Confidence 999999999999999999999999964322 123456676655544445555666553 334566778899999
Q ss_pred hccCCCCCCCCCHHHHHHHhcCCCC
Q 046097 554 LCLQRSPSKRLTMKDIVEMLTGEAE 578 (603)
Q Consensus 554 ~cl~~dP~~Rpt~~evl~~l~~~~~ 578 (603)
.||+.||++||||.||++.|+....
T Consensus 929 ~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 929 HCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred hhCcCCchhCcCHHHHHHHHHHhhc
Confidence 9999999999999999999987765
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.86 Aligned_cols=151 Identities=24% Similarity=0.298 Sum_probs=134.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... ......+.+|+.++..++|+||+++++++.+. ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEE
Confidence 468899999999999999999999999999999975321 22345688999999999999999999999886 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred EECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999999997652 2489999999999999999999999 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.24 Aligned_cols=151 Identities=28% Similarity=0.414 Sum_probs=134.8
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|.+.+.||+|+||.||+|.+..+++.||||+++... .......+.+|+.++..++|+||+++++++.+. ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE--EHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC--CeEEE
Confidence 47899999999999999999999899999999996532 113346688999999999999999999999886 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred EEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 99999999999999765 3488999999999999999999998 99999999999999999999999999987654
Q ss_pred c
Q 046097 237 E 237 (603)
Q Consensus 237 ~ 237 (603)
.
T Consensus 153 ~ 153 (350)
T cd05573 153 K 153 (350)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.50 Aligned_cols=149 Identities=27% Similarity=0.454 Sum_probs=131.9
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||.|+||.||+|.+..+++.||+|.++..........+.+|+.++++++||||+++++++.+. ...++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEEEEE
Confidence 56999999999999999999999999999999997644333445678999999999999999999999876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 83 EYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAK 153 (288)
T ss_pred eCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence 99975 8988886543 3478899999999999999999999 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=323.68 Aligned_cols=152 Identities=30% Similarity=0.536 Sum_probs=133.1
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCC-----ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSS-----QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg-----~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
++|++.+.||+|+||.||+|.....+ ..||+|.++..........+.+|+.++.+++||||+++++++.+. ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--QP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--Cc
Confidence 46888999999999999999976544 679999997655555567799999999999999999999999876 77
Q ss_pred EEEEEEccCCCCHHHHHhhcccc-------------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC
Q 046097 154 LVLIYELMENRSLQDALLDRKCE-------------ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG 220 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~-------------~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~ 220 (603)
.+++|||+++++|.+++...... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 89999999999999999764221 3478899999999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccceec
Q 046097 221 DFKAKIGDFGLARLK 235 (603)
Q Consensus 221 ~~~vKL~DFGlA~~~ 235 (603)
++.++|+|||++...
T Consensus 160 ~~~~~L~dfg~~~~~ 174 (283)
T cd05048 160 GLTVKISDFGLSRDI 174 (283)
T ss_pred CCcEEECCCcceeec
Confidence 999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.35 Aligned_cols=154 Identities=31% Similarity=0.409 Sum_probs=132.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEE-----cCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVV-----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~ 150 (603)
..++|++.+.||+|+||.||+|.. ..++..||||+++........+.+.+|+.++..+ +||||++++++|.+.
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~- 111 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG- 111 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-
Confidence 345789999999999999999974 3456789999997654445556789999999999 799999999999886
Q ss_pred CCeEEEEEEccCCCCHHHHHhhccc-------------------------------------------------------
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKC------------------------------------------------------- 175 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~------------------------------------------------------- 175 (603)
...++||||+++|+|.+++.....
T Consensus 112 -~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 112 -GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred -CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 788999999999999999865321
Q ss_pred -----------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 176 -----------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 176 -----------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceec
Confidence 11367888999999999999999999 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.55 Aligned_cols=151 Identities=24% Similarity=0.313 Sum_probs=135.4
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
+.|+.++.||.|.-|+||+++.+.++..+|+|++.+... .....+.+.|-+||+.++||+++.||+.|+.. ...|+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~--~~~cl 154 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD--KYSCL 154 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc--ceeEE
Confidence 456777899999999999999999999999999977532 23345678899999999999999999999987 89999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||||+||+|..+++.+.. ..+++..+.-++..|+.||.|||-. |||.|||||+||||.++|.+.|+||.++...
T Consensus 155 ~meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999998876654 5589999999999999999999999 9999999999999999999999999998655
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.16 Aligned_cols=150 Identities=22% Similarity=0.361 Sum_probs=132.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEc---CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVP---SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.++|++.+.||+|+||.||+|.++ ..+..||+|.++..........+.+|+.++.+++||||+++++++... ...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCc
Confidence 456889999999999999999875 346789999998755555556789999999999999999999999876 789
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.++|+|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999999987643 3488999999999999999999999 999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=341.00 Aligned_cols=153 Identities=31% Similarity=0.457 Sum_probs=139.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
...|+..++||.|+||.||+|.+..+++.||+|++..+......+.+++|+.+|.+++++||.++|+.+... ..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g--~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG--TKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec--ccHHHH
Confidence 445777789999999999999999999999999998877777788999999999999999999999999886 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
||||.+|++.+.+.... .+++..+..++.+++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+.....
T Consensus 90 Mey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999999997543 358888888999999999999999 999999999999999999999999999977654
Q ss_pred c
Q 046097 238 D 238 (603)
Q Consensus 238 ~ 238 (603)
.
T Consensus 164 ~ 164 (467)
T KOG0201|consen 164 T 164 (467)
T ss_pred h
Confidence 4
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=326.18 Aligned_cols=149 Identities=25% Similarity=0.403 Sum_probs=131.6
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeEEEE
Confidence 468999999999999999999999899999999997644333445678899999999999999999999886 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|||+. ++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 82 FEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred EECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCccee
Confidence 99995 68888776543 3378899999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.10 Aligned_cols=143 Identities=24% Similarity=0.341 Sum_probs=122.6
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhcc-CCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASS-LDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~-l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.+..+++.||||+++... .......+..|..++.. .+||||+++++++... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 36999999999999999999999999997532 11223445566666664 4799999999999876 7899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
++|+|..++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 79 ~gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 79 NGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999999886543 388999999999999999999999 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.87 Aligned_cols=144 Identities=22% Similarity=0.291 Sum_probs=124.4
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHhccCCCCceeEEEeEEec--CCCCeEEEEEEc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPHIVSLLGFASD--RRGRRLVLIYEL 160 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~--~~~~~~~LVmEy 160 (603)
..||+|++|.||+|.. +++.||||.++..... ...+.+.+|+.+|.+++||||+++++++.+ .....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999998 6889999999764221 124678899999999999999999999977 333678999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+++|+|.+++.... .+++.....++.|++.||.|||+.. +++||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 99999999997643 3788999999999999999999732 7889999999999999999999999998643
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.93 Aligned_cols=150 Identities=32% Similarity=0.525 Sum_probs=131.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCc----eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQ----PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.+|++.+.||+|+||.||+|.+..++. .||+|.++..........+.+|+.+++.++||||++++++|.. ...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCc
Confidence 568999999999999999999865555 3899999765445556789999999999999999999999986 356
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++++||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 89999999999999997643 2378899999999999999999999 999999999999999999999999999976
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 159 ~~ 160 (316)
T cd05108 159 LG 160 (316)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.54 Aligned_cols=150 Identities=25% Similarity=0.332 Sum_probs=134.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||+|++..+++.||||++.... .......+.+|+.++..++|+||+++++++.+. ...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEE
Confidence 47899999999999999999999999999999996532 122345678899999999999999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 79 v~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred EECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999999987643 389999999999999999999999 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.01 Aligned_cols=147 Identities=25% Similarity=0.299 Sum_probs=128.3
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCC-CceeEEEeEEecCCCCeEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDC-PHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~H-pNIV~l~g~~~~~~~~~~~L 156 (603)
+|++.+.||+|+||.||+|.+..+++.||||++.... .......+..|..++..+.| ++|+.+++++.+. +.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence 4788999999999999999999999999999997532 12334567889999999975 5688888888876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 v~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 999999999999886543 378899999999999999999999 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=330.13 Aligned_cols=149 Identities=26% Similarity=0.445 Sum_probs=128.6
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC---CCeEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR---GRRLV 155 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---~~~~~ 155 (603)
+|++.+.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.++++++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788899999999999999999999999999986432 2233456889999999999999999999886432 13589
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68988886543 388999999999999999999999 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.02 Aligned_cols=154 Identities=28% Similarity=0.401 Sum_probs=132.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~ 150 (603)
..++|++.+.||+|+||.||+|.... ++..||||+++..........+.+|+.+++.+ +|+||++++++|.+.
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~- 114 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG- 114 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence 44579999999999999999998643 34579999997655555567789999999999 799999999999886
Q ss_pred CCeEEEEEEccCCCCHHHHHhhccc-------------------------------------------------------
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKC------------------------------------------------------- 175 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~------------------------------------------------------- 175 (603)
...++||||+++|+|.+++.....
T Consensus 115 -~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 115 -GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred -CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 789999999999999999864321
Q ss_pred ------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 176 ------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 176 ------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~ 262 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDI 262 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeec
Confidence 12367888999999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.66 Aligned_cols=142 Identities=25% Similarity=0.349 Sum_probs=124.3
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.++.+++.||||++.... .......+..|..++..+ +||||+++++++.+. ..+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCC
Confidence 36999999999999999999999999986532 122345677888888776 699999999999886 8899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 79 NGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred CCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 9999999886543 388999999999999999999999 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.66 Aligned_cols=142 Identities=25% Similarity=0.358 Sum_probs=123.3
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.++.+++.||+|+++.... ......+..|..++... +||||+++++++.+. +.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECCC
Confidence 469999999999999999999999999975321 12334566777777654 899999999999886 8999999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
.+|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 79 NGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 9999999886543 378899999999999999999999 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.79 Aligned_cols=149 Identities=27% Similarity=0.325 Sum_probs=132.9
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||++....+++.||||++.... .......+.+|+.++.+++||||+++++++.+. ..+|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeEE
Confidence 47889999999999999999999999999999986531 122345688999999999999999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 79 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999987543 378899999999999999999999 9999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=335.96 Aligned_cols=148 Identities=24% Similarity=0.303 Sum_probs=132.7
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.++.+++|+||+++++++.+. ..+++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEEE
Confidence 5888999999999999999999999999999996532 123346788999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 80 MDYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999999987643 378899999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.49 Aligned_cols=146 Identities=26% Similarity=0.485 Sum_probs=129.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
..+|+..+.||+|+||.||+|.+..+++.||||++...........+.+|+++++.++|+||+++++++.+. +.+++|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeEEEE
Confidence 345677889999999999999999899999999997654445567799999999999999999999999876 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.... ...+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 9999999986432 256777888999999999999999 9999999999999999999999999998754
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=328.16 Aligned_cols=142 Identities=27% Similarity=0.406 Sum_probs=123.9
Q ss_pred ceeeccCceEEEEEEEc---CCCceEEEEEecCCC---ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 85 NRLGHGGFGSVYKAVVP---SSSQPLAVKILDSSG---SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~---~tg~~VAVK~l~~~~---~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+.||+|+||.||++... .+++.||||+++... .......+.+|+.++..++||||+++++++... +..|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 67999999999999863 468899999986532 122335578899999999999999999999886 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||+++++|.+++.... .+.+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 80 EYLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred eCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 9999999999986543 378888899999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=328.29 Aligned_cols=142 Identities=27% Similarity=0.370 Sum_probs=121.8
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHH-HhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELS-LASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~-iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.+..+++.||||++..... ......+..|.. +++.++||||+++++++.+. ...++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcCC
Confidence 469999999999999999999999999865321 122234455544 56789999999999999886 8899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 79 NGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 9999999886543 388999999999999999999999 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=329.25 Aligned_cols=142 Identities=24% Similarity=0.343 Sum_probs=124.3
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|++..+++.||||+++... .......+..|..++..+ +||||+++++++.+. ...|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence 36999999999999999999999999997532 122335577888888866 799999999999986 7899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++++|...+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 79 NGGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccccee
Confidence 9999998886543 378899999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=326.83 Aligned_cols=142 Identities=27% Similarity=0.396 Sum_probs=124.5
Q ss_pred ceeeccCceEEEEEEE---cCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEc
Q 046097 85 NRLGHGGFGSVYKAVV---PSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~---~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
+.||+|+||.||++.. ..+++.||+|++..... ......+..|++++.+++||||+++++++.+. ...|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEEcC
Confidence 5799999999999876 35789999999975321 12335577899999999999999999999886 889999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 80 ~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 80 LRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999999986543 389999999999999999999999 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.83 Aligned_cols=148 Identities=24% Similarity=0.319 Sum_probs=128.6
Q ss_pred CCCCCceeeccCceEEEEEEEc---CCCceEEEEEecCCC---ChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCC
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVP---SSSQPLAVKILDSSG---SLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGR 152 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~l~~~~---~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~ 152 (603)
+|++.+.||+|+||.||+++.. .+++.||+|++.... .....+.+..|+.++..++ |+||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence 4788999999999999998864 478899999986521 1223456788999999995 99999999999876 7
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
.+++||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 8999999999999999987543 388999999999999999999999 9999999999999999999999999998
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
+..
T Consensus 153 ~~~ 155 (332)
T cd05614 153 KEF 155 (332)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=327.74 Aligned_cols=142 Identities=26% Similarity=0.359 Sum_probs=123.2
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhcc-CCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASS-LDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~-l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|++..+++.||||+++.... ......+..|..++.. ++||||+++++++.+. ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence 469999999999999999999999999975321 1233456677777775 4899999999999886 7899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 79 NGGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 9999999987543 378899999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=308.90 Aligned_cols=152 Identities=29% Similarity=0.504 Sum_probs=135.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhh-HHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG-EREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~-~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.+|..++.||+|.||.||+|++..+|+.||||.++....... .....+|+..|+.++|+||+.++++|... +.+.+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~--~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK--SNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC--CceEEE
Confidence 467888999999999999999999999999999977543322 35678999999999999999999999987 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
+||++. +|...+++.. ..++..++..++.++++||+|||++ .|+||||||.|+||+++|.+||+|||+|+....
T Consensus 80 fEfm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 999964 9999997654 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred c
Q 046097 238 D 238 (603)
Q Consensus 238 ~ 238 (603)
.
T Consensus 154 p 154 (318)
T KOG0659|consen 154 P 154 (318)
T ss_pred C
Confidence 3
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=335.65 Aligned_cols=148 Identities=24% Similarity=0.303 Sum_probs=132.4
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.|++++.||+|+||.||+|+...+++.||+|++.... .......+.+|+.++.+++|+||+++++.+.+. ..+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEEE
Confidence 5888999999999999999999999999999986532 123345788999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 80 MDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999999986643 378899999999999999999999 9999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.02 Aligned_cols=149 Identities=23% Similarity=0.317 Sum_probs=132.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++++.||+|+||.||+|++..+++.||||++..... ......+.+|+.++.+++|+||+++++.+.+. +.+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEE
Confidence 468999999999999999999999999999999865221 12345688999999999999999999999886 89999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|...
T Consensus 79 v~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 999999999999997643 378889999999999999999999 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=325.61 Aligned_cols=150 Identities=26% Similarity=0.364 Sum_probs=134.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||++.+..++..+|+|++...........+.+|++++.+++|+||++++++|.+. +..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEEEE
Confidence 478999999999999999999999899999999987654444557799999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.. +|+|+||||+|||++.++.+||+|||++..
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 99999999999987543 3788999999999999999999742 799999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.02 Aligned_cols=147 Identities=25% Similarity=0.298 Sum_probs=127.9
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~L 156 (603)
+|++.+.||+|+||.||+|.+..+++.||||++..... ......+..|..++..+ .|++|+.+++++.+. ..+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence 47888999999999999999999999999999975321 22234566778888777 489999999999886 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+++|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 v~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred EEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 999999999999886543 388999999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=319.85 Aligned_cols=149 Identities=30% Similarity=0.459 Sum_probs=128.3
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCc----eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQ----PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
++|++.+.||+|+||.||+|.+..+++ .+++|.+...........+..|+..+.++.||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Ccc
Confidence 568888999999999999999876665 4778887543333444678888889999999999999998864 457
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++++||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||++++++.+||+|||+++.
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 89999999999999997543 2488999999999999999999999 999999999999999999999999999875
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 159 ~ 159 (279)
T cd05111 159 L 159 (279)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=339.78 Aligned_cols=239 Identities=26% Similarity=0.391 Sum_probs=201.7
Q ss_pred CCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 83 PSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 83 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
.++-||.|+.|.||+|+. .++.||||+++.- -..++.-|++|+|+||+.+.|+|... ..+|||||||.
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqs--PcyCIiMEfCa 195 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQS--PCYCIIMEFCA 195 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCC--ceeEEeeeccc
Confidence 356799999999999998 4788999988541 12568889999999999999999987 89999999999
Q ss_pred CCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecccccccc
Q 046097 163 NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIE 242 (603)
Q Consensus 163 ~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~~~~~ 242 (603)
.|-|...|+... .++......+..+||.||+|||.+ .|||||||.-||||..+..+||+|||.++.....
T Consensus 196 ~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---- 265 (904)
T KOG4721|consen 196 QGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---- 265 (904)
T ss_pred cccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh----
Confidence 999999997754 388889999999999999999999 9999999999999999999999999988654321
Q ss_pred cccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcchhhhHHh
Q 046097 243 GECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGRVKDYVME 322 (603)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (603)
T Consensus 266 -------------------------------------------------------------------------------- 265 (904)
T KOG4721|consen 266 -------------------------------------------------------------------------------- 265 (904)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCcCcccccc
Q 046097 323 WIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNVGEMWWQK 402 (603)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (603)
T Consensus 266 -------------------------------------------------------------------------------- 265 (904)
T KOG4721|consen 266 -------------------------------------------------------------------------------- 265 (904)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred chhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCCCCCCccC
Q 046097 403 DEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKC 482 (603)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~ 482 (603)
+....++||..|||||++.+.+.++|+
T Consensus 266 -----------------------------------------------------STkMSFaGTVaWMAPEvIrnePcsEKV 292 (904)
T KOG4721|consen 266 -----------------------------------------------------STKMSFAGTVAWMAPEVIRNEPCSEKV 292 (904)
T ss_pred -----------------------------------------------------hhhhhhhhhHhhhCHHHhhcCCccccc
Confidence 112357899999999999999999999
Q ss_pred CccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCC-CCCHHHHHHHHHHHhhccCCCCC
Q 046097 483 DVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIH-SLDKDQALLCITIALLCLQRSPS 561 (603)
Q Consensus 483 DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~ 561 (603)
||||||||||||+||..||...+... -+..+=...+. ..+..++..+.-|++.||+-.|.
T Consensus 293 DIwSfGVVLWEmLT~EiPYkdVdssA-------------------IIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR 353 (904)
T KOG4721|consen 293 DIWSFGVVLWEMLTGEIPYKDVDSSA-------------------IIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR 353 (904)
T ss_pred ceehhHHHHHHHHhcCCCccccchhe-------------------eEEeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence 99999999999999999998554321 11111122232 45667888999999999999999
Q ss_pred CCCCHHHHHHHhcC
Q 046097 562 KRLTMKDIVEMLTG 575 (603)
Q Consensus 562 ~Rpt~~evl~~l~~ 575 (603)
+||++.+|+..|+-
T Consensus 354 NRPSFrqil~HldI 367 (904)
T KOG4721|consen 354 NRPSFRQILLHLDI 367 (904)
T ss_pred CCccHHHHHHHHhh
Confidence 99999999999963
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=327.47 Aligned_cols=142 Identities=25% Similarity=0.354 Sum_probs=124.9
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.+..+++.||||+++... .......+..|..++..+ +||||+++++++.+. ..+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 46999999999999999999999999997532 122345677888888877 699999999999886 7899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++++|..++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 79 NGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 9999999886543 389999999999999999999999 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=328.78 Aligned_cols=157 Identities=27% Similarity=0.386 Sum_probs=136.8
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-------------hhHHHHHHHHHHhccCCCCce
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-------------QGEREFHNELSLASSLDCPHI 139 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-------------~~~~~~~~Ev~iL~~l~HpNI 139 (603)
+-.+..++|++++.||+|.||.|-+|++..+++.||||++.+.... ...+.+.+|+.+|+++.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 4456778999999999999999999999999999999999653111 113578999999999999999
Q ss_pred eEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccc-cCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE
Q 046097 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL-MEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL 218 (603)
Q Consensus 140 V~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~-l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl 218 (603)
|+|+.+..+.....+|||+|||..|.+...- .... +++.+++.++.+++.||.|||.+ +||||||||+|+||
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl 243 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLL 243 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEE
Confidence 9999999999889999999999988775432 2233 88999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEeeccceecc
Q 046097 219 DGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 219 d~~~~vKL~DFGlA~~~~ 236 (603)
+++|++||+|||.+....
T Consensus 244 ~~~g~VKIsDFGVs~~~~ 261 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFP 261 (576)
T ss_pred cCCCcEEeeccceeeecc
Confidence 999999999999987653
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=332.33 Aligned_cols=152 Identities=23% Similarity=0.317 Sum_probs=134.4
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
....++|++.+.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~ 116 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--K 116 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--C
Confidence 334578999999999999999999999999999999986421 122345678999999999999999999999886 8
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
.+|+||||+++|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 899999999999999998653 278899999999999999999999 9999999999999999999999999998
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
...
T Consensus 190 ~~~ 192 (370)
T cd05621 190 MKM 192 (370)
T ss_pred eec
Confidence 754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.43 Aligned_cols=144 Identities=28% Similarity=0.361 Sum_probs=125.1
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
||+|+||+||++.+..+++.||+|.+...... .....+..|+.+++.++|+||+++++++... ...++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCCC
Confidence 69999999999999999999999998653221 2235678899999999999999999998876 7899999999999
Q ss_pred CHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 165 SLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 165 sL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|..++.... ....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.++|+|||++...
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 147 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence 9998875422 223489999999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=318.06 Aligned_cols=153 Identities=27% Similarity=0.465 Sum_probs=133.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
.++|.+.+.||+|+||.||+|.... +++.||||.++..........+.+|++++.+++|+||+++++++... .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--D 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--C
Confidence 3568888999999999999998743 35789999997755444567899999999999999999999999886 7
Q ss_pred eEEEEEEccCCCCHHHHHhhccc-----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC
Q 046097 153 RLVLIYELMENRSLQDALLDRKC-----------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD 221 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~-----------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~ 221 (603)
..++||||+++++|.+++..... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence 89999999999999999976421 23478889999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccceec
Q 046097 222 FKAKIGDFGLARLK 235 (603)
Q Consensus 222 ~~vKL~DFGlA~~~ 235 (603)
+.+||+|||++...
T Consensus 159 ~~~kl~d~g~~~~~ 172 (280)
T cd05049 159 LVVKIGDFGMSRDV 172 (280)
T ss_pred CeEEECCcccceec
Confidence 99999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.16 Aligned_cols=150 Identities=29% Similarity=0.377 Sum_probs=131.2
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.|++.+.||+|+||.||++.+..+++.||+|++...... .....+.+|+.++++++|+||+++++.+.+. ..+++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEE
Confidence 478889999999999999999889999999998653221 2234577899999999999999999999876 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++|+|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++...
T Consensus 79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred EeccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 999999999988865432 3489999999999999999999999 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=323.30 Aligned_cols=142 Identities=20% Similarity=0.311 Sum_probs=125.2
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.+..+++.||+|+++... .......+..|+.++.++ +||||+++++++.+. +..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence 46999999999999999999999999997632 223345677888888776 799999999999886 8899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 79 NGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 9999998886543 389999999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=323.08 Aligned_cols=142 Identities=19% Similarity=0.313 Sum_probs=125.9
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.+..+++.||||+++... .......+..|..++..+ +||||+++++++.+. ..+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 36999999999999999999999999997632 122345678899999888 699999999999886 8899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++|+|..++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 79 SGGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 9999998886543 389999999999999999999999 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=349.84 Aligned_cols=157 Identities=26% Similarity=0.366 Sum_probs=136.3
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEe-EEecC---C
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLG-FASDR---R 150 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g-~~~~~---~ 150 (603)
....++++.+.|.+|||+.||+|++...+..||+|++-.. .......+.+|+++|+.|. |+|||.+++ ..... .
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 3456678889999999999999999887799999998664 6667788999999999997 999999999 33322 1
Q ss_pred -CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEee
Q 046097 151 -GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 151 -~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DF 229 (603)
.-.++|+||||.+|.|-++|......+ |++.++++|+.|+|+|+++||.. .++|||||||-|||||+.++..|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 246789999999999999998765544 99999999999999999999987 778999999999999999999999999
Q ss_pred ccceec
Q 046097 230 GLARLK 235 (603)
Q Consensus 230 GlA~~~ 235 (603)
|.|...
T Consensus 191 GSatt~ 196 (738)
T KOG1989|consen 191 GSATTK 196 (738)
T ss_pred cccccc
Confidence 998643
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.53 Aligned_cols=142 Identities=27% Similarity=0.358 Sum_probs=121.5
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHH-HhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELS-LASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~-iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|++..+++.||+|++..... ......+..|.. +++.++||||+++++++.+. ...++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcCC
Confidence 469999999999999999999999999865321 122334555554 67889999999999999886 7899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++++|...+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 79 NGGELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999998886543 378889999999999999999999 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=310.24 Aligned_cols=150 Identities=25% Similarity=0.367 Sum_probs=134.2
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
+|++.+.||.|+||.||++.+..+++.+|+|.++........+.+.+|+.+++.++|+||+++++.+.+. ..+++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEEe
Confidence 4788899999999999999999999999999987644445567788999999999999999999999886 89999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|+++++|.+++..... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 79 YCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred eCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceee
Confidence 9999999998865432 3478999999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.45 Aligned_cols=154 Identities=32% Similarity=0.556 Sum_probs=132.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
.+++|++.+.||+|+||.||+|.+.. ++..||||.+...........+.+|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-- 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 46789999999999999999998642 35679999986644444556789999999999999999999999875
Q ss_pred CeEEEEEEccCCCCHHHHHhhccc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcE
Q 046097 152 RRLVLIYELMENRSLQDALLDRKC-------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKA 224 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~-------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~v 224 (603)
...++||||+++++|.+++..... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 789999999999999999865322 12357788899999999999999998 99999999999999999999
Q ss_pred EEEeeccceec
Q 046097 225 KIGDFGLARLK 235 (603)
Q Consensus 225 KL~DFGlA~~~ 235 (603)
+|+|||++...
T Consensus 159 ~l~dfg~~~~~ 169 (277)
T cd05062 159 KIGDFGMTRDI 169 (277)
T ss_pred EECCCCCcccc
Confidence 99999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=316.66 Aligned_cols=152 Identities=25% Similarity=0.419 Sum_probs=123.9
Q ss_pred cCCCCCceeeccCceEEEEEEEcC-CCceEEEEEecCCCCh-hhHHHHHHHHHHhccC---CCCceeEEEeEEecC---C
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPS-SSQPLAVKILDSSGSL-QGEREFHNELSLASSL---DCPHIVSLLGFASDR---R 150 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~-tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l---~HpNIV~l~g~~~~~---~ 150 (603)
++|++.+.||+|+||.||+|++.. +++.||+|.++..... .....+.+|+.++..+ .||||++++++|... .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 478999999999999999999854 5788999998653322 2233455677666655 699999999998632 2
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
...+++||||+. ++|.+++..... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 356899999996 589998865432 3378999999999999999999999 99999999999999999999999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
++...
T Consensus 156 ~~~~~ 160 (290)
T cd07862 156 LARIY 160 (290)
T ss_pred ceEec
Confidence 98653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.48 Aligned_cols=150 Identities=32% Similarity=0.473 Sum_probs=130.7
Q ss_pred cCC-CCCceeeccCceEEEEEEE----cCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASF-SPSNRLGHGGFGSVYKAVV----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y-~i~~~LG~G~fG~Vy~a~~----~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
++| +..+.||+|+||+||++.. ..++..||+|.++..........+.+|++++++++||||+++++++.......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8889999999999988653 34678899999976544445567889999999999999999999988764567
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+++++|.+++... .+++..++.++.|++.||.|||++ +++|+||||+|||++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 89999999999999998653 289999999999999999999999 99999999999999999999999999986
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 156 ~~ 157 (283)
T cd05080 156 AV 157 (283)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.76 Aligned_cols=142 Identities=26% Similarity=0.360 Sum_probs=122.1
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHH-HhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELS-LASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~-iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.+..+++.||+|++..... ......+..|.. +++.++||||+++++++... +..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcCC
Confidence 369999999999999999999999999965321 122344555554 56778999999999999886 8899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 79 NGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 9999998886543 388999999999999999999999 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=330.61 Aligned_cols=155 Identities=28% Similarity=0.442 Sum_probs=131.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~ 150 (603)
..++|++.+.||+|+||.||+|.... +++.||+|+++..........+..|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 34579999999999999999997533 45789999997644444556788999999999 799999999988764
Q ss_pred CCeEEEEEEccCCCCHHHHHhhccc-------------------------------------------------------
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKC------------------------------------------------------- 175 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~------------------------------------------------------- 175 (603)
+..++++|||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4678999999999999999864321
Q ss_pred ---ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 176 ---EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 176 ---~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.++|+|||++...
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~ 223 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 223 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhc
Confidence 12478999999999999999999999 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=332.01 Aligned_cols=141 Identities=22% Similarity=0.335 Sum_probs=126.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
..+|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.++++++||||+++++++... ...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYN--KFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeEEE
Confidence 3679999999999999999999999999999997532 3467899999999999999999999876 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||++. ++|..++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|..
T Consensus 162 ~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred EecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 99995 68888886543 378999999999999999999999 999999999999999999999999999864
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.17 Aligned_cols=156 Identities=28% Similarity=0.455 Sum_probs=134.9
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCC-----CceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecC
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSS-----SQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDR 149 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~ 149 (603)
...++|++.+.||+|+||.||++..... ...+|+|.+...........+.+|+.++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3456789999999999999999997643 3689999997654445556788999999999 799999999999876
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRK-------------CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNI 216 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~-------------~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NI 216 (603)
+..+++|||+++++|..++.... ....+++..++.++.|++.||.|||++ +|+|+||||+||
T Consensus 89 --~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 89 --GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred --CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 78999999999999999996531 233588999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEEeeccceecc
Q 046097 217 LLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~~~ 236 (603)
|++.++.+||+|||+++...
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~ 183 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIH 183 (293)
T ss_pred EEcCCCeEEeCccccccccc
Confidence 99999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.73 Aligned_cols=149 Identities=29% Similarity=0.456 Sum_probs=132.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
.+|++.+.||.|+||.||+|.+..++..||+|.+... ......+.+|+.++.+++|+||+++++++... ...+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEEE
Confidence 4577889999999999999999888999999998753 23456788999999999999999999999876 7889999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++..... ..+++..++.++.|++.||+|||++ +++|+||||+||++++++.+||+|||++...
T Consensus 82 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 82 EFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred EeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 99999999999865432 3478999999999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=309.17 Aligned_cols=152 Identities=24% Similarity=0.447 Sum_probs=133.5
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||.|+||.||+|+...+++.||||.+.... .......+.+|+.+++.++||||+++++++.+. +..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEE
Confidence 57899999999999999999999899999999876422 233446688999999999999999999999876 78999
Q ss_pred EEEccCCCCHHHHHhhccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++++|.+++..... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 9999999999998864322 23478899999999999999999999 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=343.71 Aligned_cols=150 Identities=19% Similarity=0.203 Sum_probs=131.6
Q ss_pred CCCCCceeeccCceEEEEEEEcCC-CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSS-SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~t-g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
.|.+.+.||.|++|.||+|....+ ++.||+|.+... .......+.+|+.++..++||||+++++++... +..|+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEEEE
Confidence 488899999999999999998777 788999987543 334445678899999999999999999999886 8999999
Q ss_pred EccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++|+|.+++.... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 9999999999886532 233588999999999999999999999 9999999999999999999999999998764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.73 Aligned_cols=143 Identities=25% Similarity=0.458 Sum_probs=128.4
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
+.||+|+||.||+|.++.+++.||+|.+...........+.+|++++++++|+||+++++++... ...++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeeccCC
Confidence 36999999999999998899999999987654445567799999999999999999999999886 7899999999999
Q ss_pred CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 165 SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 165 sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcc
Confidence 9999986533 2378999999999999999999999 999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=310.88 Aligned_cols=161 Identities=25% Similarity=0.320 Sum_probs=141.2
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC---C
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR---R 150 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~---~ 150 (603)
+....++|.+.++||+|||+.||+++...+++.+|+|.+... ..+..+..++|++..++++||||++++++.... .
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~-~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH-SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc-chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 344568899999999999999999999999999999999774 356778899999999999999999999987643 1
Q ss_pred CCeEEEEEEccCCCCHHHHHhhccccc-ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEee
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEE-LMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~-~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DF 229 (603)
....|++++|+..|+|.+.+......+ .+++.+++.++.+||+||.+||+. .+.++||||||.|||+.+.+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 246899999999999999988755433 699999999999999999999998 445999999999999999999999999
Q ss_pred ccceecc
Q 046097 230 GLARLKT 236 (603)
Q Consensus 230 GlA~~~~ 236 (603)
|.+....
T Consensus 174 GS~~~a~ 180 (302)
T KOG2345|consen 174 GSATQAP 180 (302)
T ss_pred cCccccc
Confidence 9987644
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.40 Aligned_cols=142 Identities=27% Similarity=0.366 Sum_probs=120.7
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHH-HHhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNEL-SLASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev-~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|++..+++.||+|++..... ......+..|. .+++.++|+||+++++++.+. +..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeCC
Confidence 369999999999999999999999999865321 11223344444 456788999999999999886 8899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++++|.+++.... .+.+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 79 NGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999999987543 377888889999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=327.13 Aligned_cols=149 Identities=26% Similarity=0.469 Sum_probs=128.9
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC---CeEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG---RRLV 155 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~---~~~~ 155 (603)
+|++.+.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.++..++|+||+++++++..... ...|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999998899999999986532 22344678899999999999999999999987521 2789
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+. ++|.+.+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57888775432 389999999999999999999999 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.48 Aligned_cols=150 Identities=23% Similarity=0.348 Sum_probs=133.9
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++.+++|+||+++++.+.+. ..+|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEE
Confidence 47889999999999999999999999999999996532 122335688899999999999999999999986 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred EEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999999997643 389999999999999999999999 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=312.29 Aligned_cols=152 Identities=28% Similarity=0.456 Sum_probs=134.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCC---CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSS---SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.++|++.+.||+|+||.||+|..+.+ ...||||.++..........+.+|+.++.+++|+||+++++++.+. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--Cce
Confidence 35789999999999999999998643 4579999987655555567789999999999999999999999876 789
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+|+||||+||++++++.++|+|||++..
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 81 MIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999999987643 2488999999999999999999998 999999999999999999999999999876
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 156 ~~ 157 (266)
T cd05033 156 LE 157 (266)
T ss_pred cc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=314.50 Aligned_cols=153 Identities=30% Similarity=0.527 Sum_probs=133.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCC-----CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSS-----SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
.++|.+.+.||+|+||.||+|..+.. +..||+|.+...........+.+|+.++..++|+||+++++++... .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--Q 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--C
Confidence 45788999999999999999998643 4789999987654445566789999999999999999999999886 7
Q ss_pred eEEEEEEccCCCCHHHHHhhccc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEE
Q 046097 153 RLVLIYELMENRSLQDALLDRKC-------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAK 225 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~-------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vK 225 (603)
..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 89999999999999999875432 12367889999999999999999998 999999999999999999999
Q ss_pred EEeeccceec
Q 046097 226 IGDFGLARLK 235 (603)
Q Consensus 226 L~DFGlA~~~ 235 (603)
|+|||+++..
T Consensus 160 l~dfg~~~~~ 169 (277)
T cd05032 160 IGDFGMTRDI 169 (277)
T ss_pred ECCcccchhh
Confidence 9999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.21 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=217.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|..++++|+|+||.+++++++..+..+++|.+..... ...+....+|+.+++++.|||||.+.+.|.+. +..++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEEE
Confidence 578899999999999999999999999999999876542 23345788999999999999999999999986 3449999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
|+||+||+|.+.+..++ ...++++.+..++.|++.|+.|||++ .|+|||||+.|||++.++.+||+|||+|+....
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998876 34589999999999999999999998 999999999999999999999999999998765
Q ss_pred ccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcchh
Q 046097 238 DLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGRVK 317 (603)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (603)
..
T Consensus 159 ~~------------------------------------------------------------------------------ 160 (426)
T KOG0589|consen 159 ED------------------------------------------------------------------------------ 160 (426)
T ss_pred ch------------------------------------------------------------------------------
Confidence 41
Q ss_pred hhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCcCc
Q 046097 318 DYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNVGE 397 (603)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (603)
T Consensus 161 -------------------------------------------------------------------------------- 160 (426)
T KOG0589|consen 161 -------------------------------------------------------------------------------- 160 (426)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCCCC
Q 046097 398 MWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGL 477 (603)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 477 (603)
....+..||+.||+||.+.+-+
T Consensus 161 ----------------------------------------------------------~~a~tvvGTp~YmcPEil~d~p 182 (426)
T KOG0589|consen 161 ----------------------------------------------------------SLASTVVGTPYYMCPEILSDIP 182 (426)
T ss_pred ----------------------------------------------------------hhhheecCCCcccCHHHhCCCC
Confidence 0123578999999999999999
Q ss_pred CCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhhccC
Q 046097 478 LSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQ 557 (603)
Q Consensus 478 ~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 557 (603)
|..|+|||||||++|||.+-+++|...+. ...+. .++.......+...+..+..|+..||+
T Consensus 183 Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m----------~~Li~---------ki~~~~~~Plp~~ys~el~~lv~~~l~ 243 (426)
T KOG0589|consen 183 YNEKSDIWSLGCCLYEMCTLKPAFKASNM----------SELIL---------KINRGLYSPLPSMYSSELRSLVKSMLR 243 (426)
T ss_pred CCccCcchhhcchHHHHHhcccccCccch----------HHHHH---------HHhhccCCCCCccccHHHHHHHHHHhh
Confidence 99999999999999999999999986542 11111 122222445667788899999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 046097 558 RSPSKRLTMKDIVEM 572 (603)
Q Consensus 558 ~dP~~Rpt~~evl~~ 572 (603)
.+|..||++.++|.+
T Consensus 244 ~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 244 KNPEHRPSALELLRR 258 (426)
T ss_pred cCCccCCCHHHHhhC
Confidence 999999999999987
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=316.03 Aligned_cols=152 Identities=31% Similarity=0.514 Sum_probs=131.5
Q ss_pred cCCCCCceeeccCceEEEEEEEc----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVP----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.+|++.+.||+|+||.||+|... .++..|++|.+...........+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cce
Confidence 46788899999999999999853 356789999997644444556789999999999999999999998876 788
Q ss_pred EEEEEccCCCCHHHHHhhccc--------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC
Q 046097 155 VLIYELMENRSLQDALLDRKC--------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG 220 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~--------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~ 220 (603)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||++ +++|+||||+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 999999999999999864321 12378889999999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccceec
Q 046097 221 DFKAKIGDFGLARLK 235 (603)
Q Consensus 221 ~~~vKL~DFGlA~~~ 235 (603)
++.+||+|||++...
T Consensus 160 ~~~~kl~dfg~~~~~ 174 (283)
T cd05090 160 QLHVKISDLGLSREI 174 (283)
T ss_pred CCcEEeccccccccc
Confidence 999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.03 Aligned_cols=150 Identities=27% Similarity=0.376 Sum_probs=128.1
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR---- 150 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---- 150 (603)
...++|++.+.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34578999999999999999999999999999999986532 2234567889999999999999999999987542
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
....|+||||+.+ +|...+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 1357999999975 56665532 278888999999999999999999 99999999999999999999999999
Q ss_pred ccee
Q 046097 231 LARL 234 (603)
Q Consensus 231 lA~~ 234 (603)
++..
T Consensus 169 ~a~~ 172 (359)
T cd07876 169 LART 172 (359)
T ss_pred Cccc
Confidence 9864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=328.91 Aligned_cols=155 Identities=23% Similarity=0.309 Sum_probs=136.1
Q ss_pred HHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecC
Q 046097 72 NLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDR 149 (603)
Q Consensus 72 ~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~ 149 (603)
.++....++|++.+.||+|+||.||+|.++.+++.||+|++.... .......+.+|+.++..++||||+++++.+.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 345556789999999999999999999999999999999986421 122335578899999999999999999999876
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEee
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DF 229 (603)
...++||||+++|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 116 --~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 116 --RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred --CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 8899999999999999998653 278888999999999999999999 9999999999999999999999999
Q ss_pred ccceec
Q 046097 230 GLARLK 235 (603)
Q Consensus 230 GlA~~~ 235 (603)
|++...
T Consensus 187 G~a~~~ 192 (371)
T cd05622 187 GTCMKM 192 (371)
T ss_pred CceeEc
Confidence 998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.23 Aligned_cols=150 Identities=25% Similarity=0.302 Sum_probs=132.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~--~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD--KYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CEE
Confidence 4567999999999999999999999999999999996421 112334578899999999999999999999886 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999999998653 278888999999999999999999 999999999999999999999999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 192 ~ 192 (370)
T cd05596 192 M 192 (370)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.42 Aligned_cols=154 Identities=26% Similarity=0.369 Sum_probs=132.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRR 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~ 150 (603)
..++|.+.++||+|+||.||+|.+.. ++..||||+++........+.+.+|+.++.++. ||||++++++|.+.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~- 113 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS- 113 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence 46788999999999999999998743 234699999976555555678999999999996 99999999999876
Q ss_pred CCeEEEEEEccCCCCHHHHHhhccc-------------------------------------------------------
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKC------------------------------------------------------- 175 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~------------------------------------------------------- 175 (603)
...|+|||||++|+|.+++.....
T Consensus 114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 114 -GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred -CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 789999999999999998865321
Q ss_pred --------------------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeE
Q 046097 176 --------------------------------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNIL 217 (603)
Q Consensus 176 --------------------------------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NIL 217 (603)
...+++..++.++.||+.||.|||+. +|+|+||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 12367888899999999999999999 9999999999999
Q ss_pred EcCCCcEEEEeeccceec
Q 046097 218 LDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 218 ld~~~~vKL~DFGlA~~~ 235 (603)
++.++.+||+|||++...
T Consensus 270 l~~~~~~kL~DfGla~~~ 287 (400)
T cd05105 270 LAQGKIVKICDFGLARDI 287 (400)
T ss_pred EeCCCEEEEEeCCcceec
Confidence 999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=324.00 Aligned_cols=153 Identities=27% Similarity=0.443 Sum_probs=139.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
...+|++.+.||+|.||.|-+|.....|+.||||.++++. +..+.-.+.+|+++|+.++||||+.+|.+|+.. +.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk--dKI 128 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK--DKI 128 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC--ceE
Confidence 3467888999999999999999998999999999998764 334446689999999999999999999999987 899
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
.|||||..+|.|.+++.+... +++.++.+++.||++|+.|+|.+ +++|||||.+|||+|.++++||+|||++..
T Consensus 129 vivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhh
Confidence 999999999999999987654 89999999999999999999999 999999999999999999999999999876
Q ss_pred ccc
Q 046097 235 KTE 237 (603)
Q Consensus 235 ~~~ 237 (603)
+..
T Consensus 203 y~~ 205 (668)
T KOG0611|consen 203 YAD 205 (668)
T ss_pred hcc
Confidence 543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.28 Aligned_cols=152 Identities=31% Similarity=0.445 Sum_probs=127.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC---eE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR---RL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~---~~ 154 (603)
.-.|...+++|.|+||.||+|....+++.||||....+.. --.+|+++|+.+.|||||++.-+|....++ +.
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3456778999999999999999999999999998865332 224789999999999999999998865444 56
Q ss_pred EEEEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC-CcEEEEeeccc
Q 046097 155 VLIYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGLA 232 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~-~~vKL~DFGlA 232 (603)
.+||||++. +|.+.++... .+..++...+.-++.||++||.|||+. +|+||||||+|+|+|.+ |.+||||||.|
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 799999976 8998887521 123378888888999999999999998 99999999999999965 89999999999
Q ss_pred eecccc
Q 046097 233 RLKTED 238 (603)
Q Consensus 233 ~~~~~~ 238 (603)
+.....
T Consensus 174 K~L~~~ 179 (364)
T KOG0658|consen 174 KVLVKG 179 (364)
T ss_pred eeeccC
Confidence 987654
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=324.86 Aligned_cols=150 Identities=24% Similarity=0.360 Sum_probs=133.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||++..+.+++.||||+++... .......+.+|+.++..++|+||+++++.+.+. ..+++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEE
Confidence 46888999999999999999999999999999996522 122345688899999999999999999999886 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 79 v~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred EEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999999987543 388999999999999999999999 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=358.18 Aligned_cols=154 Identities=33% Similarity=0.470 Sum_probs=137.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCC-----ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSS-----QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg-----~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
..+.+....||+|.||.||.|+..... ..||||.++...+.....+|.+|..+|+.++|||||+++|+|.+. .
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--G 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--C
Confidence 445566788999999999999986433 349999998877888889999999999999999999999999995 7
Q ss_pred eEEEEEEccCCCCHHHHHhhccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEe
Q 046097 153 RLVLIYELMENRSLQDALLDRKC----EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~----~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~D 228 (603)
..+|++|||++|+|..||++.+. ...++..+.+.++.|||+|+.||+++ +.|||||..+|+|+++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 78999999999999999988632 23488999999999999999999999 999999999999999999999999
Q ss_pred eccceecc
Q 046097 229 FGLARLKT 236 (603)
Q Consensus 229 FGlA~~~~ 236 (603)
||+|+...
T Consensus 846 FGlArDiy 853 (1025)
T KOG1095|consen 846 FGLARDIY 853 (1025)
T ss_pred cchhHhhh
Confidence 99999544
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=310.44 Aligned_cols=147 Identities=27% Similarity=0.467 Sum_probs=128.9
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||+|+||.||++..+ .+..+|+|.+... ......+.+|+.++++++||||+++++++.+. ...++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEEEE
Confidence 45888899999999999999885 4567999988643 23346788999999999999999999999876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 79 EFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 9999999999987543 2378999999999999999999999 9999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=311.36 Aligned_cols=156 Identities=25% Similarity=0.366 Sum_probs=136.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhh-HHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG-EREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~-~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|+.++.|++|+||.||+|+++.+++.||+|.++.+..... --.-++|+.+|.+++|||||.+-.+.....-+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 34568888999999999999999999999999999987542222 13467999999999999999999998877668899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|||||+. +|..++..-. .++...++..++.|+++||.|||.+ .|+|||||++|+|++..|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 99999976 8999887654 4488999999999999999999999 9999999999999999999999999999876
Q ss_pred ccc
Q 046097 236 TED 238 (603)
Q Consensus 236 ~~~ 238 (603)
...
T Consensus 228 gsp 230 (419)
T KOG0663|consen 228 GSP 230 (419)
T ss_pred cCC
Confidence 543
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.40 Aligned_cols=152 Identities=24% Similarity=0.446 Sum_probs=134.1
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||+|....+++.||+|.++... .......+.+|++++++++|+||+++++++.+. ...++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 67999999999999999999998899999999886422 223356789999999999999999999999886 78999
Q ss_pred EEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++++|..++.... ....+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 999999999999886532 233478999999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.32 Aligned_cols=145 Identities=29% Similarity=0.410 Sum_probs=129.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.++.+++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEEE
Confidence 36788899999999999999999999999999987654444556799999999999999999999999986 7889999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++...
T Consensus 79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 999999996542 267888899999999999999999 9999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.98 Aligned_cols=153 Identities=29% Similarity=0.460 Sum_probs=134.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCC----------------ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSS----------------QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg----------------~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~ 141 (603)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+...........+.+|+.++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 467999999999999999999875433 5689999987655556678999999999999999999
Q ss_pred EEeEEecCCCCeEEEEEEccCCCCHHHHHhhccc--------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 046097 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKC--------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKP 213 (603)
Q Consensus 142 l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~--------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp 213 (603)
+++++... ...+++|||+++++|.+++..... ...+++..++.++.|++.||.|||++ +++|+||||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp 158 (296)
T cd05051 84 LLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158 (296)
T ss_pred EEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 99999886 789999999999999999876431 12478999999999999999999999 999999999
Q ss_pred CCeEEcCCCcEEEEeeccceec
Q 046097 214 SNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 214 ~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||+++.++.++|+|||++...
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~ 180 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred hceeecCCCceEEccccceeec
Confidence 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=316.37 Aligned_cols=155 Identities=31% Similarity=0.522 Sum_probs=132.2
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRR 150 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~ 150 (603)
...++|++.+.||+|+||.||+|..+. .+..||+|.+...........+.+|+.++++++|+||+++++++.+.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG- 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence 346789999999999999999997642 34579999987654444556788999999999999999999998876
Q ss_pred CCeEEEEEEccCCCCHHHHHhhccc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKC-------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~-------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~ 223 (603)
...++||||+++|+|.+++..... ....++..+..++.|++.||.|||++ +|+||||||+||+++.++.
T Consensus 82 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 82 -QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred -CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 778999999999999999975321 12356778889999999999999999 9999999999999999999
Q ss_pred EEEEeeccceec
Q 046097 224 AKIGDFGLARLK 235 (603)
Q Consensus 224 vKL~DFGlA~~~ 235 (603)
++|+|||+++..
T Consensus 158 ~~L~Dfg~~~~~ 169 (288)
T cd05061 158 VKIGDFGMTRDI 169 (288)
T ss_pred EEECcCCccccc
Confidence 999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=313.55 Aligned_cols=143 Identities=28% Similarity=0.404 Sum_probs=124.2
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
||+|+||.||++..+.+++.||+|.+..... ......+..|++++.+++||||+++++++.+. ...++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecCCCC
Confidence 7999999999999999999999999864321 12234556799999999999999999999876 7899999999999
Q ss_pred CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 165 SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 165 sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 79 ~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~ 145 (277)
T cd05607 79 DLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145 (277)
T ss_pred CHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence 99988865432 2378899999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.94 Aligned_cols=152 Identities=32% Similarity=0.531 Sum_probs=134.5
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
+...+|++.+.||.|+||.||+|.+.. +..+++|.+... .......+..|+.+++.++|+||+++++++.+. ...+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 78 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVY 78 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc-chhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeE
Confidence 345678999999999999999999976 889999998763 233456788999999999999999999999886 7899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999999999976443 3478999999999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=316.28 Aligned_cols=151 Identities=30% Similarity=0.469 Sum_probs=129.6
Q ss_pred CCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
+|.+.+.||+|+||.||+|.... .++.||+|+++..........+.+|+.++..++||||+++++++.+. ...
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--QPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--Cce
Confidence 46677889999999999998753 35789999997654444456788999999999999999999999886 778
Q ss_pred EEEEEccCCCCHHHHHhhcc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC
Q 046097 155 VLIYELMENRSLQDALLDRK-------------CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD 221 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~-------------~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~ 221 (603)
++++||+.+++|.+++.... ....+++..+..++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 99999999999999985321 122478888999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccceec
Q 046097 222 FKAKIGDFGLARLK 235 (603)
Q Consensus 222 ~~vKL~DFGlA~~~ 235 (603)
+.+||+|||+++..
T Consensus 161 ~~~kl~Dfg~~~~~ 174 (283)
T cd05091 161 LNVKISDLGLFREV 174 (283)
T ss_pred CceEeccccccccc
Confidence 99999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=305.94 Aligned_cols=150 Identities=30% Similarity=0.449 Sum_probs=133.8
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||+|++|.||+|....+++.|++|.+.... .......+.+|+.++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEE
Confidence 4778899999999999999999999999999986532 334557789999999999999999999999886 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 79 EYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred EeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceec
Confidence 9999999999997642 23488999999999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.09 Aligned_cols=150 Identities=27% Similarity=0.340 Sum_probs=133.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|....+++.||+|++.... ......+.+|+.++.+++||||+++++++... ...++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEE
Confidence 3457999999999999999999998899999999996532 23345688999999999999999999999876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceee
Confidence 999999999999886543 378999999999999999999999 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=317.38 Aligned_cols=149 Identities=27% Similarity=0.446 Sum_probs=131.3
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|.+.+.||+|+||.||+|+++.+++.||+|.++..........+.+|+.++++++|+||+++++++... +..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEEEE
Confidence 56899999999999999999999899999999997654444445678899999999999999999999876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++ +|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 84 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 84 EYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAK 154 (309)
T ss_pred eCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceec
Confidence 99975 8888776543 3378899999999999999999999 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=322.90 Aligned_cols=147 Identities=25% Similarity=0.311 Sum_probs=127.6
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~L 156 (603)
+|+..+.||+|+||.||+|.++.+++.||+|++.... .......+..|..++..+. |++|+++++++.+. ..+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence 4677899999999999999999999999999997532 1223356778888888886 57788899988876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+++|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 v~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 999999999999886543 388999999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=313.55 Aligned_cols=154 Identities=34% Similarity=0.451 Sum_probs=133.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
..++|.+.+.||+|++|.||+|.+.. ++..|++|.+...........+.+|+.++++++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-- 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence 35678999999999999999999976 67889999987654445556789999999999999999999998876
Q ss_pred CeEEEEEEccCCCCHHHHHhhccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC---cE
Q 046097 152 RRLVLIYELMENRSLQDALLDRKC----EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF---KA 224 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~----~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~---~v 224 (603)
...++||||+++++|.+++..... ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence 678999999999999999976532 12478999999999999999999999 999999999999998654 59
Q ss_pred EEEeeccceec
Q 046097 225 KIGDFGLARLK 235 (603)
Q Consensus 225 KL~DFGlA~~~ 235 (603)
||+|||+++..
T Consensus 159 kl~dfg~~~~~ 169 (277)
T cd05036 159 KIADFGMARDI 169 (277)
T ss_pred EeccCcccccc
Confidence 99999998765
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=315.53 Aligned_cols=151 Identities=30% Similarity=0.481 Sum_probs=130.0
Q ss_pred CCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
+|++.+.||+|+||.||+|.... ....+++|.+...........+.+|+.++..++||||+++++.+... +..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CCc
Confidence 47788999999999999998743 23568999987655555567899999999999999999999999876 778
Q ss_pred EEEEEccCCCCHHHHHhhcc---------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 046097 155 VLIYELMENRSLQDALLDRK---------------------CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKP 213 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~---------------------~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp 213 (603)
+++|||+.+++|.+++.... ....+++..++.++.|++.||.|||++ +++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 99999999999999986421 112478899999999999999999999 999999999
Q ss_pred CCeEEcCCCcEEEEeeccceec
Q 046097 214 SNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 214 ~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|||+++++.+||+|||+++..
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~ 177 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDV 177 (290)
T ss_pred heEEEcCCCcEEeccccccccc
Confidence 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=312.83 Aligned_cols=151 Identities=29% Similarity=0.514 Sum_probs=132.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCc----eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQ----PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
..+|++.+.||+|+||+||+|.+..+++ .||+|+++..........+.+|+.++..+.|+||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CC
Confidence 4578889999999999999999866665 4899999765555556788999999999999999999999976 45
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++++||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 789999999999999987543 2488999999999999999999999 99999999999999999999999999987
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 158 ~~~ 160 (279)
T cd05109 158 LLD 160 (279)
T ss_pred ecc
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=308.87 Aligned_cols=149 Identities=29% Similarity=0.457 Sum_probs=130.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.++||+|+||.||+|... ++..||+|.+... ....+.+.+|+.++++++|+||+++++.+.+. ...+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcEEE
Confidence 457889999999999999999974 5677999988653 23456789999999999999999999998876 778999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred EecCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceec
Confidence 999999999999876432 3478889999999999999999998 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=316.02 Aligned_cols=151 Identities=29% Similarity=0.498 Sum_probs=130.0
Q ss_pred cCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.+|.+.+.||+|+||.||+|... .++..+++|.+... .......+.+|+.++++++|+||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG--DP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--Cc
Confidence 45788899999999999999853 24566899988652 334456789999999999999999999999876 78
Q ss_pred EEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC
Q 046097 154 LVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG 220 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~ 220 (603)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 9999999999999999975431 22378999999999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccceec
Q 046097 221 DFKAKIGDFGLARLK 235 (603)
Q Consensus 221 ~~~vKL~DFGlA~~~ 235 (603)
++.++|+|||++...
T Consensus 159 ~~~~~l~dfg~a~~~ 173 (291)
T cd05094 159 NLLVKIGDFGMSRDV 173 (291)
T ss_pred CCcEEECCCCccccc
Confidence 999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=342.64 Aligned_cols=160 Identities=24% Similarity=0.321 Sum_probs=136.1
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC-
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG- 151 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~- 151 (603)
.....++|.+.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++..++|+||++++..+.....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445679999999999999999999999999999999986543 33445678899999999999999999887754311
Q ss_pred -----CeEEEEEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEE
Q 046097 152 -----RRLVLIYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAK 225 (603)
Q Consensus 152 -----~~~~LVmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vK 225 (603)
..+++||||+++|+|.+++.... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence 24789999999999999987533 234588999999999999999999999 999999999999999999999
Q ss_pred EEeeccceecc
Q 046097 226 IGDFGLARLKT 236 (603)
Q Consensus 226 L~DFGlA~~~~ 236 (603)
|+|||+++...
T Consensus 184 L~DFGls~~~~ 194 (496)
T PTZ00283 184 LGDFGFSKMYA 194 (496)
T ss_pred EEecccCeecc
Confidence 99999987643
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.65 Aligned_cols=150 Identities=23% Similarity=0.298 Sum_probs=132.4
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||++++..+++.||+|++.... .......+.+|..++..+.|+||+.+++++.+. +..|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEE
Confidence 47899999999999999999999999999999986421 122335578899999999999999999999886 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 79 v~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 999999999999997632 2378899999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.50 Aligned_cols=142 Identities=22% Similarity=0.308 Sum_probs=125.6
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|....+++.||+|+++.... ......+..|..++.++ +|+||+.+++++.+. ..+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence 369999999999999999999999999976422 22345688899999888 599999999999886 7899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 79 NGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 9999998886543 389999999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.71 Aligned_cols=140 Identities=25% Similarity=0.326 Sum_probs=119.9
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccC---CCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSL---DCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l---~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
||+|+||.||+|++..+++.||||++..... ......+..|..++... .||||+.+++++.+. ...|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcCC
Confidence 7999999999999999999999999864211 11223445566666655 699999999999886 8899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 79 SGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred CCChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 9999999886543 389999999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.10 Aligned_cols=151 Identities=28% Similarity=0.483 Sum_probs=124.9
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-hHHHHHHHHHHhccC---CCCceeEEEeEEecC---CCC
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-GEREFHNELSLASSL---DCPHIVSLLGFASDR---RGR 152 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-~~~~~~~Ev~iL~~l---~HpNIV~l~g~~~~~---~~~ 152 (603)
+|++.+.||+|+||.||+|.++.+++.||+|.++...... ....+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999999999999999987532211 223455677666655 799999999998653 235
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
..++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 68999999974 88888865432 3389999999999999999999999 9999999999999999999999999998
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
...
T Consensus 156 ~~~ 158 (288)
T cd07863 156 RIY 158 (288)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.82 Aligned_cols=152 Identities=26% Similarity=0.447 Sum_probs=128.6
Q ss_pred CCCCceeeccCceEEEEEEEcCC---CceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC----C
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSS---SQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRG----R 152 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~----~ 152 (603)
|.+.+.||+|+||.||+|....+ +..||+|.++.... ......+.+|+.+++.++|+||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999997643 47899999876432 3345678999999999999999999998875421 3
Q ss_pred eEEEEEEccCCCCHHHHHhhccc---ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEee
Q 046097 153 RLVLIYELMENRSLQDALLDRKC---EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~---~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DF 229 (603)
..+++|||+++++|..++..... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 47999999999999998865421 23488999999999999999999999 9999999999999999999999999
Q ss_pred ccceec
Q 046097 230 GLARLK 235 (603)
Q Consensus 230 GlA~~~ 235 (603)
|+++..
T Consensus 158 g~~~~~ 163 (273)
T cd05035 158 GLSKKI 163 (273)
T ss_pred cceeec
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=316.02 Aligned_cols=150 Identities=29% Similarity=0.517 Sum_probs=129.8
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCc--eEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQ--PLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~--~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~ 155 (603)
++|++.+.||+|+||.||+|....++. .+++|.++........+.+.+|+.++.++ +||||+++++++.+. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence 578899999999999999999876664 46888887533444556789999999999 699999999999876 7799
Q ss_pred EEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC
Q 046097 156 LIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF 222 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~ 222 (603)
+||||+++++|.+++..... ...+++..++.++.|++.||+|||++ +++||||||+|||+++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 99999999999999965321 12478899999999999999999998 999999999999999999
Q ss_pred cEEEEeeccce
Q 046097 223 KAKIGDFGLAR 233 (603)
Q Consensus 223 ~vKL~DFGlA~ 233 (603)
.+||+|||++.
T Consensus 157 ~~kl~dfg~~~ 167 (297)
T cd05089 157 ASKIADFGLSR 167 (297)
T ss_pred eEEECCcCCCc
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.88 Aligned_cols=142 Identities=37% Similarity=0.540 Sum_probs=125.7
Q ss_pred ceeeccCceEEEEEEEcCCC---ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSS---QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg---~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.+..++ ..+|+|.+.........+.+.+|+.+++++.|+||+++++++.. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEeC
Confidence 46999999999999875544 78999999875544456789999999999999999999998864 5689999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
++++|.+++.... .+++..++.++.|++.||.|||.. +++|+||||+|||++.++.+||+|||+++..
T Consensus 78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence 9999999997654 378999999999999999999999 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=318.22 Aligned_cols=147 Identities=42% Similarity=0.672 Sum_probs=127.2
Q ss_pred CCceeeccCceEEEEEEEc----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 83 PSNRLGHGGFGSVYKAVVP----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 83 i~~~LG~G~fG~Vy~a~~~----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+.+.||.|.||.||+|.+. ..+..|+||.++........+.+.+|++.+.+++||||++++|++... ...++||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~--~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN--EPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS--SSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc--ccccccc
Confidence 3578999999999999997 346789999997655555678899999999999999999999999965 6699999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++|+|.+++..... ..+++..+..|+.||+.||.|||++ +++|+||+++||++++++.+||+|||++...
T Consensus 81 e~~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp E--TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 99999999999987622 3389999999999999999999999 9999999999999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.46 Aligned_cols=151 Identities=26% Similarity=0.473 Sum_probs=132.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||.|++|.||+|.+. +++.||+|.++... ...+.+.+|+.++++++|+||+++++++... +..++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeee
Confidence 3467899999999999999999975 45789999987532 2356788999999999999999999998876 78899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 79 VTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 999999999999997644 23478999999999999999999999 99999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.16 Aligned_cols=149 Identities=27% Similarity=0.362 Sum_probs=133.1
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||+|+||.||++.+..++..+|+|.+..........++.+|++++.+++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEEe
Confidence 46889999999999999999999899999999987644444456788999999999999999999999886 8999999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ +++|+||||+|||++.++.+||+|||++..
T Consensus 79 ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 79 EHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccc
Confidence 9999999999997643 3789999999999999999999732 899999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.03 Aligned_cols=150 Identities=23% Similarity=0.280 Sum_probs=132.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||++....+++.||+|++.... .......+.+|+.++..++|+||+++++++.+. ..+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEE
Confidence 47899999999999999999999999999999986421 122345688899999999999999999999886 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 999999999999996532 2378999999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.38 Aligned_cols=151 Identities=25% Similarity=0.469 Sum_probs=133.1
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCc---eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.++|+..+.||+|+||.||+|....++. .+++|.++..........+..|++++.+++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCc
Confidence 3578888999999999999999876554 79999987654445567789999999999999999999999876 788
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 82 MIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999999986543 3478999999999999999999999 999999999999999999999999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 157 ~ 157 (268)
T cd05063 157 L 157 (268)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.38 Aligned_cols=150 Identities=25% Similarity=0.372 Sum_probs=128.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----C
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR----G 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~----~ 151 (603)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4678999999999999999999999999999999986532 2334467889999999999999999999876431 2
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
..+|+||||+++ +|...+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 468999999965 67776642 277888999999999999999999 999999999999999999999999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
++..
T Consensus 173 a~~~ 176 (364)
T cd07875 173 ARTA 176 (364)
T ss_pred cccc
Confidence 8643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.17 Aligned_cols=155 Identities=31% Similarity=0.453 Sum_probs=135.0
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCc---e-EEEEEecC--CCChhhHHHHHHHHHHhccCCCCceeEEEeEEe
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQ---P-LAVKILDS--SGSLQGEREFHNELSLASSLDCPHIVSLLGFAS 147 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~-VAVK~l~~--~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~ 147 (603)
++-..++....++||+|+||.||+|..+..+. . ||||..+. ........+|++|.++|++++|||||++||++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33344555666899999999999999865422 3 89999875 244566788999999999999999999999999
Q ss_pred cCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEE
Q 046097 148 DRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 148 ~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
+. ..+++|||+|.||+|.++|..... .++..+.+.++.+.+.||+|||++ ++|||||..+|+|++.++.+||+
T Consensus 232 ~~--~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 232 LE--EPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred CC--CccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence 87 789999999999999999987653 389999999999999999999999 99999999999999999999999
Q ss_pred eeccceec
Q 046097 228 DFGLARLK 235 (603)
Q Consensus 228 DFGlA~~~ 235 (603)
|||+++..
T Consensus 305 DFGLs~~~ 312 (474)
T KOG0194|consen 305 DFGLSRAG 312 (474)
T ss_pred ccccccCC
Confidence 99998654
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.12 Aligned_cols=145 Identities=28% Similarity=0.450 Sum_probs=121.3
Q ss_pred CceeeccCceEEEEEEEc--CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 84 SNRLGHGGFGSVYKAVVP--SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~--~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
..+||+|+||.||+|..+ .+++.||+|.+.... ....+.+|+.++++++||||+++++++........+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999975 367889999986532 234577899999999999999999999776567899999998
Q ss_pred CCCCHHHHHhhccc------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE----cCCCcEEEEeecc
Q 046097 162 ENRSLQDALLDRKC------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL----DGDFKAKIGDFGL 231 (603)
Q Consensus 162 ~~gsL~~~L~~~~~------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl----d~~~~vKL~DFGl 231 (603)
. ++|.+++..... ...+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5 588887754321 12478899999999999999999999 99999999999999 4567899999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
++..
T Consensus 159 a~~~ 162 (317)
T cd07868 159 ARLF 162 (317)
T ss_pred eecc
Confidence 8754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.07 Aligned_cols=153 Identities=25% Similarity=0.360 Sum_probs=134.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||+|+||.||++.+..++..||+|.+...........+.+|+.++.+++|+||+++++.+... +..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEEEE
Confidence 36888999999999999999998899999999987643444456789999999999999999999999886 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|..++........+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.++|+|||++...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999999998876432335899999999999999999999632 8999999999999999999999999988543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.76 Aligned_cols=152 Identities=26% Similarity=0.470 Sum_probs=133.2
Q ss_pred cCCCCCceeeccCceEEEEEEE----cCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVV----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~----~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..|++.+.||+|+||.||++.. ..++..||+|.++..........+.+|+.++++++|+||+++++++.+......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3468889999999999999984 456889999999765444555789999999999999999999999987645678
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 99999999999999986543 2378999999999999999999999 999999999999999999999999999875
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 159 ~ 159 (284)
T cd05079 159 I 159 (284)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.29 Aligned_cols=150 Identities=31% Similarity=0.525 Sum_probs=130.1
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCce--EEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQP--LAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~--VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~ 155 (603)
++|++.+.||+|+||.||+|.++.++.. +++|.++..........+.+|+.++.++ +|+||+++++++.+. +..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CCce
Confidence 5788899999999999999998776654 5777776544444556788999999999 899999999999876 7899
Q ss_pred EEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC
Q 046097 156 LIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF 222 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~ 222 (603)
+||||+++++|.+++..... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence 99999999999999975431 12478999999999999999999999 999999999999999999
Q ss_pred cEEEEeeccce
Q 046097 223 KAKIGDFGLAR 233 (603)
Q Consensus 223 ~vKL~DFGlA~ 233 (603)
.+||+|||++.
T Consensus 162 ~~kl~dfg~~~ 172 (303)
T cd05088 162 VAKIADFGLSR 172 (303)
T ss_pred cEEeCccccCc
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.37 Aligned_cols=155 Identities=32% Similarity=0.500 Sum_probs=138.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
+.+...+.++||+|.||.|.+|+.. .+..||||.++..........|..|+.+|.+++||||++++|+|... +.+++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D--ePicm 612 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD--DPLCM 612 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC--CchHH
Confidence 4555677899999999999999983 46899999999987777789999999999999999999999999987 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|+||+++|+|.+|+..+.... +......+|+.||+.||+||.+. ++|||||.++|+|++.++++||+|||+++-..
T Consensus 613 I~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999998875433 46667778999999999999998 99999999999999999999999999998665
Q ss_pred cc
Q 046097 237 ED 238 (603)
Q Consensus 237 ~~ 238 (603)
..
T Consensus 689 sg 690 (807)
T KOG1094|consen 689 SG 690 (807)
T ss_pred cC
Confidence 44
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.56 Aligned_cols=152 Identities=24% Similarity=0.441 Sum_probs=133.0
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||.|++|.||+|....+++.++||.+.... .......+.+|+.+++.++|+||+++++++.+. +..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEE
Confidence 46888899999999999999998899999999886532 223346788999999999999999999999876 78999
Q ss_pred EEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|||+++++|.+++.... ....+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 999999999999886422 223478999999999999999999999 9999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=312.93 Aligned_cols=153 Identities=29% Similarity=0.503 Sum_probs=133.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
.++|++.+.||+|+||.||+|.+. .++..||+|++...........+.+|+.++.++.||||+++++++.+. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG--K 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--C
Confidence 467999999999999999999874 357889999997655545567799999999999999999999999876 7
Q ss_pred eEEEEEEccCCCCHHHHHhhccc-------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 046097 153 RLVLIYELMENRSLQDALLDRKC-------------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKP 213 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~-------------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp 213 (603)
..++||||+++++|.+++..... ...+++..++.++.|++.||.|||++ +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 78999999999999999974321 12367888999999999999999999 999999999
Q ss_pred CCeEEcCCCcEEEEeeccceec
Q 046097 214 SNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 214 ~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||+++.++.++|+|||++...
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~ 180 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNI 180 (288)
T ss_pred hheEecCCCceEECccccceec
Confidence 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=303.58 Aligned_cols=149 Identities=29% Similarity=0.421 Sum_probs=132.5
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC----hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS----LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~----~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
++|.+.+.||+|++|.||.|....+++.||+|.+..... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeE
Confidence 578999999999999999999988999999999865321 12235688999999999999999999999987 799
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999999987643 378899999999999999999999 999999999999999999999999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 154 ~ 154 (263)
T cd06625 154 L 154 (263)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=311.45 Aligned_cols=149 Identities=29% Similarity=0.433 Sum_probs=131.2
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||.|++|.||+|....+++.||||.++..... .....+.+|+.++.+++||||+++++++.+. ...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEEE
Confidence 478889999999999999999989999999998653222 2345688999999999999999999999876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||++ ++|.+++........+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceee
Confidence 9997 68988886644445589999999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.32 Aligned_cols=151 Identities=26% Similarity=0.378 Sum_probs=128.8
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR---- 150 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---- 150 (603)
...++|++.+.||+|+||.||++.+..+++.||||.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35678999999999999999999998899999999987532 2234467889999999999999999999986531
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
....++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 2457999999965 66666642 278888999999999999999999 99999999999999999999999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
+++..
T Consensus 165 ~~~~~ 169 (355)
T cd07874 165 LARTA 169 (355)
T ss_pred ccccC
Confidence 98643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.86 Aligned_cols=151 Identities=29% Similarity=0.478 Sum_probs=131.0
Q ss_pred cCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
++|.+.+.||+|+||.||++... .++..+|+|.+... .......+.+|+.++.+++|+||+++++++... ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Cc
Confidence 56888999999999999999852 34567899988653 334456799999999999999999999999876 78
Q ss_pred EEEEEEccCCCCHHHHHhhccc----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc
Q 046097 154 LVLIYELMENRSLQDALLDRKC----------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~----------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~ 223 (603)
.++||||+++++|.+++..... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999999975431 12389999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccceec
Q 046097 224 AKIGDFGLARLK 235 (603)
Q Consensus 224 vKL~DFGlA~~~ 235 (603)
+||+|||++...
T Consensus 159 ~kl~dfg~~~~~ 170 (288)
T cd05093 159 VKIGDFGMSRDV 170 (288)
T ss_pred EEeccCCccccc
Confidence 999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=316.17 Aligned_cols=150 Identities=22% Similarity=0.281 Sum_probs=131.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||++..+.+++.+|+|++.... .......+.+|+.++..++|+||+++++++.+. ..+++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEE
Confidence 46889999999999999999999999999999985421 112234578899999999999999999999886 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 79 v~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EEeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 999999999999997532 2378899999999999999999999 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.44 Aligned_cols=154 Identities=27% Similarity=0.422 Sum_probs=134.2
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC----
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR---- 150 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~---- 150 (603)
.+++.|++.+.||+|+||.||+|....+++.||+|++.... .....+..|+.++.++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 46778999999999999999999999999999999986532 3345788999999998 6999999999987532
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
....++||||+.+++|.+++.... ...+++..+..++.|++.||+|||++ +|+|+||+|+||++++++.++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 246899999999999999987643 23488999999999999999999999 99999999999999999999999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
++...
T Consensus 157 ~~~~~ 161 (272)
T cd06637 157 VSAQL 161 (272)
T ss_pred Cceec
Confidence 98654
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.01 Aligned_cols=150 Identities=30% Similarity=0.387 Sum_probs=130.8
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++++++|+||+.+++.+.+. ...++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEE
Confidence 367788999999999999999999999999998653221 2234577899999999999999999999876 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++...
T Consensus 79 ~e~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred EEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 999999999998865432 3388999999999999999999998 9999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.60 Aligned_cols=153 Identities=29% Similarity=0.475 Sum_probs=131.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCC--------------CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSS--------------SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~t--------------g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~ 143 (603)
.++|++.+.||+|+||.||+|....+ ...||+|.++..........+.+|++++.+++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35799999999999999999987532 2358999997654445556799999999999999999999
Q ss_pred eEEecCCCCeEEEEEEccCCCCHHHHHhhcccc---------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 046097 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCE---------ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPS 214 (603)
Q Consensus 144 g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~---------~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~ 214 (603)
+++... ...++||||+++++|.+++...... ..+++..++.++.|++.||.|||++ +++|+||||+
T Consensus 84 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 84 GVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 999876 7899999999999999998653211 1367889999999999999999999 9999999999
Q ss_pred CeEEcCCCcEEEEeeccceec
Q 046097 215 NILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 215 NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++.++.+||+|||++...
T Consensus 159 Nill~~~~~~kl~dfg~~~~~ 179 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNL 179 (295)
T ss_pred hEEEcCCCcEEeccccccccc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=304.93 Aligned_cols=151 Identities=32% Similarity=0.456 Sum_probs=136.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|++++.||+|.||.||+|+.+.++..||+|++.+... .....++.+|+++-+.++||||+++|++|.+. ..+|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--KRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc--ceeE
Confidence 4679999999999999999999999999999999866431 22347799999999999999999999999997 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|++||...|.|...|..... ..+++.....++.|+|.||.|+|.. +||||||||+|+|++..+.+||+|||.+..
T Consensus 99 LilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 99999999999999986554 3378889999999999999999999 999999999999999999999999998754
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.40 Aligned_cols=150 Identities=27% Similarity=0.476 Sum_probs=132.4
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCC---ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSS---QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg---~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.++..........+.+|+.++.+++||||+++++++.+. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CccE
Confidence 56888999999999999999986444 379999987654445567899999999999999999999999876 7899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+|||++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999997643 2478899999999999999999999 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=314.75 Aligned_cols=156 Identities=28% Similarity=0.423 Sum_probs=136.2
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecC-CCChhhHHHHHHHHHHhccCCCCceeEEEeEEec---CC
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDS-SGSLQGEREFHNELSLASSLDCPHIVSLLGFASD---RR 150 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~-~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~---~~ 150 (603)
......|..++.||.|+||.|+.+.++.+|+.||||.+.. -......++..+|+.+|+.++|+||+.+++++.. ..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3455677778999999999999999999999999998863 2344556788999999999999999999999875 23
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
-..+|+|+|+| +.+|...++.+.. ++...+..++.|++.||.|+|+. +|+||||||.|+|++.++.+||+|||
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 46799999999 5699999977543 88999999999999999999999 99999999999999999999999999
Q ss_pred cceeccc
Q 046097 231 LARLKTE 237 (603)
Q Consensus 231 lA~~~~~ 237 (603)
+|+....
T Consensus 171 LAR~~~~ 177 (359)
T KOG0660|consen 171 LARYLDK 177 (359)
T ss_pred ceeeccc
Confidence 9987643
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=334.70 Aligned_cols=140 Identities=21% Similarity=0.303 Sum_probs=113.1
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC------CCceeEEEeEE
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD------CPHIVSLLGFA 146 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~------HpNIV~l~g~~ 146 (603)
++...+++|++.+.||+|+||+||+|.+..+++.||||+++.. ......+..|+.++..++ |.+++.+++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3445578899999999999999999999989999999999642 122234455666665554 55689999998
Q ss_pred ecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCC
Q 046097 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDF 222 (603)
Q Consensus 147 ~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~ 222 (603)
... ..+.|+|||++ +++|.+++.... .+++..+..++.||+.||.|||+ . +||||||||+|||++.++
T Consensus 201 ~~~-~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 201 QNE-TGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSD 269 (467)
T ss_pred EcC-CceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCC
Confidence 764 36789999988 778888886543 38899999999999999999997 5 999999999999998655
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=305.37 Aligned_cols=147 Identities=28% Similarity=0.459 Sum_probs=129.1
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.... .....+.+|+.++++++|+||+++++++... ...++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEEE
Confidence 35788899999999999999885 46689999986532 2345688899999999999999999998876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++..
T Consensus 79 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 79 EYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred ecCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceec
Confidence 99999999999875432 478999999999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.46 Aligned_cols=153 Identities=27% Similarity=0.392 Sum_probs=130.6
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCC---
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRR--- 150 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~--- 150 (603)
....++|++.+.||.|+||.||+|.+..+++.||||.+..... ......+.+|+.++++++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3466889999999999999999999999999999999865322 223456788999999999999999999876431
Q ss_pred -CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEee
Q 046097 151 -GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 151 -~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DF 229 (603)
....|++++++ +++|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 14578999988 77898877532 389999999999999999999999 9999999999999999999999999
Q ss_pred ccceec
Q 046097 230 GLARLK 235 (603)
Q Consensus 230 GlA~~~ 235 (603)
|++...
T Consensus 163 g~~~~~ 168 (343)
T cd07878 163 GLARQA 168 (343)
T ss_pred ccceec
Confidence 998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.35 Aligned_cols=152 Identities=26% Similarity=0.447 Sum_probs=127.1
Q ss_pred CCCCceeeccCceEEEEEEEcCCCc--eEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----CCe
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQ--PLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR----GRR 153 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~--~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~----~~~ 153 (603)
|.+.+.||+|+||.||+|.+..++. .+|+|.++... .......+.+|+.++..++|+||+++++++.... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567889999999999999876665 68999987642 3344567889999999999999999999875421 135
Q ss_pred EEEEEEccCCCCHHHHHhhcc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 154 LVLIYELMENRSLQDALLDRK---CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~---~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
.+++|||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999999875322 123478999999999999999999998 99999999999999999999999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
++...
T Consensus 158 ~~~~~ 162 (272)
T cd05075 158 LSKKI 162 (272)
T ss_pred ccccc
Confidence 98754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=305.20 Aligned_cols=142 Identities=29% Similarity=0.487 Sum_probs=123.9
Q ss_pred eeeccCceEEEEEEEc--CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCC
Q 046097 86 RLGHGGFGSVYKAVVP--SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMEN 163 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~--~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~ 163 (603)
.||+|+||.||+|.+. .++..||+|++.........+.+.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCCC
Confidence 3899999999999874 34567999999765444455679999999999999999999998864 568999999999
Q ss_pred CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 164 RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 164 gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 79 ~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 145 (257)
T cd05115 79 GPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145 (257)
T ss_pred CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccc
Confidence 99999986533 3489999999999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.60 Aligned_cols=147 Identities=27% Similarity=0.431 Sum_probs=128.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|.+.+.||+|+||.||.|.... +..+|+|.+.... .....+.+|+.++.+++||||+++++++.+. ...++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEEE
Confidence 457888999999999999998753 4569999986532 2346789999999999999999999999876 6789999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+.+++|.+++..... .+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||+++..
T Consensus 79 e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 79 EYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred EcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceec
Confidence 99999999999875432 489999999999999999999999 9999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.50 Aligned_cols=149 Identities=29% Similarity=0.372 Sum_probs=130.2
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
|+..+.||+|+||+||+|.+..+++.||+|.+...... .....+.+|+.++++++|+||+.+++.+... +..++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEEE
Confidence 66778999999999999999999999999998653221 2234578899999999999999999998876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 80 TIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred EeccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 99999999988865432 3489999999999999999999999 9999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=307.35 Aligned_cols=152 Identities=32% Similarity=0.495 Sum_probs=132.4
Q ss_pred cCCCCCceeeccCceEEEEEEE----cCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVV----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~----~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.+|++.+.||+|+||.||+|.. ..++..||+|.+... .......+.+|++++.+++||||+++++++.......+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 5788899999999999999984 356889999998653 33445678999999999999999999998876544678
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999986543 2378999999999999999999999 999999999999999999999999999876
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 158 ~~ 159 (284)
T cd05081 158 LP 159 (284)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.17 Aligned_cols=148 Identities=28% Similarity=0.430 Sum_probs=132.3
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-C-----CceeEEEeEEecCCCCe
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-C-----PHIVSLLGFASDRRGRR 153 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-H-----pNIV~l~g~~~~~~~~~ 153 (603)
+|.+.+.||+|+||.|.+|.+..|++.||||+++.. .....+-..|+.+|..++ | -|+|+++++|... ++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--NH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--cc
Confidence 889999999999999999999999999999999863 344566778999999986 4 4899999999998 99
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC--CcEEEEeecc
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD--FKAKIGDFGL 231 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~--~~vKL~DFGl 231 (603)
+|||+|.+. .+|.++++.....+ ++...+..|+.||+.||.+||+. +|||+||||+||||.+. ..+||+|||.
T Consensus 263 lciVfELL~-~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999994 59999999887655 89999999999999999999999 99999999999999754 4699999999
Q ss_pred ceecc
Q 046097 232 ARLKT 236 (603)
Q Consensus 232 A~~~~ 236 (603)
|....
T Consensus 338 Sc~~~ 342 (586)
T KOG0667|consen 338 SCFES 342 (586)
T ss_pred ccccC
Confidence 97654
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=300.76 Aligned_cols=147 Identities=34% Similarity=0.566 Sum_probs=130.8
Q ss_pred ceeeccCceEEEEEEEcCC---CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSS---SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~t---g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|..... +..|++|.+...........+.+|+.++..++|+||+++++++.+. ...++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE--EPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC--CceEEEEEec
Confidence 4699999999999999765 8899999998754444467899999999999999999999999885 8899999999
Q ss_pred CCCCHHHHHhhccc------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 162 ENRSLQDALLDRKC------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 162 ~~gsL~~~L~~~~~------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
++++|.+++..... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 99999999977521 24489999999999999999999999 9999999999999999999999999998765
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 156 ~ 156 (262)
T cd00192 156 Y 156 (262)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.15 Aligned_cols=152 Identities=28% Similarity=0.417 Sum_probs=132.2
Q ss_pred hcCCCCCceeeccCceEEEEEEE-----cCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVV-----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRG 151 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~ 151 (603)
.++|.+.+.||+|+||.||+|.. ..++..||+|.++........+.+.+|+.+++++ +|+||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence 35689999999999999999975 2345689999987654444556789999999999 799999999999876
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
+..++||||+.+++|.+++..... ..+++.++..++.|++.||.|||++ +++|+||||+|||++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 789999999999999999875432 3379999999999999999999999 999999999999999999999999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
+...
T Consensus 188 ~~~~ 191 (302)
T cd05055 188 ARDI 191 (302)
T ss_pred cccc
Confidence 8643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.49 Aligned_cols=154 Identities=29% Similarity=0.463 Sum_probs=131.2
Q ss_pred hcCCCCCceeeccCceEEEEEEE-----cCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVV-----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRG 151 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~ 151 (603)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++..........+.+|+.++.++ +|+||+++++++... +
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence 46799999999999999999985 2467889999997654444556788999999999 689999999988764 3
Q ss_pred CeEEEEEEccCCCCHHHHHhhccc--------------------------------------------------------
Q 046097 152 RRLVLIYELMENRSLQDALLDRKC-------------------------------------------------------- 175 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~-------------------------------------------------------- 175 (603)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 578999999999999999865321
Q ss_pred --------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 176 --------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 176 --------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 229 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence 12367888899999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.12 Aligned_cols=150 Identities=28% Similarity=0.476 Sum_probs=132.5
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCc---eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
+.|++.+.||+|+||.||+|..+.++. .||||.+...........+..|+.+++++.||||+++++++.+. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--CceE
Confidence 457888999999999999999876654 59999997654555567899999999999999999999999876 7789
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999999987543 2378999999999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=304.63 Aligned_cols=149 Identities=30% Similarity=0.414 Sum_probs=135.1
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||.|++|.||+|.+..+++.||+|.+...........+.+|+.+++.++|+||+++++++.+. ...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEE
Confidence 46888899999999999999999899999999997654444556788999999999999999999999876 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 999999999998754 489999999999999999999999 99999999999999999999999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=304.75 Aligned_cols=141 Identities=31% Similarity=0.488 Sum_probs=123.1
Q ss_pred eeeccCceEEEEEEE--cCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 86 RLGHGGFGSVYKAVV--PSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~--~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
.||+|+||.||+|.+ ..++..+|+|+++.... ....+.+.+|+.++..+.|+||+++++++.. ...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 589999999999975 45678999999865432 2345678999999999999999999999865 56789999999
Q ss_pred CCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 163 NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 163 ~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+++|.+++.... .+++..+..++.|++.||.|||++ +++||||||.||+++.++.+||+|||++...
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 79 LGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcccccc
Confidence 999999986543 388999999999999999999999 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.31 Aligned_cols=155 Identities=25% Similarity=0.354 Sum_probs=135.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcC----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPS----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+...........+.+|+.++++++|+||+++++++... +.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 35678899999999999999999865 36789999987655556667889999999999999999999988764 36
Q ss_pred eEEEEEEccCCCCHHHHHhhcccc-----cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEE
Q 046097 153 RLVLIYELMENRSLQDALLDRKCE-----ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~-----~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
..+++++|+++++|.+++...... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998764322 3488999999999999999999999 99999999999999999999999
Q ss_pred eeccceec
Q 046097 228 DFGLARLK 235 (603)
Q Consensus 228 DFGlA~~~ 235 (603)
|||+++..
T Consensus 160 d~g~~~~~ 167 (280)
T cd05043 160 DNALSRDL 167 (280)
T ss_pred CCCCcccc
Confidence 99998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=303.35 Aligned_cols=146 Identities=27% Similarity=0.444 Sum_probs=127.5
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
.+|.+.+.||+|+||.||++.. .+..||+|.++.. ...+.+.+|+.++++++|+|++++++++... +...+++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEEE
Confidence 4688899999999999999987 4788999998653 2345788999999999999999999986543 36789999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||+++++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCcccee
Confidence 99999999999876432 3478899999999999999999999 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=306.48 Aligned_cols=144 Identities=33% Similarity=0.552 Sum_probs=124.7
Q ss_pred ceeeccCceEEEEEEEcCCCc--eEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQ--PLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~--~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.+..++. .+++|.++..........+.+|++++.++ +||||+++++++... +..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeC
Confidence 368999999999999987765 46888887544445556789999999999 799999999999886 7789999999
Q ss_pred CCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEe
Q 046097 162 ENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228 (603)
Q Consensus 162 ~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~D 228 (603)
++++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 99999999875431 12378899999999999999999998 999999999999999999999999
Q ss_pred eccce
Q 046097 229 FGLAR 233 (603)
Q Consensus 229 FGlA~ 233 (603)
||++.
T Consensus 156 fgl~~ 160 (270)
T cd05047 156 FGLSR 160 (270)
T ss_pred CCCcc
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=321.72 Aligned_cols=153 Identities=27% Similarity=0.437 Sum_probs=137.0
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh--hHHHHHHHHHHhccCC-CCceeEEEeEEecCCCC
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ--GEREFHNELSLASSLD-CPHIVSLLGFASDRRGR 152 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~--~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~ 152 (603)
.....|++.+.||.|.||.||+++.+.+|+.+|+|++.+..... ....+.+|+.+|+++. |||||.+++.|++. .
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~ 109 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--D 109 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--C
Confidence 35567899999999999999999999999999999997754332 3468999999999998 99999999999998 8
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC----CCcEEEEe
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG----DFKAKIGD 228 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~----~~~vKL~D 228 (603)
.+++|||++.||.|.+.+... . +++..+..++.|++.|+.|||+. ||+||||||+|+|+.. ++.+|++|
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEee
Confidence 999999999999999999776 2 89999999999999999999998 9999999999999963 35799999
Q ss_pred eccceeccc
Q 046097 229 FGLARLKTE 237 (603)
Q Consensus 229 FGlA~~~~~ 237 (603)
||++.....
T Consensus 183 FGla~~~~~ 191 (382)
T KOG0032|consen 183 FGLAKFIKP 191 (382)
T ss_pred CCCceEccC
Confidence 999987643
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.30 Aligned_cols=150 Identities=23% Similarity=0.376 Sum_probs=124.0
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC------C
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR------R 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~------~ 150 (603)
...+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 4567999999999999999999999899999999885422 2345799999999999999999887532 1
Q ss_pred CCeEEEEEEccCCCCHHHHHhhc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC-cEEEEe
Q 046097 151 GRRLVLIYELMENRSLQDALLDR-KCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-KAKIGD 228 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~-~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-~vKL~D 228 (603)
...+++||||+++ +|.+++... .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 1357799999975 777766532 2234588999999999999999999999 999999999999998665 799999
Q ss_pred eccceec
Q 046097 229 FGLARLK 235 (603)
Q Consensus 229 FGlA~~~ 235 (603)
||+|+..
T Consensus 215 FGla~~~ 221 (440)
T PTZ00036 215 FGSAKNL 221 (440)
T ss_pred cccchhc
Confidence 9998754
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=303.63 Aligned_cols=148 Identities=29% Similarity=0.477 Sum_probs=129.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.++++++|+|++++++++.. ...+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEE
Confidence 457899999999999999999875 566799999876322 34578999999999999999999998854 567999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++..... ..+++..++.++.|++.||.|||++ +++|+||||+||++++++.++|+|||++...
T Consensus 79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 999999999999875432 3378999999999999999999999 9999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=301.22 Aligned_cols=154 Identities=27% Similarity=0.430 Sum_probs=134.5
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||.|+||.||++.+..+++.||+|.+.... .....+.+..|+.++++++|+||+++++++....+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999999899999999986533 334456788999999999999999999988766557889999
Q ss_pred EccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 159 ELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLH-----HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLH-----s~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
||+++++|.+++.... ....+++..++.++.|++.||.||| +. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999987632 2345899999999999999999999 66 9999999999999999999999999998
Q ss_pred eecc
Q 046097 233 RLKT 236 (603)
Q Consensus 233 ~~~~ 236 (603)
....
T Consensus 158 ~~~~ 161 (265)
T cd08217 158 KILG 161 (265)
T ss_pred cccc
Confidence 7643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=302.51 Aligned_cols=148 Identities=30% Similarity=0.524 Sum_probs=132.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||.|+||.||+|.. .++.||+|.+..... ..+++.+|+.++.+++|+||+++++++.+. ...++|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCC--CCeEEE
Confidence 45788999999999999999987 478899999976432 467789999999999999999999999875 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||.+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccc
Confidence 999999999999976542 2489999999999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=306.81 Aligned_cols=149 Identities=26% Similarity=0.365 Sum_probs=133.0
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||+|+||.||++....+++.||+|++...........+.+|++++..++||||+++++++... ...++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEEE
Confidence 56888899999999999999998889999999987644444567899999999999999999999999987 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||+++++|.+++.... .+++..+..++.+++.||.|||+.+ +++|+||+|+||+++.++.++|+|||++..
T Consensus 83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 83 EFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred ecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 9999999999886543 3789999999999999999999732 899999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=305.36 Aligned_cols=148 Identities=27% Similarity=0.460 Sum_probs=128.6
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|.+..+ ..||+|+++... .....+.+|+.++++++|+||+++++++.+ ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEE
Confidence 45799999999999999999998654 469999997532 234578999999999999999999998754 567999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred EEcCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeec
Confidence 999999999999975432 3478899999999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=314.19 Aligned_cols=151 Identities=31% Similarity=0.500 Sum_probs=130.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhcc--CCCCceeEEEeEEecCC--CCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASS--LDCPHIVSLLGFASDRR--GRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~--l~HpNIV~l~g~~~~~~--~~~ 153 (603)
....+..++||+|.||.||+|.. +++.||||++.. ...+.|++|-++.+. +.|+||+++++.-.... ...
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 34456667899999999999999 579999999954 566788999888875 47999999998765431 347
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhC------CCCCeEeccCCCCCeEEcCCCcEEEE
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS------CEPPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~------~~~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
.+||++|.+.|+|.++|..+. ++|....+|+..+++||+|||+. ++++|+|||||.+||||.+|+++.|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 899999999999999998754 89999999999999999999964 46799999999999999999999999
Q ss_pred eeccceecccc
Q 046097 228 DFGLARLKTED 238 (603)
Q Consensus 228 DFGlA~~~~~~ 238 (603)
|||+|......
T Consensus 359 DFGLAl~~~p~ 369 (534)
T KOG3653|consen 359 DFGLALRLEPG 369 (534)
T ss_pred ccceeEEecCC
Confidence 99999887643
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=299.70 Aligned_cols=142 Identities=29% Similarity=0.507 Sum_probs=126.0
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
++||+|+||.||+|... ++..+|+|.+...........+.+|+.++.+++||||+++++++... ...++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECCCCC
Confidence 36999999999999864 68889999987654444556789999999999999999999999876 7889999999999
Q ss_pred CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 165 SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 165 sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+|.+++.... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++..
T Consensus 78 ~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 78 DFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCcccee
Confidence 9999986543 2378999999999999999999999 999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=304.05 Aligned_cols=149 Identities=26% Similarity=0.365 Sum_probs=132.7
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++.+... ...++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEEE
Confidence 356788889999999999999998899999999987642 23345678899999999999999999999876 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred EeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 99999999999986543 388999999999999999999999 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=300.13 Aligned_cols=150 Identities=25% Similarity=0.403 Sum_probs=134.3
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|+..+.||.|+||.||.+....+++.+++|.+.... .......+.+|+.++++++|+||+++++++.+. ..++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEEE
Confidence 5888999999999999999999999999999986532 334456788999999999999999999999986 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 79 EYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred EecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 9999999999997653 23478999999999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.56 Aligned_cols=154 Identities=27% Similarity=0.444 Sum_probs=132.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEc-------CCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEec
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVP-------SSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASD 148 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~-------~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~ 148 (603)
...+|.+.+.||+|+||.||+|+.. ..+..||+|.+...........+.+|+.++..+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567888999999999999999752 234579999987644445557789999999999 79999999999988
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSN 215 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~N 215 (603)
. ...++||||+++++|.+++..... ...+++..++.++.||+.||.|||++ +++||||||+|
T Consensus 93 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 93 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred C--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 6 788999999999999999976422 12478888999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEEeeccceec
Q 046097 216 ILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 216 ILld~~~~vKL~DFGlA~~~ 235 (603)
|+++.++.+||+|||++...
T Consensus 168 ili~~~~~~kl~D~g~~~~~ 187 (304)
T cd05101 168 VLVTENNVMKIADFGLARDV 187 (304)
T ss_pred EEEcCCCcEEECCCccceec
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.36 Aligned_cols=153 Identities=27% Similarity=0.451 Sum_probs=131.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcC----------------CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPS----------------SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~----------------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~ 141 (603)
.++|++.+.||+|+||.||++.... ++..+|+|.+...........+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3579999999999999999986432 345799999976544455678999999999999999999
Q ss_pred EEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccc--------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 046097 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCE--------ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKP 213 (603)
Q Consensus 142 l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~--------~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp 213 (603)
+++++... ...++||||+++++|.+++...... ..+++..+..++.|++.||+|||+. +++|+||||
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp 158 (296)
T cd05095 84 LLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT 158 (296)
T ss_pred EEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence 99999886 7789999999999999998764321 2367888999999999999999999 999999999
Q ss_pred CCeEEcCCCcEEEEeeccceec
Q 046097 214 SNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 214 ~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|||++.++.++|+|||++...
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~ 180 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred heEEEcCCCCEEeccCcccccc
Confidence 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=304.63 Aligned_cols=153 Identities=31% Similarity=0.488 Sum_probs=134.0
Q ss_pred cCCCCCceeeccCceEEEEEEEc----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVP----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..|++.+.||+|+||.||+|... .++..||||.+...........+.+|+++++.+.|+||+++++++....+...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778899999999999999864 34789999999765433356789999999999999999999999987555789
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++..... .+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999976442 388999999999999999999999 999999999999999999999999999876
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=300.04 Aligned_cols=151 Identities=26% Similarity=0.394 Sum_probs=131.9
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||.|++|.||++.++.+++.||+|.+.... .....+.+.+|++++++++|+|++++++.+... ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 4888999999999999999999899999999986532 233446788999999999999999999887643 25789999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++..... ..+++.++..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 80 e~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 80 GFCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred cccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 99999999999976432 3479999999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=307.78 Aligned_cols=151 Identities=29% Similarity=0.471 Sum_probs=130.2
Q ss_pred cCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.+|...+.||+|+||.||++... .++..+++|.+.. ........+.+|++++.+++|+||+++++++.+. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTVLQHQHIVRFYGVCTEG--RP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--Cc
Confidence 46778899999999999999753 3466899998865 3344556899999999999999999999999876 77
Q ss_pred EEEEEEccCCCCHHHHHhhcccc------------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC
Q 046097 154 LVLIYELMENRSLQDALLDRKCE------------ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD 221 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~------------~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~ 221 (603)
.+++|||+++++|.+++...... ..+++..++.++.|++.||.|||++ +++|+||||+|||++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 89999999999999999764321 2378899999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccceec
Q 046097 222 FKAKIGDFGLARLK 235 (603)
Q Consensus 222 ~~vKL~DFGlA~~~ 235 (603)
+.+||+|||++...
T Consensus 159 ~~~kL~dfg~~~~~ 172 (280)
T cd05092 159 LVVKIGDFGMSRDI 172 (280)
T ss_pred CCEEECCCCceeEc
Confidence 99999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.17 Aligned_cols=150 Identities=29% Similarity=0.417 Sum_probs=134.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||.|+||.||+|....+++.+++|++..... .....+.+|+.++++++||||+++++++.+. ..++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CEEEEE
Confidence 4678999999999999999999988899999999976432 3557889999999999999999999999876 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+.+++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 79 MEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred EeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhh
Confidence 99999999999887642 2388999999999999999999998 9999999999999999999999999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=310.06 Aligned_cols=148 Identities=26% Similarity=0.447 Sum_probs=131.4
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|.+.+.||.|+||.||+|.+..+++.||+|.+...........+.+|+.++++++|+||+++++++... ...++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEEEEE
Confidence 56899999999999999999999899999999987644444445678899999999999999999999876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||+. ++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 84 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 84 EYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred eccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 9997 58988886543 2378899999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=313.44 Aligned_cols=153 Identities=29% Similarity=0.445 Sum_probs=132.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcC-------CCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPS-------SSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDR 149 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~ 149 (603)
.++|.+.+.||+|+||.||++.... +...+|+|.++..........+.+|+.++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4679999999999999999998643 23569999997654445556788999999999 799999999999886
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNI 216 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NI 216 (603)
...++||||+++++|.+++..... ...+++..++.++.|++.||+|||++ +++||||||+||
T Consensus 97 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 97 --GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 789999999999999999976432 12478899999999999999999998 999999999999
Q ss_pred EEcCCCcEEEEeeccceec
Q 046097 217 LLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~~ 235 (603)
+++.++.+||+|||++...
T Consensus 172 ll~~~~~~kL~dfg~a~~~ 190 (307)
T cd05098 172 LVTEDNVMKIADFGLARDI 190 (307)
T ss_pred EEcCCCcEEECCCcccccc
Confidence 9999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=301.65 Aligned_cols=149 Identities=31% Similarity=0.421 Sum_probs=131.0
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--------hhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--------QGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--------~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
+|.+...||.|++|.||+|.+..+++.+|+|.+...... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 477889999999999999999888999999988653221 1125688999999999999999999999886
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCC
Confidence 78899999999999999997643 378889999999999999999999 999999999999999999999999999
Q ss_pred ceecc
Q 046097 232 ARLKT 236 (603)
Q Consensus 232 A~~~~ 236 (603)
+....
T Consensus 153 ~~~~~ 157 (267)
T cd06628 153 SKKLE 157 (267)
T ss_pred Ccccc
Confidence 87653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.26 Aligned_cols=150 Identities=26% Similarity=0.405 Sum_probs=133.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..+.|++.+.||.|+||.||+|.+..+++.+++|.+... .......+.+|+.+++.++|+||+++++.+... +..++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--CeEEE
Confidence 346799999999999999999999989999999999763 344557788999999999999999999998876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+++++|..++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 87 MIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred EEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999988875433 2388999999999999999999998 999999999999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.30 Aligned_cols=148 Identities=30% Similarity=0.454 Sum_probs=133.4
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
..|+..+.||.|+||.||+|.+..++..||+|.+...........+.+|+.+++++.|+||+++++++.+. ...++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEEE
Confidence 45778889999999999999998889999999987654445567899999999999999999999999886 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 82 e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 82 EYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred ecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 999999999988643 378889999999999999999999 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.19 Aligned_cols=145 Identities=29% Similarity=0.376 Sum_probs=124.3
Q ss_pred ceeeccCceEEEEEEEc--CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 85 NRLGHGGFGSVYKAVVP--SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~--~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
+.||+|+||.||+|... .++..+|+|.++..........+.+|+.++.+++||||+++++++.+. ...++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEECCC
Confidence 35899999999999864 345679999987655444556788999999999999999999999876 77899999999
Q ss_pred CCCHHHHHhhccc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 163 NRSLQDALLDRKC--EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 163 ~gsL~~~L~~~~~--~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+|+|.+++..... ....++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~ 149 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccc
Confidence 9999999975432 12356778888999999999999999 999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.24 Aligned_cols=153 Identities=26% Similarity=0.345 Sum_probs=137.1
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||.|+||.||+|....++..+++|++...........+.+|+.+++.++|+||+++++.+... ...++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEEEE
Confidence 47899999999999999999998889999999997654444667899999999999999999999998876 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|++++++|.+++........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 9999999999997654334589999999999999999999999 99999999999999999999999999986554
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=302.70 Aligned_cols=150 Identities=31% Similarity=0.490 Sum_probs=130.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++++++|+||+++++++.. ...++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEE
Confidence 3467899999999999999999874 57789999987533 234678899999999999999999998754 56899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
+|||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999999999865432 3478999999999999999999998 99999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=308.43 Aligned_cols=148 Identities=26% Similarity=0.399 Sum_probs=132.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
..+|++.+.||.|+||.||+|.+..+++.|++|.+..... .....+.+|+.+++.+.|+||+++++.+... ...++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--CEEEEe
Confidence 4578899999999999999999988999999999876432 3346788999999999999999999999875 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++... .+++.++..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++...
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 9999999999998643 378899999999999999999999 9999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.55 Aligned_cols=147 Identities=32% Similarity=0.468 Sum_probs=131.1
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
.|+..+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.++++++|+||+++++++... ...++|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEEEE
Confidence 4566678999999999999998889999999987654445557789999999999999999999999876 78999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|+++++|.+++... .+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++...
T Consensus 83 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 83 YLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred ccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccc
Confidence 99999999988542 378899999999999999999998 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=304.74 Aligned_cols=162 Identities=28% Similarity=0.398 Sum_probs=138.0
Q ss_pred ccHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEe
Q 046097 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFAS 147 (603)
Q Consensus 69 ~~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~ 147 (603)
+.++.+..+.++|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.++..+ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 44556667889999999999999999999999999999999998652 22345678899999999 6999999999885
Q ss_pred cC---CCCeEEEEEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc
Q 046097 148 DR---RGRRLVLIYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 148 ~~---~~~~~~LVmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~ 223 (603)
.. .+...++||||+++++|.+++.... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 32 2467899999999999999876432 223478899999999999999999999 9999999999999999999
Q ss_pred EEEEeeccceec
Q 046097 224 AKIGDFGLARLK 235 (603)
Q Consensus 224 vKL~DFGlA~~~ 235 (603)
++|+|||++...
T Consensus 163 ~kl~dfg~~~~~ 174 (286)
T cd06638 163 VKLVDFGVSAQL 174 (286)
T ss_pred EEEccCCceeec
Confidence 999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.13 Aligned_cols=149 Identities=31% Similarity=0.394 Sum_probs=132.9
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||++.+..+++.||+|++.... .......+.+|++++++++||||+++++++.+. ...++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEE
Confidence 46889999999999999999999899999999986532 123346788999999999999999999999886 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++++|.+++.... .++...+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 79 v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 79 VMEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 999999999999987653 388999999999999999999998 9999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.10 Aligned_cols=155 Identities=26% Similarity=0.324 Sum_probs=132.5
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
+.+++++.....||+|+||.||+|.+..++..|++|.+... .....+.+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 80 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFF 80 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEE
Confidence 34556666678999999999999999888999999998753 334556789999999999999999999999886 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-CCcEEEEeeccce
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-DFKAKIGDFGLAR 233 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~-~~~vKL~DFGlA~ 233 (603)
++|+||+++++|.+++.........++..+..++.||+.||.|||+. +|+||||||+||+++. ++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999997643211127788889999999999999999 9999999999999976 6799999999886
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 158 ~~ 159 (268)
T cd06624 158 RL 159 (268)
T ss_pred ec
Confidence 43
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=299.62 Aligned_cols=151 Identities=28% Similarity=0.421 Sum_probs=132.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC----ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG----SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~----~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.+|+..+.||+|+||.||+|.+..++..|++|.+.... .......+.+|+.++++++|+||+++++++.+......
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999998899999999886432 12234568899999999999999999999887555788
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+++|||+++++|.+++.... .+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 99999999999999987543 378899999999999999999998 999999999999999999999999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 156 ~ 156 (266)
T cd06651 156 L 156 (266)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=301.75 Aligned_cols=147 Identities=37% Similarity=0.533 Sum_probs=130.1
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhH-HHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE-REFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~-~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
|++.+.||+|+||+||++....+++.||+|++......... ....+|+.++.+++|+||+++++++.+. ...++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD--NYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES--SEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc--cccccccc
Confidence 56678999999999999999999999999999875433222 2345699999999999999999999986 88999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|+++++|.+++... ..+++..++.++.|++.||.+||+. +++|+||||+||+++.++.++|+|||.+...
T Consensus 79 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 79 YCPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp EETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 99999999999732 3389999999999999999999999 9999999999999999999999999998753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.02 Aligned_cols=148 Identities=32% Similarity=0.469 Sum_probs=133.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||.|+||.||+|....+++.+++|.+... .....+.+|++++++++|+||+++++++.+. ...+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE---EDLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH---HHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEE
Confidence 36799999999999999999999888999999999653 2267899999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||+.+++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 77 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 77 MEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred EecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhc
Confidence 99999999999986533 3489999999999999999999999 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.33 Aligned_cols=147 Identities=27% Similarity=0.426 Sum_probs=130.8
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEc
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
|++.+.||.|+||.||+|.+..++..+++|.+... .......+.+|+++++.++|+||+++++++... ...++||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEEEe
Confidence 67788899999999999999989999999998653 334456788999999999999999999999876 789999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+++++|..++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence 99999998876432 3489999999999999999999999 9999999999999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.45 Aligned_cols=153 Identities=30% Similarity=0.376 Sum_probs=134.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|+..+.||.|++|.||+|.+..+++.+|+|.+...........+.+|++++++++||||++++++|.+.....+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999998899999999997654445567799999999999999999999999876556899999
Q ss_pred EccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 159 ELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||+++++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 9999999998876422 233478899999999999999999999 999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=299.25 Aligned_cols=150 Identities=23% Similarity=0.401 Sum_probs=132.8
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||+|+||.||.+....+++.||+|.+.... .......+.+|+.++++++|+||+++++++.+. ...++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEEEEE
Confidence 5888999999999999999999899999999986532 233446789999999999999999999999876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++..... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 79 DYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred ecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 99999999998875432 2378899999999999999999998 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=324.83 Aligned_cols=155 Identities=28% Similarity=0.406 Sum_probs=132.0
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecC
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDR 149 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~ 149 (603)
...++|.+.+.||+|+||.||+|++. .+++.||||+++..........+.+|+.+|.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456888999999999999999964 3456899999976544444567899999999997 99999999999886
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhccc------------------------------------------------------
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKC------------------------------------------------------ 175 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~------------------------------------------------------ 175 (603)
...++||||+++|+|.+++.....
T Consensus 114 --~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 114 --GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred --CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 789999999999999999965321
Q ss_pred -----------------------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 046097 176 -----------------------------------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPS 214 (603)
Q Consensus 176 -----------------------------------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~ 214 (603)
...+++..++.++.|++.||.|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 11356778889999999999999998 9999999999
Q ss_pred CeEEcCCCcEEEEeeccceec
Q 046097 215 NILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 215 NILld~~~~vKL~DFGlA~~~ 235 (603)
|||++.++.+||+|||+++..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~ 289 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDI 289 (401)
T ss_pred eEEEeCCCEEEEEecCcceec
Confidence 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.43 Aligned_cols=144 Identities=27% Similarity=0.446 Sum_probs=120.2
Q ss_pred ceeeccCceEEEEEEEcC--CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 85 NRLGHGGFGSVYKAVVPS--SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~--tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
.+||+|+||.||+|..+. ++..||+|.+.... ....+.+|+.++++++||||+++++++........++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 579999999999999754 56789999986532 2345788999999999999999999987655578999999986
Q ss_pred CCCHHHHHhhcc------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE----cCCCcEEEEeeccc
Q 046097 163 NRSLQDALLDRK------CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL----DGDFKAKIGDFGLA 232 (603)
Q Consensus 163 ~gsL~~~L~~~~------~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl----d~~~~vKL~DFGlA 232 (603)
+ +|.+++.... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7777765321 122478899999999999999999999 99999999999999 56678999999998
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
+..
T Consensus 160 ~~~ 162 (317)
T cd07867 160 RLF 162 (317)
T ss_pred ecc
Confidence 754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=298.43 Aligned_cols=151 Identities=29% Similarity=0.409 Sum_probs=132.3
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC----ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG----SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~----~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.+|++.+.||+|+||.||.|.+..++..||||.+.... .......+.+|+.+++++.|+||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999999999999999885422 12234678899999999999999999999887545678
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+++|||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 99999999999999987543 278888999999999999999999 999999999999999999999999998865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 156 ~ 156 (265)
T cd06652 156 L 156 (265)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=300.98 Aligned_cols=147 Identities=29% Similarity=0.479 Sum_probs=127.3
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|.+.+.||+|++|.||+|.+..+ ..+|+|.+.... ...+.+.+|+.++++++|+|++++++++.. ...++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEEE
Confidence 5688889999999999999998654 469999886532 234678899999999999999999998854 5678999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+.+++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 80 EFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred EcCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 99999999999976432 3478899999999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.27 Aligned_cols=153 Identities=29% Similarity=0.460 Sum_probs=131.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEc-------CCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVP-------SSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDR 149 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~-------~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~ 149 (603)
.++|.+.+.||+|+||.||+|+.. .....+|+|.++..........+.+|+.++.++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 467889999999999999999863 234579999987654445566788999999999 599999999999876
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNI 216 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NI 216 (603)
...+++|||+++|+|.+++..... ...+++..+..++.|++.||.|||++ +++|+||||+||
T Consensus 91 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 91 --GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 779999999999999999976421 23478899999999999999999999 999999999999
Q ss_pred EEcCCCcEEEEeeccceec
Q 046097 217 LLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~~ 235 (603)
|++.++.+||+|||+++..
T Consensus 166 ll~~~~~~kL~Dfg~~~~~ 184 (314)
T cd05099 166 LVTEDNVMKIADFGLARGV 184 (314)
T ss_pred EEcCCCcEEEccccccccc
Confidence 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.51 Aligned_cols=150 Identities=24% Similarity=0.403 Sum_probs=131.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||+|++|.||+|.++.+++.||+|.+..... ....+.+.+|+.++++++|+||+++++++... ...++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEEEE
Confidence 468899999999999999999988999999999865322 22335678999999999999999999999886 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||+++++|..++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 79 FEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred EeccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecC
Confidence 99999988887765432 389999999999999999999998 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=310.52 Aligned_cols=150 Identities=33% Similarity=0.563 Sum_probs=129.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCc----eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQ----PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.++|+..+.||+|+||.||+|.+..++. .||+|.+...........+.+|+.++..++|+||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PT 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CC
Confidence 3567888999999999999999877665 4789988765444445578899999999999999999999976 34
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++++||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence 679999999999999987543 2378899999999999999999999 99999999999999999999999999987
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 158 ~~ 159 (303)
T cd05110 158 LL 159 (303)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.58 Aligned_cols=145 Identities=27% Similarity=0.451 Sum_probs=122.9
Q ss_pred ceeeccCceEEEEEEEcC---CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPS---SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~---tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.... ....||+|.+...........+.+|+.+++.++||||+++++++... ++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecC
Confidence 368999999999998643 34579999986544444567888999999999999999999987653 25678999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
.+++|.+++..... ..++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 80 KHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999875432 257778889999999999999998 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=313.59 Aligned_cols=152 Identities=28% Similarity=0.450 Sum_probs=131.0
Q ss_pred cCCCCCceeeccCceEEEEEEEcC-------CCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPS-------SSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR 150 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~ 150 (603)
.+|.+.+.||+|+||.||+|.+.. ....||+|.++..........+.+|+.++.++ +|+||++++++|...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD- 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-
Confidence 468999999999999999998643 22368999987644445567899999999999 799999999999876
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeE
Q 046097 151 GRRLVLIYELMENRSLQDALLDRK-------------CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNIL 217 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~-------------~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NIL 217 (603)
...+++|||+++|+|.+++.... ....+++..++.++.|++.||.|||++ +++||||||+|||
T Consensus 91 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 91 -GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 78999999999999999987532 123478889999999999999999999 9999999999999
Q ss_pred EcCCCcEEEEeeccceec
Q 046097 218 LDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 218 ld~~~~vKL~DFGlA~~~ 235 (603)
++.++.+||+|||+++..
T Consensus 167 l~~~~~~kL~Dfg~~~~~ 184 (334)
T cd05100 167 VTEDNVMKIADFGLARDV 184 (334)
T ss_pred EcCCCcEEECCcccceec
Confidence 999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=349.39 Aligned_cols=147 Identities=18% Similarity=0.299 Sum_probs=124.5
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
.....++|.+++.||.|+||.||+|.+..++..||+|++.... .......+..|+.++.+++||||++++++|.+....
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445678999999999999999999999999999999987543 233456789999999999999999999998766557
Q ss_pred eEEEEEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCC----CCCeEeccCCCCCeEEcC
Q 046097 153 RLVLIYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSC----EPPVIHGDIKPSNILLDG 220 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~----~~gIVHrDLKp~NILld~ 220 (603)
.+|+||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.. ..+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 8999999999999999987532 1234899999999999999999999852 125999999999999964
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=301.84 Aligned_cols=146 Identities=37% Similarity=0.529 Sum_probs=125.2
Q ss_pred ceeeccCceEEEEEEEcCCC------ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 85 NRLGHGGFGSVYKAVVPSSS------QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg------~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+.||+|+||.||+|...... +.+|||.+...........+.+|+.+++.++||||+++++++... ...++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEEEE
Confidence 36999999999999985433 689999886644344567789999999999999999999999876 7799999
Q ss_pred EccCCCCHHHHHhhccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC-----cEEEEee
Q 046097 159 ELMENRSLQDALLDRKC----EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-----KAKIGDF 229 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~----~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-----~vKL~DF 229 (603)
||+++++|.+++..... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 99999999999975321 22378899999999999999999998 999999999999999877 8999999
Q ss_pred ccceec
Q 046097 230 GLARLK 235 (603)
Q Consensus 230 GlA~~~ 235 (603)
|++...
T Consensus 156 g~~~~~ 161 (269)
T cd05044 156 GLARDI 161 (269)
T ss_pred cccccc
Confidence 998654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.35 Aligned_cols=151 Identities=32% Similarity=0.526 Sum_probs=132.7
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCc----eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQ----PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
..+|++.+.||+|+||.||+|..+.++. .+|+|.+...........+.+|+.++.+++|+||+++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cc
Confidence 3568888999999999999999866554 5899988765554556788999999999999999999999986 57
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence 8999999999999999876432 388999999999999999999998 99999999999999999999999999987
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 158 ~~~ 160 (279)
T cd05057 158 LLD 160 (279)
T ss_pred ccc
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=296.47 Aligned_cols=150 Identities=22% Similarity=0.382 Sum_probs=131.4
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||+|+||.||++....+++.+|+|.+.... .......+.+|+.++++++|+||+++++.+... ...++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEEEEE
Confidence 5788899999999999999999999999999986542 233456789999999999999999999998875 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC-CcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~-~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++.... ...+++..+..++.+++.||.|||++ +++|+||+|+||+++.+ +.+||+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 79 EYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 9999999999997643 23478999999999999999999999 99999999999999855 46899999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=294.43 Aligned_cols=145 Identities=34% Similarity=0.482 Sum_probs=127.2
Q ss_pred ceeeccCceEEEEEEEcC-CC--ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPS-SS--QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~-tg--~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|++|.||+|.+.. ++ ..||||.+.........+.+.+|+.++++++|+||+++++++.+ ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 468999999999999855 33 36899999775443556789999999999999999999999887 6789999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
++++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++....
T Consensus 78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~ 148 (257)
T cd05040 78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALP 148 (257)
T ss_pred CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccc
Confidence 99999999977543 3489999999999999999999999 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.00 Aligned_cols=144 Identities=24% Similarity=0.370 Sum_probs=126.8
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
....+|++.+.||+|+||.||+|....+++.||+|+.... ....|+.++++++|+||+++++++... ...+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeE
Confidence 3456799999999999999999999989999999986432 234689999999999999999999886 7889
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+|||++. ++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 134 lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred EEEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 9999995 58888876533 3489999999999999999999999 999999999999999999999999999864
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=300.99 Aligned_cols=160 Identities=26% Similarity=0.390 Sum_probs=137.3
Q ss_pred cHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEec
Q 046097 70 SYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASD 148 (603)
Q Consensus 70 ~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~ 148 (603)
+..++..+.+.|++.+.||.|+||.||+|.+..+++.+|+|++... ......+..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 4455666788999999999999999999999999999999998653 23445688899999998 69999999999864
Q ss_pred C----CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcE
Q 046097 149 R----RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKA 224 (603)
Q Consensus 149 ~----~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~v 224 (603)
. .....+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 2 23678999999999999999876442 3478888999999999999999999 99999999999999999999
Q ss_pred EEEeeccceec
Q 046097 225 KIGDFGLARLK 235 (603)
Q Consensus 225 KL~DFGlA~~~ 235 (603)
+|+|||++...
T Consensus 161 ~l~dfg~~~~~ 171 (282)
T cd06636 161 KLVDFGVSAQL 171 (282)
T ss_pred EEeeCcchhhh
Confidence 99999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.49 Aligned_cols=153 Identities=25% Similarity=0.369 Sum_probs=131.3
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCc-eeEEEeEEecCC----CCe
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPH-IVSLLGFASDRR----GRR 153 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpN-IV~l~g~~~~~~----~~~ 153 (603)
.|..+++||+|+||+||+|+.+.+|+.||+|.+...... .......+|+.+|++++|+| |+.+++++.+.. ...
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 455567799999999999999999999999999775432 23355789999999999999 999999998762 137
Q ss_pred EEEEEEccCCCCHHHHHhhcccc-cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 154 LVLIYELMENRSLQDALLDRKCE-ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~-~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
+++|+||++. +|..++...... ..++...+..++.||+.||+|||++ +|+||||||+||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999954 999999875532 2377789999999999999999999 9999999999999999999999999999
Q ss_pred eecc
Q 046097 233 RLKT 236 (603)
Q Consensus 233 ~~~~ 236 (603)
+...
T Consensus 168 ra~~ 171 (323)
T KOG0594|consen 168 RAFS 171 (323)
T ss_pred HHhc
Confidence 8543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=301.00 Aligned_cols=150 Identities=27% Similarity=0.387 Sum_probs=134.8
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|+..+.||.|++|.||++.++.+++.+++|.+...........+.+|+++++++.||||+++++.+... ...++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEE
Confidence 36788889999999999999999899999999997755455567889999999999999999999999886 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++.... ..+++..+..++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999987643 348899999999999999999999 7 9999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.41 Aligned_cols=149 Identities=26% Similarity=0.394 Sum_probs=133.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
...+|++.+.||.|+||.||+|....+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++... ...++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CEEEE
Confidence 3467999999999999999999998899999999997633 23446688999999999999999999999876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+|||++.++.++|+|||++...
T Consensus 94 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 94 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred eecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 99999999999998643 378899999999999999999999 9999999999999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.97 Aligned_cols=150 Identities=27% Similarity=0.391 Sum_probs=134.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||.|+||.||+|.+..++..+|+|.+... .....+.+..|+.++++++|+||+++++++.+. ...++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE--NKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--CeEEEE
Confidence 45789999999999999999999888999999998753 344556788999999999999999999999876 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 81 IEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred eeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhh
Confidence 99999999999986533 3489999999999999999999999 9999999999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.53 Aligned_cols=150 Identities=27% Similarity=0.430 Sum_probs=130.6
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCC---CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSS---SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..+|.+.+.||+|+||.||+|.+... ...|+||...........+.+.+|+.+++++.|+||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCc
Confidence 35688889999999999999987543 356899998765445556789999999999999999999999876 457
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 89999999999999997543 2378999999999999999999998 999999999999999999999999999875
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 157 ~ 157 (270)
T cd05056 157 L 157 (270)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=299.84 Aligned_cols=144 Identities=27% Similarity=0.413 Sum_probs=123.1
Q ss_pred eeeccCceEEEEEEEcC--CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCC
Q 046097 86 RLGHGGFGSVYKAVVPS--SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMEN 163 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~~--tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~ 163 (603)
.||+|+||.||+|.... ....+++|.+...........+.+|+.+++.++|+||+++++.+.+. ...++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEeCCC
Confidence 58999999999997543 34578889876544444556788999999999999999999999876 789999999999
Q ss_pred CCHHHHHhhccc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 164 RSLQDALLDRKC--EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 164 gsL~~~L~~~~~--~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|+|.+++..... ....++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 149 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALE 149 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccc
Confidence 999999976542 12246778889999999999999999 999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=307.47 Aligned_cols=145 Identities=19% Similarity=0.212 Sum_probs=127.1
Q ss_pred CCceeecc--CceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 83 PSNRLGHG--GFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 83 i~~~LG~G--~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
++++||+| +|++||++..+.+++.||+|.+..... ......+.+|+.+++.++||||+++++++... +..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 45789999 789999999999999999999976432 23345678899999999999999999999886 78999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
|+++++|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++++||+.+.
T Consensus 80 ~~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 80 FMAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred ccCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 9999999999865432 2378999999999999999999999 99999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.35 Aligned_cols=155 Identities=30% Similarity=0.431 Sum_probs=135.4
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC----
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR---- 150 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~---- 150 (603)
..+++|++.+.||.|++|.||+|.++.+++.+++|++.... .....+.+|+.+++++ .|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 35789999999999999999999998889999999987632 3446789999999999 6999999999997642
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEee
Q 046097 151 GRRLVLIYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DF 229 (603)
+...++||||+++++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 356899999999999999886533 124589999999999999999999999 9999999999999999999999999
Q ss_pred ccceec
Q 046097 230 GLARLK 235 (603)
Q Consensus 230 GlA~~~ 235 (603)
|++...
T Consensus 158 ~~~~~~ 163 (275)
T cd06608 158 GVSAQL 163 (275)
T ss_pred ccceec
Confidence 998654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.19 Aligned_cols=144 Identities=31% Similarity=0.511 Sum_probs=126.9
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||+|+||.||++.. +++.||+|.++.. .....+.+|+.++.+++|+||+++++++.. ...++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEE
Confidence 4688999999999999999875 6888999998653 234578899999999999999999999876 3479999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 78 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 78 ELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred ECCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCcccee
Confidence 99999999999976432 3478999999999999999999998 999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=294.64 Aligned_cols=143 Identities=31% Similarity=0.540 Sum_probs=127.6
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
++||.|+||.||++.+.. ++.|++|.+...........+.+|+++++++.|+||+++++++.+. ...++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcCCCC
Confidence 469999999999999976 9999999987654444567899999999999999999999999886 7899999999999
Q ss_pred CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 165 SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 165 sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|.+++.... ..+++..++.++.+++.||.|||++ +++||||+|+||+++.++.++|+|||++...
T Consensus 78 ~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 143 (251)
T cd05041 78 SLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREE 143 (251)
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccc
Confidence 9999986543 2378899999999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.44 Aligned_cols=162 Identities=27% Similarity=0.417 Sum_probs=138.1
Q ss_pred ccHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEe
Q 046097 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFAS 147 (603)
Q Consensus 69 ~~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~ 147 (603)
+.+..+..++++|++.+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 344566678899999999999999999999999999999999986532 2345677899999998 7999999999987
Q ss_pred cCC---CCeEEEEEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc
Q 046097 148 DRR---GRRLVLIYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 148 ~~~---~~~~~LVmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~ 223 (603)
... +...++||||+++++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 542 246899999999999999886432 223478999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccceec
Q 046097 224 AKIGDFGLARLK 235 (603)
Q Consensus 224 vKL~DFGlA~~~ 235 (603)
+||+|||++...
T Consensus 167 ~kl~dfg~~~~~ 178 (291)
T cd06639 167 VKLVDFGVSAQL 178 (291)
T ss_pred EEEeecccchhc
Confidence 999999998654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.99 Aligned_cols=147 Identities=27% Similarity=0.420 Sum_probs=132.3
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
.+|++.+.||.|++|.||+|.+..+++.|++|.+.... ......+.+|+.+++.++|+||+++++++... ...++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVG--DELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecC--ceEEEEE
Confidence 46889999999999999999998899999999986532 33456788999999999999999999999876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|..++... .+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++...
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 999999999988643 378999999999999999999999 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=322.92 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=206.0
Q ss_pred eeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCCC
Q 046097 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRS 165 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gs 165 (603)
+||+|.||+||-|++..+...+|||-+... .....+-+..|+.+.++++|.|||+++|.+.+. +++-+.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek-dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen--Gf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK-DSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN--GFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc-cchhhccHHHHHHHHHHHhhHhHHHHhhccCCC--CeEEEEeecCCCCc
Confidence 799999999999999999999999999663 334456789999999999999999999998876 89999999999999
Q ss_pred HHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc-CCCcEEEEeeccceecccccccccc
Q 046097 166 LQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD-GDFKAKIGDFGLARLKTEDLMIEGE 244 (603)
Q Consensus 166 L~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld-~~~~vKL~DFGlA~~~~~~~~~~~~ 244 (603)
|.++|...-..-.-.+..+-.+.+||++||.|||.+ .|||||||-+||||+ -.|.+||+|||.++....-
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi------ 729 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI------ 729 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC------
Confidence 999998754322226778888999999999999999 999999999999996 5789999999998765322
Q ss_pred cccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcchhhhHHhhh
Q 046097 245 CVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGRVKDYVMEWI 324 (603)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (603)
T Consensus 730 -------------------------------------------------------------------------------- 729 (1226)
T KOG4279|consen 730 -------------------------------------------------------------------------------- 729 (1226)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCcCccccccch
Q 046097 325 GSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNVGEMWWQKDE 404 (603)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (603)
T Consensus 730 -------------------------------------------------------------------------------- 729 (1226)
T KOG4279|consen 730 -------------------------------------------------------------------------------- 729 (1226)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCCC--CCCccC
Q 046097 405 EVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGG--LLSEKC 482 (603)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~ 482 (603)
+.-+.++.||.+|||||++..+ .|+..+
T Consensus 730 --------------------------------------------------nP~TETFTGTLQYMAPEvIDqG~RGYG~aA 759 (1226)
T KOG4279|consen 730 --------------------------------------------------NPCTETFTGTLQYMAPEVIDQGPRGYGKAA 759 (1226)
T ss_pred --------------------------------------------------CccccccccchhhhChHhhccCCcCCCchh
Confidence 1123457799999999999875 589999
Q ss_pred CccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCC
Q 046097 483 DVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSK 562 (603)
Q Consensus 483 DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 562 (603)
|||||||++.||.||++||....++...++. -+. -..-...+.+.+.++..+|+.|+.+||.+
T Consensus 760 DIWS~GCT~vEMATGrPPF~ElgspqAAMFk------------VGm-----yKvHP~iPeelsaeak~FilrcFepd~~~ 822 (1226)
T KOG4279|consen 760 DIWSFGCTMVEMATGRPPFVELGSPQAAMFK------------VGM-----YKVHPPIPEELSAEAKNFILRCFEPDPCD 822 (1226)
T ss_pred hhhhccceeEeeccCCCCeeecCChhHhhhh------------hcc-----eecCCCCcHHHHHHHHHHHHHHcCCCccc
Confidence 9999999999999999999876655221111 000 01112567888899999999999999999
Q ss_pred CCCHHHHHHH
Q 046097 563 RLTMKDIVEM 572 (603)
Q Consensus 563 Rpt~~evl~~ 572 (603)
||++.++|+.
T Consensus 823 R~sA~~LL~D 832 (1226)
T KOG4279|consen 823 RPSAKDLLQD 832 (1226)
T ss_pred CccHHHhccC
Confidence 9999999975
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=296.04 Aligned_cols=150 Identities=30% Similarity=0.442 Sum_probs=135.9
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||.|++|.||+|.+..+++.|++|++...........+.+|+..+.+++|+||+++++++... ...++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEE
Confidence 46888999999999999999999899999999997754434567899999999999999999999999886 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||+++++|.+++... ..+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999764 348999999999999999999999 8 99999999999999999999999999887553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=304.09 Aligned_cols=148 Identities=22% Similarity=0.375 Sum_probs=132.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||.||++.+..+++.|++|.+..... ......+.+|+.++..++||||+++++.+... ..+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEEE
Confidence 468899999999999999999999999999999866422 22345688999999999999999999999876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+++++|.+++.... .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++.
T Consensus 79 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 79 VMEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999999996643 378999999999999999999999 999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=299.57 Aligned_cols=152 Identities=28% Similarity=0.416 Sum_probs=128.1
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHH-hccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSL-ASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~i-L~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||+|+||.||+|.++.+++.||+|.++..........+..|+.+ ++..+||||+++++++... ...+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence 4688999999999999999999999999999999765433444556666665 5566899999999999876 789999
Q ss_pred EEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||++ ++|.+++.... ....+++..++.++.||+.||+|||+++ +++||||||+||+++.++.+||+|||++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99996 68888776532 2345899999999999999999999753 8999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=299.98 Aligned_cols=150 Identities=26% Similarity=0.410 Sum_probs=130.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++++|.+.+.||+|+||.||+|....+++.||+|.+...........+.+|+.+++.++|+||+++++++.+. ...++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--CeEEE
Confidence 4678999999999999999999998899999999997644333344677899999999999999999999876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+. ++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred EEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 999995 67777765432 2367888889999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.40 Aligned_cols=150 Identities=29% Similarity=0.465 Sum_probs=132.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|.+.+.||+|+||.||+|... +++.||||.+.... .....+.+|+.++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecC--CceEE
Confidence 4578999999999999999999975 45789999987532 3346789999999999999999999998875 77899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred EEeccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceec
Confidence 9999999999999976432 3478999999999999999999999 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=293.37 Aligned_cols=150 Identities=34% Similarity=0.551 Sum_probs=132.8
Q ss_pred CCCCceeeccCceEEEEEEEcCCC----ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSS----QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg----~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
+++.+.||.|+||.||++.....+ ..||+|.+...........+..|+.++..++|+||+++++++.+. +..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeEE
Confidence 456789999999999999997665 889999997754444667899999999999999999999999986 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
+|||+++++|.+++...... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999998764432 178999999999999999999999 99999999999999999999999999987643
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=296.51 Aligned_cols=148 Identities=27% Similarity=0.399 Sum_probs=132.4
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC---CCceeEEEeEEecCCCCeEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD---CPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~---HpNIV~l~g~~~~~~~~~~~L 156 (603)
.|++.+.||.|+||.||+|.+..+++.||+|.+...........+.+|+.+++++. |+|++++++++.+. ...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEEEE
Confidence 47788999999999999999988999999999876544455567889999999886 99999999999875 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++++|.+++... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999988643 488999999999999999999999 99999999999999999999999999987543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=338.76 Aligned_cols=152 Identities=29% Similarity=0.359 Sum_probs=133.3
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.++||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++.+++||||+++++++.+. +..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEEEE
Confidence 579999999999999999999999999999999975422 23346789999999999999999999999886 78999
Q ss_pred EEEccCCCCHHHHHhhccc--------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEe
Q 046097 157 IYELMENRSLQDALLDRKC--------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~--------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~D 228 (603)
||||+++++|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEe
Confidence 9999999999999864211 12356677889999999999999999 999999999999999999999999
Q ss_pred eccceec
Q 046097 229 FGLARLK 235 (603)
Q Consensus 229 FGlA~~~ 235 (603)
||++...
T Consensus 157 FGLAk~i 163 (932)
T PRK13184 157 WGAAIFK 163 (932)
T ss_pred cCcceec
Confidence 9999865
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=298.02 Aligned_cols=147 Identities=29% Similarity=0.463 Sum_probs=132.1
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
-|++.+.||.|+||.||+|.+..++..||+|.+...........+.+|+.++.+++|+||+++++++.+. ...++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEEE
Confidence 4778889999999999999998889999999987644445556789999999999999999999999886 78999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 83 ~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 83 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 99999999988642 378999999999999999999998 9999999999999999999999999988654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=305.21 Aligned_cols=152 Identities=23% Similarity=0.346 Sum_probs=134.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|++|.||+|....+++.||+|.+...... .....+..|++++..++|+||+++++.+.+. ...++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEEE
Confidence 3688899999999999999999888999999999764333 2446788999999999999999999999876 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 79 VMDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999999987543 23489999999999999999999999 99999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=300.19 Aligned_cols=149 Identities=26% Similarity=0.451 Sum_probs=132.6
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
+|++.+.||.|++|.||+|++..+++.||||.++..........+.+|+.++++++|+||+++++++.+. +..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEEe
Confidence 5888999999999999999999899999999997654444456778899999999999999999999986 78899999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|+++ +|.+++........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARA 149 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence 9975 8888887654334589999999999999999999999 999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=298.64 Aligned_cols=156 Identities=28% Similarity=0.458 Sum_probs=137.4
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-------hhhHHHHHHHHHHhccC-CCCceeEEEeEE
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-------LQGEREFHNELSLASSL-DCPHIVSLLGFA 146 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-------~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~ 146 (603)
...-+.|...+.||.|..++|.++..+.+++.+|+|++..... ....+.-..|+.+|+++ .||+|+.+.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 4456678899999999999999999999999999999854321 11235567899999998 599999999999
Q ss_pred ecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEE
Q 046097 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKI 226 (603)
Q Consensus 147 ~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL 226 (603)
+.. ..+++|+|.|+.|.|.++|...-. ++++...+|+.|+..|+.|||.+ +||||||||+|||++++.++||
T Consensus 93 es~--sF~FlVFdl~prGELFDyLts~Vt---lSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 93 ESD--AFVFLVFDLMPRGELFDYLTSKVT---LSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred cCc--chhhhhhhhcccchHHHHhhhhee---ecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEE
Confidence 987 889999999999999999977543 89999999999999999999999 9999999999999999999999
Q ss_pred Eeeccceecccc
Q 046097 227 GDFGLARLKTED 238 (603)
Q Consensus 227 ~DFGlA~~~~~~ 238 (603)
+|||+|+...+.
T Consensus 165 sDFGFa~~l~~G 176 (411)
T KOG0599|consen 165 SDFGFACQLEPG 176 (411)
T ss_pred eccceeeccCCc
Confidence 999999887654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.15 Aligned_cols=274 Identities=24% Similarity=0.301 Sum_probs=224.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
-++|..+++||+|.||+|-+++.+.+++.+|+|+++++.. ......-+.|-.+|+..+||++..+--.|+.. ..+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~--drlC 244 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ--DRLC 244 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC--ceEE
Confidence 4578889999999999999999999999999999988532 22334567789999999999999998778876 8999
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||..||.|.-+|.+.. .+++....-+-..|+.||.|||++ +||.||||.+|+|+|.+|.+||.|||+++..
T Consensus 245 FVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999998887644 388888888999999999999999 9999999999999999999999999998643
Q ss_pred ccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcc
Q 046097 236 TEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGR 315 (603)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (603)
-..
T Consensus 319 I~~----------------------------------------------------------------------------- 321 (516)
T KOG0690|consen 319 IKY----------------------------------------------------------------------------- 321 (516)
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 221
Q ss_pred hhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCc
Q 046097 316 VKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNV 395 (603)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (603)
T Consensus 322 -------------------------------------------------------------------------------- 321 (516)
T KOG0690|consen 322 -------------------------------------------------------------------------------- 321 (516)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCC
Q 046097 396 GEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGG 475 (603)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 475 (603)
-..+.+++||+.|+|||++.+
T Consensus 322 -----------------------------------------------------------g~t~kTFCGTPEYLAPEVleD 342 (516)
T KOG0690|consen 322 -----------------------------------------------------------GDTTKTFCGTPEYLAPEVLED 342 (516)
T ss_pred -----------------------------------------------------------cceeccccCChhhcCchhhcc
Confidence 012467899999999999999
Q ss_pred CCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhhc
Q 046097 476 GLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLC 555 (603)
Q Consensus 476 ~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 555 (603)
..|+..+|.|.+|||||||++|+.||...... .+... +-..--.++...+.+...|+...
T Consensus 343 nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-------kLFeL-------------Il~ed~kFPr~ls~eAktLLsGL 402 (516)
T KOG0690|consen 343 NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-------KLFEL-------------ILMEDLKFPRTLSPEAKTLLSGL 402 (516)
T ss_pred ccccceeehhhhhHHHHHHHhccCcccccchh-------HHHHH-------------HHhhhccCCccCCHHHHHHHHHH
Confidence 99999999999999999999999999865422 11111 11111123444556788899999
Q ss_pred cCCCCCCCCC-----HHHHHHH-----------hcCCCCCCCCCCccCCCCCCCCC
Q 046097 556 LQRSPSKRLT-----MKDIVEM-----------LTGEAEPPHLPFEFSPSPPSNFP 595 (603)
Q Consensus 556 l~~dP~~Rpt-----~~evl~~-----------l~~~~~~~~~~~~~~~~~~~~~~ 595 (603)
|..||.+|.. +.||.+. ++...+||+.|...|....++|+
T Consensus 403 L~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD 458 (516)
T KOG0690|consen 403 LKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFD 458 (516)
T ss_pred hhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhh
Confidence 9999999974 5666543 46778999999999998888885
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=295.78 Aligned_cols=147 Identities=27% Similarity=0.437 Sum_probs=129.1
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC---------hhhHHHHHHHHHHhccCCCCceeEEEeEEecCC
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS---------LQGEREFHNELSLASSLDCPHIVSLLGFASDRR 150 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~---------~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~ 150 (603)
+|.+.+.||.|+||.||+|....+++.||+|.++.... ....+.+..|+.++..++|+||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 47788999999999999999988899999998854211 01124678899999999999999999999876
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
...++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 81 -EYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred -CceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecc
Confidence 7899999999999999998765 2488899999999999999999998 99999999999999999999999999
Q ss_pred ccee
Q 046097 231 LARL 234 (603)
Q Consensus 231 lA~~ 234 (603)
++..
T Consensus 154 ~~~~ 157 (272)
T cd06629 154 ISKK 157 (272)
T ss_pred cccc
Confidence 9864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.94 Aligned_cols=149 Identities=26% Similarity=0.396 Sum_probs=131.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+++++.++|+||+++++++.+. ...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK--KRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC--CeEEEE
Confidence 4688899999999999999999888999999998653322 2345688999999999999999999999876 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|..+..... .+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 79 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 79 FEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred EecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 99999988887765432 278999999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=295.38 Aligned_cols=147 Identities=28% Similarity=0.393 Sum_probs=129.1
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-----hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-----LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-----~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
+|.+.+.||.|+||.||+|.. .+++.+|+|.+..... ......+.+|++++++++|+||+++++++.+. ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeE
Confidence 478889999999999999987 4788999998865321 12235688999999999999999999999886 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 99999999999999996543 378899999999999999999999 999999999999999999999999998865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 152 ~ 152 (265)
T cd06631 152 L 152 (265)
T ss_pred h
Confidence 4
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=297.69 Aligned_cols=142 Identities=23% Similarity=0.375 Sum_probs=118.2
Q ss_pred ceeeccCceEEEEEEEcC------------CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 85 NRLGHGGFGSVYKAVVPS------------SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~------------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
+.||+|+||.||+|.... ....|++|.+... .......+.+|+.++..++||||+++++++... .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~--~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD--V 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--C
Confidence 368999999999998532 2235889987653 233345788899999999999999999999876 6
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc-------EE
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK-------AK 225 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~-------vK 225 (603)
..++||||+++++|..++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. ++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 7899999999999998886533 3488999999999999999999999 9999999999999986654 88
Q ss_pred EEeecccee
Q 046097 226 IGDFGLARL 234 (603)
Q Consensus 226 L~DFGlA~~ 234 (603)
++|||++..
T Consensus 153 l~d~g~~~~ 161 (262)
T cd05077 153 LSDPGIPIT 161 (262)
T ss_pred eCCCCCCcc
Confidence 899987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=295.70 Aligned_cols=149 Identities=27% Similarity=0.430 Sum_probs=131.2
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-----hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-----LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-----~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
+|+..+.||+|++|.||+|....+++.||+|.+..... ......+.+|+.++++++|+||+++++++.+. +..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeE
Confidence 47888999999999999999989999999999865321 12346789999999999999999999999886 789
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC-cEEEEeeccce
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-KAKIGDFGLAR 233 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-~vKL~DFGlA~ 233 (603)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++.
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999999987643 378899999999999999999999 999999999999998776 59999999986
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 153 ~~~ 155 (268)
T cd06630 153 RLA 155 (268)
T ss_pred ccc
Confidence 553
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.74 Aligned_cols=148 Identities=26% Similarity=0.433 Sum_probs=130.8
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||.|++|.||+|..+.+++.||||.+...........+.+|++++++++|+||+++++++.+. ...++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeEEEEE
Confidence 67899999999999999999998889999999987643333334577899999999999999999999876 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||+.+ +|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 83 e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 83 EYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccc
Confidence 99975 8999886543 2478999999999999999999999 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=301.69 Aligned_cols=141 Identities=25% Similarity=0.388 Sum_probs=118.1
Q ss_pred ceeeccCceEEEEEEEcCCCc-------eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQ-------PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~-------~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
+.||.|+||.||+|.....+. .+++|.+... .....+.+.+|+.+++.+.||||+++++++... ...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCcEEE
Confidence 469999999999999865443 4888887542 233446788999999999999999999999876 778999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc--------EEEEee
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK--------AKIGDF 229 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~--------vKL~DF 229 (603)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+. +|+||||||+||+++.++. ++++||
T Consensus 78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999999976432 478999999999999999999999 9999999999999987765 467777
Q ss_pred ccce
Q 046097 230 GLAR 233 (603)
Q Consensus 230 GlA~ 233 (603)
|++.
T Consensus 153 g~~~ 156 (258)
T cd05078 153 GISI 156 (258)
T ss_pred cccc
Confidence 7653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=298.51 Aligned_cols=151 Identities=23% Similarity=0.378 Sum_probs=131.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.+|++...||.|+||.||+|+.+. +.+.|++|.+...........+.+|+.++++++|+||+++++++.+. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--EP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--Cc
Confidence 578899999999999999999753 34679999886644333457799999999999999999999999876 77
Q ss_pred EEEEEEccCCCCHHHHHhhccccc------ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEE
Q 046097 154 LVLIYELMENRSLQDALLDRKCEE------LMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~------~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
.++||||+++++|.+++....... .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 899999999999999997654211 489999999999999999999999 99999999999999999999999
Q ss_pred eecccee
Q 046097 228 DFGLARL 234 (603)
Q Consensus 228 DFGlA~~ 234 (603)
|||++..
T Consensus 160 ~~~~~~~ 166 (275)
T cd05046 160 LLSLSKD 166 (275)
T ss_pred ccccccc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=295.05 Aligned_cols=147 Identities=27% Similarity=0.519 Sum_probs=128.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
.+|++.+.||.|+||.||+|.+. .+..+|+|.+.... .....+.+|++++++++|||++++++++... ...++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEEE
Confidence 46788899999999999999885 46789999986532 2345788999999999999999999998876 7889999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 79 EFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeec
Confidence 9999999999986543 2378899999999999999999999 9999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.93 Aligned_cols=148 Identities=28% Similarity=0.459 Sum_probs=131.2
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh----hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL----QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~----~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
+|++.+.||.|++|.||+|.+..+++.||||.+...... .....+..|+.++.+++|+||+++++++.+. ...+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--SNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--CEEE
Confidence 478889999999999999999888999999999764322 1235577899999999999999999999985 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred EEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 999999 889999997643 2489999999999999999999999 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=294.67 Aligned_cols=149 Identities=28% Similarity=0.448 Sum_probs=129.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||++... .+..+++|.+... ......+.+|+.++++++|+||+++++++.+ ...++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 3467899999999999999999864 4567999988653 2345678899999999999999999999876 56799
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 78 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred EEEeCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeec
Confidence 9999999999999976432 3478889999999999999999998 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=295.52 Aligned_cols=151 Identities=28% Similarity=0.476 Sum_probs=127.5
Q ss_pred CCCCCceeeccCceEEEEEEEcC-CCceEEEEEecCCC---------ChhhHHHHHHHHHHhcc-CCCCceeEEEeEEec
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPS-SSQPLAVKILDSSG---------SLQGEREFHNELSLASS-LDCPHIVSLLGFASD 148 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~-tg~~VAVK~l~~~~---------~~~~~~~~~~Ev~iL~~-l~HpNIV~l~g~~~~ 148 (603)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .......+..|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999977 67899999875421 12233557788888865 789999999999988
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCCcEEE
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDFKAKI 226 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~~vKL 226 (603)
. +..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|
T Consensus 81 ~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 81 N--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred C--CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEE
Confidence 6 88999999999999999875422 22348899999999999999999996 5 8999999999999999999999
Q ss_pred Eeeccceec
Q 046097 227 GDFGLARLK 235 (603)
Q Consensus 227 ~DFGlA~~~ 235 (603)
+|||++...
T Consensus 156 ~dfg~~~~~ 164 (269)
T cd08528 156 TDFGLAKQK 164 (269)
T ss_pred ecccceeec
Confidence 999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=320.90 Aligned_cols=142 Identities=25% Similarity=0.326 Sum_probs=126.1
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
..|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++++|+||+++++++... +..++||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEEE
Confidence 468999999999999999999999999999996432 2356899999999999999999998876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|++. ++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 240 e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 240 PKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred EccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 9995 68888876532 2489999999999999999999999 9999999999999999999999999998754
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=314.82 Aligned_cols=144 Identities=20% Similarity=0.296 Sum_probs=125.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEc--CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVP--SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~--~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
...+|.+.+.||.|+||.||+|... .++..||+|.+... ....+|+.++++++||||+++++++... ...
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWK--STV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeC--CEE
Confidence 4567999999999999999999764 35678999988642 2346799999999999999999999876 789
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++|||++. ++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.++|+|||++..
T Consensus 162 ~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 99999995 6888888433 3489999999999999999999999 999999999999999999999999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 235 ~ 235 (392)
T PHA03207 235 L 235 (392)
T ss_pred c
Confidence 4
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=300.31 Aligned_cols=140 Identities=24% Similarity=0.332 Sum_probs=116.6
Q ss_pred eeeccCceEEEEEEEcC------------------------CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeE
Q 046097 86 RLGHGGFGSVYKAVVPS------------------------SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~~------------------------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~ 141 (603)
.||+|+||.||+|.... ....|++|++... .......+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-HRDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-HHHHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999998532 1235889988653 2233457888999999999999999
Q ss_pred EEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC
Q 046097 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD 221 (603)
Q Consensus 142 l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~ 221 (603)
+++++.+. ...++||||+++++|..++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++..
T Consensus 81 ~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 81 VHGVCVRG--SENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEEeC--CceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 99999886 78899999999999999886532 3478899999999999999999999 99999999999999754
Q ss_pred C-------cEEEEeeccce
Q 046097 222 F-------KAKIGDFGLAR 233 (603)
Q Consensus 222 ~-------~vKL~DFGlA~ 233 (603)
+ .+||+|||++.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~ 172 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSF 172 (274)
T ss_pred CcccCccceeeecCCcccc
Confidence 3 37888888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.76 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=211.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
+.+-|.+.+.||+|-|..|-+|++.-+|..||||++.+.... .....+..|+..|+.++|||||+||.+.... ..+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ--TKly 93 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ--TKLY 93 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc--ceEE
Confidence 456688889999999999999999999999999999775422 2346788999999999999999999998876 8999
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc-CCCcEEEEeecccee
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD-GDFKAKIGDFGLARL 234 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld-~~~~vKL~DFGlA~~ 234 (603)
||+|+-.+|+|++++..+..+ +.+..+.+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||.|||++..
T Consensus 94 LiLELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEEEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecccccc
Confidence 999999999999999876543 89999999999999999999999 999999999999875 568899999999876
Q ss_pred cccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCc
Q 046097 235 KTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESG 314 (603)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (603)
+.+..
T Consensus 169 f~PG~--------------------------------------------------------------------------- 173 (864)
T KOG4717|consen 169 FQPGK--------------------------------------------------------------------------- 173 (864)
T ss_pred CCCcc---------------------------------------------------------------------------
Confidence 54431
Q ss_pred chhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCC
Q 046097 315 RVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSN 394 (603)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (603)
T Consensus 174 -------------------------------------------------------------------------------- 173 (864)
T KOG4717|consen 174 -------------------------------------------------------------------------------- 173 (864)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccC
Q 046097 395 VGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGG 474 (603)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 474 (603)
...+.+|+..|.|||.+.
T Consensus 174 --------------------------------------------------------------kL~TsCGSLAYSAPEILL 191 (864)
T KOG4717|consen 174 --------------------------------------------------------------KLTTSCGSLAYSAPEILL 191 (864)
T ss_pred --------------------------------------------------------------hhhcccchhhccCchhhh
Confidence 013468999999999999
Q ss_pred CCCCC-ccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHh
Q 046097 475 GGLLS-EKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIAL 553 (603)
Q Consensus 475 ~~~~s-~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 553 (603)
|..|. +++||||||||||.|++|+.||+..++. +.+..++|-.. ..+...+.++.+||.
T Consensus 192 GDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-------------------ETLTmImDCKY-tvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 192 GDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-------------------ETLTMIMDCKY-TVPSHVSKECRDLIQ 251 (864)
T ss_pred cCccCCcchhhhHHHHHHHHHHhCCCccccccch-------------------hhhhhhhcccc-cCchhhhHHHHHHHH
Confidence 98875 5789999999999999999999977643 11222233222 345677889999999
Q ss_pred hccCCCCCCCCCHHHHHHH
Q 046097 554 LCLQRSPSKRLTMKDIVEM 572 (603)
Q Consensus 554 ~cl~~dP~~Rpt~~evl~~ 572 (603)
.||..||.+|.+.+||+..
T Consensus 252 sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHhcCchhhccHHHHhcc
Confidence 9999999999999999864
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=299.13 Aligned_cols=150 Identities=24% Similarity=0.325 Sum_probs=130.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||+|++|.||+|.+..+++.|++|.++.... ......+.+|++++++++|+||+++++++.+. +..++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEEEEE
Confidence 468899999999999999999998999999999865322 23346789999999999999999999999885 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||++++.+..+.... ..+++..+..++.||+.||.|||++ +++|+||+|+||+++.++.+||+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 79 FEYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred EecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 9999987666555432 2378999999999999999999999 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.35 Aligned_cols=148 Identities=24% Similarity=0.407 Sum_probs=128.7
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||+|+||.||+|.+..+|+.||+|.++..... .....+.+|+.++++++|+||+++++++.+. ...++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEEE
Confidence 478889999999999999999999999999998653221 2235677899999999999999999999876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+. ++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 79 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 149 (284)
T cd07839 79 EYCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF 149 (284)
T ss_pred ecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence 9996 57888775432 3489999999999999999999999 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.68 Aligned_cols=149 Identities=27% Similarity=0.440 Sum_probs=130.0
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||.|++|.||+|.+..+++.||||.+...... .....+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEEEEe
Confidence 478899999999999999999889999999998653322 2335788999999999999999999999876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+. ++|..++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 79 e~~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 79 EFLH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred eccc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 9996 588888865432 3488999999999999999999999 9999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.52 Aligned_cols=148 Identities=28% Similarity=0.401 Sum_probs=132.4
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||.|++|.||+|.+..+++.|++|++..... ......+.+|+.++++++|+||+++++++... ...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeEEEe
Confidence 57888999999999999999988999999999876432 23346789999999999999999999999885 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+ +++|.+++.... ..+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 79 EYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLF 149 (286)
T ss_pred ccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence 999 999999986543 3489999999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.10 Aligned_cols=144 Identities=26% Similarity=0.392 Sum_probs=127.6
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEc
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
|.....||+|+||.||++....++..||||.+... .....+.+.+|+.++..++|+||+++++.+... +..++||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEEEeC
Confidence 44456799999999999999888999999998653 334456788999999999999999999999876 889999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+++++|.+++... .+++..+..++.||+.||.|||++ +|+||||||+||+++.++.++|+|||++..
T Consensus 101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 9999999988543 378899999999999999999999 999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.03 Aligned_cols=149 Identities=28% Similarity=0.490 Sum_probs=133.6
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||+|+||.||+|....+++.|++|.++..... .....+.+|+.++++++|+||+++++++.+. ...++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEEEEE
Confidence 588889999999999999999888999999998764332 3567899999999999999999999998876 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 79 EYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred ecCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 9999999999987543 378889999999999999999999 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=299.44 Aligned_cols=152 Identities=25% Similarity=0.426 Sum_probs=131.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..+.|++-+.||+|.|+.|+++....+|+.+|+|++.... .....+.+.+|+.+.+.++||||+++++.+.+. ...|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~--~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc--ceeE
Confidence 4567888899999999999999999999999999885432 223557899999999999999999999998886 8999
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC---CcEEEEeeccc
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD---FKAKIGDFGLA 232 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~---~~vKL~DFGlA 232 (603)
+|+|++.|++|..-+... ..+++..+-+.+.||+.||.|+|.+ +|||||+||+|+++.+. .-+||+|||+|
T Consensus 87 lvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceE
Confidence 999999999998766544 3378889999999999999999999 99999999999999533 35999999999
Q ss_pred eecc
Q 046097 233 RLKT 236 (603)
Q Consensus 233 ~~~~ 236 (603)
....
T Consensus 161 i~l~ 164 (355)
T KOG0033|consen 161 IEVN 164 (355)
T ss_pred EEeC
Confidence 8764
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=292.24 Aligned_cols=140 Identities=26% Similarity=0.402 Sum_probs=121.1
Q ss_pred ceeeccCceEEEEEEEcCCC----------ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 85 NRLGHGGFGSVYKAVVPSSS----------QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg----------~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
+.||+|+||.||+|.+..++ ..+++|.+..... ....+.+|+.++++++|+||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR---DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec---CCc
Confidence 46999999999999997666 3578888765322 25788899999999999999999999887 456
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC-------cEEEE
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-------KAKIG 227 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-------~vKL~ 227 (603)
++||||+++++|.+++..... .+++..++.++.||+.||.|||++ +|+|+||||+|||++.++ .+||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 899999999999999976542 478999999999999999999998 999999999999999887 79999
Q ss_pred eecccee
Q 046097 228 DFGLARL 234 (603)
Q Consensus 228 DFGlA~~ 234 (603)
|||++..
T Consensus 151 Dfg~a~~ 157 (259)
T cd05037 151 DPGIPIT 157 (259)
T ss_pred CCCcccc
Confidence 9998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=295.84 Aligned_cols=148 Identities=27% Similarity=0.406 Sum_probs=126.7
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
|++.+.||+|+||.||+|....+++.||+|.++............+|+.++.++. |+||+++++++.+...+.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 5678899999999999999998999999999876433333334567888898885 999999999998765578999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|++ ++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++. +.+||+|||++...
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 997 58888776533 3489999999999999999999999 9999999999999999 99999999998654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=291.40 Aligned_cols=148 Identities=31% Similarity=0.449 Sum_probs=131.2
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC----hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS----LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~----~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
+|+..+.||+|++|.||+|....+++.|++|.+..... ....+.+.+|+.+++.++|+||+++++++.+. ...+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEE
Confidence 47778999999999999999988899999999865321 23446789999999999999999999999876 7899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
++|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999999987543 378899999999999999999999 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=290.79 Aligned_cols=144 Identities=24% Similarity=0.385 Sum_probs=121.9
Q ss_pred eeeccCceEEEEEEEcCC--CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCC
Q 046097 86 RLGHGGFGSVYKAVVPSS--SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMEN 163 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~~t--g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~ 163 (603)
.||+|+||.||+|....+ ...+++|.+...........+.+|+.++..++||||+++++.|.+. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEecCCC
Confidence 599999999999976432 3456778776544445567899999999999999999999999876 788999999999
Q ss_pred CCHHHHHhhccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 164 RSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 164 gsL~~~L~~~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|+|.+++..... ....+...+..++.||+.||.|||+. +++|+||||+|||++.++.++|+|||++..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccc
Confidence 999999976432 22356777889999999999999999 999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.91 Aligned_cols=150 Identities=25% Similarity=0.403 Sum_probs=130.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC---CCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRR---GRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---~~~~ 154 (603)
+++|++.+.||+|+||.||+|.+..+++.||||.+...........+.+|+.++++++|+||+++++++.... ...+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5789999999999999999999999999999999865333344567888999999999999999999876531 2468
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++|+||+.+ +|...+... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999964 887777543 388999999999999999999999 999999999999999999999999999875
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 156 ~ 156 (336)
T cd07849 156 A 156 (336)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.07 Aligned_cols=152 Identities=31% Similarity=0.520 Sum_probs=131.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|++.+.||.|+||.||+|.+..+++.+|+|.+.... .......+.+|+.++.++ +|+||+++++++....+...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999998889999999885432 223345677899999999 99999999999876545678
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+. ++|..++... .+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5898888653 378889999999999999999999 999999999999999999999999999876
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 157 ~~ 158 (337)
T cd07852 157 LS 158 (337)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.45 Aligned_cols=151 Identities=32% Similarity=0.467 Sum_probs=131.9
Q ss_pred CCceeeccCceEEEEEEEcCCCceEE---EEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 83 PSNRLGHGGFGSVYKAVVPSSSQPLA---VKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 83 i~~~LG~G~fG~Vy~a~~~~tg~~VA---VK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
....||+|+|-+||+|.+..+|..|| ||+-+........++|..|+.+|+.|+|+||+++|.++.+.....+.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34679999999999999988898887 343333334455688999999999999999999999999886778999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-CCcEEEEeeccceeccc
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-DFKAKIGDFGLARLKTE 237 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~-~~~vKL~DFGlA~~~~~ 237 (603)
.+..|+|..++++.+. ++.+.+..++.||++||.|||++ +++|||||||.+||||+. .|.|||+|+|+|.....
T Consensus 124 L~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999988764 78899999999999999999998 899999999999999985 58999999999987543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.97 Aligned_cols=152 Identities=27% Similarity=0.404 Sum_probs=129.5
Q ss_pred CCCCCceeeccCceEEEEEEEcC--CCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPS--SSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~--tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
+|++.+.||+|++|.||+|.... +++.||+|.+.... .......+.+|+.++.+++||||+++++++.+..+..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999988 78999999997632 122235678899999999999999999999987567899
Q ss_pred EEEEccCCCCHHHHHhhccc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC----CCcEEEEee
Q 046097 156 LIYELMENRSLQDALLDRKC--EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG----DFKAKIGDF 229 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~--~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~----~~~vKL~DF 229 (603)
+||||+++ +|.+++..... ...+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67776654322 22578999999999999999999999 9999999999999999 899999999
Q ss_pred ccceec
Q 046097 230 GLARLK 235 (603)
Q Consensus 230 GlA~~~ 235 (603)
|++...
T Consensus 157 g~~~~~ 162 (316)
T cd07842 157 GLARLF 162 (316)
T ss_pred cccccc
Confidence 998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=296.59 Aligned_cols=150 Identities=30% Similarity=0.390 Sum_probs=129.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
....|++.+.||+|+||.||+|....+++.||+|.+.... .......+.+|+.++..++||||++++++|.+. ...
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~~ 90 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--HTA 90 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--CeE
Confidence 3456889999999999999999998889999999986432 223346788999999999999999999999986 788
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence 99999996 57777765432 2489999999999999999999999 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=302.11 Aligned_cols=145 Identities=25% Similarity=0.343 Sum_probs=127.5
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEc
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
|.....||.|+||.||+|.+..+++.||+|.+.... ......+.+|+.++..++||||+++++++... ...++||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEEEEec
Confidence 334457999999999999998889999999986532 23456788999999999999999999999876 889999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+++++|..++... .+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++...
T Consensus 100 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 100 LQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 9999999887542 378999999999999999999999 9999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.03 Aligned_cols=151 Identities=28% Similarity=0.396 Sum_probs=125.6
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|...+.||+|+||.||++.+..+++.||+|.+...........+.+|+.++.++. |+||+++++++... ...+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEEE
Confidence 45566789999999999999999999999999976544455667899999999996 99999999998876 7789999
Q ss_pred EccCCCCHHHHHhhc--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDR--KCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~--~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+.. ++.++.... .....+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||++...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99864 555543211 11234889999999999999999999632 8999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.02 Aligned_cols=142 Identities=31% Similarity=0.402 Sum_probs=125.1
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
||+|+||+||+|....+++.||+|.+.... .......+.+|+.++++++||||+++++.+... +..|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCCC
Confidence 689999999999998899999999986532 122345567899999999999999999999876 7899999999999
Q ss_pred CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 165 SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 165 sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 79 ~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 79 DLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred cHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 99999876543 3489999999999999999999999 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.35 Aligned_cols=148 Identities=27% Similarity=0.404 Sum_probs=132.1
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|.+.+.||+|+||.||++....+++.|++|.+... .....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVG--DELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC--CcEEEE
Confidence 46899999999999999999998888999999998653 233446788999999999999999999999876 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||+++++|.+++... .+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 9999999999998653 268889999999999999999999 9999999999999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=292.32 Aligned_cols=152 Identities=31% Similarity=0.472 Sum_probs=126.3
Q ss_pred CCCCceeeccCceEEEEEEEcC---CCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC----C
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPS---SSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG----R 152 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~---tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~----~ 152 (603)
|.+.+.||+|+||.||+|.+.. +++.||||++.... .....+.+.+|+.++++++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5677899999999999998643 57899999987643 23345678899999999999999999998865321 2
Q ss_pred eEEEEEEccCCCCHHHHHhhccc---ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEee
Q 046097 153 RLVLIYELMENRSLQDALLDRKC---EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~---~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DF 229 (603)
..+++++|+.+|+|.+++..... ...+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 34789999999999988754321 12378889999999999999999999 9999999999999999999999999
Q ss_pred ccceec
Q 046097 230 GLARLK 235 (603)
Q Consensus 230 GlA~~~ 235 (603)
|+++..
T Consensus 158 g~~~~~ 163 (273)
T cd05074 158 GLSKKI 163 (273)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=299.83 Aligned_cols=153 Identities=28% Similarity=0.442 Sum_probs=131.6
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhcc--CCCCceeEEEeEEecCCC--
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASS--LDCPHIVSLLGFASDRRG-- 151 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~--l~HpNIV~l~g~~~~~~~-- 151 (603)
....+..+.+.||+|.||.||+|.+ .|+.||||++.. .++..+.+|.++.+. ++|+||+.+++.-....+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3556678889999999999999999 488999999954 456778899998885 599999999876544322
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeccCCCCCeEEcCCCcEEE
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS-----CEPPVIHGDIKPSNILLDGDFKAKI 226 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~-----~~~gIVHrDLKp~NILld~~~~vKL 226 (603)
.+++||++|.+.|||.++|.+.. ++....++++..+|.||+|||.. .++.|.|||||+.||||..++.+.|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 57999999999999999998743 89999999999999999999953 4689999999999999999999999
Q ss_pred Eeeccceecccc
Q 046097 227 GDFGLARLKTED 238 (603)
Q Consensus 227 ~DFGlA~~~~~~ 238 (603)
+|+|+|-....+
T Consensus 358 ADLGLAv~h~~~ 369 (513)
T KOG2052|consen 358 ADLGLAVRHDSD 369 (513)
T ss_pred eeceeeEEeccc
Confidence 999999776544
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=296.33 Aligned_cols=153 Identities=29% Similarity=0.409 Sum_probs=131.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-hHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-GEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||.|+||.||+|.+..+++.||+|.++...... ....+.+|+.++.+++|+||+++++++.+......+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3567999999999999999999999999999999986533221 223466899999999999999999999876456789
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999964 8888876533 3489999999999999999999999 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.33 Aligned_cols=150 Identities=29% Similarity=0.407 Sum_probs=135.1
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++.|+....||+|++|.||+|.+..++..|++|++..... ....+.+|++++.+++|+||+++++.+... ...+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEE
Confidence 356678888999999999999999988899999999976432 456788999999999999999999999886 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+|+||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred EEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 9999999999999997654 2489999999999999999999998 999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.52 Aligned_cols=148 Identities=28% Similarity=0.378 Sum_probs=132.5
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
+|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE--ENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--CeEEEE
Confidence 4788899999999999999998899999999996532 123457789999999999999999999998876 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||+.+++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 79 VDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV 150 (258)
T ss_pred EeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence 9999999999998765 2488999999999999999999999 9999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=291.79 Aligned_cols=150 Identities=26% Similarity=0.465 Sum_probs=130.6
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||.|+||.||+|..+.++..+|+|.+.... .......+.+|+.+++.++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEEEEE
Confidence 4788899999999999999999999999999986532 123345788999999999999999999999876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC-cEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-KAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-~vKL~DFGlA~~~ 235 (603)
||+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++ .+||+|||.+...
T Consensus 79 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 79 EYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred ecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999999999876432 3478999999999999999999999 999999999999999886 4699999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.05 Aligned_cols=151 Identities=25% Similarity=0.334 Sum_probs=131.4
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||.|+||.||+|.+..+++.+++|.++..... .....+.+|+.++.+++||||+++++++........++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5788999999999999999999989999999999754322 223456789999999999999999999887655789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+. ++|.+++..... .+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99997 489888865432 489999999999999999999999 9999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=293.99 Aligned_cols=145 Identities=28% Similarity=0.399 Sum_probs=128.3
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
.|...+.||+|++|.||++....+++.+++|.+... .....+.+.+|+.++..+.|+||+++++++... ...++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEEEEEe
Confidence 344557899999999999999888999999998653 333456688999999999999999999998876 78999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|+++++|.+++... .+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++..
T Consensus 97 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 97 FLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred ccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 99999999998762 378899999999999999999999 999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=293.77 Aligned_cols=153 Identities=25% Similarity=0.328 Sum_probs=128.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCC-CCceeEEEeEEecCC---CCe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLD-CPHIVSLLGFASDRR---GRR 153 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~---~~~ 153 (603)
++|++.+.||.|+||.||+|.+..+++.||||.+...... .....+.+|+.++.++. |+||+++++++.... ...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999999999999999998654222 22356888999999995 699999999987641 123
Q ss_pred EEEEEEccCCCCHHHHHhhccc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-CCcEEEEeec
Q 046097 154 LVLIYELMENRSLQDALLDRKC--EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-DFKAKIGDFG 230 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~--~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~-~~~vKL~DFG 230 (603)
.|+||||+++ +|.+++..... ...+++..++.++.||+.||.|||++ +++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 88888765432 23579999999999999999999999 9999999999999998 8899999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
++...
T Consensus 157 ~~~~~ 161 (295)
T cd07837 157 LGRAF 161 (295)
T ss_pred cceec
Confidence 98654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=283.15 Aligned_cols=149 Identities=31% Similarity=0.508 Sum_probs=133.5
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
+|+..+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.++++++|+||+++++++... ...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEe
Confidence 47788999999999999999988899999999976433 3557899999999999999999999999886 78999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|+++++|.+++.... ..+++..+..++.|++.||.+||.. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 999999999987653 3489999999999999999999998 99999999999999999999999999886543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=335.47 Aligned_cols=156 Identities=29% Similarity=0.429 Sum_probs=134.4
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRR---- 150 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---- 150 (603)
.+...+|+.+++||+||||.||+++.+-+|+.||||++...........+.+|+.+|++++|||||+++..+.+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 5678889999999999999999999999999999999987655556678999999999999999999975321110
Q ss_pred --------------------------------------------------------------------------------
Q 046097 151 -------------------------------------------------------------------------------- 150 (603)
Q Consensus 151 -------------------------------------------------------------------------------- 150 (603)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHH
Q 046097 151 -------------------------G--------RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197 (603)
Q Consensus 151 -------------------------~--------~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~y 197 (603)
. ..+||-||||+..+|.+++.++.... .....++++.+|+.||.|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 0 35799999999988888887765421 467888999999999999
Q ss_pred HHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 198 LHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|++ |||||||||.|||+++++.|||+|||+|...
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhh
Confidence 9999 9999999999999999999999999999764
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=300.94 Aligned_cols=151 Identities=26% Similarity=0.391 Sum_probs=129.5
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR---- 150 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---- 150 (603)
...++|++.+.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.++++++|+||+++++++....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35678999999999999999999999999999999986432 2333456788999999999999999999986431
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
....|+||||+. ++|.+.+... ++...+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 245799999996 4888877532 78888999999999999999999 99999999999999999999999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
++...
T Consensus 164 ~~~~~ 168 (353)
T cd07850 164 LARTA 168 (353)
T ss_pred cceeC
Confidence 98654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=312.30 Aligned_cols=152 Identities=22% Similarity=0.282 Sum_probs=126.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEe-cCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKIL-DSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l-~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~ 154 (603)
....|+++++||.||.+.||++... +.+.+|+|.+ ....+......+.+|+.+|.+++ |.+||+|++|-... +++
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--~~l 435 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--GYL 435 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--ceE
Confidence 4456999999999999999999874 3455666554 34455566788999999999996 99999999998886 899
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|+||||- ..+|..+|...... ++.-.+..+..|++.|+.++|.+ ||||.||||.|+|+- .|.+||+|||+|..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 9999976 45999999776542 33237778999999999999999 999999999999986 67999999999987
Q ss_pred cccc
Q 046097 235 KTED 238 (603)
Q Consensus 235 ~~~~ 238 (603)
...+
T Consensus 509 I~~D 512 (677)
T KOG0596|consen 509 IQPD 512 (677)
T ss_pred cCcc
Confidence 7655
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.99 Aligned_cols=160 Identities=28% Similarity=0.418 Sum_probs=142.4
Q ss_pred HHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 72 NLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 72 ~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
+.++-...+....++||.|.||.||.|.++.-.-.||||.++. +....++|+.|..+|+.|.|||+|+|+|+|...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE--DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-- 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-- 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh--cchhHHHHHHHHHHHHhhcCccHHHHhhhhccC--
Confidence 4444445556667899999999999999998888999999986 345678999999999999999999999999987
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
..+|||+|||..|+|.++|++.... .++.-..+.|+.||..||.||..+ +.|||||..+|+|+.++..+||+|||+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 7899999999999999999876543 377788899999999999999999 999999999999999999999999999
Q ss_pred ceeccccc
Q 046097 232 ARLKTEDL 239 (603)
Q Consensus 232 A~~~~~~~ 239 (603)
++....+.
T Consensus 412 sRlMtgDT 419 (1157)
T KOG4278|consen 412 SRLMTGDT 419 (1157)
T ss_pred hhhhcCCc
Confidence 99988773
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=287.85 Aligned_cols=151 Identities=28% Similarity=0.423 Sum_probs=132.9
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC----ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG----SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~----~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++|+||+++++++.+..+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999999999999999875321 22334678899999999999999999999887655778
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 99999999999999986543 278889999999999999999999 999999999999999999999999999875
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 156 ~ 156 (264)
T cd06653 156 I 156 (264)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=292.23 Aligned_cols=141 Identities=34% Similarity=0.447 Sum_probs=118.3
Q ss_pred eeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHh---ccCCCCceeEEEeEEecCCCCeEEEEEEc
Q 046097 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLA---SSLDCPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL---~~l~HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
.||+|+||.||++.+..+++.+|+|.+...... .....+.+|..++ ....|+||+.+++++... +..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence 489999999999999889999999998653221 1222334444333 344799999999999876 789999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+|||+++++.++|+|||++..
T Consensus 79 ~~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 79 MNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999999887543 389999999999999999999999 999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.73 Aligned_cols=150 Identities=28% Similarity=0.461 Sum_probs=133.9
Q ss_pred CCCCceeeccCceEEEEEEEcCC----CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSS----SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~t----g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
....++||.|.||.||.|.+... .--||||..+.+......+.|+.|..+|+.++||||++++|+|.+ ...|+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cceeE
Confidence 34457899999999999998432 235899999987777778899999999999999999999999998 67899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||+++-|.|..+|..... .++......++.||+.||+|||+. ..|||||..+|||+.+...+||+|||+++...
T Consensus 468 vmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 9999999999999987654 388888999999999999999999 99999999999999999999999999999876
Q ss_pred cc
Q 046097 237 ED 238 (603)
Q Consensus 237 ~~ 238 (603)
.+
T Consensus 543 d~ 544 (974)
T KOG4257|consen 543 DD 544 (974)
T ss_pred cc
Confidence 54
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=291.36 Aligned_cols=147 Identities=27% Similarity=0.440 Sum_probs=129.1
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
|++.+.||.|++|.||+|.+..++..||+|++...... .....+.+|+.+++.++|+|++++++++.+. ...+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEe
Confidence 67789999999999999999889999999998654322 2235688899999999999999999999876 88999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|++ ++|.+++..... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 79 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 79 FLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred ccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 995 689998865442 3489999999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=301.28 Aligned_cols=151 Identities=25% Similarity=0.467 Sum_probs=129.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC---CCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR---GRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---~~~ 153 (603)
.++|.+.+.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.+++.++|+||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999999999999999986532 2223456778999999999999999999886531 135
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 899999995 68888886543 389999999999999999999999 99999999999999999999999999986
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 157 ~~ 158 (337)
T cd07858 157 TT 158 (337)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=299.70 Aligned_cols=152 Identities=24% Similarity=0.436 Sum_probs=131.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecC--CCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDR--RGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~--~~~~~ 154 (603)
..+|++.+.||.|++|.||+|....+++.||+|++..... ......+.+|+.++.+++|+||+++++++... .+...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4789999999999999999999999999999999875422 23346678899999999999999999987643 23578
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+. ++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 58988886543 389999999999999999999999 999999999999999999999999999865
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 157 ~~ 158 (334)
T cd07855 157 LS 158 (334)
T ss_pred ec
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=333.60 Aligned_cols=285 Identities=27% Similarity=0.332 Sum_probs=229.6
Q ss_pred HHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHhccCCCCceeEEEeEEecC
Q 046097 72 NLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPHIVSLLGFASDR 149 (603)
Q Consensus 72 ~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~ 149 (603)
.+++-..++|.++++||+|+||.|.+++++++++.||+|++.+.... .....|..|-.+|..-+.+-|+.++-.|++.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 45666778999999999999999999999999999999999763222 2335688999999999999999999999997
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEee
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DF 229 (603)
.++|+|||||+||+|..+|.... .+++..+.-++..|+.||.-||+. |+|||||||+|||||..|++||+||
T Consensus 148 --~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 148 --RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred --cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999997754 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCC
Q 046097 230 GLARLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGA 309 (603)
Q Consensus 230 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (603)
|.+-....+
T Consensus 220 GsClkm~~d----------------------------------------------------------------------- 228 (1317)
T KOG0612|consen 220 GSCLKMDAD----------------------------------------------------------------------- 228 (1317)
T ss_pred hhHHhcCCC-----------------------------------------------------------------------
Confidence 988665443
Q ss_pred CCCCcchhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcC
Q 046097 310 GSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRG 389 (603)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (603)
|.|
T Consensus 229 ----G~V------------------------------------------------------------------------- 231 (1317)
T KOG0612|consen 229 ----GTV------------------------------------------------------------------------- 231 (1317)
T ss_pred ----CcE-------------------------------------------------------------------------
Confidence 111
Q ss_pred CCCCCcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccC
Q 046097 390 LNSSNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIA 469 (603)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~a 469 (603)
.....+|||.|++
T Consensus 232 -------------------------------------------------------------------~s~~aVGTPDYIS 244 (1317)
T KOG0612|consen 232 -------------------------------------------------------------------RSSVAVGTPDYIS 244 (1317)
T ss_pred -------------------------------------------------------------------EeccccCCCCccC
Confidence 1123579999999
Q ss_pred ccccC----C-CCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHH
Q 046097 470 PEYGG----G-GLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQ 544 (603)
Q Consensus 470 PE~~~----~-~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
||++. + +.|+..+|.||+||++|||+.|..||.... ++.....+......+.+. ...+.
T Consensus 245 PEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----------lveTY~KIm~hk~~l~FP------~~~~V 308 (1317)
T KOG0612|consen 245 PEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----------LVETYGKIMNHKESLSFP------DETDV 308 (1317)
T ss_pred HHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----------HHHHHHHHhchhhhcCCC------ccccc
Confidence 99875 3 679999999999999999999999997432 222222222222222211 11335
Q ss_pred HHHHHHHHhhccCCCCCCCCC---HHHHHHHh---------cCCCCCCCCCCccCCCCCCCCCc
Q 046097 545 ALLCITIALLCLQRSPSKRLT---MKDIVEML---------TGEAEPPHLPFEFSPSPPSNFPF 596 (603)
Q Consensus 545 ~~~l~~l~~~cl~~dP~~Rpt---~~evl~~l---------~~~~~~~~~~~~~~~~~~~~~~~ 596 (603)
+....+||...+. +|+.|.. +.+|-... -+...||..|-..|+.+.+||..
T Consensus 309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~ 371 (1317)
T KOG0612|consen 309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDV 371 (1317)
T ss_pred CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccccc
Confidence 6677788877665 8999998 88888765 24568999999999999999954
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.57 Aligned_cols=148 Identities=29% Similarity=0.401 Sum_probs=128.0
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..|+..+.||+|+||.||++.+..++..||+|.+.... .......+.+|+.++++++|+|++++++++.+. ...++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEEE
Confidence 34778889999999999999998899999999986532 223345788999999999999999999999886 78899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+.+ +|.+.+.... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 103 v~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 103 VMEYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred EEeCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccc
Confidence 9999974 7777765432 3488999999999999999999999 999999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=286.51 Aligned_cols=142 Identities=26% Similarity=0.361 Sum_probs=120.0
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHH-hccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSL-ASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~i-L~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||.|+||.||+|....+++.||+|.+..... ......+..|..+ ....+|+|++++++++... ...++||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEecc
Confidence 569999999999999988999999999865321 1122334455444 4455899999999999876 7899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 80 NGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccccee
Confidence 9999999987543 378999999999999999999999 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=287.24 Aligned_cols=141 Identities=28% Similarity=0.392 Sum_probs=126.2
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
||.|++|.||+|.+..+++.||+|++..... ....+.+.+|+.++++++|+||+++++++.+. ...+++|||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCCC
Confidence 6899999999999988899999999865432 23446799999999999999999999999876 7899999999999
Q ss_pred CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 165 SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 165 sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~ 143 (262)
T cd05572 79 ELWTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143 (262)
T ss_pred cHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence 9999997643 278899999999999999999998 9999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=283.03 Aligned_cols=149 Identities=29% Similarity=0.422 Sum_probs=133.7
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||+|++|.||++....+++.|++|.+...... .....+.+|++++.+++|+|++++++++.+. ...+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence 478889999999999999999888999999999764321 3456799999999999999999999999876 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 79 EYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred ecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 999999999998765 3489999999999999999999999 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=310.89 Aligned_cols=148 Identities=30% Similarity=0.388 Sum_probs=129.2
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh--hHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ--GEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~--~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
|+.++.||.|+||.||.|++..+.+.||||.+....... .-..+..|+.+|.++.|||+|.+-|+|... ...||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~TaWLVM 105 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--HTAWLVM 105 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc--chHHHHH
Confidence 555567999999999999999999999999986643332 336789999999999999999999999876 7789999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||| -|+-.+++.-.+ .++.+-++..|+.+.+.||+|||++ +.||||||..|||+++.|.|||+|||.|.+..
T Consensus 106 EYC-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHH-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 999 458888876544 3488899999999999999999999 99999999999999999999999999987654
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=293.39 Aligned_cols=154 Identities=24% Similarity=0.389 Sum_probs=129.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCC-----
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRR----- 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~----- 150 (603)
.-++|++.+.||+|+||.||+|....+++.||||.+...... .....+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 345799999999999999999999999999999988653222 22345678999999999999999999987642
Q ss_pred -CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEee
Q 046097 151 -GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 151 -~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DF 229 (603)
....++||||+.+ +|.+.+.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 2456999999964 7887775432 2479999999999999999999999 9999999999999999999999999
Q ss_pred ccceecc
Q 046097 230 GLARLKT 236 (603)
Q Consensus 230 GlA~~~~ 236 (603)
|++....
T Consensus 164 g~~~~~~ 170 (310)
T cd07865 164 GLARAFS 170 (310)
T ss_pred CCccccc
Confidence 9987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=282.93 Aligned_cols=152 Identities=24% Similarity=0.451 Sum_probs=134.6
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||.|+||.||++.+..+++.|++|.+..... ......+.+|+++++.++|+|++++++.+... ...++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 57888999999999999999988899999999976432 24456788999999999999999999999886 8899999
Q ss_pred EccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||+++++|.+++.... ....+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 9999999999987643 124489999999999999999999999 99999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=277.76 Aligned_cols=152 Identities=32% Similarity=0.455 Sum_probs=134.6
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|...+.||+|++|.||+|....++..|++|++..... ....+.+.+|+.++++++|+||+++++.+.+......++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788999999999999999988899999999866432 23457789999999999999999999999875446789999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999987654 489999999999999999999998 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=285.21 Aligned_cols=149 Identities=21% Similarity=0.284 Sum_probs=124.2
Q ss_pred HHHHHhhcCCCCCcee--eccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEec
Q 046097 72 NLIRRATASFSPSNRL--GHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASD 148 (603)
Q Consensus 72 ~~l~~~t~~y~i~~~L--G~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~ 148 (603)
.+.....++|++.+.+ |.|+||.||++..+.++..+|+|.+........ |+.....+ +|+||+++++.+..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEec
Confidence 3444556778888777 999999999999999999999999865321111 22222212 69999999999988
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC-cEEEE
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-KAKIG 227 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-~vKL~ 227 (603)
. +..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+
T Consensus 81 ~--~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 81 L--KGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred C--CeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 6 78999999999999999997653 489999999999999999999999 999999999999999988 99999
Q ss_pred eecccee
Q 046097 228 DFGLARL 234 (603)
Q Consensus 228 DFGlA~~ 234 (603)
|||++..
T Consensus 153 dfg~~~~ 159 (267)
T PHA03390 153 DYGLCKI 159 (267)
T ss_pred cCcccee
Confidence 9998764
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.68 Aligned_cols=150 Identities=26% Similarity=0.393 Sum_probs=127.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||.|++|.||+|.++.+++.||+|.+...... .....+.+|+.++++++|+||+++++++.+. ...++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEEE
Confidence 5788999999999999999999889999999998653222 2335688999999999999999999999876 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-CCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-DFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~-~~~vKL~DFGlA~~~ 235 (603)
|||++ ++|.+++..... ..+++..+..++.||+.||.|||++ +++|+||+|+||+++. ++.+||+|||++...
T Consensus 80 ~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred Eeccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99996 578887754332 2357888889999999999999999 9999999999999985 567999999998643
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=284.88 Aligned_cols=150 Identities=29% Similarity=0.457 Sum_probs=124.3
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-hHHHHHHHHHHhccC---CCCceeEEEeEEecCCC---Ce
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-GEREFHNELSLASSL---DCPHIVSLLGFASDRRG---RR 153 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-~~~~~~~Ev~iL~~l---~HpNIV~l~g~~~~~~~---~~ 153 (603)
|++.+.||.|+||.||+|.++.+++.||+|.++...... ....+.+|+.++.++ .|+||+++++++.+... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 667889999999999999998889999999997533222 234566777766655 69999999999987521 23
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 89888865432 2489999999999999999999999 99999999999999999999999999886
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 156 ~~ 157 (287)
T cd07838 156 IY 157 (287)
T ss_pred ec
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=284.95 Aligned_cols=151 Identities=31% Similarity=0.484 Sum_probs=132.6
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|++.+.||.|+||.||++....+++.+++|.+.... .......+.+|+.++++++|+||+++++++.+. ...++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 4788899999999999999998899999999986532 233456778899999999999999999999876 8899999
Q ss_pred EccCCCCHHHHHhhccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+++++|.+++..... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 99999999999866321 23478999999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=288.68 Aligned_cols=153 Identities=24% Similarity=0.316 Sum_probs=115.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCC---CceEEEEEecCCCChhhH----------HHHHHHHHHhccCCCCceeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSS---SQPLAVKILDSSGSLQGE----------REFHNELSLASSLDCPHIVSLL 143 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~l~~~~~~~~~----------~~~~~Ev~iL~~l~HpNIV~l~ 143 (603)
..++|.+.++||+|+||.||+|....+ +..+|+|+.......... .....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999998776 667788865432211111 1122334456677899999999
Q ss_pred eEEecCCC--CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC
Q 046097 144 GFASDRRG--RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD 221 (603)
Q Consensus 144 g~~~~~~~--~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~ 221 (603)
+++..... ...+++++++. .++.+.+.... ..++..+..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 87665321 24577888774 46666665432 256788899999999999999999 99999999999999999
Q ss_pred CcEEEEeeccceecc
Q 046097 222 FKAKIGDFGLARLKT 236 (603)
Q Consensus 222 ~~vKL~DFGlA~~~~ 236 (603)
+.++|+|||+|+...
T Consensus 163 ~~~~l~DFGla~~~~ 177 (294)
T PHA02882 163 NRGYIIDYGIASHFI 177 (294)
T ss_pred CcEEEEEcCCceeec
Confidence 999999999997653
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=334.31 Aligned_cols=157 Identities=30% Similarity=0.419 Sum_probs=137.0
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
+...+-++.-..+||.|.||.||.|....+|...|+|-++.+... .....+.+|+.++..++|||+|+++|+-.+. .
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--e 1307 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--E 1307 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH--H
Confidence 344566677788999999999999999999999999988665333 3346788999999999999999999999987 7
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
.++|.||||++|+|.+.+..... .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccce
Confidence 89999999999999999976543 56777777899999999999999 9999999999999999999999999999
Q ss_pred eecccc
Q 046097 233 RLKTED 238 (603)
Q Consensus 233 ~~~~~~ 238 (603)
..+...
T Consensus 1382 ~ki~~~ 1387 (1509)
T KOG4645|consen 1382 VKIKNN 1387 (1509)
T ss_pred eEecCc
Confidence 876543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=298.24 Aligned_cols=150 Identities=31% Similarity=0.418 Sum_probs=135.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
..-|.++++||+|+||.||+|.++.+|+.+|||.+.. ..+.+++..|+.+++++..++||++||.|... ..+|+|
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~--sDLWIV 106 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH--SDLWIV 106 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccC--CceEee
Confidence 3447788899999999999999999999999999854 45677899999999999999999999988876 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
||||..|+..++++... .++.+.++..++...++||+|||.. .-||||||..|||++.+|.+||+|||.|...+.
T Consensus 107 MEYCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred hhhcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 99999999999997654 4589999999999999999999998 899999999999999999999999999976553
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=288.86 Aligned_cols=148 Identities=30% Similarity=0.412 Sum_probs=129.2
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
|++.+.||.|++|.||+|....+++.|+||.+.............+|+..+.++. |+||+++++++.+. ...++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN--DELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEEEEe
Confidence 6778899999999999999988899999999866433333345567999999999 99999999999885 88999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|+ +++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 79 YM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred cC-CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceec
Confidence 99 7899988876542 3489999999999999999999999 9999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=307.02 Aligned_cols=155 Identities=26% Similarity=0.394 Sum_probs=138.8
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
......|.+...||+|.|++|.+|++..++..||||++.+... ......+.+|+++|..++|||||+++.+.... ..
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~--~~ 129 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE--AT 129 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec--ce
Confidence 3456789999999999999999999999999999999977532 23345689999999999999999999999987 88
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+|+||||+.+|.+++++..... +.+..+..++.|+++|++|||++ .|||||||++|||++.+.++||+|||++.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred eEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccce
Confidence 9999999999999999987654 56688889999999999999999 99999999999999999999999999997
Q ss_pred eccc
Q 046097 234 LKTE 237 (603)
Q Consensus 234 ~~~~ 237 (603)
.+..
T Consensus 204 ~~~~ 207 (596)
T KOG0586|consen 204 FFDY 207 (596)
T ss_pred eecc
Confidence 7653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=323.11 Aligned_cols=152 Identities=23% Similarity=0.369 Sum_probs=134.9
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|.+.+.||.|+||.||+|.+..+++.||||+++... .......+..|+.++..++|+||+++++++... ..+|+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEEEE
Confidence 57899999999999999999999899999999996532 223346788999999999999999999998876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+.+++|.+++.... .+++..++.++.||+.||.|||.+ +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 VmEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 999999999999986543 378899999999999999999998 99999999999999999999999999998765
Q ss_pred cc
Q 046097 237 ED 238 (603)
Q Consensus 237 ~~ 238 (603)
..
T Consensus 156 ~~ 157 (669)
T cd05610 156 NR 157 (669)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.68 Aligned_cols=150 Identities=28% Similarity=0.413 Sum_probs=130.3
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
|++.+.||.|++|.||+|....+++.+|+|.+.... .......+.+|+.++++++|+|++++++++.+......++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999998889999999997643 2223456889999999999999999999998753468999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|+++ +|.+++.... ..+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 9975 8888886542 2489999999999999999999999 99999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=305.11 Aligned_cols=156 Identities=31% Similarity=0.399 Sum_probs=136.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..+.|..-++||+|+||.||-++.+.||+.+|.|.+.+.. ....+...++|-.+|.+++.++||.+--.|++. +.+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk--d~L 260 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK--DAL 260 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC--Cce
Confidence 3455777889999999999999999999999999885432 222345578999999999999999998888887 899
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|+||..|.||+|.-+|..... ..+++..+.-++.+|+.||.+||.. +||.|||||+|||+|+.|+++|+|+|+|..
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 999999999999998877654 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cccc
Q 046097 235 KTED 238 (603)
Q Consensus 235 ~~~~ 238 (603)
+.+.
T Consensus 337 i~~g 340 (591)
T KOG0986|consen 337 IPEG 340 (591)
T ss_pred cCCC
Confidence 6543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=289.00 Aligned_cols=140 Identities=23% Similarity=0.214 Sum_probs=120.1
Q ss_pred CceEEEEEEEcCCCceEEEEEecCC-CChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHH
Q 046097 91 GFGSVYKAVVPSSSQPLAVKILDSS-GSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDA 169 (603)
Q Consensus 91 ~fG~Vy~a~~~~tg~~VAVK~l~~~-~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~ 169 (603)
++|.||.++...+++.||||++... ........+.+|+.+++.++|+||+++++++.+. ...+++|||+++++|.++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCHHHH
Confidence 4455666666668999999999764 2344557899999999999999999999999886 789999999999999999
Q ss_pred HhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 170 LLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 170 L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
+..... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||.+....
T Consensus 90 l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 90 LKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeec
Confidence 976433 2378899999999999999999999 99999999999999999999999999886543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=296.40 Aligned_cols=289 Identities=19% Similarity=0.268 Sum_probs=215.6
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCC--C----ceeEEEeEEec
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC--P----HIVSLLGFASD 148 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~H--p----NIV~l~g~~~~ 148 (603)
...+++|.+..++|+|.||.|..+.+..++..||||+++. .....+..+-|+++|.++.+ | -+|.+.+||.-
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~--V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN--VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH--HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3448899999999999999999999999999999999975 33445667789999999942 2 37788888887
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEe
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~D 228 (603)
. ++.|+|+|.+ |.++.++|..+.. .+++...+..|+.|++.+++|||+. +++|-||||+|||+.+....++-+
T Consensus 163 r--ghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 163 R--GHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred c--CceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEec
Confidence 7 8999999998 6699999987654 3489999999999999999999999 999999999999997766655543
Q ss_pred eccc-eecccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccC
Q 046097 229 FGLA-RLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDN 307 (603)
Q Consensus 229 FGlA-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (603)
-+.. ..
T Consensus 236 ~k~~~~~------------------------------------------------------------------------- 242 (415)
T KOG0671|consen 236 PKKKVCF------------------------------------------------------------------------- 242 (415)
T ss_pred cCCccce-------------------------------------------------------------------------
Confidence 3321 00
Q ss_pred CCCCCCcchhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhh
Q 046097 308 GAGSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKK 387 (603)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (603)
T Consensus 243 -------------------------------------------------------------------------------- 242 (415)
T KOG0671|consen 243 -------------------------------------------------------------------------------- 242 (415)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCCcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCc
Q 046097 388 RGLNSSNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCY 467 (603)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y 467 (603)
...++...+++.|||+|.+..... +.++.|..|
T Consensus 243 -------------------------------------------~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHY 275 (415)
T KOG0671|consen 243 -------------------------------------------IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHY 275 (415)
T ss_pred -------------------------------------------eccCCCcceEEEecCCcceeccCc----ceeeecccc
Confidence 011233457889999998776655 567889999
Q ss_pred cCccccCCCCCCccCCccchhheeeehccCCccCcCCCCCC-----chHHH---hhHHHHH--HHHHhcCccc-------
Q 046097 468 IAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPM-----SEFER---ANLISWA--RQLAYNGKLL------- 530 (603)
Q Consensus 468 ~aPE~~~~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~-----~~~~~---~~~~~~~--~~~~~~~~~~------- 530 (603)
+|||++.+-+++.++||||+||||+||.||...|+...... +...+ ..+..-. ......+.+.
T Consensus 276 RAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~ 355 (415)
T KOG0671|consen 276 RAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSK 355 (415)
T ss_pred CCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccccc
Confidence 99999999999999999999999999999999998765210 00000 0000000 0011111100
Q ss_pred -------cccCCCCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046097 531 -------DLVDPSIH--SLDKDQALLCITIALLCLQRSPSKRLTMKDIVEM 572 (603)
Q Consensus 531 -------~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~ 572 (603)
+.+.+--. .....+...|++|+..||..||++|+|+.|++..
T Consensus 356 ~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 356 GKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred ccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 00111000 2234567789999999999999999999999864
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=285.03 Aligned_cols=141 Identities=26% Similarity=0.420 Sum_probs=126.0
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
||.|+||.||++.+..+++.+++|.+..... ......+.+|+.++.+++|+||+++++.+... ...|++|||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC--cEEEEEEecCCCC
Confidence 6899999999999988899999999865422 13456788999999999999999999998875 8899999999999
Q ss_pred CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 165 SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 165 sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|.+++.... .+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~ 143 (265)
T cd05579 79 DLASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVG 143 (265)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence 9999997643 389999999999999999999999 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=291.81 Aligned_cols=143 Identities=25% Similarity=0.298 Sum_probs=124.7
Q ss_pred ceeecc--CceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHG--GFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G--~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
..||.| +||+||++.+..+++.||+|++.... .....+.+.+|+.+++.++||||++++++|... ...++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEecc
Confidence 346666 99999999999999999999987643 223346788999999999999999999999986 7899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+.
T Consensus 82 ~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 82 AYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred cCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 99999998876533 2378899999999999999999998 99999999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=288.53 Aligned_cols=155 Identities=28% Similarity=0.404 Sum_probs=132.2
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRR---- 150 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---- 150 (603)
...++|++.+.||.|+||.||+|..+.+++.||+|.++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999999998999999999975422 223356778999999999999999999987642
Q ss_pred ----CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEE
Q 046097 151 ----GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKI 226 (603)
Q Consensus 151 ----~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL 226 (603)
...+++|+||+++ ++...+.... ..+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 2378999999976 7777765432 2489999999999999999999999 9999999999999999999999
Q ss_pred Eeeccceecc
Q 046097 227 GDFGLARLKT 236 (603)
Q Consensus 227 ~DFGlA~~~~ 236 (603)
+|||++....
T Consensus 158 ~dfg~~~~~~ 167 (302)
T cd07864 158 ADFGLARLYN 167 (302)
T ss_pred Cccccccccc
Confidence 9999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=292.38 Aligned_cols=150 Identities=28% Similarity=0.440 Sum_probs=127.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~L 156 (603)
.++|++.+.||+|++|.||+|.+..+++.||||.++..........+..|+.++.+.. |+||+++++++.+. ...++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEEE
Confidence 4678899999999999999999988899999999976444444556777887776665 99999999999886 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+. ++|..++.... ..+++..+..++.|++.||+|||+ . +|+||||+|+||+++.++.+||+|||++...
T Consensus 92 v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999985 47777765432 258899999999999999999997 5 8999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=289.33 Aligned_cols=150 Identities=29% Similarity=0.407 Sum_probs=128.7
Q ss_pred hhcCCCCC-ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC--CC
Q 046097 77 ATASFSPS-NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR--GR 152 (603)
Q Consensus 77 ~t~~y~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~--~~ 152 (603)
.+++|++. ++||-|-.|.|..+..+.+++.+|+|++.. .....+|+++.-+. .|||||.++++|+... ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 56677665 579999999999999999999999999854 23456788877666 4999999999988542 35
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc---CCCcEEEEee
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD---GDFKAKIGDF 229 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld---~~~~vKL~DF 229 (603)
.+.+|||.|+||.|...+.++.. ..+++.++..|+.||+.|+.|||+. +|.||||||+|+|.. .|..+||+||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 78899999999999999987654 4589999999999999999999999 999999999999996 4557999999
Q ss_pred ccceecc
Q 046097 230 GLARLKT 236 (603)
Q Consensus 230 GlA~~~~ 236 (603)
|+|+...
T Consensus 209 GFAK~t~ 215 (400)
T KOG0604|consen 209 GFAKETQ 215 (400)
T ss_pred ccccccC
Confidence 9998654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=286.35 Aligned_cols=141 Identities=35% Similarity=0.456 Sum_probs=118.2
Q ss_pred eeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHH---HHhccCCCCceeEEEeEEecCCCCeEEEEEEc
Q 046097 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNEL---SLASSLDCPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev---~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
.||+|+||.||+|.+..+++.||+|.+...... .....+..|. .++....||||+.+++++.+. ...++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence 489999999999999889999999998653211 1112233333 344556799999999999886 789999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+.+++|..++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 79 ~~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 79 MNGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 9999999988654 3489999999999999999999999 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=283.43 Aligned_cols=148 Identities=26% Similarity=0.433 Sum_probs=129.8
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
|++.+.||.|++|.||+|....+++.+++|.+...... .....+.+|+.++++++|+||+++++++.+. ...++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEe
Confidence 56788999999999999999889999999998664322 3356788999999999999999999999876 88999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|+++ +|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~ 149 (283)
T cd05118 79 FMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFG 149 (283)
T ss_pred ccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence 9975 8888876543 3489999999999999999999999 99999999999999999999999999886653
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=294.37 Aligned_cols=150 Identities=29% Similarity=0.443 Sum_probs=130.8
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCC---CCeEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRR---GRRLV 155 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---~~~~~ 155 (603)
+|++.+.||.|++|.||+|....+++.||||.+..... ....+.+.+|+.+++.++|+||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58889999999999999999988899999999876322 334567899999999999999999999988752 23789
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+. ++|.+++.... .+++..++.++.|++.||.|||++ +|+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 48888886543 489999999999999999999999 9999999999999999999999999998765
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 154 ~ 154 (330)
T cd07834 154 D 154 (330)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.85 Aligned_cols=148 Identities=26% Similarity=0.409 Sum_probs=125.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----CC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRR----GR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~----~~ 152 (603)
.++|.+.+.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.++..++|+||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 5789999999999999999999988999999999865322 223356889999999999999999999987541 13
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 56999999964 6766542 2378899999999999999999999 9999999999999999999999999987
Q ss_pred ee
Q 046097 233 RL 234 (603)
Q Consensus 233 ~~ 234 (603)
..
T Consensus 165 ~~ 166 (342)
T cd07879 165 RH 166 (342)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=287.32 Aligned_cols=151 Identities=30% Similarity=0.403 Sum_probs=134.4
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~ 155 (603)
++|.+.+.||.|+||.||+|....+++.||+|++.... .......+.+|+.++.++. |+||+++++++.+. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEE
Confidence 46889999999999999999999899999999986532 2233467889999999998 99999999998876 7899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|||++++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 9999999999999997653 489999999999999999999999 9999999999999999999999999998765
Q ss_pred cc
Q 046097 236 TE 237 (603)
Q Consensus 236 ~~ 237 (603)
..
T Consensus 153 ~~ 154 (280)
T cd05581 153 DP 154 (280)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.36 Aligned_cols=154 Identities=22% Similarity=0.309 Sum_probs=119.0
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCC-ceEEEEE--------------ecC--CCChhhHHHHHHHHHHhccCCCCc
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSS-QPLAVKI--------------LDS--SGSLQGEREFHNELSLASSLDCPH 138 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg-~~VAVK~--------------l~~--~~~~~~~~~~~~Ev~iL~~l~HpN 138 (603)
...++|++++.||+|+||.||+|..+... ...++|. +.+ .........+.+|+.+|.+++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998764322 1222221 100 011223456889999999999999
Q ss_pred eeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhccc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 046097 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKC--EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNI 216 (603)
Q Consensus 139 IV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~--~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NI 216 (603)
|+++++++.+. ...|+|++++. ++|.+++..... ........+..++.||+.||.|||++ +|+||||||+||
T Consensus 225 Iv~l~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NI 298 (501)
T PHA03210 225 ILKIEEILRSE--ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENI 298 (501)
T ss_pred cCcEeEEEEEC--CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 99999999986 78899999985 577777654321 11134566778999999999999999 999999999999
Q ss_pred EEcCCCcEEEEeeccceec
Q 046097 217 LLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~~ 235 (603)
|++.++.+||+|||++...
T Consensus 299 Ll~~~~~vkL~DFGla~~~ 317 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPF 317 (501)
T ss_pred EECCCCCEEEEeCCCceec
Confidence 9999999999999998764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=314.57 Aligned_cols=149 Identities=32% Similarity=0.480 Sum_probs=133.4
Q ss_pred CCCceeeccCceEEEEEEEcCCC----ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 82 SPSNRLGHGGFGSVYKAVVPSSS----QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 82 ~i~~~LG~G~fG~Vy~a~~~~tg----~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
...++||+|+||+||+|.+.-.+ -+||||++..........+++.|+-.|.+++|||+++|+|+|... .+.||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHHHH
Confidence 44578999999999999985333 478999997766667778999999999999999999999999984 48899
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
++|++.|+|.++++..+. .+.....+.++.||++||.|||.+ ++|||||-.+||||.+-..+||.|||+|+....
T Consensus 776 tq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999987653 388899999999999999999999 999999999999999999999999999998876
Q ss_pred c
Q 046097 238 D 238 (603)
Q Consensus 238 ~ 238 (603)
+
T Consensus 851 d 851 (1177)
T KOG1025|consen 851 D 851 (1177)
T ss_pred c
Confidence 5
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.59 Aligned_cols=157 Identities=27% Similarity=0.397 Sum_probs=133.4
Q ss_pred cHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEec
Q 046097 70 SYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASD 148 (603)
Q Consensus 70 ~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~ 148 (603)
...++....++|.+.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++.+++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34566778899999999999999999999998899999999987532 22234568889999999999999999998864
Q ss_pred CC----CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcE
Q 046097 149 RR----GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKA 224 (603)
Q Consensus 149 ~~----~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~v 224 (603)
.. ....+++++++ +++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 31 13478888877 77998877543 378999999999999999999999 99999999999999999999
Q ss_pred EEEeecccee
Q 046097 225 KIGDFGLARL 234 (603)
Q Consensus 225 KL~DFGlA~~ 234 (603)
||+|||++..
T Consensus 160 kl~dfg~~~~ 169 (345)
T cd07877 160 KILDFGLARH 169 (345)
T ss_pred EEeccccccc
Confidence 9999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=286.45 Aligned_cols=148 Identities=26% Similarity=0.329 Sum_probs=128.4
Q ss_pred CCCCCceeeccCceEEEEEEEc---CCCceEEEEEecCCCC---hhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCC
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVP---SSSQPLAVKILDSSGS---LQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~l~~~~~---~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~ 152 (603)
+|++.+.||.|+||.||++... .+++.||+|++..... ....+.+.+|+.++.++ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence 4788899999999999999874 4788999999865321 12345678899999999 599999999998876 7
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 8899999999999999987643 378899999999999999999999 9999999999999999999999999998
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
...
T Consensus 153 ~~~ 155 (290)
T cd05613 153 KEF 155 (290)
T ss_pred eec
Confidence 654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.77 Aligned_cols=155 Identities=28% Similarity=0.452 Sum_probs=136.6
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----CCeEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRR----GRRLVL 156 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~----~~~~~L 156 (603)
+...+.||+|+||.||+|+++.+|+.||||.++........+...+|+++|++++|+|||+++++-++.. .....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3445789999999999999999999999999988666677788999999999999999999999877664 466789
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc--CCC--cEEEEeeccc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD--GDF--KAKIGDFGLA 232 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld--~~~--~vKL~DFGlA 232 (603)
|||||.+|+|...|.+.....-+++.+.+.++.+++.||.|||++ +||||||||.||++. ++| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999998766555599999999999999999999999 999999999999984 334 4799999999
Q ss_pred eecccc
Q 046097 233 RLKTED 238 (603)
Q Consensus 233 ~~~~~~ 238 (603)
+..+.+
T Consensus 172 rel~d~ 177 (732)
T KOG4250|consen 172 RELDDN 177 (732)
T ss_pred ccCCCC
Confidence 877654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=289.49 Aligned_cols=141 Identities=28% Similarity=0.384 Sum_probs=126.0
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
..||+|+||.||++....+++.||||.+... .......+.+|+.+++.++|+||+++++++... ...++||||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEecCCCC
Confidence 5799999999999999989999999998642 334456789999999999999999999999886 8899999999999
Q ss_pred CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 165 SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 165 sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|.+++... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 999987543 378899999999999999999999 9999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=289.15 Aligned_cols=153 Identities=27% Similarity=0.409 Sum_probs=128.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-hHHHHHHHHHHhccCCCCceeEEEeEEecCC------
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-GEREFHNELSLASSLDCPHIVSLLGFASDRR------ 150 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~------ 150 (603)
.++|++.+.||.|+||.||+|.++.+++.+|||.+....... ....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999999899999999986532221 2345678999999999999999999876542
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
...+++||||+.+ +|...+.... ..+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 2367999999965 6777665432 2489999999999999999999999 99999999999999999999999999
Q ss_pred cceecc
Q 046097 231 LARLKT 236 (603)
Q Consensus 231 lA~~~~ 236 (603)
++....
T Consensus 161 ~~~~~~ 166 (311)
T cd07866 161 LARPYD 166 (311)
T ss_pred cchhcc
Confidence 987543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=289.48 Aligned_cols=148 Identities=30% Similarity=0.390 Sum_probs=127.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCC--CChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~--~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..|+..+.||.|+||.||+|....+++.+|+|.+... ........+.+|+++++.++|+|++++++++... ...++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEE
Confidence 3477778899999999999999889999999998642 2223345788999999999999999999999886 78899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+. |+|.+.+.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 93 v~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 93 VMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccccee
Confidence 999996 58877765433 3378999999999999999999999 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=309.18 Aligned_cols=151 Identities=29% Similarity=0.425 Sum_probs=132.5
Q ss_pred CCCCceeeccCceEEEEEEEcCC---CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSS---SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
....++||+|.||.|++|.+... .-.||||+++..........|++|+.+|.+|+|+|+++|||+..+ ..+.+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV 188 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMV 188 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHH
Confidence 34557899999999999999642 236899999886555577899999999999999999999999987 567899
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
||+++.|+|.+.|+. .....+-......++.|||.||.||.++ ++|||||..+|+|+-..-.+||+|||+.+.+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 3445577888889999999999999999 999999999999999999999999999987754
Q ss_pred c
Q 046097 238 D 238 (603)
Q Consensus 238 ~ 238 (603)
.
T Consensus 265 n 265 (1039)
T KOG0199|consen 265 N 265 (1039)
T ss_pred C
Confidence 4
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=280.53 Aligned_cols=151 Identities=28% Similarity=0.422 Sum_probs=129.4
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
.+.+..||.|+.|.|++++.+++|...|||.+.........++++..+.++.... .|+||+.+|+|... ..+++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHHHHHH
Confidence 4456779999999999999999999999999988776677788888998888775 89999999999986 77889999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
.|. ..+..++..-. .++++..+-++...+++||.||..++ +|+|||+||+|||+|+.|++||||||++.....+
T Consensus 172 lMs-~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHH-HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 883 35555554433 44888889999999999999999876 9999999999999999999999999998765443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=296.25 Aligned_cols=153 Identities=25% Similarity=0.392 Sum_probs=131.2
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC-
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG- 151 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~- 151 (603)
+....++|++.+.||+|+||.||+|.+..++..||||.+.... .......+.+|+.++++++|+||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3446788999999999999999999999899999999986532 22234568899999999999999999999875421
Q ss_pred ---CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEe
Q 046097 152 ---RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228 (603)
Q Consensus 152 ---~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~D 228 (603)
...++||||+ +++|..++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 2468999998 77898887542 388999999999999999999999 999999999999999999999999
Q ss_pred ecccee
Q 046097 229 FGLARL 234 (603)
Q Consensus 229 FGlA~~ 234 (603)
||++..
T Consensus 162 fg~~~~ 167 (343)
T cd07880 162 FGLARQ 167 (343)
T ss_pred cccccc
Confidence 998864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.68 Aligned_cols=150 Identities=25% Similarity=0.417 Sum_probs=133.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.+-+.|+..||.|+||.||+|..+.++-..|.|++.- .+....+.++-|++||..+.||+||+|++.|... +.++++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEE
Confidence 3446777889999999999999998888888898865 3455667899999999999999999999987765 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
.|||.||-...++.... ..+++.++..+++|++.||.|||++ +|||||||..|||++-+|.++|+|||.+...
T Consensus 108 iEFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred EeecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc
Confidence 99999999988887654 4599999999999999999999999 9999999999999999999999999987544
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=292.87 Aligned_cols=152 Identities=30% Similarity=0.396 Sum_probs=131.0
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
+...+++|++.+.||.|+||.||+|.+..+++.||||.+..... ......+.+|+.++..++||||+++++++... +.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~ 83 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LE 83 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CC
Confidence 34578899999999999999999999999999999998865322 23346788999999999999999999998764 35
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
..+++|||+ +++|..++... .++...+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 789999998 56888887542 367888889999999999999999 9999999999999999999999999987
Q ss_pred ee
Q 046097 233 RL 234 (603)
Q Consensus 233 ~~ 234 (603)
..
T Consensus 156 ~~ 157 (328)
T cd07856 156 RI 157 (328)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.75 Aligned_cols=150 Identities=23% Similarity=0.341 Sum_probs=128.5
Q ss_pred hcCCCC-CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhh-------------HHHHHHHHHHhccCCCCceeEEE
Q 046097 78 TASFSP-SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG-------------EREFHNELSLASSLDCPHIVSLL 143 (603)
Q Consensus 78 t~~y~i-~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~-------------~~~~~~Ev~iL~~l~HpNIV~l~ 143 (603)
.++|.. .+.||.|+||.||+|.+..+++.||||.+........ ...+.+|++++.+++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456654 4679999999999999988999999999865322110 12477899999999999999999
Q ss_pred eEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc
Q 046097 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 144 g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~ 223 (603)
+++... ...++||||+. ++|.+++.... .+++.....++.|++.||.|||+. +++|+||+|+||+++.++.
T Consensus 87 ~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 87 DVYVEG--DFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEEecC--CcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence 999876 78999999996 58998886533 388999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccceecc
Q 046097 224 AKIGDFGLARLKT 236 (603)
Q Consensus 224 vKL~DFGlA~~~~ 236 (603)
++|+|||++....
T Consensus 158 ~kl~dfg~~~~~~ 170 (335)
T PTZ00024 158 CKIADFGLARRYG 170 (335)
T ss_pred EEECCccceeecc
Confidence 9999999987654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=287.70 Aligned_cols=148 Identities=25% Similarity=0.355 Sum_probs=127.2
Q ss_pred CCCCCceeeccCceEEEEEEEc---CCCceEEEEEecCCCC---hhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCC
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVP---SSSQPLAVKILDSSGS---LQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~l~~~~~---~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~ 152 (603)
+|++.+.||+|++|.||++... .++..||||+++.... ......+.+|+.++.++ +|+||+++++.+... .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--T 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--C
Confidence 4778899999999999999863 4678899999865321 22345688999999999 599999999998876 7
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccc
Confidence 8999999999999999986542 378899999999999999999998 9999999999999999999999999987
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
...
T Consensus 153 ~~~ 155 (288)
T cd05583 153 KEF 155 (288)
T ss_pred ccc
Confidence 653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=287.16 Aligned_cols=145 Identities=30% Similarity=0.418 Sum_probs=126.2
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
|...+.||+|+||.||+|.+..+++.|++|.+.... .......+.+|+++++.++|+|++++++++.+. ...++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEE
Confidence 666788999999999999998899999999986532 223345688999999999999999999999986 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
||+. ++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++.
T Consensus 101 e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 101 EYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred ecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCc
Confidence 9996 57777775433 3488999999999999999999999 99999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=291.71 Aligned_cols=138 Identities=24% Similarity=0.435 Sum_probs=119.7
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-----C---CceeEEEeEEecC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-----C---PHIVSLLGFASDR 149 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-----H---pNIV~l~g~~~~~ 149 (603)
.++|.+.++||-|-|++||+|.+..+.+.||+|+.+.. ....+..+.|+.+|++++ | .+||+|+++|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 37788999999999999999999999999999999752 344466789999999883 2 3799999999853
Q ss_pred --CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC
Q 046097 150 --RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD 221 (603)
Q Consensus 150 --~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~ 221 (603)
+|.++|+|+|++ |.+|..++......+ ++...+..|+.||+.||.|||..| +|||-||||+|||+..+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 678999999999 778999888776655 899999999999999999999998 99999999999999643
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=285.09 Aligned_cols=141 Identities=29% Similarity=0.438 Sum_probs=128.4
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEEEEccCC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLIYELMEN 163 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LVmEy~~~ 163 (603)
+.||+|+|+.|-.+....++..+|||++.+. ....+.++.+|++++.+++ |+||+.|++||++. ..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEEEEecccC
Confidence 5699999999999999999999999999875 4556788999999999997 99999999999997 899999999999
Q ss_pred CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC---cEEEEeecccee
Q 046097 164 RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF---KAKIGDFGLARL 234 (603)
Q Consensus 164 gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~---~vKL~DFGlA~~ 234 (603)
|.|..++..+.. +++.++.++..+|+.||.|||.+ ||.||||||+|||..... -+|||||.+..-
T Consensus 161 GplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 161 GPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred chHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccc
Confidence 999999987665 89999999999999999999999 999999999999996543 489999988654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=281.88 Aligned_cols=150 Identities=31% Similarity=0.451 Sum_probs=126.0
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC----ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG----SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~----~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
+|.+.+.||+|+||.||++.+..++..+++|+++... .......+..|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceE
Confidence 5888899999999999999998777777777765421 122334577899999999999999999998876 6789
Q ss_pred EEEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 156 LIYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+||||+++++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.++|+|||++..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceee
Confidence 9999999999999886522 234589999999999999999999999 9999999999999975 5699999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 155 ~ 155 (260)
T cd08222 155 L 155 (260)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=289.04 Aligned_cols=150 Identities=28% Similarity=0.370 Sum_probs=125.5
Q ss_pred CCCCCceeeccCceEEEEEEEcCC--CceEEEEEecCCCC-hhhHHHHHHHHHHhccC-CCCceeEEEeEEecC--CCCe
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSS--SQPLAVKILDSSGS-LQGEREFHNELSLASSL-DCPHIVSLLGFASDR--RGRR 153 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~t--g~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~--~~~~ 153 (603)
+|++.+.||+|+||.||++.+..+ +..||+|.+..... ....+.+.+|+.++.++ .|+||+++++.+... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477889999999999999999877 88999999865322 22345678899999999 499999999875432 2245
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
++++++|+. ++|.+++.... .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788999885 68988886433 388999999999999999999999 99999999999999999999999999987
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 154 ~~~ 156 (332)
T cd07857 154 GFS 156 (332)
T ss_pred ecc
Confidence 643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=293.62 Aligned_cols=149 Identities=28% Similarity=0.455 Sum_probs=127.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC------
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG------ 151 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~------ 151 (603)
.++|.+.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|++++++++||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 4689999999999999999999999999999999866432 445678899999999999999999987665321
Q ss_pred ------CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc-CCCcE
Q 046097 152 ------RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD-GDFKA 224 (603)
Q Consensus 152 ------~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld-~~~~v 224 (603)
...++||||++ ++|.+++... .+++..+..++.||+.||.|||+. +++||||||+||+++ .++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35799999997 5888887542 378999999999999999999999 999999999999997 45678
Q ss_pred EEEeeccceec
Q 046097 225 KIGDFGLARLK 235 (603)
Q Consensus 225 KL~DFGlA~~~ 235 (603)
||+|||++...
T Consensus 155 kl~dfg~~~~~ 165 (342)
T cd07854 155 KIGDFGLARIV 165 (342)
T ss_pred EECCcccceec
Confidence 99999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=279.88 Aligned_cols=147 Identities=32% Similarity=0.475 Sum_probs=129.5
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
|+..+.||.|++|.||+|....+++.||+|.+.... .......+..|+.++++++|+||+++++++.+. ...++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEec
Confidence 566788999999999999999899999999997643 222345678899999999999999999999886 78999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|++ ++|.+++.... ..+++..+..++.|++.||.|||++ +|+|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 79 YCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred CcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccccc
Confidence 997 58999997653 2389999999999999999999999 9999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=293.35 Aligned_cols=151 Identities=27% Similarity=0.413 Sum_probs=130.0
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR---- 150 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---- 150 (603)
...++|++...||+|++|.||+|.+..+++.||||++.... .......+.+|+.+++++.|+||+++++++....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999999899999999986532 2233456788999999999999999998776541
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
....++|+||+ +++|.+++... .+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 13489999998 66999988652 389999999999999999999999 99999999999999999999999999
Q ss_pred ccee
Q 046097 231 LARL 234 (603)
Q Consensus 231 lA~~ 234 (603)
++..
T Consensus 164 ~~~~ 167 (343)
T cd07851 164 LARH 167 (343)
T ss_pred cccc
Confidence 9864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=273.75 Aligned_cols=142 Identities=30% Similarity=0.385 Sum_probs=126.5
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
||.|+||.||++....+++.+++|.+..... ......+..|+.++++++|+||+++++.+... ...++||||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE--EKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC--CeeEEEEecCCCC
Confidence 6899999999999988899999999876432 22446788999999999999999999998876 8899999999999
Q ss_pred CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 165 SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 165 sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
+|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 79 ~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 144 (250)
T cd05123 79 ELFSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELS 144 (250)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecc
Confidence 9999997653 378999999999999999999998 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-33 Score=290.22 Aligned_cols=151 Identities=26% Similarity=0.311 Sum_probs=130.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh--hHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ--GEREFHNELSLASSL-DCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~--~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~ 153 (603)
...+|..+.+||+|+||.|.+|..+.+.+.+|||+++++...+ +.+--+.|-.+|... +-|++++++.+|+.. +.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm--DR 424 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--DR 424 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh--hh
Confidence 4567899999999999999999999999999999998863222 223445677777766 478999999999987 89
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+|+||||+.||+|.-++.+-.. +.+..+.-++..|+-||-|||++ |||.||||.+|||++.+|.+||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 9999999999999988865432 77888888999999999999999 99999999999999999999999999987
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 499 En 500 (683)
T KOG0696|consen 499 EN 500 (683)
T ss_pred cc
Confidence 53
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=290.01 Aligned_cols=147 Identities=28% Similarity=0.471 Sum_probs=126.8
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMEN 163 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~ 163 (603)
+.||+|.||+||-|.++.+|+.||||++.+.. ....+.++.+|+.+|+.+.||.||.+-..|+.. ..+++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~--ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP--ERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC--ceEEEEehhhcc
Confidence 78999999999999999999999999997643 344567899999999999999999999999987 899999999955
Q ss_pred CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC---CcEEEEeeccceecccc
Q 046097 164 RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD---FKAKIGDFGLARLKTED 238 (603)
Q Consensus 164 gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~---~~vKL~DFGlA~~~~~~ 238 (603)
+..+.+..... +.+++....-++.||+.||.|||.+ +|+|+||||+|||+.+. -++||||||+|+++.+.
T Consensus 648 -DMLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 -DMLEMILSSEK-GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred -hHHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 55555544333 3488888888999999999999999 99999999999999644 47999999999987654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=270.51 Aligned_cols=131 Identities=20% Similarity=0.216 Sum_probs=114.0
Q ss_pred cCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHH
Q 046097 90 GGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDA 169 (603)
Q Consensus 90 G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~ 169 (603)
|.+|.||++.++.+++.||+|.+.... .+..|...+....||||+++++++.+. ...++||||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCHHHH
Confidence 889999999999999999999996532 223444455556799999999999876 789999999999999999
Q ss_pred HhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 170 LLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 170 L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+..
T Consensus 76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~ 134 (237)
T cd05576 76 ISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSE 134 (237)
T ss_pred HHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhc
Confidence 86543 388999999999999999999999 999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-33 Score=295.15 Aligned_cols=274 Identities=25% Similarity=0.337 Sum_probs=223.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
...+++.+..||-|+||.|=++..++....+|+|++++.+ .....+.+..|-.+|..++.|+||++|-.|.+. .++
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~--kyv 495 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS--KYV 495 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc--hhh
Confidence 3445667788999999999999987655568999998764 334456789999999999999999999999987 899
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|++||-|-||.|...|+.... ++.....-++..++.|+.|||++ +||.|||||+|++++.+|.+||.|||+|+.
T Consensus 496 YmLmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHH
Confidence 999999999999999987654 88888888999999999999999 999999999999999999999999999987
Q ss_pred cccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCc
Q 046097 235 KTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESG 314 (603)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (603)
....
T Consensus 570 i~~g---------------------------------------------------------------------------- 573 (732)
T KOG0614|consen 570 IGSG---------------------------------------------------------------------------- 573 (732)
T ss_pred hccC----------------------------------------------------------------------------
Confidence 6433
Q ss_pred chhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCC
Q 046097 315 RVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSN 394 (603)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (603)
T Consensus 574 -------------------------------------------------------------------------------- 573 (732)
T KOG0614|consen 574 -------------------------------------------------------------------------------- 573 (732)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccC
Q 046097 395 VGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGG 474 (603)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 474 (603)
..|-+++||+.|.|||.+.
T Consensus 574 -------------------------------------------------------------~KTwTFcGTpEYVAPEIIL 592 (732)
T KOG0614|consen 574 -------------------------------------------------------------RKTWTFCGTPEYVAPEIIL 592 (732)
T ss_pred -------------------------------------------------------------CceeeecCCcccccchhhh
Confidence 1134689999999999999
Q ss_pred CCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCC--CCCHHHHHHHHHHH
Q 046097 475 GGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIH--SLDKDQALLCITIA 552 (603)
Q Consensus 475 ~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~ 552 (603)
+..-..++|.||||+++|||++|++||...+.. ..+ . .+-..+. .++........+|+
T Consensus 593 nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-ktY----------n---------~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 593 NKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-KTY----------N---------LILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-HHH----------H---------HHHhhhhhhhcccccchhHHHHH
Confidence 999999999999999999999999999876532 211 0 0111111 34445556677889
Q ss_pred hhccCCCCCCCCC-----HHHHHHHh-----------cCCCCCCCCCCccCCCCCCCCC
Q 046097 553 LLCLQRSPSKRLT-----MKDIVEML-----------TGEAEPPHLPFEFSPSPPSNFP 595 (603)
Q Consensus 553 ~~cl~~dP~~Rpt-----~~evl~~l-----------~~~~~~~~~~~~~~~~~~~~~~ 595 (603)
+.....+|.+|.. +.||-+.- .+...||..|...+|.+-+||.
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd 711 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFD 711 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhcc
Confidence 9999999999986 66776553 3556788888888888888874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=304.75 Aligned_cols=160 Identities=30% Similarity=0.469 Sum_probs=137.8
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcC-------CCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeE
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPS-------SSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGF 145 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~ 145 (603)
++...++..+.+.||+|.||.|++|.... ....||||.++......+.+.+..|+++|..+. |+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34444555666799999999999998631 145799999988776677788999999999996 9999999999
Q ss_pred EecCCCCeEEEEEEccCCCCHHHHHhhcc------cc-------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 046097 146 ASDRRGRRLVLIYELMENRSLQDALLDRK------CE-------ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIK 212 (603)
Q Consensus 146 ~~~~~~~~~~LVmEy~~~gsL~~~L~~~~------~~-------~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLK 212 (603)
|... +.+++|+||+..|+|..+++..+ .. ..++..+.+.++.|||.|+.||++. ++|||||.
T Consensus 371 ~t~~--~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA 445 (609)
T KOG0200|consen 371 CTQD--GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA 445 (609)
T ss_pred eccC--CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence 9985 88999999999999999998766 00 1388899999999999999999999 99999999
Q ss_pred CCCeEEcCCCcEEEEeeccceecccc
Q 046097 213 PSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 213 p~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
.+|||+..+..+||+|||+|+.....
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~ 471 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNK 471 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCC
Confidence 99999999999999999999865543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=294.04 Aligned_cols=147 Identities=25% Similarity=0.397 Sum_probs=125.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.+..|.+...+|.|+|+.|..+.+..+++..++|++.... ....+|+.++... +||||+++++.+.+. .+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~--~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDG--KEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCC--ceee
Confidence 4678888899999999999999999999999999997642 2234667666665 599999999999987 8999
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE-cCCCcEEEEeecccee
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL-DGDFKAKIGDFGLARL 234 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl-d~~~~vKL~DFGlA~~ 234 (603)
+|||++.++-|.+.+..... ....+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++.
T Consensus 393 ~v~e~l~g~ell~ri~~~~~----~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE----FCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeehhccccHHHHHHHhcch----hHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 99999999988887765442 2267778999999999999999 99999999999999 6899999999999876
Q ss_pred ccc
Q 046097 235 KTE 237 (603)
Q Consensus 235 ~~~ 237 (603)
...
T Consensus 466 ~~~ 468 (612)
T KOG0603|consen 466 LER 468 (612)
T ss_pred Cch
Confidence 543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=291.68 Aligned_cols=164 Identities=26% Similarity=0.405 Sum_probs=143.7
Q ss_pred ccHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEe
Q 046097 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFAS 147 (603)
Q Consensus 69 ~~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~ 147 (603)
+.++.+...++-|++.+.||.|.+|.||+++.+.+++.+|+|+..... +..+++..|.++|+... |||++.++|+|.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 344555567788999999999999999999999999999999997643 34456778899999885 999999999986
Q ss_pred cC---CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcE
Q 046097 148 DR---RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKA 224 (603)
Q Consensus 148 ~~---~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~v 224 (603)
.. .++++|||||||.+|+.-++++... +..+.|..+..|+..++.||.|||.+ .++|||||-.|||++.++.+
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 32 4578999999999999999998776 56699999999999999999999999 99999999999999999999
Q ss_pred EEEeeccceecccc
Q 046097 225 KIGDFGLARLKTED 238 (603)
Q Consensus 225 KL~DFGlA~~~~~~ 238 (603)
||+|||.+...+..
T Consensus 163 KLvDFGvSaQldsT 176 (953)
T KOG0587|consen 163 KLVDFGVSAQLDST 176 (953)
T ss_pred EEeeeeeeeeeecc
Confidence 99999999876544
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=272.11 Aligned_cols=157 Identities=28% Similarity=0.468 Sum_probs=131.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCC----ceEEEEEecCCCChhh-HHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSS----QPLAVKILDSSGSLQG-EREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg----~~VAVK~l~~~~~~~~-~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
....|+.+..||+|.||.||+|..+.++ +.+|||.++.+..... .....+|+.+++.++|+||+.+..++... .
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-D 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-C
Confidence 3456999999999999999999775543 3689999977533322 35678999999999999999999988874 4
Q ss_pred CeEEEEEEccCCCCHHHHHhhccc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC----CcEE
Q 046097 152 RRLVLIYELMENRSLQDALLDRKC--EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD----FKAK 225 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~--~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~----~~vK 225 (603)
..+++++||.+. +|..+++-... ...++...+..|+.||+.|+.|||++ =|+||||||.||||..+ |.+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 789999999976 88888765432 23488899999999999999999999 89999999999999876 8999
Q ss_pred EEeeccceecccc
Q 046097 226 IGDFGLARLKTED 238 (603)
Q Consensus 226 L~DFGlA~~~~~~ 238 (603)
|+|||+++.....
T Consensus 177 IaDlGlaR~~~~p 189 (438)
T KOG0666|consen 177 IADLGLARLFNNP 189 (438)
T ss_pred eecccHHHHhhcc
Confidence 9999999987655
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=278.05 Aligned_cols=163 Identities=22% Similarity=0.278 Sum_probs=140.6
Q ss_pred HHHHHhhcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEE
Q 046097 72 NLIRRATASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146 (603)
Q Consensus 72 ~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~ 146 (603)
.++.....+++...++.+|.||.||.|.++. +.+.|.+|.++...+......++.|..++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3566677788888999999999999997753 34567889998877777888899999999999999999999998
Q ss_pred ecCCCCeEEEEEEccCCCCHHHHHh-----hcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC
Q 046097 147 SDRRGRRLVLIYELMENRSLQDALL-----DRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD 221 (603)
Q Consensus 147 ~~~~~~~~~LVmEy~~~gsL~~~L~-----~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~ 221 (603)
.+. ....++++.++.-|+|..||. +....+.++..+...++.|++.|++|||.+ ++||.||..+|.+|++.
T Consensus 357 ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 357 IED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 875 467889999999999999998 333344578889999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccceecccc
Q 046097 222 FKAKIGDFGLARLKTED 238 (603)
Q Consensus 222 ~~vKL~DFGlA~~~~~~ 238 (603)
.++||+|-.+++..-+.
T Consensus 433 LqVkltDsaLSRDLFP~ 449 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPG 449 (563)
T ss_pred eeEEeccchhccccCcc
Confidence 99999999998866443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=269.11 Aligned_cols=149 Identities=28% Similarity=0.398 Sum_probs=125.8
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
+..||.|+||+|++-.++.+|+..|||.++......+.++++.|.+...+- +.||||++||.+..+ +..|+.||+|.
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcWiCMELMd 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCWICMELMD 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--CceeeeHHHHh
Confidence 467999999999999999999999999998877767778888888876665 599999999998876 78899999994
Q ss_pred CCCHHHHHhhc--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 163 NRSLQDALLDR--KCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 163 ~gsL~~~L~~~--~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
.+|..+.+.- .....+++...-+|....+.||.||-... .|||||+||+|||++..|.+||||||++.....
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 4776654431 11234888888899999999999999764 999999999999999999999999999866543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=268.37 Aligned_cols=151 Identities=19% Similarity=0.289 Sum_probs=133.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~ 153 (603)
..++|.++.+||.|+|++|.+++++.+.+.+|+|+++++. ..++..-++.|-.+..+. +||++|-++.+|+.. ..
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte--sr 325 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE--SR 325 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc--ce
Confidence 4567999999999999999999999999999999998753 223345677787777776 599999999999987 88
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+++|.||++||+|.-++.+++. ++++.+.-+...|+.||.|||++ |||.||||..|+|+|..|.+||.|+|+++
T Consensus 326 lffvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 9999999999999888866544 89999999999999999999999 99999999999999999999999999986
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 400 e~ 401 (593)
T KOG0695|consen 400 EG 401 (593)
T ss_pred cC
Confidence 53
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=254.75 Aligned_cols=138 Identities=34% Similarity=0.490 Sum_probs=123.2
Q ss_pred CceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHHH
Q 046097 91 GFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDAL 170 (603)
Q Consensus 91 ~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L 170 (603)
+||.||+|....+++.+++|++...........+.+|++.+++++|+||+++++++... ...++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHHH
Confidence 58999999998889999999997643333267899999999999999999999999876 7899999999999999998
Q ss_pred hhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 171 LDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 171 ~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
..... +++..+..++.+++.+|.|||+. +++|+||+|.||+++.++.++|+|||.+....
T Consensus 79 ~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~ 138 (244)
T smart00220 79 KKRGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLD 138 (244)
T ss_pred HhccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeec
Confidence 76443 78899999999999999999999 99999999999999999999999999987654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=289.67 Aligned_cols=151 Identities=23% Similarity=0.260 Sum_probs=107.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCC----CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEe----c
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSS----SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFAS----D 148 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~t----g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~----~ 148 (603)
..++|++.+.||+|+||.||+|.+..+ +..||||.+..... .+....+ .+....+.++..++..+. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 567899999999999999999999888 89999998864221 1111111 111222222222221111 1
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcccc-----------------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKCE-----------------ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDI 211 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~~-----------------~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDL 211 (603)
..+...++||||+.+++|.+++...... .......+..++.||+.||.|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 2246789999999999999998754211 0012344567999999999999999 9999999
Q ss_pred CCCCeEEcC-CCcEEEEeeccceec
Q 046097 212 KPSNILLDG-DFKAKIGDFGLARLK 235 (603)
Q Consensus 212 Kp~NILld~-~~~vKL~DFGlA~~~ 235 (603)
||+|||++. ++.+||+|||+|+..
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l 306 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADL 306 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccc
Confidence 999999985 579999999999654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=277.45 Aligned_cols=149 Identities=24% Similarity=0.322 Sum_probs=131.9
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
-|..++.||-|+||.|.+++-..|...||+|.+++.... .....+..|-.||.....+-||+||-.|++. +.+|+|
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk--dnLYFV 707 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFV 707 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC--CceEEE
Confidence 366778999999999999999889999999999774322 2335578899999999999999999999998 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|+|++||++..+|-+.. .+.+..+.-++..+..|+.+.|.. |.|||||||+|||||.+|.+||.|||++.-+.
T Consensus 708 MdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999987653 488888888999999999999999 99999999999999999999999999986544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.47 Aligned_cols=156 Identities=32% Similarity=0.462 Sum_probs=134.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh------hHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ------GEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~------~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
.++|-.+.+||.|+|+.||+|.+....+.||||+......-. ..+...+|..+.+.+.||.||++|++|.-. .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-t 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-T 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-c
Confidence 445777789999999999999998889999999975432211 235578899999999999999999999864 3
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc---CCCcEEEEe
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD---GDFKAKIGD 228 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld---~~~~vKL~D 228 (603)
..+|.|+|||+|.+|.-+|+.... +++.++..|+.||+.||.||... .++|||-||||.|||+. .-|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 678999999999999999987654 89999999999999999999987 88999999999999995 457899999
Q ss_pred eccceecccc
Q 046097 229 FGLARLKTED 238 (603)
Q Consensus 229 FGlA~~~~~~ 238 (603)
||++++...+
T Consensus 617 FGLSKIMddd 626 (775)
T KOG1151|consen 617 FGLSKIMDDD 626 (775)
T ss_pred cchhhhccCC
Confidence 9999987765
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=285.35 Aligned_cols=146 Identities=33% Similarity=0.452 Sum_probs=116.6
Q ss_pred CCCCceeeccCceE-EEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEEE
Q 046097 81 FSPSNRLGHGGFGS-VYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 81 y~i~~~LG~G~fG~-Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
|...+.+|.|+.|+ ||+|.. .++.||||.+-. ....-..+|+..|+.-+ |||||++++.-.+. ...||.+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~--qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDR--QFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCC--ceEEEEe
Confidence 44557899999986 799998 688999998843 33456789999999885 99999997776665 8999999
Q ss_pred EccCCCCHHHHHhhccccccc-CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC---C--CcEEEEeeccc
Q 046097 159 ELMENRSLQDALLDRKCEELM-EWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG---D--FKAKIGDFGLA 232 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l-~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~---~--~~vKL~DFGlA 232 (603)
|.|.. +|.+++......... .....+.++.|+++||+|||+. +||||||||.||||+. + .+++|+|||++
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99965 999999874111111 1144567889999999999998 9999999999999975 3 46999999999
Q ss_pred eecccc
Q 046097 233 RLKTED 238 (603)
Q Consensus 233 ~~~~~~ 238 (603)
+....+
T Consensus 659 Kkl~~~ 664 (903)
T KOG1027|consen 659 KKLAGG 664 (903)
T ss_pred cccCCC
Confidence 876544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=240.53 Aligned_cols=149 Identities=23% Similarity=0.411 Sum_probs=131.1
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-hHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-GEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+|...++||+|.||+||+|+.+.+++.||+|.++.+...+ ......+|+-+|+.+.|.|||++++..... ..+.+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd--kkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC--ceeEEeH
Confidence 4566678999999999999999999999999997754333 336788999999999999999999998876 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||.. +|..+..... +.++...+..++.|+++||.|+|++ ++.||||||+|.||+.+|++||+|||+++...
T Consensus 81 e~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafg 152 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFG 152 (292)
T ss_pred HHhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence 99954 8888776543 3489999999999999999999999 99999999999999999999999999998654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-31 Score=259.04 Aligned_cols=152 Identities=24% Similarity=0.420 Sum_probs=127.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCC------C
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRR------G 151 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~------~ 151 (603)
+.|.-..+||+|.||.||+|+.+.+++.||+|++-.+... ..-....+|+.+|..+.|+|++.++..|.... .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4456667899999999999999999999999876432211 22245678999999999999999998876431 2
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
..+|+||++|+. +|..+|..... .++..++.+++.++..||.|+|++ .|+|||+|+.|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 458999999976 88888866432 388999999999999999999999 999999999999999999999999999
Q ss_pred ceecc
Q 046097 232 ARLKT 236 (603)
Q Consensus 232 A~~~~ 236 (603)
++...
T Consensus 171 ar~fs 175 (376)
T KOG0669|consen 171 ARAFS 175 (376)
T ss_pred cccee
Confidence 97654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=240.22 Aligned_cols=160 Identities=28% Similarity=0.397 Sum_probs=136.5
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCC
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~ 152 (603)
++...+....+..||.|++|.|-+-++..+|...|+|.+......+..+++++|+.+..+. ..|++|++||.+... .
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--g 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--G 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--c
Confidence 4555666677788999999999999999999999999998876667778889999887766 599999999988876 8
Q ss_pred eEEEEEEccCCCCHHHHHhhc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 153 RLVLIYELMENRSLQDALLDR-KCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~-~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
.+++.||.|. .+|..+...- ..+..+++..+-+|+..++.||.|||++. .+||||+||+||||+.+|++|+||||+
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence 8999999994 5887766542 23455899999999999999999999875 999999999999999999999999999
Q ss_pred ceecccc
Q 046097 232 ARLKTED 238 (603)
Q Consensus 232 A~~~~~~ 238 (603)
+.....+
T Consensus 196 sG~L~dS 202 (282)
T KOG0984|consen 196 SGYLVDS 202 (282)
T ss_pred ceeehhh
Confidence 9776543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=265.61 Aligned_cols=154 Identities=23% Similarity=0.346 Sum_probs=118.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEc----------------CCCceEEEEEecCCCChhhHHH--------------HHH
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVP----------------SSSQPLAVKILDSSGSLQGERE--------------FHN 126 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~----------------~tg~~VAVK~l~~~~~~~~~~~--------------~~~ 126 (603)
..++|++.++||+|+||.||+|... ..++.||||.+..... ...+. ...
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHH
Confidence 4678999999999999999999752 2346799999865321 11122 334
Q ss_pred HHHHhccCCCCce-----eEEEeEEecC------CCCeEEEEEEccCCCCHHHHHhhccc--------------------
Q 046097 127 ELSLASSLDCPHI-----VSLLGFASDR------RGRRLVLIYELMENRSLQDALLDRKC-------------------- 175 (603)
Q Consensus 127 Ev~iL~~l~HpNI-----V~l~g~~~~~------~~~~~~LVmEy~~~gsL~~~L~~~~~-------------------- 175 (603)
|+.++.+++|.++ ++++++|... ..+..++||||+++++|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6667777766554 6777777532 12568999999999999999864211
Q ss_pred -ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 176 -EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 176 -~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~ 358 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVD 358 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccc
Confidence 11246778889999999999999999 999999999999999999999999999854
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=256.92 Aligned_cols=156 Identities=24% Similarity=0.313 Sum_probs=132.8
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC------CCceeEEEeEEe
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD------CPHIVSLLGFAS 147 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~------HpNIV~l~g~~~ 147 (603)
.+..-++|.+....|+|-|++|.+|.+...|+.||||++... ....+.=+.|+++|.+|+ --|+++++-.|.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 345567899999999999999999999888999999999763 233455678999999994 247899998888
Q ss_pred cCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC-CcEEE
Q 046097 148 DRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKI 226 (603)
Q Consensus 148 ~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~-~~vKL 226 (603)
.. +++|||+|-+ .-+|.+.|+.....--+....+..++.|+..||..|-.. +|+|.||||.||||++. ..+||
T Consensus 505 hk--nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 505 HK--NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred hc--ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence 87 9999999988 459999998866655588899999999999999999987 99999999999999865 56899
Q ss_pred Eeeccceeccc
Q 046097 227 GDFGLARLKTE 237 (603)
Q Consensus 227 ~DFGlA~~~~~ 237 (603)
||||.|....+
T Consensus 579 CDfGSA~~~~e 589 (752)
T KOG0670|consen 579 CDFGSASFASE 589 (752)
T ss_pred ccCcccccccc
Confidence 99999876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=224.10 Aligned_cols=143 Identities=39% Similarity=0.631 Sum_probs=127.0
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCCCH
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSL 166 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL 166 (603)
||+|++|.||++....+++.+++|++...........+.+|+..+..+.|++|+++++++... ...++++|++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCcH
Confidence 689999999999997779999999997643322456799999999999999999999999986 789999999999999
Q ss_pred HHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-CCcEEEEeeccceecc
Q 046097 167 QDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-DFKAKIGDFGLARLKT 236 (603)
Q Consensus 167 ~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~-~~~vKL~DFGlA~~~~ 236 (603)
.+++.... ..++...+..++.+++.+|.+||+. +++|+||+|.||+++. ++.++|+|||.+....
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~ 144 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLT 144 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence 99987642 2378899999999999999999999 9999999999999998 8999999999987654
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=261.43 Aligned_cols=151 Identities=24% Similarity=0.338 Sum_probs=131.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhh-------HHHHHHHHHHhccCC---CCceeEEEeEEe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG-------EREFHNELSLASSLD---CPHIVSLLGFAS 147 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~-------~~~~~~Ev~iL~~l~---HpNIV~l~g~~~ 147 (603)
..+|..++.||.|+||.|++|.++++...|+||.+.++....+ .-.+-.|+++|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3458899999999999999999999999999999876432111 122557999999997 999999999999
Q ss_pred cCCCCeEEEEEEcc-CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEE
Q 046097 148 DRRGRRLVLIYELM-ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKI 226 (603)
Q Consensus 148 ~~~~~~~~LVmEy~-~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL 226 (603)
+. ++.||+||-. ++.+|.+++..+.. +++.++..|++||+.|+++||++ +|||||||-+|+.++.+|-+||
T Consensus 640 dd--d~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 640 DD--DYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred cC--CeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence 97 8999999965 56799999977654 89999999999999999999999 9999999999999999999999
Q ss_pred Eeeccceecc
Q 046097 227 GDFGLARLKT 236 (603)
Q Consensus 227 ~DFGlA~~~~ 236 (603)
+|||.|....
T Consensus 712 idfgsaa~~k 721 (772)
T KOG1152|consen 712 IDFGSAAYTK 721 (772)
T ss_pred eeccchhhhc
Confidence 9999986654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=249.58 Aligned_cols=150 Identities=25% Similarity=0.385 Sum_probs=131.3
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcC---CCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEec
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPS---SSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASD 148 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~---tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~ 148 (603)
.+....+.|..+++||+|.|++||++.+.. ..+.||+|.+... .....+.+|+++|..+. +.||+.+.+++..
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t---s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT---SSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc---cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 345567789999999999999999999876 7889999998653 34456899999999996 9999999999887
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc-CCCcEEEE
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD-GDFKAKIG 227 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld-~~~~vKL~ 227 (603)
. +.+.+||||++.....+++.. ++..++..++..++.||.++|.+ |||||||||.|+|.+ ..+.-.|+
T Consensus 107 n--d~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 107 N--DQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred C--CeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEE
Confidence 6 899999999999999988854 67788999999999999999999 999999999999997 45678999
Q ss_pred eeccceecc
Q 046097 228 DFGLARLKT 236 (603)
Q Consensus 228 DFGlA~~~~ 236 (603)
|||+|....
T Consensus 176 DFgLA~~~d 184 (418)
T KOG1167|consen 176 DFGLAQRYD 184 (418)
T ss_pred echhHHHHH
Confidence 999998533
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-28 Score=243.80 Aligned_cols=149 Identities=28% Similarity=0.418 Sum_probs=124.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCC-CChhhHHHHHHHHHHhccCCCCceeEEEeEEecC----CCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS-GSLQGEREFHNELSLASSLDCPHIVSLLGFASDR----RGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~-~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~----~~~ 152 (603)
..+|.-+..+|.|.- .|..+.+.-.+++||+|..... ......++..+|..++..+.|+||++++.+|.-. .-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777788999998 7888888888999999987443 2233446778999999999999999999998633 124
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
.+|+|||+|. .+|...+... ++-..+..+..|++.|+.|||+. +|+||||||+||++..++.+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILME-----LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 6899999995 5888877632 67788999999999999999999 9999999999999999999999999999
Q ss_pred eecc
Q 046097 233 RLKT 236 (603)
Q Consensus 233 ~~~~ 236 (603)
+...
T Consensus 166 r~e~ 169 (369)
T KOG0665|consen 166 RTED 169 (369)
T ss_pred cccC
Confidence 7543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-29 Score=247.37 Aligned_cols=152 Identities=28% Similarity=0.500 Sum_probs=125.7
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCC-CChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC---CeEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS-GSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG---RRLV 155 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~-~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~---~~~~ 155 (603)
+.+..+.||-|+||.||.+++.++|+.||+|++..- ......+.+.+|+.+|.-++|.|++..+++.+-..- ..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345567899999999999999999999999987542 122344778999999999999999999988764421 2467
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+++|.|.. +|..++.... .++...+.-+++||++||.|||+. +|.||||||.|.|+++|..+||||||+|+..
T Consensus 134 V~TELmQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 88888854 7877775543 378888888999999999999999 9999999999999999999999999999875
Q ss_pred ccc
Q 046097 236 TED 238 (603)
Q Consensus 236 ~~~ 238 (603)
+.+
T Consensus 207 e~d 209 (449)
T KOG0664|consen 207 DQR 209 (449)
T ss_pred chh
Confidence 543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=229.73 Aligned_cols=149 Identities=21% Similarity=0.444 Sum_probs=131.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+++|.|.|+.||.|....+++.++||+++. -..+.+.+|+.+|..+. ||||++++++..++......
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 45678999999999999999999988999999999976 34567899999999997 99999999999998778889
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC-CcEEEEeecccee
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGLARL 234 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~-~~vKL~DFGlA~~ 234 (603)
+|+||+.+.+...+... ++...+..++.+++.||.|+|++ ||.|||+||.|++||.. -.++|+|.|+|..
T Consensus 112 LiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 99999999888776532 67788889999999999999999 99999999999999854 5699999999977
Q ss_pred cccc
Q 046097 235 KTED 238 (603)
Q Consensus 235 ~~~~ 238 (603)
..+.
T Consensus 183 YHp~ 186 (338)
T KOG0668|consen 183 YHPG 186 (338)
T ss_pred cCCC
Confidence 6543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=221.75 Aligned_cols=149 Identities=34% Similarity=0.507 Sum_probs=131.9
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEc
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
|.+.+.||.|++|.||++....+++.+++|.+...........+.+|++.+.+++|+|++++++++... ...++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEEec
Confidence 567789999999999999998888999999997643322567889999999999999999999998876 788999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
+++++|.+++...... +++..+..++.+++.+|.+||+. +++|+||+|.||+++.++.++|+|||.+....
T Consensus 79 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 79 CEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred cCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 9999999998764321 68899999999999999999999 99999999999999999999999999987654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=277.24 Aligned_cols=95 Identities=16% Similarity=0.156 Sum_probs=77.8
Q ss_pred CCC-CceeEEEeEEecC-----CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 046097 134 LDC-PHIVSLLGFASDR-----RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVI 207 (603)
Q Consensus 134 l~H-pNIV~l~g~~~~~-----~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIV 207 (603)
+.| .||..++++|... ....++++||++ +++|.+++... ...+++.+++.++.||+.||.|||++ +|+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 345 5777788876221 114577888887 66999999643 23489999999999999999999999 999
Q ss_pred eccCCCCCeEEcCCCcEEEEeecccee
Q 046097 208 HGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 208 HrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||||+||||+..+.+|++|||++..
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~ 129 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSD 129 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCc
Confidence 999999999999999999999998864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=227.88 Aligned_cols=148 Identities=20% Similarity=0.354 Sum_probs=127.0
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeE-EecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGF-ASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~-~~~~~~~~~ 154 (603)
..+.|.+.+.||+|.||.+.+++++.+...+++|.+.. .......|.+|...--.+. |.||+.-|+. |+.. +..
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~--p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~--d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR--PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS--DAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc--chhhHHHHHHHhccceeeccchhhhHHHHHHhhcC--ceE
Confidence 45679999999999999999999999999999999975 3456678999998777775 9999998876 4444 688
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc--CCCcEEEEeeccc
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD--GDFKAKIGDFGLA 232 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld--~~~~vKL~DFGlA 232 (603)
++++||++.|+|.+-+.... +.+.....++.|+++||.|||+. ++||||||.+||||- +..++||||||..
T Consensus 98 vF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence 89999999999988775532 77888899999999999999999 999999999999993 4458999999998
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
+..
T Consensus 171 ~k~ 173 (378)
T KOG1345|consen 171 RKV 173 (378)
T ss_pred ccc
Confidence 654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-27 Score=256.33 Aligned_cols=153 Identities=28% Similarity=0.376 Sum_probs=137.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|+.+..+|.|+||.||+++++.+++..|+|+++.. ......-++.|+-+++.++|+||+.++|-+... ..+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-p~dd~~~iqqei~~~~dc~h~nivay~gsylr~--dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR--DKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeecc-CCccccccccceeeeecCCCcChHHHHhhhhhh--cCcEE
Confidence 457899999999999999999999999999999999874 334556788999999999999999999999876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
+||||.+|+|++..+-. +++++.++..+++..+.||+|||+. +-+|||||-.||++++.|.+|++|||.+..+.
T Consensus 90 cMEycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEEecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence 99999999999977543 4589999999999999999999999 99999999999999999999999999987655
Q ss_pred cc
Q 046097 237 ED 238 (603)
Q Consensus 237 ~~ 238 (603)
..
T Consensus 164 at 165 (829)
T KOG0576|consen 164 AT 165 (829)
T ss_pred hh
Confidence 43
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-24 Score=201.75 Aligned_cols=102 Identities=21% Similarity=0.249 Sum_probs=71.1
Q ss_pred ccccCccCccccCCCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCC
Q 046097 462 RGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLD 541 (603)
Q Consensus 462 ~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+..... . . .+......
T Consensus 65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~-~-----~-~~~~~~~~ 132 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----SAILEILLNGMP-A-----D-DPRDRSNL 132 (176)
T ss_pred CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----cHHHHHHHHHhc-c-----C-CccccccH
Confidence 3788899999999999999999999999999999999998643321 111111111100 0 0 01000111
Q ss_pred HHHHH--HHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 046097 542 KDQAL--LCITIALLCLQRSPSKRLTMKDIVEMLTG 575 (603)
Q Consensus 542 ~~~~~--~l~~l~~~cl~~dP~~Rpt~~evl~~l~~ 575 (603)
..... .+.+++..||+.||.+||++.|+++.+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 22222 68999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=228.38 Aligned_cols=146 Identities=24% Similarity=0.308 Sum_probs=115.6
Q ss_pred CCCceeeccCceEEEEEEEcCCCceEEEEEec----CCCChhhH-HHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 82 SPSNRLGHGGFGSVYKAVVPSSSQPLAVKILD----SSGSLQGE-REFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 82 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~----~~~~~~~~-~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
.....+|.|++|.|+........+.++.|.+. ........ ..+..|+.+-..+.|+|++..+..+.+. ....-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccchh
Confidence 45678999999988888876666656666543 22222222 2277788888899999998888777765 33344
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
.||||++ +|..++... ..+...++..++.|++.|+.|||.. ||.|||||++|+++..+|.+||+|||.+....
T Consensus 399 ~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeec
Confidence 4999999 999998765 2378889999999999999999999 99999999999999999999999999986543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-21 Score=190.21 Aligned_cols=148 Identities=36% Similarity=0.523 Sum_probs=126.4
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh--hHHHHHHHHHHhccCCCC-ceeEEEeEEecCCCCeEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ--GEREFHNELSLASSLDCP-HIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~--~~~~~~~Ev~iL~~l~Hp-NIV~l~g~~~~~~~~~~~LV 157 (603)
|.+...||.|+||.||.+.+. ..+++|.+....... ....+.+|+.++..+.|+ +++++++++... ...+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEEE
Confidence 667788999999999999985 788999997754443 367899999999999988 799999999664 558999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC-cEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-KAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-~vKL~DFGlA~~~~ 236 (603)
++++.++++.+++........+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999997765543112478899999999999999999999 999999999999999988 79999999987443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=206.28 Aligned_cols=144 Identities=21% Similarity=0.157 Sum_probs=115.8
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcC-CCceEEEEEecCCC----ChhhHHHHHHHHHHhccCCCCceeEEEeEEecC
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPS-SSQPLAVKILDSSG----SLQGEREFHNELSLASSLDCPHIVSLLGFASDR 149 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~-tg~~VAVK~l~~~~----~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~ 149 (603)
....++|.+.+.||+|+||+||+|.++. +++.||||++.... .......+.+|+++|.+++|+|++..+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456789999999999999999999875 67888999875321 122356689999999999999998533221
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCeEEcCCCcEEEEe
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDI-KPSNILLDGDFKAKIGD 228 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDL-Kp~NILld~~~~vKL~D 228 (603)
+..++||||+++++|... . . .. ...++.|++.||.|||++ ||+|||| ||+|||++.++.+||+|
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~--~----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-R--P----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-C--c----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence 346999999999999632 1 1 11 135788999999999999 9999999 99999999999999999
Q ss_pred eccceecc
Q 046097 229 FGLARLKT 236 (603)
Q Consensus 229 FGlA~~~~ 236 (603)
||+|+...
T Consensus 156 FGlA~~~~ 163 (365)
T PRK09188 156 FQLASVFR 163 (365)
T ss_pred Cccceecc
Confidence 99998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=198.57 Aligned_cols=147 Identities=27% Similarity=0.370 Sum_probs=121.5
Q ss_pred CCCCCceeeccCceEEEEEEEcCCC-ceEEEEEecCCCChhhHHHHHHHHHHhccCCC----CceeEEEeEEe-cCCCCe
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSS-QPLAVKILDSSGSLQGEREFHNELSLASSLDC----PHIVSLLGFAS-DRRGRR 153 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg-~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~H----pNIV~l~g~~~-~~~~~~ 153 (603)
+|.+.+.||+|+||.||.+.+..++ ..+|+|........... .+..|..++..+.. .++..+++... .. ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~--~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE--DF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCC--ce
Confidence 8999999999999999999987664 67899987653322222 56778888887762 58888888884 43 78
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC-----CcEEEEe
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-----FKAKIGD 228 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~-----~~vKL~D 228 (603)
.++||+.+ |.+|.++..... ...++..+.+.++.|++.+|.+||+. |++||||||.|+++... ..+.|.|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 89999988 789999886655 45599999999999999999999999 99999999999999754 4699999
Q ss_pred ecccee
Q 046097 229 FGLARL 234 (603)
Q Consensus 229 FGlA~~ 234 (603)
||+++.
T Consensus 171 fGlar~ 176 (322)
T KOG1164|consen 171 FGLARR 176 (322)
T ss_pred cCCCcc
Confidence 999983
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=183.70 Aligned_cols=150 Identities=24% Similarity=0.369 Sum_probs=124.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCC-CceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC-PHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~H-pNIV~l~g~~~~~~~~~~~ 155 (603)
..+.|.++++||.|+||.+|+|....+|+.||||+-.... ...++..|..+...+++ ..|..+..+..+. .+-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~--~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEK--DYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhcccc--ccce
Confidence 4578999999999999999999999999999999975532 23456778888888864 5666776666665 7789
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC---CCcEEEEeeccc
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG---DFKAKIGDFGLA 232 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~---~~~vKL~DFGlA 232 (603)
+||+.+ |.+|.+++.-- ...++..+++.++.|++.-+.|+|.+ +.|||||||+|+|+.- ...+.|+|||+|
T Consensus 88 lVMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 999998 88999987543 33488999999999999999999999 9999999999999963 346899999999
Q ss_pred eeccc
Q 046097 233 RLKTE 237 (603)
Q Consensus 233 ~~~~~ 237 (603)
+....
T Consensus 162 Kky~d 166 (341)
T KOG1163|consen 162 KKYRD 166 (341)
T ss_pred hhhcc
Confidence 87643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-20 Score=186.31 Aligned_cols=151 Identities=23% Similarity=0.390 Sum_probs=125.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~ 155 (603)
..-.|.+.++||+|+||.++.|...-++++||||.-... ....++..|....+.|. .++|..+|-|... |.+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqe--G~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQE--GKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccc--cchhh
Confidence 345799999999999999999999999999999986442 33456778888888775 7888888765554 47788
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC-----CcEEEEeec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-----FKAKIGDFG 230 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~-----~~vKL~DFG 230 (603)
||+|++ |.+|.++..- +++.++.++++.++.|++.-+.|+|++ .+|.|||||+|+||..- ..+.|+|||
T Consensus 101 LVidLL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhhhhh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEecc
Confidence 999988 8899998754 334589999999999999999999999 99999999999999643 358999999
Q ss_pred cceecccc
Q 046097 231 LARLKTED 238 (603)
Q Consensus 231 lA~~~~~~ 238 (603)
+|+.....
T Consensus 175 mAK~YrDp 182 (449)
T KOG1165|consen 175 MAKEYRDP 182 (449)
T ss_pred chhhhcCc
Confidence 99876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=177.30 Aligned_cols=140 Identities=19% Similarity=0.184 Sum_probs=107.9
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-h------------------------HHHHHHHHHHhccCCCCc
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-G------------------------EREFHNELSLASSLDCPH 138 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-~------------------------~~~~~~Ev~iL~~l~HpN 138 (603)
...||+|++|.||+|.+. +|+.||||+++...... . ......|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999996 89999999997642110 0 112345899999998777
Q ss_pred eeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeccCCCCCeE
Q 046097 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL-HHSCEPPVIHGDIKPSNIL 217 (603)
Q Consensus 139 IV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yL-Hs~~~~gIVHrDLKp~NIL 217 (603)
+.....+... ..++||||++++++....... ..++...+..++.|++.+|.+| |+. +|+||||||+|||
T Consensus 81 v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIl 150 (190)
T cd05147 81 IPCPEPILLK----SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLL 150 (190)
T ss_pred CCCCcEEEec----CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEE
Confidence 6443333222 238999999988776543222 2378899999999999999999 688 9999999999999
Q ss_pred EcCCCcEEEEeeccceec
Q 046097 218 LDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 218 ld~~~~vKL~DFGlA~~~ 235 (603)
++ ++.++|+|||+|...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-20 Score=187.62 Aligned_cols=139 Identities=23% Similarity=0.421 Sum_probs=115.0
Q ss_pred CCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-hHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 83 PSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-GEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 83 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
..-+|.+...|..|+|++. |..+++|++.-..... ..+.|..|.-.|+.+.||||+.++|.|..+ ..+.++..||
T Consensus 194 l~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~isq~m 269 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVIISQYM 269 (448)
T ss_pred hhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEeeeec
Confidence 3456888899999999994 5567788886543322 236789999999999999999999999987 7899999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEE
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
+.|+|...|+.... -.++..++.+++.++++|++|||+. ++-|.---|....++||++.+++|+
T Consensus 270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence 99999999987653 3478889999999999999999997 4444455789999999999888774
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.4e-19 Score=170.74 Aligned_cols=143 Identities=22% Similarity=0.161 Sum_probs=112.2
Q ss_pred CCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-------------------------hHHHHHHHHHHhccCCCC
Q 046097 83 PSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-------------------------GEREFHNELSLASSLDCP 137 (603)
Q Consensus 83 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-------------------------~~~~~~~Ev~iL~~l~Hp 137 (603)
+...||+|++|.||+|.+. +|+.||||+++...... ....+..|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 89999999997642110 012246789999999999
Q ss_pred ceeEEEeEEecCCCCeEEEEEEccCCCCHHHH-HhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCC
Q 046097 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDA-LLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSN 215 (603)
Q Consensus 138 NIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~-L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~N 215 (603)
++.....+.... .++||||++++++... +.. ..++......++.|++.+|.+||+ . ||+||||||+|
T Consensus 80 ~i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~N 148 (190)
T cd05145 80 GVPVPEPILLKK----NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYN 148 (190)
T ss_pred CCCCceEEEecC----CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhh
Confidence 875544443332 3899999998755443 322 236788899999999999999999 8 99999999999
Q ss_pred eEEcCCCcEEEEeeccceecccc
Q 046097 216 ILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 216 ILld~~~~vKL~DFGlA~~~~~~ 238 (603)
||++ ++.++|+|||++......
T Consensus 149 Ill~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 149 ILYH-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred EEEE-CCCEEEEEcccceecCCC
Confidence 9999 889999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-20 Score=214.86 Aligned_cols=142 Identities=21% Similarity=0.245 Sum_probs=112.0
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhH---HHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE---REFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~---~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
+|...+.||.+.|=+|.+|++.. |. |+||++-+....-.. .+-..|++ ...++|||++++.-+-... ...|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~--kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD--KAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh--HHHHH
Confidence 67777899999999999999853 44 999998665433333 33444455 5556899999987665544 55678
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
|-+|... +|.+.+..+. .+...+..-|+.|++.||..+|.. ||+|||||.+||||+.-.-+.|+||..-+
T Consensus 99 vRqyvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHHHHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccC
Confidence 8888855 8888886543 377788888999999999999999 99999999999999999999999997543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.2e-19 Score=178.66 Aligned_cols=143 Identities=14% Similarity=0.154 Sum_probs=115.8
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhH--HH------HHHHHHHhccCCCCceeEEEeEEe
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--RE------FHNELSLASSLDCPHIVSLLGFAS 147 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~--~~------~~~Ev~iL~~l~HpNIV~l~g~~~ 147 (603)
-..++|.+.++||.|+||.||++.. ++..+|||++......... .. +.+|+..+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3578999999999999999999766 4668999999764322221 22 678999999999999999999876
Q ss_pred cCC------CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC
Q 046097 148 DRR------GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD 221 (603)
Q Consensus 148 ~~~------~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~ 221 (603)
... .+..++||||++|.+|.++.. ++. ....+++.+|..||.. |++|||++|+||+++.+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 432 235799999999999987632 222 2455999999999999 99999999999999988
Q ss_pred CcEEEEeeccceec
Q 046097 222 FKAKIGDFGLARLK 235 (603)
Q Consensus 222 ~~vKL~DFGlA~~~ 235 (603)
+ ++|+|||.....
T Consensus 172 g-i~liDfg~~~~~ 184 (232)
T PRK10359 172 G-LRIIDLSGKRCT 184 (232)
T ss_pred C-EEEEECCCcccc
Confidence 8 999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.4e-18 Score=176.15 Aligned_cols=151 Identities=23% Similarity=0.340 Sum_probs=97.6
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCC----------CceeEEEeEEe-
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDC----------PHIVSLLGFAS- 147 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~H----------pNIV~l~g~~~- 147 (603)
+.....||.|+++.||.+++..+++.+|||++.... .....+++.+|.-....+.+ -.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 344578999999999999999999999999875432 22345667777755555432 11222222211
Q ss_pred --------cCCC-C-----eEEEEEEccCCCCHHHHHhh---ccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 046097 148 --------DRRG-R-----RLVLIYELMENRSLQDALLD---RKC-EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHG 209 (603)
Q Consensus 148 --------~~~~-~-----~~~LVmEy~~~gsL~~~L~~---~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHr 209 (603)
...+ . ..+++|+-+ .++|.+++.. ... ...+....++.+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1100 1 236778877 4588887653 111 11234455667789999999999999 99999
Q ss_pred cCCCCCeEEcCCCcEEEEeeccceec
Q 046097 210 DIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 210 DLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+|+|++++.+|.+.|+||+.....
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~ 195 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRA 195 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEET
T ss_pred ccceeeEEEcCCCCEEEcChHHHeec
Confidence 99999999999999999999876554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-18 Score=179.31 Aligned_cols=92 Identities=26% Similarity=0.379 Sum_probs=75.2
Q ss_pred CCCceeEEEeEEecCC-------------------------CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHH
Q 046097 135 DCPHIVSLLGFASDRR-------------------------GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI 189 (603)
Q Consensus 135 ~HpNIV~l~g~~~~~~-------------------------~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~ 189 (603)
+|||||+++++|.+.. +..+|+||..++. +|.+++..+. .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 6999999999876531 3578999998865 8999997654 45566677889
Q ss_pred HHHHHHHHHHhCCCCCeEeccCCCCCeEEc--CCC--cEEEEeecccee
Q 046097 190 DIAKGLEYLHHSCEPPVIHGDIKPSNILLD--GDF--KAKIGDFGLARL 234 (603)
Q Consensus 190 qIa~aL~yLHs~~~~gIVHrDLKp~NILld--~~~--~vKL~DFGlA~~ 234 (603)
|+++|+.|||.+ ||.|||||.+|||+. +++ .+.|+|||++-.
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA 394 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA 394 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence 999999999999 999999999999993 343 478899998743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-19 Score=195.97 Aligned_cols=143 Identities=22% Similarity=0.262 Sum_probs=116.2
Q ss_pred eeeccCceEEEEEEE---cCCCceEEEEEecCCCChh-hHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEEEEc
Q 046097 86 RLGHGGFGSVYKAVV---PSSSQPLAVKILDSSGSLQ-GEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~---~~tg~~VAVK~l~~~~~~~-~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
.+|+|.||.|++++- ...+..+|+|+.++..... .......|..++..++ ||.+++++-.++.. ...++++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc--cchhHhhhh
Confidence 379999999998653 3457788999886642111 1124456778888887 99999999988887 889999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
..+|.|...+..... +++.....+...++-|++++|+. +|+|||+|++||+++.+|.+++.|||+++...
T Consensus 79 ~rgg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred cccchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhH
Confidence 999999888765443 66777777888999999999999 99999999999999999999999999987643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=163.51 Aligned_cols=141 Identities=23% Similarity=0.358 Sum_probs=108.9
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-----CCCceeEEEeEEecCCC-CeE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-----DCPHIVSLLGFASDRRG-RRL 154 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-----~HpNIV~l~g~~~~~~~-~~~ 154 (603)
+.-..+||+|+||.||. +..++.. +||++.... ....+.+.+|+.++..+ .||||++++|++++..+ +.+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34457899999999996 6566665 699886632 23456789999999999 67999999999998643 343
Q ss_pred E-EEEEc--cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeccCCCCCeEEcC----CCcEEE
Q 046097 155 V-LIYEL--MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGL-EYLHHSCEPPVIHGDIKPSNILLDG----DFKAKI 226 (603)
Q Consensus 155 ~-LVmEy--~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL-~yLHs~~~~gIVHrDLKp~NILld~----~~~vKL 226 (603)
+ +|||| +.+++|.+++.+.. +++. ..++.+++.++ .|||++ +|+||||||+|||++. ++.++|
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 4 78999 55799999996532 4444 35677888787 999999 9999999999999974 347999
Q ss_pred Ee-ecccee
Q 046097 227 GD-FGLARL 234 (603)
Q Consensus 227 ~D-FGlA~~ 234 (603)
+| ||....
T Consensus 151 iDg~G~~~~ 159 (210)
T PRK10345 151 CDNIGESTF 159 (210)
T ss_pred EECCCCcce
Confidence 99 554444
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-19 Score=192.22 Aligned_cols=80 Identities=38% Similarity=0.546 Sum_probs=70.6
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
++|+.|++|...+|.++|.........++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999876655557888899999999999999 6 9999999999999999999999999998
Q ss_pred eecccc
Q 046097 233 RLKTED 238 (603)
Q Consensus 233 ~~~~~~ 238 (603)
......
T Consensus 404 ts~~~~ 409 (516)
T KOG1033|consen 404 TSQDKD 409 (516)
T ss_pred eecccC
Confidence 765543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=182.54 Aligned_cols=99 Identities=33% Similarity=0.558 Sum_probs=89.1
Q ss_pred hccCCCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCe-Eec
Q 046097 131 ASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV-IHG 209 (603)
Q Consensus 131 L~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gI-VHr 209 (603)
|+.+.|.|+.+++|.+.+. ...++|.+||..|+|.+.+.... ..+++.....++.+|+.||.|||.- .| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeee
Confidence 4678999999999999997 88999999999999999998743 2388999999999999999999987 55 999
Q ss_pred cCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 210 DIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 210 DLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
.|++.|.+++....+||.|||+.....
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred eeccccceeeeeEEEEechhhhccccc
Confidence 999999999999999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=156.60 Aligned_cols=133 Identities=19% Similarity=0.140 Sum_probs=104.9
Q ss_pred CCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC---hhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEE
Q 046097 82 SPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS---LQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 82 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~---~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.+...|+.|+||+|+.+.. .+.+++.+.+....- ......+.+|+++|+++. |+++++++++ ...+++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEE
Confidence 4567899999999998776 678888777755321 111235789999999995 5889999885 235899
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDI-KPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDL-Kp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+.|.+|...+.. ....++.|++.+|.++|++ ||+|||| ||+|||++.++.++|+|||+|...
T Consensus 77 meyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 77 RSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG 142 (218)
T ss_pred EeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence 999999888654311 1134678999999999999 9999999 799999999999999999999754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.4e-17 Score=163.20 Aligned_cols=152 Identities=22% Similarity=0.201 Sum_probs=115.2
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEE-EcCCCceEEEEEecCCCChh-----------------------hHHHHHHHHH
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAV-VPSSSQPLAVKILDSSGSLQ-----------------------GEREFHNELS 129 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~-~~~tg~~VAVK~l~~~~~~~-----------------------~~~~~~~Ev~ 129 (603)
+..-..-|++.+.||+|++|.||+|. +..+|+.||||+++...... ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33434458889999999999999998 66789999999987532100 1123568999
Q ss_pred HhccCCCC--ceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCC-e
Q 046097 130 LASSLDCP--HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP-V 206 (603)
Q Consensus 130 iL~~l~Hp--NIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g-I 206 (603)
++.++.+. .+.+++++ ...++||||+++.+|...+... ..+.......++.|++.+|.+||.. + +
T Consensus 103 ~L~~L~~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~i 170 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GEL 170 (237)
T ss_pred HHHHHHhcCCCCCeeeEe------cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence 99999753 33444432 1247999999998887654222 1255666778999999999999999 9 9
Q ss_pred EeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 207 IHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 207 VHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
+|+||||+||+++ ++.++|+|||.+......
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence 9999999999999 889999999998865443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.2e-16 Score=153.31 Aligned_cols=137 Identities=20% Similarity=0.276 Sum_probs=112.8
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-------hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-------QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-------~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
+.||+|++|.||+|.. .+..+++|+....... .....+.+|+.++..+.|++|.....++.+. ...+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEE
Confidence 5799999999999987 6778999986543211 1124578899999999999887777676655 567899
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||++|++|.+++.... . ....++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++....
T Consensus 78 ~e~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred EEEeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 99999999999885421 2 7778999999999999999 999999999999999 7899999999987643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-17 Score=187.61 Aligned_cols=126 Identities=20% Similarity=0.215 Sum_probs=86.1
Q ss_pred CCcccccCccCccccCCCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCC
Q 046097 459 PSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIH 538 (603)
Q Consensus 459 ~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
..++||+.|+|||++....|+..+|+|++|+|+||.+.|..||+..... + +...+ ... ...+ .
T Consensus 216 KqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--e-----lfg~v---isd--~i~w-----p 278 (1205)
T KOG0606|consen 216 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--E-----LFGQV---ISD--DIEW-----P 278 (1205)
T ss_pred ccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--H-----HHhhh---hhh--hccc-----c
Confidence 3578999999999999999999999999999999999999999876422 1 11111 100 0001 1
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--------hcCC----CCCCCCCCccCCCCCCCCCcccccc
Q 046097 539 SLDKDQALLCITIALLCLQRSPSKRLTMKDIVEM--------LTGE----AEPPHLPFEFSPSPPSNFPFKSQKK 601 (603)
Q Consensus 539 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--------l~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (603)
+-++....++.+++..+|+.+|..|.....-+++ |+-- -+..+.|-.......++|...+.++
T Consensus 279 E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfdTRs~Ry 353 (1205)
T KOG0606|consen 279 EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFDTRSDRY 353 (1205)
T ss_pred ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccchhhcccchhe
Confidence 1122234467788899999999999743333222 2211 1356777778888888888877765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.1e-16 Score=150.87 Aligned_cols=133 Identities=21% Similarity=0.295 Sum_probs=105.5
Q ss_pred eeeccCceEEEEEEEcCCCceEEEEEecCCCCh-------hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-------QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-------~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
.||+|++|.||+|.. ++..+++|........ .....+.+|+.++..+.|+++.....++... ...++||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEE
Confidence 489999999999995 5788999986542111 1125678899999999887655444444443 4568999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||+++++|.+++..... .++.+++.+|.+||+. +++|+|++|.||+++ ++.++|+|||++....
T Consensus 77 e~~~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred EEECCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 99999999988754210 6888999999999999 999999999999999 8899999999987654
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=149.89 Aligned_cols=147 Identities=20% Similarity=0.232 Sum_probs=112.5
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh---------------------hhHHHHHHHHHHh
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL---------------------QGEREFHNELSLA 131 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~---------------------~~~~~~~~Ev~iL 131 (603)
++......|.+.+.||+|+||.||++... +++.||||++...... .....+..|..++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 44454455888999999999999999874 7999999987653200 0112366788888
Q ss_pred ccCCCCc--eeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 046097 132 SSLDCPH--IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHG 209 (603)
Q Consensus 132 ~~l~HpN--IV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHr 209 (603)
..+.|++ +...++. ...++||||+++++|...... .....++.+++.++.++|+. +++|+
T Consensus 88 ~~l~~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~ 149 (198)
T cd05144 88 KALYEEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHG 149 (198)
T ss_pred HHHHHcCCCCCceeec------CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcC
Confidence 8887773 4444432 345899999999988765321 23456888999999999998 99999
Q ss_pred cCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 210 DIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 210 DLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
||+|+||++++++.++|+|||++......
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccCCCc
Confidence 99999999999999999999999665543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.6e-15 Score=169.07 Aligned_cols=144 Identities=18% Similarity=0.246 Sum_probs=113.5
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCC-CCh------hhHHHHHHHHHHhccCCCCceeEEEeEEe
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS-GSL------QGEREFHNELSLASSLDCPHIVSLLGFAS 147 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~-~~~------~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~ 147 (603)
......|...+.||+|+||.||+|.+. +..+++|+.... ... ...+.+.+|++++..++|++++....++.
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 344555677899999999999999874 334444443211 111 12356889999999999999988877776
Q ss_pred cCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEE
Q 046097 148 DRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 148 ~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
+. ...++||||+++++|.+++. ....++.+++.+|.+||+. +++||||||+|||+ .++.++|+
T Consensus 407 ~~--~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 407 DP--EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred eC--CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEE
Confidence 64 55789999999999998874 2456889999999999999 99999999999999 67899999
Q ss_pred eeccceeccc
Q 046097 228 DFGLARLKTE 237 (603)
Q Consensus 228 DFGlA~~~~~ 237 (603)
|||+++....
T Consensus 470 DFGla~~~~~ 479 (535)
T PRK09605 470 DFGLGKYSDL 479 (535)
T ss_pred eCcccccCCc
Confidence 9999987543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-15 Score=176.24 Aligned_cols=151 Identities=25% Similarity=0.299 Sum_probs=111.9
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC---CCceeEEEeEEecC
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD---CPHIVSLLGFASDR 149 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~---HpNIV~l~g~~~~~ 149 (603)
+.+.....|.|...||+|+||.||+|.... ++.||+|+-+....-+-. -=.+++.+|+ -+.|+.+...+.-.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY----I~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY----ICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee----ehHHHHHhhchhhhcchHHHHHHHccC
Confidence 445566778899999999999999999966 999999998764322111 0112222222 12333333333332
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc-------CCC
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD-------GDF 222 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld-------~~~ 222 (603)
+..+||+||.+.|+|.+++.. ...+++...+.+..|++.-+.+||.. +|||+||||+|+||. ...
T Consensus 767 --~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 767 --NASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred --CcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence 456899999999999999973 34489999999999999999999999 999999999999994 234
Q ss_pred cEEEEeeccceecc
Q 046097 223 KAKIGDFGLARLKT 236 (603)
Q Consensus 223 ~vKL~DFGlA~~~~ 236 (603)
-++|+|||.+-...
T Consensus 839 ~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMK 852 (974)
T ss_pred ceEEEecccceeee
Confidence 59999999886543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=130.70 Aligned_cols=138 Identities=22% Similarity=0.229 Sum_probs=113.2
Q ss_pred CCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCC--CceeEEEeEEecCCCCeEEEEEEc
Q 046097 83 PSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC--PHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 83 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~H--pNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
+.+.||.|.++.||++... +..+++|....... ...+..|+.++..+.| .+++++++++... +..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEe
Confidence 4578999999999999984 47899999866432 4578899999999976 5899998887765 678999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
++++.+..+ +......++.+++.+|.+||.....+++|+||+|+||+++..+.++++|||.+.....
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~~ 141 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCCh
Confidence 988777543 3455566888999999999986444799999999999999989999999999876543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.3e-14 Score=138.27 Aligned_cols=138 Identities=24% Similarity=0.283 Sum_probs=97.6
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhh-HHH----------------------HHHHHHHhccCCCCc--
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG-ERE----------------------FHNELSLASSLDCPH-- 138 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~-~~~----------------------~~~Ev~iL~~l~HpN-- 138 (603)
.+.||+|+||.||+|.+. +++.||||+++....... ... ...|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 789999999875321111 111 134555555554332
Q ss_pred eeEEEeEEecCCCCeEEEEEEccCCCCHHHH-HhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCe
Q 046097 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDA-LLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNI 216 (603)
Q Consensus 139 IV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~-L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NI 216 (603)
+.+.+++ ...++||||++++.+... +.... .. ..+..++.+++.++.++|. . +|+|+||||+||
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Ni 146 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNI 146 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhE
Confidence 4444332 234899999998543221 11110 11 5667889999999999999 7 999999999999
Q ss_pred EEcCCCcEEEEeeccceeccc
Q 046097 217 LLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~~~~ 237 (603)
+++ ++.++|+|||.+.....
T Consensus 147 li~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEE-CCcEEEEECcccccccC
Confidence 999 89999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=2e-13 Score=138.33 Aligned_cols=139 Identities=22% Similarity=0.237 Sum_probs=106.1
Q ss_pred ceee-ccCceEEEEEEEcCCCceEEEEEecCCCC------------hhhHHHHHHHHHHhccCCCCce--eEEEeEEecC
Q 046097 85 NRLG-HGGFGSVYKAVVPSSSQPLAVKILDSSGS------------LQGEREFHNELSLASSLDCPHI--VSLLGFASDR 149 (603)
Q Consensus 85 ~~LG-~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~------------~~~~~~~~~Ev~iL~~l~HpNI--V~l~g~~~~~ 149 (603)
..|| .|+.|+||.+.. .+..++||.+..... ......+.+|+.++.++.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4587 888899999887 477899998853210 1223567889999999998774 6777765443
Q ss_pred CCC--eEEEEEEccCC-CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEE
Q 046097 150 RGR--RLVLIYELMEN-RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKI 226 (603)
Q Consensus 150 ~~~--~~~LVmEy~~~-gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL 226 (603)
.+. ..++|||++++ .+|.+++... .++.. .+.+|+.+|.+||+. ||+|+||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 221 23599999997 6898887542 24433 356899999999999 9999999999999999899999
Q ss_pred Eeeccceecc
Q 046097 227 GDFGLARLKT 236 (603)
Q Consensus 227 ~DFGlA~~~~ 236 (603)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999988754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.5e-15 Score=165.65 Aligned_cols=152 Identities=26% Similarity=0.322 Sum_probs=119.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcC-CCceEEEEEecCCC-ChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPS-SSQPLAVKILDSSG-SLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~-tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~ 154 (603)
...|.+.+.||+|+|+.|-...... ....+|+|.+.... ..........|..+-..+. |.|++.+++...+. ...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--RSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC--ccc
Confidence 4567788889999999998887643 34456667664432 2333345556777777777 99999999998887 788
Q ss_pred EEEEEccCCCCHHHHHh-hcccccccCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeccCCCCCeEEcCCC-cEEEEeecc
Q 046097 155 VLIYELMENRSLQDALL-DRKCEELMEWNKRFEIAIDIAKGLEYLH-HSCEPPVIHGDIKPSNILLDGDF-KAKIGDFGL 231 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~-~~~~~~~l~~~~~l~Ia~qIa~aL~yLH-s~~~~gIVHrDLKp~NILld~~~-~vKL~DFGl 231 (603)
+++++|..++++.+.+. .... ..+....-.++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred ccccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchh
Confidence 99999999999998883 3221 2555666778999999999999 77 999999999999999999 999999999
Q ss_pred ceecc
Q 046097 232 ARLKT 236 (603)
Q Consensus 232 A~~~~ 236 (603)
|....
T Consensus 172 At~~~ 176 (601)
T KOG0590|consen 172 ATAYR 176 (601)
T ss_pred hcccc
Confidence 87643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.7e-11 Score=134.79 Aligned_cols=144 Identities=24% Similarity=0.249 Sum_probs=99.7
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhH---------------------------------------HHHH
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE---------------------------------------REFH 125 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~---------------------------------------~~~~ 125 (603)
+.||.|++|.||+|+.+ +|+.||||+.+......-. -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999985 6899999998764211100 0134
Q ss_pred HHHHHhccC----CCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHH-HHHHHHh
Q 046097 126 NELSLASSL----DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK-GLEYLHH 200 (603)
Q Consensus 126 ~Ev~iL~~l----~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~-aL~yLHs 200 (603)
+|...+.++ .|.+-+.+-.++.+. .+..++||||++|++|.++....... .+ ...++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHh
Confidence 445444444 233333433333322 13468999999999998876532211 22 2345556655 4678888
Q ss_pred CCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 201 ~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
. |++|+|++|.||+++.+++++|+|||++......
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 8 9999999999999999999999999999887654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.6e-11 Score=113.73 Aligned_cols=133 Identities=26% Similarity=0.218 Sum_probs=96.2
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCce-eEEEeEEecCCCCeEEEEEEccC
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI-VSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNI-V~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
++.|+.|.++.||+++. .+..|++|+...... ....+..|+.++..+.+.++ .+++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEecC
Confidence 35789999999999987 477899999865321 12345778888888765444 34554433 22479999999
Q ss_pred CCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 163 NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC--EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 163 ~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~--~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
+.++.... . ....++.+++.+|+.||... ..+++|+|++|.||+++ ++.++|+|||.+....
T Consensus 75 G~~l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~ 138 (170)
T cd05151 75 GSELLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND 138 (170)
T ss_pred CCcccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence 98775430 1 11235678999999999882 11259999999999999 6789999999987654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.8e-11 Score=136.79 Aligned_cols=149 Identities=19% Similarity=0.183 Sum_probs=97.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh---------------------------------hHHH-
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ---------------------------------GERE- 123 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~---------------------------------~~~~- 123 (603)
-..|+. +.||+|++|.||+|+.+.+|+.||||+.++..... ..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 78999999999999998789999999997642110 0111
Q ss_pred -----HHHHHHHhccC----CCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccc---cccCHHHHHHHHHHH
Q 046097 124 -----FHNELSLASSL----DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCE---ELMEWNKRFEIAIDI 191 (603)
Q Consensus 124 -----~~~Ev~iL~~l----~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~---~~l~~~~~l~Ia~qI 191 (603)
+.+|...+.++ .+.+.+.+-.++.+- .+..++||||++|+.+.++..-...+ ..+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-
Confidence 33444444433 244444444444332 14568999999999998743211111 01222222233333
Q ss_pred HHHHHHHHhCCCCCeEeccCCCCCeEEcCCC----cEEEEeeccceecccc
Q 046097 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDGDF----KAKIGDFGLARLKTED 238 (603)
Q Consensus 192 a~aL~yLHs~~~~gIVHrDLKp~NILld~~~----~vKL~DFGlA~~~~~~ 238 (603)
+... |++|+|++|.||+++.++ +++++|||++......
T Consensus 276 ------if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 ------VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3345 999999999999999888 9999999999887655
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-11 Score=125.59 Aligned_cols=99 Identities=25% Similarity=0.404 Sum_probs=81.9
Q ss_pred HHHhccCCCCceeEEEeEEecCC---CCeEEEEEEccCCCCHHHHHhhccc-ccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 046097 128 LSLASSLDCPHIVSLLGFASDRR---GRRLVLIYELMENRSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCE 203 (603)
Q Consensus 128 v~iL~~l~HpNIV~l~g~~~~~~---~~~~~LVmEy~~~gsL~~~L~~~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~ 203 (603)
..-|.++.|.|||+++.|+.+.. .....++.||+..|+|..+|++... ...+....-.+++.||+.||.|||+. +
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34455667999999999987642 2457899999999999999987443 33467777788999999999999995 8
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEE
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
+.|+|+++..+-|++..+|-+|+.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred CccccCCcchhheeecCCceEEec
Confidence 999999999999999999888874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.8e-11 Score=131.94 Aligned_cols=152 Identities=26% Similarity=0.278 Sum_probs=119.5
Q ss_pred cCCCCCceeec--cCceEEEEEEE--cCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCC
Q 046097 79 ASFSPSNRLGH--GGFGSVYKAVV--PSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGR 152 (603)
Q Consensus 79 ~~y~i~~~LG~--G~fG~Vy~a~~--~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~ 152 (603)
..|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... ......=.+|.....+++ |+|.++.+..+... +
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~--~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS--G 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC--C
Confidence 45667788999 99999999998 88899999997433211 122233346777777776 99999977777775 8
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeccCCCCCeEEcCC-CcEEEE
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK----GLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKIG 227 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~----aL~yLHs~~~~gIVHrDLKp~NILld~~-~~vKL~ 227 (603)
..++-+|++. .+|..+..... ..++....+....+... ||.++|.. +++|-|+||.||++..+ ..++++
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 8899999984 68888776533 33677788888888888 99999999 99999999999999999 889999
Q ss_pred eeccceecccc
Q 046097 228 DFGLARLKTED 238 (603)
Q Consensus 228 DFGlA~~~~~~ 238 (603)
|||+.......
T Consensus 266 df~~v~~i~~~ 276 (524)
T KOG0601|consen 266 DFGLVSKISDG 276 (524)
T ss_pred CcceeEEccCC
Confidence 99998766543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.3e-10 Score=108.49 Aligned_cols=139 Identities=15% Similarity=0.161 Sum_probs=98.7
Q ss_pred CceeeccCceEEEEEEEcC------CCceEEEEEecCCC------------C---------hhhHHHH----HHHHHHhc
Q 046097 84 SNRLGHGGFGSVYKAVVPS------SSQPLAVKILDSSG------------S---------LQGEREF----HNELSLAS 132 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~------tg~~VAVK~l~~~~------------~---------~~~~~~~----~~Ev~iL~ 132 (603)
...||.|.-+.||.|.... .+..+|||+++-.. . ......+ .+|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3569999999999998643 25789999874320 0 0112223 38999999
Q ss_pred cCCC--CceeEEEeEEecCCCCeEEEEEEccCCCCHHH-HHhhcccccccCHHHHHHHHHHHHHHHHHH-HhCCCCCeEe
Q 046097 133 SLDC--PHIVSLLGFASDRRGRRLVLIYELMENRSLQD-ALLDRKCEELMEWNKRFEIAIDIAKGLEYL-HHSCEPPVIH 208 (603)
Q Consensus 133 ~l~H--pNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~-~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yL-Hs~~~~gIVH 208 (603)
++.. -++..++++ ..-++||||+.+..+.. .+.+. .++......+..+++.+|..| |.. +|||
T Consensus 82 rl~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVH 148 (197)
T cd05146 82 RMQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVH 148 (197)
T ss_pred HHHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 8853 456666654 22379999997654422 22221 245556677889999999999 787 9999
Q ss_pred ccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 209 GDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 209 rDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
+||++.||+++ ++.+.|+|||.+....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.5e-10 Score=123.59 Aligned_cols=126 Identities=17% Similarity=0.291 Sum_probs=105.0
Q ss_pred EEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccc
Q 046097 97 KAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCE 176 (603)
Q Consensus 97 ~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~ 176 (603)
.|..+.++.+|.|..++.... .......+.++.|+.++||||++++..++.. +..|+|+|.+. -|..++.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~--~~~ylvTErV~--Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEE--GTLYLVTERVR--PLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhccc--CceEEEeeccc--cHHHHHHHh---
Confidence 466778899999999877544 4455678889999999999999999999887 78999999885 566677553
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 177 ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 177 ~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
.......-+.||+.||.|||..+ +++|++|....|+|++.|..||++|.++...
T Consensus 102 ---~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 102 ---GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 34556667889999999999665 9999999999999999999999999887544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.2e-10 Score=123.76 Aligned_cols=153 Identities=24% Similarity=0.270 Sum_probs=117.5
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEc-CCCceEEEEEecCCCChhhH-HHHHHHHHHhccCC-CCceeEEEeEEecCC
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVP-SSSQPLAVKILDSSGSLQGE-REFHNELSLASSLD-CPHIVSLLGFASDRR 150 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~-~tg~~VAVK~l~~~~~~~~~-~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~ 150 (603)
....+.+|..+..||.|.|+.|+..... .++-.|++|-+......... ..-..|+.+...+. |.+++..+..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~- 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL- 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-
Confidence 4567788999999999999999998765 57788999987654322222 22345666666664 88888866555544
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC-CcEEEEee
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKIGDF 229 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~-~~vKL~DF 229 (603)
...|+-.|||+++++...+.-. ..+++...+.+..|++.++.++|+. .++|+|++|+||++..+ +..++.||
T Consensus 339 -r~~~ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 339 -RQGYIPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred -ccccCchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccc
Confidence 5567999999999888766322 2378888999999999999999998 99999999999999876 77888888
Q ss_pred cccee
Q 046097 230 GLARL 234 (603)
Q Consensus 230 GlA~~ 234 (603)
|++..
T Consensus 412 ~~~t~ 416 (524)
T KOG0601|consen 412 GCWTR 416 (524)
T ss_pred ccccc
Confidence 88754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=3e-09 Score=104.46 Aligned_cols=148 Identities=21% Similarity=0.276 Sum_probs=108.6
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCC--CceeEEEeEEecCC-CCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC--PHIVSLLGFASDRR-GRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~H--pNIV~l~g~~~~~~-~~~~~LVmEy~ 161 (603)
+.|+.|..+.||++... +|..+++|+............+..|..++..+.+ .++.+++.+..... .+..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 56899999999999874 3578999998653322234567889999999875 34567777665431 12568999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC--------------------------------------- 202 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~--------------------------------------- 202 (603)
++.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99888765421 12566667777788888888887420
Q ss_pred --------------CCCeEeccCCCCCeEEcC--CCcEEEEeeccceeccc
Q 046097 203 --------------EPPVIHGDIKPSNILLDG--DFKAKIGDFGLARLKTE 237 (603)
Q Consensus 203 --------------~~gIVHrDLKp~NILld~--~~~vKL~DFGlA~~~~~ 237 (603)
...++|+|+.+.||+++. ++.+.|+||+.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~~ 209 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGDP 209 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCCh
Confidence 246899999999999998 56789999999876554
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.2e-10 Score=131.93 Aligned_cols=150 Identities=18% Similarity=0.228 Sum_probs=108.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..+.+.+.+-+..|.++.++.+.-..++...++|+....... ...+....+-.++-...||.++...--+.. ....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC--CCCc
Confidence 445677788899999999999888777766676665442111 112333334444444456666655443222 3668
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+|+++|+.+++|...|+.... .+..-.......+..++.+||.. .++|+|++|.|+++..++..++.|||+...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred chhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 999999999999998876543 45555566677889999999997 799999999999999999999999996543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.6e-09 Score=99.26 Aligned_cols=136 Identities=21% Similarity=0.300 Sum_probs=99.2
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEe-cCCCCh------hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKIL-DSSGSL------QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l-~~~~~~------~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
..+++|+-+.++.+.+ -|..+++|.= .+.... -......+|..++.++.--.|...+-+..+. ....++
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--DNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCEEE
Confidence 4578999999999977 3445777753 222111 1124567899999988644444444445554 556799
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
|||++|..|.+.+... ...++..+-.-+.-||.. +|||+||.++||++.... +.++|||++.....
T Consensus 78 me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 78 MEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred EEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 9999999998888654 134677788888999999 999999999999998655 99999999986554
Q ss_pred c
Q 046097 238 D 238 (603)
Q Consensus 238 ~ 238 (603)
.
T Consensus 144 ~ 144 (204)
T COG3642 144 V 144 (204)
T ss_pred H
Confidence 4
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.3e-08 Score=97.80 Aligned_cols=147 Identities=22% Similarity=0.219 Sum_probs=105.3
Q ss_pred CCceeeccCceEEEEEEEcCCCceEEEEEe-cCCC------ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 83 PSNRLGHGGFGSVYKAVVPSSSQPLAVKIL-DSSG------SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 83 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l-~~~~------~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
...+|-+|+-+.|+++.+ .|+.++||.- .+.. ..-...+..+|...|.++.--.|....-++.+. ..-.
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQ 86 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCe
Confidence 567899999999999998 6888888753 2211 111235678899999887544444333355555 3346
Q ss_pred EEEEccCC-CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC---cEEEEeecc
Q 046097 156 LIYELMEN-RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF---KAKIGDFGL 231 (603)
Q Consensus 156 LVmEy~~~-gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~---~vKL~DFGl 231 (603)
++|||+++ .++.+++....... ........++.+|-..+.-||.+ +|||+||..+||++..++ .+.|+|||+
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecc
Confidence 89999976 47788876654332 22333367889999999999999 999999999999997554 468999999
Q ss_pred ceeccc
Q 046097 232 ARLKTE 237 (603)
Q Consensus 232 A~~~~~ 237 (603)
+.....
T Consensus 163 s~~s~~ 168 (229)
T KOG3087|consen 163 SSVSRL 168 (229)
T ss_pred hhcccC
Confidence 876543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.1e-07 Score=98.23 Aligned_cols=144 Identities=15% Similarity=0.074 Sum_probs=99.6
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhH----------HHHHHHHHHhccCCCC--ceeEEEeEEecCC--
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE----------REFHNELSLASSLDCP--HIVSLLGFASDRR-- 150 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~----------~~~~~Ev~iL~~l~Hp--NIV~l~g~~~~~~-- 150 (603)
+.+-......|++... .|+.|.||........... ..+.+|...+.++... .++.++++.+...
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4444444455667765 5788999977442211111 1367888888777422 2334455554321
Q ss_pred -CCeEEEEEEccCCC-CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-------C
Q 046097 151 -GRRLVLIYELMENR-SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-------D 221 (603)
Q Consensus 151 -~~~~~LVmEy~~~g-sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~-------~ 221 (603)
....++|||++++. +|.+++..... ...+......++.+++..+.-||.. ||+|+||++.|||++. +
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 13578999999886 89888754221 2245667778999999999999999 9999999999999975 4
Q ss_pred CcEEEEeecccee
Q 046097 222 FKAKIGDFGLARL 234 (603)
Q Consensus 222 ~~vKL~DFGlA~~ 234 (603)
+.+.|+||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.6e-08 Score=94.14 Aligned_cols=127 Identities=23% Similarity=0.265 Sum_probs=81.1
Q ss_pred EEEEEEEcCCCceEEEEEecCCCC-------------------------hhhHHHHHHHHHHhccCCCC--ceeEEEeEE
Q 046097 94 SVYKAVVPSSSQPLAVKILDSSGS-------------------------LQGEREFHNELSLASSLDCP--HIVSLLGFA 146 (603)
Q Consensus 94 ~Vy~a~~~~tg~~VAVK~l~~~~~-------------------------~~~~~~~~~Ev~iL~~l~Hp--NIV~l~g~~ 146 (603)
.||.|.. ..+..+|||+.+.... ........+|.+.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888887 4577999999844200 00124577899999999755 566666543
Q ss_pred ecCCCCeEEEEEEccC--CCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeccCCCCCeEEcCCCc
Q 046097 147 SDRRGRRLVLIYELME--NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY-LHHSCEPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 147 ~~~~~~~~~LVmEy~~--~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~y-LHs~~~~gIVHrDLKp~NILld~~~~ 223 (603)
. -++||||++ |..+..+... . ++......++.+++..+.. +|.. ||+|+||.+.||+++++ .
T Consensus 80 ~------~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 R------NVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp T------TEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-C
T ss_pred C------CEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-e
Confidence 2 269999998 5455443322 1 1123345567777776655 4677 99999999999999987 9
Q ss_pred EEEEeeccceecc
Q 046097 224 AKIGDFGLARLKT 236 (603)
Q Consensus 224 vKL~DFGlA~~~~ 236 (603)
+.|+|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.4e-08 Score=113.51 Aligned_cols=95 Identities=19% Similarity=0.236 Sum_probs=62.4
Q ss_pred cccCccCccccCCCCCCccCCccchhheeeehcc-CCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCC
Q 046097 463 GTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLIS-GRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLD 541 (603)
Q Consensus 463 gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
....|.|||++.+...+.++|+||+||++|.+.. |+.-+........... -....+.......
T Consensus 171 ~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~----------------~~~~~~~~~~~~s 234 (700)
T KOG2137|consen 171 PHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF----------------SRNLLNAGAFGYS 234 (700)
T ss_pred cCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhh----------------hhccccccccccc
Confidence 4456999999999889999999999999999994 5555443322210000 0001111111222
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 046097 542 KDQALLCITIALLCLQRSPSKRLTMKDIVEML 573 (603)
Q Consensus 542 ~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~l 573 (603)
...+.++.+=+..++..++.-||++.++....
T Consensus 235 ~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 235 NNLPSELRESLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred ccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence 34555677888889999999999887776543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.7e-07 Score=92.84 Aligned_cols=145 Identities=19% Similarity=0.205 Sum_probs=99.8
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC---------------------hhhHHHHHHHHHHh
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS---------------------LQGEREFHNELSLA 131 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~---------------------~~~~~~~~~Ev~iL 131 (603)
.+.+...-+.+...||-|.-+.||.|.+. .|.++|||.-+.... ........+|.+.|
T Consensus 85 ~l~~r~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L 163 (304)
T COG0478 85 ALVKRGIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEAL 163 (304)
T ss_pred HHHHcChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHH
Confidence 34444444677789999999999999985 688999998643210 11234467899999
Q ss_pred ccCCCC--ceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 046097 132 SSLDCP--HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHG 209 (603)
Q Consensus 132 ~~l~Hp--NIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHr 209 (603)
.++... .|.+.+++ +...+|||+++|--|...- ++....-.++..|+.-+..+-.. ||||+
T Consensus 164 ~~L~~~G~~VP~P~~~------nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHG 226 (304)
T COG0478 164 QRLYPEGVKVPKPIAW------NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHG 226 (304)
T ss_pred HHhhhcCCCCCCcccc------ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---Ccccc
Confidence 988644 56665543 4457999999886554322 12223333444455544444455 99999
Q ss_pred cCCCCCeEEcCCCcEEEEeeccceec
Q 046097 210 DIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 210 DLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|+++-||+++++|.+.++||--+...
T Consensus 227 DlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 227 DLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred CCchheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999999766443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.8e-06 Score=85.49 Aligned_cols=109 Identities=26% Similarity=0.350 Sum_probs=83.1
Q ss_pred HHHHHHHHHhccCC--CCceeEEEeEEecCCC--CeEEEEEEccCCC-CHHHHHhhcccccccCHHHHHHHHHHHHHHHH
Q 046097 122 REFHNELSLASSLD--CPHIVSLLGFASDRRG--RRLVLIYELMENR-SLQDALLDRKCEELMEWNKRFEIAIDIAKGLE 196 (603)
Q Consensus 122 ~~~~~Ev~iL~~l~--HpNIV~l~g~~~~~~~--~~~~LVmEy~~~g-sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~ 196 (603)
....+|...+.++. .-.+.+.+++.+...+ ...++|+|++++. +|.+++..... .+......++.+++..+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 45677777766663 2335555666654322 3458999999874 79888875332 455667789999999999
Q ss_pred HHHhCCCCCeEeccCCCCCeEEcCCC---cEEEEeeccceecc
Q 046097 197 YLHHSCEPPVIHGDIKPSNILLDGDF---KAKIGDFGLARLKT 236 (603)
Q Consensus 197 yLHs~~~~gIVHrDLKp~NILld~~~---~vKL~DFGlA~~~~ 236 (603)
-||.. ||+|+|+++.|||++.+. .+.|+||+.++...
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999 999999999999999877 89999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.8e-06 Score=94.09 Aligned_cols=144 Identities=16% Similarity=0.168 Sum_probs=112.7
Q ss_pred CceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC--CCCeEEEEEEccCC-CCHH
Q 046097 91 GFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR--RGRRLVLIYELMEN-RSLQ 167 (603)
Q Consensus 91 ~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~--~~~~~~LVmEy~~~-gsL~ 167 (603)
-..+.|++....+|..|++|+++..... .......-++.++++.|.|||++..+|... ....+++|++|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3457899999999999999999543221 112233457889999999999999887732 12568999999986 6777
Q ss_pred HHHhhccc------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 168 DALLDRKC------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 168 ~~L~~~~~------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+....... ....++..++.++.|+..||.++|+. |+..+-|.+.+||++.+.+++|+..|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 76544322 12367899999999999999999999 9999999999999999999999988887776
Q ss_pred ccc
Q 046097 236 TED 238 (603)
Q Consensus 236 ~~~ 238 (603)
..+
T Consensus 444 ~~d 446 (655)
T KOG3741|consen 444 QED 446 (655)
T ss_pred cCC
Confidence 655
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.9e-05 Score=78.36 Aligned_cols=143 Identities=17% Similarity=0.119 Sum_probs=101.5
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCC--C---hhhHHHHHHHHHHhccCCC--CceeEEEeEEec--CCCCeEEEE
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSG--S---LQGEREFHNELSLASSLDC--PHIVSLLGFASD--RRGRRLVLI 157 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~---~~~~~~~~~Ev~iL~~l~H--pNIV~l~g~~~~--~~~~~~~LV 157 (603)
-|.||.+.|+.... .|+.+-+|.-.... + ......|.+|...+.++.. -.+.++...... ...-.-+||
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 46688888998776 34567888654211 0 2245779999999888842 224455422211 112346899
Q ss_pred EEccCC-CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc--EEEEeecccee
Q 046097 158 YELMEN-RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK--AKIGDFGLARL 234 (603)
Q Consensus 158 mEy~~~-gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~--vKL~DFGlA~~ 234 (603)
+|-+.+ .+|.+++..... ...+......+..+++..+.-||.. |+.|+|+-+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997754 588888765432 2356777788999999999999999 9999999999999986666 99999987765
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 4
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.9e-06 Score=93.78 Aligned_cols=144 Identities=20% Similarity=0.251 Sum_probs=91.8
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhh---------------------------------------HHHHH
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG---------------------------------------EREFH 125 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~---------------------------------------~~~~~ 125 (603)
..|+.++-|.||+|+.++ |+.||||+.++.....- +-.+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 679999999999999964 99999999866421110 01123
Q ss_pred HHHHHhccC----C-CCceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHh
Q 046097 126 NELSLASSL----D-CPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200 (603)
Q Consensus 126 ~Ev~iL~~l----~-HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs 200 (603)
+|...+.++ . .+++ .+=.+|.+- .+.-.++|||++|..+.+...-... .++...+.....++. +..+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia~~~~~~f--~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSA--GIDRKELAELLVRAF--LRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-Eeceeehhc-cCCcEEEEEeeCCEecccHHHHHhc--CCCHHHHHHHHHHHH--HHHHHh
Confidence 344433333 2 2332 222233321 1456899999999888887433221 144333332222222 222323
Q ss_pred CCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 201 ~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
. |..|.|..|.||+++.+|++.+.|||+.....+.
T Consensus 284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred c---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 3 9999999999999999999999999999887765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.9e-05 Score=84.38 Aligned_cols=139 Identities=17% Similarity=0.306 Sum_probs=87.8
Q ss_pred CCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEe-----cCCCCeEE
Q 046097 82 SPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFAS-----DRRGRRLV 155 (603)
Q Consensus 82 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~-----~~~~~~~~ 155 (603)
.....||+|+.+.+|-.-.- + ..+.|++...-.... . ..+..|... .||-+..-+.|-. -..+...-
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~-a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQ-A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchh--h-chhheeecCCCchHH-H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 34567999999999965431 1 234588765322111 1 123333333 4665443222211 11123366
Q ss_pred EEEEccCCC-CHHHHHhhc---ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 156 LIYELMENR-SLQDALLDR---KCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 156 LVmEy~~~g-sL~~~L~~~---~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
++|..+.+- -...++... ..-...+|...++++..++.+.+-||.. |.+-+|+.++|+|+.+++.+.|.|-.
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 778877653 222232211 1112368999999999999999999999 99999999999999999999998743
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.5e-05 Score=78.58 Aligned_cols=143 Identities=17% Similarity=0.263 Sum_probs=85.0
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCc--eeEEEeEEecCCCCeEEEEEEccC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH--IVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpN--IV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
.+||+|..+.||+. .+..+++|+..... ....+.+|.+++..+..-. +.+.+++..+. +...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~--~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDG--GRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecC--CeeeeeeeecC
Confidence 56899999999983 24467889886532 2345688998888875332 46666676654 55788999998
Q ss_pred CCC-HHHHHh--------------h-----ccc-ccccCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEe
Q 046097 163 NRS-LQDALL--------------D-----RKC-EELMEWNKRF-EIAI----------DIAK-GLEYLHHS-CEPPVIH 208 (603)
Q Consensus 163 ~gs-L~~~L~--------------~-----~~~-~~~l~~~~~l-~Ia~----------qIa~-aL~yLHs~-~~~gIVH 208 (603)
|.+ +...+. . +.. .......... .+-. .+.. ...+|... ....++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 221111 0 000 0000100000 0000 0111 12222211 1346799
Q ss_pred ccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 209 GDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 209 rDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
+|+.|.||++++++ +.|+||+.+.....
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~Gdp 185 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGYGNP 185 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCcCCH
Confidence 99999999999888 99999999876553
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.5e-05 Score=77.98 Aligned_cols=141 Identities=16% Similarity=0.187 Sum_probs=91.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhH--------HHHHHHHHHhccCC---CCceeEEEeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--------REFHNELSLASSLD---CPHIVSLLGF 145 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~--------~~~~~Ev~iL~~l~---HpNIV~l~g~ 145 (603)
..++|.+.+.+-......|.+-.. .++.+++|..+......+. ....+.+..+.++. -.....++..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 567888888888887777777766 6788999988664322111 11223333333332 2233332222
Q ss_pred EecC---CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC
Q 046097 146 ASDR---RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF 222 (603)
Q Consensus 146 ~~~~---~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~ 222 (603)
.+-. .....+++|||++|..|.++.. +++ .+...+..++.-||.. |+.|+|..|.|++++.+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-
Confidence 2211 1144578999999988766542 222 2445677889999999 99999999999999855
Q ss_pred cEEEEeecccee
Q 046097 223 KAKIGDFGLARL 234 (603)
Q Consensus 223 ~vKL~DFGlA~~ 234 (603)
.++++||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 499999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.9e-05 Score=75.45 Aligned_cols=149 Identities=22% Similarity=0.241 Sum_probs=86.1
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCC--ceeEEEeEEecC-CCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCP--HIVSLLGFASDR-RGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~Hp--NIV~l~g~~~~~-~~~~~~LVmEy~ 161 (603)
+.|+.|..+.||+..... ..+++|..... .....+..|..++..+... .+.+++.+.... .....+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 578999999999999843 58999998552 4456777888888877522 356666654332 224579999999
Q ss_pred CCCCHHH----------------HHhh---cc-cccccCHHH---------HHHH------------HHHHHH-HHHHHH
Q 046097 162 ENRSLQD----------------ALLD---RK-CEELMEWNK---------RFEI------------AIDIAK-GLEYLH 199 (603)
Q Consensus 162 ~~gsL~~----------------~L~~---~~-~~~~l~~~~---------~l~I------------a~qIa~-aL~yLH 199 (603)
++..+.. .+.. .. ......... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987777 1110 00 000000000 0000 111222 233333
Q ss_pred h----CCCCCeEeccCCCCCeEEc-CCCcEEEEeeccceecccc
Q 046097 200 H----SCEPPVIHGDIKPSNILLD-GDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 200 s----~~~~gIVHrDLKp~NILld-~~~~vKL~DFGlA~~~~~~ 238 (603)
. .....++|+|+.|.|||++ +++.+-|+||+.+......
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~~~~ 201 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWGDPA 201 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEEETH
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceECCHH
Confidence 2 1234799999999999999 6677789999998766443
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.0001 Score=74.60 Aligned_cols=156 Identities=21% Similarity=0.187 Sum_probs=102.8
Q ss_pred ccccHHHHHHhhcCCCCCceee---ccCceEEEEEEEcCCCceEEEEEecCCCChhh-----------------------
Q 046097 67 RRFSYNLIRRATASFSPSNRLG---HGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG----------------------- 120 (603)
Q Consensus 67 ~~~~~~~l~~~t~~y~i~~~LG---~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~----------------------- 120 (603)
-..+...+....++..+....| +|.-+.||+|.. .++..+|||+++.....-.
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 3455667777777777776655 566668999886 4688999999855311110
Q ss_pred HHHHHHHHHHhccCC--CCceeEEEeEEecCCCCeEEEEEEccCCC-CHHHHHhhcccccccCHHHHHHHHHHHHHHHHH
Q 046097 121 EREFHNELSLASSLD--CPHIVSLLGFASDRRGRRLVLIYELMENR-SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197 (603)
Q Consensus 121 ~~~~~~Ev~iL~~l~--HpNIV~l~g~~~~~~~~~~~LVmEy~~~g-sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~y 197 (603)
..-...|+.-|.++. +-.+.+-+++.. -.|||||+... .-.-.|.+ ..+...+...+..+++..+.-
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~------nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~ 181 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFRN------NVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRR 181 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeecC------CeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHH
Confidence 011345777777663 334445554443 26999998543 11111111 113333566677788888887
Q ss_pred HHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 198 LHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|-..+ ++||+||+.-|||+. ++.+.|+|||-|....
T Consensus 182 l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 182 LYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 77622 999999999999999 8899999999886654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=5.8e-05 Score=84.47 Aligned_cols=142 Identities=17% Similarity=0.148 Sum_probs=89.2
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhh------------------------------HHH------HHHHH
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG------------------------------ERE------FHNEL 128 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~------------------------------~~~------~~~Ev 128 (603)
+.||..+.|.||+|+.+. |+.||||+-++...... .+. |.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999975 99999999866422110 011 23333
Q ss_pred HHhc----cCCCCc------eeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHH
Q 046097 129 SLAS----SLDCPH------IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198 (603)
Q Consensus 129 ~iL~----~l~HpN------IV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yL 198 (603)
+-.. .+.|-+ |.+++-.+. ....|+||||+|..+.+.-.-... .++...+..-+.++..-+-+-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHHh
Confidence 2222 223444 334332222 456899999999866654322221 155554444333332222222
Q ss_pred HhCCCCCeEeccCCCCCeEEcC----CCcEEEEeeccceecccc
Q 046097 199 HHSCEPPVIHGDIKPSNILLDG----DFKAKIGDFGLARLKTED 238 (603)
Q Consensus 199 Hs~~~~gIVHrDLKp~NILld~----~~~vKL~DFGlA~~~~~~ 238 (603)
| |.+|+|-.|.||++.. ++.+.+.|||+.......
T Consensus 320 ~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 T-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred c-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2 9999999999999983 678999999998776654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00017 Score=85.82 Aligned_cols=155 Identities=16% Similarity=0.239 Sum_probs=95.0
Q ss_pred CceeeccCceEEEEEEEcCCC--ceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCce--eEEEeEEecCC-CCeEEEE
Q 046097 84 SNRLGHGGFGSVYKAVVPSSS--QPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHI--VSLLGFASDRR-GRRLVLI 157 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg--~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNI--V~l~g~~~~~~-~~~~~LV 157 (603)
...|+.|.++.+|+.....++ ..+++|+............+.+|..+++.+. |.+| .+++.+|.+.. .+..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 467899999999998774332 4677887654332233456889999999985 6654 78888887631 2457899
Q ss_pred EEccCCCCHHH--------------------HH---hhcccc--------cccC--HHHHHHHH---------------H
Q 046097 158 YELMENRSLQD--------------------AL---LDRKCE--------ELME--WNKRFEIA---------------I 189 (603)
Q Consensus 158 mEy~~~gsL~~--------------------~L---~~~~~~--------~~l~--~~~~l~Ia---------------~ 189 (603)
|||++|..+.+ .| +..... .+.. ..++..+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 11 110000 0000 01111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCeEeccCCCCCeEEcCC-Cc-EEEEeeccceecccc
Q 046097 190 DIAKGLEYLHHSCE--------PPVIHGDIKPSNILLDGD-FK-AKIGDFGLARLKTED 238 (603)
Q Consensus 190 qIa~aL~yLHs~~~--------~gIVHrDLKp~NILld~~-~~-vKL~DFGlA~~~~~~ 238 (603)
.+...+.+|..+.. +.+||+|+++.||+++.+ .. +-|.|+.++....+.
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdPl 261 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQM 261 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCChH
Confidence 12234566644321 359999999999999853 33 579999998877654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.0002 Score=72.19 Aligned_cols=143 Identities=18% Similarity=0.150 Sum_probs=84.1
Q ss_pred eeccCc-eEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEEEEccCCC
Q 046097 87 LGHGGF-GSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 87 LG~G~f-G~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
|..|.+ ..||+.... +..+.||+..... ...+.+|+.++..+. +--+.+++++.... +..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCc
Confidence 445555 788998763 4678889885532 234567777777663 34466777776654 5678999999988
Q ss_pred CHHHHHh-------------------hccc-ccccCHH--HHHHHHH--------------------HHHHHHHHHHhC-
Q 046097 165 SLQDALL-------------------DRKC-EELMEWN--KRFEIAI--------------------DIAKGLEYLHHS- 201 (603)
Q Consensus 165 sL~~~L~-------------------~~~~-~~~l~~~--~~l~Ia~--------------------qIa~aL~yLHs~- 201 (603)
+|..... .... ...+... ....... .+...+..|-..
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 7764321 0000 0001000 0000000 011112222111
Q ss_pred ---CCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 202 ---CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 202 ---~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
..+.++|+|+.|.|||++++..+.|+||+.+.....
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gdp 196 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVADR 196 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccccccH
Confidence 134699999999999999887788999998876553
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00021 Score=68.85 Aligned_cols=130 Identities=18% Similarity=0.252 Sum_probs=91.0
Q ss_pred CCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCcee-EEEeEEecCCCCeEEEEEEc
Q 046097 82 SPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV-SLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 82 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV-~l~g~~~~~~~~~~~LVmEy 160 (603)
...+.|++|.+|.||+|.+ .+..+|+|+-+.+ .....+..|.++|..+.-.++. +++.|-.+ ++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d---s~r~~l~kEakiLeil~g~~~~p~vy~yg~~------~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD---SPRRNLEKEAKILEILAGEGVTPEVYFYGED------FIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCC---cchhhHHHHHHHHHHhhhcCCCceEEEechh------hhhhhh
Confidence 4457899999999999998 4668999987653 3456788999999988755554 34444333 466999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC-CCCeEEcCCCcEEEEeeccceec
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIK-PSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLK-p~NILld~~~~vKL~DFGlA~~~ 235 (603)
+.|-.|.+.-... +..++. .++.+-.-|-.. ||-|+.|+ |..++|..+..+.|+||..|...
T Consensus 94 i~G~~L~~~~~~~------~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 94 IDGRPLGKLEIGG------DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hcCcchhhhhhcc------cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9998887765321 223333 344443344444 99999994 66666666779999999998744
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00011 Score=71.87 Aligned_cols=106 Identities=23% Similarity=0.202 Sum_probs=81.5
Q ss_pred HHHHHHhccCCC-CceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 046097 125 HNELSLASSLDC-PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203 (603)
Q Consensus 125 ~~Ev~iL~~l~H-pNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~ 203 (603)
.+|.-+++.+++ +++.+++|+|-. ++|.||...+++......-..-...+|..+.+|+.+++..+.+|+....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357888888875 699999999954 5788999877654220000000115899999999999999999998644
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
..+...|++++|+-+++++++|++|...+....
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 467889999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00076 Score=66.67 Aligned_cols=138 Identities=18% Similarity=0.248 Sum_probs=95.0
Q ss_pred cccccccHHHHHHhhcCCCCCceeeccCc-eEEEEEEEcCCCceEEEEEecC---CCC-----------h------hhHH
Q 046097 64 NHCRRFSYNLIRRATASFSPSNRLGHGGF-GSVYKAVVPSSSQPLAVKILDS---SGS-----------L------QGER 122 (603)
Q Consensus 64 ~~~~~~~~~~l~~~t~~y~i~~~LG~G~f-G~Vy~a~~~~tg~~VAVK~l~~---~~~-----------~------~~~~ 122 (603)
.....|.. -+.+++.++.||.|.. |.||+++. +|+.+|+|+++. ... . ....
T Consensus 27 PKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~ 99 (207)
T PF13095_consen 27 PKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYAD 99 (207)
T ss_pred CCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcC
Confidence 34445554 2278899999999999 99999998 688999999322 000 0 1113
Q ss_pred HHHHHHHHhccCC---CCce--eEEEeEEecC----------------CCCeEEEEEEccCCCCHHHHHhhcccccccCH
Q 046097 123 EFHNELSLASSLD---CPHI--VSLLGFASDR----------------RGRRLVLIYELMENRSLQDALLDRKCEELMEW 181 (603)
Q Consensus 123 ~~~~Ev~iL~~l~---HpNI--V~l~g~~~~~----------------~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~ 181 (603)
-|..|.....+++ +.++ |+++||..-. ......||.||.+... .+..
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~ 167 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI 167 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch
Confidence 4677877777764 4566 9999997422 0123467888776543 0222
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 182 NKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 182 ~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
. -+.+|.+-|..+|.. ||+-+|+++.|.. .-||+|||.+
T Consensus 168 ~----~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 R----DIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred h----HHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 2 244677778899998 9999999999998 3489999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00064 Score=68.38 Aligned_cols=34 Identities=29% Similarity=0.532 Sum_probs=28.3
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
..++|+|+.+.||+++.+...-|+||+.+.....
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~gDp 197 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVGDP 197 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCcCCh
Confidence 4699999999999998766567999999876543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.002 Score=63.66 Aligned_cols=136 Identities=22% Similarity=0.328 Sum_probs=90.2
Q ss_pred CCceeeccCceEEEEEEEcCCCceEEEEEecCCC---------------ChhhHHHHHHHHHHhccCC------CCceeE
Q 046097 83 PSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG---------------SLQGEREFHNELSLASSLD------CPHIVS 141 (603)
Q Consensus 83 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~---------------~~~~~~~~~~Ev~iL~~l~------HpNIV~ 141 (603)
....||+|+.-.||.-- .....+||+..... ......+..+|+.....+. +.+|.+
T Consensus 5 ~~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 34679999999999743 34557899987654 0112345556665544444 889999
Q ss_pred EEeEEecCCCCeEEEEEEccCC------CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 046097 142 LLGFASDRRGRRLVLIYELMEN------RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSN 215 (603)
Q Consensus 142 l~g~~~~~~~~~~~LVmEy~~~------gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~N 215 (603)
++|+.++. .-.-+|+|.+.+ .+|.+++.... ++. .....+ -.-..||-.+ .|+.+||+|.|
T Consensus 82 ~~G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L---~~f~~~l~~~---~Iv~~dl~~~N 148 (199)
T PF10707_consen 82 FYGFVETN--LGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQAL---DEFKRYLLDH---HIVIRDLNPHN 148 (199)
T ss_pred EeEEEecC--CceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHH---HHHHHHHHHc---CCeecCCCccc
Confidence 99999987 446788887642 36777775432 444 333333 3334667777 89999999999
Q ss_pred eEEcCC---C-cEEEEe-ecccee
Q 046097 216 ILLDGD---F-KAKIGD-FGLARL 234 (603)
Q Consensus 216 ILld~~---~-~vKL~D-FGlA~~ 234 (603)
|++... . .+.|+| ||....
T Consensus 149 Iv~~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred EEEEecCCCceEEEEEeCCCCccc
Confidence 999632 2 577777 565443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0012 Score=65.93 Aligned_cols=146 Identities=17% Similarity=0.183 Sum_probs=81.9
Q ss_pred ceeeccCceEEEEEEEcC-CCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 85 NRLGHGGFGSVYKAVVPS-SSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~-tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
+.|..|-...+|+..... .++.|++|+...... ......+|+.++..+. +....++++.+.. .++|||++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~------~~l~e~i~ 75 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQN------GLIYEFIP 75 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeCC------cEEEEeeC
Confidence 567788888999987632 256788998754211 1122346777777774 3334445443321 37999999
Q ss_pred CCCHHHH-------Hh----------hccccc--------ccC-HHHHHHHHH----------------------HHHHH
Q 046097 163 NRSLQDA-------LL----------DRKCEE--------LME-WNKRFEIAI----------------------DIAKG 194 (603)
Q Consensus 163 ~gsL~~~-------L~----------~~~~~~--------~l~-~~~~l~Ia~----------------------qIa~a 194 (603)
|.++... +. ...... ... +..+..+.. .+...
T Consensus 76 G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 155 (235)
T cd05157 76 GRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDE 155 (235)
T ss_pred CCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHH
Confidence 8765321 10 000000 011 111111111 11111
Q ss_pred HHHH----HhC-CCCCeEeccCCCCCeEEcC-CCcEEEEeeccceecccc
Q 046097 195 LEYL----HHS-CEPPVIHGDIKPSNILLDG-DFKAKIGDFGLARLKTED 238 (603)
Q Consensus 195 L~yL----Hs~-~~~gIVHrDLKp~NILld~-~~~vKL~DFGlA~~~~~~ 238 (603)
+..| ... ....++|+|+.+.|||++. ++.+.|+||..|......
T Consensus 156 ~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~~~ 205 (235)
T cd05157 156 ISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNYRA 205 (235)
T ss_pred HHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCchh
Confidence 1111 111 1247999999999999997 578999999988776544
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.002 Score=67.61 Aligned_cols=80 Identities=14% Similarity=0.085 Sum_probs=55.9
Q ss_pred CCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCC---CceeEEEeEEecC-CCCeEEEE
Q 046097 82 SPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC---PHIVSLLGFASDR-RGRRLVLI 157 (603)
Q Consensus 82 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~H---pNIV~l~g~~~~~-~~~~~~LV 157 (603)
.-.+.||.|..+.||.... ++..+.+|..+. ......+..|...|+.+.- -.+.++++++.+. ..+..++|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 17 SRVECISEQPYAALWALYD--SQGNPMPLMARS---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred heeeecCCccceeEEEEEc--CCCCEEEEEecc---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3346799999999999875 233577787543 1123467888888887742 3678888887642 22568999
Q ss_pred EEccCCCCH
Q 046097 158 YELMENRSL 166 (603)
Q Consensus 158 mEy~~~gsL 166 (603)
||++++.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=3.7e-05 Score=85.92 Aligned_cols=136 Identities=16% Similarity=0.071 Sum_probs=86.7
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCc-eeEEEeEEecCCCCeEEEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH-IVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpN-IV~l~g~~~~~~~~~~~LVmE 159 (603)
+...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+..+ .+.+++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E--~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGE--DYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcc--cccchhhh
Confidence 333456889999999998874433333 5555331 34456789999999999 55444444433 78899999
Q ss_pred ccCCC-CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 160 LMENR-SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 160 y~~~g-sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
++..+ +-...+. .....+...+...+...-++++++||+. .-+|+| ||+..+ +..+..||+.+...
T Consensus 315 i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 315 ICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhcCCccccccCC--hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCccc
Confidence 99776 2211110 1111133444555667778899999986 568888 777654 56777777766543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0014 Score=66.80 Aligned_cols=143 Identities=10% Similarity=0.052 Sum_probs=78.7
Q ss_pred eeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCce-eEEEeEEecCCCCeEEEEEEccCCC
Q 046097 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI-VSLLGFASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNI-V~l~g~~~~~~~~~~~LVmEy~~~g 164 (603)
.+..|-.+.+|+... +++.+++|......... .....+|..+++.+....+ .+++..+. + ++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~--~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVNE----H--WLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEeC----C--EEEEEeccCc
Confidence 356677888998874 56788899865422111 0124667777777753322 33443332 1 5899999886
Q ss_pred CHHHH--------------H---hhccc-ccccCHHH-HHHHHHHH---------HHHHHHHHhC-----CCCCeEeccC
Q 046097 165 SLQDA--------------L---LDRKC-EELMEWNK-RFEIAIDI---------AKGLEYLHHS-----CEPPVIHGDI 211 (603)
Q Consensus 165 sL~~~--------------L---~~~~~-~~~l~~~~-~l~Ia~qI---------a~aL~yLHs~-----~~~gIVHrDL 211 (603)
.+... + +.... ...++... +..+..++ ...+..+-.. ....++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 54321 1 11100 11112111 11111111 1112222111 1236899999
Q ss_pred CCCCeEEcCCCcEEEEeeccceecccc
Q 046097 212 KPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 212 Kp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
.|.||++++++ +.|+||..|....+.
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~gdp~ 179 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASDGDIA 179 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCcCCHH
Confidence 99999999877 789999998876654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0023 Score=66.66 Aligned_cols=146 Identities=22% Similarity=0.221 Sum_probs=84.3
Q ss_pred ceeeccCceEEEEEEEcC------CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCC-ceeEEEeEEecCCCCeEEEE
Q 046097 85 NRLGHGGFGSVYKAVVPS------SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCP-HIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~Hp-NIV~l~g~~~~~~~~~~~LV 157 (603)
+.|..|-...+|+..... .++.+++|+..... .......+|..++..+... -..++++++.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFPN------GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeCC------Cch
Confidence 456667778899887643 25789999976532 1223456677777766422 23455555532 258
Q ss_pred EEccCCCCHHHHH-----------------hhccccc------ccC--HHHHH--------------------------H
Q 046097 158 YELMENRSLQDAL-----------------LDRKCEE------LME--WNKRF--------------------------E 186 (603)
Q Consensus 158 mEy~~~gsL~~~L-----------------~~~~~~~------~l~--~~~~l--------------------------~ 186 (603)
+||++|..+.... +...... ..+ +..+. .
T Consensus 76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (302)
T cd05156 76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL 155 (302)
T ss_pred hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence 8998887654311 1100000 000 00100 0
Q ss_pred HHHHHHHHHHHHHh------CCCCCeEeccCCCCCeEEcCC----CcEEEEeeccceecccc
Q 046097 187 IAIDIAKGLEYLHH------SCEPPVIHGDIKPSNILLDGD----FKAKIGDFGLARLKTED 238 (603)
Q Consensus 187 Ia~qIa~aL~yLHs------~~~~gIVHrDLKp~NILld~~----~~vKL~DFGlA~~~~~~ 238 (603)
+...+...+.+|.. .....++|+|+.+.||+++.+ +.+.|+||..|......
T Consensus 156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p~ 217 (302)
T cd05156 156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYRG 217 (302)
T ss_pred HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCcH
Confidence 11122223334432 134589999999999999975 88999999999876654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0064 Score=66.36 Aligned_cols=77 Identities=12% Similarity=0.096 Sum_probs=52.3
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCC-----CC-hhhHHHHHHHHHHhccCC---CCceeEEEeEEecCCCCeEE
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSS-----GS-LQGEREFHNELSLASSLD---CPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~-----~~-~~~~~~~~~Ev~iL~~l~---HpNIV~l~g~~~~~~~~~~~ 155 (603)
+.||.|.+..||++....+++.|+||.-... .. .....+...|.+.|..+. ..++.+++.+.. ...+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~----~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE----ELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC----CCCE
Confidence 5699999999999998644468999985321 00 123455667777777652 346777876643 3468
Q ss_pred EEEEccCCCC
Q 046097 156 LIYELMENRS 165 (603)
Q Consensus 156 LVmEy~~~gs 165 (603)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0043 Score=64.37 Aligned_cols=147 Identities=17% Similarity=0.168 Sum_probs=83.3
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCC--ceeEEEeEEe----cCCCCeEEEE
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCP--HIVSLLGFAS----DRRGRRLVLI 157 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~Hp--NIV~l~g~~~----~~~~~~~~LV 157 (603)
.+.|..|....+|+... .+..+++|+... .....+..|+.++..+.+. .+.+++.... ...++..++|
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 45677787789998865 345788998864 1233455667666666432 2444433211 0112456899
Q ss_pred EEccCCCCHHH----HH----------hhccc--c------cccCHHHHH----------HHHHHHHHHHHHHHh----C
Q 046097 158 YELMENRSLQD----AL----------LDRKC--E------ELMEWNKRF----------EIAIDIAKGLEYLHH----S 201 (603)
Q Consensus 158 mEy~~~gsL~~----~L----------~~~~~--~------~~l~~~~~l----------~Ia~qIa~aL~yLHs----~ 201 (603)
+++++|..+.. .. +.... . ....+.... .....+..++.++.. .
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99998865421 11 00000 0 001111110 011123334444443 1
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 202 ~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
...+++|+|+.|.||++++++.+.|+||+.+....
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g~ 207 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACTDA 207 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhcCch
Confidence 13479999999999999988778899999887654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.019 Score=60.24 Aligned_cols=34 Identities=32% Similarity=0.396 Sum_probs=28.4
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 203 ~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
..++||+|+.|.||+++.+...-|+||+.+....
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~~ 219 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACNDK 219 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccCCc
Confidence 3489999999999999976656899999887543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0027 Score=75.73 Aligned_cols=77 Identities=17% Similarity=0.172 Sum_probs=57.9
Q ss_pred HHHHHHHHHhccCCCCceeEEEeEEecCCC-C-eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHH
Q 046097 122 REFHNELSLASSLDCPHIVSLLGFASDRRG-R-RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199 (603)
Q Consensus 122 ~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~-~-~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLH 199 (603)
....-|+..+..+.|+|++.++.|-..... + .+.+..+++..-++...+.... .++....+.+..++..||.|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHH
Confidence 334567788889999999999988765421 1 2234457787778887776543 3788888899999999999999
Q ss_pred hC
Q 046097 200 HS 201 (603)
Q Consensus 200 s~ 201 (603)
+.
T Consensus 304 ~~ 305 (1351)
T KOG1035|consen 304 SL 305 (1351)
T ss_pred Hh
Confidence 87
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.00092 Score=70.07 Aligned_cols=135 Identities=19% Similarity=0.227 Sum_probs=90.1
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC---------------------ChhhHHHHHHHHHHhccCC-
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG---------------------SLQGEREFHNELSLASSLD- 135 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~---------------------~~~~~~~~~~Ev~iL~~l~- 135 (603)
..-+.++++||-|.-+.||.+-+. .|.+.++|+.+... ..-.+-...+|...|+.+.
T Consensus 91 ~~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 91 GSVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred chhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 335788899999999999999884 57788888653310 0001233567888888774
Q ss_pred CCc-eeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 046097 136 CPH-IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPS 214 (603)
Q Consensus 136 HpN-IV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~ 214 (603)
|-+ |.+.+++ +..++|||++.+..|...-+- .+...+. ..+..-+--|..+ |+||+|..--
T Consensus 170 ~gfpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly---~~lm~~Iv~la~~---GlIHgDFNEF 231 (465)
T KOG2268|consen 170 RGFPVPKPIDH------NRHCVVMELVDGYPLRQVRHV------EDPPTLY---DDLMGLIVRLANH---GLIHGDFNEF 231 (465)
T ss_pred cCCCCCCcccc------cceeeHHHhhcccceeeeeec------CChHHHH---HHHHHHHHHHHHc---Cceecccchh
Confidence 322 3333332 456899999988777654322 2223332 2333333445556 9999999999
Q ss_pred CeEEcCCCcEEEEeecc
Q 046097 215 NILLDGDFKAKIGDFGL 231 (603)
Q Consensus 215 NILld~~~~vKL~DFGl 231 (603)
||++++++.++++||--
T Consensus 232 Nimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 232 NIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred eeEEecCCCEEEeechH
Confidence 99999999999999954
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.038 Score=57.85 Aligned_cols=160 Identities=18% Similarity=0.235 Sum_probs=86.8
Q ss_pred HHHHHhhcCCCC-----CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCC--ceeEEEe
Q 046097 72 NLIRRATASFSP-----SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCP--HIVSLLG 144 (603)
Q Consensus 72 ~~l~~~t~~y~i-----~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~Hp--NIV~l~g 144 (603)
+.+......|.+ +..++.|....+|+... ++..+++|+...... ...+..|.+++..+... .+.+++.
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEEe--CCCcEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 444444445544 34567777788998865 344678898754221 23344556666555321 2344433
Q ss_pred EEe----cCCCCeEEEEEEccCCCCHH----H-------H---Hhhcccc------c---ccCHHHHH------------
Q 046097 145 FAS----DRRGRRLVLIYELMENRSLQ----D-------A---LLDRKCE------E---LMEWNKRF------------ 185 (603)
Q Consensus 145 ~~~----~~~~~~~~LVmEy~~~gsL~----~-------~---L~~~~~~------~---~l~~~~~l------------ 185 (603)
... ...++..+++++|++|..+. . . ++..... . .-.|....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 211 11135678999999885431 1 1 1110000 0 00111100
Q ss_pred HHHHHHHHHHHHHHh----CCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 186 EIAIDIAKGLEYLHH----SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 186 ~Ia~qIa~aL~yLHs----~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
.....+...++++.. ....+++|+|+.+.||+++.++.+.|+||+.+....
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~~ 219 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACTDA 219 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccCcc
Confidence 011123334555542 123589999999999999988877899999886543
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.041 Score=58.97 Aligned_cols=146 Identities=16% Similarity=0.186 Sum_probs=80.9
Q ss_pred ceeeccCceEEEEEEEcC----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCce-eEEEeEEecCCCCeEEEEEE
Q 046097 85 NRLGHGGFGSVYKAVVPS----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI-VSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNI-V~l~g~~~~~~~~~~~LVmE 159 (603)
..|..|-...+|++.... +++.|++|+..... . ..-.-.+|..++..+...++ .++++++.. + .|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~---g---~v~e 113 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPN---G---RVEE 113 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-C-eeechHHHHHHHHHHHHcCCCCceEEEECC---c---eEEE
Confidence 345557778899987532 24689999886532 1 11122567777777653333 345555532 2 5789
Q ss_pred ccCCCCHHHH-----------------Hhhcccc--c-ccCHHHHHHHHH-----------------HHHHHHHHHH---
Q 046097 160 LMENRSLQDA-----------------LLDRKCE--E-LMEWNKRFEIAI-----------------DIAKGLEYLH--- 199 (603)
Q Consensus 160 y~~~gsL~~~-----------------L~~~~~~--~-~l~~~~~l~Ia~-----------------qIa~aL~yLH--- 199 (603)
|+++.+|... ++..... . ...+..+..+.. .+...+..|.
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9877665421 0110100 0 111222222221 1111222222
Q ss_pred -h-CCCCCeEeccCCCCCeEEcC-CCcEEEEeeccceecccc
Q 046097 200 -H-SCEPPVIHGDIKPSNILLDG-DFKAKIGDFGLARLKTED 238 (603)
Q Consensus 200 -s-~~~~gIVHrDLKp~NILld~-~~~vKL~DFGlA~~~~~~ 238 (603)
. .....++|+|+++.|||+++ ++.+.|+||..|......
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~~~ 235 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNPVA 235 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccchH
Confidence 1 12347899999999999986 468999999999876643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.029 Score=60.02 Aligned_cols=142 Identities=19% Similarity=0.193 Sum_probs=92.8
Q ss_pred CCceeeccCceEEEEEEEcCCCceEEEEEecCCC--------------------Ch----h-hHHHHHHHHHHhccCCCC
Q 046097 83 PSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--------------------SL----Q-GEREFHNELSLASSLDCP 137 (603)
Q Consensus 83 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--------------------~~----~-~~~~~~~Ev~iL~~l~Hp 137 (603)
+-..|..|.-+-||.|.. .+|..+|||+++-.. +. . ..-....|+.-|.++...
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345678899999999987 467789999874320 00 0 011234577777777554
Q ss_pred ceeEEEeEEecCCCCeEEEEEEccCCCCH-HHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 046097 138 HIVSLLGFASDRRGRRLVLIYELMENRSL-QDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNI 216 (603)
Q Consensus 138 NIV~l~g~~~~~~~~~~~LVmEy~~~gsL-~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NI 216 (603)
.|...--+.. ....|||+++..... .-.|+ ...++...+..+-.|++.-|.-|.+.| ++||.||.--|+
T Consensus 227 GIP~PePIlL----k~hVLVM~FlGrdgw~aPkLK----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~ 296 (520)
T KOG2270|consen 227 GIPCPEPILL----KNHVLVMEFLGRDGWAAPKLK----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNL 296 (520)
T ss_pred CCCCCCceee----ecceEeeeeccCCCCcCcccc----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhh
Confidence 4332211121 234799999853211 11121 123666677778888888888888877 999999999999
Q ss_pred EEcCCCcEEEEeeccceecc
Q 046097 217 LLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~~~ 236 (603)
|+. +|.+.|+|-+-+....
T Consensus 297 Lyh-dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 297 LYH-DGKLYIIDVSQSVEHD 315 (520)
T ss_pred eEE-CCEEEEEEccccccCC
Confidence 986 6789999987765443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.041 Score=58.25 Aligned_cols=143 Identities=16% Similarity=0.244 Sum_probs=84.0
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecC-CCChhhHHHHHHHHHHhccCCC--CceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDS-SGSLQGEREFHNELSLASSLDC--PHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~-~~~~~~~~~~~~Ev~iL~~l~H--pNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.+..|..-.+|.... ++++++++ ... ...........+|+.++..+.- --+...+++|.+..-+..+.||+++
T Consensus 31 ~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 31 EEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 3443344444555544 37788888 331 2333444566778887777642 3345556677665224679999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHH-HHHHHH----------------------------------------------
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIA-IDIAKG---------------------------------------------- 194 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia-~qIa~a---------------------------------------------- 194 (603)
+|..+...+.... .. ..++ ..++..
T Consensus 108 eGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 108 EGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred cceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 8842222111000 00 0011 122233
Q ss_pred ----HHHHHhCC-----CCCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 195 ----LEYLHHSC-----EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 195 ----L~yLHs~~-----~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
..||+.+- .+.++|+|+.+.||+++...-+=|.||+++....+.
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 33444331 247999999999999998888999999999887665
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.051 Score=56.43 Aligned_cols=35 Identities=29% Similarity=0.573 Sum_probs=29.0
Q ss_pred CCeEeccCCCCCeEEcCCCc-EEEEeeccceecccc
Q 046097 204 PPVIHGDIKPSNILLDGDFK-AKIGDFGLARLKTED 238 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~-vKL~DFGlA~~~~~~ 238 (603)
..++|+|+.+.|||++.++. .-|+||+.+....+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDPa 220 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDPA 220 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCHH
Confidence 46899999999999997555 569999999877654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.087 Score=56.76 Aligned_cols=74 Identities=15% Similarity=0.127 Sum_probs=46.0
Q ss_pred eeeccCceEEEEEEEcCCCceEEEEEecCC------CChhhHHHHHHHHHHhccCC--CC-ceeEEEeEEecCCCCeEEE
Q 046097 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSS------GSLQGEREFHNELSLASSLD--CP-HIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~------~~~~~~~~~~~Ev~iL~~l~--Hp-NIV~l~g~~~~~~~~~~~L 156 (603)
.||.|....||++....+++.|+||.-..- .-.....+..-|.+.|.... -| .+.+++.+-. ....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~----e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT----EMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc----cccee
Confidence 479999999999998544468999974221 11122344456666666543 23 4556654433 44569
Q ss_pred EEEccCC
Q 046097 157 IYELMEN 163 (603)
Q Consensus 157 VmEy~~~ 163 (603)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.083 Score=56.22 Aligned_cols=146 Identities=17% Similarity=0.233 Sum_probs=79.0
Q ss_pred ceeeccCceEEEEEEEcCC---CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCce-eEEEeEEecCCCCeEEEEEEc
Q 046097 85 NRLGHGGFGSVYKAVVPSS---SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI-VSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~t---g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNI-V~l~g~~~~~~~~~~~LVmEy 160 (603)
+.|..|-...+|+...... +..|++|+...... ..-.-.+|..+++.+..-++ .++++++.. + +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~---G---~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGN---G---MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCC---c---Eeehh
Confidence 4455577778998875432 33789998865321 11123467777777654333 355555532 2 58888
Q ss_pred cCCCCHHHH-------H----------hhcc-cc-c-ccCHHHHHHHHHH----------------------HHHHHHHH
Q 046097 161 MENRSLQDA-------L----------LDRK-CE-E-LMEWNKRFEIAID----------------------IAKGLEYL 198 (603)
Q Consensus 161 ~~~gsL~~~-------L----------~~~~-~~-~-~l~~~~~l~Ia~q----------------------Ia~aL~yL 198 (603)
+++.+|... + +... .. . +.-+..+..+..+ +..-+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 877654220 1 1100 00 0 0012222222111 11112222
Q ss_pred HhC-----CCCCeEeccCCCCCeEEcC-CCcEEEEeeccceecccc
Q 046097 199 HHS-----CEPPVIHGDIKPSNILLDG-DFKAKIGDFGLARLKTED 238 (603)
Q Consensus 199 Hs~-----~~~gIVHrDLKp~NILld~-~~~vKL~DFGlA~~~~~~ 238 (603)
... ...-.+|.||.+.|||+++ ++.++++||..|......
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd~~ 217 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSYRG 217 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCccH
Confidence 111 1124799999999999974 578999999999876654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.25 Score=54.11 Aligned_cols=81 Identities=17% Similarity=0.143 Sum_probs=50.8
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCC---h---hhHHHHHHHHHHhccCC---CCceeEEEeEEecCCCCeE
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS---L---QGEREFHNELSLASSLD---CPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~---~---~~~~~~~~Ev~iL~~l~---HpNIV~l~g~~~~~~~~~~ 154 (603)
.+.||.|....||+... .+..++||.-..... . ....+-..|...|..+. ..++.+++.++.+. .
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~----~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM----A 110 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC----C
Confidence 45789999999999887 345688997542110 0 12223334455555443 35788898888753 4
Q ss_pred EEEEEccCC--CCHHHHH
Q 046097 155 VLIYELMEN--RSLQDAL 170 (603)
Q Consensus 155 ~LVmEy~~~--gsL~~~L 170 (603)
+++||++++ ..+.+.+
T Consensus 111 vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 111 LIGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEEeecCCcceehhhhh
Confidence 788999976 3444433
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.11 Score=54.51 Aligned_cols=73 Identities=15% Similarity=0.250 Sum_probs=44.4
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC---CCCceeEEEeEEecCCCCeEEEEEEc
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL---DCPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l---~HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
.+.++.|....+|+.. .+++.+.||+-.. .....|..|..-|+.| .--.+.+++++.... +..+|||||
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLlle~ 93 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLLLEF 93 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEEEE-
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEEEEe
Confidence 3568888889999877 4788899998753 2234566777766666 345677888887765 445999999
Q ss_pred cCCC
Q 046097 161 MENR 164 (603)
Q Consensus 161 ~~~g 164 (603)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.03 Score=55.25 Aligned_cols=34 Identities=32% Similarity=0.502 Sum_probs=24.6
Q ss_pred CeEeccCCCCCeEE-cCCCcEEEEeeccceecccc
Q 046097 205 PVIHGDIKPSNILL-DGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 205 gIVHrDLKp~NILl-d~~~~vKL~DFGlA~~~~~~ 238 (603)
.++|+||.+.|||+ +.++.++|+||..|......
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~n~~~ 178 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGYNDRA 178 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EEEEHH
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhhccch
Confidence 68999999999999 88999999999999876644
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.28 Score=50.99 Aligned_cols=32 Identities=25% Similarity=0.283 Sum_probs=27.2
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
.+++|+|+.+.||+++. +.+.|+||+.+....
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~~~ 218 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTIDL 218 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccccCC
Confidence 48999999999999987 678999999776543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.0021 Score=78.22 Aligned_cols=113 Identities=9% Similarity=-0.041 Sum_probs=79.5
Q ss_pred HHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhccccc-ccCHHHHHHHHHHHHHHHHHHHhCC
Q 046097 124 FHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEE-LMEWNKRFEIAIDIAKGLEYLHHSC 202 (603)
Q Consensus 124 ~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~-~l~~~~~l~Ia~qIa~aL~yLHs~~ 202 (603)
...|...++...|+++.....-.........+.+++|+..|.+.+.+-...... .++..-+.....+.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 445555666678998887766555544566789999999999999886543322 2333344444444366666666543
Q ss_pred --CCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 203 --EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 203 --~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
..-.+|++||+-|.+|..+..+|++++|+.++..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn 1391 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN 1391 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccC
Confidence 2357899999999999999999999999998543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.16 Score=51.07 Aligned_cols=117 Identities=21% Similarity=0.192 Sum_probs=71.2
Q ss_pred cCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHH
Q 046097 90 GGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDA 169 (603)
Q Consensus 90 G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~ 169 (603)
++..+.-.+..+- | +..+|++..-.......-+.++..++.++. .|+++. .+ .+-..-+++|+|-....
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~---ND-n~~~yGvIlE~Cy~~~i--- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK---ND-NNYKYGVILERCYKIKI--- 141 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee---cC-CCceeEEEEeeccCccc---
Confidence 3444444444322 2 345565543222223445678888888764 466665 22 34567789998843211
Q ss_pred HhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 170 LLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 170 L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
+.-.. |. -=+.+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|-+.
T Consensus 142 ---------~~~N~---i~-agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ---------NFSNF---IT-AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ---------chhHH---HH-HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 11111 11 114567778865 45899999999999999999999999764
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.13 Score=55.14 Aligned_cols=77 Identities=19% Similarity=0.216 Sum_probs=60.1
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
+.+.|++|++. |+.+...- ...+.+++.++.+.+.-++-+.... ..-||||.-.||||+ .|++.|+||-
T Consensus 298 ~~y~yl~~kdh-gt~is~ik-------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 298 TLYLYLHFKDH-GTPISIIK-------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred ceEEEEEEecC-Cceeeeee-------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 45678888876 54553221 1467888889988888888777664 889999999999999 9999999999
Q ss_pred cceecccc
Q 046097 231 LARLKTED 238 (603)
Q Consensus 231 lA~~~~~~ 238 (603)
+++.....
T Consensus 367 lsRl~~~q 374 (488)
T COG5072 367 LSRLSYSQ 374 (488)
T ss_pred eeecccCC
Confidence 99976554
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.21 E-value=0.22 Score=54.43 Aligned_cols=75 Identities=13% Similarity=0.165 Sum_probs=48.0
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCC-----CChhhHHHHHHHHHHhccCC--CC-ceeEEEeEEecCCCCeEEE
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSS-----GSLQGEREFHNELSLASSLD--CP-HIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~-----~~~~~~~~~~~Ev~iL~~l~--Hp-NIV~l~g~~~~~~~~~~~L 156 (603)
+.||.|.-..||++.+..+++.|+||.-..- .-....++..-|.+.|+... -| .+.+++.+-. ....+
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~----e~~~~ 110 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS----VMNCC 110 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc----HHhhH
Confidence 5789999999999998444567999964221 11223355566667776553 23 5666754433 34578
Q ss_pred EEEccCC
Q 046097 157 IYELMEN 163 (603)
Q Consensus 157 VmEy~~~ 163 (603)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9999854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.70 E-value=1.4 Score=54.17 Aligned_cols=34 Identities=38% Similarity=0.465 Sum_probs=27.7
Q ss_pred CCCeEeccCCCCCeEEcCCC--cEE-EEeeccceecc
Q 046097 203 EPPVIHGDIKPSNILLDGDF--KAK-IGDFGLARLKT 236 (603)
Q Consensus 203 ~~gIVHrDLKp~NILld~~~--~vK-L~DFGlA~~~~ 236 (603)
..++||+|+.+.|||++.++ ++. |+|||.+....
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~~ 238 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVHAP 238 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccccc
Confidence 44899999999999999775 555 99999876543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.66 E-value=1 Score=47.30 Aligned_cols=36 Identities=19% Similarity=0.254 Sum_probs=31.1
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 203 ~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
..+++|+|+.+.|||++.++.+-|+||..+......
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d~~~ 230 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASFASPL 230 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcccCCcH
Confidence 348999999999999999999999999988776543
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.15 E-value=0.25 Score=53.76 Aligned_cols=62 Identities=18% Similarity=0.087 Sum_probs=43.2
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG 220 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~ 220 (603)
...++-+|..|.++..++.... .++....+++.-.+.|+--+--.. +.+|.|+.|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence 3456777888888888887654 344556666666667764433221 8999999999999953
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.84 E-value=0.86 Score=48.68 Aligned_cols=143 Identities=24% Similarity=0.302 Sum_probs=79.3
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC---CCc---eeEEEeEEecCCCC--eEEEEE
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD---CPH---IVSLLGFASDRRGR--RLVLIY 158 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~---HpN---IV~l~g~~~~~~~~--~~~LVm 158 (603)
|.+ .-..+|+.... +..+++|+.... ....++..|+..+..+. .+- |..+-|-....... ..+-++
T Consensus 34 l~s-~eN~~f~~~~~--~g~~iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 34 LNS-EENSNFRVQTE--DGRYILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccc-ccCceEEEEec--CCCeEEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 444 45678888763 334489999764 23345556666666552 221 22222222211124 788899
Q ss_pred EccCCCCHHH-----HH----------hh----cc---c--ccccCHHH-------------HHHHHHHHHHHHHHHHhC
Q 046097 159 ELMENRSLQD-----AL----------LD----RK---C--EELMEWNK-------------RFEIAIDIAKGLEYLHHS 201 (603)
Q Consensus 159 Ey~~~gsL~~-----~L----------~~----~~---~--~~~l~~~~-------------~l~Ia~qIa~aL~yLHs~ 201 (603)
+|++|..+.. .+ +. .. + .....|.. ......++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999877762 11 00 00 0 00122220 001233444455555543
Q ss_pred C----CC-C--eEeccCCCCCeEEcCCCc-EEEEeeccceec
Q 046097 202 C----EP-P--VIHGDIKPSNILLDGDFK-AKIGDFGLARLK 235 (603)
Q Consensus 202 ~----~~-g--IVHrDLKp~NILld~~~~-vKL~DFGlA~~~ 235 (603)
. .. + +||+|+.|.||+++.+.. +-++||+.+...
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~~ 229 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGYG 229 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccccc
Confidence 1 11 3 999999999999998874 899999988653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.70 E-value=2.7 Score=44.60 Aligned_cols=32 Identities=34% Similarity=0.481 Sum_probs=26.3
Q ss_pred CCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 203 ~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
..++||+|+.+.|||++ + .+.|+||+.+....
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~g~ 226 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARMGP 226 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCCCCC
Confidence 34789999999999995 4 57899999887543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.57 E-value=0.75 Score=50.14 Aligned_cols=34 Identities=24% Similarity=0.111 Sum_probs=27.9
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
...+|.||-+.||+.++ ..+.++||..|......
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~n~~~ 260 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGFNYVG 260 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccCCchH
Confidence 37799999999999764 46999999998776544
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.15 E-value=1.1 Score=49.89 Aligned_cols=34 Identities=18% Similarity=0.241 Sum_probs=28.0
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
..++|.|+.+.|||.+.++ ++|+||..|......
T Consensus 284 ~VfCHNDl~~~NiL~~~~~-l~LIDfEYAg~ndpa 317 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNKC-LRLIDFEYSGYNFLA 317 (442)
T ss_pred eeEEeCCCCccceeecCCC-EEEEeecccccccHH
Confidence 3689999999999886544 999999998876544
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=90.31 E-value=2 Score=43.71 Aligned_cols=74 Identities=15% Similarity=0.228 Sum_probs=45.2
Q ss_pred eeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC---CCCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL---DCPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l---~HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
.+..|.--..|...+ +..++-||+=. ......|..|+.-|..+ +.-.|.+++.+-.+. .+.|+||||++
T Consensus 23 ~v~gG~inea~~v~d--g~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~--~~sylVle~L~ 94 (286)
T COG3001 23 EVSGGDINEAWRLRD--GTDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGASR--DHSYLVLEYLP 94 (286)
T ss_pred ccCCccccceeEeec--CCcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCC--CeeEEEEeecc
Confidence 344444344444443 45677788643 23445677777666555 334566666665554 89999999998
Q ss_pred CCCHH
Q 046097 163 NRSLQ 167 (603)
Q Consensus 163 ~gsL~ 167 (603)
-+.+.
T Consensus 95 ~~~~d 99 (286)
T COG3001 95 TGPLD 99 (286)
T ss_pred CCCCC
Confidence 76554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 603 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-25 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-25 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-66
Identities = 66/173 (38%), Positives = 98/173 (56%), Gaps = 4/173 (2%)
Query: 67 RRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN 126
+RFS ++ A+ +FS N LG GGFG VYK + + +AVK L + GE +F
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL-VAVKRLKEERTQGGELQFQT 76
Query: 127 ELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL-MEWNKRF 185
E+ + S +++ L GF +L+Y M N S+ L +R + ++W KR
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 186 EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IA+ A+GL YLH C+P +IH D+K +NILLD +F+A +GDFGLA+L
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 43/122 (35%), Positives = 63/122 (51%), Gaps = 3/122 (2%)
Query: 462 RGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWAR 521
RGT+ +IAPEY G SEK DV+ +GV++L LI+G+R + + L+ W +
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD--VMLLDWVK 253
Query: 522 QLAYNGKLLDLVDPSIHS-LDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTGEAEPP 580
L KL LVD + ++ I +ALLC Q SP +R M ++V ML G+
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313
Query: 581 HL 582
Sbjct: 314 RW 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-64
Identities = 66/184 (35%), Positives = 94/184 (51%), Gaps = 16/184 (8%)
Query: 64 NHCRRFSYNLIRRATASFSP------SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS-- 115
FS+ ++ T +F N++G GGFG VYK V + +AVK L +
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVD 67
Query: 116 -GSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRK 174
+ + +++F E+ + + ++V LLGF+SD G L L+Y M N SL D L
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 175 CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+ W+ R +IA A G+ +LH E IH DIK +NILLD F AKI DFGLAR
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 235 KTED 238
+
Sbjct: 183 SEKF 186
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 29/116 (25%), Positives = 52/116 (44%), Gaps = 8/116 (6%)
Query: 463 GTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQ 522
GT Y+APE G ++ K D+YSFGV++L +I+G + P L+ +
Sbjct: 197 GTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ------LLLDIKEE 249
Query: 523 LAYN-GKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTGEA 577
+ + D +D ++ D ++A CL +KR +K + ++L
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 4e-63
Identities = 68/196 (34%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 44 TYRKLYRNRTAPSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSS 103
Y K + R + AT +F +GHG FG VYK V+
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 104 SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMEN 163
+A+K + S QG EF E+ S PH+VSL+GF + ++LIY+ MEN
Sbjct: 64 -AKVALKRR-TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEMILIYKYMEN 119
Query: 164 RSLQDALLDR-KCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF 222
+L+ L M W +R EI I A+GL YLH +IH D+K NILLD +F
Sbjct: 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENF 176
Query: 223 KAKIGDFGLARLKTED 238
KI DFG+++ TE
Sbjct: 177 VPKITDFGISKKGTEL 192
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 40/120 (33%), Positives = 58/120 (48%), Gaps = 6/120 (5%)
Query: 457 STPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANL 516
ST GT+ YI PEY G L+EK DVYSFGV++ ++ R + E NL
Sbjct: 198 STVVK-GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI----VQSLPREMVNL 252
Query: 517 ISWARQLAYNGKLLDLVDPSIHS-LDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTG 575
WA + NG+L +VDP++ + + A+ CL S R +M D++ L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-41
Identities = 49/190 (25%), Positives = 73/190 (38%), Gaps = 20/190 (10%)
Query: 61 PNHNHC---RRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS 117
+H+H + + G FG V+KA + + + +AVKI
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDK 60
Query: 118 LQGEREFHNELSLASSLDCPHIVSLLGF--ASDRRGRRLVLIYELMENRSLQDALLDRKC 175
+ E+ E+ + +I+ +G L LI E SL D L
Sbjct: 61 QSWQNEY--EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV- 117
Query: 176 EELMEWNKRFEIAIDIAKGLEYLHH-------SCEPPVIHGDIKPSNILLDGDFKAKIGD 228
+ WN+ IA +A+GL YLH +P + H DIK N+LL + A I D
Sbjct: 118 ---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 229 FGLARLKTED 238
FGLA
Sbjct: 175 FGLALKFEAG 184
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 20/123 (16%), Positives = 37/123 (30%), Gaps = 16/123 (13%)
Query: 463 GTVCYIAPEYGGGGLL-----SEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLI 517
GT Y+APE G + + D+Y+ G+++ L S
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY----MLPFE 250
Query: 518 SWARQLAYNGKLLDLV-----DPSI-HSLDKDQALLCIT-IALLCLQRSPSKRLTMKDIV 570
Q + ++V P + K + + C RL+ +
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 571 EML 573
E +
Sbjct: 311 ERI 313
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKIL------DSSGSLQGEREFHNELSLASSLDCPH 138
++G GGFG V+K + +A+K L + ++ +EF E+ + S+L+ P+
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
IV L G + ++ E + L LLD+ ++W+ + + +DIA G+EY+
Sbjct: 85 IVKLYGLMHNP----PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYM 138
Query: 199 HHSCEPPVIHGDIKPSNILLD-----GDFKAKIGDFGLARLKTEDLM 240
+ PP++H D++ NI L AK+ DFGL++ +
Sbjct: 139 Q-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS 184
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 23/122 (18%), Positives = 43/122 (35%), Gaps = 28/122 (22%)
Query: 460 SMRGTVCYIAPE--YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFE--RAN 515
+ G ++APE +EK D YSF +++ +++G P F+
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----------FDEYSYG 234
Query: 516 LISWARQLAYNGKLLDL---VDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEM 572
I + + G + P + ++ + C P KR IV+
Sbjct: 235 KIKFINMIREEGLRPTIPEDCPPRLRNVIEL-----------CWSGDPKKRPHFSYIVKE 283
Query: 573 LT 574
L+
Sbjct: 284 LS 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 49/157 (31%), Positives = 84/157 (53%), Gaps = 6/157 (3%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKIL-DSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
++G G FG+V++A +AVKIL + + EF E+++ L P+IV +
Sbjct: 43 EKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
G + + L ++ E + SL L E ++ +R +A D+AKG+ YLH +
Sbjct: 101 GAVT--QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLM 240
PP++H ++K N+L+D + K+ DFGL+RLK +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 29/126 (23%), Positives = 54/126 (42%), Gaps = 24/126 (19%)
Query: 451 KSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSE 510
K+ S+ S GT ++APE +EK DVYSFGV++ L + ++P
Sbjct: 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP---------- 238
Query: 511 FERANLISWARQLAYNGKLLDL---VDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMK 567
+ N + + K L++ ++P + ++ + C P KR +
Sbjct: 239 WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG-----------CWTNEPWKRPSFA 287
Query: 568 DIVEML 573
I+++L
Sbjct: 288 TIMDLL 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+G G FG V KA ++ +A+K ++S + F EL S ++ P+IV L G
Sbjct: 14 EVVGRGAFGVVCKAKW--RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ + L+ E E SL + L + + ++G+ YLH
Sbjct: 69 ACLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 205 PVIHGDIKPSNILLDGDFK-AKIGDFGLARLKTEDLM 240
+IH D+KP N+LL KI DFG A +
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT 161
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 37/145 (25%), Positives = 65/145 (44%), Gaps = 32/145 (22%)
Query: 460 SMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISW 519
+ +G+ ++APE G SEKCDV+S+G+++ +I+ R+P F+ ++
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----------FDEIGGPAF 211
Query: 520 -ARQLAYNGKLLDL---VDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLT- 574
+NG L + I SL C + PS+R +M++IV+++T
Sbjct: 212 RIMWAVHNGTRPPLIKNLPKPIESLMTR-----------CWSKDPSQRPSMEEIVKIMTH 260
Query: 575 ------GEAEPPHLPFEFSPSPPSN 593
G EP P + S P +
Sbjct: 261 LMRYFPGADEPLQYPCQHSLPPGED 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-38
Identities = 31/154 (20%), Positives = 64/154 (41%), Gaps = 5/154 (3%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLL 143
+L G ++K + VK+L S + R+F+ E P+++ +L
Sbjct: 16 TKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
G LI M SL + L + + + ++ + A+D+A+G+ +LH + E
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLH-TLE 131
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
P + + ++++D D A+I +
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 24/123 (19%), Positives = 42/123 (34%), Gaps = 27/123 (21%)
Query: 457 STPSMRGTVCYIAPE---YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFER 513
+P ++APE D++SF VL+ L++ P F
Sbjct: 164 QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP----------FAD 213
Query: 514 ANLISWARQLAYNGKLLDL---VDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIV 570
+ + ++A G + + P + L K C+ P+KR IV
Sbjct: 214 LSNMEIGMKVALEGLRPTIPPGISPHVSKLMKI-----------CMNEDPAKRPKFDMIV 262
Query: 571 EML 573
+L
Sbjct: 263 PIL 265
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 41/187 (21%), Positives = 72/187 (38%), Gaps = 25/187 (13%)
Query: 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNEL 128
+ + + +G G +G+VYK + +P+AVK+ + F NE
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSF----ANRQNFINEK 56
Query: 129 S--LASSLDCPHIVSLLGFASDRRG-----RRLVLIYELMENRSLQDALLDRKCEELMEW 181
+ ++ +I + D R +L+ E N SL L +W
Sbjct: 57 NIYRVPLMEHDNIARFIV--GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDW 110
Query: 182 NKRFEIAIDIAKGLEYLH------HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235
+A + +GL YLH +P + H D+ N+L+ D I DFGL+
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 236 TEDLMIE 242
T + ++
Sbjct: 171 TGNRLVR 177
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 24/173 (13%), Positives = 55/173 (31%), Gaps = 24/173 (13%)
Query: 441 SQDWASGDIPKSGGISSTPSMR-GTVCYIAPEYGGGGL-------LSEKCDVYSFGVLIL 492
S + + G + GT+ Y+APE G + ++ D+Y+ G++
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 493 VLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVD--------PSI-HSLDKD 543
+ R + E++ A + ++ + D+ P + ++
Sbjct: 227 EIFM-RCTDLFPGESVPEYQMA----FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN 281
Query: 544 QALLCITIALL--CLQRSPSKRLTMKDIVEMLTGEAEPPHLPFEFSPSPPSNF 594
+ + C + RLT + E + SP+ +
Sbjct: 282 SLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHH 334
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 48/167 (28%), Positives = 68/167 (40%), Gaps = 19/167 (11%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG---SLQGEREFHNELSLASSLDCPHIVS 141
+G GGFG VY+A +AVK Q E L + L P+I++
Sbjct: 13 EIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
L G + L L+ E L L ++ + + A+ IA+G+ YLH
Sbjct: 71 LRGVCL--KEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDE 124
Query: 202 CEPPVIHGDIKPSNILLDGDFK--------AKIGDFGLARLKTEDLM 240
P+IH D+K SNIL+ + KI DFGLAR
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 27/117 (23%), Positives = 46/117 (39%), Gaps = 24/117 (20%)
Query: 460 SMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISW 519
S G ++APE + S+ DV+S+GVL+ L++G P F + ++
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----------FRGIDGLAV 222
Query: 520 ARQLAYNGKLLDL---VDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEML 573
A +A N L + L +D C P R + +I++ L
Sbjct: 223 AYGVAMNKLALPIPSTCPEPFAKLMED-----------CWNPDPHSRPSFTNILDQL 268
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 23/164 (14%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLA--SSLDCPHIVSL 142
+G G +G V++ + +AVKI S + E+ + E L L +I+
Sbjct: 14 ECVGKGRYGEVWRGSW--QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGF 67
Query: 143 LGFASDRRGR----RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+ SD R +L LI E SL D L ++ I + IA GL +L
Sbjct: 68 IA--SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHL 121
Query: 199 H-----HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
H +P + H D+K NIL+ + + I D GLA + ++
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 21/122 (17%), Positives = 44/122 (36%), Gaps = 14/122 (11%)
Query: 463 GTVCYIAPE------YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFE---- 512
GT Y+APE ++ D+++FG+++ + + F
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 513 -RANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE 571
+ + + + + ++ P+ D L + C ++PS RLT I +
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNI--PNRWFSDPTLTSLAKLMK-ECWYQNPSARLTALRIKK 295
Query: 572 ML 573
L
Sbjct: 296 TL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 23/165 (13%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLA--SSLDCPHIVSL 142
++G G +G V+ + +AVK+ + E + E + + +I+
Sbjct: 43 KQIGKGRYGEVWMGKW--RGEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENILGF 96
Query: 143 LGFASDRRGR----RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+ +D +G +L LI + EN SL D L ++ ++A GL +L
Sbjct: 97 IA--ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHL 150
Query: 199 H-----HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
H +P + H D+K NIL+ + I D GLA D
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 21/122 (17%), Positives = 40/122 (32%), Gaps = 8/122 (6%)
Query: 460 SMRGTVCYIAPEYGGGGLL------SEKCDVYSFGVLILVLISGRRPLQVTASPMSEFER 513
+ GT Y+ PE L D+YSFG+++ + + +
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 514 ANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALL--CLQRSPSKRLTMKDIVE 571
+ + + + PS + L L+ C +P+ RLT + +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 572 ML 573
L
Sbjct: 325 TL 326
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG G FG K + + + +K L +R F E+ + L+ P+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-QRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ +RL I E ++ +L+ + + + W++R A DIA G+ YLH
Sbjct: 75 VLY--KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSM--- 127
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+IH D+ N L+ + + DFGLARL ++
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 25/145 (17%), Positives = 43/145 (29%), Gaps = 20/145 (13%)
Query: 429 GFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFG 488
G + R K ++ G ++APE G EK DV+SFG
Sbjct: 153 GLA---RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG 209
Query: 489 VLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLC 548
+++ +I P + N+ + + PS +
Sbjct: 210 IVLCEIIGRVNADP-DYLPRTMDFGLNVRGFLDRYCPPN-----CPPSFFPI-------- 255
Query: 549 ITIALLCLQRSPSKRLTMKDIVEML 573
+ C P KR + + L
Sbjct: 256 ---TVRCCDLDPEKRPSFVKLEHWL 277
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 19/165 (11%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLA--SSLDCPHIVSL 142
+G G FG V++ + +AVKI S + ER + E + L +I+
Sbjct: 48 ESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGF 101
Query: 143 LGFASDRRGR--RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH- 199
+ + G +L L+ + E+ SL D L + ++A+ A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHM 157
Query: 200 ----HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLM 240
+P + H D+K NIL+ + I D GLA
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 16/122 (13%), Positives = 41/122 (33%), Gaps = 14/122 (11%)
Query: 463 GTVCYIAPEYGGGGLL------SEKCDVYSFGVLILVLISGRRPLQVTASPMSEFE---- 512
GT Y+APE + ++ D+Y+ G++ + + +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 513 -RANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE 571
++ + + ++ P+ + ++ + C + + RLT I +
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNI--PNRWQSCEALRVMAKIMR-ECWYANGAARLTALRIKK 329
Query: 572 ML 573
L
Sbjct: 330 TL 331
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 12/154 (7%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLL 143
+G G FG VY +A++++D + + F E+ ++V +
Sbjct: 39 ELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
G A L +I L + R+L + D K ++ NK +IA +I KG+ YLH
Sbjct: 96 G-AC-MSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLH---A 148
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
++H D+K N+ D + K I DFGL +
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 29/148 (19%), Positives = 51/148 (34%), Gaps = 35/148 (23%)
Query: 462 RGTVCYIAPE---------YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFE 512
G +C++APE S+ DV++ G + L + P F+
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----------FK 244
Query: 513 RANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEM 572
+ Q+ K P++ + + + I L C +R T +++M
Sbjct: 245 TQPAEAIIWQMGTGMK------PNLSQIGMGKEI--SDILLFCWAFEQEERPTFTKLMDM 296
Query: 573 LTGEAEPPHLP-FEFSPSPPSNFPFKSQ 599
L LP S P +F +KS
Sbjct: 297 LE------KLPKRNRRLSHPGHF-WKSA 317
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 51/158 (32%), Positives = 78/158 (49%), Gaps = 20/158 (12%)
Query: 85 NRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHI 139
R+G G FG+VYK V AVK+L+ + + Q + F NE+ + +I
Sbjct: 30 QRIGSGSFGTVYKGKWHGDV-------AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
+ +G+++ + L ++ + E SL L E E K +IA A+G++YLH
Sbjct: 83 LLFMGYSTAPQ---LAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLH 137
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
+IH D+K +NI L D KIGDFGLA K+
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 22/117 (18%), Positives = 46/117 (39%), Gaps = 17/117 (14%)
Query: 460 SMRGTVCYIAPE---YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANL 516
+ G++ ++APE S + DVY+FG+++ L++G+ P + N
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----------YSNINN 230
Query: 517 ISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEML 573
++ G L + + K L CL++ +R + I+ +
Sbjct: 231 RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEI 283
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 44/183 (24%), Positives = 69/183 (37%), Gaps = 13/183 (7%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
LG GGFG V++A A+K + + E+ + L+ P IV
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 146 ----------ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGL 195
L + +L +L+D + R E E + I + IA+ +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDVNEDN 255
E+LH ++H D+KPSNI D K+GDFGL +D +
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 256 GSI 258
G +
Sbjct: 189 GQV 191
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 7/153 (4%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
++G G FG V+ + + + +AVK + + +F E + P+IV L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
+ ++ +V+ EL++ L R + ++ D A G+EYL
Sbjct: 181 CTQKQPIYIVM--ELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLE---SKC 233
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ N L+ KI DFG++R + +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 15/168 (8%)
Query: 82 SPSNR-------LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASS 133
S R +G G F +VYK + ++ +A L + ER+ F E +
Sbjct: 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 81
Query: 134 LDCPHIVSLLGFASD--RRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDI 191
L P+IV + + +VL+ ELM + +L+ L K ++ I
Sbjct: 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS---WCRQI 138
Query: 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDG-DFKAKIGDFGLARLKTED 238
KGL++LH + PP+IH D+K NI + G KIGD GLA LK
Sbjct: 139 LKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 23/113 (20%), Positives = 43/113 (38%), Gaps = 18/113 (15%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
S ++ GT ++APE E DVY+FG+ +L + + P + + R
Sbjct: 185 SFAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKD 568
+G D K+ I C++++ +R ++KD
Sbjct: 244 ----------SGVKPASFDKVAIPEVKE-------IIEGCIRQNKDERYSIKD 279
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 35/180 (19%), Positives = 64/180 (35%), Gaps = 17/180 (9%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+LG GGF V A+K + Q E E + + P+I+ L+ +
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 146 ASDRRG--RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------IAIDIAKGLEY 197
RG L+ + +L + + K + + + I +GLE
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLK-----DKGNFLTEDQILWLLLGICRGLEA 149
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDVNEDNGS 257
+H H D+KP+NILL + + + D G + + + +D +
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 21/117 (17%), Positives = 42/117 (35%), Gaps = 20/117 (17%)
Query: 460 SMRGTVCYIAPE---YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANL 516
+ R T+ Y APE ++ E+ DV+S G ++ ++ G P ++
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----------YDMVFQ 251
Query: 517 ISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEML 573
+ LA +L + HS + + P +R + ++ L
Sbjct: 252 KGDSVALAVQNQL-SIPQSPRHSSA------LWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 48/161 (29%), Positives = 68/161 (42%), Gaps = 17/161 (10%)
Query: 85 NRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
LG G FG V + + +AVK L + Q + E+ + +L HI+
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRK--CEELMEWNKRFEIAIDIAKGLEYL 198
G D L L+ E + SL+D L +L+ + A I +G+ YL
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYL 150
Query: 199 H-HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
H IH D+ N+LLD D KIGDFGLA+ E
Sbjct: 151 HAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 11/159 (6%)
Query: 85 NRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
LG G FG V ++ + +AVK L + E+ + +L +IV
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH- 199
G ++ G + LI E + + SL++ L K + + ++ + A+ I KG++YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ N+L++ + + KIGDFGL + D
Sbjct: 145 RQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 17/161 (10%)
Query: 85 NRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
LG G FG VY+ V +A+K ++ + S++ EF NE S+ +C H+
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKR-------FEIAIDIA 192
V LLG S +G+ ++I ELM L+ L + ++A +IA
Sbjct: 91 VRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
G+ YL+ +H D+ N ++ DF KIGDFG+ R
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 42/153 (27%), Positives = 67/153 (43%), Gaps = 4/153 (2%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREF-HNELSLASSLDCPHIVSLLG 144
+G G +G K S + L K LD + E++ +E++L L P+IV
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLD-RKCEELMEWNKRFEIAIDIAKGLEYLH--HS 201
DR L ++ E E L + K + ++ + + L+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
V+H D+KP+N+ LDG K+GDFGLAR+
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 24/110 (21%), Positives = 42/110 (38%), Gaps = 19/110 (17%)
Query: 463 GTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQ 522
GT Y++PE +EK D++S G L+ L + P F + A +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----------FTAFSQKELAGK 227
Query: 523 LAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEM 572
+ GK + P +S + I L R ++++I+E
Sbjct: 228 IR-EGKFRRI--PYRYSDE------LNEIITRMLNLKDYHRPSVEEILEN 268
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 19/157 (12%)
Query: 85 NRLGHGGFGSVYKAVV---PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
+G G FG VY + AVK L+ + +F E + P+++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRK----CEELMEWNKRFEIAIDIAKGLEY 197
LLG G LV + M++ L++ + + ++L+ + +AKG++Y
Sbjct: 91 LLGICLRSEGSPLV-VLPYMKHGDLRNFIRNETHNPTVKDLI------GFGLQVAKGMKY 143
Query: 198 LH-HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
L +H D+ N +LD F K+ DFGLAR
Sbjct: 144 LASKKF----VHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 38/164 (23%), Positives = 66/164 (40%), Gaps = 7/164 (4%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
LG G +V++ + A+K+ ++ L+ E + L+ +IV L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
+ R VLI E SL L + + ++ + D+ G+ +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 206 VIHGDIKPSNILL----DGDFKAKIGDFGLARLKTEDLMIEGEC 245
++H +IKP NI+ DG K+ DFG AR +D
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 21/131 (16%), Positives = 38/131 (29%), Gaps = 17/131 (12%)
Query: 460 SMRGTVCYIAPEYGGGGLL--------SEKCDVYSFGVLILVLISGRRPLQVTASP---- 507
S+ GT Y+ P+ +L D++S GV +G P + P
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 508 -----MSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSK 562
+ + + IS ++ P SL + +L + L+ K
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
Query: 563 RLTMKDIVEML 573
Sbjct: 294 CWGFDQFFAET 304
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 23/178 (12%)
Query: 70 SYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELS 129
++ + +R F +G GGFG V+KA + +K + + E+
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-----YNNEKAEREVK 56
Query: 130 LASSLDCPHIVSLLGF--------------ASDRRGRRLVLIYELMENRSLQDALLDRKC 175
+ LD +IV G +S + + L + E + +L+ + R+
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 176 EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
E+L + E+ I KG++Y+H +I+ D+KPSNI L + KIGDFGL
Sbjct: 117 EKLDK-VLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 22/116 (18%), Positives = 43/116 (37%), Gaps = 36/116 (31%)
Query: 460 SMRGTVCYIAPE------YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFER 513
+GT+ Y++PE YG ++ D+Y+ G+++ L+ FE
Sbjct: 180 RSKGTLRYMSPEQISSQDYG------KEVDLYALGLILAELLHVCDTA---------FET 224
Query: 514 ANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
+ + R +G + D+ D +L + L + P R +I
Sbjct: 225 SKFFTDLR----DGIISDIFDKKEKTL--------LQ---KLLSKKPEDRPNTSEI 265
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 53/251 (21%), Positives = 97/251 (38%), Gaps = 33/251 (13%)
Query: 5 MAP--PVIHHRRHNH-------QAHFLPAILAGTLVLTCFILIIITIFTYRK-----LYR 50
M+P P+ HH H+ +P G + + +++
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG 60
Query: 51 NRTAPSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVV---PSSSQPL 107
T DL + N + + +I ++ + +G G FG VY +
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120
Query: 108 AVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQ 167
AVK L+ + +F E + P+++SLLG G LV + M++ L+
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLR 179
Query: 168 DALLDRK----CEELMEWNKRFEIAIDIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDF 222
+ + + ++L+ + +AKG+++L +H D+ N +LD F
Sbjct: 180 NFIRNETHNPTVKDLI------GFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKF 229
Query: 223 KAKIGDFGLAR 233
K+ DFGLAR
Sbjct: 230 TVKVADFGLAR 240
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 7/163 (4%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G +V++ + A+K+ ++ L+ E + L+ +IV L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206
+ R VLI E SL L + + ++ + D+ G+ +L + +
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 207 IHGDIKPSNILL----DGDFKAKIGDFGLARLKTEDLMIEGEC 245
+H +IKP NI+ DG K+ DFG AR +D
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 20/129 (15%), Positives = 37/129 (28%), Gaps = 17/129 (13%)
Query: 463 GTVCYIAPEYGGGGLL--------SEKCDVYSFGVLILVLISGRRPLQVTASP------- 507
GT Y+ P+ +L D++S GV +G P + P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 508 --MSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLT 565
+ + + IS ++ P SL + +L + L+ K
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 566 MKDIVEMLT 574
+
Sbjct: 297 FDQFFAETS 305
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 85 NRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
++LG G FGSV ++ +AVK L SG Q +R+F E+ + +L IV
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIV 87
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH- 199
G + + L L+ E + + L+D L ++ ++ ++ + I KG+EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
C +H D+ NIL++ + KI DFGLA+L D
Sbjct: 146 RRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLD 180
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 12/176 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGF 145
L GGF VY+A S + A+K L S+ + R E+ L P+IV
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 146 ASDRR-----GRRLVLIYELME--NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
AS + G+ L+ L E L + L + + + +I + ++++
Sbjct: 95 ASIGKEESDTGQAEFLL--LTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDVNED 254
H +PP+IH D+K N+LL K+ DFG A + ++ V E+
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 42/166 (25%), Positives = 64/166 (38%), Gaps = 11/166 (6%)
Query: 73 LIRRATASFSPSNRLGHGGFGSVYKAVV---PSSSQPLAVKILDSSGSLQGEREFHNELS 129
LI +G G FG VY + A+K L +Q F E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 130 LASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI 189
L L+ P++++L+G G V + M + L + R + +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHV-LLPYMCHGDLLQFI--RSPQRNPTVKDLISFGL 131
Query: 190 DIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+A+G+EYL +H D+ N +LD F K+ DFGLAR
Sbjct: 132 QVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 85 NRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
+LG G FGSV ++ + +AVK L + + R+F E+ + SL +IV
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIV 74
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH- 199
G R L LI E + SL+D L +K +E ++ K + I KG+EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ NIL++ + + KIGDFGL ++ +D
Sbjct: 133 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQD 167
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 25/169 (14%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC-PH 138
LG G FG V +A ++ + +AVK+L + R +EL + + +
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------------ 186
+V+LLG A + G L++I E + +L L ++ E + +
Sbjct: 93 VVNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 187 -IAIDIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ +AKG+E+L C IH D+ NILL KI DFGLAR
Sbjct: 152 CYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 85 NRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
+LG G FGSV ++ + +AVK L + + R+F E+ + SL +IV
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIV 105
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH- 199
G R L LI E + SL+D L +K +E ++ K + I KG+EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ NIL++ + + KIGDFGL ++ +D
Sbjct: 164 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQD 198
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 45/177 (25%), Positives = 72/177 (40%), Gaps = 35/177 (19%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
LG G FG V KA + +AVK+L + S R+ +E ++ ++ PH+
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------------- 186
+ L G S + L+LI E + SL+ L + +
Sbjct: 89 IKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 187 --------IAIDIAKGLEYL--HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
A I++G++YL ++H D+ NIL+ K KI DFGL+R
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 24/175 (13%)
Query: 73 LIRRATASFSPSNRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNEL 128
+++ LG G FG+VYK + P+A+K L + S + +E +E
Sbjct: 11 ILKETEFKKI--KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 129 SLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRK----CEELMEWNKR 184
+ +S+D PH+ LLG + LI +LM L D + + K + L+ W
Sbjct: 69 YVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--- 122
Query: 185 FEIAIDIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ IAKG+ YL +H D+ N+L+ KI DFGLA+L +
Sbjct: 123 ---CVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 52/160 (32%), Positives = 73/160 (45%), Gaps = 18/160 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG--EREFHNELSLASSLDCPHIVSLLG 144
LG GGF ++ + + A KI+ S L+ + E+S+ SL H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F D + ++ EL RSL + RK L E R+ I G +YLH +
Sbjct: 83 FFEDND--FVFVVLELCRRRSLLELHKRRKA--LTEPEARY-YLRQIVLGCQYLHRNR-- 135
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLA--------RLKT 236
VIH D+K N+ L+ D + KIGDFGLA R K
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 9e-05
Identities = 32/133 (24%), Positives = 49/133 (36%), Gaps = 26/133 (19%)
Query: 463 GTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFER--ANLISWA 520
GT YIAPE S + DV+S G ++ L+ G+ P + T+ + R N S
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIP 235
Query: 521 RQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEM--LTGEAE 578
+ + L I + LQ P+ R T+ +++ T
Sbjct: 236 KHINPVAASL------IQKM---------------LQTDPTARPTINELLNDEFFTSGYI 274
Query: 579 PPHLPFEFSPSPP 591
P LP PP
Sbjct: 275 PARLPITCLTIPP 287
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 24/167 (14%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC-PH 138
LG G FG V +A + +AVK+L S+ + +EL + S L +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE-----------I 187
IV+LLG + G +++I E L + L + +
Sbjct: 112 IVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 188 AIDIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ +A+G+ +L +C IH D+ N+LL AKIGDFGLAR
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 52/160 (32%), Positives = 73/160 (45%), Gaps = 18/160 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG--EREFHNELSLASSLDCPHIVSLLG 144
LG GGF ++ + + A KI+ S L+ + E+S+ SL H+V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
F D + ++ EL RSL + RK L E R+ I G +YLH +
Sbjct: 109 FFEDND--FVFVVLELCRRRSLLELHKRRKA--LTEPEARY-YLRQIVLGCQYLHRNR-- 161
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLA--------RLKT 236
VIH D+K N+ L+ D + KIGDFGLA R K
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 32/134 (23%), Positives = 50/134 (37%), Gaps = 28/134 (20%)
Query: 463 GTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFER--ANLISWA 520
GT YIAPE S + DV+S G ++ L+ G+ P + T+ + R N S
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKNEYSIP 261
Query: 521 RQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE---MLTGEA 577
+ + L I + LQ P+ R T+ +++ +G
Sbjct: 262 KHINPVAASL------IQKM---------------LQTDPTARPTINELLNDEFFTSG-Y 299
Query: 578 EPPHLPFEFSPSPP 591
P LP PP
Sbjct: 300 IPARLPITCLTIPP 313
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 49/183 (26%), Positives = 73/183 (39%), Gaps = 22/183 (12%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
LG G FG V KA S+ A+K + + +E+ L +SL+ ++V
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK--LSTILSEVMLLASLNHQYVVRYYAA 70
Query: 146 ASDRRGRR-----------LVLIYELMENRSLQDALLDRKC--EELMEWNKRFEIAIDIA 192
+RR L + E EN +L D + + W + I
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR----LFRQIL 126
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDVN 252
+ L Y+H +IH D+KP NI +D KIGDFGLA+ L I + +
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 253 EDN 255
DN
Sbjct: 184 SDN 186
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 27/142 (19%), Positives = 53/142 (37%), Gaps = 22/142 (15%)
Query: 429 GFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPE-YGGGGLLSEKCDVYSF 487
G + + + + S ++S GT Y+A E G G +EK D+YS
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTS---AIGTAMYVATEVLDGTGHYNEKIDMYSL 217
Query: 488 GVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALL 547
G++ +I + ER N++ R ++ D + ++K ++
Sbjct: 218 GIIFFEMIYP---------FSTGMERVNILKKLRSVSIE--FPPDFDDNKMKVEKK--II 264
Query: 548 CITIALLCLQRSPSKRLTMKDI 569
L + P+KR + +
Sbjct: 265 R-----LLIDHDPNKRPGARTL 281
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 28/171 (16%)
Query: 85 NRLGHGGFGSVYKAVV-------PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC- 136
LG G FG V A P + +AVK+L + + + +E+ + +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 137 PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE---------- 186
+I++LLG + L +I E +L++ L R+ +
Sbjct: 101 KNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 187 ---IAIDIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+A+G+EYL C IH D+ N+L+ + KI DFGLAR
Sbjct: 159 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 42/161 (26%), Positives = 68/161 (42%), Gaps = 17/161 (10%)
Query: 85 NRLGHGGFGSVYKAVV---PSSSQPLAVKILDSSGSLQGER-EFHNELSLASSLDCPHIV 140
LG G FGSV + + +S +AVK + S Q E EF +E + P+++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 141 SLLGFASDRRGRRLVLIY---ELMENRSLQDALLDRKCEELMEW---NKRFEIAIDIAKG 194
LLG + + + M+ L LL + E + + +DIA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 195 LEYL--HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+EYL + +H D+ N +L D + DFGL++
Sbjct: 160 MEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 54/208 (25%), Positives = 73/208 (35%), Gaps = 27/208 (12%)
Query: 46 RKLYRNRTAPSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQ 105
R++ A L+SP ++ R S SF +RLGHG +G V+K +
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPES-----FFQQSFQRLSRLGHGSYGEVFKVRSKEDGR 83
Query: 106 PLAVKILDSSGSLQGERE-FHNE-LSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMEN 163
AVK S +R E S P V L + G L L EL
Sbjct: 84 LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ--AWEEGGILYLQTELCG- 140
Query: 164 RSLQDALLDRKCEELMEWNKRFE------IAIDIAKGLEYLHHSCEPPVIHGDIKPSNIL 217
SLQ W D L +LH ++H D+KP+NI
Sbjct: 141 PSLQQHC--------EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIF 189
Query: 218 LDGDFKAKIGDFGLARLKTEDLMIEGEC 245
L + K+GDFGL E +
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQE 217
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 20/122 (16%), Positives = 35/122 (28%), Gaps = 32/122 (26%)
Query: 456 SSTPSMRGTVCYIAPE-----YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSE 510
+ G Y+APE YG DV+S G+ IL +
Sbjct: 211 GAGEVQEGDPRYMAPELLQGSYG------TAADVFSLGLTILEVACNMEL---------- 254
Query: 511 FERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIV 570
RQ + + + S+ + L+ P R T + ++
Sbjct: 255 PHGGEGWQQLRQGYLPPEFTAGLSSELRSVLV-----------MMLEPDPKLRATAEALL 303
Query: 571 EM 572
+
Sbjct: 304 AL 305
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/164 (31%), Positives = 69/164 (42%), Gaps = 23/164 (14%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
LGHG FG VY+ V S +AVK L S Q E +F E + S + +I
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAK 193
V +G + + ++ ELM L+ L R+ +A DIA
Sbjct: 96 VRCIGVSL--QSLPRFILMELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 194 GLEYL-HHSCEPPVIHGDIKPSNILLDG---DFKAKIGDFGLAR 233
G +YL + IH DI N LL AKIGDFG+AR
Sbjct: 152 GCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 46/162 (28%), Positives = 70/162 (43%), Gaps = 18/162 (11%)
Query: 85 NRLGHGGFGSVYKAVV---PSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIV 140
LG G FGSV +A + S +AVK+L + + E F E + D PH+
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 141 SLLGFASDRRGRR----LVLIYELMENRSLQDALLDRKCEE---LMEWNKRFEIAIDIAK 193
L+G + R + ++I M++ L LL + E + +DIA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 194 GLEYL--HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
G+EYL + IH D+ N +L D + DFGL+R
Sbjct: 149 GMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 38/178 (21%), Positives = 74/178 (41%), Gaps = 10/178 (5%)
Query: 61 PNHNHCRRFSYNLIRRATAS---FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS 117
+H+H S + ++G G FG + +K ++ S
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM 62
Query: 118 LQGEREF-HNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCE 176
ERE E+++ +++ P+IV + L ++ + E L + +K
Sbjct: 63 SSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGV 120
Query: 177 ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
E ++ + + I L+++H + ++H DIK NI L D ++GDFG+AR+
Sbjct: 121 LFQE-DQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 45/177 (25%), Positives = 70/177 (39%), Gaps = 35/177 (19%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
+G G FG V++A P +AVK+L S + +F E +L + D P+I
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------------- 186
V LLG + G+ + L++E M L + L + +
Sbjct: 113 VKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 187 --------IAIDIAKGLEYL--HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IA +A G+ YL +H D+ N L+ + KI DFGL+R
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 28/171 (16%)
Query: 85 NRLGHGGFGSVYKAVV-------PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC- 136
LG G FG V A P+ +AVK+L S + + + +E+ + +
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 137 PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE---------- 186
+I++LLG + + L +I E +L++ L R+ L
Sbjct: 135 KNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 187 ---IAIDIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
A +A+G+EYL C IH D+ N+L+ D KI DFGLAR
Sbjct: 193 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG--EREFHNELSLASSLDCPHIVSLLG 144
LG G F VY+A + +A+K++D + + NE+ + L P I+ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ D + L+ E+ N + L + + E R + I G+ YLH
Sbjct: 79 YFEDSN--YVYLVLEMCHNGEMNR-YLKNRVKPFSENEARHFMH-QIITGMLYLHSHG-- 132
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLA--------RLKT 236
++H D+ SN+LL + KI DFGLA + T
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 52/164 (31%), Positives = 69/164 (42%), Gaps = 23/164 (14%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
LGHG FG VY+ V S +AVK L S Q E +F E + S + +I
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAK 193
V +G + + ++ ELM L+ L R+ +A DIA
Sbjct: 137 VRCIGVSL--QSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 194 GLEYL-HHSCEPPVIHGDIKPSNILLDG---DFKAKIGDFGLAR 233
G +YL + IH DI N LL AKIGDFG+AR
Sbjct: 193 GCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 45/169 (26%), Positives = 68/169 (40%), Gaps = 27/169 (15%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
LG FG VYK + +Q +A+K L EF +E L + L P++
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------------- 186
V LLG + + + L +I+ + L + L+ R +
Sbjct: 75 VCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 187 IAIDIAKGLEYL--HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ IA G+EYL HH V+H D+ N+L+ KI D GL R
Sbjct: 133 LVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 46/170 (27%), Positives = 67/170 (39%), Gaps = 26/170 (15%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC-PH 138
LG G FG V +A ++ +AVK+L S L +EL + S L +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------------ 186
IV+LLG + G ++I E L + L ++ +
Sbjct: 89 IVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 187 ---IAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ +AKG+ +L IH D+ NILL KI DFGLAR
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 42/171 (24%), Positives = 70/171 (40%), Gaps = 28/171 (16%)
Query: 85 NRLGHGGFGSVYKAVV-------PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC- 136
LG G FG V A P + +AVK+L + + + +E+ + +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 137 PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE---------- 186
+I++LLG + + L +I E +L++ L R+ +
Sbjct: 147 KNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 187 ---IAIDIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+A+G+EYL C IH D+ N+L+ + KI DFGLAR
Sbjct: 205 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 46/158 (29%), Positives = 66/158 (41%), Gaps = 21/158 (13%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
R+G G FG V++ + AVK + EL + L P IV L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV------EELVACAGLSSPRIVPLYG 117
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGLEYLHHS 201
+ R G + + EL+E SL + ++ L E +GLEYLH
Sbjct: 118 --AVREGPWVNIFMELLEGGSLGQLI--KQMGCLPE----DRALYYLGQALEGLEYLHTR 169
Query: 202 CEPPVIHGDIKPSNILLDGD-FKAKIGDFGLARLKTED 238
++HGD+K N+LL D +A + DFG A D
Sbjct: 170 R---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 37/170 (21%), Positives = 64/170 (37%), Gaps = 27/170 (15%)
Query: 86 RLGHGGFGSVYKAV-------VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH 138
LG G F ++K V + +K+LD F S+ S L H
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKLSHKH 73
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+V G G +L+ E ++ SL L +K + + + E+A +A + +L
Sbjct: 74 LVLNYGVCV--CGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL 129
Query: 199 --HHSCEPPVIHGDIKPSNILLDGDFK--------AKIGDFGLARLKTED 238
+ +IHG++ NILL + K+ D G++
Sbjct: 130 EENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 6e-24
Identities = 22/188 (11%), Positives = 54/188 (28%), Gaps = 33/188 (17%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSS---------------------------GSL 118
LG + +A + + V + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 119 QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELME--NRSLQDALLDRKCE 176
+ F L ++ + D +Y M+ ++ + LL
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 177 -ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235
+ + + R ++ + + + L LHH ++H ++P +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 236 TEDLMIEG 243
++
Sbjct: 257 GARVVSSV 264
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 16/132 (12%), Positives = 33/132 (25%), Gaps = 45/132 (34%)
Query: 456 SSTPSMRGTVCYIAPEY-----------GGGGLLSEKCDVYSFGVLILVLISGRRPLQVT 504
+ + + PE L++ D ++ G++I + P
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP---- 312
Query: 505 ASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKD-----QALLCITIALLCLQRS 559
+ + + I K+ +ALL L+
Sbjct: 313 ------ITKDAALGGSEW--------------IFRSCKNIPQPVRALLE-----GFLRYP 347
Query: 560 PSKRLTMKDIVE 571
RL +E
Sbjct: 348 KEDRLLPLQAME 359
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 45/169 (26%), Positives = 70/169 (41%), Gaps = 28/169 (16%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
LG G FG V+ A +AVK L +L ++F E L ++L HI
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHI 79
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------------- 186
V G G L++++E M++ L L + ++ + +
Sbjct: 80 VKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 187 IAIDIAKGLEYL--HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
IA IA G+ YL H +H D+ N L+ + KIGDFG++R
Sbjct: 138 IASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 43/167 (25%), Positives = 64/167 (38%), Gaps = 25/167 (14%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
LG G FG V+ A +AVK L S ++F E L + L HI
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHI 105
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKR------------FEI 187
V G + GR L++++E M + L L + + +
Sbjct: 106 VRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 188 AIDIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
A +A G+ YL +H D+ N L+ KIGDFG++R
Sbjct: 164 ASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
F+ ++G G FG V+K + + + +A+KI+D + + E+++ S D P++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGLEY 197
G S + +L +I E + S D L +E +IA +I KGL+Y
Sbjct: 84 KYYG--SYLKDTKLWIIMEYLGGGSALDLLEPGPLDET-------QIATILREILKGLDY 134
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
LH IH DIK +N+LL + K+ DFG+A
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 45/157 (28%), Positives = 69/157 (43%), Gaps = 13/157 (8%)
Query: 86 RLGHGGFGSVYKAV---VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG VY+ V +AVK +L + +F +E + +LD PHIV L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL-HHS 201
+G +I EL L L + + ++ ++ I K + YL +
Sbjct: 79 IGIIE---EEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
C +H DI NIL+ K+GDFGL+R ++
Sbjct: 134 C----VHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 47/166 (28%), Positives = 69/166 (41%), Gaps = 23/166 (13%)
Query: 85 NRLGHGGFGSVYKAVV--PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC-PHIVS 141
+ +G G FG V KA + A+K + S R+F EL + L P+I++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE-------------IA 188
LLG L L E + +L D L + E A
Sbjct: 91 LLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 189 IDIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
D+A+G++YL IH D+ NIL+ ++ AKI DFGL+R
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 16/155 (10%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
++ ++G G G+VY A+ ++ Q +A++ ++ + NE+ + P+IV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIV 80
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGLEY 197
+ L S G L ++ E + SL D + + +E +IA + + LE+
Sbjct: 81 NYLD--SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEF 131
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
LH + VIH DIK NILL D K+ DFG
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 8/154 (5%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
++LG G +G VY+ V S +AVK L +++ E EF E ++ + P++V LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 76
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ R +I E M +L D L + +E+ +A I+ +EYL
Sbjct: 77 VCT--REPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN-- 131
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ N L+ + K+ DFGL+RL T D
Sbjct: 132 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 22/163 (13%)
Query: 85 NRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
LG G FG+VYK + P+A+K L + S + +E +E + +S+D PH+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRK----CEELMEWNKRFEIAIDIAKGLE 196
LLG + LI +LM L D + + K + L+ W + IAKG+
Sbjct: 81 RLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMN 131
Query: 197 YL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
YL +H D+ N+L+ KI DFGLA+L +
Sbjct: 132 YLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 38/157 (24%), Positives = 66/157 (42%), Gaps = 13/157 (8%)
Query: 86 RLGHGGFGSVYKAV---VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
+G G FG V++ + + + +A+K + S +F E D PHIV L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL-HHS 201
+G + + +I EL L+ L + + ++ A ++ L YL
Sbjct: 82 IGVIT---ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H DI N+L+ + K+GDFGL+R +
Sbjct: 137 F----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 86 RLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
+G G FG VYK + P+A+K L + + + +F E + +I+
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
L G S + + +++I E MEN +L L R+ + + + IA G++YL +
Sbjct: 111 LEGVIS--KYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ NIL++ + K+ DFGL+R+ +D
Sbjct: 167 N---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 45/176 (25%), Positives = 68/176 (38%), Gaps = 33/176 (18%)
Query: 85 NRLGHGGFGSVYKAVV-----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC-PH 138
LG G FG V A S +AVK+L +EL + + L +
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------------ 186
IV+LLG + + LI+E L + L ++ + + +
Sbjct: 111 IVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 187 --------IAIDIAKGLEYL-HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
A +AKG+E+L SC +H D+ N+L+ KI DFGLAR
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
++LG G +G VY+ V S +AVK L EF E ++ + P++V LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLG 283
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ R +I E M +L D L + +E+ +A I+ +EYL
Sbjct: 284 VCT--REPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN-- 338
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH ++ N L+ + K+ DFGL+RL T D
Sbjct: 339 -FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 31/232 (13%)
Query: 10 IHHRRHNHQAHFLPAILAGTLVLTCFILIIITIFTYRKLYRNRTAPSDLKSPNHNHCRRF 69
+HH H+ + F + Y + P + P R F
Sbjct: 1 MHHHHHH----------SSGRENLYFQGKLPEPQFYAE-------PHTYEEPG-RAGRSF 42
Query: 70 SYNLIRRATASFSPSNRLGHGGFGSVYKAV---VPSSSQPLAVKILDSSGSLQGEREFHN 126
+ + +G G G V P+A+K L + + + R+F +
Sbjct: 43 TREIEAS---RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS 99
Query: 127 ELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE 186
E S+ D P+I+ L G + RGR +++ E MEN SL L R + +
Sbjct: 100 EASIMGQFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVG 155
Query: 187 IAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ + G+ YL +H D+ N+L+D + K+ DFGL+R+ +D
Sbjct: 156 MLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 12/153 (7%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+G G V A + +A+K ++ E E+ S P+IVS
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT- 80
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE---IAI---DIAKGLEYLH 199
S L L+ +L+ S+ D ++ + + + IA ++ +GLEYLH
Sbjct: 81 -SFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+ IH D+K NILL D +I DFG++
Sbjct: 139 KN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 22/163 (13%)
Query: 85 NRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
LG G FG+V+K V S P+ +K+++ Q + + + SLD HIV
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRK----CEELMEWNKRFEIAIDIAKGLE 196
LLG G L L+ + + SL D + + + L+ W + IAKG+
Sbjct: 79 RLLGLCP---GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMY 129
Query: 197 YLH-HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
YL H +H ++ N+LL + ++ DFG+A L D
Sbjct: 130 YLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 16/155 (10%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
++G G G V A S + +AVK++D Q NE+ + ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVV 105
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGLEY 197
+ S G L ++ E ++ +L D + + E +IA + + L Y
Sbjct: 106 EMYK--SYLVGEELWVLMEFLQGGALTDIVSQVRLNEE-------QIATVCEAVLQALAY 156
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
LH VIH DIK +ILL D + K+ DFG
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 8e-23
Identities = 26/209 (12%), Positives = 47/209 (22%), Gaps = 34/209 (16%)
Query: 54 APSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILD 113
A + P + S L+ + L G V+ + A+K+
Sbjct: 39 AVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFT 96
Query: 114 SSGSLQG--EREFHNELSLASSL------------------------DCPHIVSLLGFAS 147
H A+ L P L
Sbjct: 97 MGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQD 156
Query: 148 DRRGRRLVLIYELM--ENRSLQDALLDR-KCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
D +L+ + L L + + + L
Sbjct: 157 DYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
++HG P N+ + D + +GD
Sbjct: 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALW 242
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 13/118 (11%), Positives = 32/118 (27%), Gaps = 13/118 (11%)
Query: 456 SSTPSMRGTVCYIAPEY--GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFER 513
+ P+ V Y E+ + + + G+ I + P + + +
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305
Query: 514 ANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE 571
+ + + + +L I L +RL + +E
Sbjct: 306 RPSLRVPGTDSLAFGSCTPLPDFVKTL----------IGRF-LNFDRRRRLLPLEAME 352
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 17/160 (10%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELS-LASSLDCPHI 139
F +G+G +G VYK + Q A+K++D +G E E E++ L +I
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNI 83
Query: 140 VSLLG----FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIA 192
+ G +L L+ E S+ D + + K L E IA +I
Sbjct: 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE----EWIAYICREIL 139
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+GL +LH VIH DIK N+LL + + K+ DFG++
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 12/156 (7%)
Query: 86 RLGHGGFGSVYKAV--VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
LG G FGSV + V + +A+K+L E E + LD P+IV L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL-HHSC 202
G L+L+ E+ L L E + + E+ ++ G++YL +
Sbjct: 77 GVCQ---AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ N+LL AKI DFGL++ D
Sbjct: 132 ----VHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
+G G FG V + S+ +A+K L + + R+F E S+ D P+I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
L G + + + ++++ E MEN SL L RK + + + IA G++YL
Sbjct: 111 LEGVVT--KSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ NIL++ + K+ DFGL R+ +D
Sbjct: 167 G---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 35/162 (21%), Positives = 66/162 (40%), Gaps = 13/162 (8%)
Query: 86 RLGHGGFGSVYKAV-VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+ HGG G +Y A+ + +P+ +K L SG + + E + + P IV +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 145 FASDRRGRRLVLIY---ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
F + Y E + +SL+ + + + + ++I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEG 243
+++ D+KP NI+L + + K+ D G + G
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYG 239
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 12/46 (26%), Positives = 19/46 (41%), Gaps = 1/46 (2%)
Query: 455 ISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRP 500
I+S + GT + APE G + D+Y+ G + L
Sbjct: 231 INSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 21/162 (12%)
Query: 86 RLGHGGFGSVYKAV---VPSSSQPLAVKIL--DSSGSLQGEREFHNELSLASSLDCPHIV 140
+LG G FG V + + +AVK L D + +F E++ SLD +++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRK----CEELMEWNKRFEIAIDIAKGLE 196
L G + ++ EL SL D L + L + A+ +A+G+
Sbjct: 85 RLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMG 135
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
YL IH D+ N+LL KIGDFGL R ++
Sbjct: 136 YLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 12/150 (8%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+G G FG V +AVK + + + + F E S+ + L ++V LLG
Sbjct: 27 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL-HHSCE 203
+ +G L ++ E M SL D L R L + + ++D+ + +EYL ++
Sbjct: 82 VIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+H D+ N+L+ D AK+ DFGL +
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 17/155 (10%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELS-LASSLDCPHIVSLL 143
LG G +G V K S Q +AVK + ++ + Q ++ +L ++DCP V+
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------IAIDIAKGLEY 197
G + R + + ELM D LD+ +++++ + IA+ I K LE+
Sbjct: 73 G--ALFREGDVWICMELM------DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
LH + VIH D+KPSN+L++ + K+ DFG++
Sbjct: 125 LHS--KLSVIHRDVKPSNVLINALGQVKMCDFGIS 157
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 12/156 (7%)
Query: 86 RLGHGGFGSVYKAV--VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
LG G FGSV + V + +A+K+L E E + LD P+IV L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL-HHSC 202
G L+L+ E+ L L E + + E+ ++ G++YL +
Sbjct: 403 GVCQ---AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H ++ N+LL AKI DFGL++ D
Sbjct: 458 ----VHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 55/155 (35%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
F +LG G +GSVYKA+ + Q +A+K + LQ E E+S+ D PH+V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ---EIIKEISIMQQCDSPHVV 87
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGLEY 197
G S + L ++ E S+ D ++ + + L E EIA KGLEY
Sbjct: 88 KYYG--SYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTE----DEIATILQSTLKGLEY 140
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
LH IH DIK NILL+ + AK+ DFG+A
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 38/154 (24%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+ LG G G V+K S +A K++ + EL + + P+IV G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------IAIDIAKGLEYL 198
+ + + E M+ SL +++ R ++I + KGL YL
Sbjct: 99 --AFYSDGEISICMEHMDGGSLDQ---------VLKKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+ ++H D+KPSNIL++ + K+ DFG++
Sbjct: 148 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 39/191 (20%), Positives = 70/191 (36%), Gaps = 22/191 (11%)
Query: 51 NRTAPSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK 110
+ P P YN + F ++G G F VY+A P+A+K
Sbjct: 8 MQGPPVPQFQPQKALRPDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALK 63
Query: 111 ILDSSGSLQGE--REFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQD 168
+ + + + E+ L L+ P+++ S L ++ EL + L
Sbjct: 64 KVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA--SFIEDNELNIVLELADAGDLSR 121
Query: 169 ALLDRKCEELMEWNKRFE------IAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF 222
+ + + + + LE++H V+H DIKP+N+ +
Sbjct: 122 -----MIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATG 173
Query: 223 KAKIGDFGLAR 233
K+GD GL R
Sbjct: 174 VVKLGDLGLGR 184
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 37/155 (23%), Positives = 73/155 (47%), Gaps = 14/155 (9%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
+ LG G FG VYKA + A K++++ + E ++ E+ + ++ D P+IV
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIV 79
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGLEY 197
LLG + +L ++ E ++ ++ L E +I + + + L +
Sbjct: 80 KLLG--AYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTE----PQIQVVCRQMLEALNF 132
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
LH +IH D+K N+L+ + ++ DFG++
Sbjct: 133 LH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 4e-22
Identities = 22/178 (12%), Positives = 54/178 (30%), Gaps = 33/178 (18%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--REFHNELSLASSL--------- 134
LG + +A + + V + + ++ E+ L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 135 ----------------DCPHIVSLLGFASDRRGRRLVLIYELME--NRSLQDALLDRKCE 176
++ + D +Y M+ ++ + LL
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 177 -ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ + + R ++ + + + L LHH ++H ++P +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 19/158 (12%), Positives = 35/158 (22%), Gaps = 43/158 (27%)
Query: 452 SGGISSTPSMRGTVCYIAPE-----YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTAS 506
+ +S A L++ D ++ G+ I + P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP------ 316
Query: 507 PMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKD-----QALLCITIALLCLQRSPS 561
+ + I K+ +ALL L+
Sbjct: 317 ----NTDDAALGGSEW--------------IFRSCKNIPQPVRALLE-----GFLRYPKE 353
Query: 562 KRLTMKDIVEM----LTGEAEPPHLPFEFSPSPPSNFP 595
RL +E LP + P+
Sbjct: 354 DRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREG 391
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 49/148 (33%), Positives = 69/148 (46%), Gaps = 10/148 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
LG G FG+VY A S LA+K+L + + E E+ + S L P+I+ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ D R+ LI E ++ L +K + E I ++A L Y H
Sbjct: 77 YFHDAT--RVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT-ELANALSYCHSKR-- 129
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLA 232
VIH DIKP N+LL + KI DFG +
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 26/112 (23%), Positives = 49/112 (43%), Gaps = 26/112 (23%)
Query: 463 GTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQ 522
GT+ Y+ PE G + EK D++S GVL + G+ P + + ++R IS
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKR---ISRV-- 222
Query: 523 LAYNGKLLDLVDPSIHSLD-KDQALLCITIALLC--LQRSPSKRLTMKDIVE 571
+ P + +D L+ L+ +PS+R +++++E
Sbjct: 223 --------EFTFPDFVTEGARD---------LISRLLKHNPSQRPMLREVLE 257
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 5e-22
Identities = 30/154 (19%), Positives = 59/154 (38%), Gaps = 15/154 (9%)
Query: 85 NRLGHG--GFGSVYKAVVPSSSQPLAVKILD-SSGSLQGEREFHNELSLASSLDCPHIVS 141
+G G +V A + + + V+ ++ + S + EL ++ + P+IV
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGLEYL 198
+ L ++ M S +D + + + E IA + K L+Y+
Sbjct: 91 YRA--TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE----LAIAYILQGVLKALDYI 144
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
HH +H +K S+IL+ D K +
Sbjct: 145 HHM---GYVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 40/156 (25%), Positives = 66/156 (42%), Gaps = 14/156 (8%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG G FG V +A+K++ E EF E + +L +V L G
Sbjct: 30 KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL--HHSC 202
+ + R + +I E M N L + L R+ + + E+ D+ + +EYL
Sbjct: 87 VCT--KQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 140
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ N L++ K+ DFGL+R +D
Sbjct: 141 ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 51/157 (32%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--REFHNELSLASSLDCPH 138
FS +GHG FG+VY A +S+ +A+K + SG E ++ E+ L P+
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI---DIAKGL 195
+ G R L+ E S D LL+ + L E EIA +GL
Sbjct: 116 TIQYRG--CYLREHTAWLVMEYCLG-SASD-LLEVHKKPLQE----VEIAAVTHGALQGL 167
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
YLH +IH D+K NILL K+GDFG A
Sbjct: 168 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 46/152 (30%), Positives = 66/152 (43%), Gaps = 16/152 (10%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELS-LASSLDCPHIVSLLG 144
+G G +GSV K V S Q +AVK + S+ + +++ +L + S DCP+IV G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------IAIDIAKGLEYL 198
+ R + ELM + S + I + K L +L
Sbjct: 89 --ALFREGDCWICMELM-STSFDKFYKYVYSVL----DDVIPEEILGKITLATVKALNHL 141
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230
+IH DIKPSNILLD K+ DFG
Sbjct: 142 KE--NLKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 8e-22
Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 13/157 (8%)
Query: 86 RLGHGGFGSVYKAV---VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
+G G FG V++ + + + +A+K + S +F E D PHIV L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH-HS 201
+G ++ + +I EL L+ L + + ++ A ++ L YL
Sbjct: 457 IGVITENP---VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H DI N+L+ + K+GDFGL+R +
Sbjct: 512 F----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 10/163 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+LG G FG V+ + + +A+K L F E + L +V L
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
S+ + ++ E M SL D L + L + ++A IA G+ Y+
Sbjct: 247 VVSEEP---IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN-- 300
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVK 247
+H D++ +NIL+ + K+ DFGLARL ++ + K
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 342
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 10/154 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+G G FG V+ + +A+K + E +F E + L P +V L G
Sbjct: 14 QEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ L+ E ME+ L D L R L + +D+ +G+ YL +C
Sbjct: 71 VCL--EQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 124
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
VIH D+ N L+ + K+ DFG+ R +D
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 10/153 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
LG G FG V +AVK++ E EF E L P +V G
Sbjct: 15 ELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
S + + ++ E + N L + L R + +E ++ E+ D+ +G+ +L
Sbjct: 72 CS--KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--- 124
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ N L+D D K+ DFG+ R +D
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+G G FG V +AVK + + + + F E S+ + L ++V LLG
Sbjct: 199 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 253
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ +G L ++ E M SL D L R L + + ++D+ + +EYL +
Sbjct: 254 VIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLEGNN-- 309
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+H D+ N+L+ D AK+ DFGL +
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 22/161 (13%)
Query: 86 RLGHGGFGSVYKAV--VPSSSQPLAVKIL-DSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG+V K + + +AVKIL + + + E E ++ LD P+IV +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRK---CEELMEWNKRFEIAIDIAKGLEYL- 198
+G +L+ E+ E L L + + ++E ++ G++YL
Sbjct: 84 IGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYLE 134
Query: 199 -HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ +H D+ N+LL AKI DFGL++ D
Sbjct: 135 ESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 8/148 (5%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELS-LASSLDCPHIVSLLG 144
+G G G V+K + +AVK + SG+ + + +L + S DCP+IV G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ + + ELM + L R + E ++ + I K L YL +
Sbjct: 92 --TFITNTDVFIAMELM-GTCA-EKLKKRMQGPIPE-RILGKMTVAIVKALYYLKE--KH 144
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLA 232
VIH D+KPSNILLD + K+ DFG++
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 42/194 (21%), Positives = 70/194 (36%), Gaps = 27/194 (13%)
Query: 72 NLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILD-SSGSLQGEREFHNELS- 129
+ R T F ++G G FGSV+K V A+K E+ E+
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63
Query: 130 LASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLD-RKCEELMEWNKRFEIA 188
A H+V + +++ E SL DA+ + + + + ++
Sbjct: 64 HAVLGQHSHVVRYFS--AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-------------------FKAKIGDF 229
+ + +GL Y+H ++H DIKPSNI + KIGD
Sbjct: 122 LQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 230 GLARLKTEDLMIEG 243
G + + EG
Sbjct: 179 GHVTRISSPQVEEG 192
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 47/155 (30%), Positives = 67/155 (43%), Gaps = 21/155 (13%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKI--LDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG G +G VY S+ +A+K S Q H E++L L +IV LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLKHKNIVQYLG 86
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAI-----DIAKGLEYLH 199
S + + E + SL LL K L K E I I +GL+YLH
Sbjct: 87 --SFSENGFIKIFMEQVPGGSLSA-LLRSKWGPL----KDNEQTIGFYTKQILEGLKYLH 139
Query: 200 HSCEPPVIHGDIKPSNILLD-GDFKAKIGDFGLAR 233
+ ++H DIK N+L++ KI DFG ++
Sbjct: 140 DNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSK 171
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 48/154 (31%), Positives = 69/154 (44%), Gaps = 10/154 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
RLG G FG V+ + +AVK L F E +L L +V L
Sbjct: 19 ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ + +I E MEN SL D L +L NK ++A IA+G+ ++
Sbjct: 76 VVT---QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN-- 129
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D++ +NIL+ KI DFGLARL ++
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 3e-21
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 10/163 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+LG G FG V+ + + +A+K L F E + L +V L
Sbjct: 273 VKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYA 329
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
S+ + ++ E M SL D L + L + ++A IA G+ Y+
Sbjct: 330 VVSEEP---IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN-- 383
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVK 247
+H D++ +NIL+ + K+ DFGLARL ++ + K
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 425
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 39/156 (25%), Positives = 63/156 (40%), Gaps = 14/156 (8%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE----FHNELSLASSLDCPHIVS 141
+G GG G VY+A + +A+K++ + L + E A L PH+V
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSET--LSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
+ F +L + L+ L L + + + I I L+ H +
Sbjct: 99 IHDFGEI--DGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA 153
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237
H D+KP NIL+ D A + DFG+A T+
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 10/49 (20%), Positives = 23/49 (46%)
Query: 452 SGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRP 500
++ + GT+ Y+APE + + D+Y+ ++ ++G P
Sbjct: 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 10/154 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+LG G FG V+ A + +AVK + F E ++ +L +V L
Sbjct: 194 KKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ + +I E M SL D L + + K + + IA+G+ ++
Sbjct: 251 VVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN-- 304
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D++ +NIL+ KI DFGLAR+ ++
Sbjct: 305 -YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 16/158 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
LG G FG+VY A + +A+K+L S + E E+ + S L P+I+ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ DR+ R+ L+ E L L +K E + ++A L Y H
Sbjct: 82 YFHDRK--RIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFME-ELADALHYCHERK-- 134
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLA------RLKT 236
VIH DIKP N+L+ + KI DFG + R +T
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT 171
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE----FHNELSLASSLDCPHIVS 141
+LG GG +VY A + +A+K + + + E F E+ +S L +IVS
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIP--PREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
++ + LV+ E +E +L + + + + I G+++ H
Sbjct: 76 MIDVDEEDDCYYLVM--EYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM 130
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLM 240
++H DIKP NIL+D + KI DFG+A+ +E +
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 15/49 (30%), Positives = 25/49 (51%)
Query: 452 SGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRP 500
++ T + GTV Y +PE G E D+YS G+++ ++ G P
Sbjct: 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 17/159 (10%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
SF P + LGHG G++ + ++ +AVK + +RE L S + P++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECFSFADREVQL---LRESDEHPNV 80
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
+ DR+ + + + EL +LQ+ + + L + + GL +LH
Sbjct: 81 IRYFCTEKDRQFQYIAI--ELCAA-TLQEYVEQKDFAHLGL--EPITLLQQTTSGLAHLH 135
Query: 200 HSCEPPVIHGDIKPSNILL-----DGDFKAKIGDFGLAR 233
++H D+KP NIL+ G KA I DFGL +
Sbjct: 136 SLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 22/123 (17%), Positives = 35/123 (28%), Gaps = 19/123 (15%)
Query: 450 PKSGGISSTPSMRGTVCYIAPEY---GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTAS 506
S + GT +IAPE + D++S G + +IS
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH------ 228
Query: 507 PMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTM 566
P + + RQ L + A I + P KR +
Sbjct: 229 PFGKSLQ-------RQANILLGACSLDCLHPEKHEDVIARELIE---KMIAMDPQKRPSA 278
Query: 567 KDI 569
K +
Sbjct: 279 KHV 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 14/154 (9%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE----FHNELSLASSLDCPHIVS 141
LG GG V+ A + +AVK+L + L + F E A++L+ P IV+
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 142 LL--GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
+ G A G ++ E ++ +L+D + M + E+ D + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ +IH D+KP+NI++ K+ DFG+AR
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 14/49 (28%), Positives = 27/49 (55%)
Query: 452 SGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRP 500
++ T ++ GT Y++PE G + + DVYS G ++ +++G P
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 93.6 bits (232), Expect = 4e-20
Identities = 45/168 (26%), Positives = 70/168 (41%), Gaps = 12/168 (7%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL-- 143
RLG GGFG V + + + + +A+K S + + E+ + L+ P++VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 144 --GFASDRRGRRLVLIYELMENRSLQDALLDR-KCEELMEWNKRFEIAIDIAKGLEYLHH 200
G +L E E L+ L C L E R + DI+ L YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHE 139
Query: 201 SCEPPVIHGDIKPSNILLDGDFKA---KIGDFGLARLKTEDLMIEGEC 245
+ +IH D+KP NI+L + KI D G A+ + +
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 24/112 (21%), Positives = 36/112 (32%), Gaps = 6/112 (5%)
Query: 463 GTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMS-----EFERANLI 517
GT+ Y+APE + D +SFG L I+G RP P+ + I
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244
Query: 518 SWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
L K ++ H L + + L +R T
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM-LMWHQRQRGTDPQN 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 14/159 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G G V + + Q A+K+L S + E + H + S PHIV +L
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQAS-----GGPHIVCILDVY 91
Query: 147 SDR--RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ R L++I E ME L + +R + E EI DI +++LH
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-EIMRDIGTAIQFLHSHN-- 148
Query: 205 PVIHGDIKPSNILL---DGDFKAKIGDFGLARLKTEDLM 240
+ H D+KP N+L + D K+ DFG A+ T++ +
Sbjct: 149 -IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 32/155 (20%), Positives = 67/155 (43%), Gaps = 14/155 (9%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLD--CPHIVSLL 143
+G GG V++ + Q A+K ++ + + + NE++ + L I+ L
Sbjct: 36 IGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
+ + + ++ E N L L +K + W ++ ++ + + +H
Sbjct: 95 DYEITDQ--YIYMVMEC-GNIDLNSWLKKKKS--IDPWERKS-YWKNMLEAVHTIHQHG- 147
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
++H D+KP+N L+ D K+ DFG+A D
Sbjct: 148 --IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 25/121 (20%), Positives = 50/121 (41%), Gaps = 28/121 (23%)
Query: 460 SMRGTVCYIAPE-----------YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPM 508
S GTV Y+ PE +S K DV+S G ++ + G+ P Q + +
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 509 SEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKD 568
S+ +I ++ + D+ + + + K CL+R P +R+++ +
Sbjct: 247 SKLHA--IIDPNHEIEFP----DIPEKDLQDVLK-----------CCLKRDPKQRISIPE 289
Query: 569 I 569
+
Sbjct: 290 L 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 32/157 (20%), Positives = 68/157 (43%), Gaps = 14/157 (8%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLD--CPHIVS 141
++G GG V++ + Q A+K ++ + + + NE++ + L I+
Sbjct: 15 KQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
L + + + ++ E N L L +K + W ++ ++ + + +H
Sbjct: 74 LYDYEITDQ--YIYMVMEC-GNIDLNSWLKKKKS--IDPWERKS-YWKNMLEAVHTIHQH 127
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
++H D+KP+N L+ D K+ DFG+A D
Sbjct: 128 G---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 26/121 (21%), Positives = 48/121 (39%), Gaps = 28/121 (23%)
Query: 460 SMRGTVCYIAPE-----------YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPM 508
S GTV Y+ PE +S K DV+S G ++ + G+ P Q + +
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
Query: 509 SEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKD 568
S+ +I ++ + P I D + CL+R P +R+++ +
Sbjct: 228 SKLHA--IIDPNHEIEF---------PDIPEKD------LQDVLKCCLKRDPKQRISIPE 270
Query: 569 I 569
+
Sbjct: 271 L 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 37/192 (19%), Positives = 78/192 (40%), Gaps = 14/192 (7%)
Query: 50 RNRTAPSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAV 109
R DL + + + + I +S ++G GG V++ + Q A+
Sbjct: 27 RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAI 85
Query: 110 KILDSSGSLQGERE-FHNELSLASSLD--CPHIVSLLGFASDRRGRRLVLIYELMENRSL 166
K ++ + + + NE++ + L I+ L + + + ++ E N L
Sbjct: 86 KYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIYMVME-CGNIDL 142
Query: 167 QDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKI 226
L +K + W ++ ++ + + +H ++H D+KP+N L+ D K+
Sbjct: 143 NSWLKKKKS--IDPWERKS-YWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKL 195
Query: 227 GDFGLARLKTED 238
DFG+A D
Sbjct: 196 IDFGIANQMQPD 207
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 25/121 (20%), Positives = 47/121 (38%), Gaps = 28/121 (23%)
Query: 460 SMRGTVCYIAPE-----------YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPM 508
S G V Y+ PE +S K DV+S G ++ + G+ P Q + +
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 509 SEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKD 568
S+ +I ++ + P I D + CL+R P +R+++ +
Sbjct: 275 SKLHA--IIDPNHEIEF---------PDIPEKD------LQDVLKCCLKRDPKQRISIPE 317
Query: 569 I 569
+
Sbjct: 318 L 318
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 34/175 (19%), Positives = 64/175 (36%), Gaps = 27/175 (15%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH----------------NELSL 130
L G F + ++ A+K + S + NEL +
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 131 ASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE---- 186
+ + + ++ G ++ + +IYE MEN S+ +
Sbjct: 97 ITDIKNEYCLTCEGIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 187 -IAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLM 240
I + Y+H+ E + H D+KPSNIL+D + + K+ DFG + + +
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 22/120 (18%), Positives = 43/120 (35%), Gaps = 20/120 (16%)
Query: 463 GTVCYIAPE--YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN----- 515
GT ++ PE K D++S G+ + V+ P + S + F
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 516 --LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLC--LQRSPSKRLTMKDIVE 571
L K + + + D D L L+++P++R+T +D ++
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDID---------FLKLFLRKNPAERITSEDALK 322
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 21/150 (14%), Positives = 47/150 (31%), Gaps = 12/150 (8%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--REFHNELSLASSLDCPHIVSLL 143
G ++A+ + + +A+ +D G L + +E + S +D P + +L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
+++ E + SLQ+ + +A + H +
Sbjct: 98 DVVHT--RAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
V PS + + D +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 32/145 (22%), Positives = 50/145 (34%), Gaps = 5/145 (3%)
Query: 114 SSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDR 173
S ++ + V L + +L +L+D + R
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVG--QLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 174 KCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
E E I I IA+ +E+LH ++H D+KPSNI D K+GDFGL
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT 212
Query: 234 LKTEDLMIEGECVKKRDVNEDNGSI 258
+D + G +
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQV 237
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 26/133 (19%), Positives = 49/133 (36%), Gaps = 22/133 (16%)
Query: 440 SSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRR 499
++ + P + T GT Y++PE G S K D++S G+++ L+
Sbjct: 216 QDEEEQTVLTPMPAYATHT-GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-- 272
Query: 500 PLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRS 559
++ ER +I+ R L + + ++ L S
Sbjct: 273 -------FSTQMERVRIITDVRNLKF--------PLLFTQKYPQEHMMV----QDMLSPS 313
Query: 560 PSKRLTMKDIVEM 572
P++R DI+E
Sbjct: 314 PTERPEATDIIEN 326
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 40/177 (22%), Positives = 66/177 (37%), Gaps = 32/177 (18%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGEREFHN---------ELSL 130
++ + G +G+V V S P+A+K + ++ + + E+ L
Sbjct: 24 YTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 131 ASSLDCPHIVSLL---GFASDRRGRRLVLIYELMEN------RSLQDALLDRKCEELMEW 181
+ P+I+ L + +L L+ ELM + + + + M
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM-- 140
Query: 182 NKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
I GL LH V+H D+ P NILL + I DF LAR T D
Sbjct: 141 -------YHILLGLHVLH-EAG--VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 40/156 (25%), Positives = 61/156 (39%), Gaps = 19/156 (12%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G FG V+ SS +K ++ S + E+ + SLD P+I+ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAKGLEYLHH 200
D + ++ E E L + ++ + K E+ + L Y H
Sbjct: 90 EDY--HNMYIVMETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFH- 141
Query: 201 SCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLAR 233
V+H D+KP NIL KI DFGLA
Sbjct: 142 --SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 29/171 (16%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELS-LASSLDCPHI 139
LG+G G+V +P+AVK + + E+ L S D P++
Sbjct: 17 VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPNV 71
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKC-EELMEWNKRFEIAI---DIAKGL 195
+ + R + L EL +LQD + + +E ++ K + IA G+
Sbjct: 72 IRYYCSETTDRFLYIAL--ELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 196 EYLHHSCEPPVIHGDIKPSNILLD-------------GDFKAKIGDFGLAR 233
+LH +IH D+KP NIL+ + + I DFGL +
Sbjct: 129 AHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 20/115 (17%), Positives = 40/115 (34%), Gaps = 23/115 (20%)
Query: 463 GTVCYIAPE-------YGGGGLLSEKCDVYSFGVLILVLIS-GRRPLQVTASPMSEFERA 514
GT + APE L+ D++S G + ++S G+ P ++ R
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG------DKYSRE 247
Query: 515 NLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
+ I + ++ + + +A I+ + P KR T +
Sbjct: 248 SNI---IRGIFSLDEMKCLHDRSLI---AEATDLIS---QMIDHDPLKRPTAMKV 293
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 17/168 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD-------SSGSLQGERE-FHNELSLASSLDC-P 137
LG G V + + + + AVKI+D S+ +Q RE E+ + + P
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
+I+ L LV +LM+ L D L ++ L E R +I + + +
Sbjct: 85 NIIQLKDTYETNTFFFLVF--DLMKKGELFDYLTEKVT--LSEKETR-KIMRALLEVICA 139
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGEC 245
LH ++H D+KP NILLD D K+ DFG + + C
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 24/163 (14%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G F V+ + + A+K + S + NE+++ + +IV+L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKS-PAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAKGLEYLHH 200
LV+ +L+ L D +L+R + + + ++YLH
Sbjct: 76 ESTTHYYLVM--QLVSGGELFDRILER---------GVYTEKDASLVIQQVLSAVKYLH- 123
Query: 201 SCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLARLKTEDLM 240
E ++H D+KP N+L + + K I DFGL++++ +M
Sbjct: 124 --ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 9e-18
Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 14/157 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G G V + + + A+K+L + E E H S CPHIV ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS-----QCPHIVRIVDVY 124
Query: 147 SDRRGRR--LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ R L+++ E ++ L + DR + E EI I + ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH---SI 180
Query: 205 PVIHGDIKPSNILL---DGDFKAKIGDFGLARLKTED 238
+ H D+KP N+L + K+ DFG A+ T
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 9e-18
Identities = 45/182 (24%), Positives = 77/182 (42%), Gaps = 30/182 (16%)
Query: 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGEREFHN-ELSLAS 132
R S++ + +G+G FG VY+A + S + +A+K +L ++ F N EL +
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMR 102
Query: 133 SLDCPHIVSLLGF----ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIA 188
LD +IV L F + L L+ + + + + R + +
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ET--VYRVARHYSRAKQTLPVI 156
Query: 189 I------DIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGLAR-LKTEDLM 240
+ + L Y+H + H DIKP N+LLD D K+ DFG A+ L +
Sbjct: 157 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 241 IE 242
+
Sbjct: 214 VS 215
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 14/190 (7%)
Query: 62 NHNHCRRFSYNLIRRA--TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ 119
+H+H NL + ++ LG G FG V K + Q AVK+++ + +
Sbjct: 3 HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 120 GERE-FHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL 178
+ E+ L LD P+I+ L D +V EL L D ++ RK
Sbjct: 63 KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG--ELYTGGELFDEIIKRKR--F 118
Query: 179 MEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLARLK 235
E + I + G+ Y+H ++H D+KP NILL + D KI DFGL+
Sbjct: 119 SEHDAA-RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 236 TEDLMIEGEC 245
++ ++
Sbjct: 175 QQNTKMKDRI 184
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 34/165 (20%), Positives = 58/165 (35%), Gaps = 24/165 (14%)
Query: 87 LGHGGFGSVYKAV-----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS 141
LG G F VY+A + Q +K+ + + + +
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG-TQLMERLKPSMQHMFMK 131
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRK--CEELMEWNKRFEIAIDIAKGLEYLH 199
+ G VL+ EL +L +A+ K E++M A+ + +E +H
Sbjct: 132 FYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 200 HSCEPPVIHGDIKPSNILL-----------DGDFKAKIGDFGLAR 233
+ +IHGDIKP N +L D + D G +
Sbjct: 190 ---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 42/156 (26%), Positives = 65/156 (41%), Gaps = 19/156 (12%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLD-CPHIVSLLG 144
LG G F V + + S+ Q A K L Q R +E+++ CP +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK----GLEYLHH 200
+ ++LI E + L E + E I + K G+ YLH
Sbjct: 97 VYENT--SEIILILEYAAGGEIFSLCLPELAEMVSE-----NDVIRLIKQILEGVYYLHQ 149
Query: 201 SCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLAR 233
+ ++H D+KP NILL KI DFG++R
Sbjct: 150 NN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
+ S + LG G FG V+K ++ LA KI+ + ++ + E NE+S+ + LD ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANL 148
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
+ L + +VL+ E ++ L D ++D L E + I +G+ ++H
Sbjct: 149 IQLYDAFESK--NDIVLVMEYVDGGELFDRIIDESY-NLTELDTI-LFMKQICEGIRHMH 204
Query: 200 HSCEPPVIHGDIKPSNILL--DGDFKAKIGDFGLAR 233
++H D+KP NIL + KI DFGLAR
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 16/178 (8%)
Query: 62 NHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE 121
+H+ R + ++ LG G FG V K + Q AVK+++ + + +
Sbjct: 5 HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 122 RE-FHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKC--EEL 178
E+ L LD P+I+ L D +V EL L D ++ RK E
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG--ELYTGGELFDEIIKRKRFSEH- 121
Query: 179 MEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLAR 233
I + G+ Y+H ++H D+KP NILL + D KI DFGL+
Sbjct: 122 ----DAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 45/202 (22%), Positives = 79/202 (39%), Gaps = 28/202 (13%)
Query: 63 HNHCRRFSYNLIRRATASFSPSN---------RLGHGGFGSVYKAVVPSSSQPLAVKILD 113
+ + F + + S P LG G G V A + + +A++I+
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169
Query: 114 -------SSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSL 166
S+ E+ + L+ P I+ + F ++ ELME L
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA---EDYYIVLELMEGGEL 226
Query: 167 QDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL---DGDFK 223
D ++ K L E + + ++YLH + +IH D+KP N+LL + D
Sbjct: 227 FDKVVGNKR--LKEATCK-LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL 280
Query: 224 AKIGDFGLARLKTEDLMIEGEC 245
KI DFG +++ E ++ C
Sbjct: 281 IKITDFGHSKILGETSLMRTLC 302
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 38/157 (24%), Positives = 60/157 (38%), Gaps = 25/157 (15%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELS-LASSLDCPHIVSLLGF 145
LG G V + +SQ AVKI++ E+ L +++ L+ F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAKGLEYLH 199
+ R L++E M S+ + R+ F + D+A L++LH
Sbjct: 80 FEEE--DRFYLVFEKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLH 128
Query: 200 HSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLAR 233
+ H D+KP NIL + KI DF L
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 41/151 (27%), Positives = 65/151 (43%), Gaps = 14/151 (9%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G G V + + + A+K+L + E E H S CPHIV ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS-----QCPHIVRIVDVY 80
Query: 147 SDRRGRR--LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ R L+++ E ++ L + DR + E EI I + ++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH---SI 136
Query: 205 PVIHGDIKPSNILL---DGDFKAKIGDFGLA 232
+ H D+KP N+L + K+ DFG A
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 42/165 (25%), Positives = 68/165 (41%), Gaps = 16/165 (9%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLLGF 145
LG G +G V + A+KI+ + E+++ LD P+I+ L F
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKC--EELMEWNKRFEIAIDIAKGLEYLHHSCE 203
D+R L+ E + L D ++ R E I + G+ YLH
Sbjct: 105 FEDKRN--YYLVMECYKGGELFDEIIHRMKFNEV-----DAAVIIKQVLSGVTYLHKHN- 156
Query: 204 PPVIHGDIKPSNILL---DGDFKAKIGDFGLARLKTEDLMIEGEC 245
++H D+KP N+LL + D KI DFGL+ + ++
Sbjct: 157 --IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 27/112 (24%), Positives = 44/112 (39%), Gaps = 27/112 (24%)
Query: 463 GTVCYIAPE-----YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLI 517
GT YIAPE Y EKCDV+S GV++ +L++G P ++ E +
Sbjct: 200 GTAYYIAPEVLRKKYD------EKCDVWSIGVILFILLAGYPPFG----GQTDQEILRKV 249
Query: 518 SWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
+ ++ V KD L+ LQ +R++ +
Sbjct: 250 E-KGKYTFDSPEWKNVSEGA----KD--LIK-----QMLQFDSQRRISAQQA 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 16/155 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD------SSGSLQGERE-FHNELSLASSL-DCPH 138
+G G V + V ++ AVKI++ S L+ RE E + + PH
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
I++L+ LV +LM L D L ++ L E R I + + + +L
Sbjct: 162 IITLIDSYESSSFMFLVF--DLMRKGELFDYLTEKVA--LSEKETR-SIMRSLLEAVSFL 216
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
H + ++H D+KP NILLD + + ++ DFG +
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSC 248
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 41/208 (19%), Positives = 82/208 (39%), Gaps = 42/208 (20%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---------ELSLA 131
+ + +G G +G VY A ++ + +A+K + R F + E+++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--------NRMFEDLIDCKRILREITIL 79
Query: 132 SSLDCPHIVSLLGF---ASDRRGRRLVLIYELMEN------RSLQDALLDRKCEELMEWN 182
+ L +I+ L + L ++ E+ ++ ++ L E +
Sbjct: 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF---------LTEEH 130
Query: 183 KRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIE 242
+ I ++ G ++H +IH D+KP+N LL+ D K+ DFGLAR +
Sbjct: 131 IKT-ILYNLLLGENFIH-ESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 243 GECVKKRDVNEDNGSILEE---TESVVT 267
+ + + + T VVT
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVT 214
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-17
Identities = 41/150 (27%), Positives = 62/150 (41%), Gaps = 12/150 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
+G G +G V AV + A K + ++ F E+ + SLD P+I+ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKY-FVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206
D LV+ EL L + ++ ++ E + I D+ + Y H V
Sbjct: 76 EDNTDIYLVM--ELCTGGELFERVVHKRV--FRESDAA-RIMKDVLSAVAYCHKL---NV 127
Query: 207 IHGDIKPSNILL---DGDFKAKIGDFGLAR 233
H D+KP N L D K+ DFGLA
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 9e-17
Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 12/163 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLLGF 145
LG G F V + V ++ A KI+++ + + E + L P+IV L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
+ LV +L+ L + ++ R+ E + I + + Y H +
Sbjct: 74 IQEESFHYLVF--DLVTGGELFEDIVAREF--YSEADAS-HCIQQILESIAYCHSNG--- 125
Query: 206 VIHGDIKPSNILL---DGDFKAKIGDFGLARLKTEDLMIEGEC 245
++H ++KP N+LL K+ DFGLA + G
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 168
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 43/165 (26%), Positives = 67/165 (40%), Gaps = 23/165 (13%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD----SSGSLQGEREFHNELSLASSLDCPHIVSL 142
+G G F V + + + Q AVKI+D +S + E S+ L PHIV L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAKGLE 196
L S L +++E M+ L ++ R + + I + L
Sbjct: 92 LETYSSD--GMLYMVFEFMDGADLCFEIVKRA-----DAGFVYSEAVASHYMRQILEALR 144
Query: 197 YLHHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLARLKTED 238
Y H + +IH D+KP +LL + K+G FG+A E
Sbjct: 145 YCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 42/162 (25%), Positives = 67/162 (41%), Gaps = 28/162 (17%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
+G G + + + +++ AVKI+D S E L P+I++L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKS-KRDPTEE---IEILLRYGQHPNIITLKDVY 85
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAKGLEYLHH 200
D + + ++ ELM+ L D +L +K F + I K +EYLH
Sbjct: 86 DDG--KYVYVVTELMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLH- 133
Query: 201 SCEPPVIHGDIKPSNILL----DGDFKAKIGDFGLARLKTED 238
V+H D+KPSNIL +I DFG A+ +
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 45/156 (28%), Positives = 63/156 (40%), Gaps = 17/156 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER-----EFHNELSLASSLDCPHIVS 141
LG G F V K S+ A K + S R E E+S+ + ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
L +R +VLI EL+ L D L + E L E I G+ YLH
Sbjct: 80 LHDVYENR--TDVVLILELVSGGELFDFLAQK--ESLSEEEAT-SFIKQILDGVNYLH-- 132
Query: 202 CEPPVIHGDIKPSNILL----DGDFKAKIGDFGLAR 233
+ H D+KP NI+L K+ DFGLA
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 37/170 (21%), Positives = 65/170 (38%), Gaps = 25/170 (14%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLLGF 145
LG G F V + V + Q A I+++ + + E + L P+IV L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAKGLEYLH 199
S+ L+ +L+ L + ++ R + + I + + + H
Sbjct: 79 ISEEGHHYLIF--DLVTGGELFEDIVAR---------EYYSEADASHCIQQILEAVLHCH 127
Query: 200 HSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLAR-LKTEDLMIEGEC 245
V+H ++KP N+LL K+ DFGLA ++ E G
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 44/154 (28%), Positives = 65/154 (42%), Gaps = 17/154 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--REFHNELSLASSLDCPHIVSLLG 144
LG G FG V + Q AVK++ Q E+ L LD P+I+ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKC--EELMEWNKRFEIAIDIAKGLEYLHHSC 202
F D+ L+ E+ L D ++ RK E I + G+ Y+H +
Sbjct: 94 FFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVLSGITYMHKNK 146
Query: 203 EPPVIHGDIKPSNILL---DGDFKAKIGDFGLAR 233
++H D+KP N+LL D +I DFGL+
Sbjct: 147 ---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 47/156 (30%), Positives = 64/156 (41%), Gaps = 17/156 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER-----EFHNELSLASSLDCPHIVS 141
LG G F V K S+ A K + S R E E+S+ + P+I++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
L +R +VLI EL+ L D L + E L E I G+ YLH
Sbjct: 80 LHDVYENR--TDVVLILELVSGGELFDFLAQK--ESLSEEEAT-SFIKQILDGVNYLH-- 132
Query: 202 CEPPVIHGDIKPSNILL----DGDFKAKIGDFGLAR 233
+ H D+KP NI+L K+ DFGLA
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 28/172 (16%)
Query: 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGEREFHN------ 126
++ + + LG G F +VYKA +++Q +A+K I L E +
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK-----LGHRSEAKDGINRTA 59
Query: 127 --ELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQD--ALLDRKCEELMEWN 182
E+ L L P+I+ LL + + L+++ ME D ++ L +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKS--NISLVFDFME----TDLEVIIKDNSLVLTPSH 113
Query: 183 -KRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
K + + +GLEYLH ++H D+KP+N+LLD + K+ DFGLA+
Sbjct: 114 IKAY--MLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 48/241 (19%), Positives = 92/241 (38%), Gaps = 44/241 (18%)
Query: 50 RNRTAPSDLKSPNHNHCRRFS-YNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLA 108
+ P + R S + + R + + +G G +G V +A + +A
Sbjct: 27 GQQRKQHHSSKPTASMPRPHSDWQIPDR----YEIRHLIGTGSYGHVCEAYDKLEKRVVA 82
Query: 109 VKILDSSGSLQGEREFHN---------ELSLASSLDCPHIVSLL---GFASDRRGRRLVL 156
+K + R F + E+++ + L+ H+V +L + L +
Sbjct: 83 IKKIL--------RVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 157 IYELMENRSLQD--ALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPS 214
+ E+ + D L R L E + + + ++ G++Y+H S ++H D+KP+
Sbjct: 135 VLEIAD----SDFKKLF-RTPVYLTELHIKT-LLYNLLVGVKYVH-SAG--ILHRDLKPA 185
Query: 215 NILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDVNEDNGSILEE--------TESVV 266
N L++ D K+ DFGLAR + ++ N T VV
Sbjct: 186 NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245
Query: 267 T 267
T
Sbjct: 246 T 246
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 44/163 (26%), Positives = 64/163 (39%), Gaps = 30/163 (18%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG G F K V S+Q AVKI+ + Q E P+IV L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE-----GHPNIVKLHE 73
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAKGLEYL 198
D+ L+ EL+ L + + +K F I + + ++
Sbjct: 74 VFHDQ--LHTFLVMELLNGGELFERIKKKKH---------FSETEASYIMRKLVSAVSHM 122
Query: 199 HHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLARLKTED 238
H V+H D+KP N+L + + + KI DFG ARLK D
Sbjct: 123 HDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 37/149 (24%), Positives = 61/149 (40%), Gaps = 11/149 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G FG V++ V SS + K + G + E+S+ + +I+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESF 70
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206
LV+I+E + + + + EL E + + L++LH +
Sbjct: 71 ESM--EELVMIFEFISGLDIFERINTSAF-ELNEREIV-SYVHQVCEALQFLHSH---NI 123
Query: 207 IHGDIKPSNILL--DGDFKAKIGDFGLAR 233
H DI+P NI+ KI +FG AR
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQAR 152
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD------------SSGSLQGEREFHNELSLASSL 134
LG G +G V + A+K++ + + E +NE+SL SL
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 135 DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKC--EELMEWNKRFEIAIDIA 192
D P+I+ L D+ + L+ E E L + +++R E I I
Sbjct: 104 DHPNIIKLFDVFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDA-----ANIMKQIL 156
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLAR 233
G+ YLH ++H DIKP NILL + KI DFGL+
Sbjct: 157 SGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 26/112 (23%), Positives = 41/112 (36%), Gaps = 27/112 (24%)
Query: 463 GTVCYIAPE-----YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLI 517
GT YIAPE Y EKCDV+S GV++ +L+ G P + +
Sbjct: 210 GTAYYIAPEVLKKKYN------EKCDVWSCGVIMYILLCGYPPF--GGQNDQDIIKKVE- 260
Query: 518 SWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
+ ++ + K+ I L L +KR T ++
Sbjct: 261 --KGKYYFDFNDWKNISDEA----KE----LIK---LMLTYDYNKRCTAEEA 299
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 39/172 (22%), Positives = 73/172 (42%), Gaps = 30/172 (17%)
Query: 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGEREFHN-ELSLAS 132
+ +++ +G+G FG V++A + S +A+K +L ++ F N EL +
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKL-VESDEVAIKKVLQ-------DKRFKNRELQIMR 87
Query: 133 SLDCPHIVSLLGF----ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIA 188
+ P++V L F + L L+ E + + + R + + +
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ET--VYRASRHYAKLKQTMPML 141
Query: 189 I------DIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGLAR 233
+ + + L Y+H + H DIKP N+LLD K+ DFG A+
Sbjct: 142 LIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 18/153 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G FG V++ V ++ + K +++ + NE+S+ + L P +++L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK----GLEYLHHSC 202
D+ +VLI E + L D + ++ E I+ + GL+++H
Sbjct: 118 EDK--YEMVLILEFLSGGELFDRIAAEDY-KMSE-----AEVINYMRQACEGLKHMH--- 166
Query: 203 EPPVIHGDIKPSNILL--DGDFKAKIGDFGLAR 233
E ++H DIKP NI+ KI DFGLA
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 4e-16
Identities = 42/190 (22%), Positives = 75/190 (39%), Gaps = 14/190 (7%)
Query: 50 RNRTAPSDLKSPNHNHCRRFSYNLIRRATASFSP----SNRLGHGGFGSVYKAVVPSSSQ 105
T S+ + + +++ + LG G FG V++ ++
Sbjct: 124 GKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGN 183
Query: 106 PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRS 165
A K + + + E+ S L P +V+L D +V+IYE M
Sbjct: 184 NFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIYEFMSGGE 240
Query: 166 LQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL--DGDFK 223
L + + D ++ E ++ E + KGL ++H E +H D+KP NI+ +
Sbjct: 241 LFEKVADEH-NKMSE-DEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNE 295
Query: 224 AKIGDFGLAR 233
K+ DFGL
Sbjct: 296 LKLIDFGLTA 305
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 27/159 (16%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN-----ELSLASSLDCPHI 139
++G G +G V+K + Q +A+K + E+ + L P++
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 140 VSLLGFASD--RRGRRLVLIYELMENRSLQD--ALLDRKCEELMEWN-KRFEIAIDIAKG 194
V+LL + RR RRL L++E + LDR + E K +
Sbjct: 65 VNLL----EVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSI--TWQTLQA 114
Query: 195 LEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ + H IH D+KP NIL+ K+ DFG AR
Sbjct: 115 VNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 19/169 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD-------SSGSLQGEREFHNELSLASSLDCPHI 139
LG G G V A + + +A+KI+ S+ E+ + L+ P I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
+ + F ++ ELME L D ++ K L E + + ++YLH
Sbjct: 78 IKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKR--LKEATCK-LYFYQMLLAVQYLH 131
Query: 200 HSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLARLKTEDLMIEGEC 245
+ +IH D+KP N+LL + D KI DFG +++ E ++ C
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 36/178 (20%)
Query: 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---------EL 128
++ +G G +GSV A+ S + +A+K L R F + EL
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--------SRPFQSEIFAKRAYREL 74
Query: 129 SLASSLDCPHIVSLLG-FASDRRGRRLVLIY---ELME---NRSLQDALLDRKCEELMEW 181
L + +++ LL F R Y M+ + + + K + L+
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-- 132
Query: 182 NKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
+ KGL+Y+H S V+H D+KP N+ ++ D + KI DFGLAR ++
Sbjct: 133 -------YQMLKGLKYIH-SAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 41/206 (19%), Positives = 66/206 (32%), Gaps = 48/206 (23%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD----SSGSLQGEREFHNELSLASSLDCPHIVSL 142
+G G +G V A+ + A+KI++ + + E+ L L P+I L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF----------------- 185
D + + L+ EL L D L + +
Sbjct: 94 YEVYEDE--QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 186 --------------------EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL--DGDFK 223
I I L YLH + H DIKP N L + F+
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFE 208
Query: 224 AKIGDFGLARLKTEDLMIEGECVKKR 249
K+ DFGL++ + E + +
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTK 234
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 6e-16
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 25/158 (15%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHN----ELSLASSLDCPHI 139
++G G +G+V+KA + + +A+K + L + E + E+ L L +I
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 140 VSLLG-FASDRRGRRLVLIYELMENRSLQD--ALLDRKCEELMEWN-KRFEIAIDIAKGL 195
V L SD++ L L++E + QD D +L K F + KGL
Sbjct: 64 VRLHDVLHSDKK---LTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSF--LFQLLKGL 114
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ H V+H D+KP N+L++ + + K+ +FGLAR
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 42/188 (22%), Positives = 70/188 (37%), Gaps = 17/188 (9%)
Query: 54 APSDLKSPNHNHCRRFSYNLIRRATASFS----PSNRLGHGGFGSVYKAVVPSSSQPLAV 109
P R S + A+ FS LG G F V + V ++ A
Sbjct: 1 GPHMASMTGGQQMGRGS-EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 110 KILDSSGSLQGERE-FHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQD 168
KI+++ + + E + L P+IV L + LV +L+ L +
Sbjct: 60 KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF--DLVTGGELFE 117
Query: 169 ALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL---DGDFKAK 225
++ R+ E + I + + Y H ++H ++KP N+LL K
Sbjct: 118 DIVAREF--YSEADAS-HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVK 171
Query: 226 IGDFGLAR 233
+ DFGLA
Sbjct: 172 LADFGLAI 179
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 17/156 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER-----EFHNELSLASSLDCPHIVS 141
LG G F V K S+ A K + + R + E+S+ + P++++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
L ++ ++LI EL+ L D L ++ E L E + E I G+ YLH
Sbjct: 79 LHEVYENK--TDVILILELVAGGELFDFLAEK--ESLTE-EEATEFLKQILNGVYYLHSL 133
Query: 202 CEPPVIHGDIKPSNILL----DGDFKAKIGDFGLAR 233
+ H D+KP NI+L + KI DFGLA
Sbjct: 134 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 42/156 (26%), Positives = 69/156 (44%), Gaps = 17/156 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER-----EFHNELSLASSLDCPHIVS 141
LG G F V K + + A K + R E E+++ + P+I++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
L ++ +VLI EL+ L D L ++ E L E ++ + I G+ YLH
Sbjct: 73 LHDIFENK--TDVVLILELVSGGELFDFLAEK--ESLTE-DEATQFLKQILDGVHYLH-- 125
Query: 202 CEPPVIHGDIKPSNILL----DGDFKAKIGDFGLAR 233
+ H D+KP NI+L + + K+ DFG+A
Sbjct: 126 -SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 32/201 (15%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---------ELSLA 131
+ +LG G +G V+K++ + + +AVK + F N E+ +
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--------FDAFQNSTDAQRTFREIMIL 62
Query: 132 SSL-DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDR--KCEELMEWNKRFEIA 188
+ L +IV+LL R + L+++ ME D L + L +K++ +
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYME----TD--LHAVIRANILEPVHKQY-VV 115
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKK 248
+ K ++YLH S ++H D+KPSNILL+ + K+ DFGL+R +
Sbjct: 116 YQLIKVIKYLH-SGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 249 RDVNEDNGSILEE--TESVVT 267
+ N +N + T+ V T
Sbjct: 173 INENTENFDDDQPILTDYVAT 193
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 20/156 (12%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN-----ELSLASSLDCPHI 139
++G G +G VYKA + + +A+K + L E E E+SL L+ P+I
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKI----RLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQD--ALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
V LL +L L++E + QD +D + + +GL +
Sbjct: 65 VKLLDVIHTEN--KLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
H V+H D+KP N+L++ + K+ DFGLAR
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 39/168 (23%), Positives = 72/168 (42%), Gaps = 26/168 (15%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G VY+ + +P A+K+L + ++ E+ + L P+I+ L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAKGLEYLHH 200
LVL EL+ L D ++++ + + I + + YLH
Sbjct: 118 ETPTEISLVL--ELVTGGELFDRIVEK---------GYYSERDAADAVKQILEAVAYLHE 166
Query: 201 SCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLARLKTEDLMIEGEC 245
+ ++H D+KP N+L D KI DFGL+++ ++++ C
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC 211
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 42/186 (22%), Positives = 68/186 (36%), Gaps = 32/186 (17%)
Query: 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGEREFHN----ELS 129
R+ F G G FG+V S+ +A+K ++ + F N +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-------DPRFRNRELQIMQ 71
Query: 130 LASSLDCPHIVSLLGF-----ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKR 184
+ L P+IV L + DRR L ++ E + L R C
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT--LHRCCRNYYRRQVA 125
Query: 185 FEIAI------DIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-DFKAKIGDFGLAR-LKT 236
+ + + + LH V H DIKP N+L++ D K+ DFG A+ L
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 237 EDLMIE 242
+ +
Sbjct: 185 SEPNVA 190
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 40/204 (19%)
Query: 59 KSPNHNHCRRFSYNLIRRA---TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS 115
S + + +S + + +G G G V A + +A+K L
Sbjct: 39 MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--- 95
Query: 116 GSLQGEREFHN---------ELSLASSLDCPHIVSLL----GFASDRRGRRLVLIYELME 162
R F N EL L ++ +I+SLL + + + L+ ELM+
Sbjct: 96 -----SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD 150
Query: 163 ---NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD 219
+ +Q L + L+ + G+++LH + +IH D+KPSNI++
Sbjct: 151 ANLCQVIQMELDHERMSYLL---------YQMLCGIKHLHSAG---IIHRDLKPSNIVVK 198
Query: 220 GDFKAKIGDFGLAR-LKTEDLMIE 242
D KI DFGLAR T +M
Sbjct: 199 SDCTLKILDFGLARTAGTSFMMTP 222
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 32/163 (19%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD-------SSGSLQGEREFHNELSLASSLDCPHI 139
LG G +G V + + + AVKIL +G ++E + L L ++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLLRRLRHKNV 68
Query: 140 VSL---LGFASDRRGRRLVLIYELME-----NRSLQDALLDRKCEELMEWNKRFEIAIDI 191
+ L L ++ +Y +ME + + D++ +++ + + F ID
Sbjct: 69 IQLVDVLYNEEKQK------MYMVMEYCVCGMQEMLDSVPEKRFPV-CQAHGYFCQLID- 120
Query: 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
GLEYLH ++H DIKP N+LL KI G+A
Sbjct: 121 --GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 45/185 (24%), Positives = 79/185 (42%), Gaps = 33/185 (17%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD------------------SSGSLQGEREFHN-- 126
+G G +G V A + + A+K+L + + G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 127 -----ELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEW 181
E+++ LD P++V L+ D L +++EL+ + + + E +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE-DQA 139
Query: 182 NKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL-KTEDLM 240
F+ D+ KG+EYLH+ +IH DIKPSN+L+ D KI DFG++ K D +
Sbjct: 140 RFYFQ---DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 241 IEGEC 245
+
Sbjct: 194 LSNTV 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 30/168 (17%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--------REFHNELSLA 131
++ ++LG G + +VYK + +A+K + L+ E RE +SL
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIRE----VSLL 54
Query: 132 SSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQD--ALLDRKCEELMEWN-KRFEIA 188
L +IV+L + L L++E ++ +D LD + N K F
Sbjct: 55 KDLKHANIVTLHDIIHTEK--SLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLF--L 106
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236
+ +GL Y H V+H D+KP N+L++ + K+ DFGLAR K+
Sbjct: 107 FQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS 151
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 43/199 (21%), Positives = 76/199 (38%), Gaps = 38/199 (19%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---------ELSLA 131
F + LG G +G V A + + +A+K ++ F E+ +
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP---------FDKPLFALRTLREIKIL 63
Query: 132 SSLDCPHIVSLLGF--ASDRRGRRLV-LIYELMENRSLQDALLDRKCEELMEWNKRFEIA 188
+I+++ V +I ELM+ L + + L + + ++
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI---STQMLSDDHIQY-FI 118
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKK 248
+ ++ LH VIH D+KPSN+L++ + K+ DFGLAR+ E E
Sbjct: 119 YQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE---- 171
Query: 249 RDVNEDNGSILEETESVVT 267
S + E V T
Sbjct: 172 ---PTGQQSGM--VEFVAT 185
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 38/165 (23%), Positives = 67/165 (40%), Gaps = 19/165 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD---------SSGSLQGEREFHNELSLASSLDCP 137
LG GGFG+V+ + +A+K++ S S+ E + + P
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 138 HIVSLLGFASDRRGRRLVLIYELMEN-RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLE 196
++ LL + + +L+ E + L D + ++ L E R + ++
Sbjct: 99 GVIRLLDWFETQ--EGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRC-FFGQVVAAIQ 153
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGLARLKTEDLM 240
+ H V+H DIK NIL+D AK+ DFG L ++
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY 195
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 33/134 (24%), Positives = 52/134 (38%), Gaps = 30/134 (22%)
Query: 463 GTVCYIAPEY-GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWAR 521
GT Y PE+ + V+S G+L+ ++ G P FER I A
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP----------FERDQEILEA- 248
Query: 522 QLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE---MLTGEAE 578
+L P+ S D C + CL PS R ++++I+ M T +
Sbjct: 249 ---------ELHFPAHVSPD------CCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293
Query: 579 PPHLPFEFSPSPPS 592
P P + P+P +
Sbjct: 294 VPLNPSKGGPAPLA 307
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 29/175 (16%)
Query: 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---------EL 128
A + +G G +G+V AV + +A+K L R F + EL
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--------YRPFQSELFAKRAYREL 75
Query: 129 SLASSLDCPHIVSLL----GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKR 184
L + +++ LL + L+ M L + K E+L E +
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM---KHEKLGEDRIQ 131
Query: 185 FEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
F + + KGL Y+H + +IH D+KP N+ ++ D + KI DFGLAR ++
Sbjct: 132 F-LVYQMLKGLRYIH-AAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 23/162 (14%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--------REFHNELSLASSLDC 136
+LG+G + +VYK + ++ +A+K + L E RE +SL L
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIRE----ISLMKELKH 62
Query: 137 PHIVSLLGFASDRRGRRLVLIYELMEN--RSLQDALLDRKCEELMEWNKRFEIAIDIAKG 194
+IV L +L L++E M+N + D+ +E N + +G
Sbjct: 63 ENIVRLYDVIHTEN--KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 195 LEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236
L + H + ++H D+KP N+L++ + K+GDFGLAR
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 48/164 (29%), Positives = 72/164 (43%), Gaps = 27/164 (16%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN-----ELSLASSLDCPHI 139
+LG G +G VYKA+ +++ +A+K + L+ E E E+SL L +I
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI----RLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQD--ALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
+ L RL LI+E E D +D+ + M K F + G+ +
Sbjct: 96 IELKSVIHHNH--RLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSF--LYQLINGVNF 147
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKA-----KIGDFGLARLKT 236
H +H D+KP N+LL + KIGDFGLAR
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHI 139
+ +LG G + V++A+ ++++ + VKIL +++ E+ + +L P+I
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGPNI 93
Query: 140 VSLLGFASDRRGRRLVLIYELMEN---RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLE 196
++L D R L++E + N + L L D M +EI K L+
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-----YEIL----KALD 144
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKA-KIGDFGLAR 233
Y H ++H D+KP N+++D + + ++ D+GLA
Sbjct: 145 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 42/175 (24%), Positives = 73/175 (41%), Gaps = 33/175 (18%)
Query: 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---------EL 128
++ + +G G +G V A + +A+K + F + E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---------FEHQTYCQRTLREI 76
Query: 129 SLASSLDCPHIVSLLGF--ASDRRGRRLV-LIYELMENRSLQDALLDR--KCEELMEWNK 183
+ +I+ + A + V ++ +LME L + K + L +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME------TDLYKLLKTQHLSNDHI 130
Query: 184 RFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ I +GL+Y+H S V+H D+KPSN+LL+ KI DFGLAR+ D
Sbjct: 131 CY-FLYQILRGLKYIH-SAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 49/174 (28%), Positives = 82/174 (47%), Gaps = 27/174 (15%)
Query: 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---------EL 128
+ + +G G +GSV A + +AVK L R F + EL
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--------SRPFQSIIHAKRTYREL 79
Query: 129 SLASSLDCPHIVSLLG-FASDRRGRRLVLIYELMENRSLQDALLDR--KCEELMEWNKRF 185
L + +++ LL F R +Y + L A L+ KC++L + + +F
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH---LMGADLNNIVKCQKLTDDHVQF 136
Query: 186 EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
+ I +GL+Y+H S + +IH D+KPSN+ ++ D + KI DFGLAR +++
Sbjct: 137 -LIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 41/160 (25%), Positives = 66/160 (41%), Gaps = 9/160 (5%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLLGF 145
+G G F V A + + +A+KI+D + + E+ + L+ P+IV L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
+ L LI E + D L+ + E R I ++Y H
Sbjct: 83 IETEK--TLYLIMEYASGGEVFDYLVAHGR--MKEKEAR-SKFRQIVSAVQYCHQKR--- 134
Query: 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGEC 245
++H D+K N+LLD D KI DFG + T ++ C
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC 174
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 36/159 (22%), Positives = 65/159 (40%), Gaps = 27/159 (16%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN-----ELSLASSLDCPHI 139
+G G +G V K + + +A+K + + E+ L L ++
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 140 VSLLGFASD--RRGRRLVLIYELMENRSLQD--ALLDRKCEELMEWN-KRFEIAIDIAKG 194
V+LL + ++ +R L++E ++ L+ L +++ I G
Sbjct: 87 VNLL----EVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKY--LFQIING 136
Query: 195 LEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ + H +IH DIKP NIL+ K+ DFG AR
Sbjct: 137 IGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 48/174 (27%), Positives = 83/174 (47%), Gaps = 27/174 (15%)
Query: 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN--------E 127
AT+ + P +G G +G+VYKA P S +A+K + + E
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVRE 61
Query: 128 LSLASSLDC---PHIVSLLG-FASDRRGR--RLVLIYELMENRSLQD--ALLDRKCEELM 179
++L L+ P++V L+ A+ R R ++ L++E ++ QD LD+ +
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGL 117
Query: 180 EWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
++ +GL++LH +C ++H D+KP NIL+ K+ DFGLAR
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 24/157 (15%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN-----ELSLASSLDCPHI 139
++G G +G VYKA + + A+K + L+ E E E+S+ L +I
Sbjct: 8 EKIGEGTYGVVYKAQ-NNYGETFALKKI----RLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQD--ALLDRKCEELMEWN-KRFEIAIDIAKGLE 196
V L ++ RLVL++E ++ QD LLD L K F + + G+
Sbjct: 63 VKLYDVIHTKK--RLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSF--LLQLLNGIA 114
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
Y H V+H D+KP N+L++ + + KI DFGLAR
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 48/182 (26%), Positives = 73/182 (40%), Gaps = 37/182 (20%)
Query: 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN---------EL 128
+ +G G G V A + +A+K L R F N EL
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--------SRPFQNQTHAKRAYREL 75
Query: 129 SLASSLDCPHIVSLLG-FASDRRGRRLVLIY---ELME---NRSLQDALLDRKCEELMEW 181
L ++ +I+ LL F + +Y ELM+ + +Q L + L+
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-- 133
Query: 182 NKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR-LKTEDLM 240
+ G+++LH S +IH D+KPSNI++ D KI DFGLAR T +M
Sbjct: 134 -------YQMLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 241 IE 242
Sbjct: 184 TP 185
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 29/166 (17%)
Query: 86 RLGHGGFGSVYKAVV--PSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSL 142
++G G +G VYKA + A+K ++ +G S+ RE ++L L P+++SL
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISL 83
Query: 143 LGFASDRRGRRLVLIYELMENRSLQD--ALLDRKCEELMEWNKRFEIAIDIAK------- 193
R++ L+++ E D ++ K ++ + K
Sbjct: 84 QKVFLSHADRKVWLLFDYAE----HDLWHIIK-FHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 194 -GLEYLHHSCEPPVIHGDIKPSNILLDGDFKA----KIGDFGLARL 234
G+ YLH + V+H D+KP+NIL+ G+ KI D G ARL
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 17/162 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD-----SSGSLQGEREFHNELSLASSLD--CPHI 139
LG GGFGSVY + S + P+A+K ++ G L E+ L + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 140 VSLLGFASDRRGRRLVLIYELMENR-SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+ LL + VLI E E L D + +R L E R + + + +
Sbjct: 111 IRLLDWFERP--DSFVLILERPEPVQDLFDFITERGA--LQEELARS-FFWQVLEAVRHC 165
Query: 199 HHSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGLARLKTEDL 239
H+ V+H DIK NIL+D + + K+ DFG L + +
Sbjct: 166 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 204
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 26/134 (19%), Positives = 38/134 (28%), Gaps = 30/134 (22%)
Query: 463 GTVCYIAPEY-GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWAR 521
GT Y PE+ V+S G+L+ ++ G P FE I
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----------FEHDEEI---- 255
Query: 522 QLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE---MLTGEAE 578
G+ + S + C + CL PS R T ++I M
Sbjct: 256 ---IRGQ---VFFRQRVSSE------CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303
Query: 579 PPHLPFEFSPSPPS 592
P
Sbjct: 304 QETAEIHLHSLSPG 317
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 24/157 (15%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHN----ELSLASSLDCPHI 139
++G G +G VYKA S + +A+K + L E E + E+SL L P+I
Sbjct: 27 EKVGEGTYGVVYKAK-DSQGRIVALKRI----RLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQD--ALLDRKCEELMEWN-KRFEIAIDIAKGLE 196
VSL+ R L L++E ME +D +LD L + K + + +G+
Sbjct: 82 VSLIDVIHSER--CLTLVFEFME----KDLKKVLDENKTGLQDSQIKIY--LYQLLRGVA 133
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ H ++H D+KP N+L++ D K+ DFGLAR
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 40/172 (23%), Positives = 76/172 (44%), Gaps = 27/172 (15%)
Query: 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGERE-FHN----ELS 129
+ + ++G G FG V+KA + Q +A+K +L ++ E+E F E+
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIK 68
Query: 130 LASSLDCPHIVSLLGFASDRRGRR------LVLIYELMENRSLQD--ALLDRKCEELMEW 181
+ L ++V+L+ + + L+++ E D LL +
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLS 124
Query: 182 NKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ + + GL Y+H + ++H D+K +N+L+ D K+ DFGLAR
Sbjct: 125 EIK-RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 35/170 (20%), Positives = 64/170 (37%), Gaps = 22/170 (12%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD-----SSGSLQGEREFH--NELSLASSLDCPHI 139
LG G FG V+ AV ++ + VK + ++ + E+++ S ++ +I
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 140 VSLLGFASDRRGRRLVLIYELMENRS----LQDALLDRKCEELMEWNKRFEIAIDIAKGL 195
+ +L ++ +ME L + + + F + +
Sbjct: 92 IKVLDIFENQG-----FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR---QLVSAV 143
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGEC 245
YL +IH DIK NI++ DF K+ DFG A + C
Sbjct: 144 GYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 35/171 (20%), Positives = 65/171 (38%), Gaps = 36/171 (21%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKIL----DSSGSLQGEREFHNELSLASSLDCPHIVS 141
++G GGFG +Y A + + A ++ +G L E +F+ ++ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 142 LL-----------GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF----- 185
L G + ++ E + LQ + N F
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK---------ISGQNGTFKKSTV 153
Query: 186 -EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKI--GDFGLAR 233
++ I + LEY+H + +HGDIK +N+LL ++ D+GL+
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NE---LSLASSLDCPHIVS 141
+G GGFG VY + + A+K LD + E NE LSL S+ DCP IV
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 142 LLG-FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
+ F + + L I +LM L L + E + RF A +I GLE++H
Sbjct: 257 MSYAFHTPDK---LSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAA-EIILGLEHMH- 309
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
V++ D+KP+NILLD +I D GLA ++
Sbjct: 310 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 10/161 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG G FG V + +AVKIL+ SL + E+ PHI+ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
S ++ E + L D + E ME + F+ I ++Y H
Sbjct: 79 VISTPT--DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCHRHM-- 131
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGEC 245
V+H D+KP N+LLD AKI DFGL+ + ++ + C
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 171
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 37/205 (18%), Positives = 72/205 (35%), Gaps = 50/205 (24%)
Query: 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVK-ILDSSGSLQGEREFHN-ELSLASSLD 135
+ +S LG G FG V + S + A+K +L + + N EL + LD
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-------DPRYKNRELDIMKVLD 58
Query: 136 CPHIVSLLGF---ASDRRGRRLVLIYELMENRSLQDALLDRKCE---------------E 177
+I+ L+ + D + + + + + + E
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 178 LME----------WNKRFEIAID--------IAKGLEYLHHSCEPPVIHGDIKPSNILLD 219
+ I ++ + + + ++H S + H DIKP N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLG--ICHRDIKPQNLLVN 175
Query: 220 G-DFKAKIGDFGLAR-LKTEDLMIE 242
D K+ DFG A+ L + +
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVA 200
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 25/172 (14%)
Query: 76 RATASFSPSNRLGHGGFGSVYKAV-VPSSSQPLAVKILDSSGSLQGEREFHN-----ELS 129
RA + +G G +G V+KA + + + +A+K + +Q E E++
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVA 63
Query: 130 LASSLDC---PHIVSLLG---FASDRRGRRLVLIYELMENRSLQD--ALLDRKCEELMEW 181
+ L+ P++V L + R +L L++E ++ QD LD+ E +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPT 119
Query: 182 NKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
++ + +GL++LH V+H D+KP NIL+ + K+ DFGLAR
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 38/200 (19%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
+ LG GG G V+ AV + +A+K + + + E+ + LD +IV
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIV 71
Query: 141 SLLGF--ASDRRGRRLV----------LIYELMENRSLQDALLDRKCEELMEWNKRFEIA 188
+ S + V ++ E ME L + L + L+E + R
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARL-FM 126
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLD-GDFKAKIGDFGLARLKTEDLMIEGECVK 247
+ +GL+Y+H S V+H D+KP+N+ ++ D KIGDFGLAR+
Sbjct: 127 YQLLRGLKYIH-SAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIM------------ 171
Query: 248 KRDVNEDNGSILEETESVVT 267
D + + L +E +VT
Sbjct: 172 --DPHYSHKGHL--SEGLVT 187
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
LG G F +V A ++S+ A+KIL+ ++ + + E + S LD P V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 145 -FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
F D + L +N L + RK E RF A +I LEYLH
Sbjct: 98 TFQDDEK---LYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTA-EIVSALEYLHGK-- 149
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+IH D+KP NILL+ D +I DFG A++ + +
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 43/177 (24%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD----SSGSLQG--EREFHNELSLASSLDCPHIV 140
LG G FG V A + Q +A+K + + ERE L L L PHI+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY-LKL---LRHPHII 72
Query: 141 SLLGFASDRRGRRLVLIYELMENRS------------LQDALLDRKCEELMEWNKRFEIA 188
L Y+++ + L D ++++K E + F+
Sbjct: 73 KL---------------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQ-- 115
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGEC 245
I +EY H ++H D+KP N+LLD + KI DFGL+ + T+ ++ C
Sbjct: 116 -QIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 41/148 (27%), Positives = 62/148 (41%), Gaps = 8/148 (5%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G +G V AV + + +AVKI+D ++ E+ + L+ ++V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206
+ L E L D + + + F + G+ YLH +
Sbjct: 75 REGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIG---I 126
Query: 207 IHGDIKPSNILLDGDFKAKIGDFGLARL 234
H DIKP N+LLD KI DFGLA +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATV 154
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 47/165 (28%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILD------SSGSLQGEREFHNELSLASSLDCPHIV 140
LG G FG V + +AVKIL+ + RE N L L PHI+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQN-LKL---FRHPHII 79
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
L S + ++ E + L D + + E + F+ I G++Y H
Sbjct: 80 KLYQVISTPS--DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ---QILSGVDYCHR 134
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGEC 245
V+H D+KP N+LLD AKI DFGL+ + ++ + C
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 176
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 42/161 (26%), Positives = 65/161 (40%), Gaps = 34/161 (21%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146
LG G +G V AV + + +AVKI+D ++ E+ + L+ ++V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70
Query: 147 SDRRGRRLVLIYELMENRS-----LQDA----LLDRKCEE--LMEWNKR--FEIAIDIAK 193
Y + L+ L DR + + E + + F +
Sbjct: 71 -----------YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
G+ YLH + H DIKP N+LLD KI DFGLA +
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 44/152 (28%), Positives = 67/152 (44%), Gaps = 18/152 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
LG G FG V S A+KILD ++ ++ H NE + +++ P +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 145 FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
D +V+ Y E+ + L R+ E + RF A I EYLH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMF-------SHL-RRIGRFSEPHARFYAA-QIVLTFEYLHS 159
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+I+ D+KP N+L+D ++ DFG A
Sbjct: 160 LD---LIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 32/176 (18%), Positives = 64/176 (36%), Gaps = 41/176 (23%)
Query: 85 NRLGHGGFGSVYKAV--------VPSSSQPLAVKILDSSGSLQGEREFH---------NE 127
+ G +Y+A Q ++K+ G L E+ F N+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 128 LSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKR--- 184
S I + +GF + R L+ + RSLQ ++ + +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL-GRSLQS---------ALDVSPKHVL 156
Query: 185 -----FEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKI--GDFGLAR 233
++A + LE+LH + +HG++ NI +D + ++++ +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 47/161 (29%), Positives = 68/161 (42%), Gaps = 8/161 (4%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
LG GGFG V V ++ + A K L+ + + E NE + ++ +VSL
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-- 249
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ L L+ LM L+ + E F A +I GLE LH
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLH---RE 305
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGEC 245
+++ D+KP NILLD +I D GLA E I+G
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV 346
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 17/158 (10%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
+G G FG V + ++ + A+KIL+ L+ E + + D I +L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 145 FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
D LV+ Y +L+ LL + + L E RF +A ++ ++ +H
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLL-------TLLSKFEDRLPEEMARFYLA-EMVIAIDSVH- 192
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ +H DIKP NIL+D + ++ DFG ED
Sbjct: 193 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 36/155 (23%), Positives = 67/155 (43%), Gaps = 12/155 (7%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
+G G FG V + + A+K ++ ++ + EL + L+ P +V+L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 145 -FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
F + + ++ +L+ L+ L ++ E + I ++ L+YL
Sbjct: 83 SFQDEED---MFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFIC-ELVMALDYLQ---N 133
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+IH D+KP NILLD I DF +A + +
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 39/152 (25%), Positives = 61/152 (40%), Gaps = 17/152 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
+G G F V + + Q A+KI++ L+ E + + D I L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 145 FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
D LV+ Y +L+ LL + E + RF +A +I ++ +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDLL-------TLLSKFGERIPAEMARFYLA-EIVMAIDSVH- 179
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+H DIKP NILLD ++ DFG
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSC 209
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 42/156 (26%), Positives = 65/156 (41%), Gaps = 10/156 (6%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
LG GGFG V+ + ++ + A K L+ + + E + + + IVSL
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-- 250
Query: 145 FASDRRGRRLVLIYELMENRSL--QDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
+ L L+ +M + +D E F A I GLE+LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLH--- 306
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ +I+ D+KP N+LLD D +I D GLA
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREF-------HNELSLASSLDCP 137
LG G F +V+ A ++ +A+KI+ E E + + S+
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86
Query: 138 HIVSLLG-FASDRRGRR---LVLIYELMENRSLQDALLDRKCEEL-MEWNKRFEIAIDIA 192
HI+ LL F + +G +V+++E++ +L + + + + + K+ + +
Sbjct: 87 HILKLLDHF--NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI--SKQLL 141
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLD------GDFKAKIGDFGLARLKTEDL 239
GL+Y+H C +IH DIKP N+L++ + KI D G A E
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 42/173 (24%), Positives = 64/173 (36%), Gaps = 37/173 (21%)
Query: 86 RLGHGGFGSVYKAVVPSSS-----QPLAVKIL-DSSGSLQGEREFHNELSLASSLDCPHI 139
+G GGFG +Y A + SS P VK+ +G L E +F+ + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 140 VSLL-----------GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF--- 185
L G +I + LQ KRF
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY--EAN------AKRFSRK 152
Query: 186 ---EIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKI--GDFGLAR 233
++++ I LEY+H +HGDIK SN+LL+ ++ D+GLA
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 8e-11
Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
LG G FG V+ + + A+K+L ++ ++ H +E + S + P I+ + G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 145 FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
D + +++ Y EL +LL RK + +F A ++ LEYLH
Sbjct: 74 TFQDAQQIFMIMDYIEGGELF-------SLL-RKSQRFPNPVAKFYAA-EVCLALEYLHS 124
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+I+ D+KP NILLD + KI DFG A
Sbjct: 125 K---DIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 31/160 (19%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVK---ILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
++G G FG +Y ++ + +A+K + L E + + + I ++
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-----GGVGIPTI 70
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------IAIDIAKGLE 196
++ G V++ EL+ SL+D L C +++F +A + +E
Sbjct: 71 RWCGAE--GDYNVMVMELL-GPSLED--LFNFC------SRKFSLKTVLLLADQMISRIE 119
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAK---IGDFGLAR 233
Y+H IH D+KP N L+ K I DFGLA+
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 38/152 (25%), Positives = 63/152 (41%), Gaps = 19/152 (12%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
+G G FG V S+ + A+K+L ++ E + + + P +V L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 145 FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
D R +V+ Y +L+ L+ ++ E RF A ++ L+ +H
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLV-------NLMSN--YDVPEKWARFYTA-EVVLALDAIHS 186
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
IH D+KP N+LLD K+ DFG
Sbjct: 187 MG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 39/176 (22%), Positives = 63/176 (35%), Gaps = 42/176 (23%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG--EREFHNELSLASSLDCPHIVSLLG 144
+G G FG + + +AVK ++ ++ +RE N SL P+IV
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN----HRSLRHPNIVRF-- 81
Query: 145 FASDRRGRRLVLIYELMENRS-----LQDA----LLDRKCEE--LMEWNKR--FEIAIDI 191
E++ + ++ A L +R C E R F+ +
Sbjct: 82 -------------KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS- 127
Query: 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKA--KIGDFGLARLKTEDLMIEGEC 245
G+ Y H + H D+K N LLDG KI DFG ++ +
Sbjct: 128 --GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 38/162 (23%), Positives = 68/162 (41%), Gaps = 33/162 (20%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSG---SLQGEREFHNELSLASSLDCPHIVSL 142
++G G FG + +++ +A+K+ L E F+ +L I +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-----SGDGIPQV 70
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------IAIDIAKGLE 196
F G+ ++ EL+ SL+D L C ++ F IAI + +E
Sbjct: 71 YYFGPC--GKYNAMVLELL-GPSLED--LFDLC------DRTFSLKTVLMIAIQLISRME 119
Query: 197 YLHHSCEPPVIHGDIKPSNILL--DGDFKAKIG---DFGLAR 233
Y+H +I+ D+KP N L+ G+ ++ DF LA+
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 34/162 (20%), Positives = 66/162 (40%), Gaps = 33/162 (20%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVK---ILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
R+G G FG +++ ++Q +A+K + L+ E + L+ C I ++
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA-----GCTGIPNV 71
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF------EIAIDIAKGLE 196
F + LV+ +L+ SL+D L C ++F A + ++
Sbjct: 72 YYFGQEGLHNVLVI--DLL-GPSLED--LLDLC------GRKFSVKTVAMAAKQMLARVQ 120
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAK-----IGDFGLAR 233
+H +++ DIKP N L+ + DFG+ +
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 43/159 (27%), Positives = 63/159 (39%), Gaps = 31/159 (19%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
LG G FG V + + + AVKIL D E+ LA P
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-----LALPGKPPF 403
Query: 139 IVSLLG-FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK 193
+ L F + R V+ Y +LM +Q + E + F A +IA
Sbjct: 404 LTQLHSCFQTMDR-LYFVMEYVNGGDLM--YHIQ------QVGRFKEPHAVFYAA-EIAI 453
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
GL +L +I+ D+K N++LD + KI DFG+
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 36/173 (20%), Positives = 63/173 (36%), Gaps = 17/173 (9%)
Query: 85 NRLGHGGFGSVYKAVV-----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC-PH 138
LG G FG V +A ++ + +AVK+L + R +EL + + +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+V+LLG A + G L++I E + +L L +KR E KG +
Sbjct: 88 VVNLLG-ACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDV 251
I D+K + + F + ++ E +D
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 24/64 (37%), Positives = 33/64 (51%), Gaps = 7/64 (10%)
Query: 187 IAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECV 246
+ +AKG+E+L IH D+ NILL KI DFGLAR D+ + + V
Sbjct: 198 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYV 250
Query: 247 KKRD 250
+K D
Sbjct: 251 RKGD 254
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 43/159 (27%), Positives = 63/159 (39%), Gaps = 31/159 (19%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
LG G FG V + + + AVKIL D E+ LA P
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-----LALPGKPPF 82
Query: 139 IVSLLG-FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK 193
+ L F + R V+ Y +LM +Q + E + F A +IA
Sbjct: 83 LTQLHSCFQTMDR-LYFVMEYVNGGDLM--YHIQ------QVGRFKEPHAVFYAA-EIAI 132
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
GL +L +I+ D+K N++LD + KI DFG+
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 43/159 (27%), Positives = 65/159 (40%), Gaps = 31/159 (19%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
LG G FG V A V + AVK+L D E+ L+ + + P
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRI-----LSLARNHPF 85
Query: 139 IVSLLG-FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK 193
+ L F + R V+ + +LM +Q K E RF A +I
Sbjct: 86 LTQLFCCFQTPDR-LFFVMEFVNGGDLM--FHIQ------KSRRFDEARARFYAA-EIIS 135
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
L +LH + +I+ D+K N+LLD + K+ DFG+
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 38/159 (23%), Positives = 71/159 (44%), Gaps = 31/159 (19%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
+G G + V + + + A+K++ + +Q E+ + + P
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-----FEQASNHPF 71
Query: 139 IVSLLG-FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK 193
+V L F ++ R V+ Y +LM + +Q + +L E + RF A +I+
Sbjct: 72 LVGLHSCFQTESR-LFFVIEYVNGGDLMFH--MQ------RQRKLPEEHARFYSA-EISL 121
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
L YLH E +I+ D+K N+LLD + K+ D+G+
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 31/159 (19%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
+G G + V + + + A++++ + +Q E+ + + P
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV-----FEQASNHPF 114
Query: 139 IVSLLG-FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK 193
+V L F ++ R V+ Y +LM + +Q + +L E + RF A +I+
Sbjct: 115 LVGLHSCFQTESR-LFFVIEYVNGGDLMFH--MQ------RQRKLPEEHARFYSA-EISL 164
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
L YLH E +I+ D+K N+LLD + K+ D+G+
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 31/159 (19%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
LG G FG V+ A ++Q A+K L D E+ L+ + + P
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-----LSLAWEHPF 79
Query: 139 IVSLLG-FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK 193
+ + F + V+ Y +LM + +Q C + F A +I
Sbjct: 80 LTHMFCTFQTKEN-LFFVMEYLNGGDLMYH--IQ------SCHKFDLSRATFYAA-EIIL 129
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
GL++LH +++ D+K NILLD D KI DFG+
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 4e-09
Identities = 31/206 (15%), Positives = 56/206 (27%), Gaps = 47/206 (22%)
Query: 68 RFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKI--LDSSGSLQGE---- 121
FS+ L T ++G G FG V++ + + P+A+KI ++ + G
Sbjct: 12 PFSHCL---PTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 122 -REFHNE---------LSLASSLDCPHIVSLLGF--ASDRRGRRLVLIYELMENRSLQD- 168
E E LS + L L+ ++ +
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 169 ---------------------ALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVI 207
L++ +L I + L S
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FE 184
Query: 208 HGDIKPSNILLDGDFKAKIGDFGLAR 233
H D+ N+LL K+ +
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 47/160 (29%), Positives = 65/160 (40%), Gaps = 33/160 (20%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
+G G FG V A + AVK+L + ER L ++ P
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-----LLKNVKHPF 100
Query: 139 IVSLLGFASDRRGRRL--VLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIA 192
+V L S + +L VL Y EL + LQ + +E RF A +IA
Sbjct: 101 LVGL--HFSFQTADKLYFVLDYINGGELFYH--LQ------RERCFLEPRARFYAA-EIA 149
Query: 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
L YLH +++ D+KP NILLD + DFGL
Sbjct: 150 SALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 19/159 (11%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVSLLG 144
LG G FG V ++ + A+KIL + + H E + + P + +L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 145 -FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
F + R V+ Y EL + L + E RF A +I L+YLH
Sbjct: 216 SFQTHDR-LCFVMEYANGGELFFH--LS------RERVFSEDRARFYGA-EIVSALDYLH 265
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
E V++ D+K N++LD D KI DFGL + +D
Sbjct: 266 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 15/153 (9%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFH--NELSLASSLDCPHIVSL 142
+G G FG V KA Q +A+K++ + Q E L + +++ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL-MEWNKRFEIAIDIAKGLEYLHHS 201
L + R + + +EL+ +L + + K + + ++F A I + L+ LH +
Sbjct: 165 LENFTFRN--HICMTFELLSM-NLYELIKKNKFQGFSLPLVRKF--AHSILQCLDALHKN 219
Query: 202 CEPPVIHGDIKPSNILLDGDFKA--KIGDFGLA 232
+IH D+KP NILL ++ K+ DFG +
Sbjct: 220 R---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 31/160 (19%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVK---ILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
++G G FG +Y +++ +A+K + L E + + L I ++
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ-----GGTGIPNV 68
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFE------IAIDIAKGLE 196
F + G VL+ +L+ SL+D L C +++ +A + +E
Sbjct: 69 RWFGVE--GDYNVLVMDLL-GPSLED--LFNFC------SRKLSLKTVLMLADQMINRVE 117
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAK---IGDFGLAR 233
++H +H DIKP N L+ +A I DFGLA+
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGERE--FHNELSLASSLDCPHIVSL 142
+G G FG V KA + +A+KI+ + + Q + E ++ + +IV L
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL-MEWNKRFEIAIDIAKGLEYLHHS 201
R L L++E++ +L D L + + + ++F A + L +L
Sbjct: 122 KRHFMFRN--HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKF--AQQMCTALLFLATP 176
Query: 202 CEPPVIHGDIKPSNILLDGDFKA--KIGDFGLARLKTEDL 239
E +IH D+KP NILL ++ KI DFG + + +
Sbjct: 177 -ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 45/159 (28%), Positives = 62/159 (38%), Gaps = 32/159 (20%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKIL--------DSSGSLQGEREFHNELSLASSLDCPH 138
LG G FG V ++ + A+KIL D E + + P
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES------RVLQNTRHPF 66
Query: 139 IVSLLG-FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK 193
+ +L F + R V+ Y EL + L + E RF A +I
Sbjct: 67 LTALKYAFQTHDR-LCFVMEYANGGELFFH--LS------RERVFTEERARFYGA-EIVS 116
Query: 194 GLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
LEYLH V++ DIK N++LD D KI DFGL
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 25/158 (15%)
Query: 87 LGHGGFGSVY---KAVVPSSSQPLAVKILDSSGSLQGEREFHNELS----LASSLDCPHI 139
LG G +G V+ K + + A+K+L + +Q + + + L P +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 140 VSLLG-FASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKG 194
V+L F ++ + L+L Y EL + L + E E + + +I
Sbjct: 122 VTLHYAFQTETK-LHLILDYINGGELFTH--LS------QRERFTEHEVQIYVG-EIVLA 171
Query: 195 LEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
LE+LH + +I+ DIK NILLD + + DFGL+
Sbjct: 172 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 3e-08
Identities = 46/377 (12%), Positives = 103/377 (27%), Gaps = 110/377 (29%)
Query: 49 YRNRTAPSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLG-HG--GFGSVYKAVVPSSSQ 105
R+R + +N R Y +R+A P+ + G G G K
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTW------ 165
Query: 106 PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV-----LIYEL 160
+A+ + S +Q + +F + L + ++ L+Y++
Sbjct: 166 -VALDVCLSY-KVQCKMDFK--------------IFWLNLKNCNSPETVLEMLQKLLYQI 209
Query: 161 MEN---RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNIL 217
N RS + + + + +R + L ++ +++ +
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL----------LVLLNVQNAKAW 259
Query: 218 LDGDFKAKI----GDFGLARLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAY-EES 272
+ KI + D + + +E +S++ Y +
Sbjct: 260 NAFNLSCKILLTTRFKQVT-----DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 273 AGGGNGVDRSPESC-----VVRVFDAEGGSRRDW---W--WKQDNGAGSESGRVKDYVME 322
D E + + S RD W WK N + + + +
Sbjct: 315 PQ-----DLPREVLTTNPRRLSII---AESIRDGLATWDNWKHVN--CDKLTTIIESSLN 364
Query: 323 WIGSEIKKER-------PKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWW-- 373
+ ++ P + + P+ L + W+
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAHI--PTIL--------LSLI---------------WFDV 399
Query: 374 KEEFCEELTKKKKKRGL 390
+ + K K L
Sbjct: 400 IKSDVMVVVNKLHKYSL 416
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 6e-06
Identities = 67/441 (15%), Positives = 140/441 (31%), Gaps = 125/441 (28%)
Query: 221 DFKAKIGDFGLARLKTEDLM--IEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNG 278
DF + G + + +D++ E V D + + + +S+++ E
Sbjct: 8 DF-----ETGEHQYQYKDILSVFEDAFVDNFDCKD----VQDMPKSILSKEE-------- 50
Query: 279 VDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGRVKDYVMEWIGSEIKKERPKNEWV 338
+D ++ DA G+ R +W E V+ +V E + R +++
Sbjct: 51 IDH-----IIMSKDAVSGTLRLFWTLLSKQ---EEM-VQKFVEEVL-------RINYKFL 94
Query: 339 ASPSSTENNGSSSKLEM---KKDRIRKKEKNRKPREWWKEEFCEELTKK----KKKRG-- 389
SP TE S M ++DR+ + + + +L + + +
Sbjct: 95 MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVL 154
Query: 390 ----------------LNSSNV-----GEMWW------QKDEEVVVQE----RKKRKNKT 418
S V +++W E V+ + N T
Sbjct: 155 IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT 214
Query: 419 SRGS--------IDWWLDGFSGELRTGR-----------RSSQDWASGDIP-K----SGG 454
SR I L++ ++++ W + ++ K +
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF 274
Query: 455 ISSTPSMRG-TVCYIAPEYGGGGLLSEKCDVYSFGVLILVL--ISGRRPLQV-TASPM-- 508
T + T +I+ ++ L ++ +L+ L P +V T +P
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDE----VKSLLLKYLDCRPQDLPREVLTTNPRRL 330
Query: 509 ---SEFERANLISWARQLAYNG-KLLDLVDPSIHSLD--------KDQALL----CITIA 552
+E R L +W N KL +++ S++ L+ ++ I
Sbjct: 331 SIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTI 390
Query: 553 LLCLQRSPSKRLTMKDIVEML 573
LL L + + +V L
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKL 411
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 6e-08
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 24/157 (15%)
Query: 87 LGHGGFGSVY---KAVVPSSSQPLAVKILDSSGSLQGEREFHN---ELSLASSLDCPHIV 140
LG GG+G V+ K ++ + A+K+L + ++ ++ + E ++ + P IV
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 141 SLL-GFASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGL 195
L+ F + + L+L Y EL L+ + ME F +A +I+ L
Sbjct: 85 DLIYAFQTGGK-LYLILEYLSGGELFMQ--LE------REGIFMEDTACFYLA-EISMAL 134
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+LH + +I+ D+KP NI+L+ K+ DFGL
Sbjct: 135 GHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 34/140 (24%), Positives = 61/140 (43%), Gaps = 12/140 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGS----LQGEREFHNELSLASSLD--CPHIV 140
LG G F +V+ + + +A+K++ S+ E + + D +V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 141 SLLG-FASDR-RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
LL F G + +++E++ L + + + + +I + +GL+YL
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLK-WIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162
Query: 199 HHSCEPPVIHGDIKPSNILL 218
H C +IH DIKP NILL
Sbjct: 163 HTKCR--IIHTDIKPENILL 180
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 8e-08
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 24/156 (15%)
Query: 87 LGHGGFGSVY---KAVVPSSSQPLAVKILDSSGSLQGEREFH--NELSLASSLDCPHIVS 141
LG G FG V+ K + Q A+K+L +L+ E + ++ P IV
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 142 LL-GFASDRRGRRLVLIY----ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLE 196
L F ++ + L+L + +L L K E + +F +A ++A L+
Sbjct: 91 LHYAFQTEGK-LYLILDFLRGGDLFTR--LS------KEVMFTEEDVKFYLA-ELALALD 140
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+LH +I+ D+KP NILLD + K+ DFGL+
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 33/150 (22%), Positives = 56/150 (37%), Gaps = 40/150 (26%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHN----ELSLASSL-----DCP 137
+G G FG V + + AVK++ + +++ E + + +
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRN------IKKYTRSAKIEADILKKIQNDDINNN 96
Query: 138 HIVSLLG-FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF--------EIA 188
+IV G F + LI+E + SL + ++ N
Sbjct: 97 NIVKYHGKF--MYYD-HMCLIFEPLG-PSLYE---------IITRNNYNGFHIEDIKLYC 143
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILL 218
I+I K L YL + + H D+KP NILL
Sbjct: 144 IEILKALNYLR---KMSLTHTDLKPENILL 170
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 33/152 (21%), Positives = 59/152 (38%), Gaps = 42/152 (27%)
Query: 87 LGHGGFGSVYKAV-VPSSSQPLAVKILDSSGSLQGEREFHN----ELSLASSL------D 135
LG G FG V + + + + +AVKI+ + + E+ + L
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKN------VDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 136 CPHIVSLLG-FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRF--------E 186
V +L F + G + +++EL+ S D ++ N +
Sbjct: 76 TFRCVQMLEWF--EHHGH-ICIVFELLG-LSTYD---------FIKENGFLPFRLDHIRK 122
Query: 187 IAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL 218
+A I K + +LH + + H D+KP NIL
Sbjct: 123 MAYQICKSVNFLHSNK---LTHTDLKPENILF 151
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 603 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.54 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.42 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.81 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.76 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.64 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.32 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.25 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.82 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.78 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.55 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.52 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.46 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.4 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.69 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.66 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.28 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 87.6 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 82.72 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=426.91 Aligned_cols=149 Identities=32% Similarity=0.526 Sum_probs=130.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..+++.+.+.||+|+||+||+|+++ ..||||+++... .....+.|.+|+.+|++++|||||+++|++.+ +.++
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~ 107 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLA 107 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEE
Confidence 3467888899999999999999874 359999997543 34456789999999999999999999999865 4589
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||||++|+|.+++.... ..+++..++.|+.|||.||+|||++ +||||||||+||||++++.+||+|||+|+..
T Consensus 108 iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999997543 3489999999999999999999999 9999999999999999999999999999764
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 183 ~ 183 (307)
T 3omv_A 183 S 183 (307)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=434.95 Aligned_cols=152 Identities=28% Similarity=0.448 Sum_probs=129.9
Q ss_pred cCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.+|.+.+.||+|+||+||+|+++ .+++.||||+++. ......+.|.+|+++|++++|||||+++|+|.+. ..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEG--RP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 45677789999999999999875 3678999999976 3455667899999999999999999999999986 78
Q ss_pred EEEEEEccCCCCHHHHHhhccc------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC
Q 046097 154 LVLIYELMENRSLQDALLDRKC------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD 221 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~ 221 (603)
+|+|||||++|+|.+++..... ...+++.+++.|+.|||.||.|||++ +||||||||+||||+++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 9999999999999999976432 23589999999999999999999999 99999999999999999
Q ss_pred CcEEEEeeccceecc
Q 046097 222 FKAKIGDFGLARLKT 236 (603)
Q Consensus 222 ~~vKL~DFGlA~~~~ 236 (603)
+.+||+|||+|+...
T Consensus 195 ~~~Ki~DFGla~~~~ 209 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIY 209 (329)
T ss_dssp TEEEECCCC------
T ss_pred CcEEEcccccceecc
Confidence 999999999997653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=439.28 Aligned_cols=152 Identities=22% Similarity=0.391 Sum_probs=132.3
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++++.||+|+||+||+|+++.+++.||||++.... .....+.+.+|+.+|++++|||||++++++.+. +.+|+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEE
Confidence 68999999999999999999999999999999997643 334457899999999999999999999999987 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||++|+|.+++..... ..+++..++.++.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+...
T Consensus 102 mEy~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EeCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 999999999999976542 3478999999999999999999999 99999999999999999999999999997653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=434.18 Aligned_cols=148 Identities=26% Similarity=0.357 Sum_probs=135.1
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
..|++.+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|++++|||||+++++|.+. +.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEE
Confidence 56999999999999999999999999999999996532 23345688999999999999999999999987 8999999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||++|+|.+++... .+++..+..++.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+...
T Consensus 151 Ey~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 151 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp CCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 999999999998653 389999999999999999999999 99999999999999999999999999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=431.20 Aligned_cols=153 Identities=29% Similarity=0.453 Sum_probs=132.9
Q ss_pred cCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.++++.+.||+|+||+||+|++. .+++.||||+++........+.|.+|+.++++++|||||+++|+|.+. +.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--QP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--CE
Confidence 34566789999999999999963 357899999998765555668899999999999999999999999986 77
Q ss_pred EEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC
Q 046097 154 LVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG 220 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~ 220 (603)
+++|||||++|+|.++|..... ...+++..++.|+.|||.||.|||++ +||||||||+||||++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence 8999999999999999965321 23589999999999999999999999 9999999999999999
Q ss_pred CCcEEEEeeccceecc
Q 046097 221 DFKAKIGDFGLARLKT 236 (603)
Q Consensus 221 ~~~vKL~DFGlA~~~~ 236 (603)
++.+||+|||+|+...
T Consensus 181 ~~~~Ki~DFGlar~~~ 196 (308)
T 4gt4_A 181 KLNVKISDLGLFREVY 196 (308)
T ss_dssp GGCEEECCSCCBCGGG
T ss_pred CCCEEECCcccceecc
Confidence 9999999999997653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=432.71 Aligned_cols=152 Identities=29% Similarity=0.469 Sum_probs=132.7
Q ss_pred cCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
++|.+.+.||+|+||+||+|++. .++..||||+++. ......++|.+|+++|++++|||||+++|+|.+. +.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CE
Confidence 56788899999999999999874 3578899999976 3455667899999999999999999999999986 78
Q ss_pred EEEEEEccCCCCHHHHHhhcc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc
Q 046097 154 LVLIYELMENRSLQDALLDRK----------CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~----------~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~ 223 (603)
+++|||||++|+|.++|.... ....+++..++.++.||+.||.|||++ +||||||||+|||+++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999997643 123589999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccceecc
Q 046097 224 AKIGDFGLARLKT 236 (603)
Q Consensus 224 vKL~DFGlA~~~~ 236 (603)
+||+|||+|+...
T Consensus 167 ~Ki~DFGla~~~~ 179 (299)
T 4asz_A 167 VKIGDFGMSRDVY 179 (299)
T ss_dssp EEECCCSCHHHHT
T ss_pred EEECCcccceecC
Confidence 9999999997653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=426.62 Aligned_cols=146 Identities=28% Similarity=0.383 Sum_probs=130.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.+.|++.++||+|+||.||+|+++.+|+.||||+++.+.. ..+|+.++++++|||||++++++.+. +.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~--~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREG--PWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEE
Confidence 3457778899999999999999999999999999976432 24699999999999999999999986 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC-cEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-KAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-~vKL~DFGlA~~~~ 236 (603)
||||++|+|.+++.... .+++..+..++.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+...
T Consensus 129 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999997653 389999999999999999999999 999999999999999987 69999999998764
Q ss_pred c
Q 046097 237 E 237 (603)
Q Consensus 237 ~ 237 (603)
.
T Consensus 203 ~ 203 (336)
T 4g3f_A 203 P 203 (336)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=427.15 Aligned_cols=150 Identities=29% Similarity=0.376 Sum_probs=136.8
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++++.||+|+||+||+|+++.+++.||||++.+.. .....+.+.+|+++|++++|||||++++++++. +.+|+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYF 109 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEE
Confidence 56999999999999999999999999999999996532 122346799999999999999999999999987 89999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||||++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 110 vmEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999997643 389999999999999999999999 99999999999999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=414.46 Aligned_cols=148 Identities=28% Similarity=0.485 Sum_probs=128.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||+||+|+++.+++.||||++..... ......+.+|+.+|++++|||||++++++.+. +.+|+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEE
Confidence 689999999999999999999999999999999976432 23346799999999999999999999999987 89999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+ +|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 91 vmEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 99999 679999987643 389999999999999999999999 9999999999999999999999999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=434.08 Aligned_cols=149 Identities=26% Similarity=0.354 Sum_probs=136.1
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.+.|++.+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|++++|||||+++++|.+. +.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEEEE
Confidence 356999999999999999999999999999999997643 23445688999999999999999999999987 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||++|+|.+++... .+++..+..++.||+.||.|||++ +||||||||+||||+.+|.+||+|||+|+...
T Consensus 227 mEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 9999999999998653 389999999999999999999999 99999999999999999999999999998654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=414.88 Aligned_cols=147 Identities=29% Similarity=0.421 Sum_probs=129.6
Q ss_pred CCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecC--CCCeEEEEE
Q 046097 82 SPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDR--RGRRLVLIY 158 (603)
Q Consensus 82 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~--~~~~~~LVm 158 (603)
++.+.||+|+||+||+|.++.+++.||||++.... .....+.|.+|+.+|++++|||||+++++|.+. ....+|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999999999999999986543 334457799999999999999999999998753 235689999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCeEEc-CCCcEEEEeecccee
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP--VIHGDIKPSNILLD-GDFKAKIGDFGLARL 234 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g--IVHrDLKp~NILld-~~~~vKL~DFGlA~~ 234 (603)
|||++|+|.+++.... .+++..+..++.||+.||+|||++ + ||||||||+||||+ .++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999997643 489999999999999999999998 6 99999999999998 479999999999964
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=423.26 Aligned_cols=149 Identities=26% Similarity=0.364 Sum_probs=127.3
Q ss_pred cCCCCCceeeccCceEEEEEEEc---CCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVP---SSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
++|++++.||+|+||+||+|++. .+++.||||+++... .......+.+|+.+|++++|||||++++++.+. +.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE--GKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET--TEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence 57999999999999999999874 467899999996532 112234688899999999999999999999987 899
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|+|||||++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999997653 389999999999999999999999 999999999999999999999999999975
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 176 ~ 176 (304)
T 3ubd_A 176 S 176 (304)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=425.03 Aligned_cols=162 Identities=27% Similarity=0.400 Sum_probs=140.9
Q ss_pred HHHHHHhhcCCCCCceeeccCceEEEEEEEcCC-----CceEEEEEecCCCChhhHHHHHHHHHHhccCCC-CceeEEEe
Q 046097 71 YNLIRRATASFSPSNRLGHGGFGSVYKAVVPSS-----SQPLAVKILDSSGSLQGEREFHNELSLASSLDC-PHIVSLLG 144 (603)
Q Consensus 71 ~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~H-pNIV~l~g 144 (603)
.+.++...++|++.+.||+|+||+||+|.+..+ ++.||||.++........+.|.+|+.+|.++.| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 345566778999999999999999999998643 367999999876666667889999999999975 89999999
Q ss_pred EEecCCCCeEEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 046097 145 FASDRRGRRLVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDI 211 (603)
Q Consensus 145 ~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDL 211 (603)
+|.+. +..+++|||||++|+|.++|..... ...+++..++.++.|||.||.|||++ +||||||
T Consensus 136 ~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 136 ACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 99764 3568999999999999999976432 23489999999999999999999999 9999999
Q ss_pred CCCCeEEcCCCcEEEEeeccceecc
Q 046097 212 KPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 212 Kp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||+|||+++++.+||+|||+|+...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~ 236 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIY 236 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTT
T ss_pred CccceeeCCCCCEEECcchhhhhcc
Confidence 9999999999999999999998654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=412.63 Aligned_cols=151 Identities=26% Similarity=0.364 Sum_probs=127.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC--CeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG--RRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~--~~~~L 156 (603)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.. ......+..|+..+.+++|||||+++++|.+... ..+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~--~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc--chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4577789999999999999998 6899999999653 1222234456777778999999999999986532 36899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS-----CEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~-----~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
|||||++|+|.+++... .+++..+++++.|++.||+|||++ +.++||||||||+||||+.++++||+|||+
T Consensus 79 V~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999999754 389999999999999999999975 245899999999999999999999999999
Q ss_pred ceeccc
Q 046097 232 ARLKTE 237 (603)
Q Consensus 232 A~~~~~ 237 (603)
|+....
T Consensus 155 a~~~~~ 160 (303)
T 3hmm_A 155 AVRHDS 160 (303)
T ss_dssp CEEEET
T ss_pred CccccC
Confidence 987543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=410.43 Aligned_cols=157 Identities=29% Similarity=0.428 Sum_probs=133.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC-------
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG------- 151 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~------- 151 (603)
++|++++.||+|+||+||+|+++.+++.||||+++........+.+.+|+.+|++++|||||++++++.+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4689999999999999999999999999999999775555566789999999999999999999999875421
Q ss_pred ---CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEe
Q 046097 152 ---RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228 (603)
Q Consensus 152 ---~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~D 228 (603)
.++|+|||||++|+|.+++.........++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 24799999999999999998765444467778899999999999999999 999999999999999999999999
Q ss_pred eccceecccc
Q 046097 229 FGLARLKTED 238 (603)
Q Consensus 229 FGlA~~~~~~ 238 (603)
||+|+.....
T Consensus 162 FGla~~~~~~ 171 (299)
T 4g31_A 162 FGLVTAMDQD 171 (299)
T ss_dssp CCCC------
T ss_pred CccceecCCC
Confidence 9999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=399.34 Aligned_cols=152 Identities=24% Similarity=0.427 Sum_probs=134.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecC----CCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDR----RGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~----~~~ 152 (603)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ....+.+.+|+.+|+.++|||||++++++... ..+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3579999999999999999999999999999999976432 33456788999999999999999999998653 236
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
.+|+|||||+ |+|.+++.... .+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 7999999996 68999987543 499999999999999999999999 9999999999999999999999999999
Q ss_pred eecc
Q 046097 233 RLKT 236 (603)
Q Consensus 233 ~~~~ 236 (603)
+...
T Consensus 206 ~~~~ 209 (398)
T 4b99_A 206 RGLC 209 (398)
T ss_dssp BCC-
T ss_pred eecc
Confidence 7653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=417.31 Aligned_cols=150 Identities=32% Similarity=0.393 Sum_probs=131.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-----ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-----SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-----~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ..........++.++..++|||||+++++|++. .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--~ 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--D 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--S
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--C
Confidence 367999999999999999999999999999999996521 111122233456788889999999999999997 8
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
.+|+|||||+||+|.+++.... .+++..+..++.||+.||.|||++ +||||||||+||||+.+|.+||+|||+|
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEeccccee
Confidence 9999999999999999997653 389999999999999999999999 9999999999999999999999999999
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
+..
T Consensus 340 ~~~ 342 (689)
T 3v5w_A 340 CDF 342 (689)
T ss_dssp EEC
T ss_pred eec
Confidence 764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=392.65 Aligned_cols=151 Identities=23% Similarity=0.362 Sum_probs=133.4
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEc---CCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEec
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVP---SSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASD 148 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~ 148 (603)
.+....++|++.+.||+|+||+||+|+++ .+++.||||.+... ....++.+|+++|..+ +||||+++++++.+
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 34456789999999999999999999874 46789999998653 2345688999999998 59999999999998
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC-CcEEEE
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKIG 227 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~-~~vKL~ 227 (603)
. +++|+||||+++|+|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+
T Consensus 92 ~--~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 92 N--DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp T--TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred C--CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEEC
Confidence 7 89999999999999999983 288999999999999999999999 99999999999999876 799999
Q ss_pred eeccceeccc
Q 046097 228 DFGLARLKTE 237 (603)
Q Consensus 228 DFGlA~~~~~ 237 (603)
|||+|+....
T Consensus 161 DFGla~~~~~ 170 (361)
T 4f9c_A 161 DFGLAQGTHD 170 (361)
T ss_dssp CCTTCEECTT
T ss_pred cCCCCcccCC
Confidence 9999987654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=409.01 Aligned_cols=151 Identities=26% Similarity=0.414 Sum_probs=136.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.+|+.++|||||+++++|.+. ..+|+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEE
Confidence 46899999999999999999999999999999999763 344567789999999999999999999999987 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC--CcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD--FKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~--~~vKL~DFGlA~~~ 235 (603)
||||++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 233 ~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999999996543 3489999999999999999999999 99999999999999854 89999999999875
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 308 ~ 308 (573)
T 3uto_A 308 D 308 (573)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=373.33 Aligned_cols=295 Identities=37% Similarity=0.632 Sum_probs=240.1
Q ss_pred cccccccHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEE
Q 046097 64 NHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLL 143 (603)
Q Consensus 64 ~~~~~~~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~ 143 (603)
.....+++.++....++|++.+.||+|+||.||+|.. .+++.||||++...........+.+|+.++..++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 3456788999999999999999999999999999986 468899999997654333344789999999999999999999
Q ss_pred eEEecCCCCeEEEEEEccCCCCHHHHHhhccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC
Q 046097 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF 222 (603)
Q Consensus 144 g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~ 222 (603)
+++.+. ...++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++.++|+||||||+|||++.++
T Consensus 94 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 94 GFCMTP--TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp EEECCS--SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred EEEecC--CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 999886 778999999999999999976542 23489999999999999999999998777999999999999999999
Q ss_pred cEEEEeeccceecccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCccccc
Q 046097 223 KAKIGDFGLARLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWW 302 (603)
Q Consensus 223 ~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (603)
.+||+|||++.......
T Consensus 172 ~~kl~Dfg~~~~~~~~~--------------------------------------------------------------- 188 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKD--------------------------------------------------------------- 188 (326)
T ss_dssp CEEECCCSSCEECCSSS---------------------------------------------------------------
T ss_pred CEEeccCccccccCccc---------------------------------------------------------------
Confidence 99999999997653220
Q ss_pred ccccCCCCCCCcchhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHH
Q 046097 303 WKQDNGAGSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELT 382 (603)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (603)
T Consensus 189 -------------------------------------------------------------------------------- 188 (326)
T 3uim_A 189 -------------------------------------------------------------------------------- 188 (326)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HhhhhcCCCCCCcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcc
Q 046097 383 KKKKKRGLNSSNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMR 462 (603)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 462 (603)
........
T Consensus 189 ------------------------------------------------------------------------~~~~~~~~ 196 (326)
T 3uim_A 189 ------------------------------------------------------------------------THVTTAVR 196 (326)
T ss_dssp ------------------------------------------------------------------------SCEECCCC
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00012345
Q ss_pred cccCccCccccCCCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCC-CCC
Q 046097 463 GTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIH-SLD 541 (603)
Q Consensus 463 gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 541 (603)
||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+..|+........+....+..+. ...
T Consensus 197 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 3uim_A 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN--DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYK 274 (326)
T ss_dssp SCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT--TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCC
T ss_pred CCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc--ccchhHHHHHHHHhhchhhhhhcChhhccccC
Confidence 8999999999988899999999999999999999999996321110 1123445555555555555666665554 667
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 046097 542 KDQALLCITIALLCLQRSPSKRLTMKDIVEMLTGEAE 578 (603)
Q Consensus 542 ~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~l~~~~~ 578 (603)
...+..+.+|+..||+.||.+|||+.||++.|++...
T Consensus 275 ~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 275 DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp HHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 8888999999999999999999999999999987543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=365.49 Aligned_cols=284 Identities=37% Similarity=0.578 Sum_probs=234.2
Q ss_pred ccHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEec
Q 046097 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASD 148 (603)
Q Consensus 69 ~~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~ 148 (603)
+.+.++...+++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 344456678899999999999999999999974 6889999998764 33456789999999999999999999999987
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEE
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
. +..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 107 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 107 R--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp T--TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred C--CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence 6 788999999999999998865432 22489999999999999999999999 99999999999999999999999
Q ss_pred eeccceecccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccC
Q 046097 228 DFGLARLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDN 307 (603)
Q Consensus 228 DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (603)
|||++........
T Consensus 182 Dfg~~~~~~~~~~------------------------------------------------------------------- 194 (321)
T 2qkw_B 182 DFGISKKGTELDQ------------------------------------------------------------------- 194 (321)
T ss_dssp CCTTCEECSSSSC-------------------------------------------------------------------
T ss_pred ecccccccccccc-------------------------------------------------------------------
Confidence 9999876432200
Q ss_pred CCCCCCcchhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhh
Q 046097 308 GAGSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKK 387 (603)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (603)
T Consensus 195 -------------------------------------------------------------------------------- 194 (321)
T 2qkw_B 195 -------------------------------------------------------------------------------- 194 (321)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCCcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCc
Q 046097 388 RGLNSSNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCY 467 (603)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y 467 (603)
........||+.|
T Consensus 195 -------------------------------------------------------------------~~~~~~~~gt~~y 207 (321)
T 2qkw_B 195 -------------------------------------------------------------------THLSTVVKGTLGY 207 (321)
T ss_dssp -------------------------------------------------------------------CCCBCCCEEETTT
T ss_pred -------------------------------------------------------------------cccccccCCCccc
Confidence 0001234689999
Q ss_pred cCccccCCCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCC-CCCHHHHH
Q 046097 468 IAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIH-SLDKDQAL 546 (603)
Q Consensus 468 ~aPE~~~~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 546 (603)
+|||++.+..++.++|||||||++|||++|+.||...... .......|.........+...+++.+. ........
T Consensus 208 ~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (321)
T 2qkw_B 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR----EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLR 283 (321)
T ss_dssp CCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS----SCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHH
T ss_pred cCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH----HHHHHHHHhhhccccccHHHhcChhhccccCHHHHH
Confidence 9999998889999999999999999999999999765432 123445555555556666677776665 56778889
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 046097 547 LCITIALLCLQRSPSKRLTMKDIVEMLTGEA 577 (603)
Q Consensus 547 ~l~~l~~~cl~~dP~~Rpt~~evl~~l~~~~ 577 (603)
.+.+|+..||+.||.+|||+.||++.|+...
T Consensus 284 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 284 KFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 9999999999999999999999999997543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=371.18 Aligned_cols=274 Identities=23% Similarity=0.308 Sum_probs=223.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|++.+.||+|+||.||+|+.+.+++.||||+++... .......+.+|+.++..++||||+++++++.+. ..+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEEE
Confidence 357899999999999999999999999999999996531 122346788999999999999999999999987 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999999987643 389999999999999999999999 9999999999999999999999999998643
Q ss_pred ccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcc
Q 046097 236 TEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGR 315 (603)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (603)
....
T Consensus 156 ~~~~---------------------------------------------------------------------------- 159 (337)
T 1o6l_A 156 ISDG---------------------------------------------------------------------------- 159 (337)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred ccCC----------------------------------------------------------------------------
Confidence 2110
Q ss_pred hhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCc
Q 046097 316 VKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNV 395 (603)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (603)
T Consensus 160 -------------------------------------------------------------------------------- 159 (337)
T 1o6l_A 160 -------------------------------------------------------------------------------- 159 (337)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCC
Q 046097 396 GEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGG 475 (603)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 475 (603)
......+||+.|+|||++.+
T Consensus 160 ------------------------------------------------------------~~~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 160 ------------------------------------------------------------ATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp ------------------------------------------------------------CCBCCCEECGGGCCGGGGSS
T ss_pred ------------------------------------------------------------CcccccccChhhCChhhhcC
Confidence 00134579999999999999
Q ss_pred CCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhhc
Q 046097 476 GLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLC 555 (603)
Q Consensus 476 ~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 555 (603)
..++.++|||||||+||||++|+.||..... .. ........ .+ .++...+..+.+|+..|
T Consensus 180 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~---~~~~i~~~-~~---------~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ER---LFELILME-EI---------RFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HH---HHHHHHHC-CC---------CCCTTSCHHHHHHHHHH
T ss_pred CCCCchhhcccchhHHHHHhcCCCCCCCCCH-------HH---HHHHHHcC-CC---------CCCCCCCHHHHHHHHHH
Confidence 9999999999999999999999999975431 11 11111111 10 11222345788999999
Q ss_pred cCCCCCCCC-----CHHHHHHH-----------hcCCCCCCCCCCccCCCCCCCCC
Q 046097 556 LQRSPSKRL-----TMKDIVEM-----------LTGEAEPPHLPFEFSPSPPSNFP 595 (603)
Q Consensus 556 l~~dP~~Rp-----t~~evl~~-----------l~~~~~~~~~~~~~~~~~~~~~~ 595 (603)
|+.||.+|| ++.||++. +.....||..|-..++...++|.
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~ 295 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSC
T ss_pred hhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhccc
Confidence 999999999 89999864 34667888888888888888886
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=356.64 Aligned_cols=156 Identities=24% Similarity=0.343 Sum_probs=139.6
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|.+.+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.++++++||||+++++++........++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 46789999999999999999999999999999999764444456778899999999999999999999988755689999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE----cCCCcEEEEeeccce
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL----DGDFKAKIGDFGLAR 233 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl----d~~~~vKL~DFGlA~ 233 (603)
|||+++++|.+++........+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999998765544589999999999999999999999 99999999999999 778889999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 165 ~~~ 167 (319)
T 4euu_A 165 ELE 167 (319)
T ss_dssp ECC
T ss_pred ecC
Confidence 653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.09 Aligned_cols=150 Identities=27% Similarity=0.396 Sum_probs=135.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC--CEEEE
Confidence 3568999999999999999999999999999999986532 23356788999999999999999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999999754 388999999999999999999999 99999999999999999999999999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=359.41 Aligned_cols=156 Identities=30% Similarity=0.527 Sum_probs=133.6
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
++....++|++.+.||+|+||.||+|++ +++.||||++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 106 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-- 106 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--
Confidence 3344567899999999999999999987 68899999997643 234456789999999999999999999999886
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCeEEcCCCcEEEEee
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP--VIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g--IVHrDLKp~NILld~~~~vKL~DF 229 (603)
...++||||+++++|.+++........+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 77899999999999999998755444589999999999999999999999 8 999999999999999999999999
Q ss_pred ccceec
Q 046097 230 GLARLK 235 (603)
Q Consensus 230 GlA~~~ 235 (603)
|++...
T Consensus 184 g~a~~~ 189 (309)
T 3p86_A 184 GLSRLK 189 (309)
T ss_dssp C-----
T ss_pred CCCccc
Confidence 998643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=371.66 Aligned_cols=150 Identities=25% Similarity=0.337 Sum_probs=133.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~ 153 (603)
..++|++.+.||+|+||.||+|+++.+++.||||+++... .......+.+|..++..+ +||||+++++++.+. ..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CE
Confidence 4578999999999999999999999999999999996531 122345688899999988 699999999999987 88
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+|+||||+++|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999999997653 389999999999999999999999 99999999999999999999999999986
Q ss_pred e
Q 046097 234 L 234 (603)
Q Consensus 234 ~ 234 (603)
.
T Consensus 173 ~ 173 (353)
T 3txo_A 173 E 173 (353)
T ss_dssp C
T ss_pred e
Confidence 4
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=366.71 Aligned_cols=271 Identities=25% Similarity=0.299 Sum_probs=223.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|++.+.||+|+||.||+|+++.+++.||||++.... .......+.+|+.++..++||||+++++++.+. ..+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 117 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEEE
Confidence 357899999999999999999999999999999996532 112346788999999999999999999999986 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 118 lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999999997643 389999999999999999999999 9999999999999999999999999998754
Q ss_pred ccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcc
Q 046097 236 TEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGR 315 (603)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (603)
...
T Consensus 192 ~~~----------------------------------------------------------------------------- 194 (350)
T 1rdq_E 192 KGR----------------------------------------------------------------------------- 194 (350)
T ss_dssp SSC-----------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 221
Q ss_pred hhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCc
Q 046097 316 VKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNV 395 (603)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (603)
T Consensus 195 -------------------------------------------------------------------------------- 194 (350)
T 1rdq_E 195 -------------------------------------------------------------------------------- 194 (350)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCC
Q 046097 396 GEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGG 475 (603)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 475 (603)
....+||+.|+|||++.+
T Consensus 195 --------------------------------------------------------------~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 195 --------------------------------------------------------------TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp --------------------------------------------------------------BCCCEECGGGCCHHHHTT
T ss_pred --------------------------------------------------------------cccccCCccccCHHHhcC
Confidence 123468999999999999
Q ss_pred CCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhhc
Q 046097 476 GLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLC 555 (603)
Q Consensus 476 ~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 555 (603)
..++.++|||||||+||||++|+.||..... .......... .+ .++...+..+.+|+..|
T Consensus 213 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------~~~~~~i~~~-~~---------~~p~~~~~~~~~li~~l 272 (350)
T 1rdq_E 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQP----------IQIYEKIVSG-KV---------RFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHHC-CC---------CCCTTCCHHHHHHHHHH
T ss_pred CCCCCcCCEecccHhHhHHhhCCCCCCCCCH----------HHHHHHHHcC-CC---------CCCCCCCHHHHHHHHHH
Confidence 9999999999999999999999999975431 1111111111 11 11222345688999999
Q ss_pred cCCCCCCCCC-----HHHHHHH-----------hcCCCCCCCCCCccCCCCCCCCC
Q 046097 556 LQRSPSKRLT-----MKDIVEM-----------LTGEAEPPHLPFEFSPSPPSNFP 595 (603)
Q Consensus 556 l~~dP~~Rpt-----~~evl~~-----------l~~~~~~~~~~~~~~~~~~~~~~ 595 (603)
|+.||.+||+ +.||++. ..+...||..|-..++...++|.
T Consensus 273 L~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~ 328 (350)
T 1rdq_E 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC
T ss_pred hhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc
Confidence 9999999998 8888764 34677888888888888888886
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.91 Aligned_cols=285 Identities=33% Similarity=0.542 Sum_probs=233.0
Q ss_pred ccccccHHHHHHhhcCCCCC------ceeeccCceEEEEEEEcCCCceEEEEEecCCC---ChhhHHHHHHHHHHhccCC
Q 046097 65 HCRRFSYNLIRRATASFSPS------NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG---SLQGEREFHNELSLASSLD 135 (603)
Q Consensus 65 ~~~~~~~~~l~~~t~~y~i~------~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~---~~~~~~~~~~Ev~iL~~l~ 135 (603)
....+++.++..++++|... +.||+|+||.||+|.. +++.||||++.... .....+.+.+|+.++.+++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 34678899999999999887 8999999999999987 68899999986532 2234577999999999999
Q ss_pred CCceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 046097 136 CPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSN 215 (603)
Q Consensus 136 HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~N 215 (603)
||||+++++++.+. ...++||||+++++|.+++........+++..++.++.|++.||.|||++ +|+||||||+|
T Consensus 89 h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 89 HENLVELLGFSSDG--DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp CTTBCCEEEEECSS--SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred CCCeEEEEEEEecC--CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 99999999999886 78899999999999999997655445689999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEEeeccceecccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCC
Q 046097 216 ILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEG 295 (603)
Q Consensus 216 ILld~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 295 (603)
|+++.++.+||+|||++........
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------------- 188 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQ------------------------------------------------------- 188 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSS-------------------------------------------------------
T ss_pred EEEcCCCcEEEeecccccccccccc-------------------------------------------------------
Confidence 9999999999999999876432200
Q ss_pred CCcccccccccCCCCCCCcchhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhH
Q 046097 296 GSRRDWWWKQDNGAGSESGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKE 375 (603)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (603)
T Consensus 189 -------------------------------------------------------------------------------- 188 (307)
T 2nru_A 189 -------------------------------------------------------------------------------- 188 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHHHHHHHhhhhcCCCCCCcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCC
Q 046097 376 EFCEELTKKKKKRGLNSSNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGI 455 (603)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 455 (603)
.
T Consensus 189 -------------------------------------------------------------------------------~ 189 (307)
T 2nru_A 189 -------------------------------------------------------------------------------T 189 (307)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred CCcCCcccccCccCccccCCCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHH-hcCccccccC
Q 046097 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLA-YNGKLLDLVD 534 (603)
Q Consensus 456 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 534 (603)
.......||+.|+|||.+.+ .++.++|||||||++|+|++|..||........ +..+..... ....+...++
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 262 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL------LLDIKEEIEDEEKTIEDYID 262 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB------TTHHHHHHHTTSCCHHHHSC
T ss_pred ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH------HHHHHHHhhhhhhhhhhhcc
Confidence 00122468999999998865 589999999999999999999999986543311 111221211 2233455666
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 046097 535 PSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTGEA 577 (603)
Q Consensus 535 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~l~~~~ 577 (603)
+.+..........+.+|+..||+.||.+|||+.+|++.|+...
T Consensus 263 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 263 KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 6677778888899999999999999999999999999998653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=361.77 Aligned_cols=150 Identities=28% Similarity=0.387 Sum_probs=134.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|++.+.||+|+||.||+|+.+.+++.||+|+++.... ....+.+.+|..++..++||||+++++++.+. ..+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEEE
Confidence 3578999999999999999999999999999999965311 12346688999999999999999999999986 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 83 lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceec
Confidence 9999999999999997643 389999999999999999999999 9999999999999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=368.28 Aligned_cols=150 Identities=19% Similarity=0.296 Sum_probs=132.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~ 153 (603)
..++|++.+.||+|+||.||+|+++.+++.||||+++.... ......+..|..++.++ +||||+++++++.+. ..
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CE
Confidence 34679999999999999999999999999999999976422 22234578899999877 799999999999987 88
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+++||||+++|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceee
Confidence 999999999999999997643 389999999999999999999999 99999999999999999999999999986
Q ss_pred e
Q 046097 234 L 234 (603)
Q Consensus 234 ~ 234 (603)
.
T Consensus 202 ~ 202 (396)
T 4dc2_A 202 E 202 (396)
T ss_dssp C
T ss_pred e
Confidence 4
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=362.46 Aligned_cols=151 Identities=25% Similarity=0.407 Sum_probs=136.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+. +..+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEE
Confidence 4578999999999999999999999999999999996542 334457789999999999999999999999886 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999997653 389999999999999999999999 9999999999999999999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=353.42 Aligned_cols=153 Identities=27% Similarity=0.494 Sum_probs=137.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+.. ........+.+|+.++.+++||||+++++++.+. ...++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--CeeEEE
Confidence 4678889999999999999999999999999999865 3455667899999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999997643 3489999999999999999999999 999999999999999999999999999987644
Q ss_pred c
Q 046097 238 D 238 (603)
Q Consensus 238 ~ 238 (603)
.
T Consensus 161 ~ 161 (310)
T 3s95_A 161 E 161 (310)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.73 Aligned_cols=149 Identities=19% Similarity=0.302 Sum_probs=134.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~ 154 (603)
.++|++.+.||+|+||.||+|+++.+++.||||+++... .......+.+|..++.++ +||||+++++++.+. ..+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRL 85 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CEE
Confidence 357899999999999999999999999999999997642 233456788999999988 799999999999986 899
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccc
Confidence 99999999999999997643 389999999999999999999999 999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=354.32 Aligned_cols=159 Identities=28% Similarity=0.404 Sum_probs=139.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC-----
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG----- 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~----- 151 (603)
..++|++.+.||+|+||.||+|+++.+++.||||+++........+.+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 346789999999999999999999989999999999765555566789999999999999999999999865321
Q ss_pred --------------------------------------------------CeEEEEEEccCCCCHHHHHhhcccccccCH
Q 046097 152 --------------------------------------------------RRLVLIYELMENRSLQDALLDRKCEELMEW 181 (603)
Q Consensus 152 --------------------------------------------------~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~ 181 (603)
...++||||+++++|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 248999999999999999988665555777
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 182 NKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 182 ~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 88999999999999999999 9999999999999999999999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=368.32 Aligned_cols=276 Identities=26% Similarity=0.349 Sum_probs=208.3
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCC
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~ 152 (603)
...++|.+.+.||+|+||.||+|+++.+++.||||+++.... ......+..|..++..+ +||||+++++++.+. .
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--E 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--S
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--C
Confidence 456789999999999999999999999999999999965311 12345678899998876 899999999999987 8
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 8999999999999999997643 389999999999999999999999 9999999999999999999999999998
Q ss_pred eecccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCC
Q 046097 233 RLKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSE 312 (603)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (603)
+......
T Consensus 166 ~~~~~~~------------------------------------------------------------------------- 172 (345)
T 1xjd_A 166 KENMLGD------------------------------------------------------------------------- 172 (345)
T ss_dssp BCCCCTT-------------------------------------------------------------------------
T ss_pred hhcccCC-------------------------------------------------------------------------
Confidence 6432110
Q ss_pred CcchhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCC
Q 046097 313 SGRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNS 392 (603)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (603)
T Consensus 173 -------------------------------------------------------------------------------- 172 (345)
T 1xjd_A 173 -------------------------------------------------------------------------------- 172 (345)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccc
Q 046097 393 SNVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEY 472 (603)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 472 (603)
..+...+||+.|+|||+
T Consensus 173 ---------------------------------------------------------------~~~~~~~gt~~y~aPE~ 189 (345)
T 1xjd_A 173 ---------------------------------------------------------------AKTNTFCGTPDYIAPEI 189 (345)
T ss_dssp ---------------------------------------------------------------CCBCCCCSCGGGCCHHH
T ss_pred ---------------------------------------------------------------CcccCCCCCcccCChhh
Confidence 00234579999999999
Q ss_pred cCCCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHH
Q 046097 473 GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIA 552 (603)
Q Consensus 473 ~~~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 552 (603)
+.+..++.++|||||||++|||++|+.||..... .. ........ . +. ++...+..+.+|+
T Consensus 190 ~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~---~~~~i~~~-~------~~---~p~~~s~~~~~li 249 (345)
T 1xjd_A 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EE---LFHSIRMD-N------PF---YPRWLEKEAKDLL 249 (345)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH---HHHHHHHC-C------CC---CCTTSCHHHHHHH
T ss_pred hcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------HH---HHHHHHhC-C------CC---CCcccCHHHHHHH
Confidence 9999999999999999999999999999975431 11 11111111 1 11 1122345688999
Q ss_pred hhccCCCCCCCCCHH-HHHHH-----------hcCCCCCCCCCCccCCCCCCCCC
Q 046097 553 LLCLQRSPSKRLTMK-DIVEM-----------LTGEAEPPHLPFEFSPSPPSNFP 595 (603)
Q Consensus 553 ~~cl~~dP~~Rpt~~-evl~~-----------l~~~~~~~~~~~~~~~~~~~~~~ 595 (603)
..||+.||.+||++. ||++. ......||..|-..++...+||.
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~ 304 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFD 304 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC----------------
T ss_pred HHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcc
Confidence 999999999999997 77532 24567888888877777778876
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=376.79 Aligned_cols=275 Identities=23% Similarity=0.314 Sum_probs=213.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCC--CChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~--~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++... ........+.+|+.+++.++||||+++++++.+. +.+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET--TEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CEE
Confidence 346799999999999999999999999999999999653 1223345678999999999999999999999986 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCce
Confidence 99999999999999987643 38999999999999999999998 8 99999999999999999999999999986
Q ss_pred ecccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCC
Q 046097 234 LKTEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSES 313 (603)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (603)
......
T Consensus 298 ~~~~~~-------------------------------------------------------------------------- 303 (446)
T 4ejn_A 298 EGIKDG-------------------------------------------------------------------------- 303 (446)
T ss_dssp TTCC----------------------------------------------------------------------------
T ss_pred eccCCC--------------------------------------------------------------------------
Confidence 432110
Q ss_pred cchhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCC
Q 046097 314 GRVKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSS 393 (603)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (603)
T Consensus 304 -------------------------------------------------------------------------------- 303 (446)
T 4ejn_A 304 -------------------------------------------------------------------------------- 303 (446)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcCccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCcccc
Q 046097 394 NVGEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYG 473 (603)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 473 (603)
......+||+.|+|||++
T Consensus 304 --------------------------------------------------------------~~~~~~~gt~~y~aPE~~ 321 (446)
T 4ejn_A 304 --------------------------------------------------------------ATMKTFCGTPEYLAPEVL 321 (446)
T ss_dssp -----------------------------------------------------------------CCSSSCGGGCCHHHH
T ss_pred --------------------------------------------------------------cccccccCCccccCHhhc
Confidence 001235799999999999
Q ss_pred CCCCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHh
Q 046097 474 GGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIAL 553 (603)
Q Consensus 474 ~~~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 553 (603)
.+..++.++|||||||+||||++|+.||..... ..+ ....... .. .++...+..+.+|+.
T Consensus 322 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~---~~~i~~~-~~---------~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKL---FELILME-EI---------RFPRTLGPEAKSLLS 381 (446)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH---HHHHHHC-CC---------CCCTTSCHHHHHHHH
T ss_pred CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHH---HHHHHhC-CC---------CCCccCCHHHHHHHH
Confidence 999999999999999999999999999975431 111 1111111 10 111223456889999
Q ss_pred hccCCCCCCCC-----CHHHHHHH-----------hcCCCCCCCCCCccCCCCCCCCC
Q 046097 554 LCLQRSPSKRL-----TMKDIVEM-----------LTGEAEPPHLPFEFSPSPPSNFP 595 (603)
Q Consensus 554 ~cl~~dP~~Rp-----t~~evl~~-----------l~~~~~~~~~~~~~~~~~~~~~~ 595 (603)
.||+.||.+|| ++.|+++. ++....||..|-..++...++|.
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~ 439 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFD 439 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcc
Confidence 99999999999 99999863 35667788888887877887774
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=361.81 Aligned_cols=152 Identities=26% Similarity=0.444 Sum_probs=136.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCc---eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.++|++.+.||+|+||.||+|.+..+++ .||||+++........+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG--RLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG--GCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--Ccc
Confidence 4568888999999999999999976555 49999998765666677899999999999999999999999876 788
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999996543 3489999999999999999999999 999999999999999999999999999986
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 201 ~~ 202 (325)
T 3kul_A 201 LE 202 (325)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=364.44 Aligned_cols=154 Identities=28% Similarity=0.444 Sum_probs=136.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEc-------CCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVP-------SSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDR 149 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~-------~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~ 149 (603)
.++|.+.+.||+|+||.||+|++. .++..||||+++..........+.+|+.++.++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999874 345679999998765555667899999999999 899999999999886
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNI 216 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NI 216 (603)
+.+|+||||+++|+|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+||
T Consensus 160 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 234 (370)
T 2psq_A 160 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 234 (370)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred --CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence 789999999999999999986532 13478999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEEeeccceecc
Q 046097 217 LLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~~~ 236 (603)
|++.++.+||+|||++....
T Consensus 235 ll~~~~~~kl~DFG~a~~~~ 254 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDIN 254 (370)
T ss_dssp EECTTCCEEECCCSSCEETT
T ss_pred EECCCCCEEEccccCCcccC
Confidence 99999999999999997643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=362.90 Aligned_cols=163 Identities=27% Similarity=0.426 Sum_probs=142.2
Q ss_pred ccHHHHHHhhcCCCCCceeeccCceEEEEEE-----EcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEE
Q 046097 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAV-----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSL 142 (603)
Q Consensus 69 ~~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~-----~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l 142 (603)
+.........++|++.+.||+|+||.||+|+ ...+++.||||+++........+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4455666778999999999999999999999 45567899999998765656667899999999999 79999999
Q ss_pred EeEEecCCCCeEEEEEEccCCCCHHHHHhhccc-----------------------------------------------
Q 046097 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKC----------------------------------------------- 175 (603)
Q Consensus 143 ~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~----------------------------------------------- 175 (603)
++++.+. +...++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 92 LGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999875 3558999999999999999976432
Q ss_pred ----------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 176 ----------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 176 ----------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 11288999999999999999999999 9999999999999999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=351.73 Aligned_cols=160 Identities=23% Similarity=0.307 Sum_probs=140.7
Q ss_pred ccccHHHHHHhhcC----------CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCC
Q 046097 67 RRFSYNLIRRATAS----------FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC 136 (603)
Q Consensus 67 ~~~~~~~l~~~t~~----------y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~H 136 (603)
..++++++..++.. |+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++.+++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence 34677777777654 666789999999999999998899999999997643 3445678999999999999
Q ss_pred CceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 046097 137 PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNI 216 (603)
Q Consensus 137 pNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NI 216 (603)
|||+++++++... ...++||||+++++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+||
T Consensus 102 ~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI 172 (321)
T 2c30_A 102 FNVVEMYKSYLVG--EELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172 (321)
T ss_dssp TTBCCEEEEEEET--TEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred CCcceEEEEEEEC--CEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence 9999999999986 7899999999999999998643 389999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEEeeccceecc
Q 046097 217 LLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~~~ 236 (603)
|++.++.+||+|||++....
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQIS 192 (321)
T ss_dssp EECTTCCEEECCCTTCEECC
T ss_pred EECCCCcEEEeeeeeeeecc
Confidence 99999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.41 Aligned_cols=150 Identities=25% Similarity=0.402 Sum_probs=136.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+.+|+.++.+++||||+++++++.+. +..+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED--DCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS--SEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC--CeEE
Confidence 568999999999999999999999999999999985532 334457799999999999999999999999886 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 88 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999997653 389999999999999999999999 9999999999999999999999999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=362.80 Aligned_cols=150 Identities=24% Similarity=0.379 Sum_probs=135.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++..++||||+++++++.+. ..+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 91 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--EDMF 91 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEE
Confidence 367899999999999999999999999999999986532 112346788999999999999999999999987 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+.+|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 92 lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999997643 389999999999999999999999 9999999999999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=364.13 Aligned_cols=150 Identities=24% Similarity=0.278 Sum_probs=133.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~ 153 (603)
..++|++.+.||+|+||.||+|+++.+++.||||+++... .......+..|..++..+ +||||+++++++.+. ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CE
Confidence 4578999999999999999999999999999999996531 112346688999999988 799999999999986 89
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999999997643 389999999999999999999999 99999999999999999999999999986
Q ss_pred e
Q 046097 234 L 234 (603)
Q Consensus 234 ~ 234 (603)
.
T Consensus 170 ~ 170 (353)
T 2i0e_A 170 E 170 (353)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=360.88 Aligned_cols=152 Identities=28% Similarity=0.392 Sum_probs=136.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-----hHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-----GEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-----~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
..+.|++.+.||+|+||.||+|.++.+++.||+|+++...... ..+.+.+|+.++.+++||||+++++++.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-- 87 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-- 87 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC--
Confidence 4578999999999999999999999999999999997643221 356789999999999999999999999986
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC----cEEEE
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF----KAKIG 227 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~----~vKL~ 227 (603)
..+++||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 88999999999999999996543 489999999999999999999999 999999999999998776 79999
Q ss_pred eeccceecc
Q 046097 228 DFGLARLKT 236 (603)
Q Consensus 228 DFGlA~~~~ 236 (603)
|||++....
T Consensus 162 DFG~a~~~~ 170 (361)
T 2yab_A 162 DFGLAHEIE 170 (361)
T ss_dssp CCSSCEECC
T ss_pred ecCCceEcC
Confidence 999987643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=378.67 Aligned_cols=159 Identities=22% Similarity=0.277 Sum_probs=138.8
Q ss_pred HHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHhccCCCCceeEEEeEEec
Q 046097 71 YNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPHIVSLLGFASD 148 (603)
Q Consensus 71 ~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~ 148 (603)
+.++....++|++.+.||+|+||+||+|+++.+++.||||+++..... .....+.+|..++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 344555678999999999999999999999999999999999652111 112337899999999999999999999998
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEe
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~D 228 (603)
. ..+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 146 ~--~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 146 D--NNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp S--SEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred C--CEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 7 88999999999999999997632 3489999999999999999999999 999999999999999999999999
Q ss_pred eccceecc
Q 046097 229 FGLARLKT 236 (603)
Q Consensus 229 FGlA~~~~ 236 (603)
||+|+...
T Consensus 219 FGla~~~~ 226 (437)
T 4aw2_A 219 FGSCLKLM 226 (437)
T ss_dssp CTTCEECC
T ss_pred hhhhhhcc
Confidence 99997643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=356.71 Aligned_cols=151 Identities=27% Similarity=0.391 Sum_probs=133.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeEEEE
Confidence 468999999999999999999999999999999997654444456788999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999999886543 389999999999999999999999 99999999999999999999999999997653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=357.93 Aligned_cols=149 Identities=28% Similarity=0.449 Sum_probs=132.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--TDIV 85 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 4689999999999999999999999999999999864211 11235688999999999999999999999987 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+ +|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 86 lv~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EEEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 999999 789999887643 389999999999999999999999 9999999999999999999999999998654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=365.51 Aligned_cols=149 Identities=26% Similarity=0.348 Sum_probs=125.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHH-hccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSL-ASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~i-L~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.++|++.+.||+|+||.||+|+++.+++.||||+++.... ......+..|..+ ++.++||||+++++++.+. ..+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~~~ 114 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKL 114 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS--SEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--CEE
Confidence 4679999999999999999999999999999999976432 2234556777776 5678999999999999987 899
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 99999999999999997643 388999999999999999999999 999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=372.86 Aligned_cols=156 Identities=23% Similarity=0.305 Sum_probs=137.0
Q ss_pred HHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecC
Q 046097 72 NLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDR 149 (603)
Q Consensus 72 ~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~ 149 (603)
.++....++|++.+.||+|+||.||+|+++.+++.||+|+++.... ......+.+|+.++..++||||++++++|.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3455567889999999999999999999999999999999865211 01123478899999999999999999999986
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEee
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DF 229 (603)
..+|+||||+++|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 142 --~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 142 --RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp --SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred --CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 8899999999999999998653 289999999999999999999999 9999999999999999999999999
Q ss_pred ccceecc
Q 046097 230 GLARLKT 236 (603)
Q Consensus 230 GlA~~~~ 236 (603)
|+++...
T Consensus 213 G~a~~~~ 219 (410)
T 3v8s_A 213 GTCMKMN 219 (410)
T ss_dssp TTCEECC
T ss_pred ceeEeec
Confidence 9997643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.39 Aligned_cols=149 Identities=25% Similarity=0.363 Sum_probs=126.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEc---CCCceEEEEEecCCCC---hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVP---SSSQPLAVKILDSSGS---LQGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~l~~~~~---~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
.++|++.+.||+|+||.||+|+.. .+++.||+|+++.... ......+.+|+.++..++||||+++++++.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-- 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence 467999999999999999999985 6889999999976422 22345678899999999999999999999986
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
+..|+||||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred CEEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 88999999999999999997643 388999999999999999999999 999999999999999999999999999
Q ss_pred cee
Q 046097 232 ARL 234 (603)
Q Consensus 232 A~~ 234 (603)
+..
T Consensus 168 ~~~ 170 (327)
T 3a62_A 168 CKE 170 (327)
T ss_dssp C--
T ss_pred ccc
Confidence 864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=356.61 Aligned_cols=158 Identities=28% Similarity=0.473 Sum_probs=139.6
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEec
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASD 148 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~ 148 (603)
+....++|++.+.||+|+||.||+|++. .+++.||||+++..........+.+|+.++.+++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3446688999999999999999999986 34589999999876555666789999999999999999999999988
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhccc---------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKC---------------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVI 207 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~---------------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIV 207 (603)
. ...++||||+++++|.+++..... ...+++..++.++.||+.||.|||++ +|+
T Consensus 122 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 122 G--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred C--CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 6 788999999999999999976421 13589999999999999999999999 999
Q ss_pred eccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 208 HGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 208 HrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||||+|||++.++.+||+|||++....
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 225 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIY 225 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccc
Confidence 99999999999999999999999987543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=351.16 Aligned_cols=152 Identities=30% Similarity=0.432 Sum_probs=131.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC--CCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRR--GRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~--~~~~ 154 (603)
..++|++.+.||+|+||.||+|++. ++.||||++... .........|+.++.+++||||+++++++.+.. ...+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 4568999999999999999999984 789999999653 233455677999999999999999999998752 2458
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEeccCCCCCeEEcCCCcEEEE
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS-------CEPPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~-------~~~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
++||||+++|+|.+++.... +++..++.++.|++.||.|||+. +..+|+||||||+|||++.++.+||+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999997532 89999999999999999999975 13389999999999999999999999
Q ss_pred eeccceecc
Q 046097 228 DFGLARLKT 236 (603)
Q Consensus 228 DFGlA~~~~ 236 (603)
|||++....
T Consensus 174 DFg~a~~~~ 182 (322)
T 3soc_A 174 DFGLALKFE 182 (322)
T ss_dssp CCTTCEEEC
T ss_pred cCCcccccc
Confidence 999997654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.50 Aligned_cols=150 Identities=27% Similarity=0.417 Sum_probs=134.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-----hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-----QGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-----~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
.+.|.+.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.++.+++||||+++++++.+. .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--T 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--C
Confidence 45689999999999999999999999999999999764322 1357799999999999999999999999986 8
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC----cEEEEe
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF----KAKIGD 228 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~----~vKL~D 228 (603)
..++||||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 8999999999999999996543 389999999999999999999999 999999999999999877 899999
Q ss_pred eccceec
Q 046097 229 FGLARLK 235 (603)
Q Consensus 229 FGlA~~~ 235 (603)
||++...
T Consensus 162 fg~a~~~ 168 (326)
T 2y0a_A 162 FGLAHKI 168 (326)
T ss_dssp CTTCEEC
T ss_pred CCCCeEC
Confidence 9998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=365.62 Aligned_cols=152 Identities=23% Similarity=0.399 Sum_probs=137.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|.+.+.||+|+||.||+|.+..+++.||||+++..........+.+|+.++++++||||+++++++.+. ...++
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 189 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYI 189 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SSCEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CCcEE
Confidence 4567888999999999999999998899999999997654445556789999999999999999999999876 77899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999999997543 2389999999999999999999999 9999999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.73 Aligned_cols=149 Identities=23% Similarity=0.398 Sum_probs=131.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++++.+. ...++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEEEE
Confidence 578899999999999999999999999999999976433 23346788999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++ +|.+.+.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp EECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999976 6666554432 3489999999999999999999999 9999999999999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.65 Aligned_cols=153 Identities=33% Similarity=0.492 Sum_probs=134.1
Q ss_pred hcCCCCCceeeccCceEEEEEE----EcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~----~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.++|++.+.||+|+||.||+|+ ...+++.||||++... .....+.+.+|+.++.+++||||+++++++.......
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 4678999999999999999998 4568899999999763 4455578999999999999999999999987653466
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 899999999999999997654 2389999999999999999999999 99999999999999999999999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 163 ~~~ 165 (295)
T 3ugc_A 163 VLP 165 (295)
T ss_dssp ---
T ss_pred ccc
Confidence 654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=359.83 Aligned_cols=151 Identities=31% Similarity=0.503 Sum_probs=126.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCce----EEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQP----LAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~----VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.++|++.+.||+|+||.||+|++..+++. ||+|.+...........+.+|+.++.+++||||++++++|.+. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---S
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---C
Confidence 45789999999999999999998777664 5888876544445567899999999999999999999999874 4
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++|+||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 789999999999999997643 3489999999999999999999999 99999999999999999999999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 166 ~~~ 168 (327)
T 3poz_A 166 LLG 168 (327)
T ss_dssp HHT
T ss_pred Ecc
Confidence 653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.57 Aligned_cols=151 Identities=22% Similarity=0.306 Sum_probs=136.0
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.++..++||||+++++++.+. ...++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESM--EELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEEEE
Confidence 357899999999999999999999999999999999753 34456788999999999999999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC--CCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG--DFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~--~~~vKL~DFGlA~~ 234 (603)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++..
T Consensus 79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 79 IFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 999999999999996543 2489999999999999999999999 9999999999999987 78999999999976
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 154 ~~ 155 (321)
T 1tki_A 154 LK 155 (321)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.69 Aligned_cols=155 Identities=30% Similarity=0.461 Sum_probs=137.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
..++|.+.+.||+|+||.||+|.+. .+++.||||+++........+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-- 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC--
Confidence 4567899999999999999999973 456889999998765566668899999999999999999999999886
Q ss_pred CeEEEEEEccCCCCHHHHHhhccc---------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKC---------------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGD 210 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~---------------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrD 210 (603)
+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||++ +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 778999999999999999976432 12388999999999999999999999 999999
Q ss_pred CCCCCeEEcCCCcEEEEeeccceecc
Q 046097 211 IKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 211 LKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||+|||++.++.+||+|||++....
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~ 201 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVY 201 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECT
T ss_pred cchheEEEcCCCCEEEcccccccccc
Confidence 99999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=342.74 Aligned_cols=148 Identities=27% Similarity=0.413 Sum_probs=126.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhcc--CCCCceeEEEeEEecC--CCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASS--LDCPHIVSLLGFASDR--RGR 152 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~--l~HpNIV~l~g~~~~~--~~~ 152 (603)
..++|++.+.||+|+||.||+|.+ +++.||||++.. .....+..|.+++.. ++||||+++++++.+. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 457899999999999999999998 689999999965 234455566666665 7899999999987643 235
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeccCCCCCeEEcCCCcE
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH--------HSCEPPVIHGDIKPSNILLDGDFKA 224 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLH--------s~~~~gIVHrDLKp~NILld~~~~v 224 (603)
..++||||+++|+|.+++... .+++..++.++.|++.||.||| +. +|+||||||+|||++.++.+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 689999999999999999543 3899999999999999999999 77 99999999999999999999
Q ss_pred EEEeeccceeccc
Q 046097 225 KIGDFGLARLKTE 237 (603)
Q Consensus 225 KL~DFGlA~~~~~ 237 (603)
||+|||++.....
T Consensus 153 kl~Dfg~a~~~~~ 165 (301)
T 3q4u_A 153 CIADLGLAVMHSQ 165 (301)
T ss_dssp EECCCTTCEEEET
T ss_pred EEeeCCCeeeccc
Confidence 9999999976543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=364.84 Aligned_cols=152 Identities=27% Similarity=0.461 Sum_probs=130.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEc---CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVP---SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.++|++.+.||+|+||.||+|++. .++..||||+++........+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--Cce
Confidence 457999999999999999999986 457789999998765556667899999999999999999999999876 788
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999997543 3489999999999999999999999 999999999999999999999999999876
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 197 ~~ 198 (373)
T 2qol_A 197 LE 198 (373)
T ss_dssp --
T ss_pred cc
Confidence 53
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=342.74 Aligned_cols=152 Identities=26% Similarity=0.429 Sum_probs=130.6
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-------------------------hhHHHHHHHHHHhc
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-------------------------QGEREFHNELSLAS 132 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-------------------------~~~~~~~~Ev~iL~ 132 (603)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999999999999999999654211 11356889999999
Q ss_pred cCCCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 046097 133 SLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIK 212 (603)
Q Consensus 133 ~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLK 212 (603)
+++||||+++++++.+......++||||+++++|.+++.. ..+++..++.++.||+.||.|||++ +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999997655789999999999999876432 3489999999999999999999999 99999999
Q ss_pred CCCeEEcCCCcEEEEeeccceecc
Q 046097 213 PSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 213 p~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|+|||++.++.+||+|||++....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~ 188 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFK 188 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECS
T ss_pred HHHEEECCCCCEEEecCCCccccc
Confidence 999999999999999999987643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.16 Aligned_cols=152 Identities=27% Similarity=0.458 Sum_probs=121.7
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|.++.+++.||||+++..........+.+|+.++++++||||+++++++.+. +..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE--NKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--CeEEEE
Confidence 468999999999999999999999999999999997654444456788999999999999999999999886 889999
Q ss_pred EEccCCCCHHHHHhhccc---ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 158 YELMENRSLQDALLDRKC---EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~---~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|||++ ++|.+++..... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99997 599998876431 12488999999999999999999999 999999999999999999999999999876
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 158 ~ 158 (317)
T 2pmi_A 158 F 158 (317)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=354.89 Aligned_cols=160 Identities=31% Similarity=0.520 Sum_probs=139.9
Q ss_pred HHHHHhhcCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEE
Q 046097 72 NLIRRATASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146 (603)
Q Consensus 72 ~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~ 146 (603)
++++...++|++.+.||+|+||.||+|.+. .+++.||||++...........+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556788999999999999999999875 357889999998765556667899999999999999999999999
Q ss_pred ecCCCCeEEEEEEccCCCCHHHHHhhcccc-------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc
Q 046097 147 SDRRGRRLVLIYELMENRSLQDALLDRKCE-------ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD 219 (603)
Q Consensus 147 ~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~-------~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld 219 (603)
.+. ...++||||+++++|.+++...... ..+++..++.++.||+.||.|||++ +|+||||||+||+++
T Consensus 98 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 98 SQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 172 (322)
T ss_dssp CSS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred ccC--CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence 876 7789999999999999999764321 3368999999999999999999999 999999999999999
Q ss_pred CCCcEEEEeeccceecc
Q 046097 220 GDFKAKIGDFGLARLKT 236 (603)
Q Consensus 220 ~~~~vKL~DFGlA~~~~ 236 (603)
.++.+||+|||++....
T Consensus 173 ~~~~~kl~Dfg~~~~~~ 189 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIY 189 (322)
T ss_dssp TTCCEEECCTTCCCGGG
T ss_pred CCCeEEECcCccccccc
Confidence 99999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=356.38 Aligned_cols=152 Identities=23% Similarity=0.417 Sum_probs=135.3
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
...++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 103 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFH 103 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEE
Confidence 34568999999999999999999999999999999997643 334456789999999999999999999999986 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC---CcEEEEeecc
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD---FKAKIGDFGL 231 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~---~~vKL~DFGl 231 (603)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999999987543 389999999999999999999999 99999999999999865 4599999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
+...
T Consensus 178 a~~~ 181 (362)
T 2bdw_A 178 AIEV 181 (362)
T ss_dssp CBCC
T ss_pred ceEe
Confidence 8654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=357.95 Aligned_cols=151 Identities=26% Similarity=0.430 Sum_probs=131.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCce----EEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQP----LAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~----VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.++|++.+.||+|+||.||+|.+..+++. ||+|.+...........+.+|+.++.+++||||+++++++.+ ..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---SS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---SS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---Cc
Confidence 35788899999999999999999877775 788877554333344567889999999999999999999875 56
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred cEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence 899999999999999997643 3488899999999999999999999 99999999999999999999999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 164 ~~~ 166 (325)
T 3kex_A 164 LLP 166 (325)
T ss_dssp GSC
T ss_pred ccC
Confidence 653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=354.38 Aligned_cols=146 Identities=25% Similarity=0.317 Sum_probs=127.7
Q ss_pred cccccHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-----CCcee
Q 046097 66 CRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-----CPHIV 140 (603)
Q Consensus 66 ~~~~~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-----HpNIV 140 (603)
...+++.......++|.+.+.||+|+||.||+|++..+++.||||+++. .......+..|+.++..+. ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3445566666778899999999999999999999999999999999964 3344566788999999886 99999
Q ss_pred EEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC
Q 046097 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG 220 (603)
Q Consensus 141 ~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~ 220 (603)
++++++... ...++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~--~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 100 KYHGKFMYY--DHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDD 172 (360)
T ss_dssp CEEEEEEET--TEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESC
T ss_pred cccceeeEC--CeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcc
Confidence 999999986 8899999999 8999999976543 2389999999999999999999999 9999999999999976
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=364.41 Aligned_cols=152 Identities=25% Similarity=0.365 Sum_probs=134.2
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.++++++||||+++++++.+. +..
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 85 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE--GHH 85 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--SEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--CEE
Confidence 3567899999999999999999999999999999999764432 3446789999999999999999999999986 899
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc---CCCcEEEEeecc
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD---GDFKAKIGDFGL 231 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld---~~~~vKL~DFGl 231 (603)
++||||+++|+|.+.+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999987653 389999999999999999999999 999999999999998 467899999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
+...
T Consensus 160 a~~~ 163 (444)
T 3soa_A 160 AIEV 163 (444)
T ss_dssp CBCC
T ss_pred eEEe
Confidence 8654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=337.96 Aligned_cols=148 Identities=30% Similarity=0.550 Sum_probs=129.7
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhH------HHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE------REFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~------~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
.++|++.+.||+|+||.||+|++..+++.||||++......... +.+.+|+.++.+++||||+++++++.+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 46789999999999999999999999999999998654322211 6789999999999999999999999764
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCeEEcCCCc-----E
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP--VIHGDIKPSNILLDGDFK-----A 224 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g--IVHrDLKp~NILld~~~~-----v 224 (603)
. ++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ + |+||||||+|||++.++. +
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred C--eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence 3 69999999999999886543 3489999999999999999999998 8 999999999999987776 9
Q ss_pred EEEeecccee
Q 046097 225 KIGDFGLARL 234 (603)
Q Consensus 225 KL~DFGlA~~ 234 (603)
||+|||++..
T Consensus 169 kl~Dfg~~~~ 178 (287)
T 4f0f_A 169 KVADFGLSQQ 178 (287)
T ss_dssp EECCCTTCBC
T ss_pred EeCCCCcccc
Confidence 9999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=348.01 Aligned_cols=148 Identities=23% Similarity=0.325 Sum_probs=131.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~L 156 (603)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++.++ +||||+++++++.+. ...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccEE
Confidence 4679999999999999999999999999999999865322 23578999999999 899999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc-----EEEEeecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK-----AKIGDFGL 231 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~-----vKL~DFGl 231 (603)
||||+ +++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 99999 999999997642 3489999999999999999999999 9999999999999998887 99999999
Q ss_pred ceecc
Q 046097 232 ARLKT 236 (603)
Q Consensus 232 A~~~~ 236 (603)
+....
T Consensus 157 a~~~~ 161 (330)
T 2izr_A 157 AKEYI 161 (330)
T ss_dssp CEESB
T ss_pred ceeee
Confidence 98654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=339.62 Aligned_cols=150 Identities=26% Similarity=0.433 Sum_probs=133.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|.+. ++..||+|+++... .....+.+|+.++.+++||||+++++++.+. ...++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 80 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE--YPIYI 80 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CceEE
Confidence 3467899999999999999999885 57789999997633 2346789999999999999999999999876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred EEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 999999999999997643 3489999999999999999999999 99999999999999999999999999987653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=358.55 Aligned_cols=156 Identities=24% Similarity=0.343 Sum_probs=139.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|.+.+.||+|+||.||+|++..+++.||||++.........+.+.+|+.++++++||||+++++++.+..+...++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 46789999999999999999999999999999999764444456778899999999999999999999998755688999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE----cCCCcEEEEeeccce
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL----DGDFKAKIGDFGLAR 233 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl----d~~~~vKL~DFGlA~ 233 (603)
|||+++|+|.+++........+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998765444489999999999999999999999 99999999999999 777889999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 165 ~~~ 167 (396)
T 4eut_A 165 ELE 167 (396)
T ss_dssp ECC
T ss_pred Ecc
Confidence 653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=355.01 Aligned_cols=154 Identities=19% Similarity=0.207 Sum_probs=137.8
Q ss_pred hhcCCCCCceeecc--CceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHG--GFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G--~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
..++|++.+.||+| +||.||+|+++.+++.||||++.... .......+.+|+.+++.++||||+++++++.+. +.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--CE
Confidence 35679999999999 99999999999999999999997643 233456788999999999999999999999986 88
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+++||||+++++|.+++..... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||.+.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999999999999976532 3389999999999999999999999 99999999999999999999999999987
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 177 ~~~ 179 (389)
T 3gni_B 177 SMI 179 (389)
T ss_dssp ECE
T ss_pred eec
Confidence 543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.93 Aligned_cols=153 Identities=33% Similarity=0.434 Sum_probs=133.5
Q ss_pred hcCCCCCceeeccCceEEEEEEE-----cCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVV-----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
.++|++.+.||+|+||.||+|.. ..+++.||||+++..........+.+|+.++.+++||||+++++++.+. .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--L 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--C
Confidence 46788999999999999999994 4467889999997765666677899999999999999999999999876 7
Q ss_pred eEEEEEEccCCCCHHHHHhhccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC---cEE
Q 046097 153 RLVLIYELMENRSLQDALLDRKC----EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF---KAK 225 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~----~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~---~vK 225 (603)
..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 78999999999999999986532 13488999999999999999999999 999999999999999554 599
Q ss_pred EEeeccceec
Q 046097 226 IGDFGLARLK 235 (603)
Q Consensus 226 L~DFGlA~~~ 235 (603)
|+|||+++..
T Consensus 225 L~DFG~a~~~ 234 (367)
T 3l9p_A 225 IGDFGMARDI 234 (367)
T ss_dssp ECCCHHHHHH
T ss_pred ECCCcccccc
Confidence 9999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=352.58 Aligned_cols=154 Identities=27% Similarity=0.398 Sum_probs=133.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC----ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG----SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~----~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.++|++.+.||+|+||.||+|.++.+++.||||++.... .....+.+.+|+.++..++||||+++++++.+. +.
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GM 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 467999999999999999999999999999999985421 112356789999999999999999999999986 88
Q ss_pred EEEEEEccCCCCHHHHHhhccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc---EEEEee
Q 046097 154 LVLIYELMENRSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK---AKIGDF 229 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~---vKL~DF 229 (603)
+|+||||+++++|.+.+..... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999999988765432 23479999999999999999999999 9999999999999986554 999999
Q ss_pred ccceecc
Q 046097 230 GLARLKT 236 (603)
Q Consensus 230 GlA~~~~ 236 (603)
|++....
T Consensus 178 g~a~~~~ 184 (351)
T 3c0i_A 178 GVAIQLG 184 (351)
T ss_dssp TTCEECC
T ss_pred cceeEec
Confidence 9997653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.65 Aligned_cols=157 Identities=27% Similarity=0.412 Sum_probs=133.4
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEec
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASD 148 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~ 148 (603)
....++|.+.+.||+|+||.||+|.+. .++..||||++...........+.+|+.++.++ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 335678999999999999999999973 356789999997654444557899999999999 89999999999988
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcccc--------------------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKCE--------------------ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIH 208 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~~--------------------~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVH 208 (603)
. +..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||++ +|+|
T Consensus 121 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 121 S--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred C--CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 6 7889999999999999999764321 2378999999999999999999999 9999
Q ss_pred ccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 209 GDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 209 rDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||||+|||++.++.+||+|||++....
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~ 223 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIM 223 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGG
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccc
Confidence 9999999999999999999999987553
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=340.34 Aligned_cols=149 Identities=24% Similarity=0.369 Sum_probs=131.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCC-------ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSS-------QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRR 150 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg-------~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~ 150 (603)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+.++.+++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG- 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-
Confidence 467889999999999999999997766 46999999653 334567899999999999999999999999986
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc-------
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK------- 223 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~------- 223 (603)
...++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 85 -~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 -DENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp -TCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred -CCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 77899999999999999997653 3389999999999999999999999 9999999999999998877
Q ss_pred -EEEEeecccee
Q 046097 224 -AKIGDFGLARL 234 (603)
Q Consensus 224 -vKL~DFGlA~~ 234 (603)
+||+|||++..
T Consensus 159 ~~kl~Dfg~~~~ 170 (289)
T 4fvq_A 159 FIKLSDPGISIT 170 (289)
T ss_dssp EEEECCCCSCTT
T ss_pred eeeeccCccccc
Confidence 99999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=343.11 Aligned_cols=152 Identities=27% Similarity=0.409 Sum_probs=127.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCC---CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSS---SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
..++|++.+.||+|+||.||+|.+..+ +..||+|++.........+.+.+|+.++.+++||||+++++++.+ +.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~ 89 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---Cc
Confidence 456789999999999999999998653 456999999775555566789999999999999999999999854 56
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 799999999999999997543 2389999999999999999999999 99999999999999999999999999987
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 165 ~~~ 167 (281)
T 1mp8_A 165 YME 167 (281)
T ss_dssp ---
T ss_pred ccC
Confidence 643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=335.85 Aligned_cols=151 Identities=24% Similarity=0.422 Sum_probs=134.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++++.+. ...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHY 81 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--CEEE
Confidence 4578999999999999999999999999999999986543 334457788999999999999999999999886 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc---EEEEeeccc
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK---AKIGDFGLA 232 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~---vKL~DFGlA 232 (603)
+||||+++++|.+.+.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++. +||+|||++
T Consensus 82 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999999887653 389999999999999999999999 9999999999999986655 999999998
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
...
T Consensus 156 ~~~ 158 (284)
T 3kk8_A 156 IEV 158 (284)
T ss_dssp EEC
T ss_pred EEc
Confidence 654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=336.40 Aligned_cols=150 Identities=19% Similarity=0.333 Sum_probs=133.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
.++|++.+.||+|+||.||+|++ .++.||||+++... .....+.+.+|+.++++++||||+++++++.+..+...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 35789999999999999999998 48899999997643 3344567999999999999999999999998865678899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP--VIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g--IVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ + ++||||||+||+++.++.++|+|||++.
T Consensus 87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence 9999999999999976432 3489999999999999999999998 7 9999999999999999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=364.91 Aligned_cols=159 Identities=23% Similarity=0.230 Sum_probs=138.9
Q ss_pred HHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEec
Q 046097 71 YNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASD 148 (603)
Q Consensus 71 ~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~ 148 (603)
+.++....++|++.+.||+|+||.||+|+.+.+++.||||++++... ......+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 34445567899999999999999999999999999999999965211 1122347889999999999999999999998
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEe
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~D 228 (603)
. ..+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 133 ~--~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 133 E--NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp S--SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred C--CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 7 88999999999999999997642 2489999999999999999999999 999999999999999999999999
Q ss_pred eccceecc
Q 046097 229 FGLARLKT 236 (603)
Q Consensus 229 FGlA~~~~ 236 (603)
||++....
T Consensus 206 FGla~~~~ 213 (412)
T 2vd5_A 206 FGSCLKLR 213 (412)
T ss_dssp CTTCEECC
T ss_pred chhheecc
Confidence 99997653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.82 Aligned_cols=151 Identities=26% Similarity=0.406 Sum_probs=134.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|.++.+++.||+|++... .......+.+|+.++..++||||+++++++.+. ...++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CEEEEE
Confidence 46799999999999999999999999999999999763 334456789999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC--CCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG--DFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~--~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++...
T Consensus 127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999999986543 2489999999999999999999999 9999999999999974 578999999999765
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 202 ~ 202 (387)
T 1kob_A 202 N 202 (387)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.97 Aligned_cols=158 Identities=28% Similarity=0.439 Sum_probs=123.5
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCc---eEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQ---PLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
...++|++.+.||+|+||.||+|.+..++. .||||+++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 456789999999999999999999876665 89999997643 33445789999999999999999999999987521
Q ss_pred C----eEEEEEEccCCCCHHHHHhhcccc---cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcE
Q 046097 152 R----RLVLIYELMENRSLQDALLDRKCE---ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKA 224 (603)
Q Consensus 152 ~----~~~LVmEy~~~gsL~~~L~~~~~~---~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~v 224 (603)
. ..++||||+++++|.+++...... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 1 238999999999999999764321 1489999999999999999999999 99999999999999999999
Q ss_pred EEEeeccceecc
Q 046097 225 KIGDFGLARLKT 236 (603)
Q Consensus 225 KL~DFGlA~~~~ 236 (603)
||+|||++....
T Consensus 177 kl~Dfg~a~~~~ 188 (323)
T 3qup_A 177 CVADFGLSRKIY 188 (323)
T ss_dssp EECCCCC-----
T ss_pred EEeecccccccc
Confidence 999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=342.40 Aligned_cols=150 Identities=29% Similarity=0.442 Sum_probs=130.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .....+.+|+.++++++||||+++++++.+. ...+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 95 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE--RCLT 95 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--SCEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--CEEE
Confidence 4578999999999999999999985 5899999999754322 2346788999999999999999999999886 7899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++ +|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 96 lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EEEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EEEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 99999975 8888876543 3389999999999999999999999 9999999999999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=345.96 Aligned_cols=155 Identities=30% Similarity=0.411 Sum_probs=137.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEE-----cCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVV-----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~ 150 (603)
..++|++.+.||+|+||.||+|.+ ..+++.||||+++........+.+.+|+.++.++ +||||+++++++.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 99 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-
Confidence 456899999999999999999985 4567899999998765556668899999999999 899999999999886
Q ss_pred CCeEEEEEEccCCCCHHHHHhhccc---------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKC---------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSN 215 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~---------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~N 215 (603)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 100 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 100 -GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred -CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 778999999999999999976532 12489999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEEeeccceecc
Q 046097 216 ILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 216 ILld~~~~vKL~DFGlA~~~~ 236 (603)
|+++.++.+||+|||++....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~ 196 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIK 196 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTT
T ss_pred EEEcCCCCEEEcccccccccc
Confidence 999999999999999987643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.56 Aligned_cols=154 Identities=26% Similarity=0.460 Sum_probs=132.6
Q ss_pred cCCCCCceeeccCceEEEEEE----EcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~----~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..|++.+.||+|+||.||+|+ ...+++.||||++...........+.+|+.++.+++||||+++++++.+.....+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 458889999999999999999 4668999999999765544556789999999999999999999999988655778
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999996543 3389999999999999999999999 999999999999999999999999999976
Q ss_pred ccc
Q 046097 235 KTE 237 (603)
Q Consensus 235 ~~~ 237 (603)
...
T Consensus 176 ~~~ 178 (302)
T 4e5w_A 176 IET 178 (302)
T ss_dssp CCT
T ss_pred ccC
Confidence 543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.33 Aligned_cols=141 Identities=24% Similarity=0.368 Sum_probs=122.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+..+..+ +||||+++++++.+. +..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeE
Confidence 4577999999999999999999999899999999997642 234456788999999999 899999999999886 899
Q ss_pred EEEEEccCCCCHHHHHhhccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC
Q 046097 155 VLIYELMENRSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF 222 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~ 222 (603)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~ 152 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTS 152 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCC
Confidence 999999999999999976432 13489999999999999999999999 999999999999998655
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=356.47 Aligned_cols=155 Identities=29% Similarity=0.430 Sum_probs=137.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcC-------CCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEec
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPS-------SSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASD 148 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~ 148 (603)
..++|.+.+.||+|+||.||+|++.. .+..||||+++..........+.+|+.++.++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 45688999999999999999999753 33579999998766666668899999999999 89999999999988
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSN 215 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~N 215 (603)
. +..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 147 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 147 D--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred C--CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 6 778999999999999999987542 13489999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEEeeccceecc
Q 046097 216 ILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 216 ILld~~~~vKL~DFGlA~~~~ 236 (603)
||++.++.+||+|||++....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~ 242 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIH 242 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSS
T ss_pred EEEcCCCcEEEcccCcccccc
Confidence 999999999999999987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=339.99 Aligned_cols=149 Identities=26% Similarity=0.480 Sum_probs=132.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.++.+++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CceEEE
Confidence 357888999999999999999986 57789999997632 3346789999999999999999999999886 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred EEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccc
Confidence 99999999999996543 3489999999999999999999999 99999999999999999999999999987543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.58 Aligned_cols=149 Identities=33% Similarity=0.549 Sum_probs=125.8
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
...++|++.+.||+|+||.||+|.+. ..||||+++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 94 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQL 94 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---Ccc
Confidence 35678999999999999999999873 359999997643 33445779999999999999999999997654 568
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccc
Confidence 99999999999999996543 3489999999999999999999999 999999999999999999999999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 170 ~ 170 (289)
T 3og7_A 170 K 170 (289)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.44 Aligned_cols=148 Identities=25% Similarity=0.466 Sum_probs=124.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|.+..+++.||||+++.. ...+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc---hhHHHHHHHHHHHHhCCCCCCcceeeeEecC--CeEEE
Confidence 457899999999999999999999999999999999753 2345688999999999999999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC---CCcEEEEeeccce
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG---DFKAKIGDFGLAR 233 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~---~~~vKL~DFGlA~ 233 (603)
||||+++++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++.
T Consensus 126 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999997643 389999999999999999999999 9999999999999975 8899999999986
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 200 ~~ 201 (349)
T 2w4o_A 200 IV 201 (349)
T ss_dssp --
T ss_pred cc
Confidence 54
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.58 Aligned_cols=153 Identities=29% Similarity=0.456 Sum_probs=136.6
Q ss_pred hcCCCCCceeeccCceEEEEEE----EcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAV----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~----~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.++|++.+.||+|+||.||+|+ ...+++.||||++... .....+.+.+|+.++.+++||||+++++++.......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 3678899999999999999999 4568899999999763 4455577999999999999999999999998655678
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999976432 389999999999999999999999 99999999999999999999999999998
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 176 ~~~ 178 (327)
T 3lxl_A 176 LLP 178 (327)
T ss_dssp ECC
T ss_pred ecc
Confidence 654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=337.12 Aligned_cols=148 Identities=28% Similarity=0.443 Sum_probs=130.4
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||+|+||.||+|++ .+++.||+|++...... .....+.+|+.++++++||||+++++++.+. +..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEEEE
Confidence 5788999999999999999998 67899999999664322 2236788999999999999999999999986 789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++ +|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 79 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp EECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 999975 8998886543 3388999999999999999999999 9999999999999999999999999998654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=336.69 Aligned_cols=150 Identities=21% Similarity=0.345 Sum_probs=132.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..+ +|+|++.+++++.+. ...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC--ceeE
Confidence 3567999999999999999999998999999999986532 234577899999999 799999999999876 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc-----EEEEeec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK-----AKIGDFG 230 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~-----vKL~DFG 230 (603)
+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||
T Consensus 83 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 999999 999999997643 3489999999999999999999999 9999999999999987765 9999999
Q ss_pred cceeccc
Q 046097 231 LARLKTE 237 (603)
Q Consensus 231 lA~~~~~ 237 (603)
++.....
T Consensus 157 ~~~~~~~ 163 (298)
T 1csn_A 157 MVKFYRD 163 (298)
T ss_dssp TCEESBC
T ss_pred ccccccc
Confidence 9986543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=349.46 Aligned_cols=158 Identities=28% Similarity=0.399 Sum_probs=138.5
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCc-----eEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEe
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQ-----PLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFAS 147 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~-----~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~ 147 (603)
.....++|++.+.||+|+||.||+|.+..+++ .||+|.+...........+.+|+.++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999999876554 79999998765556677899999999999 8999999999998
Q ss_pred cCCCCeEEEEEEccCCCCHHHHHhhccc-----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 046097 148 DRRGRRLVLIYELMENRSLQDALLDRKC-----------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNI 216 (603)
Q Consensus 148 ~~~~~~~~LVmEy~~~gsL~~~L~~~~~-----------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NI 216 (603)
+. +..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+||
T Consensus 121 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 195 (333)
T 2i1m_A 121 HG--GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV 195 (333)
T ss_dssp SS--SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGC
T ss_pred cC--CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceE
Confidence 76 788999999999999999976431 23478999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEEeeccceecc
Q 046097 217 LLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~~~ 236 (603)
|++.++.+||+|||++....
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~ 215 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIM 215 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGG
T ss_pred EECCCCeEEECccccccccc
Confidence 99999999999999987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=337.47 Aligned_cols=152 Identities=30% Similarity=0.451 Sum_probs=136.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+. +..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--CEE
Confidence 3467899999999999999999999999999999986542 234457789999999999999999999999986 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 99999999999999886643 389999999999999999999999 999999999999999999999999999876
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 165 ~~ 166 (294)
T 2rku_A 165 VE 166 (294)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.12 Aligned_cols=151 Identities=27% Similarity=0.379 Sum_probs=135.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-----hHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-----GEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-----~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++....... ..+.+.+|+.++.+++||||+++++++.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 87 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-- 87 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 3467999999999999999999999999999999997643221 357799999999999999999999999986
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC----cEEEE
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF----KAKIG 227 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~----~vKL~ 227 (603)
...++||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .+||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEc
Confidence 88999999999999999997643 388999999999999999999999 999999999999999887 79999
Q ss_pred eeccceec
Q 046097 228 DFGLARLK 235 (603)
Q Consensus 228 DFGlA~~~ 235 (603)
|||++...
T Consensus 162 Dfg~~~~~ 169 (321)
T 2a2a_A 162 DFGLAHEI 169 (321)
T ss_dssp CCTTCEEC
T ss_pred cCccceec
Confidence 99998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=339.18 Aligned_cols=150 Identities=32% Similarity=0.446 Sum_probs=133.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEE
Confidence 34679999999999999999999999999999999854211 11246688999999999999999999999986 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEecccccc
Confidence 99999999999999987643 389999999999999999999999 999999999999999999999999998743
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=347.54 Aligned_cols=154 Identities=25% Similarity=0.371 Sum_probs=133.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC--C
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG--R 152 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~--~ 152 (603)
..++|++.+.||+|+||.||+|++..+++.||||+++... .......+.+|+.++.+++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3578999999999999999999999999999999997643 22334678999999999999999999999876422 3
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
..|+||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 5699999999999999997643 389999999999999999999999 9999999999999999999999999998
Q ss_pred eecc
Q 046097 233 RLKT 236 (603)
Q Consensus 233 ~~~~ 236 (603)
....
T Consensus 164 ~~~~ 167 (311)
T 3ork_A 164 RAIA 167 (311)
T ss_dssp ----
T ss_pred cccc
Confidence 7643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.50 Aligned_cols=158 Identities=25% Similarity=0.352 Sum_probs=135.4
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC----ChhhHHHHHHHHHHhccCCCCceeEEEeEEecC
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG----SLQGEREFHNELSLASSLDCPHIVSLLGFASDR 149 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~----~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~ 149 (603)
+....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4566788999999999999999999999999999999986431 233457899999999999999999999999886
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcc-------------------------------------cccccCHHHHHHHHHHHH
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRK-------------------------------------CEELMEWNKRFEIAIDIA 192 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~-------------------------------------~~~~l~~~~~l~Ia~qIa 192 (603)
...++||||+++|+|.+++.... ....+++..+..++.||+
T Consensus 101 --~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 101 --QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp --SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred --CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 88999999999999999885211 011246778889999999
Q ss_pred HHHHHHHhCCCCCeEeccCCCCCeEEcCCC--cEEEEeeccceecc
Q 046097 193 KGLEYLHHSCEPPVIHGDIKPSNILLDGDF--KAKIGDFGLARLKT 236 (603)
Q Consensus 193 ~aL~yLHs~~~~gIVHrDLKp~NILld~~~--~vKL~DFGlA~~~~ 236 (603)
.||.|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus 179 ~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~ 221 (345)
T 3hko_A 179 SALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY 221 (345)
T ss_dssp HHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGG
T ss_pred HHHHHHHHC---CccccCCChhhEEEecCCCceEEEeecccccccc
Confidence 999999999 999999999999998776 89999999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=350.77 Aligned_cols=154 Identities=26% Similarity=0.477 Sum_probs=129.1
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCC-CChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCe
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS-GSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~-~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~ 153 (603)
...++|++.+.||+|+||.||+|.+..+++.||||++... ........+.+|+.++..+. ||||+++++++.......
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567899999999999999999999999999999998653 23345567889999999997 999999999998765568
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+|+||||++ ++|..++... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 999999997 5899988653 388999999999999999999999 99999999999999999999999999998
Q ss_pred eccc
Q 046097 234 LKTE 237 (603)
Q Consensus 234 ~~~~ 237 (603)
....
T Consensus 158 ~~~~ 161 (388)
T 3oz6_A 158 SFVN 161 (388)
T ss_dssp ESSS
T ss_pred cccc
Confidence 7643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=342.09 Aligned_cols=155 Identities=26% Similarity=0.420 Sum_probs=136.1
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+..+...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999999999999999997643 3344577999999999999999999999987654578999
Q ss_pred EEEccCCCCHHHHHhhccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEeccCCCCCeEEcCCCcEEEEeec
Q 046097 157 IYELMENRSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCEPP-----VIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g-----IVHrDLKp~NILld~~~~vKL~DFG 230 (603)
||||+++++|.+++..... ...+++..++.++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999976432 23489999999999999999999998 7 9999999999999999999999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
++...
T Consensus 162 ~~~~~ 166 (279)
T 2w5a_A 162 LARIL 166 (279)
T ss_dssp HHHHC
T ss_pred hheee
Confidence 98654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=334.65 Aligned_cols=153 Identities=28% Similarity=0.457 Sum_probs=135.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|.+.+.||+|+||.||+|++..+++.||||++..... ......+.+|+.++.+++||||+++++++.+. ...
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 86 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--NYV 86 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--SEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--CeE
Confidence 34679999999999999999999988999999999964211 11236789999999999999999999999986 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++..
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 99999999999999997642 3489999999999999999999999 999999999999999999999999999876
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 162 ~~ 163 (278)
T 3cok_A 162 LK 163 (278)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=345.94 Aligned_cols=164 Identities=27% Similarity=0.423 Sum_probs=141.3
Q ss_pred ccHHHHHHhhcCCCCCceeeccCceEEEEEEE-----cCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEE
Q 046097 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVV-----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSL 142 (603)
Q Consensus 69 ~~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l 142 (603)
+.........++|++.+.||+|+||.||+|.+ ..+++.||||+++..........+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455566778999999999999999999985 3567899999998765555667899999999999 69999999
Q ss_pred EeEEecCCCCeEEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 046097 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHG 209 (603)
Q Consensus 143 ~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHr 209 (603)
++++... +...++||||+++++|.+++..... ...+++..++.++.|++.||.|||++ +|+||
T Consensus 97 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 97 LGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 9998865 3568999999999999999976542 12278999999999999999999999 99999
Q ss_pred cCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 210 DIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 210 DLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+||+++.++.+||+|||++....
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~ 199 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIY 199 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred cCccceEEECCCCCEEECCCccccccc
Confidence 999999999999999999999987543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=366.29 Aligned_cols=153 Identities=27% Similarity=0.434 Sum_probs=134.2
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
++...++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.++++++||||+++++++.. ..
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~ 256 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EP 256 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEECS---SS
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC---Cc
Confidence 3445678899999999999999999985 47789999997632 346789999999999999999999999874 56
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 8999999999999999975432 2378899999999999999999999 99999999999999999999999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 333 ~~~ 335 (454)
T 1qcf_A 333 VIE 335 (454)
T ss_dssp GBC
T ss_pred EcC
Confidence 643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.38 Aligned_cols=148 Identities=29% Similarity=0.402 Sum_probs=126.1
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|.+ .++.||||++.. ....+.+.+|+.++++++||||+++++++.+ ..++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEEE
Confidence 35688899999999999999998 478899999964 2345778999999999999999999998874 36899
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc-EEEEeecccee
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK-AKIGDFGLARL 234 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~-vKL~DFGlA~~ 234 (603)
|||+++++|.+++........+++..++.++.|++.||.|||+.+..+|+||||||+|||++.++. +||+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 999999999999987654445789999999999999999999932229999999999999998886 79999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=370.75 Aligned_cols=153 Identities=28% Similarity=0.439 Sum_probs=136.9
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
....+|++.+.||+|+||.||+|.++.++..||||+++... ...+.+.+|+.+|++++||||++++++|.+. ..++
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 292 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFY 292 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEE
Confidence 34567888899999999999999998889999999997643 3457899999999999999999999999886 7789
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 293 lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999976432 3488999999999999999999999 9999999999999999999999999999765
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 369 ~ 369 (495)
T 1opk_A 369 T 369 (495)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=352.47 Aligned_cols=151 Identities=31% Similarity=0.503 Sum_probs=130.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceE----EEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPL----AVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~V----AVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.++|++.+.||+|+||.||+|.+..+++.+ |+|.+...........+.+|+.++.+++||||+++++++.+. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---S
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---C
Confidence 467999999999999999999998777654 777776544555677899999999999999999999999874 4
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++|++|+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 789999999999999997643 3389999999999999999999999 99999999999999999999999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 166 ~~~ 168 (327)
T 3lzb_A 166 LLG 168 (327)
T ss_dssp ---
T ss_pred Ecc
Confidence 653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.83 Aligned_cols=153 Identities=27% Similarity=0.398 Sum_probs=135.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|.+.+.||+|+||.||+|.+..++..||+|++.........+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY--HNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC--CeEEEE
Confidence 457899999999999999999999999999999997755555567899999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE---cCCCcEEEEeeccce
Q 046097 158 YELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLAR 233 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl---d~~~~vKL~DFGlA~ 233 (603)
|||+++++|.+++.... ....+++..++.++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999999999886542 224489999999999999999999999 99999999999999 456789999999986
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 176 ~~ 177 (285)
T 3is5_A 176 LF 177 (285)
T ss_dssp C-
T ss_pred ec
Confidence 54
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=338.34 Aligned_cols=154 Identities=28% Similarity=0.474 Sum_probs=127.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC----hhhHHHHHHHHHHhccC---CCCceeEEEeEEecC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS----LQGEREFHNELSLASSL---DCPHIVSLLGFASDR 149 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~----~~~~~~~~~Ev~iL~~l---~HpNIV~l~g~~~~~ 149 (603)
..++|++.+.||+|+||.||+|++..+++.||||++..... ......+.+|+.+++++ .||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46799999999999999999999999999999999864321 11124566777776666 599999999999875
Q ss_pred CCC---eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEE
Q 046097 150 RGR---RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKI 226 (603)
Q Consensus 150 ~~~---~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL 226 (603)
... ..++||||+. ++|.+++..... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 221 5899999996 599999976543 2389999999999999999999999 9999999999999999999999
Q ss_pred Eeeccceec
Q 046097 227 GDFGLARLK 235 (603)
Q Consensus 227 ~DFGlA~~~ 235 (603)
+|||++...
T Consensus 162 ~Dfg~a~~~ 170 (308)
T 3g33_A 162 ADFGLARIY 170 (308)
T ss_dssp CSCSCTTTS
T ss_pred eeCcccccc
Confidence 999998643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=351.79 Aligned_cols=148 Identities=22% Similarity=0.320 Sum_probs=132.0
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++||||+++++++.+. ...++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeC--CEEEE
Confidence 3568999999999999999999999999999999997633 2235688999999999999999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc--EEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK--AKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~--vKL~DFGlA~~ 234 (603)
||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++.
T Consensus 94 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999999987643 389999999999999999999999 9999999999999987765 99999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=349.32 Aligned_cols=145 Identities=29% Similarity=0.452 Sum_probs=125.0
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCC
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMEN 163 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~ 163 (603)
.+.||+|+||.||+|.+..+++.||+|+++.. .....+.+.+|+.++.+++||||+++++++.+. ...++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEeCCCC
Confidence 46799999999999999999999999999763 334567899999999999999999999999986 889999999999
Q ss_pred CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE--cCCCcEEEEeeccceecc
Q 046097 164 RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL--DGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 164 gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl--d~~~~vKL~DFGlA~~~~ 236 (603)
++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++....
T Consensus 171 ~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 171 GELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp CEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 99999886543 2389999999999999999999999 99999999999999 567899999999997653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=344.51 Aligned_cols=141 Identities=30% Similarity=0.441 Sum_probs=126.2
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
.+.||+|+||.||+|.++.+++.||||++.. .....+.+|+.++..+. ||||+++++++.+. ...++||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEEccC
Confidence 3789999999999999999999999999964 34567789999999997 99999999999986 88999999999
Q ss_pred CCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC---cEEEEeeccceecc
Q 046097 163 NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF---KAKIGDFGLARLKT 236 (603)
Q Consensus 163 ~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~---~vKL~DFGlA~~~~ 236 (603)
+|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++....
T Consensus 90 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 90 GGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp SCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999997653 389999999999999999999999 999999999999997665 89999999997643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=336.37 Aligned_cols=155 Identities=25% Similarity=0.374 Sum_probs=132.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC---ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG---SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~---~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
..++|.+.+.||+|+||.||+|.+..+++.||+|+++... .......+.+|+.++.+++||||+++++++.......
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999999999999999996531 1234567999999999999999999999996554578
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||++++ |.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 99999999876 777776543 23489999999999999999999999 99999999999999999999999999987
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 158 ~~~ 160 (305)
T 2wtk_C 158 ALH 160 (305)
T ss_dssp ECC
T ss_pred ccC
Confidence 653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=345.55 Aligned_cols=152 Identities=30% Similarity=0.451 Sum_probs=136.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|.+.+.||+|+||.||++.+..+++.||+|++.... .....+.+.+|+.++..++|+||+++++++.+. +..
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 116 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DFV 116 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeE
Confidence 4567999999999999999999999999999999986532 234457789999999999999999999999986 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 99999999999999887643 389999999999999999999999 999999999999999999999999999876
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 191 ~~ 192 (335)
T 2owb_A 191 VE 192 (335)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=359.29 Aligned_cols=148 Identities=26% Similarity=0.436 Sum_probs=131.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|.+ .++.||||+++... ..+.+.+|+.++++++||||+++++++.+. ...+++
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~i 264 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 264 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEE
Confidence 456788899999999999999998 47899999997643 456799999999999999999999998765 247899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 265 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 9999999999999976532 3378999999999999999999999 999999999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=340.50 Aligned_cols=153 Identities=29% Similarity=0.443 Sum_probs=137.4
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
...++|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 85 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFY 85 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCEE
Confidence 3567789999999999999999999989999999999753 34457889999999999999999999999886 7899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++++|.+++..... ..+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999976433 3489999999999999999999999 9999999999999999999999999998754
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 162 ~ 162 (288)
T 3kfa_A 162 T 162 (288)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=336.35 Aligned_cols=150 Identities=26% Similarity=0.398 Sum_probs=134.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.++.+++||||+++++++.+. ...++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeEEEE
Confidence 6789999999999999999999999999999998664332 3346788999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 99999999998876543 389999999999999999999999 99999999999999999999999999997653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=333.38 Aligned_cols=151 Identities=26% Similarity=0.401 Sum_probs=135.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 83 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN--TDIYL 83 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CeEEE
Confidence 4567999999999999999999999999999999987632 23456789999999999999999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE---cCCCcEEEEeeccce
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLAR 233 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl---d~~~~vKL~DFGlA~ 233 (603)
||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999999887643 389999999999999999999999 99999999999999 788999999999987
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 158 ~~~ 160 (277)
T 3f3z_A 158 RFK 160 (277)
T ss_dssp ECC
T ss_pred ecc
Confidence 643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.40 Aligned_cols=147 Identities=33% Similarity=0.469 Sum_probs=122.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh---hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL---QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~---~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.++|++.+.||+|+||.||+|.+ +++.||||+++..... ...+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--PNL 81 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----C
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cce
Confidence 46788999999999999999998 4889999998654222 2346789999999999999999999999886 778
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeccCCCCCeEEcC--------CCc
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP---VIHGDIKPSNILLDG--------DFK 223 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g---IVHrDLKp~NILld~--------~~~ 223 (603)
++||||+++++|.+++... .+++..++.++.|++.||.|||++ + |+||||||+|||++. ++.
T Consensus 82 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp EEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred EEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcc
Confidence 9999999999999998543 389999999999999999999999 7 999999999999986 678
Q ss_pred EEEEeeccceec
Q 046097 224 AKIGDFGLARLK 235 (603)
Q Consensus 224 vKL~DFGlA~~~ 235 (603)
+||+|||++...
T Consensus 155 ~kl~Dfg~~~~~ 166 (271)
T 3dtc_A 155 LKITDFGLAREW 166 (271)
T ss_dssp EEECCCCC----
T ss_pred eEEccCCccccc
Confidence 999999998643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=342.14 Aligned_cols=149 Identities=28% Similarity=0.301 Sum_probs=128.8
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.++||+|+||+||+|.+..+++.||||++.... .......+..|+..+.++ +|+||++++++|.+. +.+++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEEE
Confidence 57999999999999999999999899999999986543 223344555666666555 899999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 679999887653 3489999999999999999999999 9999999999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=362.78 Aligned_cols=150 Identities=27% Similarity=0.446 Sum_probs=134.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~ 92 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDIF 92 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 4678999999999999999999999999999999965311 12346789999999999999999999999987 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 93 lv~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999986543 389999999999999999999999 9999999999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=349.70 Aligned_cols=155 Identities=25% Similarity=0.348 Sum_probs=128.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCC-----CceEEEEEecCCCChhh----------HHHHHHHHHHhccCCCCceeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSS-----SQPLAVKILDSSGSLQG----------EREFHNELSLASSLDCPHIVS 141 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAVK~l~~~~~~~~----------~~~~~~Ev~iL~~l~HpNIV~ 141 (603)
..++|++.+.||+|+||.||+|.+..+ ++.||||++........ ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456899999999999999999998764 58899999876431110 022445666788889999999
Q ss_pred EEeEEecCCC--CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc
Q 046097 142 LLGFASDRRG--RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD 219 (603)
Q Consensus 142 l~g~~~~~~~--~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld 219 (603)
+++++..... ...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 9999876422 4689999999 999999997642 3489999999999999999999999 999999999999999
Q ss_pred --CCCcEEEEeeccceeccc
Q 046097 220 --GDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 220 --~~~~vKL~DFGlA~~~~~ 237 (603)
.++.+||+|||+++....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~ 206 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCP 206 (364)
T ss_dssp SSCTTCEEECCCTTCEESSG
T ss_pred cCCCCeEEEEECCcceeccc
Confidence 889999999999987643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.27 Aligned_cols=149 Identities=26% Similarity=0.433 Sum_probs=130.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 96 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFI 96 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecC--CCeEE
Confidence 4567889999999999999999885 67789999997632 2346789999999999999999999999876 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 97 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp EECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccc
Confidence 999999999999997643 2389999999999999999999999 9999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=333.37 Aligned_cols=152 Identities=27% Similarity=0.382 Sum_probs=137.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.++..++||||+++++++.+. ...++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEEEE
Confidence 3467899999999999999999999899999999997654445567899999999999999999999999886 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999999988643 2389999999999999999999999 99999999999999999999999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=347.68 Aligned_cols=151 Identities=30% Similarity=0.458 Sum_probs=134.4
Q ss_pred cCC-CCCceeeccCceEEEEEEE----cCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASF-SPSNRLGHGGFGSVYKAVV----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y-~i~~~LG~G~fG~Vy~a~~----~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
++| ++.+.||+|+||.||++.+ ..+++.||||+++..........+.+|+.++++++||||+++++++.+.....
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 8899999999999988865 34788999999987655566778999999999999999999999999865578
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+++||||+++++|.+++.... +++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence 999999999999999996543 89999999999999999999999 99999999999999999999999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 183 ~~~ 185 (318)
T 3lxp_A 183 AVP 185 (318)
T ss_dssp ECC
T ss_pred ccc
Confidence 654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=380.10 Aligned_cols=151 Identities=24% Similarity=0.278 Sum_probs=133.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~ 153 (603)
..++|++++.||+|+||.||+|+++.+++.||||+++... .......+..|..++..+ +||||+.+++++.+. ..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--SE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--CE
Confidence 4578999999999999999999999999999999996531 112345678899999988 699999999999886 88
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+|+||||+++|+|..++.... .+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999997653 389999999999999999999999 99999999999999999999999999997
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 491 ~~ 492 (674)
T 3pfq_A 491 EN 492 (674)
T ss_dssp EC
T ss_pred cc
Confidence 53
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.91 Aligned_cols=151 Identities=28% Similarity=0.464 Sum_probs=132.6
Q ss_pred hcCCCCCc-eeeccCceEEEEEEEc--CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSN-RLGHGGFGSVYKAVVP--SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~-~LG~G~fG~Vy~a~~~--~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.++|.+.+ .||+|+||.||+|.+. .++..||||+++........+.+.+|+.++.+++||||+++++++.. ...
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CCc
Confidence 34566666 8999999999999864 46788999999876555667889999999999999999999999954 568
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 99999999999999996532 3489999999999999999999999 999999999999999999999999999976
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 160 ~~ 161 (287)
T 1u59_A 160 LG 161 (287)
T ss_dssp CT
T ss_pred ec
Confidence 54
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.81 Aligned_cols=151 Identities=25% Similarity=0.320 Sum_probs=132.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEc---CCCceEEEEEecCCC---ChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVP---SSSQPLAVKILDSSG---SLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR 150 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~l~~~~---~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~ 150 (603)
.++|++.+.||+|+||.||+|+.. .+++.||||+++... .......+.+|+.++.++ +||||+++++++.+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 367999999999999999999984 478999999986532 112234567899999999 699999999999886
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
...++||||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 132 -~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 132 -TKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred -ceEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence 78999999999999999997643 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecc
Q 046097 231 LARLKT 236 (603)
Q Consensus 231 lA~~~~ 236 (603)
+++...
T Consensus 205 ~a~~~~ 210 (355)
T 1vzo_A 205 LSKEFV 210 (355)
T ss_dssp EEEECC
T ss_pred CCeecc
Confidence 997643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=333.13 Aligned_cols=150 Identities=25% Similarity=0.415 Sum_probs=134.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-----hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-----QGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-----~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
.++|++.+.||+|+||.||+|.+..+++.||+|+++..... ...+.+.+|+.++.+++||||+++++++.+. .
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 81 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--T 81 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--C
Confidence 35688999999999999999999989999999998764321 1357899999999999999999999999986 8
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC----cEEEEe
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF----KAKIGD 228 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~----~vKL~D 228 (603)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||++ +++|+||||+||+++.++ .+||+|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred eEEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEe
Confidence 8999999999999999997543 389999999999999999999999 999999999999998877 899999
Q ss_pred eccceec
Q 046097 229 FGLARLK 235 (603)
Q Consensus 229 FGlA~~~ 235 (603)
||++...
T Consensus 156 fg~~~~~ 162 (283)
T 3bhy_A 156 FGIAHKI 162 (283)
T ss_dssp CTTCEEC
T ss_pred cccceec
Confidence 9998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=345.15 Aligned_cols=155 Identities=28% Similarity=0.447 Sum_probs=135.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEc-------CCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEec
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVP-------SSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASD 148 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~-------~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~ 148 (603)
..++|.+.+.||+|+||.||+|.+. .++..||||+++..........+.+|+.++.++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999975 356789999998765556667899999999999 89999999999988
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSN 215 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~N 215 (603)
. +..++||||+++++|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 113 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 113 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp S--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred C--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 6 788999999999999999976532 12378999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEEeeccceecc
Q 046097 216 ILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 216 ILld~~~~vKL~DFGlA~~~~ 236 (603)
||++.++.+||+|||++....
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~ 208 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDIN 208 (334)
T ss_dssp EEECTTCCEEECCCTTCEECT
T ss_pred EEEcCCCCEEEcccccccccc
Confidence 999999999999999997653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=338.10 Aligned_cols=151 Identities=29% Similarity=0.457 Sum_probs=137.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..+.|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.++.+++||||+++++++.+. ...++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEE
Confidence 3467899999999999999999999999999999997765555678899999999999999999999999986 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++++|.+++... .+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++....
T Consensus 98 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999999998642 389999999999999999999999 99999999999999999999999999987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=335.46 Aligned_cols=150 Identities=29% Similarity=0.447 Sum_probs=133.6
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++.+++||||+++++++.+. ...+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 90 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--KRIY 90 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--CEEE
Confidence 3678999999999999999999998999999999864211 12246788999999999999999999999986 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999997653 389999999999999999999999 9999999999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=344.87 Aligned_cols=151 Identities=26% Similarity=0.359 Sum_probs=136.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.++.+++||||+++++++.+. +..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEEEEE
Confidence 467899999999999999999999999999999998765556667899999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++...
T Consensus 110 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 99999999999997643 3899999999999999999999831 8999999999999999999999999998543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=347.35 Aligned_cols=151 Identities=28% Similarity=0.487 Sum_probs=129.8
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCC----ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSS----QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg----~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.+|.+.+.||+|+||.||+|.+..++ ..||||+++..........+.+|+.++.+++||||+++++++.+. ...
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--CCc
Confidence 45667799999999999999986543 359999998765555667899999999999999999999999876 789
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999997643 3489999999999999999999999 999999999999999999999999999876
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 197 ~~ 198 (333)
T 1mqb_A 197 LE 198 (333)
T ss_dssp --
T ss_pred hc
Confidence 53
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=348.07 Aligned_cols=152 Identities=24% Similarity=0.341 Sum_probs=134.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-------hHHHHHHHHHHhccCCCCceeEEEeEEecC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-------GEREFHNELSLASSLDCPHIVSLLGFASDR 149 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-------~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~ 149 (603)
..++|++.+.||+|+||.||+|++..+++.||||++....... ....+.+|+.++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 5678999999999999999999999999999999997643211 234577899999999999999999999986
Q ss_pred CCCeEEEEEEccCCC-CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEe
Q 046097 150 RGRRLVLIYELMENR-SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228 (603)
Q Consensus 150 ~~~~~~LVmEy~~~g-sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~D 228 (603)
+..++||||+.+| +|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 102 --~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 102 --GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp --SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred --CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEee
Confidence 8899999999776 9999987653 389999999999999999999999 999999999999999999999999
Q ss_pred eccceecc
Q 046097 229 FGLARLKT 236 (603)
Q Consensus 229 FGlA~~~~ 236 (603)
||++....
T Consensus 174 fg~a~~~~ 181 (335)
T 3dls_A 174 FGSAAYLE 181 (335)
T ss_dssp CTTCEECC
T ss_pred cccceECC
Confidence 99987643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.93 Aligned_cols=156 Identities=21% Similarity=0.299 Sum_probs=135.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC--CCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR--RGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~--~~~~~ 154 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.. ......+.+.+|+.+++.++||||+++++++... .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 45789999999999999999999999999999999865 3445567899999999999999999999998732 22578
Q ss_pred EEEEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 155 VLIYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 99999999999999987632 224589999999999999999999999 99999999999999999999999999987
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 183 ~~~ 185 (317)
T 2buj_A 183 QAC 185 (317)
T ss_dssp ESC
T ss_pred hcc
Confidence 654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.66 Aligned_cols=146 Identities=24% Similarity=0.470 Sum_probs=131.7
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~L 156 (603)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ....+.+|+.++.++. ||||+++++++.+......++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 46799999999999999999999999999999999652 3467889999999997 999999999999865578999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC-cEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-KAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-~vKL~DFGlA~~~ 235 (603)
||||+.+++|.+++.. +++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++...
T Consensus 111 v~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 9999999999988742 78899999999999999999999 999999999999999776 8999999999764
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 182 ~ 182 (330)
T 3nsz_A 182 H 182 (330)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=336.26 Aligned_cols=154 Identities=24% Similarity=0.411 Sum_probs=132.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCC---CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSS---SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
...+|++.+.||+|+||.||+|.+..+ ...||+|.+.........+.+.+|+.++++++||||+++++++.+. .+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 101 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGS 101 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CCc
Confidence 345688889999999999999997543 3468999998765666678899999999999999999999997654 367
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred eEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence 899999999999999997543 3478999999999999999999999 99999999999999999999999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 177 ~~~ 179 (298)
T 3f66_A 177 DMY 179 (298)
T ss_dssp CCS
T ss_pred ccc
Confidence 654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=337.57 Aligned_cols=151 Identities=30% Similarity=0.443 Sum_probs=132.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcC---CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPS---SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~---tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++.........+.+.+|+.++++++||||+++++++.+ ..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CC
Confidence 35678999999999999999999753 3446999999876555667889999999999999999999999876 45
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence 689999999999999997643 3388999999999999999999999 99999999999999999999999999987
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 162 ~~ 163 (281)
T 3cc6_A 162 YI 163 (281)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.79 Aligned_cols=153 Identities=24% Similarity=0.391 Sum_probs=135.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC---CCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR---RGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~---~~~~ 153 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.++++++||||+++++++... ....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999999899999999997655555567788999999999999999999988653 1367
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+. ++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 5899988653 389999999999999999999999 99999999999999999999999999998
Q ss_pred eccc
Q 046097 234 LKTE 237 (603)
Q Consensus 234 ~~~~ 237 (603)
....
T Consensus 161 ~~~~ 164 (353)
T 2b9h_A 161 IIDE 164 (353)
T ss_dssp ECC-
T ss_pred cccc
Confidence 7643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=344.93 Aligned_cols=149 Identities=27% Similarity=0.462 Sum_probs=129.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|.+.+.||+|+||.||+|.+..+++.||||++...........+.+|+.++++++||||+++++++.+. ...++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEEEEe
Confidence 57889999999999999999999999999999997643322223456799999999999999999999986 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||++ ++|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 80 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp ECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred cccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 9997 58988887643 3489999999999999999999999 9999999999999999999999999998753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=333.26 Aligned_cols=151 Identities=25% Similarity=0.350 Sum_probs=132.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++.+++||||+++++++.+. +..
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID--GQL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--CeE
Confidence 4578999999999999999999999899999999997542 222347789999999999999999999999886 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999997643 389999999999999999999999 999999999999999999999999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 184 ~ 184 (309)
T 2h34_A 184 T 184 (309)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=356.71 Aligned_cols=150 Identities=27% Similarity=0.381 Sum_probs=128.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----C
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR----G 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~----~ 151 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.... .
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999999999999999997532 3344577899999999999999999999997542 2
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
..+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 578999999976 56666642 278999999999999999999999 999999999999999999999999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
++..
T Consensus 211 a~~~ 214 (464)
T 3ttj_A 211 ARTA 214 (464)
T ss_dssp C---
T ss_pred eeec
Confidence 8754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=364.27 Aligned_cols=154 Identities=26% Similarity=0.355 Sum_probs=135.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|.+.+.||+|+||.||+|+++.+++.||||++..... ......+.+|+.++.+++||||+++++++.+. ..+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~ 261 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDLC 261 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--CEEE
Confidence 3678888999999999999999999999999999965321 12346788999999999999999999999986 8899
Q ss_pred EEEEccCCCCHHHHHhhccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 156 LIYELMENRSLQDALLDRKC-EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~-~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+||||+++|+|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 99999999999999876432 23489999999999999999999999 999999999999999999999999999976
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 339 ~~ 340 (543)
T 3c4z_A 339 LK 340 (543)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.12 Aligned_cols=150 Identities=26% Similarity=0.455 Sum_probs=123.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHH--HHHhccCCCCceeEEEeEEec---CCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNE--LSLASSLDCPHIVSLLGFASD---RRGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~E--v~iL~~l~HpNIV~l~g~~~~---~~~~ 152 (603)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..| +..+..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 46789999999999999999987 6899999999652 23334444 444556899999999986543 2234
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeccCCCCCeEEcCCCcEEE
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC------EPPVIHGDIKPSNILLDGDFKAKI 226 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~------~~gIVHrDLKp~NILld~~~~vKL 226 (603)
..++||||+++|+|.+++.... .++..++.++.||+.||.|||+.+ .++|+||||||+|||++.++.+||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 6799999999999999996543 588899999999999999999762 238999999999999999999999
Q ss_pred Eeeccceeccc
Q 046097 227 GDFGLARLKTE 237 (603)
Q Consensus 227 ~DFGlA~~~~~ 237 (603)
+|||++.....
T Consensus 162 ~DFG~a~~~~~ 172 (336)
T 3g2f_A 162 SDFGLSMRLTG 172 (336)
T ss_dssp CCCTTCEECSS
T ss_pred eeccceeeccc
Confidence 99999987643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.18 Aligned_cols=151 Identities=26% Similarity=0.384 Sum_probs=127.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC----
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG---- 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~---- 151 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4578999999999999999999999999999999996532 33345678999999999999999999999986421
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
..+|+||||+ +++|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 3569999999 78999998753 388999999999999999999999 999999999999999999999999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
++..
T Consensus 175 a~~~ 178 (367)
T 1cm8_A 175 ARQA 178 (367)
T ss_dssp CEEC
T ss_pred cccc
Confidence 8753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=336.14 Aligned_cols=149 Identities=23% Similarity=0.416 Sum_probs=131.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|.+.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++.+++||||+++++++.+. ...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYEST--THYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccC--CEEEE
Confidence 3467899999999999999999999899999999997632 23345788999999999999999999999886 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE---cCCCcEEEEeeccce
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLAR 233 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl---d~~~~vKL~DFGlA~ 233 (603)
||||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+|+||||+||++ +.++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 84 VMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999999986643 389999999999999999999999 99999999999999 788899999999986
Q ss_pred e
Q 046097 234 L 234 (603)
Q Consensus 234 ~ 234 (603)
.
T Consensus 158 ~ 158 (304)
T 2jam_A 158 M 158 (304)
T ss_dssp C
T ss_pred e
Confidence 4
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.42 Aligned_cols=140 Identities=24% Similarity=0.399 Sum_probs=118.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC--------CCceeEEEeEEecC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD--------CPHIVSLLGFASDR 149 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~--------HpNIV~l~g~~~~~ 149 (603)
.++|++.+.||+|+||.||+|++..+++.||||+++. .......+.+|+.++..++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec--CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 5789999999999999999999999999999999975 2344567889999999885 78899999998732
Q ss_pred --CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc
Q 046097 150 --RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 150 --~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~ 223 (603)
.+...++||||+ +++|.+.+..... ..+++..++.++.||+.||.|||+++ +|+||||||+|||++.++.
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccch
Confidence 236899999999 5677776655432 34899999999999999999999853 8999999999999997763
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=333.64 Aligned_cols=151 Identities=25% Similarity=0.390 Sum_probs=131.3
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCc---eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
.|.+.+.||+|+||.||+|.+..+++ .||+|++.........+.+.+|+.++++++||||+++++++.+. ....++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-EGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-CCCcEE
Confidence 45566899999999999999755444 79999998755556668899999999999999999999999875 244589
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 101 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999997633 3478999999999999999999999 99999999999999999999999999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=334.80 Aligned_cols=154 Identities=25% Similarity=0.377 Sum_probs=128.7
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhcc--CCCCceeEEEeEEecCC
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASS--LDCPHIVSLLGFASDRR 150 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~--l~HpNIV~l~g~~~~~~ 150 (603)
......++|++.+.||+|+||.||+|.+ +++.||||++.. .....+..|.+++.. ++||||+++++++.+..
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEec----cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3344567899999999999999999998 489999999864 223344555555555 48999999999988753
Q ss_pred C--CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeccCCCCCeEEcCCCc
Q 046097 151 G--RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC-----EPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 151 ~--~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~-----~~gIVHrDLKp~NILld~~~~ 223 (603)
+ ...++||||+++|+|.+++... .+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 3 5789999999999999999654 3899999999999999999999751 338999999999999999999
Q ss_pred EEEEeeccceecc
Q 046097 224 AKIGDFGLARLKT 236 (603)
Q Consensus 224 vKL~DFGlA~~~~ 236 (603)
+||+|||++....
T Consensus 181 ~kl~Dfg~a~~~~ 193 (337)
T 3mdy_A 181 CCIADLGLAVKFI 193 (337)
T ss_dssp EEECCCTTCEECC
T ss_pred EEEEeCCCceeec
Confidence 9999999997654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.57 Aligned_cols=148 Identities=25% Similarity=0.435 Sum_probs=125.6
Q ss_pred hcCCCCC-ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhc-cCCCCceeEEEeEEec--CCCCe
Q 046097 78 TASFSPS-NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLAS-SLDCPHIVSLLGFASD--RRGRR 153 (603)
Q Consensus 78 t~~y~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~-~l~HpNIV~l~g~~~~--~~~~~ 153 (603)
.++|.+. +.||+|+||+||+|.++.+++.||||++... ..+.+|+.++. ..+||||+++++++.. .....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 4566666 6899999999999999999999999999642 35667888774 4579999999999875 12367
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC---CCcEEEEeec
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG---DFKAKIGDFG 230 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~---~~~vKL~DFG 230 (603)
+|+||||+++|+|.+++..... ..+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 8999999999999999976432 3489999999999999999999999 9999999999999997 7899999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
+++..
T Consensus 210 ~a~~~ 214 (400)
T 1nxk_A 210 FAKET 214 (400)
T ss_dssp TCEEC
T ss_pred ccccc
Confidence 98754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.77 Aligned_cols=152 Identities=29% Similarity=0.456 Sum_probs=126.1
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh----hHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ----GEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~----~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
...++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.++.+++||||+++++++.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-- 84 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--
Confidence 45678999999999999999999999899999999997532211 124678999999999999999999999876
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
...++||||+++ +|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred CceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 788999999976 8888886543 3478889999999999999999999 999999999999999999999999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
+...
T Consensus 159 a~~~ 162 (346)
T 1ua2_A 159 AKSF 162 (346)
T ss_dssp GSTT
T ss_pred ceec
Confidence 8654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=367.85 Aligned_cols=153 Identities=29% Similarity=0.373 Sum_probs=135.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|++.+.||+|+||.||+|+++.+++.||||++.... .......+.+|+.+|..++||||+++++++.+. ..+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--CEE
Confidence 3466889999999999999999999999999999996521 112345688999999999999999999999986 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999999876432 3389999999999999999999999 999999999999999999999999999976
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 336 ~ 336 (576)
T 2acx_A 336 V 336 (576)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.91 Aligned_cols=152 Identities=22% Similarity=0.363 Sum_probs=126.9
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
...++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..++|++++..+.++... +...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceE
Confidence 45688999999999999999999999999999999875532 223578899999999988888777776543 37889
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE---cCCCcEEEEeeccc
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLA 232 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl---d~~~~vKL~DFGlA 232 (603)
+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 999999 999999987533 2389999999999999999999999 99999999999999 78899999999999
Q ss_pred eeccc
Q 046097 233 RLKTE 237 (603)
Q Consensus 233 ~~~~~ 237 (603)
.....
T Consensus 156 ~~~~~ 160 (296)
T 4hgt_A 156 KKYRD 160 (296)
T ss_dssp EECBC
T ss_pred eeccC
Confidence 87543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=343.27 Aligned_cols=151 Identities=31% Similarity=0.519 Sum_probs=131.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceE--EEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPL--AVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~V--AVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~ 155 (603)
++|++.+.||+|+||.||+|++..++..+ |+|.++..........+.+|+.++.++ +||||+++++++.+. +..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--CceE
Confidence 57899999999999999999998888765 999987644445566789999999999 899999999999886 8899
Q ss_pred EEEEccCCCCHHHHHhhcc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC
Q 046097 156 LIYELMENRSLQDALLDRK-------------CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF 222 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~-------------~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~ 222 (603)
+||||+++++|.+++.... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence 9999999999999997643 123489999999999999999999999 999999999999999999
Q ss_pred cEEEEeecccee
Q 046097 223 KAKIGDFGLARL 234 (603)
Q Consensus 223 ~vKL~DFGlA~~ 234 (603)
.+||+|||++..
T Consensus 180 ~~kL~Dfg~~~~ 191 (327)
T 1fvr_A 180 VAKIADFGLSRG 191 (327)
T ss_dssp CEEECCTTCEES
T ss_pred eEEEcccCcCcc
Confidence 999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=356.37 Aligned_cols=154 Identities=21% Similarity=0.358 Sum_probs=125.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC---CC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR---GR 152 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---~~ 152 (603)
..++|++.+.||+|+||.||+|.++.+++.||||++.... .....+.+.+|+.+|.+++||||+++++++.... ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3478999999999999999999999999999999986532 3344577999999999999999999999986431 25
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 799999998 568999886543 389999999999999999999999 9999999999999999999999999999
Q ss_pred eeccc
Q 046097 233 RLKTE 237 (603)
Q Consensus 233 ~~~~~ 237 (603)
+....
T Consensus 204 ~~~~~ 208 (458)
T 3rp9_A 204 RTVDY 208 (458)
T ss_dssp BCTTS
T ss_pred hhccC
Confidence 87643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=361.06 Aligned_cols=152 Identities=26% Similarity=0.448 Sum_probs=131.3
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
+...++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.++++++||||+++++++.+ ...
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~ 253 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 253 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---Cce
Confidence 3455778889999999999999999964 5679999997643 235679999999999999999999999876 567
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 999999999999999975332 3488999999999999999999999 999999999999999999999999999876
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 330 ~~ 331 (452)
T 1fmk_A 330 IE 331 (452)
T ss_dssp --
T ss_pred cC
Confidence 43
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=344.92 Aligned_cols=153 Identities=21% Similarity=0.300 Sum_probs=125.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcC---CCceEEEEEecCCCChhh----------HHHHHHHHHHhccCCCCceeEEEe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPS---SSQPLAVKILDSSGSLQG----------EREFHNELSLASSLDCPHIVSLLG 144 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~---tg~~VAVK~l~~~~~~~~----------~~~~~~Ev~iL~~l~HpNIV~l~g 144 (603)
.++|.+.+.||+|+||.||+|.+.. ++..+|||++........ ...+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4679999999999999999999976 788999999876432211 133667888999999999999999
Q ss_pred EEecC--CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC
Q 046097 145 FASDR--RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF 222 (603)
Q Consensus 145 ~~~~~--~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~ 222 (603)
++.+. .....++||||+ +++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 98872 237899999999 999999987644 489999999999999999999999 999999999999999887
Q ss_pred --cEEEEeeccceeccc
Q 046097 223 --KAKIGDFGLARLKTE 237 (603)
Q Consensus 223 --~vKL~DFGlA~~~~~ 237 (603)
.+||+|||+++....
T Consensus 189 ~~~~kL~Dfg~a~~~~~ 205 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCP 205 (345)
T ss_dssp TTSEEECCCTTCEESSG
T ss_pred CCcEEEEeCCCceeccc
Confidence 999999999987643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.36 Aligned_cols=152 Identities=27% Similarity=0.409 Sum_probs=129.1
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
....++|++.+.||+|+||.||+|.+..+++.||||+++..... .....+.+|+.++++++||||+++++++.+. ..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 107 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--HR 107 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET--TE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC--CE
Confidence 34567899999999999999999999999999999999764322 2245678999999999999999999999986 88
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc-----CCCcEEEEe
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD-----GDFKAKIGD 228 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld-----~~~~vKL~D 228 (603)
.++||||++ ++|.+++..... +++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEEEecCC-CCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECc
Confidence 999999997 499999876543 89999999999999999999999 999999999999994 555699999
Q ss_pred eccceec
Q 046097 229 FGLARLK 235 (603)
Q Consensus 229 FGlA~~~ 235 (603)
||++...
T Consensus 181 fg~a~~~ 187 (329)
T 3gbz_A 181 FGLARAF 187 (329)
T ss_dssp TTHHHHH
T ss_pred CCCcccc
Confidence 9998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=337.07 Aligned_cols=150 Identities=31% Similarity=0.484 Sum_probs=131.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|+.++.+++||||+++++++.+ +..++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEE
Confidence 4567899999999999999999985 57789999997632 345678999999999999999999999875 45899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++++|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 9999999999999865431 2489999999999999999999999 99999999999999999999999999997654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=338.45 Aligned_cols=150 Identities=24% Similarity=0.374 Sum_probs=131.3
Q ss_pred hcCCCCC-ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPS-NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.+.|.+. +.||+|+||.||+|.+..+++.||||++... .......+.+|+.++.++ +||||+++++++.+. +..+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEE
Confidence 4678774 7899999999999999999999999999764 234456789999999985 699999999999986 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc---EEEEeeccc
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK---AKIGDFGLA 232 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~---vKL~DFGlA 232 (603)
+||||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 88 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999997653 389999999999999999999999 9999999999999988765 999999998
Q ss_pred eecc
Q 046097 233 RLKT 236 (603)
Q Consensus 233 ~~~~ 236 (603)
....
T Consensus 162 ~~~~ 165 (316)
T 2ac3_A 162 SGIK 165 (316)
T ss_dssp C---
T ss_pred cccc
Confidence 7543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.89 Aligned_cols=151 Identities=25% Similarity=0.401 Sum_probs=130.0
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-------hhhHHHHHHHHHHhccCCCCceeEEEeEEec
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-------LQGEREFHNELSLASSLDCPHIVSLLGFASD 148 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-------~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~ 148 (603)
...++|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456889999999999999999999999999999999865321 1112347899999999999999999999865
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC---CcEE
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD---FKAK 225 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~---~~vK 225 (603)
...++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+|
T Consensus 212 ---~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 212 ---EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp ---SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred ---CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence 56899999999999998886543 389999999999999999999999 99999999999999754 4599
Q ss_pred EEeeccceec
Q 046097 226 IGDFGLARLK 235 (603)
Q Consensus 226 L~DFGlA~~~ 235 (603)
|+|||+++..
T Consensus 283 l~DFG~a~~~ 292 (419)
T 3i6u_A 283 ITDFGHSKIL 292 (419)
T ss_dssp ECCSSTTTSC
T ss_pred Eeecccceec
Confidence 9999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=331.66 Aligned_cols=151 Identities=28% Similarity=0.429 Sum_probs=134.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.+. ...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 86 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDF 86 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeE
Confidence 3467999999999999999999998899999999986521 112346788999999999999999999999886 889
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccc
Confidence 99999999999999997643 389999999999999999999999 999999999999999999999999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 161 ~ 161 (276)
T 2h6d_A 161 M 161 (276)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=328.44 Aligned_cols=151 Identities=22% Similarity=0.358 Sum_probs=130.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..+.|++++..+.++... +...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCC-CCceEE
Confidence 45789999999999999999999999999999999865332 24588999999999988877777666543 378899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE---cCCCcEEEEeeccce
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLAR 233 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl---d~~~~vKL~DFGlA~ 233 (603)
||||+ +++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++.
T Consensus 83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 99999 899999997433 3489999999999999999999999 99999999999999 488899999999998
Q ss_pred eccc
Q 046097 234 LKTE 237 (603)
Q Consensus 234 ~~~~ 237 (603)
....
T Consensus 157 ~~~~ 160 (296)
T 3uzp_A 157 KYRD 160 (296)
T ss_dssp ECBC
T ss_pred cccc
Confidence 6543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=329.09 Aligned_cols=150 Identities=26% Similarity=0.324 Sum_probs=131.4
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYE 159 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmE 159 (603)
+|.....||+|+||.||+|.+..+++.||||.+... .....+.+.+|+.++..++||||+++++++.+. +..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEE
Confidence 345556899999999999999999999999999764 334457789999999999999999999999886 78999999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-CCcEEEEeeccceec
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-DFKAKIGDFGLARLK 235 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~-~~~vKL~DFGlA~~~ 235 (603)
|+++++|.+++........+++..+..++.|++.||.|||++ +|+|+||||+||+++. ++.+||+|||++...
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 999999999998754434467899999999999999999999 9999999999999987 899999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=327.40 Aligned_cols=151 Identities=28% Similarity=0.435 Sum_probs=132.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC-------
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR------- 149 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~------- 149 (603)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4567999999999999999999998899999999997532 3567899999999999999999988641
Q ss_pred -------CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC
Q 046097 150 -------RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF 222 (603)
Q Consensus 150 -------~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~ 222 (603)
.....++||||+++++|.+++..... ..+++..++.++.||+.||.|||++ +|+|+||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 12568999999999999999976432 3489999999999999999999999 999999999999999999
Q ss_pred cEEEEeeccceecc
Q 046097 223 KAKIGDFGLARLKT 236 (603)
Q Consensus 223 ~vKL~DFGlA~~~~ 236 (603)
.+||+|||++....
T Consensus 160 ~~kl~Dfg~~~~~~ 173 (284)
T 2a19_B 160 QVKIGDFGLVTSLK 173 (284)
T ss_dssp EEEECCCTTCEESS
T ss_pred CEEECcchhheecc
Confidence 99999999987643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=331.48 Aligned_cols=154 Identities=24% Similarity=0.433 Sum_probs=130.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++.+++||||+++++++.+. +..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CcE
Confidence 3467999999999999999999998899999999997532 334557789999999999999999999999986 789
Q ss_pred EEEEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 155 VLIYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
++||||+++++|.+++.... ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 99999999999999987532 234489999999999999999999999 99999999999999999999999999986
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 185 ~~ 186 (310)
T 2wqm_A 185 FF 186 (310)
T ss_dssp --
T ss_pred ee
Confidence 54
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=338.75 Aligned_cols=156 Identities=25% Similarity=0.340 Sum_probs=135.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEec------C
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASD------R 149 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~------~ 149 (603)
...+|++.+.||+|+||.||+|++..+++.||||++... .......+.+|+.++.++. ||||+++++++.. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 456799999999999999999999999999999998653 3455677899999999996 9999999999852 2
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCeEEcCCCcEEEE
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP--VIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g--IVHrDLKp~NILld~~~~vKL~ 227 (603)
.....++||||+. |+|.+++........+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 2356899999996 69999887644445689999999999999999999998 8 9999999999999999999999
Q ss_pred eeccceeccc
Q 046097 228 DFGLARLKTE 237 (603)
Q Consensus 228 DFGlA~~~~~ 237 (603)
|||++.....
T Consensus 181 Dfg~~~~~~~ 190 (337)
T 3ll6_A 181 DFGSATTISH 190 (337)
T ss_dssp CCTTCBCCSS
T ss_pred cCccceeccc
Confidence 9999976543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=341.29 Aligned_cols=154 Identities=32% Similarity=0.425 Sum_probs=131.1
Q ss_pred hhcCCCCCceeeccCceEEEEEE-----EcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAV-----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~-----~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
..++|++.+.||+|+||.||+|. ...+++.||||++...........+.+|+.++.+++||||+++++++.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC--
Confidence 45789999999999999999999 44578899999997655666677899999999999999999999999986
Q ss_pred CeEEEEEEccCCCCHHHHHhhccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC---CCcE
Q 046097 152 RRLVLIYELMENRSLQDALLDRKC----EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG---DFKA 224 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~----~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~---~~~v 224 (603)
...++||||+++++|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 678999999999999999986532 13488999999999999999999999 9999999999999984 4469
Q ss_pred EEEeeccceec
Q 046097 225 KIGDFGLARLK 235 (603)
Q Consensus 225 KL~DFGlA~~~ 235 (603)
||+|||++...
T Consensus 183 kl~Dfg~~~~~ 193 (327)
T 2yfx_A 183 KIGDFGMARDI 193 (327)
T ss_dssp EECCCHHHHHH
T ss_pred EECcccccccc
Confidence 99999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=330.77 Aligned_cols=148 Identities=26% Similarity=0.471 Sum_probs=132.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.++.+++||||+++++++.+. +..++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCeEEE
Confidence 357888999999999999999986 67889999997643 2346789999999999999999999999886 778999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 82 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154 (267)
T ss_dssp ECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred EeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccc
Confidence 99999999999997643 3488999999999999999999999 9999999999999999999999999998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=336.29 Aligned_cols=155 Identities=25% Similarity=0.342 Sum_probs=119.7
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
...++|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.++.+++||||+++++++... +..+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK--DELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS--SCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec--CCcE
Confidence 34678999999999999999999998889999999987654444557788999999999999999999999986 7899
Q ss_pred EEEEccCCCCHHHHHhhcc-----cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 156 LIYELMENRSLQDALLDRK-----CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~-----~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
+||||+++++|.+++.... ....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 9999999999999987521 123489999999999999999999999 99999999999999999999999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
++...
T Consensus 167 ~~~~~ 171 (303)
T 2vwi_A 167 VSAFL 171 (303)
T ss_dssp HHHHC
T ss_pred chhee
Confidence 98654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=341.64 Aligned_cols=150 Identities=29% Similarity=0.393 Sum_probs=131.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.+.|++.+.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEE
Confidence 3558889999999999999999989999999999975432 22346789999999999999999999999986 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+. |+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 131 lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 9999997 68888875433 3489999999999999999999999 9999999999999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.52 Aligned_cols=153 Identities=15% Similarity=0.205 Sum_probs=125.1
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCC--CChhhHHHHHHHH---HHhccCCCCceeEEE-------eE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNEL---SLASSLDCPHIVSLL-------GF 145 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~--~~~~~~~~~~~Ev---~iL~~l~HpNIV~l~-------g~ 145 (603)
.++|.+.+.||+|+||.||+|++..+++.||||++... ......+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999999889999999998743 2334457889999 556666899999998 66
Q ss_pred EecCCC----------C-----eEEEEEEccCCCCHHHHHhhccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 046097 146 ASDRRG----------R-----RLVLIYELMENRSLQDALLDRKC----EELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206 (603)
Q Consensus 146 ~~~~~~----------~-----~~~LVmEy~~~gsL~~~L~~~~~----~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gI 206 (603)
+.+... . ..|+||||+ +|+|.+++..... ...+++..++.++.||+.||.|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 655411 0 378999999 6799999976432 11234588889999999999999999 99
Q ss_pred EeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 207 IHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 207 VHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+||||||+|||++.++.+||+|||++..
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~ 255 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVR 255 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhhee
Confidence 9999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=349.28 Aligned_cols=151 Identities=24% Similarity=0.410 Sum_probs=125.5
Q ss_pred CCCCCceeeccCceEEEEEEEcCC---CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSS---SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
.|.+.+.||+|+||.||+|.+..+ ...||||.++........+.+.+|+.++++++||||+++++++.+. .+..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCCeEE
Confidence 356678999999999999997533 2468999997655556678899999999999999999999997654 257789
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999997543 2378899999999999999999999 99999999999999999999999999997543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=329.43 Aligned_cols=150 Identities=27% Similarity=0.433 Sum_probs=130.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||+|+||.||+|+++.+++.||||++..... ......+.+|+.++++++||||+++++++.+. +..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLV 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecC--CceEEE
Confidence 578899999999999999999998999999999865422 12236788999999999999999999999986 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+. ++|.+++..... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++...
T Consensus 81 ~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 153 (299)
T 2r3i_A 81 FEFLH-QDLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 153 (299)
T ss_dssp EECCS-EEHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred EEccc-CCHHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcchhhhhc
Confidence 99997 599999876543 2378999999999999999999999 9999999999999999999999999998654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.44 Aligned_cols=151 Identities=25% Similarity=0.404 Sum_probs=132.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||+|+||.||+|++..+++.||||++..... ......+.+|+.++.+++||||+++++++.+. ...+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--KRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--CEEE
Confidence 34678999999999999999999999999999999865433 23346688999999999999999999999986 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 101 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999988888765433 389999999999999999999999 9999999999999999999999999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.35 Aligned_cols=147 Identities=28% Similarity=0.467 Sum_probs=128.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||+|+||.||+|.++.+++.||||++..... ...+|++++.++ +||||+++++++.+. ..+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDG--KYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECS--SEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcC--CEEE
Confidence 45679999999999999999999999999999999976432 234678888877 799999999999986 8999
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC----CcEEEEeecc
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD----FKAKIGDFGL 231 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~----~~vKL~DFGl 231 (603)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||+... +.+||+|||+
T Consensus 93 lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999999997643 389999999999999999999999 99999999999998533 3599999999
Q ss_pred ceecc
Q 046097 232 ARLKT 236 (603)
Q Consensus 232 A~~~~ 236 (603)
+....
T Consensus 167 a~~~~ 171 (342)
T 2qr7_A 167 AKQLR 171 (342)
T ss_dssp CEECB
T ss_pred cccCc
Confidence 87643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.74 Aligned_cols=150 Identities=29% Similarity=0.410 Sum_probs=131.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecC--CCCeEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDR--RGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~--~~~~~~ 155 (603)
..|.+.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.++++++||||+++++++... ....++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677789999999999999999999999999986543 344557799999999999999999999998753 236689
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCeEEc-CCCcEEEEeeccc
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP--VIHGDIKPSNILLD-GDFKAKIGDFGLA 232 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g--IVHrDLKp~NILld-~~~~vKL~DFGlA 232 (603)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++ + |+|+||||+|||++ .++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999997643 389999999999999999999998 7 99999999999997 7899999999998
Q ss_pred ee
Q 046097 233 RL 234 (603)
Q Consensus 233 ~~ 234 (603)
..
T Consensus 180 ~~ 181 (290)
T 1t4h_A 180 TL 181 (290)
T ss_dssp GG
T ss_pred cc
Confidence 54
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.20 Aligned_cols=163 Identities=25% Similarity=0.406 Sum_probs=139.8
Q ss_pred cccHHHHHHhhcCCCCC-ceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCC-CCceeEEEe
Q 046097 68 RFSYNLIRRATASFSPS-NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLD-CPHIVSLLG 144 (603)
Q Consensus 68 ~~~~~~l~~~t~~y~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g 144 (603)
.+.+.......++|.+. +.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++..+. ||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34455566677888887 88999999999999999999999999987642 2234577899999999995 799999999
Q ss_pred EEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC---C
Q 046097 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG---D 221 (603)
Q Consensus 145 ~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~---~ 221 (603)
++.+. ...++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++. +
T Consensus 97 ~~~~~--~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 97 VYENT--SEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp EEECS--SEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTB
T ss_pred EEEeC--CeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCC
Confidence 99986 88999999999999999885532 23489999999999999999999999 9999999999999987 7
Q ss_pred CcEEEEeeccceecc
Q 046097 222 FKAKIGDFGLARLKT 236 (603)
Q Consensus 222 ~~vKL~DFGlA~~~~ 236 (603)
+.+||+|||++....
T Consensus 171 ~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIG 185 (327)
T ss_dssp CCEEECCGGGCEEC-
T ss_pred CcEEEeeCccccccC
Confidence 899999999997643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=339.75 Aligned_cols=153 Identities=23% Similarity=0.377 Sum_probs=132.1
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCC------
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRR------ 150 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~------ 150 (603)
.++|++.+.||+|+||.||+|++..+++.||||++...... .....+.+|+.++..++||||+++++++.+..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46799999999999999999999999999999998654322 23456789999999999999999999998742
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
++..++||||+++ +|.+.+.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 3578999999975 7777776543 2389999999999999999999999 99999999999999999999999999
Q ss_pred cceecc
Q 046097 231 LARLKT 236 (603)
Q Consensus 231 lA~~~~ 236 (603)
++....
T Consensus 170 ~a~~~~ 175 (351)
T 3mi9_A 170 LARAFS 175 (351)
T ss_dssp TCEECC
T ss_pred hccccc
Confidence 997654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=332.69 Aligned_cols=153 Identities=27% Similarity=0.411 Sum_probs=133.0
Q ss_pred HHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhcc--CCCCceeEEEeEEec
Q 046097 71 YNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASS--LDCPHIVSLLGFASD 148 (603)
Q Consensus 71 ~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~--l~HpNIV~l~g~~~~ 148 (603)
........++|.+.+.||+|+||.||+|.+ +++.||||++.. .....+.+|.+++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 334455678899999999999999999998 589999999964 334567788888877 789999999999987
Q ss_pred CCC--CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeccCCCCCeEE
Q 046097 149 RRG--RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH--------HSCEPPVIHGDIKPSNILL 218 (603)
Q Consensus 149 ~~~--~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLH--------s~~~~gIVHrDLKp~NILl 218 (603)
..+ ...++||||+++|+|.+++... .+++..++.++.|++.||.||| +. +|+||||||+|||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV 180 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence 632 2789999999999999999653 3899999999999999999999 77 99999999999999
Q ss_pred cCCCcEEEEeeccceecc
Q 046097 219 DGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 219 d~~~~vKL~DFGlA~~~~ 236 (603)
+.++.+||+|||++....
T Consensus 181 ~~~~~~kL~Dfg~~~~~~ 198 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHD 198 (342)
T ss_dssp CTTSCEEECCCTTCEEEE
T ss_pred CCCCCEEEEECCCceecc
Confidence 999999999999997654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=334.74 Aligned_cols=151 Identities=28% Similarity=0.446 Sum_probs=130.2
Q ss_pred hhcCCCCCc-eeeccCceEEEEEEE--cCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 77 ATASFSPSN-RLGHGGFGSVYKAVV--PSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 77 ~t~~y~i~~-~LG~G~fG~Vy~a~~--~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
..++|.+.+ .||+|+||.||+|.+ ..+++.||||+++.... ....+.+.+|+.++..++||||+++++++.. .
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---E 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---S
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---C
Confidence 345677777 999999999999954 55678999999976432 2335779999999999999999999999954 6
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 7899999999999999997643 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecc
Q 046097 233 RLKT 236 (603)
Q Consensus 233 ~~~~ 236 (603)
....
T Consensus 165 ~~~~ 168 (291)
T 1xbb_A 165 KALR 168 (291)
T ss_dssp EECC
T ss_pred eeec
Confidence 7654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=331.95 Aligned_cols=147 Identities=27% Similarity=0.438 Sum_probs=126.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|.+ +++.||||+++.. ...+.+.+|+.++.+++||||+++++++.+. .+..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEEE
Confidence 46789999999999999999988 4889999999753 2456789999999999999999999997654 2568999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
|||+++++|.+++..... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 94 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp ECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccc
Confidence 999999999999976432 2378899999999999999999999 999999999999999999999999998864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=355.23 Aligned_cols=152 Identities=31% Similarity=0.487 Sum_probs=132.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh------------hhHHHHHHHHHHhccCCCCceeEEEe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL------------QGEREFHNELSLASSLDCPHIVSLLG 144 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~------------~~~~~~~~Ev~iL~~l~HpNIV~l~g 144 (603)
..++|.+.+.||+|+||+||+|.++.+++.||||++...... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 567899999999999999999999999999999999764321 23467899999999999999999999
Q ss_pred EEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC--
Q 046097 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-- 222 (603)
Q Consensus 145 ~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-- 222 (603)
++.+. ...++||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 114 ~~~~~--~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDK--KYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECS--SEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCC
T ss_pred EEEcC--CEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCC
Confidence 99986 88999999999999999887643 389999999999999999999999 999999999999998775
Q ss_pred -cEEEEeeccceecc
Q 046097 223 -KAKIGDFGLARLKT 236 (603)
Q Consensus 223 -~vKL~DFGlA~~~~ 236 (603)
.+||+|||++....
T Consensus 186 ~~~kl~Dfg~a~~~~ 200 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFS 200 (504)
T ss_dssp SSEEECCCTTCEECC
T ss_pred ccEEEEECCCCEEcC
Confidence 69999999997653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.01 Aligned_cols=150 Identities=25% Similarity=0.372 Sum_probs=128.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----C
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR----G 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~----~ 151 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.... .
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3578999999999999999999999999999999997542 3344567889999999999999999999998652 1
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
...++||||+++ +|.+.+.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 378999999975 78887742 278999999999999999999999 999999999999999999999999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
+...
T Consensus 174 a~~~ 177 (371)
T 2xrw_A 174 ARTA 177 (371)
T ss_dssp ----
T ss_pred cccc
Confidence 8653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=343.31 Aligned_cols=149 Identities=22% Similarity=0.349 Sum_probs=129.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCC--CceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDC--PHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~H--pNIV~l~g~~~~~~~~~ 153 (603)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... .......+.+|+.++.+++| +||+++++++.+. ..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~ 83 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QY 83 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--CE
Confidence 346799999999999999999998 468899999997643 33445778999999999986 9999999999986 89
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||| +.+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||++.
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred EEEEEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 999999 55789999997653 389999999999999999999999 999999999999997 6789999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 156 ~~~ 158 (343)
T 3dbq_A 156 QMQ 158 (343)
T ss_dssp CC-
T ss_pred ccC
Confidence 653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=355.74 Aligned_cols=152 Identities=28% Similarity=0.467 Sum_probs=130.0
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||+|+||.||+|+++.++..||||++.... .......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 112 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RNYY 112 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 3457999999999999999999999999999999997643 122346789999999999999999999999986 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC---CCcEEEEeeccc
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG---DFKAKIGDFGLA 232 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~---~~~vKL~DFGlA 232 (603)
+||||+++|+|.+.+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 113 lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999999887653 389999999999999999999999 9999999999999976 455999999998
Q ss_pred eecc
Q 046097 233 RLKT 236 (603)
Q Consensus 233 ~~~~ 236 (603)
....
T Consensus 187 ~~~~ 190 (494)
T 3lij_A 187 AVFE 190 (494)
T ss_dssp EECB
T ss_pred eECC
Confidence 7643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=338.71 Aligned_cols=148 Identities=21% Similarity=0.338 Sum_probs=127.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcC--------CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeE--------
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPS--------SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVS-------- 141 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~--------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~-------- 141 (603)
.++|.+.+.||+|+||.||+|++.. .++.||||++... ..+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 4689999999999999999999987 3889999999753 35788999999999999887
Q ss_pred -------EEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 046097 142 -------LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPS 214 (603)
Q Consensus 142 -------l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~ 214 (603)
+++++... +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 56676652 37899999999 999999998652 23489999999999999999999999 9999999999
Q ss_pred CeEEcCCC--cEEEEeeccceeccc
Q 046097 215 NILLDGDF--KAKIGDFGLARLKTE 237 (603)
Q Consensus 215 NILld~~~--~vKL~DFGlA~~~~~ 237 (603)
|||++.++ .+||+|||++.....
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~ 213 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCP 213 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSG
T ss_pred HEEEcCCCCceEEEecCcceeeccC
Confidence 99999998 899999999976543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.76 Aligned_cols=151 Identities=28% Similarity=0.449 Sum_probs=135.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
..++|++.+.||+|+||.||+|.++.+++.||||++..... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 101 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GYF 101 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEE
Confidence 34679999999999999999999999999999999965432 33467899999999999999999999999986 899
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE---cCCCcEEEEeecc
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGL 231 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl---d~~~~vKL~DFGl 231 (603)
++||||+.+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999999987643 389999999999999999999999 99999999999999 5678999999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
+...
T Consensus 176 a~~~ 179 (484)
T 3nyv_A 176 STHF 179 (484)
T ss_dssp HHHB
T ss_pred eEEc
Confidence 8654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.01 Aligned_cols=159 Identities=25% Similarity=0.420 Sum_probs=129.2
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcC---CCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecC
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPS---SSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDR 149 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~---tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~ 149 (603)
+....++|.+.+.||+|+||.||+|.+.. +++.||||+++... .....+.+.+|+.++.+++||||+++++++.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 34456778888999999999999998764 45689999997643 334457799999999999999999999999875
Q ss_pred CCC---eEEEEEEccCCCCHHHHHhhcc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc
Q 046097 150 RGR---RLVLIYELMENRSLQDALLDRK---CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 150 ~~~---~~~LVmEy~~~gsL~~~L~~~~---~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~ 223 (603)
... ..++||||+++++|.+++.... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence 222 4699999999999999985432 224589999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccceec
Q 046097 224 AKIGDFGLARLK 235 (603)
Q Consensus 224 vKL~DFGlA~~~ 235 (603)
+||+|||++...
T Consensus 186 ~kl~Dfg~~~~~ 197 (313)
T 3brb_A 186 VCVADFGLSKKI 197 (313)
T ss_dssp EEECSCSCC---
T ss_pred EEEeecCcceec
Confidence 999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=356.06 Aligned_cols=151 Identities=29% Similarity=0.472 Sum_probs=133.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++.+. ...+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS--SSFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC--CEEE
Confidence 3467999999999999999999999999999999985421 122356789999999999999999999999986 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc---CCCcEEEEeeccc
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD---GDFKAKIGDFGLA 232 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld---~~~~vKL~DFGlA 232 (603)
+||||+.+++|.+.+.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999999887653 389999999999999999999999 999999999999995 4567999999998
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
...
T Consensus 172 ~~~ 174 (486)
T 3mwu_A 172 TCF 174 (486)
T ss_dssp TTB
T ss_pred eEC
Confidence 654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=338.47 Aligned_cols=161 Identities=27% Similarity=0.420 Sum_probs=138.3
Q ss_pred ccHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEe
Q 046097 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFAS 147 (603)
Q Consensus 69 ~~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~ 147 (603)
+.+..+....++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++.++ +||||+++++++.
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 334445567889999999999999999999999899999999997532 3346788999999998 7999999999998
Q ss_pred cCC----CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc
Q 046097 148 DRR----GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK 223 (603)
Q Consensus 148 ~~~----~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~ 223 (603)
... ....++||||+++++|.+++..... ..+++..++.++.||+.||.|||++ +|+|+||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence 642 3689999999999999999976532 3489999999999999999999999 9999999999999999999
Q ss_pred EEEEeeccceec
Q 046097 224 AKIGDFGLARLK 235 (603)
Q Consensus 224 vKL~DFGlA~~~ 235 (603)
+||+|||++...
T Consensus 168 ~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 168 VKLVDFGVSAQL 179 (326)
T ss_dssp EEECCCTTTC--
T ss_pred EEEeeCcCceec
Confidence 999999998654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=339.33 Aligned_cols=152 Identities=24% Similarity=0.375 Sum_probs=135.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC---CCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRR---GRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---~~~ 153 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.++.+++||||+++++++.... ...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 45689999999999999999999999999999999976555555678999999999999999999999997642 246
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+. ++|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 899999997 5899988653 389999999999999999999999 99999999999999999999999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 177 ~~~ 179 (364)
T 3qyz_A 177 VAD 179 (364)
T ss_dssp ECC
T ss_pred ecC
Confidence 654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=341.33 Aligned_cols=156 Identities=22% Similarity=0.433 Sum_probs=137.3
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-------hhHHHHHHHHHHhccC-CCCceeEEEe
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-------QGEREFHNELSLASSL-DCPHIVSLLG 144 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-------~~~~~~~~Ev~iL~~l-~HpNIV~l~g 144 (603)
......++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3445667899999999999999999999889999999998764311 1135688999999999 7999999999
Q ss_pred EEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcE
Q 046097 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKA 224 (603)
Q Consensus 145 ~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~v 224 (603)
++... ...++||||+++++|.+++.... .+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+
T Consensus 168 ~~~~~--~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 168 SYESS--SFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEBS--SEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEeeC--CEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 99886 88999999999999999997543 389999999999999999999999 99999999999999999999
Q ss_pred EEEeeccceecc
Q 046097 225 KIGDFGLARLKT 236 (603)
Q Consensus 225 KL~DFGlA~~~~ 236 (603)
||+|||++....
T Consensus 240 kl~DfG~~~~~~ 251 (365)
T 2y7j_A 240 RLSDFGFSCHLE 251 (365)
T ss_dssp EECCCTTCEECC
T ss_pred EEEecCcccccC
Confidence 999999987653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=327.29 Aligned_cols=153 Identities=25% Similarity=0.401 Sum_probs=135.5
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--------hhhHHHHHHHHHHhccCC-CCceeEEEeEE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--------LQGEREFHNELSLASSLD-CPHIVSLLGFA 146 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--------~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~ 146 (603)
...++|++.+.||+|+||.||+|.++.+++.||||++..... ....+.+.+|+.++.++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345789999999999999999999999999999999975421 122456889999999996 99999999999
Q ss_pred ecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEE
Q 046097 147 SDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKI 226 (603)
Q Consensus 147 ~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL 226 (603)
.+. ...++||||+++++|.+++.... .+++..+..++.||+.||.|||++ +++|+||||+||+++.++.+||
T Consensus 94 ~~~--~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETN--TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECS--SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred ccC--CeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEE
Confidence 886 88999999999999999997643 389999999999999999999999 9999999999999999999999
Q ss_pred Eeeccceecc
Q 046097 227 GDFGLARLKT 236 (603)
Q Consensus 227 ~DFGlA~~~~ 236 (603)
+|||++....
T Consensus 166 ~dfg~~~~~~ 175 (298)
T 1phk_A 166 TDFGFSCQLD 175 (298)
T ss_dssp CCCTTCEECC
T ss_pred ecccchhhcC
Confidence 9999987643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.80 Aligned_cols=151 Identities=11% Similarity=0.132 Sum_probs=114.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHH---HHhccCCCCceeEEE-------eE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNEL---SLASSLDCPHIVSLL-------GF 145 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev---~iL~~l~HpNIV~l~-------g~ 145 (603)
..+|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+ .+|.. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 3458889999999999999999999999999999987542 23345677784 55555 799988865 44
Q ss_pred EecCCC---------------CeEEEEEEccCCCCHHHHHhhcccccccCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 046097 146 ASDRRG---------------RRLVLIYELMENRSLQDALLDRKCEELMEWNKR------FEIAIDIAKGLEYLHHSCEP 204 (603)
Q Consensus 146 ~~~~~~---------------~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~------l~Ia~qIa~aL~yLHs~~~~ 204 (603)
+..... ..+|+||||++ ++|.+++..... .+++..+ +.++.||+.||+|||++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 433211 34899999998 899999986532 2444555 67889999999999999
Q ss_pred CeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 205 gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|+||||||+|||++.++.+||+|||+++..
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~ 244 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEET
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeec
Confidence 9999999999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=334.52 Aligned_cols=150 Identities=25% Similarity=0.406 Sum_probs=128.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-------hhhHHHHHHHHHHhccCCCCceeEEEeEEecC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-------LQGEREFHNELSLASSLDCPHIVSLLGFASDR 149 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-------~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~ 149 (603)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++.+++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 45679999999999999999999999999999999965321 11224588999999999999999999999764
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc---EEE
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK---AKI 226 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~---vKL 226 (603)
..++||||+++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||
T Consensus 88 ---~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 ---DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp ---SEEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEE
T ss_pred ---ceEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEE
Confidence 4899999999999999886543 389999999999999999999999 9999999999999987654 999
Q ss_pred Eeeccceec
Q 046097 227 GDFGLARLK 235 (603)
Q Consensus 227 ~DFGlA~~~ 235 (603)
+|||++...
T Consensus 159 ~Dfg~~~~~ 167 (322)
T 2ycf_A 159 TDFGHSKIL 167 (322)
T ss_dssp CCCTTCEEC
T ss_pred ccCccceec
Confidence 999998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.12 Aligned_cols=147 Identities=22% Similarity=0.361 Sum_probs=128.5
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCC--CCceeEEEeEEecCCCCeEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLD--CPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~--HpNIV~l~g~~~~~~~~~~~ 155 (603)
.+|++.+.||+|+||.||+|.+.. ++.||||++.... .......+.+|+.++.+++ |+||+++++++... ..++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~~ 132 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIY 132 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEEE
Confidence 459999999999999999999864 8899999997643 3345578999999999996 59999999999986 7899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||| +.+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||++...
T Consensus 133 lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 9999 56889999997654 388899999999999999999999 999999999999995 589999999998764
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 205 ~ 205 (390)
T 2zmd_A 205 Q 205 (390)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=337.07 Aligned_cols=159 Identities=21% Similarity=0.246 Sum_probs=120.1
Q ss_pred HHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC-
Q 046097 72 NLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRR- 150 (603)
Q Consensus 72 ~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~- 150 (603)
.......++|++.+.||+|+||.||+|.+..+++.||||++.... .......+++..+..++||||+++++++....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 445677889999999999999999999999999999999986532 22335667888888899999999999987531
Q ss_pred ----CCeEEEEEEccCCCCHHHHHhh-cccccccCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeccCCCCCeEEcC-CC
Q 046097 151 ----GRRLVLIYELMENRSLQDALLD-RKCEELMEWNKRFEIAIDIAKGLEYLH--HSCEPPVIHGDIKPSNILLDG-DF 222 (603)
Q Consensus 151 ----~~~~~LVmEy~~~gsL~~~L~~-~~~~~~l~~~~~l~Ia~qIa~aL~yLH--s~~~~gIVHrDLKp~NILld~-~~ 222 (603)
...+++||||+++ +|...+.. ......+++..+..++.|++.||.||| ++ +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 1248899999986 55544432 222344889999999999999999999 77 9999999999999996 89
Q ss_pred cEEEEeeccceecc
Q 046097 223 KAKIGDFGLARLKT 236 (603)
Q Consensus 223 ~vKL~DFGlA~~~~ 236 (603)
.+||+|||++....
T Consensus 170 ~~kl~Dfg~a~~~~ 183 (360)
T 3e3p_A 170 TLKLCDFGSAKKLS 183 (360)
T ss_dssp EEEECCCTTCBCCC
T ss_pred cEEEeeCCCceecC
Confidence 99999999987543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=335.83 Aligned_cols=153 Identities=33% Similarity=0.493 Sum_probs=133.6
Q ss_pred hcCCCCCceeeccCceEEEEEEE----cCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVV----PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~----~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
.++|++.+.||+|+||.||+|.. ..+++.||||++... .....+.+.+|+.++++++||||+++++++.......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 45688999999999999999984 567999999999763 3455678999999999999999999999988764457
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 899999999999999997653 2389999999999999999999999 99999999999999999999999999997
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 194 ~~~ 196 (326)
T 2w1i_A 194 VLP 196 (326)
T ss_dssp ECC
T ss_pred hcc
Confidence 654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=330.61 Aligned_cols=151 Identities=33% Similarity=0.477 Sum_probs=129.5
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++.+++||||+++++++.+. ...+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKN--TDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEE
Confidence 45678999999999999999999999899999999997632 345788999999999999999999999886 7899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 101 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999999986432 3489999999999999999999999 9999999999999999999999999998764
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 176 ~ 176 (314)
T 3com_A 176 T 176 (314)
T ss_dssp B
T ss_pred h
Confidence 3
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=337.81 Aligned_cols=152 Identities=24% Similarity=0.281 Sum_probs=129.4
Q ss_pred HhhcCCCCCceeeccCceEEEEEE-----EcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC---CCceeEEEeEEe
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAV-----VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD---CPHIVSLLGFAS 147 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~-----~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~---HpNIV~l~g~~~ 147 (603)
...++|.+.+.||+|+||.||+|. ...+++.||||+++.. ....+..|+.++.++. |+||+.+++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 356789999999999999999994 5668999999999753 2345667777777775 999999999999
Q ss_pred cCCCCeEEEEEEccCCCCHHHHHhhcc--cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-----
Q 046097 148 DRRGRRLVLIYELMENRSLQDALLDRK--CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG----- 220 (603)
Q Consensus 148 ~~~~~~~~LVmEy~~~gsL~~~L~~~~--~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~----- 220 (603)
.. +..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.
T Consensus 138 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 138 FQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp CS--SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred cC--CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence 86 78899999999999999997532 234589999999999999999999999 9999999999999988
Q ss_pred ------CCcEEEEeeccceecc
Q 046097 221 ------DFKAKIGDFGLARLKT 236 (603)
Q Consensus 221 ------~~~vKL~DFGlA~~~~ 236 (603)
++.+||+|||+|....
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp ------CTTEEECCCTTCEEGG
T ss_pred cccccccCCEEEeeCchhhhhh
Confidence 8999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.65 Aligned_cols=149 Identities=24% Similarity=0.405 Sum_probs=126.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEE-cCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCC------ceeEEEeEEecC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVV-PSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCP------HIVSLLGFASDR 149 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~-~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~Hp------NIV~l~g~~~~~ 149 (603)
..++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ......+.+|+.++..++|+ +++++++++.+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 356899999999999999999998 567899999999652 34456788899988888655 599999999886
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC---------
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG--------- 220 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~--------- 220 (603)
+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus 90 --~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 90 --GHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp --TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred --CcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence 8999999999 8899999976542 3488999999999999999999999 9999999999999987
Q ss_pred ----------CCcEEEEeecccee
Q 046097 221 ----------DFKAKIGDFGLARL 234 (603)
Q Consensus 221 ----------~~~vKL~DFGlA~~ 234 (603)
++.+||+|||++..
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~ 186 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATY 186 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEE
T ss_pred ccccccccccCCCceEeeCccccc
Confidence 45577777776653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=348.14 Aligned_cols=149 Identities=25% Similarity=0.370 Sum_probs=129.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC------CCCceeEEEeEEecCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL------DCPHIVSLLGFASDRR 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l------~HpNIV~l~g~~~~~~ 150 (603)
...+|++.+.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.++..+ .|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR- 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-
Confidence 456799999999999999999999999999999999752 33445677788777766 678999999999986
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc--EEEEe
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK--AKIGD 228 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~--vKL~D 228 (603)
..+++||||+. ++|.+++..... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 172 -~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 172 -NHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp -TEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred -CeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence 89999999996 699998876543 2389999999999999999999999 9999999999999999887 99999
Q ss_pred ecccee
Q 046097 229 FGLARL 234 (603)
Q Consensus 229 FGlA~~ 234 (603)
||++..
T Consensus 246 FG~a~~ 251 (429)
T 3kvw_A 246 FGSSCY 251 (429)
T ss_dssp CTTCEE
T ss_pred ccccee
Confidence 999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=366.50 Aligned_cols=143 Identities=29% Similarity=0.482 Sum_probs=127.7
Q ss_pred eeeccCceEEEEEEEc--CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEccCC
Q 046097 86 RLGHGGFGSVYKAVVP--SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMEN 163 (603)
Q Consensus 86 ~LG~G~fG~Vy~a~~~--~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~ 163 (603)
.||+|+||.||+|.++ .++..||||+++........+.+.+|+.+|.+++||||++++++|.+ ..+++||||+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEEEEEeCCC
Confidence 7999999999999875 35667999999875555567889999999999999999999999986 458999999999
Q ss_pred CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 164 RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 164 gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 420 g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 420 GPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp CBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999996542 3489999999999999999999999 99999999999999999999999999997543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=344.18 Aligned_cols=152 Identities=27% Similarity=0.440 Sum_probs=120.4
Q ss_pred hcCCCC-CceeeccCceEEEEEEEc--CCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSP-SNRLGHGGFGSVYKAVVP--SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i-~~~LG~G~fG~Vy~a~~~--~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.+.|++ .++||+|+||.||+|+++ .+++.||||++..... ...+.+|+.+|++++||||+++++++.......+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 345666 458999999999999975 4688999999975322 3467899999999999999999999976556889
Q ss_pred EEEEEccCCCCHHHHHhhccc------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE----cCCCcE
Q 046097 155 VLIYELMENRSLQDALLDRKC------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL----DGDFKA 224 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl----d~~~~v 224 (603)
++||||+. ++|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence 99999996 488887764321 12389999999999999999999999 99999999999999 678899
Q ss_pred EEEeeccceecc
Q 046097 225 KIGDFGLARLKT 236 (603)
Q Consensus 225 KL~DFGlA~~~~ 236 (603)
||+|||++....
T Consensus 172 kl~Dfg~a~~~~ 183 (405)
T 3rgf_A 172 KIADMGFARLFN 183 (405)
T ss_dssp EECCTTCCC---
T ss_pred EEEECCCceecC
Confidence 999999997653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=338.37 Aligned_cols=158 Identities=25% Similarity=0.338 Sum_probs=134.2
Q ss_pred cHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh----------hhHHHHHHHHHHhccCCCCce
Q 046097 70 SYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL----------QGEREFHNELSLASSLDCPHI 139 (603)
Q Consensus 70 ~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~----------~~~~~~~~Ev~iL~~l~HpNI 139 (603)
...++....++|.+.+.||+|+||.||+|.+.. ++.||||++...... ...+.+.+|+.++.+++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 356788899999999999999999999999854 899999998553221 123678999999999999999
Q ss_pred eEEEeEEecC---CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 046097 140 VSLLGFASDR---RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNI 216 (603)
Q Consensus 140 V~l~g~~~~~---~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NI 216 (603)
+++++++... .....++||||+. |+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 9999998642 2357899999997 68888886543 3489999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEEeecccee
Q 046097 217 LLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~ 234 (603)
|++.++.+||+|||++..
T Consensus 166 l~~~~~~~kl~Dfg~~~~ 183 (362)
T 3pg1_A 166 LLADNNDITICDFNLARE 183 (362)
T ss_dssp EECTTCCEEECCTTC---
T ss_pred EEcCCCCEEEEecCcccc
Confidence 999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=342.40 Aligned_cols=154 Identities=23% Similarity=0.389 Sum_probs=135.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC---C
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG---R 152 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~---~ 152 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|++++|+||+++++++..... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4678999999999999999999999999999999997542 33445789999999999999999999999876522 5
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
.+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999986 59999987543 389999999999999999999999 9999999999999999999999999999
Q ss_pred eeccc
Q 046097 233 RLKTE 237 (603)
Q Consensus 233 ~~~~~ 237 (603)
+....
T Consensus 177 ~~~~~ 181 (432)
T 3n9x_A 177 RTINS 181 (432)
T ss_dssp EEC--
T ss_pred ccccc
Confidence 87654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=339.90 Aligned_cols=149 Identities=26% Similarity=0.353 Sum_probs=123.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC----CCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR----RGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~----~~~~ 153 (603)
..+|++.+.||+|+||.||+|++..+++.||||++..... ...+|++++++++||||++++++|... ...+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 3468889999999999999999999999999999865321 234799999999999999999998642 1235
Q ss_pred EEEEEEccCCCCHHHHHhhc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC-CcEEEEeecc
Q 046097 154 LVLIYELMENRSLQDALLDR-KCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGL 231 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~-~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~-~~vKL~DFGl 231 (603)
+++||||+++ +|.+.+... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 7899999976 666655432 2234589999999999999999999999 99999999999999955 6789999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
++..
T Consensus 204 a~~~ 207 (420)
T 1j1b_A 204 AKQL 207 (420)
T ss_dssp CEEC
T ss_pred hhhc
Confidence 9764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.96 Aligned_cols=152 Identities=26% Similarity=0.436 Sum_probs=129.5
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-----------CCceeEEEeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-----------CPHIVSLLGFA 146 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-----------HpNIV~l~g~~ 146 (603)
.++|.+.+.||+|+||.||+|.+..+++.||||++.. .......+.+|+.++.++. |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 4689999999999999999999999999999999975 2344567888999998876 89999999998
Q ss_pred ecC--CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc-----
Q 046097 147 SDR--RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD----- 219 (603)
Q Consensus 147 ~~~--~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld----- 219 (603)
... .+...++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 864 123789999999 8899999976443 33899999999999999999999843 899999999999994
Q ss_pred -CCCcEEEEeeccceec
Q 046097 220 -GDFKAKIGDFGLARLK 235 (603)
Q Consensus 220 -~~~~vKL~DFGlA~~~ 235 (603)
..+.+||+|||++...
T Consensus 172 ~~~~~~kl~Dfg~a~~~ 188 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWY 188 (373)
T ss_dssp TTEEEEEECCCTTCEET
T ss_pred cCcceEEEccccccccc
Confidence 4458999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.30 Aligned_cols=153 Identities=24% Similarity=0.350 Sum_probs=126.9
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC-----
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR----- 149 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~----- 149 (603)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4567889999999999999999999999999999999865322 223799999999999999999998542
Q ss_pred -------------------------------CCCeEEEEEEccCCCCHHHHHhhc-ccccccCHHHHHHHHHHHHHHHHH
Q 046097 150 -------------------------------RGRRLVLIYELMENRSLQDALLDR-KCEELMEWNKRFEIAIDIAKGLEY 197 (603)
Q Consensus 150 -------------------------------~~~~~~LVmEy~~~gsL~~~L~~~-~~~~~l~~~~~l~Ia~qIa~aL~y 197 (603)
....+++||||++ ++|.+.+... .....+++..+..++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 1245899999998 5888777642 123458999999999999999999
Q ss_pred HHhCCCCCeEeccCCCCCeEEc-CCCcEEEEeeccceecc
Q 046097 198 LHHSCEPPVIHGDIKPSNILLD-GDFKAKIGDFGLARLKT 236 (603)
Q Consensus 198 LHs~~~~gIVHrDLKp~NILld-~~~~vKL~DFGlA~~~~ 236 (603)
||++ +|+||||||+|||++ .++.+||+|||++....
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 193 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI 193 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECC
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccC
Confidence 9999 999999999999998 68899999999997653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=328.70 Aligned_cols=150 Identities=23% Similarity=0.408 Sum_probs=132.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.++..++||||+++++++.+. +..++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD--GKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--CeEEE
Confidence 457899999999999999999999999999999999763 334457889999999999999999999999986 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 94 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp EEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred EEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 999999999999886533 3389999999999999999999999 999999999999999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=363.38 Aligned_cols=151 Identities=26% Similarity=0.451 Sum_probs=132.3
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
+...++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.+|++++|+||+++++++.+ ...
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~ 336 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 336 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccc
Confidence 3455678889999999999999999964 5679999997643 335679999999999999999999999876 568
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred eEeeehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 999999999999999975432 3488999999999999999999999 999999999999999999999999999875
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 413 ~ 413 (535)
T 2h8h_A 413 I 413 (535)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=325.71 Aligned_cols=154 Identities=29% Similarity=0.384 Sum_probs=124.0
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHH-HHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~-~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||+|+||.||+|.+..+++.||||+++.......... +.++...++.++||||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SSEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CCEE
Confidence 35689999999999999999999999999999999976544443333 44555568888999999999999986 7899
Q ss_pred EEEEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 156 LIYELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+||||++ |+|.+++.... ....+++..++.++.|++.||.|||+++ +|+||||||+||+++.++.+||+|||++..
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999997 48888776521 2345899999999999999999999842 899999999999999999999999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 160 ~ 160 (290)
T 3fme_A 160 L 160 (290)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=342.51 Aligned_cols=150 Identities=27% Similarity=0.408 Sum_probs=119.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecC----CC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDR----RG 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~----~~ 151 (603)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4578999999999999999999999999999999996532 334457788999999999999999999998753 12
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
...++|||++ +++|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 68999988652 389999999999999999999999 999999999999999999999999999
Q ss_pred cee
Q 046097 232 ARL 234 (603)
Q Consensus 232 A~~ 234 (603)
++.
T Consensus 179 a~~ 181 (367)
T 2fst_X 179 ARH 181 (367)
T ss_dssp ---
T ss_pred ccc
Confidence 865
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.77 Aligned_cols=151 Identities=25% Similarity=0.354 Sum_probs=122.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----CC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRR----GR 152 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~----~~ 152 (603)
...+|.+.+.||+|+||.||+|.+..+++ ||+|++...... ..+|+.+++.++||||+++++++.... ..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 34579999999999999999999976665 888877543221 236999999999999999999986531 23
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc-CCCcEEEEeecc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD-GDFKAKIGDFGL 231 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld-~~~~vKL~DFGl 231 (603)
.+++||||++++.+............+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 4889999998754444433333334589999999999999999999999 999999999999999 799999999999
Q ss_pred ceecc
Q 046097 232 ARLKT 236 (603)
Q Consensus 232 A~~~~ 236 (603)
++...
T Consensus 189 a~~~~ 193 (394)
T 4e7w_A 189 AKILI 193 (394)
T ss_dssp CEECC
T ss_pred ccccc
Confidence 97653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.32 Aligned_cols=150 Identities=27% Similarity=0.403 Sum_probs=128.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC---
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR--- 152 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~--- 152 (603)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999999999999999997643 233457789999999999999999999999875211
Q ss_pred -eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 153 -RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 153 -~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
..++||||+. ++|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 2499999997 588877632 289999999999999999999999 999999999999999999999999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
+...
T Consensus 191 a~~~ 194 (371)
T 4exu_A 191 ARHA 194 (371)
T ss_dssp C---
T ss_pred cccc
Confidence 8643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=332.56 Aligned_cols=154 Identities=27% Similarity=0.325 Sum_probs=130.1
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CC-----ceeEEEeEEec
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CP-----HIVSLLGFASD 148 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-Hp-----NIV~l~g~~~~ 148 (603)
....++|++.+.||+|+||.||+|.+..+++.||||+++.. ......+..|+.++..+. |+ +|+++++++..
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 34568899999999999999999999999999999999752 334566778888888775 44 49999999998
Q ss_pred CCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc--CCCcEEE
Q 046097 149 RRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD--GDFKAKI 226 (603)
Q Consensus 149 ~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld--~~~~vKL 226 (603)
. ...++||||+. ++|.+++..... ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||
T Consensus 128 ~--~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 128 R--NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp T--TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred C--CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence 6 89999999996 599999976543 2389999999999999999999952 23999999999999994 5788999
Q ss_pred Eeeccceec
Q 046097 227 GDFGLARLK 235 (603)
Q Consensus 227 ~DFGlA~~~ 235 (603)
+|||++...
T Consensus 203 ~DFG~a~~~ 211 (382)
T 2vx3_A 203 VDFGSSCQL 211 (382)
T ss_dssp CCCTTCEET
T ss_pred EeccCceec
Confidence 999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=328.59 Aligned_cols=153 Identities=29% Similarity=0.396 Sum_probs=129.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHH-HhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELS-LASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~-iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
.++|++.+.||+|+||.||+|.+..+++.||||++...........+..|+. +++.++||||+++++++.+. +..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--CceEE
Confidence 4788999999999999999999998999999999987555555556666666 77888999999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcc--cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 157 IYELMENRSLQDALLDRK--CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~--~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||+++ +|.+++.... ....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++..
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 9999975 8888776421 1345899999999999999999999842 899999999999999999999999999865
Q ss_pred c
Q 046097 235 K 235 (603)
Q Consensus 235 ~ 235 (603)
.
T Consensus 176 ~ 176 (327)
T 3aln_A 176 L 176 (327)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.30 Aligned_cols=149 Identities=19% Similarity=0.349 Sum_probs=124.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCC-ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCc------eeEEEeEEecC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSS-QPLAVKILDSSGSLQGEREFHNELSLASSLDCPH------IVSLLGFASDR 149 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg-~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpN------IV~l~g~~~~~ 149 (603)
..++|++.+.||+|+||.||+|.+..++ +.||||+++. .......+.+|+.++.++.|++ ++.+++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc--cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 3578999999999999999999997766 7899999965 2344567888999999887655 99999999886
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE-----------
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL----------- 218 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl----------- 218 (603)
+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 95 --~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 95 --GHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp --TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred --CeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence 8899999999 6677777765432 3489999999999999999999999 99999999999999
Q ss_pred --------cCCCcEEEEeecccee
Q 046097 219 --------DGDFKAKIGDFGLARL 234 (603)
Q Consensus 219 --------d~~~~vKL~DFGlA~~ 234 (603)
+.++.+||+|||++..
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~ 191 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATF 191 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEE
T ss_pred cccccccccCCCcEEEeecCcccc
Confidence 4456677777776653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=363.71 Aligned_cols=143 Identities=29% Similarity=0.470 Sum_probs=126.0
Q ss_pred ceeeccCceEEEEEEE--cCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVV--PSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~--~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
+.||+|+||.||+|.+ +.+++.||||+++... .....+.+.+|+.++.+++||||+++++++.+ ...++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence 3799999999999965 4567899999997642 22345789999999999999999999999975 4589999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 452 ~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 452 ELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp TTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred CCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 9999999997543 389999999999999999999999 99999999999999999999999999997654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=325.00 Aligned_cols=155 Identities=26% Similarity=0.427 Sum_probs=128.2
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEc-CCCceEEEEEecCCCCh-hhHHHHHHHHHHhccC---CCCceeEEEeEEec--
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVP-SSSQPLAVKILDSSGSL-QGEREFHNELSLASSL---DCPHIVSLLGFASD-- 148 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~-~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l---~HpNIV~l~g~~~~-- 148 (603)
...++|++.+.||+|+||.||+|.+. .+++.||||++...... .....+.+|+.+++.+ .||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45678999999999999999999995 67899999998653211 1123455677666655 89999999999872
Q ss_pred -CCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEE
Q 046097 149 -RRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 149 -~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
......++||||+. |+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 12367899999997 699999876543 3389999999999999999999999 99999999999999999999999
Q ss_pred eeccceec
Q 046097 228 DFGLARLK 235 (603)
Q Consensus 228 DFGlA~~~ 235 (603)
|||++...
T Consensus 163 Dfg~~~~~ 170 (326)
T 1blx_A 163 DFGLARIY 170 (326)
T ss_dssp SCCSCCCC
T ss_pred cCcccccc
Confidence 99998654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=321.17 Aligned_cols=153 Identities=29% Similarity=0.412 Sum_probs=135.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC-------
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR------- 149 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~------- 149 (603)
..++|++.+.||+|+||.||+|++..+++.||||++.. .......+.+|+.++.+++||||+++++++.+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 45679999999999999999999998999999999964 234457789999999999999999999988653
Q ss_pred ----CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEE
Q 046097 150 ----RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAK 225 (603)
Q Consensus 150 ----~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vK 225 (603)
.....++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+|+||||+|||++.++.+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 1367899999999999999997643 2378899999999999999999999 999999999999999999999
Q ss_pred EEeeccceecc
Q 046097 226 IGDFGLARLKT 236 (603)
Q Consensus 226 L~DFGlA~~~~ 236 (603)
|+|||++....
T Consensus 157 l~dfg~~~~~~ 167 (303)
T 1zy4_A 157 IGDFGLAKNVH 167 (303)
T ss_dssp ECCCCCCSCTT
T ss_pred EeeCcchhhcc
Confidence 99999987654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.93 Aligned_cols=151 Identities=28% Similarity=0.409 Sum_probs=124.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcC-CCc--eEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPS-SSQ--PLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~-tg~--~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
.++|++.+.||+|+||.||+|++.. +++ .||||+++... .....+.+.+|+.++.+++||||+++++++.+.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 4679999999999999999998643 333 68999987542 234457899999999999999999999999874
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccc
Confidence 3789999999999999997643 3489999999999999999999999 9999999999999999999999999998
Q ss_pred eecc
Q 046097 233 RLKT 236 (603)
Q Consensus 233 ~~~~ 236 (603)
....
T Consensus 169 ~~~~ 172 (291)
T 1u46_A 169 RALP 172 (291)
T ss_dssp EECC
T ss_pred cccc
Confidence 7654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=324.86 Aligned_cols=151 Identities=27% Similarity=0.445 Sum_probs=126.6
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC-------
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR------- 149 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~------- 149 (603)
..++|.+.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 357899999999999999999999999999999998753 345567889999999999999999999988532
Q ss_pred -----CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc-CCCc
Q 046097 150 -----RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD-GDFK 223 (603)
Q Consensus 150 -----~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld-~~~~ 223 (603)
.....++||||++ |+|.+++... .+++..++.++.|++.||.|||++ +|+||||||+|||++ .++.
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 2367899999997 6999998642 388999999999999999999999 999999999999997 5679
Q ss_pred EEEEeeccceecc
Q 046097 224 AKIGDFGLARLKT 236 (603)
Q Consensus 224 vKL~DFGlA~~~~ 236 (603)
+||+|||++....
T Consensus 160 ~kl~Dfg~~~~~~ 172 (320)
T 2i6l_A 160 LKIGDFGLARIMD 172 (320)
T ss_dssp EEECCCTTCBCC-
T ss_pred EEEccCccccccC
Confidence 9999999987643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=330.02 Aligned_cols=148 Identities=28% Similarity=0.412 Sum_probs=129.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC----C
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG----R 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~----~ 152 (603)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++..++||||+++++++..... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999999999999999997643 23345678999999999999999999999987521 2
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
..++||||+. ++|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 4599999997 588776632 289999999999999999999999 9999999999999999999999999998
Q ss_pred ee
Q 046097 233 RL 234 (603)
Q Consensus 233 ~~ 234 (603)
..
T Consensus 174 ~~ 175 (353)
T 3coi_A 174 RH 175 (353)
T ss_dssp TC
T ss_pred cC
Confidence 64
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=335.03 Aligned_cols=151 Identities=23% Similarity=0.342 Sum_probs=132.0
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh----------------hHHHHHHHHHHhccCCCCcee
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ----------------GEREFHNELSLASSLDCPHIV 140 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~----------------~~~~~~~Ev~iL~~l~HpNIV 140 (603)
..++|.+.+.||+|+||.||+|.+ +++.||||++....... ....+.+|+.++.+++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 357899999999999999999999 89999999986421110 117899999999999999999
Q ss_pred EEEeEEecCCCCeEEEEEEccCCCCHHHH------HhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCC
Q 046097 141 SLLGFASDRRGRRLVLIYELMENRSLQDA------LLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKP 213 (603)
Q Consensus 141 ~l~g~~~~~~~~~~~LVmEy~~~gsL~~~------L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp 213 (603)
++++++.+. +..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ + +|+|+||||
T Consensus 107 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p 180 (348)
T 2pml_X 107 TCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKP 180 (348)
T ss_dssp CCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCG
T ss_pred eEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCCh
Confidence 999999986 889999999999999988 44321 3458999999999999999999999 8 999999999
Q ss_pred CCeEEcCCCcEEEEeeccceec
Q 046097 214 SNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 214 ~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||+++.++.+||+|||++...
T Consensus 181 ~Nil~~~~~~~kl~dfg~~~~~ 202 (348)
T 2pml_X 181 SNILMDKNGRVKLSDFGESEYM 202 (348)
T ss_dssp GGEEECTTSCEEECCCTTCEEC
T ss_pred HhEEEcCCCcEEEecccccccc
Confidence 9999999999999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=321.60 Aligned_cols=153 Identities=28% Similarity=0.457 Sum_probs=134.8
Q ss_pred HHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 75 ~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
....++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++.+. ..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS--SS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC--Ce
Confidence 345678999999999999999999999899999999986532 223457789999999999999999999999886 88
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC---CcEEEEeec
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD---FKAKIGDFG 230 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~---~~vKL~DFG 230 (603)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||++ +++|+||||+||+++.+ +.+||+|||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999999886543 389999999999999999999999 99999999999999754 469999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
++...
T Consensus 170 ~~~~~ 174 (287)
T 2wei_A 170 LSTCF 174 (287)
T ss_dssp GGGTB
T ss_pred cceee
Confidence 98654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=330.48 Aligned_cols=155 Identities=23% Similarity=0.320 Sum_probs=124.9
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-----hHHHHHHHHHHhccC----CCCceeEEE
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-----GEREFHNELSLASSL----DCPHIVSLL 143 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-----~~~~~~~Ev~iL~~l----~HpNIV~l~ 143 (603)
+.....++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34556788999999999999999999999999999999996643211 223456788888888 899999999
Q ss_pred eEEecCCCCeEEEEEEc-cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc-CC
Q 046097 144 GFASDRRGRRLVLIYEL-MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD-GD 221 (603)
Q Consensus 144 g~~~~~~~~~~~LVmEy-~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld-~~ 221 (603)
+++.+. +..++|||+ +.+++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+||+++ .+
T Consensus 105 ~~~~~~--~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQ--EGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-------CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTT
T ss_pred EEEecC--CeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCC
Confidence 999876 778999999 78999999997643 389999999999999999999999 999999999999999 88
Q ss_pred CcEEEEeeccceec
Q 046097 222 FKAKIGDFGLARLK 235 (603)
Q Consensus 222 ~~vKL~DFGlA~~~ 235 (603)
+.+||+|||++...
T Consensus 177 ~~~kl~dfg~~~~~ 190 (312)
T 2iwi_A 177 GCAKLIDFGSGALL 190 (312)
T ss_dssp TEEEECCCSSCEEC
T ss_pred CeEEEEEcchhhhc
Confidence 99999999998764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=339.21 Aligned_cols=150 Identities=23% Similarity=0.365 Sum_probs=127.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCC-CceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC-PHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~H-pNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.++..+.| ++|..+..++.+. ...+
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~--~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEG--DYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEET--TEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeC--CEEE
Confidence 35789999999999999999999999999999999865432 2357889999999986 4555555555544 7889
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEE---cCCCcEEEEeeccc
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILL---DGDFKAKIGDFGLA 232 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILl---d~~~~vKL~DFGlA 232 (603)
+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||| +.++.+||+|||++
T Consensus 80 lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 999999 999999997533 3489999999999999999999999 99999999999999 68899999999999
Q ss_pred eeccc
Q 046097 233 RLKTE 237 (603)
Q Consensus 233 ~~~~~ 237 (603)
+....
T Consensus 154 ~~~~~ 158 (483)
T 3sv0_A 154 KKYRD 158 (483)
T ss_dssp EECBC
T ss_pred eeccC
Confidence 87543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=323.29 Aligned_cols=152 Identities=26% Similarity=0.428 Sum_probs=128.3
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
......++|++.+.||+|+||.||+|.+.. .+|+|+++.... ....+.+.+|+.++.+++|+||+++++++.+.
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 101 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-- 101 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS--
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--
Confidence 344456889999999999999999999843 599999875422 22235577899999999999999999999986
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
...++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 78999999999999999997543 3488999999999999999999999 999999999999998 67999999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
+...
T Consensus 176 ~~~~ 179 (319)
T 2y4i_B 176 FSIS 179 (319)
T ss_dssp CC--
T ss_pred cccc
Confidence 8654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.11 Aligned_cols=150 Identities=29% Similarity=0.394 Sum_probs=123.5
Q ss_pred hhcCCCCCc-eeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC--CCCe
Q 046097 77 ATASFSPSN-RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR--RGRR 153 (603)
Q Consensus 77 ~t~~y~i~~-~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~--~~~~ 153 (603)
..++|.+.+ .||+|+||.||+|.++.+++.||||++... .... .+....+..+.||||+++++++... .+..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 467888855 699999999999999999999999999652 2222 2223345667899999999998752 1256
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC---CCcEEEEeec
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG---DFKAKIGDFG 230 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~---~~~vKL~DFG 230 (603)
+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 8999999999999999976542 3489999999999999999999999 9999999999999976 4559999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
++...
T Consensus 177 ~~~~~ 181 (336)
T 3fhr_A 177 FAKET 181 (336)
T ss_dssp TCEEC
T ss_pred cceec
Confidence 98754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.85 Aligned_cols=157 Identities=20% Similarity=0.334 Sum_probs=132.5
Q ss_pred ccHHHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCC--CCceeEEEeE
Q 046097 69 FSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLD--CPHIVSLLGF 145 (603)
Q Consensus 69 ~~~~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~--HpNIV~l~g~ 145 (603)
+.++.+....++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++.+++ |+||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 333444456678999999999999999999985 58899999996543 3345578899999999997 5999999999
Q ss_pred EecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEE
Q 046097 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAK 225 (603)
Q Consensus 146 ~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vK 225 (603)
+.+. ...++||| +.+++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||+++ +.+|
T Consensus 97 ~~~~--~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 97 EITD--QYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp EECS--SEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEE
T ss_pred eecC--CEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEE
Confidence 9986 78999999 56789999997653 388999999999999999999999 9999999999999964 8999
Q ss_pred EEeeccceecc
Q 046097 226 IGDFGLARLKT 236 (603)
Q Consensus 226 L~DFGlA~~~~ 236 (603)
|+|||++....
T Consensus 167 L~Dfg~~~~~~ 177 (313)
T 3cek_A 167 LIDFGIANQMQ 177 (313)
T ss_dssp ECCCSSSCC--
T ss_pred Eeecccccccc
Confidence 99999987643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=358.76 Aligned_cols=151 Identities=27% Similarity=0.410 Sum_probs=132.8
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCC---CceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSS---SQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
..++|++.+.||+|+||.||+|.+..+ +..||||.++........+.+.+|+.++.+++||||+++++++.+ +.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cc
Confidence 446678889999999999999998643 457999998775555566789999999999999999999999864 56
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence 899999999999999997543 2388999999999999999999999 99999999999999999999999999987
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 540 ~~ 541 (656)
T 2j0j_A 540 YM 541 (656)
T ss_dssp SC
T ss_pred ec
Confidence 64
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=317.36 Aligned_cols=150 Identities=27% Similarity=0.384 Sum_probs=118.6
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHH-HHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~-~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
.++|++.+.||+|+||.||+|.+..+++.||||++........... +.++..++..++||||+++++++.+. ...++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEEE
Confidence 4678889999999999999999998999999999976544443333 44455577888999999999999986 78999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+ ++.+..+.... ...+++..+..++.|++.||.|||+ + +|+|+||||+||+++.++.+||+|||++...
T Consensus 102 v~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 99999 55555554432 2348999999999999999999998 6 8999999999999999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.12 Aligned_cols=155 Identities=26% Similarity=0.363 Sum_probs=132.8
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh-----hHHHHHHHHHHhccCC--CCceeEEEeE
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ-----GEREFHNELSLASSLD--CPHIVSLLGF 145 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~-----~~~~~~~Ev~iL~~l~--HpNIV~l~g~ 145 (603)
......++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.++.++. |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 34456788999999999999999999999999999999996542211 2245678899999986 5999999999
Q ss_pred EecCCCCeEEEEEEccCC-CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc-CCCc
Q 046097 146 ASDRRGRRLVLIYELMEN-RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD-GDFK 223 (603)
Q Consensus 146 ~~~~~~~~~~LVmEy~~~-gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld-~~~~ 223 (603)
+.+. ...++|||++.+ ++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.
T Consensus 117 ~~~~--~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 117 FERP--DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EECS--SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred EecC--CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 9986 889999999976 89999987643 389999999999999999999999 999999999999999 7899
Q ss_pred EEEEeeccceec
Q 046097 224 AKIGDFGLARLK 235 (603)
Q Consensus 224 vKL~DFGlA~~~ 235 (603)
+||+|||++...
T Consensus 189 ~kL~Dfg~~~~~ 200 (320)
T 3a99_A 189 LKLIDFGSGALL 200 (320)
T ss_dssp EEECCCTTCEEC
T ss_pred EEEeeCcccccc
Confidence 999999998764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.18 Aligned_cols=147 Identities=27% Similarity=0.341 Sum_probs=117.4
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
+.|.+.+.||+|+||+||.+.. .+++.||||++.. ...+.+.+|+.++.++ +||||+++++++.+. ..+++|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVIRYYCSETTD--RFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEG----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECS--SEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcH----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CeEEEE
Confidence 3445568899999999986543 5799999999865 2345678899999876 799999999999886 889999
Q ss_pred EEccCCCCHHHHHhhccccc----ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCC------------
Q 046097 158 YELMENRSLQDALLDRKCEE----LMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGD------------ 221 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~----~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~------------ 221 (603)
|||+. |+|.+++....... ..++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCC
Confidence 99996 69999997654211 012334577999999999999999 99999999999999754
Q ss_pred -CcEEEEeeccceecc
Q 046097 222 -FKAKIGDFGLARLKT 236 (603)
Q Consensus 222 -~~vKL~DFGlA~~~~ 236 (603)
+.+||+|||++....
T Consensus 164 ~~~~kL~DFG~a~~~~ 179 (434)
T 2rio_A 164 NLRILISDFGLCKKLD 179 (434)
T ss_dssp SCEEEECCCTTCEECC
T ss_pred ceEEEEcccccceecC
Confidence 489999999998654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=349.26 Aligned_cols=155 Identities=26% Similarity=0.349 Sum_probs=134.6
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC----CCCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR----RGRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~----~~~~ 153 (603)
.++|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.++.+++||||+++++++... .+..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999999999999999998765666677899999999999999999999997651 2467
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCc---EEEEeec
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFK---AKIGDFG 230 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~---vKL~DFG 230 (603)
.++||||+++|+|.+++........+++..++.++.|++.||.|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998755444588899999999999999999999 9999999999999997664 9999999
Q ss_pred cceec
Q 046097 231 LARLK 235 (603)
Q Consensus 231 lA~~~ 235 (603)
++...
T Consensus 170 ~a~~~ 174 (676)
T 3qa8_A 170 YAKEL 174 (676)
T ss_dssp CCCBT
T ss_pred ccccc
Confidence 98754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.38 Aligned_cols=140 Identities=15% Similarity=0.092 Sum_probs=125.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++.+++||||+++++++.+. +..|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~ 107 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGGL 107 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcEE
Confidence 4679999999999999999999998999999999976533 33447799999999999999999999999986 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEE
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
+||||+++++|.+++... ....++..++.||+.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 108 lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEEC
T ss_pred EEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEE
Confidence 999999999999998542 35567888999999999999999 99999999999999999999886
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=343.95 Aligned_cols=150 Identities=22% Similarity=0.369 Sum_probs=129.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcC-CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC---C
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPS-SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG---R 152 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~-tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~---~ 152 (603)
..++|++.+.||+|+||.||+|.+.. +++.||||++...........+.+|+.++.+++||||+++++++..... .
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 35789999999999999999999975 7899999999765555566788999999999999999999999987521 1
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
..|+||||+++++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 27999999999999987754 389999999999999999999999 99999999999999875 8999999998
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
...
T Consensus 229 ~~~ 231 (681)
T 2pzi_A 229 SRI 231 (681)
T ss_dssp EET
T ss_pred hhc
Confidence 653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.04 Aligned_cols=147 Identities=26% Similarity=0.357 Sum_probs=119.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~ 155 (603)
...+|++.+.||+|+||+|+... ..+++.||||++..... ..+.+|+.+|+.+ +||||+++++++.+. ...|
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~~ 94 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDR--QFQY 94 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEET--TEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecC--CEEE
Confidence 44568888999999999965433 35789999999965322 2356799999999 799999999999886 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-----CCcEEEEeec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-----DFKAKIGDFG 230 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~-----~~~vKL~DFG 230 (603)
+||||+. |+|.+++..... ......++.++.||+.||.|||++ +|+||||||+|||++. ...+||+|||
T Consensus 95 lv~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp EEEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred EEEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 9999996 599999976542 244455678999999999999999 9999999999999953 3368899999
Q ss_pred cceecc
Q 046097 231 LARLKT 236 (603)
Q Consensus 231 lA~~~~ 236 (603)
++....
T Consensus 169 ~a~~~~ 174 (432)
T 3p23_A 169 LCKKLA 174 (432)
T ss_dssp EEECC-
T ss_pred ceeecc
Confidence 997653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.75 Aligned_cols=148 Identities=25% Similarity=0.433 Sum_probs=127.5
Q ss_pred hhcCCCCC-ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHh-ccCCCCceeEEEeEEec--CCCC
Q 046097 77 ATASFSPS-NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLA-SSLDCPHIVSLLGFASD--RRGR 152 (603)
Q Consensus 77 ~t~~y~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL-~~l~HpNIV~l~g~~~~--~~~~ 152 (603)
..++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +..+||||+++++++.. ....
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 34567776 779999999999999999999999999964 23566788887 55689999999999876 1236
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC---CCcEEEEee
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG---DFKAKIGDF 229 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~---~~~vKL~DF 229 (603)
..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 78999999999999999987542 3489999999999999999999999 9999999999999997 788999999
Q ss_pred cccee
Q 046097 230 GLARL 234 (603)
Q Consensus 230 GlA~~ 234 (603)
|++..
T Consensus 165 g~a~~ 169 (299)
T 3m2w_A 165 GFAKE 169 (299)
T ss_dssp TTCEE
T ss_pred ccccc
Confidence 98854
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.24 Aligned_cols=154 Identities=15% Similarity=0.174 Sum_probs=116.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChh--hHHHHHHHHHHhccCCC-Cce----------eE---
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQ--GEREFHNELSLASSLDC-PHI----------VS--- 141 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~--~~~~~~~Ev~iL~~l~H-pNI----------V~--- 141 (603)
...|...+.||+|+||.||+|++..+++.||||++....... ..+.+.+|+.++..+.| +|. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345777789999999999999999999999999997433222 24678999999999987 221 11
Q ss_pred --------EEeEEecCC---CCeEEEEEEccCCCCHHHHHhhc----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 046097 142 --------LLGFASDRR---GRRLVLIYELMENRSLQDALLDR----KCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPV 206 (603)
Q Consensus 142 --------l~g~~~~~~---~~~~~LVmEy~~~gsL~~~L~~~----~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gI 206 (603)
++.++.... ....+++|+++ +++|.+++... .....+++..++.++.||+.||.|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 111111110 13467777766 67999988521 1133478889999999999999999999 99
Q ss_pred EeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 207 IHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 207 VHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||||+|||++.++.+||+|||+++..
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~ 261 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred ccCCcccceEEEecCCeEEEEeccceeec
Confidence 99999999999999999999999998753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=305.73 Aligned_cols=149 Identities=20% Similarity=0.324 Sum_probs=121.7
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-------ChhhHHHHHHHHHHhccCC---------CCceeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-------SLQGEREFHNELSLASSLD---------CPHIVS 141 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-------~~~~~~~~~~Ev~iL~~l~---------HpNIV~ 141 (603)
.++|++.+.||+|+||.||+|++ +++.||||++.... .....+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46789999999999999999998 68999999997643 1223467888888888775 888888
Q ss_pred EEeEEecC----------------------------CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHH
Q 046097 142 LLGFASDR----------------------------RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAK 193 (603)
Q Consensus 142 l~g~~~~~----------------------------~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~ 193 (603)
+++.+... ....+|+||||+++|++.+.+.. ..+++..++.++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence 77765311 13789999999999977666643 33799999999999999
Q ss_pred HHHHHH-hCCCCCeEeccCCCCCeEEcCCC--------------------cEEEEeeccceec
Q 046097 194 GLEYLH-HSCEPPVIHGDIKPSNILLDGDF--------------------KAKIGDFGLARLK 235 (603)
Q Consensus 194 aL~yLH-s~~~~gIVHrDLKp~NILld~~~--------------------~vKL~DFGlA~~~ 235 (603)
||.||| ++ +|+||||||+|||++.++ .+||+|||+|+..
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~ 232 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEE
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEec
Confidence 999999 88 999999999999999876 7888888887653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=279.12 Aligned_cols=139 Identities=18% Similarity=0.199 Sum_probs=111.7
Q ss_pred eeccCceEEEEEEEcCCCceEEEEEecCCCC---------hhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEEE
Q 046097 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGS---------LQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 87 LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~---------~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++.|++|.+..++....|+.|++|++..... ....++|.+|+++|+++ .|+||+++++++++. +..||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~yL 319 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSGWL 319 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEEEE
Confidence 5566677666666666799999999976421 12236699999999999 599999999999987 89999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||++|++|.+.+.... +++.. .|+.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999997653 36654 4788999999999999 99999999999999999999999999997653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-24 Score=241.50 Aligned_cols=137 Identities=20% Similarity=0.269 Sum_probs=105.0
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-h------hHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-Q------GEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~------~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
+...+.||+|+||.||+|.. .++.+++|........ . ..+.+.+|++++++++||||+++..++... ..
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~ 413 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL--DN 413 (540)
T ss_dssp ----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--TT
T ss_pred CCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--Cc
Confidence 34567899999999999954 5788999986442211 1 134589999999999999999555455444 55
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.|+||||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+|||++. .+||+|||+++
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~ 477 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGK 477 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred cEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCE
Confidence 6999999999999999864 457899999999999999 9999999999999998 99999999998
Q ss_pred eccc
Q 046097 234 LKTE 237 (603)
Q Consensus 234 ~~~~ 237 (603)
....
T Consensus 478 ~~~~ 481 (540)
T 3en9_A 478 ISNL 481 (540)
T ss_dssp ECCC
T ss_pred ECCC
Confidence 7643
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-20 Score=194.29 Aligned_cols=144 Identities=17% Similarity=0.162 Sum_probs=116.1
Q ss_pred HHHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-----------------hhHHHHHHHHHHhccC
Q 046097 72 NLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-----------------QGEREFHNELSLASSL 134 (603)
Q Consensus 72 ~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-----------------~~~~~~~~Ev~iL~~l 134 (603)
..+......|.+.+.||+|+||.||+|.+ .+++.||||+++..... .....+.+|+.+++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34555566677889999999999999999 78999999999653211 1346789999999999
Q ss_pred CCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 046097 135 DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPS 214 (603)
Q Consensus 135 ~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~ 214 (603)
+ | +++++++.. +..++||||+++++|.+ +.. .....++.|++.||.|||++ +|+||||||+
T Consensus 162 ~--~-~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~ 222 (282)
T 1zar_A 162 Q--G-LAVPKVYAW---EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQY 222 (282)
T ss_dssp T--T-SSSCCEEEE---ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred c--C-CCcCeEEec---cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHH
Confidence 9 4 666665544 44699999999999987 421 12346899999999999999 9999999999
Q ss_pred CeEEcCCCcEEEEeeccceecc
Q 046097 215 NILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 215 NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||++ ++.+||+|||+|....
T Consensus 223 NILl~-~~~vkl~DFG~a~~~~ 243 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVEVG 243 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEETT
T ss_pred HEEEE-CCcEEEEECCCCeECC
Confidence 99999 9999999999998654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-18 Score=175.40 Aligned_cols=139 Identities=18% Similarity=0.141 Sum_probs=106.9
Q ss_pred CCCCceeeccCceEEEEEEEcCCCce--EEEEEecCCCCh-----------------------hhHHHHHHHHHHhccCC
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQP--LAVKILDSSGSL-----------------------QGEREFHNELSLASSLD 135 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~--VAVK~l~~~~~~-----------------------~~~~~~~~Ev~iL~~l~ 135 (603)
|++.+.||+|+||.||+|.+..+|+. ||||+++..... .....+.+|+.+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66788999999999999998677888 999997553111 11236789999999998
Q ss_pred CCce--eEEEeEEecCCCCeEEEEEEccCC-C----CHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHH-hCCCCCeE
Q 046097 136 CPHI--VSLLGFASDRRGRRLVLIYELMEN-R----SLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH-HSCEPPVI 207 (603)
Q Consensus 136 HpNI--V~l~g~~~~~~~~~~~LVmEy~~~-g----sL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLH-s~~~~gIV 207 (603)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+
T Consensus 129 ~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred hCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 7754 334332 234899999942 3 66665422 223456789999999999999 88 999
Q ss_pred eccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 208 HGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 208 HrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||||+|||++. .++|+|||+|....
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999999998 99999999997654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.3e-15 Score=162.98 Aligned_cols=146 Identities=15% Similarity=0.120 Sum_probs=102.0
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-------------hhH--------HHHHHHHHHh
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-------------QGE--------REFHNELSLA 131 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-------------~~~--------~~~~~Ev~iL 131 (603)
.+.....-|++...||+|++|.||+|.+. +|+.||||+++..... ... .....|...|
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 34444445999999999999999999984 6899999997542100 000 1123566667
Q ss_pred ccCCCCceeEEEeEEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 046097 132 SSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDI 211 (603)
Q Consensus 132 ~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDL 211 (603)
.++.+.++....-+... ..+|||||+++++|..+.. ......++.||+.+|.+||+. |||||||
T Consensus 168 ~rL~~~gv~vp~p~~~~----~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~---gIVHrDL 231 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQS----RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKH---GLIHGDF 231 (397)
T ss_dssp HHHHHTTCSCCCEEEEE----TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred HHHHhcCCCCCeeeecc----CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHC---CCcCCCC
Confidence 76654443222111122 1279999999888754321 123346788999999999999 9999999
Q ss_pred CCCCeEEcCCC----------cEEEEeeccceec
Q 046097 212 KPSNILLDGDF----------KAKIGDFGLARLK 235 (603)
Q Consensus 212 Kp~NILld~~~----------~vKL~DFGlA~~~ 235 (603)
||.|||+++++ .+.|+||+-+...
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99999998776 3899999977653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=2.3e-11 Score=121.62 Aligned_cols=151 Identities=17% Similarity=0.135 Sum_probs=114.4
Q ss_pred HHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCC
Q 046097 74 IRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGR 152 (603)
Q Consensus 74 l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~ 152 (603)
+......|.+...++.|+.+.||++.. .++.+++|+...... .....+.+|+.++..+. +..+.++++++.+. +
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~ 83 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--G 83 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--T
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--C
Confidence 345556788888889899999999975 467899999864211 11235788888888874 67788899988875 7
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC------------------------------ 202 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~------------------------------ 202 (603)
..|+|||+++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 84 ~~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred ceEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 8899999999999876531 11223357889999999999810
Q ss_pred --------------------------CCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 203 --------------------------EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 203 --------------------------~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
...++|+|++|.||+++.+..+.|+||+.+.....
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~gd~ 216 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADK 216 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEEEH
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccCCH
Confidence 13599999999999998765667999999876543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=2.9e-10 Score=112.46 Aligned_cols=141 Identities=18% Similarity=0.121 Sum_probs=99.5
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCc--eeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH--IVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpN--IV~l~g~~~~~~~~~~~L 156 (603)
..|.+....+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.+ +.+++++..+. +..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEE
Confidence 3444433334566699999975 45678999998653 1235678888888875434 55688877765 66899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC---------------------------------- 202 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~---------------------------------- 202 (603)
||||++|.+|. ... .+. ..++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~~~------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEECCSSEETT--TSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEecCCcccC--cCc------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999998874 211 111 246677788888888641
Q ss_pred ---------------------CCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 203 ---------------------EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 203 ---------------------~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
...++|+|++|.||+++.++.+.|+||+.+.....
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~~ 217 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADR 217 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEET
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCCh
Confidence 11399999999999998776677999999877654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.1e-09 Score=115.02 Aligned_cols=148 Identities=18% Similarity=0.233 Sum_probs=107.0
Q ss_pred CCceeeccCceEEEEEEEcCCCceEEEEEec--CCCChhhHHHHHHHHHHhccCC--CCceeEEEeEEecCCC-CeEEEE
Q 046097 83 PSNRLGHGGFGSVYKAVVPSSSQPLAVKILD--SSGSLQGEREFHNELSLASSLD--CPHIVSLLGFASDRRG-RRLVLI 157 (603)
Q Consensus 83 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~--~~~~~~~~~~~~~Ev~iL~~l~--HpNIV~l~g~~~~~~~-~~~~LV 157 (603)
..+.|+.|.++.||+... .+..+++|+.. ..........+.+|..+++.+. +..+.+++.++.+... +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999886 35678899876 3222223456788999998886 4568888888876421 457899
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC----------------------------------- 202 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~----------------------------------- 202 (603)
|||++|..+.+.. ...++......++.+++..|..||+..
T Consensus 120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999987774311 112677788889999999999999731
Q ss_pred --------------------CCCeEeccCCCCCeEEcCCCc--EEEEeeccceeccc
Q 046097 203 --------------------EPPVIHGDIKPSNILLDGDFK--AKIGDFGLARLKTE 237 (603)
Q Consensus 203 --------------------~~gIVHrDLKp~NILld~~~~--vKL~DFGlA~~~~~ 237 (603)
...++|+|+++.|||++.++. +.|+||+.+.....
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~p 251 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGHP 251 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEECH
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCCH
Confidence 247999999999999987653 68999999987554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.8e-06 Score=86.15 Aligned_cols=140 Identities=17% Similarity=0.165 Sum_probs=100.9
Q ss_pred eeeccCce-EEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEEEEccCC
Q 046097 86 RLGHGGFG-SVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLIYELMEN 163 (603)
Q Consensus 86 ~LG~G~fG-~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LVmEy~~~ 163 (603)
.+..|..| .||+.....++..+++|+-.. .....+.+|...|..+. +--+.++++++.+. +..++|||++++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCC
Confidence 45556555 699988777788899998754 23456788888888774 43477888888876 788999999999
Q ss_pred CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 046097 164 RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC----------------------------------------- 202 (603)
Q Consensus 164 gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~----------------------------------------- 202 (603)
.++.+...... .....++.+++..|..||+..
T Consensus 105 ~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 105 KTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred ccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 88877654321 122345566677777777430
Q ss_pred --------------CCCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 203 --------------EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 203 --------------~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
...++|+|+.+.|||++.++.+-|+||+.+......
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gdp~ 227 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRY 227 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEETH
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCCHH
Confidence 113899999999999998777789999998876543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.36 E-value=9.7e-07 Score=90.27 Aligned_cols=141 Identities=21% Similarity=0.229 Sum_probs=100.6
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCc--eeEEEeEEecCCC-CeEEEEEE
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPH--IVSLLGFASDRRG-RRLVLIYE 159 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpN--IV~l~g~~~~~~~-~~~~LVmE 159 (603)
.+.++.|....||+.. ..+++|+... ......+.+|..+|..+. +.. +.+++........ ...|+||+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999853 4688998743 234567889999988773 322 4455544433211 23488999
Q ss_pred ccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 046097 160 LMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC------------------------------------- 202 (603)
Q Consensus 160 y~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~------------------------------------- 202 (603)
+++|.+|.+.... .++..+...++.+++..|..||+..
T Consensus 97 ~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 97 KIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred ccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999888754321 1567777788888888888888610
Q ss_pred ------------------CCCeEeccCCCCCeEEcC--CCcEEEEeeccceeccc
Q 046097 203 ------------------EPPVIHGDIKPSNILLDG--DFKAKIGDFGLARLKTE 237 (603)
Q Consensus 203 ------------------~~gIVHrDLKp~NILld~--~~~vKL~DFGlA~~~~~ 237 (603)
...++|+|++|.||+++. ...+.|+||+.+.....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~ 226 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP 226 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh
Confidence 135899999999999998 45688999999887644
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=7.7e-06 Score=84.06 Aligned_cols=141 Identities=21% Similarity=0.253 Sum_probs=95.9
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCC---ceeEEEeEEecCCCCeEEEEEEc
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCP---HIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~Hp---NIV~l~g~~~~~~~~~~~LVmEy 160 (603)
.+.++.|....||+. +..+++|+-.. ......+.+|..+|..+.+. .+.+++.++... .+..++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEEEEec
Confidence 356888998999987 46688898532 33456788999999988642 356666666532 3567899999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS--------------------------------------- 201 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~--------------------------------------- 201 (603)
++|..+....... ++......++.+++..|..||+.
T Consensus 95 i~G~~l~~~~~~~-----l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 95 VQGQILGEDGMAV-----LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCSEECHHHHHTT-----SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred cCCeECchhhhhh-----CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9998876632110 23344444444555555555432
Q ss_pred ------------------CCCCeEeccCCCCCeEEcC---CCc-EEEEeeccceecccc
Q 046097 202 ------------------CEPPVIHGDIKPSNILLDG---DFK-AKIGDFGLARLKTED 238 (603)
Q Consensus 202 ------------------~~~gIVHrDLKp~NILld~---~~~-vKL~DFGlA~~~~~~ 238 (603)
....++|+|+++.||+++. ++. +.|+||+.+......
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~ 228 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPD 228 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGG
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHH
Confidence 1235799999999999987 455 589999998876543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=3.8e-05 Score=81.35 Aligned_cols=77 Identities=13% Similarity=0.078 Sum_probs=47.6
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCC------hhhHHHHHHHHHHhccCCC--C-ceeEEEeEEecCCCCeE
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS------LQGEREFHNELSLASSLDC--P-HIVSLLGFASDRRGRRL 154 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~------~~~~~~~~~Ev~iL~~l~H--p-NIV~l~g~~~~~~~~~~ 154 (603)
.+.||.|..+.||++....+++.++||....... ......+..|.+++..+.. + .+.+++.+. . ...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Ccc
Confidence 3579999999999997655678899998653211 0112345678888776632 3 344565443 2 234
Q ss_pred EEEEEccCCC
Q 046097 155 VLIYELMENR 164 (603)
Q Consensus 155 ~LVmEy~~~g 164 (603)
++|||++++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=2.2e-05 Score=81.77 Aligned_cols=83 Identities=5% Similarity=0.027 Sum_probs=52.2
Q ss_pred cee-eccCceEEEEEEEc---C---CCceEEEEEecCCCC--hhhHHHHHHHHHHhccCC-C--CceeEEEeEEecCC-C
Q 046097 85 NRL-GHGGFGSVYKAVVP---S---SSQPLAVKILDSSGS--LQGEREFHNELSLASSLD-C--PHIVSLLGFASDRR-G 151 (603)
Q Consensus 85 ~~L-G~G~fG~Vy~a~~~---~---tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~-H--pNIV~l~g~~~~~~-~ 151 (603)
+.| +.|....+|+.... . ++..+++|+...... ......+.+|+.++..+. + -.+.+++.++.+.. .
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999988753 0 156788998754210 001134567777777664 2 34677777776531 1
Q ss_pred CeEEEEEEccCCCCHH
Q 046097 152 RRLVLIYELMENRSLQ 167 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~ 167 (603)
+..++|||+++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00028 Score=72.13 Aligned_cols=34 Identities=21% Similarity=0.261 Sum_probs=29.9
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
..++|+|+.+.|||++.++.+.|+||+.+.....
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g~~ 255 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFDLP 255 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEECCT
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcccCCh
Confidence 4899999999999998888899999999876543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00084 Score=69.39 Aligned_cols=138 Identities=18% Similarity=0.250 Sum_probs=89.5
Q ss_pred CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC---CCceeEEEeEEecCCCCeEEEEEEc
Q 046097 84 SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD---CPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~---HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+.+++.++... +..++|||+
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEe
Confidence 35789999999999875 4678889987542 3556788888888773 35688888887765 678999999
Q ss_pred cCCCCHH--------H---HHhhccc-cc------------------ccCHHHHH---HHH----------------HHH
Q 046097 161 MENRSLQ--------D---ALLDRKC-EE------------------LMEWNKRF---EIA----------------IDI 191 (603)
Q Consensus 161 ~~~gsL~--------~---~L~~~~~-~~------------------~l~~~~~l---~Ia----------------~qI 191 (603)
+++..+. . .|+.... .. .-+|.... ++. ..+
T Consensus 113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l 192 (312)
T 3jr1_A 113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI 192 (312)
T ss_dssp CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence 9987542 1 1222111 00 01343321 111 112
Q ss_pred HHHH-HHHHh-CCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 192 AKGL-EYLHH-SCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 192 a~aL-~yLHs-~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
+..+ ..|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2222 23421 1246899999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00077 Score=72.06 Aligned_cols=33 Identities=18% Similarity=0.348 Sum_probs=29.1
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
..++|+|+++.|||++.++ ++|+||+.+.....
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p 264 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM 264 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCch
Confidence 4899999999999998776 99999999987653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0029 Score=63.76 Aligned_cols=78 Identities=19% Similarity=0.240 Sum_probs=52.3
Q ss_pred CCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-C--CceeEEEeEEecCCCCeEEEE
Q 046097 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-C--PHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 81 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-H--pNIV~l~g~~~~~~~~~~~LV 157 (603)
..-.+.+|.|..+.||+.+. .+|+.|.+|+..... ......|..|...|+.+. . --+.+++++.. -++|
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~------~~lv 88 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD------RTLA 88 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET------TEEE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEeccC------ceEE
Confidence 44457799999999999987 468899999875432 222335677888777663 1 23455554422 2689
Q ss_pred EEccCCCCH
Q 046097 158 YELMENRSL 166 (603)
Q Consensus 158 mEy~~~gsL 166 (603)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0019 Score=65.61 Aligned_cols=34 Identities=21% Similarity=0.126 Sum_probs=28.2
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
..++|+|+.+.||+ ..++.+.|+||..+......
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~~~ 206 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMNDPL 206 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEECTH
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCCCHH
Confidence 35899999999999 56677899999998876543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0031 Score=66.93 Aligned_cols=146 Identities=15% Similarity=0.183 Sum_probs=83.8
Q ss_pred ceeeccCceEEEEEEEcC-------CCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEE
Q 046097 85 NRLGHGGFGSVYKAVVPS-------SSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~L 156 (603)
+.|..|-...+|++.... +++.+++|+.... ......+.+|..+++.+. +.-..++++++.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE------GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------cc
Confidence 567778888999988742 3478999986331 223445668888887774 3334566666543 28
Q ss_pred EEEccCCCCHHH--------------HH---hhccc--ccccC--HHHHHHHHHHHH-------------------HHHH
Q 046097 157 IYELMENRSLQD--------------AL---LDRKC--EELME--WNKRFEIAIDIA-------------------KGLE 196 (603)
Q Consensus 157 VmEy~~~gsL~~--------------~L---~~~~~--~~~l~--~~~~l~Ia~qIa-------------------~aL~ 196 (603)
||||++|.+|.. .| +.... ..... +.++.++..++. ..+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999998755421 01 11100 01111 334444443332 1223
Q ss_pred HHH----hC-CCCCeEeccCCCCCeEEcCC----CcEEEEeeccceecccc
Q 046097 197 YLH----HS-CEPPVIHGDIKPSNILLDGD----FKAKIGDFGLARLKTED 238 (603)
Q Consensus 197 yLH----s~-~~~gIVHrDLKp~NILld~~----~~vKL~DFGlA~~~~~~ 238 (603)
.|. .. ....++|+|+.+.||+++.+ +.+.|+||..+......
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~~~~ 258 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYNYRG 258 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEEEHH
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcCChH
Confidence 332 21 12478999999999999876 78999999999876544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.55 E-value=0.012 Score=59.78 Aligned_cols=161 Identities=17% Similarity=0.212 Sum_probs=86.3
Q ss_pred ccHHHHHHhhcCCCCC-----ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCc--eeE
Q 046097 69 FSYNLIRRATASFSPS-----NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH--IVS 141 (603)
Q Consensus 69 ~~~~~l~~~t~~y~i~-----~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpN--IV~ 141 (603)
++.+++......|.+. +.|+.|....+|+.... +..+++|+...... ...+..|+.++..+...+ +.+
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC--CccEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCc
Confidence 4556666666667653 34666888899998763 33688999865211 123445666655543111 233
Q ss_pred EEeE------EecCCCCeEEEEEEccCCCCHHH--------------HHhhc--c--cc-----cccCHHHHHH------
Q 046097 142 LLGF------ASDRRGRRLVLIYELMENRSLQD--------------ALLDR--K--CE-----ELMEWNKRFE------ 186 (603)
Q Consensus 142 l~g~------~~~~~~~~~~LVmEy~~~gsL~~--------------~L~~~--~--~~-----~~l~~~~~l~------ 186 (603)
++.. ... .+..+++|++++|..+.. .++.. . .. ....|.....
T Consensus 82 ~~~~~~g~~~~~~--~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~ 159 (322)
T 2ppq_A 82 PLPRKDGELLGEL--SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA 159 (322)
T ss_dssp BCCBTTCCSCEEE--TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred ccCCCCCCEEEEE--CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHH
Confidence 3221 111 256789999998754310 01111 0 00 0001211100
Q ss_pred ------HHHHHHHHHHHHHhC----CCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 187 ------IAIDIAKGLEYLHHS----CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 187 ------Ia~qIa~aL~yLHs~----~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
+...+...+.+++.. ...+++|+|+.+.|||++.+..+.|+||+.+....
T Consensus 160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g~ 219 (322)
T 2ppq_A 160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACNDL 219 (322)
T ss_dssp GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccCch
Confidence 011234445555532 13479999999999999987666899999887653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0088 Score=61.32 Aligned_cols=35 Identities=23% Similarity=0.290 Sum_probs=30.0
Q ss_pred CCeEeccCCCCCeEEcCC----CcEEEEeeccceecccc
Q 046097 204 PPVIHGDIKPSNILLDGD----FKAKIGDFGLARLKTED 238 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~----~~vKL~DFGlA~~~~~~ 238 (603)
..++|+|+.+.||+++.+ +.+.|+||+.+......
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~~ 221 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHRA 221 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECTT
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCCH
Confidence 489999999999999874 67999999999876544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.46 E-value=0.004 Score=67.03 Aligned_cols=72 Identities=14% Similarity=0.139 Sum_probs=47.8
Q ss_pred ceeeccCceEEEEEEEcC-------CCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEE
Q 046097 85 NRLGHGGFGSVYKAVVPS-------SSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~L 156 (603)
+.|+.|-...+|++.... .+..+++|+..... ....+..|..++..+. +.-..++++.+.+ .+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~------g~ 149 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG------GR 149 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC------CE
Confidence 567888889999998742 25789999984321 1134557888887774 3333567766542 28
Q ss_pred EEEccCCCC
Q 046097 157 IYELMENRS 165 (603)
Q Consensus 157 VmEy~~~gs 165 (603)
|+||++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999998633
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0072 Score=65.71 Aligned_cols=74 Identities=14% Similarity=0.079 Sum_probs=45.5
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCc-eeEEEeEEecCCCCeEEEEEEccCC
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPH-IVSLLGFASDRRGRRLVLIYELMEN 163 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpN-IV~l~g~~~~~~~~~~~LVmEy~~~ 163 (603)
+.|+.|-...+|++....++..+++|+....... .-...+|..++..+...+ ..++++++.. .+||||++|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~~------G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFTN------GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEETT------EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeCC------eEEEEeeCC
Confidence 5688888899999987543578999988542111 011246777777775333 3567776632 259999987
Q ss_pred CCH
Q 046097 164 RSL 166 (603)
Q Consensus 164 gsL 166 (603)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.18 E-value=0.048 Score=55.43 Aligned_cols=164 Identities=14% Similarity=0.110 Sum_probs=86.7
Q ss_pred cccHHHHHHhhcCCCC-----CceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCC--cee
Q 046097 68 RFSYNLIRRATASFSP-----SNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCP--HIV 140 (603)
Q Consensus 68 ~~~~~~l~~~t~~y~i-----~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~Hp--NIV 140 (603)
..+.+.+......|.+ ...|+ |....||+... .+|+.+++|+..... .....+..|..++..+... .+.
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQD-EDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECC-TTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEc-CCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeec
Confidence 3444444444444432 24566 77789998765 346679999986421 1234556677766665311 234
Q ss_pred EEEeEEecC----CCCeEEEEEEccCCCCHH-----H------H---Hhhccc------ccccCHHHH----HHH-----
Q 046097 141 SLLGFASDR----RGRRLVLIYELMENRSLQ-----D------A---LLDRKC------EELMEWNKR----FEI----- 187 (603)
Q Consensus 141 ~l~g~~~~~----~~~~~~LVmEy~~~gsL~-----~------~---L~~~~~------~~~l~~~~~----l~I----- 187 (603)
+++.. ... .++..+++|++++|..+. . . ++.... ....+.... ..+
T Consensus 86 ~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 86 APVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred ceeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 44432 100 125668899999874331 1 1 111000 001121111 000
Q ss_pred ----------HHHHHHHHHHHHhC----CCCCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 188 ----------AIDIAKGLEYLHHS----CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 188 ----------a~qIa~aL~yLHs~----~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
...+...+..+... ....++|+|+++.||+++ + .+.|+||+.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~~~ 227 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGPAV 227 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEECTT
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCcHH
Confidence 01111223333221 234689999999999999 4 8999999988765443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.85 E-value=0.01 Score=61.91 Aligned_cols=33 Identities=18% Similarity=0.271 Sum_probs=27.2
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
..++|+|+.+.|||++.+. +.|+||..+.....
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g~~ 244 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGFNFL 244 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEEEEH
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCCCch
Confidence 4799999999999998654 89999998876553
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.69 E-value=0.074 Score=54.96 Aligned_cols=35 Identities=23% Similarity=0.313 Sum_probs=30.3
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
..++|+|+.+.||+++.++.+.|+||+.+......
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~~ 240 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPKE 240 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEECTH
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCHH
Confidence 47999999999999998888999999988766543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.80 E-value=0.069 Score=52.28 Aligned_cols=60 Identities=12% Similarity=0.040 Sum_probs=41.6
Q ss_pred CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEE
Q 046097 164 RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIG 227 (603)
Q Consensus 164 gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~ 227 (603)
-+|.++|.... .++++++++.++.|.+.+|.-+-..- .-..+=+.|..|++..+|.+.+.
T Consensus 33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~ 92 (229)
T 2yle_A 33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLA 92 (229)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEEC
T ss_pred ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceecc
Confidence 48899987543 56999999999999999987762210 10112234678888888877654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.66 E-value=0.17 Score=54.29 Aligned_cols=34 Identities=15% Similarity=0.304 Sum_probs=29.4
Q ss_pred CCeEeccCCCCCeEEcCCCcEEEEeeccceecccc
Q 046097 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 204 ~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~~ 238 (603)
..++|+|+.+.||+ +.++.+.|+||..|......
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~~~~ 295 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAINFAG 295 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEEEEHH
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCcCChH
Confidence 36899999999999 88889999999999876543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.28 E-value=0.22 Score=52.59 Aligned_cols=34 Identities=26% Similarity=0.316 Sum_probs=28.6
Q ss_pred CeEeccCCCCCeEE------cCCCcEEEEeeccceecccc
Q 046097 205 PVIHGDIKPSNILL------DGDFKAKIGDFGLARLKTED 238 (603)
Q Consensus 205 gIVHrDLKp~NILl------d~~~~vKL~DFGlA~~~~~~ 238 (603)
.++|+|+.+.|||+ +++..+.|+||.+|......
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~~~ 284 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRG 284 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEEHH
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCCCch
Confidence 36799999999999 45677999999999887654
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=87.60 E-value=0.91 Score=32.68 Aligned_cols=26 Identities=15% Similarity=0.349 Sum_probs=11.3
Q ss_pred chhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046097 20 HFLPAILAGTLVLTCFILIIITIFTYR 46 (603)
Q Consensus 20 ~~i~aii~~~l~~~~~v~i~~~i~~~r 46 (603)
..+.+.++| +++++++.+++++|..|
T Consensus 12 ~~Ia~~vVG-vll~vi~~l~~~~~~RR 37 (44)
T 2jwa_A 12 TSIISAVVG-ILLVVVLGVVFGILIKR 37 (44)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHH-HHHHHHHHHHHHhheeh
Confidence 445555555 33333333344444333
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.72 E-value=2.1 Score=30.86 Aligned_cols=17 Identities=29% Similarity=0.536 Sum_probs=6.1
Q ss_pred HHHHHHHHHHHHHHHHH
Q 046097 27 AGTLVLTCFILIIITIF 43 (603)
Q Consensus 27 ~~~l~~~~~v~i~~~i~ 43 (603)
++.+++++++++++++|
T Consensus 18 VgGv~~~~ii~~~~~~~ 34 (44)
T 2ks1_B 18 VGALLLLLVVALGIGLF 34 (44)
T ss_dssp HHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHH
Confidence 33333333333333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 603 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-39 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-18 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-39 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-11 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-11 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-37 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-10 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-12 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-35 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-09 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-35 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-12 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-11 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-34 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-10 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-13 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-13 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-33 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-11 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-15 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-16 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-11 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-14 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-32 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-13 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-14 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-04 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-13 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-31 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-15 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-31 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-11 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-12 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-12 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-11 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-11 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-07 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-30 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-14 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-30 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-09 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-08 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-29 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-12 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-09 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-05 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-28 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-07 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-09 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-13 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-11 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-06 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-06 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-06 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-26 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-09 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-07 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-26 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-09 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-07 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-12 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-09 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-04 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-09 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-06 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-06 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-07 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-05 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 0.001 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-08 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-22 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-09 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-04 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-06 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-04 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-21 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-09 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-06 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILD-SSGSLQGEREFHNELSLASSLDCPHIVSLL 143
R+G G FG+VYK +AVK+L+ ++ + Q + F NE+ + +I+ +
Sbjct: 14 QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
G+++ + L ++ + E SL L E E K +IA A+G++YLH
Sbjct: 71 GYSTAPQ---LAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHA--- 122
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+IH D+K +NI L D KIGDFGLA +K+
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (204), Expect = 4e-18
Identities = 22/131 (16%), Positives = 48/131 (36%), Gaps = 17/131 (12%)
Query: 446 SGDIPKSGGISSTPSMRGTVCYIAPEY---GGGGLLSEKCDVYSFGVLILVLISGRRPLQ 502
+ + G + G++ ++APE S + DVY+FG+++ L++G+ P
Sbjct: 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-- 208
Query: 503 VTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSK 562
+ N + G L P + + + + CL++ +
Sbjct: 209 --------YSNINNRDQIIFMVGRGYL----SPDLSKVRSNCPKAMKRLMAECLKKKRDE 256
Query: 563 RLTMKDIVEML 573
R I+ +
Sbjct: 257 RPLFPQILASI 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 6e-39
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 7/160 (4%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
F + LG G G V+K S +A K++ + EL + + P+IV
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
G + + E M+ SL L + +++I + KGL YL
Sbjct: 68 GFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLM 240
++H D+KPSNIL++ + K+ DFG++ + +
Sbjct: 123 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 160
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.5 bits (154), Expect = 2e-11
Identities = 25/140 (17%), Positives = 51/140 (36%), Gaps = 24/140 (17%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTAS--------- 506
S S GT Y++PE G S + D++S G+ ++ + GR P+ +
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217
Query: 507 ----------PMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALL-- 554
P L S+ + +L+D ++ ++
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
Query: 555 ---CLQRSPSKRLTMKDIVE 571
CL ++P++R +K ++
Sbjct: 278 VNKCLIKNPAERADLKQLMV 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-39
Identities = 43/158 (27%), Positives = 68/158 (43%), Gaps = 4/158 (2%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLL 143
+G G +G K S + L K LD + E++ +E++L L P+IV
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLD-RKCEELMEWNKRFEIAIDIAKGLEYLH--H 200
DR L ++ E E L + K + ++ + + L+ H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
V+H D+KP+N+ LDG K+GDFGLAR+ D
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.9 bits (150), Expect = 3e-11
Identities = 25/120 (20%), Positives = 45/120 (37%), Gaps = 19/120 (15%)
Query: 452 SGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEF 511
+ S + GT Y++PE +EK D++S G L+ L + P F
Sbjct: 165 NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----------F 214
Query: 512 ERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE 571
+ A ++ GK + P +S + I L R ++++I+E
Sbjct: 215 TAFSQKELAGKIR-EGKFRRI--PYRYSDE------LNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 3e-37
Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 10/165 (6%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--REFHNELSLASSLDCPH 138
FS +GHG FG+VY A +S+ +A+K + SG E ++ E+ L P+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+ G L+ E + + +K ++ + + +GL YL
Sbjct: 77 TIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYL 131
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEG 243
H +IH D+K NILL K+GDFG A + G
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG 173
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 58.5 bits (141), Expect = 7e-10
Identities = 26/120 (21%), Positives = 44/120 (36%), Gaps = 21/120 (17%)
Query: 455 ISSTPSMRGTVCYIAPEY---GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEF 511
++ S GT ++APE G K DV+S G+ + L + P
Sbjct: 165 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------L 214
Query: 512 ERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE 571
N +S +A N P++ S + CLQ+ P R T + +++
Sbjct: 215 FNMNAMSALYHIAQNE------SPALQSGHWSEYF--RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (343), Expect = 1e-36
Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 19/182 (10%)
Query: 69 FSYNLIRRATASFSPS---------NRLGHGGFGSVYKAVVPSSSQ---PLAVKILDSSG 116
F++ A F+ +G G FG V + + +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 117 SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCE 176
+ + R+F +E S+ D P+++ L G + +++I E MEN SL R+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENGSLDS--FLRQND 122
Query: 177 ELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236
+ + IA G++YL +H D+ NIL++ + K+ DFGL+R
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 237 ED 238
+D
Sbjct: 180 DD 181
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 65.5 bits (159), Expect = 3e-12
Identities = 22/126 (17%), Positives = 42/126 (33%), Gaps = 18/126 (14%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
+S + + + APE + DV+S+G+++ ++S P + +
Sbjct: 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER------PYWDMTNQD 241
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTG 575
+I+ Q D P + L C Q+ + R IV L
Sbjct: 242 VINAIEQ--------DYRLPPPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 576 EAEPPH 581
P+
Sbjct: 290 MIRNPN 295
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-35
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 8/154 (5%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG G FG VYKA +S A K++D+ S + ++ E+ + +S D P+IV LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLD 76
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
L ++ E ++ +L+ + + ++ + L YLH +
Sbjct: 77 AFYYEN--NLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLH---DN 129
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+IH D+K NIL D K+ DFG++ T
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.8 bits (134), Expect = 4e-09
Identities = 23/125 (18%), Positives = 42/125 (33%), Gaps = 22/125 (17%)
Query: 452 SGGISSTPSMRGTVCYIAPEY-----GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTAS 506
+ I S GT ++APE K DV+S G+ ++ + P
Sbjct: 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP------ 214
Query: 507 PMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTM 566
N + ++A + L PS S + CL+++ R T
Sbjct: 215 ----HHELNPMRVLLKIA-KSEPPTLAQPSRWSSN------FKDFLKKCLEKNVDARWTT 263
Query: 567 KDIVE 571
+++
Sbjct: 264 SQLLQ 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-35
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 8/160 (5%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLL 143
+G G F +VYK + ++ +A L + ER+ F E + L P+IV
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 144 GF--ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
++ + + +VL+ ELM + +L+ L K M+ I KGL++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTR 131
Query: 202 CEPPVIHGDIKPSNILLDG-DFKAKIGDFGLARLKTEDLM 240
PP+IH D+K NI + G KIGD GLA LK
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.6 bits (162), Expect = 1e-12
Identities = 22/116 (18%), Positives = 45/116 (38%), Gaps = 18/116 (15%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
S ++ GT ++APE E DVY+FG+ +L + + P +
Sbjct: 168 SFAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYP----------YSECQ 216
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE 571
+ + +G D K+ I C++++ +R ++KD++
Sbjct: 217 NAAQIYRRVTSGVKPASFDKVAIPEVKE-------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-35
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 10/154 (6%)
Query: 87 LGHGGFGSVYKAVVPSSS--QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
LG G FGSV + V +A+K+L E E + LD P+IV L+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ L+L+ E+ L L+ ++ E + + E+ ++ G++YL
Sbjct: 77 VC---QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE---K 128
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ N+LL AKI DFGL++ D
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.0 bits (150), Expect = 4e-11
Identities = 16/124 (12%), Positives = 41/124 (33%), Gaps = 18/124 (14%)
Query: 450 PKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMS 509
++ + + + + APE S + DV+S+GV + +S + P
Sbjct: 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK------PYK 214
Query: 510 EFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
+ + ++++ Q + P +++L C R +
Sbjct: 215 KMKGPEVMAFIEQ-GKRMECPPECPPELYAL-----------MSDCWIYKWEDRPDFLTV 262
Query: 570 VEML 573
+ +
Sbjct: 263 EQRM 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 3e-34
Identities = 43/158 (27%), Positives = 63/158 (39%), Gaps = 8/158 (5%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
+ LG G +G V AV + + +AVKI+D ++ E+ + L+ ++V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
G R G L E L D + M + G+ YLH
Sbjct: 67 KFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ H DIKP N+LLD KI DFGLA + +
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.7 bits (139), Expect = 9e-10
Identities = 25/113 (22%), Positives = 44/113 (38%), Gaps = 18/113 (15%)
Query: 460 SMRGTVCYIAPEY-GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLIS 518
M GT+ Y+APE +E DV+S G+++ +++G P S
Sbjct: 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP-------------S 210
Query: 519 WARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE 571
+ Q + K +D + + L +PS R+T+ DI +
Sbjct: 211 DSCQEYSDWKEKKTYLNPWKKIDSA----PLALLHKILVENPSARITIPDIKK 259
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 6e-34
Identities = 51/163 (31%), Positives = 71/163 (43%), Gaps = 10/163 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
RLG G FG V+ +AVK L F E +L L +V L
Sbjct: 19 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ + +I E MEN SL D L +L NK ++A IA+G+ ++ E
Sbjct: 76 VVTQEP---IYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---ER 128
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVK 247
IH D++ +NIL+ KI DFGLARL ++ E K
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.8 bits (165), Expect = 3e-13
Identities = 23/131 (17%), Positives = 46/131 (35%), Gaps = 18/131 (13%)
Query: 443 DWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQ 502
D+ + + ++ + + + APE G + K DV+SFG+L+ +++ R
Sbjct: 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI-- 209
Query: 503 VTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSK 562
P +I + +V P + + LC + P
Sbjct: 210 ----PYPGMTNPEVIQNLE------RGYRMVRPDNCPEE------LYQLMRLCWKERPED 253
Query: 563 RLTMKDIVEML 573
R T + +L
Sbjct: 254 RPTFDYLRSVL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-33
Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 10/154 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+G G FG V +AVK + + + Q F E S+ + L ++V LLG
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLG 67
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ +G L ++ E M SL D L R L + + ++D+ + +EYL
Sbjct: 68 VIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLEG---N 122
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ N+L+ D AK+ DFGL + +
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.3 bits (164), Expect = 4e-13
Identities = 23/118 (19%), Positives = 42/118 (35%), Gaps = 18/118 (15%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
S+ + + V + APE S K DV+SFG+L+ + S R P +
Sbjct: 155 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV------PYPRIPLKD 208
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEML 573
++ + Y D P+++ + C + R + + E L
Sbjct: 209 VVPRVEK-GYKMDAPDGCPPAVYEV-----------MKNCWHLDAAMRPSFLQLREQL 254
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 4e-33
Identities = 47/162 (29%), Positives = 67/162 (41%), Gaps = 10/162 (6%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS--GSLQGEREFHNELSLASSLDCPH 138
F LG G FG+VY A S LA+K+L + E + E+ + S L P+
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
I+ L G+ D R+ LI E ++ L + + ++A L Y
Sbjct: 68 ILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLM 240
H VIH DIKP N+LL + KI DFG +
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.3 bits (151), Expect = 3e-11
Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 20/121 (16%)
Query: 451 KSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSE 510
S ++ GT+ Y+ PE G + EK D++S GVL + G+ P + +
Sbjct: 154 VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE----ANTY 209
Query: 511 FERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIV 570
E IS D V L L+ +PS+R +++++
Sbjct: 210 QETYKRISRVE-----FTFPDFVTEGARDL-----------ISRLLKHNPSQRPMLREVL 253
Query: 571 E 571
E
Sbjct: 254 E 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-33
Identities = 41/160 (25%), Positives = 65/160 (40%), Gaps = 15/160 (9%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
+G G FG V++ + +AVKI S RE E+ L +I+ +
Sbjct: 10 SIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAA 65
Query: 146 ASDRRGR--RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC- 202
+ G +L L+ + E+ SL D L + ++A+ A GL +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 203 ----EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+P + H D+K NIL+ + I D GLA
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 2e-15
Identities = 18/126 (14%), Positives = 39/126 (30%), Gaps = 8/126 (6%)
Query: 457 STPSMRGTVCYIAPEY------GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSE 510
+ GT Y+APE ++ D+Y+ G++ + +
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 511 FERANLISWARQLAYNGKLLDLVDPSI--HSLDKDQALLCITIALLCLQRSPSKRLTMKD 568
+ + + + P+I + + I C + + RLT
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 569 IVEMLT 574
I + L+
Sbjct: 288 IKKTLS 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 7e-33
Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 10/167 (5%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
+ +G G FG V+ + +A+K + E +F E + L P +V
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLV 63
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
L G + + L++E ME+ L D R L + +D+ +G+ +
Sbjct: 64 QLYGVCLE--QAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGM---AY 116
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVK 247
E VIH D+ N L+ + K+ DFG+ R +D K
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 163
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.4 bits (190), Expect = 2e-16
Identities = 27/136 (19%), Positives = 42/136 (30%), Gaps = 18/136 (13%)
Query: 443 DWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQ 502
D+ +S+ + V + +PE S K DV+SFGVL+ + S +
Sbjct: 144 DFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203
Query: 503 VTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSK 562
S E + L P + S I C + P
Sbjct: 204 ENRSNSEVVEDIS------------TGFRLYKPRLASTH------VYQIMNHCWKERPED 245
Query: 563 RLTMKDIVEMLTGEAE 578
R ++ L AE
Sbjct: 246 RPAFSRLLRQLAEIAE 261
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (315), Expect = 8e-33
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 8/158 (5%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
+ ++LG G +G VY+ V S +AVK L EF E ++ + P++V
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLV 76
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
LLG + +I E M +L D L + +E+ +A I+ +EYL
Sbjct: 77 QLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLE- 132
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ IH D+ N L+ + K+ DFGL+RL T D
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 61.3 bits (148), Expect = 6e-11
Identities = 20/131 (15%), Positives = 42/131 (32%), Gaps = 18/131 (13%)
Query: 443 DWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQ 502
D+ + ++ + + + APE S K DV++FGVL+ + +
Sbjct: 158 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-- 215
Query: 503 VTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSK 562
P + + + + D + + C Q +PS
Sbjct: 216 ----PYPGIDLSQVYELLEK--------DYRMERPEGCPEK----VYELMRACWQWNPSD 259
Query: 563 RLTMKDIVEML 573
R + +I +
Sbjct: 260 RPSFAEIHQAF 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-32
Identities = 39/158 (24%), Positives = 66/158 (41%), Gaps = 10/158 (6%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
+ LG G FG V +A+K++ E EF E + +L +V
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLV 62
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
L G + R + +I E M N L + L + + + + E+ D+ + +EYL
Sbjct: 63 QLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES 118
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ N L++ K+ DFGL+R +D
Sbjct: 119 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.5 bits (172), Expect = 4e-14
Identities = 27/131 (20%), Positives = 46/131 (35%), Gaps = 18/131 (13%)
Query: 443 DWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQ 502
D+ +S+ + V + PE S K D+++FGVL+ + S +
Sbjct: 143 DFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP- 201
Query: 503 VTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSK 562
+ER A +A + L L P + S TI C +
Sbjct: 202 --------YERFTNSETAEHIA---QGLRLYRPHLASEK------VYTIMYSCWHEKADE 244
Query: 563 RLTMKDIVEML 573
R T K ++ +
Sbjct: 245 RPTFKILLSNI 255
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 6e-32
Identities = 50/171 (29%), Positives = 79/171 (46%), Gaps = 13/171 (7%)
Query: 73 LIRRATAS-FSPSNRLGHGGFGSVYKAVVPSSSQ----PLAVKILDSSGSLQGEREFHNE 127
L+R + F LG G FG+VYK + + P+A+K L + S + +E +E
Sbjct: 2 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 128 LSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEI 187
+ +S+D PH+ LLG + LI +LM L D + + K +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDN--IGSQYLLNW 116
Query: 188 AIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ IAKG+ YL ++H D+ N+L+ KI DFGLA+L +
Sbjct: 117 CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.4 bits (169), Expect = 2e-13
Identities = 21/150 (14%), Positives = 46/150 (30%), Gaps = 18/150 (12%)
Query: 446 SGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTA 505
+ + + + ++A E + + + DV+S+GV + L++
Sbjct: 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----- 212
Query: 506 SPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLT 565
P + + S K L P I ++D I + C R
Sbjct: 213 -PYDGIPASEISSILE------KGERLPQPPICTID------VYMIMVKCWMIDADSRPK 259
Query: 566 MKDIVEMLTGEAEPPHLPFEFSPSPPSNFP 595
++++ + A P + P
Sbjct: 260 FRELIIEFSKMARDPQRYLVIQGDERMHLP 289
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 6e-32
Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 10/154 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+LG G FG V+ +++ +A+K L F E + L +V L
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
S+ + ++ E M SL D L + + + ++A IA G+ Y+
Sbjct: 80 VVSEEP---IYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN-- 133
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D++ +NIL+ + K+ DFGLARL ++
Sbjct: 134 -YVHRDLRAANILVGENLVCKVADFGLARLIEDN 166
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.3 bits (174), Expect = 3e-14
Identities = 23/146 (15%), Positives = 47/146 (32%), Gaps = 21/146 (14%)
Query: 443 DWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQ 502
D+ + + ++ + + + APE G + K DV+SFG+L+ L + R
Sbjct: 156 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215
Query: 503 VTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSK 562
++ + + + C ++ P +
Sbjct: 216 PGMVNREVLDQ------------------VERGYRMPCPPECPESLHDLMCQCWRKEPEE 257
Query: 563 RLTMKDIVEMLTG---EAEPPHLPFE 585
R T + + L EP + P E
Sbjct: 258 RPTFEYLQAFLEDYFTSTEPQYQPGE 283
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 123 bits (309), Expect = 2e-31
Identities = 53/165 (32%), Positives = 71/165 (43%), Gaps = 13/165 (7%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNE---LSLASSLD 135
FS +G GGFG VY + + A+K LD QGE NE LSL S+ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 136 CPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGL 195
CP IV + +L I +LM L L A +I GL
Sbjct: 66 CPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGL 120
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLM 240
E++H V++ D+KP+NILLD +I D GLA ++
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.6 bits (97), Expect = 2e-04
Identities = 28/163 (17%), Positives = 51/163 (31%), Gaps = 34/163 (20%)
Query: 449 IPKSGGISSTPSMRGTVCYIAPEY-GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASP 507
+ + GT Y+APE G D +S G ++ L+ G P +
Sbjct: 153 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR----Q 208
Query: 508 MSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLT-- 565
++ + +A +L D P + SL + LQR ++RL
Sbjct: 209 HKTKDKHEIDRMTLTMAV--ELPDSFSPELRSLLEG-----------LLQRDVNRRLGCL 255
Query: 566 ------------MKDIV--EMLTGEAEPPHLPFEFSPSPPSNF 594
+ + + + PP +P + F
Sbjct: 256 GRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAF 298
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (304), Expect = 2e-31
Identities = 45/184 (24%), Positives = 72/184 (39%), Gaps = 31/184 (16%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLD 135
+G G FG V++A P +AVK+L S + +F E +L + D
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 136 CPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL----------------- 178
P+IV LLG + G+ + L++E M L + L +
Sbjct: 75 NPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 179 ----MEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
+ ++ IA +A G+ YL +H D+ N L+ + KI DFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 235 KTED 238
Sbjct: 190 IYSA 193
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 68.0 bits (165), Expect = 5e-13
Identities = 19/133 (14%), Positives = 45/133 (33%), Gaps = 18/133 (13%)
Query: 446 SGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTA 505
S +I + + + + ++ PE + + DV+++GV++ + S
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 506 SPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLT 565
+ + D +I + ++ L + LC + P+ R +
Sbjct: 247 AHEEVIYY------------------VRDGNILACPENCPLELYNLMRLCWSKLPADRPS 288
Query: 566 MKDIVEMLTGEAE 578
I +L E
Sbjct: 289 FCSIHRILQRMCE 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 43/189 (22%), Positives = 74/189 (39%), Gaps = 9/189 (4%)
Query: 53 TAPSDLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQ---PLAV 109
T DL + N + + +I ++ + +G G FG VY + + AV
Sbjct: 1 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60
Query: 110 KILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDA 169
K L+ + +F E + P+++SLLG G L ++ M++ L++
Sbjct: 61 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRN- 118
Query: 170 LLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229
R + +AKG+ +H D+ N +LD F K+ DF
Sbjct: 119 -FIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADF 174
Query: 230 GLARLKTED 238
GLAR +
Sbjct: 175 GLARDMYDK 183
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 2e-15
Identities = 22/125 (17%), Positives = 41/125 (32%), Gaps = 18/125 (14%)
Query: 450 PKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMS 509
+ + + + V ++A E + K DV+SFGVL+ L++ P
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------- 234
Query: 510 EFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
+ N L +LL P + L C R + ++
Sbjct: 235 -YPDVNTFDITVYLLQGRRLL---QPEYCPDP------LYEVMLKCWHPKAEMRPSFSEL 284
Query: 570 VEMLT 574
V ++
Sbjct: 285 VSRIS 289
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-31
Identities = 44/179 (24%), Positives = 68/179 (37%), Gaps = 31/179 (17%)
Query: 86 RLGHGGFGSVYKAVVPSSSQ-----PLAVKILDSSGSLQGEREFHNELSLASSL-DCPHI 139
LG G FG V A S+ +AVK+L +EL + + L +I
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRK--------------------CEELM 179
V+LLG + + LI+E L + L ++ ++
Sbjct: 104 VNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 180 EWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ A +AKG+E+L +H D+ N+L+ KI DFGLAR D
Sbjct: 162 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (153), Expect = 2e-11
Identities = 25/128 (19%), Positives = 46/128 (35%), Gaps = 17/128 (13%)
Query: 446 SGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTA 505
+ DI + R V ++APE G+ + K DV+S+G+L+ + S
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP---- 266
Query: 506 SPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLT 565
+ + + +L NG +D P + + I C KR +
Sbjct: 267 -----YPGIPVDANFYKLIQNGFKMDQ--PFYATEE------IYIIMQSCWAFDSRKRPS 313
Query: 566 MKDIVEML 573
++ L
Sbjct: 314 FPNLTSFL 321
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 6e-31
Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 12/157 (7%)
Query: 85 NRLGHGGFGSVYKAVVPSSS--QPLAVKILDSSGSLQGER-EFHNELSLASSLDCPHIVS 141
LG G FG+V K + +AVKIL + + + E E ++ LD P+IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 142 LLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
++G +L+ E+ E L L + ++ E+ ++ G++YL S
Sbjct: 73 MIGICEAES---WMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+H D+ N+LL AKI DFGL++ D
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (160), Expect = 2e-12
Identities = 21/118 (17%), Positives = 37/118 (31%), Gaps = 18/118 (15%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
+ + V + APE S K DV+SFGVL+ S + P + +
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK------PYRGMKGSE 218
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEML 573
+ + G+ + P+ + + LC R + L
Sbjct: 219 VT----AMLEKGERMGC--PAGCPRE------MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 47/176 (26%), Positives = 74/176 (42%), Gaps = 21/176 (11%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSS--QPLAVKILDSSGSLQGEREFHNELSLASSL-DCP 137
+ +G G FG V KA + A+K + S R+F EL + L P
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL-------------MEWNKR 184
+I++LLG L L E + +L D L + E + +
Sbjct: 72 NIINLLGA--CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 185 FEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLM 240
A D+A+G++YL + IH D+ NIL+ ++ AKI DFGL+R + +
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (157), Expect = 5e-12
Identities = 18/118 (15%), Positives = 37/118 (31%), Gaps = 18/118 (15%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
R V ++A E + + DV+S+GVL+ ++S +
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------PYCGMT 231
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEML 573
+L +L ++ + C + P +R + I+ L
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDE---------VYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 47/175 (26%), Positives = 71/175 (40%), Gaps = 26/175 (14%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPH 138
LG G FG V +A ++ +AVK+L S L +EL + S L + +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL---------------MEWNK 183
IV+LLG + G ++I E L + L ++ + ++
Sbjct: 89 IVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 184 RFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ +AKG+ +L IH D+ NILL KI DFGLAR D
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (153), Expect = 1e-11
Identities = 26/137 (18%), Positives = 46/137 (33%), Gaps = 19/137 (13%)
Query: 441 SQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRP 500
+ DI + R V ++APE + + + DV+S+G+ + L S
Sbjct: 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 501 LQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALL-CITIALLCLQRS 559
S+F + ++ L + A I C
Sbjct: 247 PYPGMPVDSKFYK------------------MIKEGFRMLSPEHAPAEMYDIMKTCWDAD 288
Query: 560 PSKRLTMKDIVEMLTGE 576
P KR T K IV+++ +
Sbjct: 289 PLKRPTFKQIVQLIEKQ 305
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 3e-30
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 10/165 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
++G G G+VY A+ ++ Q +A++ ++ + NE+ + P+IV+ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
G L ++ E + SL D + E M+ + + + + LE+LH +
Sbjct: 85 SYLV--GDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 205 PVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKR 249
VIH DIK NILL D K+ DFG T + V
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.7 bits (152), Expect = 3e-11
Identities = 24/116 (20%), Positives = 45/116 (38%), Gaps = 17/116 (14%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
S +M GT ++APE K D++S G++ + +I G P + N
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----------YLNEN 220
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE 571
+ +A NG + ++ +D CL KR + K++++
Sbjct: 221 PLRALYLIATNGTPELQNPEKLSAIFRD-------FLNRCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 5e-30
Identities = 43/160 (26%), Positives = 65/160 (40%), Gaps = 10/160 (6%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPH 138
F LG G F +V A ++S+ A+KIL+ + E + S LD P
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
V L D +L +N L + RK E A+ + L
Sbjct: 70 FVKLYFTFQD--DEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTAEIVSAL 121
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ +IH D+KP NILL+ D +I DFG A++ + +
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (118), Expect = 4e-07
Identities = 21/114 (18%), Positives = 43/114 (37%), Gaps = 20/114 (17%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
+ S GT Y++PE + D+++ G +I L++G P + + F++
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKII 223
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
+ + + K DLV+ L +KRL +++
Sbjct: 224 KLEYDFPEKFFPKARDLVE-------------------KLLVLDATKRLGCEEM 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 5e-30
Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 11/163 (6%)
Query: 80 SFSPSNRLGHGGFGSVYKAVVPSSSQ----PLAVKILDSSGSLQGEREFHNELSLASSLD 135
+ +G G FG VYK ++ +SS P+A+K L + + + +F E +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 136 CPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGL 195
+I+ L G S + +++I E MEN +L R+ + + + IA G+
Sbjct: 68 HHNIIRLEGVISK--YKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ +H D+ NIL++ + K+ DFGL+R+ +D
Sbjct: 124 ---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 5e-14
Identities = 19/126 (15%), Positives = 42/126 (33%), Gaps = 20/126 (15%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
+T + + + APE + DV+SFG+++ +++ S
Sbjct: 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------- 220
Query: 516 LISWARQLAYNGKLLDLVDPSIH-SLDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLT 574
+++ ++ D + + C Q+ ++R DIV +L
Sbjct: 221 ------------EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
Query: 575 GEAEPP 580
P
Sbjct: 269 KLIRAP 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 118 bits (297), Expect = 7e-30
Identities = 39/155 (25%), Positives = 65/155 (41%), Gaps = 10/155 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
LG G FG V++ ++ A K + + + E+ S L P +V+L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
D +V+IYE M L + + D + M ++ E + KGL ++H +
Sbjct: 92 FED--DNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENN--- 144
Query: 206 VIHGDIKPSNILL--DGDFKAKIGDFGLARLKTED 238
+H D+KP NI+ + K+ DFGL
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 56.2 bits (135), Expect = 4e-09
Identities = 29/159 (18%), Positives = 47/159 (29%), Gaps = 21/159 (13%)
Query: 447 GDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTAS 506
G S GT + APE G + D++S GVL +L+SG P
Sbjct: 171 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG---- 226
Query: 507 PMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTM 566
++ E + + + + D I KD L P+ R+T+
Sbjct: 227 GENDDETLRNV-----KSCDWNMDDSAFSGISEDGKD-------FIRKLLLADPNTRMTI 274
Query: 567 KDIVE-----MLTGEAEPPHLPFEFSPSPPSNFPFKSQK 600
+E +P + K
Sbjct: 275 HQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 313
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 118 bits (297), Expect = 7e-30
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 10/163 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
LG G FG V++ V ++ + K +++ + NE+S+ + L P +++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
D+ +VLI E + L D + + M + +GL+++H E
Sbjct: 95 FEDK--YEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH---EHS 147
Query: 206 VIHGDIKPSNILLD--GDFKAKIGDFGLARLKTEDLMIEGECV 246
++H DIKP NI+ + KI DFGLA D +++
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 190
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 53.5 bits (128), Expect = 3e-08
Identities = 33/150 (22%), Positives = 50/150 (33%), Gaps = 23/150 (15%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
T + APE + D+++ GVL VL+SG P + E
Sbjct: 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA----GEDDLETLQ 238
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEM--L 573
+ + + + S+ KD LQ+ P KRLT+ D +E L
Sbjct: 239 NV-----KRCDWEFDEDAFSSVSPEAKD-------FIKNLLQKEPRKRLTVHDALEHPWL 286
Query: 574 TGEAEPPHLPFEFSPSPPSNFPFKSQKKAR 603
G+ S P S + QK
Sbjct: 287 KGDHSNLT-----SRIPSSRYNKIRQKIKE 311
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-29
Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 13/159 (8%)
Query: 85 NRLGHGGFGSVYKAVVPSSS---QPLAVKIL--DSSGSLQGEREFHNELSLASSLDCPHI 139
+LG G FG V + + S +AVK L D + +F E++ SLD ++
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
+ L G + ++ EL SL D RK + A+ +A+G+ YL
Sbjct: 74 IRLYGVVLTPP---MKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
IH D+ N+LL KIGDFGL R ++
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (155), Expect = 7e-12
Identities = 20/123 (16%), Positives = 37/123 (30%), Gaps = 18/123 (14%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
+ + APE S D + FGV + + + + + N
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---------WIGLN 219
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEMLTG 575
++ G+ L P +D + + C P R T + + L
Sbjct: 220 GSQILHKIDKEGERL----PRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL- 270
Query: 576 EAE 578
EA+
Sbjct: 271 EAQ 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-29
Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 11/165 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQP---LAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSL 142
+G G FG V++ + S P +A+K + S +F E D PHIV L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
+G ++ + +I EL L+ + + ++ A ++ L YL
Sbjct: 74 IGVITENP---VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLE--- 125
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVK 247
+H DI N+L+ + K+GDFGL+R + + K
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.1 bits (137), Expect = 1e-09
Identities = 20/132 (15%), Positives = 40/132 (30%), Gaps = 18/132 (13%)
Query: 443 DWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQ 502
D+ + + + ++APE + DV+ FGV + ++
Sbjct: 151 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210
Query: 503 VTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSK 562
R I +L + P+++SL C PS+
Sbjct: 211 QGVKNNDVIGR---IENGERL----PMPPNCPPTLYSL-----------MTKCWAYDPSR 252
Query: 563 RLTMKDIVEMLT 574
R ++ L+
Sbjct: 253 RPRFTELKAQLS 264
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 8e-29
Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 13/169 (7%)
Query: 75 RRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL 134
R S++ + +G+G FG VY+A + S + +A+K + LQ +R + EL + L
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKL 70
Query: 135 DCPHIVSLLGF----ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAID 190
D +IV L F + L L+ + + + A + ++ +
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 191 IAKGLEYLHHSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGLARLKTED 238
+ + L Y+H + H DIKP N+LLD D K+ DFG A+
Sbjct: 131 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 1e-05
Identities = 27/159 (16%), Positives = 47/159 (29%), Gaps = 21/159 (13%)
Query: 456 SSTPSMRGTVCYIAP-EYGGGGLLSEKCDVYSFGVLILVLISGRRP-------------L 501
S + Y AP G + DV+S G ++ L+ G+ +
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 502 QVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPS 561
+V +P E R ++ K + I + L+ +P+
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE----AIALCSRLLEYTPT 292
Query: 562 KRLTMKDIVEM--LTGEAEPPH-LPFEFSPSPPSNFPFK 597
RLT + +P LP NF +
Sbjct: 293 ARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ 331
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-28
Identities = 35/151 (23%), Positives = 61/151 (40%), Gaps = 11/151 (7%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
LG G FG V++ V SS + K + G + E+S+ + +I+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHES 69
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
LV+I+E + + + + E + + + + L++LH
Sbjct: 70 FES--MEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLH---SHN 122
Query: 206 VIHGDIKPSNILLD--GDFKAKIGDFGLARL 234
+ H DI+P NI+ KI +FG AR
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (123), Expect = 1e-07
Identities = 20/116 (17%), Positives = 37/116 (31%), Gaps = 16/116 (13%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
+ + Y APE ++S D++S G L+ VL+SG P + +
Sbjct: 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL----AETNQQIIE 213
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE 571
I + + I D L + R+T + ++
Sbjct: 214 NI-----MNAEYTFDEEAFKEISIEAMD-------FVDRLLVKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (282), Expect = 3e-28
Identities = 35/165 (21%), Positives = 64/165 (38%), Gaps = 5/165 (3%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIV 140
+ + LG G F V A + + +A+K + E NE+++ + P+IV
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
+L G L LI +L+ L D ++++ + + ++YLH
Sbjct: 71 ALDDIYES--GGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHD 125
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGEC 245
LD D K I DFGL++++ ++ C
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 170
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 57.4 bits (138), Expect = 1e-09
Identities = 30/150 (20%), Positives = 51/150 (34%), Gaps = 19/150 (12%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
S + GT Y+APE S+ D +S GV+ +L+ G P F N
Sbjct: 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----------FYDEN 213
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEM--L 573
Q+ + P + +++ P KR T + ++ +
Sbjct: 214 DAKLFEQILKAE--YEFDSPYWDDISDS----AKDFIRHLMEKDPEKRFTCEQALQHPWI 267
Query: 574 TGE-AEPPHLPFEFSPSPPSNFPFKSQKKA 602
G+ A ++ S NF K+A
Sbjct: 268 AGDTALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-28
Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLD 135
+ S LG G FG VY+ V +A+K ++ + S++ EF NE S+ +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 136 CPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEEL-------MEWNKRFEIA 188
C H+V LLG S +G+ ++I ELM L+ L + +K ++A
Sbjct: 82 CHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 189 IDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+IA G+ YL+ + +H D+ N ++ DF KIGDFG+ R E
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.0 bits (165), Expect = 5e-13
Identities = 28/143 (19%), Positives = 52/143 (36%), Gaps = 20/143 (13%)
Query: 448 DIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASP 507
DI ++ V +++PE G+ + DV+SFGV++ + + S
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 508 MSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMK 567
+ G LLD D + + + +C Q +P R +
Sbjct: 242 E----------QVLRFVMEGGLLDKPD--------NCPDMLFELMRMCWQYNPKMRPSFL 283
Query: 568 DIVEMLTGEAEPP--HLPFEFSP 588
+I+ + E EP + F +S
Sbjct: 284 EIISSIKEEMEPGFREVSFYYSE 306
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 45/172 (26%), Positives = 70/172 (40%), Gaps = 21/172 (12%)
Query: 85 NRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI 139
LG G FG V +A ++ + +AVK+L + R +EL + +
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCE-------------ELMEWNKRFE 186
V L A + G L++I E + +L L ++ E + +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 187 IAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ +AKG+E+L IH D+ NILL KI DFGLAR +D
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.6 bits (151), Expect = 2e-11
Identities = 26/133 (19%), Positives = 45/133 (33%), Gaps = 17/133 (12%)
Query: 441 SQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRP 500
+ DI K R + ++APE + + + DV+SFGVL+ + S
Sbjct: 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
Query: 501 LQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSP 560
+ + + G + D + + L C P
Sbjct: 236 P---------YPGVKIDEEFCRRLKEGTRMRAPDYTTPEM--------YQTMLDCWHGEP 278
Query: 561 SKRLTMKDIVEML 573
S+R T ++VE L
Sbjct: 279 SQRPTFSELVEHL 291
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 110 bits (275), Expect = 2e-27
Identities = 38/167 (22%), Positives = 68/167 (40%), Gaps = 17/167 (10%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--------QGEREFHNELSLAS 132
+ P LG G V + + + + AVKI+D +G + E+ +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 133 SL-DCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDI 191
+ P+I+ L L+++LM+ L D L ++ + + +I +
Sbjct: 65 KVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119
Query: 192 AKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ + LH ++H D+KP NILLD D K+ DFG +
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 47.4 bits (112), Expect = 2e-06
Identities = 20/122 (16%), Positives = 37/122 (30%), Gaps = 22/122 (18%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLL------SEKCDVYSFGVLILVLISGRRPLQVTASPMS 509
+ GT Y+APE + ++ D++S GV++ L++G P
Sbjct: 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW----HRK 219
Query: 510 EFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDI 569
+ +I P + L P KR T ++
Sbjct: 220 QMLMLRMIMSGN--------YQFGSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEA 267
Query: 570 VE 571
+
Sbjct: 268 LA 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (275), Expect = 3e-27
Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 10/156 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKIL--DSSGSLQGEREFHNELSLASSLDCPHIVSL 142
LG G FG V+ + + A+K+L + L+ ++E + S + P I+ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 143 LGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC 202
G D +++ +I + +E L + + A ++ LEYLH
Sbjct: 70 WGTFQD--AQQIFMIMDYIEGGELFS---LLRKSQRFPNPVAKFYAAEVCLALEYLH--- 121
Query: 203 EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+I+ D+KP NILLD + KI DFG A+ +
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.2 bits (109), Expect = 5e-06
Identities = 31/152 (20%), Positives = 56/152 (36%), Gaps = 37/152 (24%)
Query: 460 SMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISW 519
++ GT YIAPE ++ D +SFG+LI +++G P ++ M +E
Sbjct: 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYE------- 211
Query: 520 ARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLT-------------- 565
+ L + + + L + R S+RL
Sbjct: 212 -KILNAELRFPPFFNEDVKDLLSR-----------LITRDLSQRLGNLQNGTEDVKNHPW 259
Query: 566 MKDIV--EMLTGEAEPPHLP-FEFSPSPPSNF 594
K++V ++L+ E P+ P + S F
Sbjct: 260 FKEVVWEKLLSRNIETPYEPPIQQGQGDTSQF 291
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 9e-27
Identities = 35/155 (22%), Positives = 64/155 (41%), Gaps = 7/155 (4%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLG 144
+ +G G +G V A + +A+K + + E+ + +I+ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 145 FASDRRGRRLVLIYELME-NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
++ +Y + + LL + + + I +GL+Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---S 127
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
V+H D+KPSN+LL+ KI DFGLAR+ D
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (110), Expect = 5e-06
Identities = 26/165 (15%), Positives = 47/165 (28%), Gaps = 17/165 (10%)
Query: 450 PKSGGISSTPSMRGTVCYIAPEY-GGGGLLSEKCDVYSFGVLILVLISGRRPLQ------ 502
P T Y APE ++ D++S G ++ ++S R
Sbjct: 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
Query: 503 -----VTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQ 557
+ E N I + Y L + L + + + L
Sbjct: 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 280
Query: 558 RSPSKRLTMKDIVEM--LTGEAEPPHLPFEFSPSPPSNFPFKSQK 600
+P KR+ ++ + L +P P P F +
Sbjct: 281 FNPHKRIEVEQALAHPYLEQYYDPSDEPI---AEAPFKFDMELDD 322
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 37/157 (23%), Positives = 65/157 (41%), Gaps = 14/157 (8%)
Query: 87 LGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF- 145
LG G G V + + + A+K+L + E E H CPHIV ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA-----SQCPHIVRIVDVY 74
Query: 146 -ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEP 204
+ L+++ E ++ L + + ++ + EI I + ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFS-RIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 205 PVIHGDIKPSNILLD---GDFKAKIGDFGLARLKTED 238
+ H D+KP N+L + K+ DFG A+ T
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.6 bits (136), Expect = 3e-09
Identities = 25/148 (16%), Positives = 57/148 (38%), Gaps = 14/148 (9%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
+S + T Y+APE G + CD++S GV++ +L+ G P F +
Sbjct: 168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----------FYSNH 217
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEM--L 573
++ + + ++ P+ + + + + L+ P++R+T+ + + +
Sbjct: 218 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEV--KMLIRNLLKTEPTQRMTITEFMNHPWI 275
Query: 574 TGEAEPPHLPFEFSPSPPSNFPFKSQKK 601
+ P P S + K
Sbjct: 276 MQSTKVPQTPLHTSRVLKEDKERWEDVK 303
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-26
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 12/167 (7%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE----REFHNELSLASSLDCPHIV 140
+ LG G F +VYKA +++Q +A+K + + + R E+ L L P+I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
LL + + L+++ ME + + ++ + + +GLEYLH
Sbjct: 64 GLLDAFGHKS--NISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVK 247
++H D+KP+N+LLD + K+ DFGLA+ V
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 162
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (120), Expect = 2e-07
Identities = 24/143 (16%), Positives = 43/143 (30%), Gaps = 18/143 (12%)
Query: 463 GTVCYIAPE-YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFER-------A 514
T Y APE G + D+++ G ++ L+ L S + + R
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTRIFETLGTP 220
Query: 515 NLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALL--CLQRSPSKRLTMKDIVEM 572
W + + P I A + L+ +P R+T ++M
Sbjct: 221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
Query: 573 LTGEAEPPHLPFEFSPSPPSNFP 595
+ P+P P
Sbjct: 281 -------KYFSNRPGPTPGCQLP 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 106 bits (265), Expect = 3e-26
Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKIL--DSSGSLQGEREFHNELSLASSLDCPHIVSLL 143
LG GG V+ A + +AVK+L D + F E A++L+ P IV++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 144 GF--ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS 201
A G ++ E ++ +L+D + M + E+ D + L +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFS--- 127
Query: 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+ +IH D+KP+NI++ K+ DFG+AR
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR 159
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 55.9 bits (134), Expect = 3e-09
Identities = 26/120 (21%), Positives = 47/120 (39%), Gaps = 17/120 (14%)
Query: 455 ISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERA 514
++ T ++ GT Y++PE G + + DVYS G ++ +++G P F
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----------FTGD 217
Query: 515 NLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRL-TMKDIVEML 573
+ +S A Q + S D + L L ++P R T ++ L
Sbjct: 218 SPVSVAYQHVREDPIPPSARHEGLSAD------LDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-26
Identities = 41/170 (24%), Positives = 71/170 (41%), Gaps = 8/170 (4%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHI 139
F ++G G +G VYKA + + +A+K + +G E+SL L+ P+I
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 140 VSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH 199
V LL +L L++E + + +D + + +GL +
Sbjct: 64 VKLLDVIHT--ENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC- 118
Query: 200 HSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGECVKKR 249
V+H D+KP N+L++ + K+ DFGLAR + V
Sbjct: 119 --HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 166
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.0 bits (121), Expect = 2e-07
Identities = 20/158 (12%), Positives = 39/158 (24%), Gaps = 12/158 (7%)
Query: 437 GRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLIS 496
G D+ + T + G S D++S G + +++
Sbjct: 139 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198
Query: 497 GRRP---------LQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALL 547
R L + + Y +
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDED 258
Query: 548 CITIALLCLQRSPSKRLTMKDIVEM--LTGEAEP-PHL 582
++ L P+KR++ K + +P PHL
Sbjct: 259 GRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-25
Identities = 46/175 (26%), Positives = 72/175 (41%), Gaps = 26/175 (14%)
Query: 85 NRLGHGGFGSVYKAV-------VPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DC 136
LG G FG V A P+ +AVK+L S + + + +E+ + +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 137 PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKC-------------EELMEWNK 183
+I++LLG + L +I E +L++ L R+ EE +
Sbjct: 79 KNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 184 RFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
A +A+G+EYL IH D+ N+L+ D KI DFGLAR
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.3 bits (158), Expect = 3e-12
Identities = 30/133 (22%), Positives = 49/133 (36%), Gaps = 18/133 (13%)
Query: 441 SQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRP 500
+ + DI T + R V ++APE + + + DV+SFGVL+ + +
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
Query: 501 LQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSP 560
P L + G +D PS + + + C P
Sbjct: 237 ------PYPGVPVEELFKLLK----EGHRMDK--PSNCTNE------LYMMMRDCWHAVP 278
Query: 561 SKRLTMKDIVEML 573
S+R T K +VE L
Sbjct: 279 SQRPTFKQLVEDL 291
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 3e-25
Identities = 37/156 (23%), Positives = 63/156 (40%), Gaps = 11/156 (7%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG---EREFHNELSLASSLDCP 137
F LG G FG V+ A ++Q A+K L L E + L+ + + P
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
+ + + L + E + L + + ++ A +I GL++
Sbjct: 64 FLTHMFCTFQTKE--NLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
L +++ D+K NILLD D KI DFG+ +
Sbjct: 119 L---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCK 151
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (133), Expect = 6e-09
Identities = 34/147 (23%), Positives = 56/147 (38%), Gaps = 32/147 (21%)
Query: 460 SMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISW 519
+ GT YIAPE G + D +SFGVL+ ++ G+ P F +
Sbjct: 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----------FHGQDE--- 208
Query: 520 ARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIV--------- 570
+L ++ ++ + P + + + R P KRL ++ +
Sbjct: 209 -EELFHSIRMDNPFYPRWLEKE------AKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
Query: 571 ---EMLTGEAEPPHLPFEFSPSPPSNF 594
E+ E +PP P SP SNF
Sbjct: 262 NWEELERKEIDPPFRPKVKSPFDCSNF 288
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 8e-25
Identities = 35/157 (22%), Positives = 68/157 (43%), Gaps = 13/157 (8%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGER-EFHNELSLASSLDCPHIVSLL 143
++G G FG V+KA + Q +A+K + +G E+ + L ++V+L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 144 GF------ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
+R + L+++ E+ + + + KR + L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQML-----LNG 129
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234
L++ ++H D+K +N+L+ D K+ DFGLAR
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (96), Expect = 2e-04
Identities = 21/141 (14%), Positives = 45/141 (31%), Gaps = 21/141 (14%)
Query: 448 DIPKSGGISSTPSMRGTVCYIAPE-YGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTAS 506
+ K+ + + T+ Y PE G D++ G ++ + + +Q
Sbjct: 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ---- 223
Query: 507 PMSEFERANLISWA--------------RQLAYNGKLLDLVDPSIHSLDKDQALLCITIA 552
+E + LIS +L +L+ + K +
Sbjct: 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283
Query: 553 LL--CLQRSPSKRLTMKDIVE 571
L+ L P++R+ D +
Sbjct: 284 LIDKLLVLDPAQRIDSDDALN 304
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 40/176 (22%), Positives = 76/176 (43%), Gaps = 9/176 (5%)
Query: 76 RATASFSPSNRLGHGGFGSVYKAV-VPSSSQPLAVKILDSSGSLQGEREFH----NELSL 130
RA + +G G +G V+KA + + + +A+K + +G L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 131 ASSLDCPHIVSLLGFASDRRGRRLVLIYELMEN-RSLQDALLDRKCEELMEWNKRFEIAI 189
+ + P++V L + R R + + E+ LD+ E + ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 190 DIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGEC 245
+ +GL++LH V+H D+KP NIL+ + K+ DFGLAR+ + + +
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 176
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (134), Expect = 4e-09
Identities = 22/120 (18%), Positives = 43/120 (35%), Gaps = 9/120 (7%)
Query: 460 SMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFER------ 513
S+ T+ Y APE + D++S G + + + + +S + + +
Sbjct: 174 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILDVIG 232
Query: 514 -ANLISWARQLAYNGKLLDLVDP-SIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE 571
W R +A + I D L + L CL +P+KR++ +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 4e-24
Identities = 38/163 (23%), Positives = 64/163 (39%), Gaps = 15/163 (9%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSS-----GSLQGEREFHNELSLASSLDCPH-- 138
LG GGFGSVY + S + P+A+K ++ G L E+ L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
++ LL + VLI E E + + ++ + + + +
Sbjct: 71 VIRLLDWFER--PDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHC 126
Query: 199 HHSCEPPVIHGDIKPSNILLDGD-FKAKIGDFGLARLKTEDLM 240
V+H DIK NIL+D + + K+ DFG L + +
Sbjct: 127 ---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 166
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (113), Expect = 1e-06
Identities = 23/113 (20%), Positives = 35/113 (30%), Gaps = 27/113 (23%)
Query: 460 SMRGTVCYIAPEY-GGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLIS 518
GT Y PE+ V+S G+L+ ++ G P FE I
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----------FEHDEEII 217
Query: 519 WARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE 571
+ + S + C + CL PS R T ++I
Sbjct: 218 RGQ----------VFFRQRVSSE------CQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 99 bits (248), Expect = 5e-24
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG-EREFHNELSLASSLDCPHIVSLL 143
++G G +G VYKA + A+K + +G E+S+ L +IV L
Sbjct: 8 EKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
+RLVL++E ++ + CE +E + + G+ Y H +
Sbjct: 67 DVIHT--KKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCH---D 118
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
V+H D+KP N+L++ + + KI DFGLAR
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 46.4 bits (109), Expect = 4e-06
Identities = 20/138 (14%), Positives = 37/138 (26%), Gaps = 9/138 (6%)
Query: 443 DWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRP-- 500
D+ T + G S D++S G + +++G
Sbjct: 143 DFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
Query: 501 -------LQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIAL 553
L + N + Y+ S K I +
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262
Query: 554 LCLQRSPSKRLTMKDIVE 571
L+ P++R+T K +E
Sbjct: 263 KMLKLDPNQRITAKQALE 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 6e-24
Identities = 36/155 (23%), Positives = 63/155 (40%), Gaps = 9/155 (5%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLL 143
++G G +G+V+KA + + +A+K + +G E+ L L +IV L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
+ LV E C ++ + KGL + H
Sbjct: 68 DVLHSDKKLTLV-----FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
V+H D+KP N+L++ + + K+ +FGLAR
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (117), Expect = 5e-07
Identities = 19/147 (12%), Positives = 44/147 (29%), Gaps = 10/147 (6%)
Query: 435 RTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVL 494
R G ++ + + G L S D++S G + L
Sbjct: 136 RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 495 ISGRRPLQVTASPMSEFER----------ANLISWARQLAYNGKLLDLVDPSIHSLDKDQ 544
+ RPL + +R S + Y + S+ ++
Sbjct: 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255
Query: 545 ALLCITIALLCLQRSPSKRLTMKDIVE 571
+ L+ +P +R++ ++ ++
Sbjct: 256 NATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.9 bits (248), Expect = 1e-23
Identities = 37/160 (23%), Positives = 57/160 (35%), Gaps = 10/160 (6%)
Query: 81 FSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGE--REFHNELSLASSLDCPH 138
F LG G FG V ++ + A+KIL + + E + + P
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 139 IVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYL 198
+ +L RL + E L L + E A+ + L
Sbjct: 67 LTALKYAFQT--HDRLCFVMEYANGGELFFHL--SRERVFTEE----RARFYGAEIVSAL 118
Query: 199 HHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTED 238
+ V++ DIK N++LD D KI DFGL + D
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 2e-05
Identities = 25/155 (16%), Positives = 50/155 (32%), Gaps = 36/155 (23%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
++ + GT Y+APE D + GV++ ++ GR P F +
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----------FYNQD 209
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMK-------- 567
+L + ++ P S + ++ L++ P +RL
Sbjct: 210 ----HERLFELILMEEIRFPRTLSPE------AKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
Query: 568 --------DIVEMLTGEAEPPHLPFEFSPSPPSNF 594
+ +++ + PP P S F
Sbjct: 260 EHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYF 294
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 98.8 bits (245), Expect = 3e-23
Identities = 38/164 (23%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC-PHIVSLL 143
+LG G + V++A+ ++++ + VKIL +++ E+ + +L P+I++L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLA 96
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
D R L++E + N + + L +++ RF +I K L+Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKALDYCHSMG- 149
Query: 204 PPVIHGDIKPSNILLDGDF-KAKIGDFGLARLKTEDLMIEGECV 246
++H D+KP N+++D + K ++ D+GLA
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 191
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 39.4 bits (91), Expect = 0.001
Identities = 15/128 (11%), Positives = 36/128 (28%), Gaps = 19/128 (14%)
Query: 463 GTVCYIAPEYG-GGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMS------------ 509
+ + PE + D++S G ++ +I + P
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 510 -EFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALL-----CLQRSPSKR 563
++ + + +N L + ++ L L+ R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 564 LTMKDIVE 571
LT ++ +E
Sbjct: 311 LTAREAME 318
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 96.8 bits (240), Expect = 8e-23
Identities = 30/159 (18%), Positives = 60/159 (37%), Gaps = 15/159 (9%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
R+G G FG +++ ++Q +A+K R+ + L + C I ++ F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAG--CTGIPNVYYF 69
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
+ G VL+ +L+ L C A + ++ +H
Sbjct: 70 GQE--GLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--- 121
Query: 206 VIHGDIKPSNILLD-----GDFKAKIGDFGLARLKTEDL 239
+++ DIKP N L+ + DFG+ + + +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 53.7 bits (128), Expect = 2e-08
Identities = 13/117 (11%), Positives = 32/117 (27%), Gaps = 12/117 (10%)
Query: 457 STPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANL 516
++ GT Y++ G S + D+ + G + + + G P Q + ++
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL-KAATNKQKYER 227
Query: 517 ISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVEML 573
I +Q +L + + + +
Sbjct: 228 IGEKKQSTPLRELCAGFPEEFY-----------KYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 2e-22
Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 17/162 (10%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILD-----SSGSLQGEREFHNELSLASSLDCPHIV 140
LG G F V K S+ A K + SS + E+S+ + P+++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 141 SLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
+L ++ ++LI EL+ L D L +++ + + E I G +++
Sbjct: 77 TLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG---VYY 128
Query: 201 SCEPPVIHGDIKPSNILLDGD----FKAKIGDFGLARLKTED 238
+ H D+KP NI+L + KI DFGLA
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (135), Expect = 3e-09
Identities = 31/141 (21%), Positives = 53/141 (37%), Gaps = 29/141 (20%)
Query: 456 SSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERAN 515
+ ++ GT ++APE L + D++S GV+ +L+SG P
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------- 223
Query: 516 LISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE---- 571
+ A A N + D + +L KD L + P KR+T++D ++
Sbjct: 224 --TLANVSAVNYEFEDEYFSNTSALAKD-------FIRRLLVKDPKKRMTIQDSLQHPWI 274
Query: 572 -------MLTGEAEPPHLPFE 585
L+ P FE
Sbjct: 275 KPKDTQQALSSAWSHP--QFE 293
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 95.3 bits (236), Expect = 7e-22
Identities = 42/179 (23%), Positives = 68/179 (37%), Gaps = 20/179 (11%)
Query: 57 DLKSPNHNHCRRFSYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSS- 115
++P+ N + ++ I+ LG G FG V S A+KILD
Sbjct: 29 KWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKILDKQK 78
Query: 116 -GSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRK 174
L+ NE + +++ P +V L D L ++ E + + L
Sbjct: 79 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGEMFSHLRRIG 136
Query: 175 CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
A I EYLH +I+ D+KP N+L+D ++ DFG A+
Sbjct: 137 R---FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.1 bits (98), Expect = 1e-04
Identities = 29/146 (19%), Positives = 52/146 (35%), Gaps = 26/146 (17%)
Query: 460 SMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISW 519
++ GT +APE ++ D ++ GVLI + +G P P+ +E+
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSGKV 255
Query: 520 ARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLTMKDIVE-------- 571
++ L DL+ + L D +R + + + DI
Sbjct: 256 RFPSHFSSDLKDLLR---NLLQVDLT-----------KRFGNLKNGVNDIKNHKWFATTD 301
Query: 572 ---MLTGEAEPPHLPFEFSPSPPSNF 594
+ + E P +P P SNF
Sbjct: 302 WIAIYQRKVEAPFIPKFKGPGDTSNF 327
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 8e-22
Identities = 36/159 (22%), Positives = 67/159 (42%), Gaps = 13/159 (8%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNELSLASSLDCPHIVSLLG 144
+G G +G+V AV + +A+K L + + + EL L + +++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 145 FASDRRGR----RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH 200
+ L+ M L+ + + ++ + + KGL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIHA 139
Query: 201 SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDL 239
+ H D+KP N+ ++ D + KI DFGLAR ++
Sbjct: 140 AGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEM 175
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (115), Expect = 1e-06
Identities = 19/141 (13%), Positives = 47/141 (33%), Gaps = 15/141 (10%)
Query: 444 WASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRP--- 500
+ + T + ++ D++S G ++ +I+G+
Sbjct: 162 ILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221
Query: 501 ----------LQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCIT 550
++VT +P +EF + + Y L +L S+ + + L +
Sbjct: 222 SDHLDQLKEIMKVTGTPPAEFVQR--LQSDEAKNYMKGLPELEKKDFASILTNASPLAVN 279
Query: 551 IALLCLQRSPSKRLTMKDIVE 571
+ L +R+T + +
Sbjct: 280 LLEKMLVLDAEQRVTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 1e-21
Identities = 43/181 (23%), Positives = 81/181 (44%), Gaps = 18/181 (9%)
Query: 70 SYNLIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGERE-FHNEL 128
++ +++R + +G G G V A + +A+K L Q + + EL
Sbjct: 12 TFTVLKR----YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 129 SLASSLDCPHIVSLLGFASDRR----GRRLVLIYELMENRSLQDALLDRKCEELMEWNKR 184
L ++ +I+SLL + ++ + + L+ ELM+ Q + ++ +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV------IQMELDHERM 121
Query: 185 FEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTEDLMIEGE 244
+ + G+++LH + +IH D+KPSNI++ D KI DFGLAR M+
Sbjct: 122 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178
Query: 245 C 245
Sbjct: 179 V 179
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 27/165 (16%), Positives = 56/165 (33%), Gaps = 28/165 (16%)
Query: 461 MRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRP-------------LQVTASP 507
T Y APE G E D++S G ++ ++ + ++ +P
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 508 MSEFERANLISWARQLAYNGKLLDLVDPSIHS---------LDKDQALLCITIALLCLQR 558
EF + + + K L P + +K +A + L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 559 SPSKRLTMKDIVEM--LTGEAEPPHLPFEFSPSPPSNFPFKSQKK 601
P+KR+++ D ++ + + P E PP + + ++
Sbjct: 298 DPAKRISVDDALQHPYINVW----YDPAEVEAPPPQIYDKQLDER 338
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 91.1 bits (225), Expect = 7e-21
Identities = 32/151 (21%), Positives = 56/151 (37%), Gaps = 13/151 (8%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGF 145
++G G FG +Y ++ + +A+K+ + H E + + + + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 146 ASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205
G V++ EL+ L C +A + +EY+H
Sbjct: 71 -CGAEGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--- 123
Query: 206 VIHGDIKPSNIL---LDGDFKAKIGDFGLAR 233
IH D+KP N L I DFGLA+
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 57.5 bits (138), Expect = 1e-09
Identities = 14/152 (9%), Positives = 38/152 (25%), Gaps = 13/152 (8%)
Query: 423 IDWWLDGFSGELR-TGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGGLLSEK 481
L + ++ + + ++ GT Y + G S +
Sbjct: 134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR 193
Query: 482 CDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLD 541
D+ S G +++ G + +A + K+ ++
Sbjct: 194 DDLESLGYVLMYFNLGS--------LPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 542 KDQALLCITIALLCLQRSPSKRLTMKDIVEML 573
+ T C + + ++
Sbjct: 246 SE----FATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (222), Expect = 4e-20
Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 5/149 (3%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLL 143
+ +G G +GSV A + +AVK L S+ + + EL L + +++ LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 144 GFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCE 203
+ R L+ + D KC++L + + +F + I +GL+Y+H +
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSAD- 141
Query: 204 PPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
+IH D+KPSN+ ++ D + KI DFGLA
Sbjct: 142 --IIHRDLKPSNLAVNEDCELKILDFGLA 168
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (107), Expect = 9e-06
Identities = 27/148 (18%), Positives = 51/148 (34%), Gaps = 22/148 (14%)
Query: 460 SMRGTVCYIAPE-YGGGGLLSEKCDVYSFGVLILVLISGRRP-------------LQVTA 505
T Y APE ++ D++S G ++ L++GR L++
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 506 SPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCLQRSPSKRLT 565
+P +E + AR Y L + + ++ L + + L KR+T
Sbjct: 237 TPGAELLKKISSESARN--YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 566 MKDI------VEMLTGEAEPPHLPFEFS 587
+ + EP P++ S
Sbjct: 295 AAQALAHAYFAQYHDPDDEPVADPYDQS 322
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 1e-18
Identities = 37/155 (23%), Positives = 63/155 (40%), Gaps = 15/155 (9%)
Query: 85 NRLGHGGFGSVYKA---VVPSSSQPLAVKILDSSGSLQGE---REFHNELSLASSL-DCP 137
LG G +G V+ + + A+K+L + +Q E + + P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 138 HIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEY 197
+V+L +L LI + + L L + E E E+ I + + +
Sbjct: 90 FLVTLHYAFQT--ETKLHLILDYINGGELFTHL--SQRERFTEH----EVQIYVGEIVLA 141
Query: 198 LHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232
L H + +I+ DIK NILLD + + DFGL+
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.0 bits (199), Expect = 3e-18
Identities = 24/158 (15%), Positives = 51/158 (32%), Gaps = 22/158 (13%)
Query: 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS---------LQGEREFHNELSLASSLD 135
+G G +V+ VK + G+ F ++ +
Sbjct: 6 KLMGEGKESAVFNCYSEKF-GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 136 CPHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGL 195
+ L G + +Y N L + + ++ + N E+ I + +
Sbjct: 65 FRALQKLQGL-------AVPKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEV 116
Query: 196 EYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233
+H ++HGD+ N+L+ + I DF +
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.2 bits (204), Expect = 7e-18
Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 17/170 (10%)
Query: 86 RLGHGGFGSVYKAVVPSSSQPLAVKIL--DSSGSLQGEREF-------HNELSLASSLDC 136
+LG G F +V+ A ++ +A+KI+ D + E E + + S+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 137 PHIVSLLGFASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLE 196
HI+ LL + + + ++ AL+ + + +I+ + GL+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 197 YLHHSCEPPVIHGDIKPSNILLDGD------FKAKIGDFGLARLKTEDLM 240
Y+H C +IH DIKP N+L++ + KI D G A E
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 38.5 bits (88), Expect = 0.002
Identities = 29/167 (17%), Positives = 43/167 (25%), Gaps = 32/167 (19%)
Query: 461 MRGTVCYIAPEYGGGGLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWA 520
T Y +PE G D++S LI LI+G + + ++
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 521 RQL----------------------------AYNGKLLDLVDPSIHSLDKDQALLCITIA 552
L L+ V + KD+A
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 553 LLCLQRSPSKRLTMKDIVEM----LTGEAEPPHLPFEFSPSPPSNFP 595
LQ P KR +V T E +P S+ P
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIP 355
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 603 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.61 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.26 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.81 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.47 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=412.15 Aligned_cols=151 Identities=27% Similarity=0.391 Sum_probs=134.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||+||+|+++.+++.||||++.........+.+.+|+.+|++++||||+++++++.+. +.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeEEE
Confidence 357999999999999999999999999999999997654444556789999999999999999999999987 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 mEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 99999999999986533 489999999999999999999999 99999999999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=411.17 Aligned_cols=158 Identities=25% Similarity=0.407 Sum_probs=129.4
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|++++++++|||||++++++.+...+.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999999999999999997653 33445678999999999999999999999987655779999
Q ss_pred EEccCCCCHHHHHhhcc-cccccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 158 YELMENRSLQDALLDRK-CEELMEWNKRFEIAIDIAKGLEYLHHSC--EPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~-~~~~l~~~~~l~Ia~qIa~aL~yLHs~~--~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
||||++|+|.+++.... ....+++..++.++.||+.||.|||++. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 2345899999999999999999999861 11499999999999999999999999999976
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 164 ~~ 165 (269)
T d2java1 164 LN 165 (269)
T ss_dssp C-
T ss_pred cc
Confidence 43
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=408.18 Aligned_cols=149 Identities=32% Similarity=0.451 Sum_probs=134.4
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||+||+|+++.+++.||||++.... .......+.+|+.++++++||||+++++++.+. +.+|+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEEE
Confidence 46899999999999999999999999999999986421 112346789999999999999999999999987 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||||++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|...
T Consensus 84 vmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeec
Confidence 999999999999997643 389999999999999999999999 9999999999999999999999999998653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=407.57 Aligned_cols=148 Identities=27% Similarity=0.401 Sum_probs=135.3
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+. +.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC--CEEEEEE
Confidence 57999999999999999999999999999999997643 23456799999999999999999999999987 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||++|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence 999999999987653 389999999999999999999999 99999999999999999999999999997653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=405.60 Aligned_cols=149 Identities=33% Similarity=0.556 Sum_probs=130.4
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
..++|++.+.||+|+||+||+|+.+ ..||||+++... .....+.|.+|+.+|++++|||||++++++.+ ..++
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~ 79 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLA 79 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEE
Confidence 3578999999999999999999863 359999997543 34456789999999999999999999999865 5679
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|||||++|+|.+++.... ..+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 80 lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 9999999999999997543 3489999999999999999999999 9999999999999999999999999999764
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 155 ~ 155 (276)
T d1uwha_ 155 S 155 (276)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=413.06 Aligned_cols=151 Identities=26% Similarity=0.360 Sum_probs=138.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++++.||+|+||+||+|+++.+++.||+|+++..........+.+|+.+|++++|||||+++++|.+. +.+|+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 3578999999999999999999999999999999998765555667899999999999999999999999987 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+|+..
T Consensus 82 VmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999997643 38999999999999999999996 6 8999999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-50 Score=412.09 Aligned_cols=152 Identities=27% Similarity=0.458 Sum_probs=128.0
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCc---eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQ---PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
++|++.++||+|+||+||+|+++.+++ .||||.+.........+.|.+|+.+|++++|||||+++|+|.+. +.++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CEEE
Confidence 456677899999999999999976654 58999987766666678899999999999999999999999876 7899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|||||++|+|.+++.... ..+++.+++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+..
T Consensus 104 iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999999887543 3489999999999999999999999 9999999999999999999999999999865
Q ss_pred cc
Q 046097 236 TE 237 (603)
Q Consensus 236 ~~ 237 (603)
..
T Consensus 179 ~~ 180 (299)
T d1jpaa_ 179 ED 180 (299)
T ss_dssp --
T ss_pred cC
Confidence 43
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=410.16 Aligned_cols=274 Identities=23% Similarity=0.307 Sum_probs=223.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
.++|++++.||+|+||.||+|+++.+++.||||++++.. .......+.+|+.+|++++||||+++++++.+. ..+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--cccc
Confidence 357999999999999999999999999999999996532 122356788999999999999999999999987 8999
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|||||++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+|+..
T Consensus 82 iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred cceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999999999987654 389999999999999999999999 9999999999999999999999999999754
Q ss_pred ccccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcc
Q 046097 236 TEDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGR 315 (603)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (603)
....
T Consensus 156 ~~~~---------------------------------------------------------------------------- 159 (337)
T d1o6la_ 156 ISDG---------------------------------------------------------------------------- 159 (337)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred ccCC----------------------------------------------------------------------------
Confidence 3220
Q ss_pred hhhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCc
Q 046097 316 VKDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNV 395 (603)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (603)
T Consensus 160 -------------------------------------------------------------------------------- 159 (337)
T d1o6la_ 160 -------------------------------------------------------------------------------- 159 (337)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCC
Q 046097 396 GEMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGG 475 (603)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 475 (603)
......+||+.|+|||++.+
T Consensus 160 ------------------------------------------------------------~~~~~~~GT~~Y~aPE~~~~ 179 (337)
T d1o6la_ 160 ------------------------------------------------------------ATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp ------------------------------------------------------------CCBCCCEECGGGCCGGGGSS
T ss_pred ------------------------------------------------------------cccccceeCHHHhhhhhccC
Confidence 01234679999999999999
Q ss_pred CCCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhhc
Q 046097 476 GLLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLC 555 (603)
Q Consensus 476 ~~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 555 (603)
..|+.++|||||||+||||++|+.||...+. .. ........ .+ .++...+..+.+||..|
T Consensus 180 ~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~---~~~~i~~~-~~---------~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ER---LFELILME-EI---------RFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HH---HHHHHHHC-CC---------CCCTTSCHHHHHHHHHH
T ss_pred CCCChhhcccchhhHHHHHHHCCCCCCCcCH-------HH---HHHHHhcC-CC---------CCCccCCHHHHHHHHhh
Confidence 9999999999999999999999999986441 11 11111111 11 11223445688999999
Q ss_pred cCCCCCCCCC-----HHHHHHH-----------hcCCCCCCCCCCccCCCCCCCCC
Q 046097 556 LQRSPSKRLT-----MKDIVEM-----------LTGEAEPPHLPFEFSPSPPSNFP 595 (603)
Q Consensus 556 l~~dP~~Rpt-----~~evl~~-----------l~~~~~~~~~~~~~~~~~~~~~~ 595 (603)
|++||.+||+ +.||++. +.+...||..|-..++...++|.
T Consensus 240 L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~ 295 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSC
T ss_pred ccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcC
Confidence 9999999995 7888773 34667788877766777677764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-50 Score=411.87 Aligned_cols=153 Identities=29% Similarity=0.444 Sum_probs=137.4
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
...++|++.+.||+|+||+||+|+++.+++.||||+++... ...++|.+|+.+|++++|||||+++++|.+. +..+
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeC--CeeE
Confidence 34567888999999999999999999999999999997643 3456799999999999999999999999886 7889
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+|||||++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999999999976433 3489999999999999999999999 9999999999999999999999999999764
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 166 ~ 166 (287)
T d1opja_ 166 T 166 (287)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-49 Score=408.01 Aligned_cols=151 Identities=25% Similarity=0.415 Sum_probs=126.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..+.|++.+.||+|+||+||+|+++.+++.||||++...........+.+|+.+|++++||||+++++++.+. +.+|+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG--GHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS--SEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 3567999999999999999999999999999999997654444456788999999999999999999999987 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc---CCCcEEEEeeccce
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD---GDFKAKIGDFGLAR 233 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld---~~~~vKL~DFGlA~ 233 (603)
|||||++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||+. +++.+||+|||+|+
T Consensus 85 vmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999997643 489999999999999999999999 999999999999995 57899999999987
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 159 ~~ 160 (307)
T d1a06a_ 159 ME 160 (307)
T ss_dssp --
T ss_pred Ec
Confidence 54
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=405.45 Aligned_cols=149 Identities=28% Similarity=0.421 Sum_probs=135.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
+.|++++.||+|+||.||+|+++.+++.||||+++.. .....+.+.+|+++|++++|||||++++++.+. +.+++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CeEEEEE
Confidence 5689999999999999999999999999999999764 334556789999999999999999999999987 8899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|...
T Consensus 89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhcc
Confidence 9999999999876532 3489999999999999999999999 9999999999999999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=400.05 Aligned_cols=148 Identities=26% Similarity=0.483 Sum_probs=128.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.+.||+|+||+||+|.++ +++.||||+++... ...++|.+|+.++++++||||++++|+|.+. +..++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccC--CceEEEE
Confidence 57888999999999999999985 56789999997633 3456799999999999999999999999886 7789999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||+++|+|.+++.... ..+++..++.++.|||.||.|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 80 E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred EecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheecc
Confidence 9999999999987643 3488999999999999999999999 99999999999999999999999999997643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=396.11 Aligned_cols=147 Identities=29% Similarity=0.421 Sum_probs=129.3
Q ss_pred CCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecC--CCCeEEEEE
Q 046097 82 SPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDR--RGRRLVLIY 158 (603)
Q Consensus 82 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~--~~~~~~LVm 158 (603)
++.+.||+|+||+||+|+++.+++.||+|.+.... .....+.+.+|+++|++++|||||++++++.+. ....+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999999999999999986543 344456799999999999999999999998753 235689999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCeEEc-CCCcEEEEeecccee
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPP--VIHGDIKPSNILLD-GDFKAKIGDFGLARL 234 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g--IVHrDLKp~NILld-~~~~vKL~DFGlA~~ 234 (603)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ + |+||||||+|||++ .++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999997643 389999999999999999999998 6 99999999999996 578999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=400.71 Aligned_cols=151 Identities=28% Similarity=0.455 Sum_probs=132.0
Q ss_pred cCCCCCce-eeccCceEEEEEEEcC--CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEE
Q 046097 79 ASFSPSNR-LGHGGFGSVYKAVVPS--SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~-LG~G~fG~Vy~a~~~~--tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
++|.+.+. ||+|+||.||+|.++. ++..||||+++........+.|.+|+++|++++|||||+++|++.+ +.+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeEE
Confidence 45666664 9999999999998754 4557999999876666667889999999999999999999999976 4589
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999999986543 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred cc
Q 046097 236 TE 237 (603)
Q Consensus 236 ~~ 237 (603)
..
T Consensus 160 ~~ 161 (285)
T d1u59a_ 160 GA 161 (285)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=406.33 Aligned_cols=150 Identities=29% Similarity=0.376 Sum_probs=135.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++.+.||+|+||+||+|+++.+++.||||++.... .....+.+.+|+.++++++||||+++++++.+. +.+|+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEE
Confidence 56999999999999999999999999999999986532 122346789999999999999999999999987 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||||++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 86 vmEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999999887654 389999999999999999999999 99999999999999999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=397.40 Aligned_cols=151 Identities=26% Similarity=0.409 Sum_probs=135.7
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-----hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-----LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-----~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~ 152 (603)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.... ....+.+.+|+.+|++++|||||++++++.+. .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--T 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence 4679999999999999999999999999999999865322 12357899999999999999999999999987 8
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC----cEEEEe
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF----KAKIGD 228 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~----~vKL~D 228 (603)
.+|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecc
Confidence 9999999999999999997653 389999999999999999999999 999999999999998776 499999
Q ss_pred eccceecc
Q 046097 229 FGLARLKT 236 (603)
Q Consensus 229 FGlA~~~~ 236 (603)
||+|....
T Consensus 161 fG~a~~~~ 168 (293)
T d1jksa_ 161 FGLAHKID 168 (293)
T ss_dssp CTTCEECT
T ss_pred hhhhhhcC
Confidence 99987653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=408.28 Aligned_cols=155 Identities=28% Similarity=0.420 Sum_probs=131.7
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCc-----eEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQ-----PLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~-----~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~ 150 (603)
..++|++.+.||+|+||+||+|++..+++ .||+|.+...........+.+|+.++.++ +|||||++++++.+.
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~- 113 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 113 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-
Confidence 34678999999999999999999865543 69999997655555557899999999998 799999999999987
Q ss_pred CCeEEEEEEccCCCCHHHHHhhccc--------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKC--------------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGD 210 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~--------------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrD 210 (603)
+.+++|||||++|+|.+++..... ...+++..++.++.||+.||.|||++ +|||||
T Consensus 114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 114 -GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp -SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred -CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 789999999999999999976431 13489999999999999999999999 999999
Q ss_pred CCCCCeEEcCCCcEEEEeeccceecc
Q 046097 211 IKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 211 LKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||+|||++.++.+||+|||+|+...
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~ 215 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIM 215 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGG
T ss_pred CchhccccccCCeEEEeecccccccc
Confidence 99999999999999999999997654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=400.57 Aligned_cols=151 Identities=28% Similarity=0.487 Sum_probs=130.8
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCC----ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSS----QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg----~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
+.|++.++||+|+||.||+|.++.++ ..||||+++..........|.+|+.++++++|||||+++|++.+. ...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC--Cce
Confidence 56788899999999999999987554 469999998766666667899999999999999999999999886 789
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+.++++.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999999886543 3489999999999999999999999 999999999999999999999999999976
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 160 ~~ 161 (283)
T d1mqba_ 160 LE 161 (283)
T ss_dssp --
T ss_pred cc
Confidence 54
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-49 Score=398.66 Aligned_cols=150 Identities=31% Similarity=0.484 Sum_probs=132.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..++|++.+.||+|+||.||+|+++ +++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~i 84 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEE
Confidence 3467888999999999999999985 57889999997532 345679999999999999999999998865 45789
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+++|+|.+++..... ..+++..++.++.||+.||.|||++ +|+||||||+||||++++.+||+|||+|+...
T Consensus 85 v~Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence 9999999999998765443 3489999999999999999999999 99999999999999999999999999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-48 Score=406.80 Aligned_cols=270 Identities=25% Similarity=0.302 Sum_probs=222.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.+. ...++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc--ccccc
Confidence 47999999999999999999999999999999986421 112346789999999999999999999999987 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||+.+|+|..++.... .+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+...
T Consensus 119 v~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999999997654 389999999999999999999999 99999999999999999999999999997643
Q ss_pred cccccccccccccccccCCCccccccchhhhhhhhcCCCCCCCCCCCCcceeeeeccCCCCcccccccccCCCCCCCcch
Q 046097 237 EDLMIEGECVKKRDVNEDNGSILEETESVVTAYEESAGGGNGVDRSPESCVVRVFDAEGGSRRDWWWKQDNGAGSESGRV 316 (603)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (603)
..
T Consensus 193 ~~------------------------------------------------------------------------------ 194 (350)
T d1rdqe_ 193 GR------------------------------------------------------------------------------ 194 (350)
T ss_dssp SC------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 21
Q ss_pred hhhHHhhhhccccccCCCCcccCCCCCCCCCCCchhhHHHHHHHHhhhcCCCCchhhhHHHHHHHHHhhhhcCCCCCCcC
Q 046097 317 KDYVMEWIGSEIKKERPKNEWVASPSSTENNGSSSKLEMKKDRIRKKEKNRKPREWWKEEFCEELTKKKKKRGLNSSNVG 396 (603)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (603)
T Consensus 195 -------------------------------------------------------------------------------- 194 (350)
T d1rdqe_ 195 -------------------------------------------------------------------------------- 194 (350)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccchhHHHHHHhhccccCCCCcccccccCCcccccccccccCCCcCCCCCCCCCCCCcCCcccccCccCccccCCC
Q 046097 397 EMWWQKDEEVVVQERKKRKNKTSRGSIDWWLDGFSGELRTGRRSSQDWASGDIPKSGGISSTPSMRGTVCYIAPEYGGGG 476 (603)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 476 (603)
.....||+.|||||++.+.
T Consensus 195 -------------------------------------------------------------~~~~~Gt~~Y~APE~~~~~ 213 (350)
T d1rdqe_ 195 -------------------------------------------------------------TWTLCGTPEALAPEIILSK 213 (350)
T ss_dssp -------------------------------------------------------------BCCCEECGGGCCHHHHTTC
T ss_pred -------------------------------------------------------------cccccCccccCCHHHHcCC
Confidence 1235699999999999999
Q ss_pred CCCccCCccchhheeeehccCCccCcCCCCCCchHHHhhHHHHHHHHHhcCccccccCCCCCCCCHHHHHHHHHHHhhcc
Q 046097 477 LLSEKCDVYSFGVLILVLISGRRPLQVTASPMSEFERANLISWARQLAYNGKLLDLVDPSIHSLDKDQALLCITIALLCL 556 (603)
Q Consensus 477 ~~s~~~DVwS~Gvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 556 (603)
.++.++|||||||+||||+||+.||...+. .......... .. ..+...+..+.+|+..||
T Consensus 214 ~~~~~~DiwSlGvilyemltG~~Pf~~~~~----------~~~~~~i~~~-~~---------~~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQP----------IQIYEKIVSG-KV---------RFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHHC-CC---------CCCTTCCHHHHHHHHHHS
T ss_pred CCCccccccchhHHHHHHHhCCCCCCCcCH----------HHHHHHHhcC-CC---------CCCccCCHHHHHHHHHHh
Confidence 999999999999999999999999975431 1111111111 10 112233456889999999
Q ss_pred CCCCCCCC-----CHHHHHHH-----------hcCCCCCCCCCCccCCCCCCCCC
Q 046097 557 QRSPSKRL-----TMKDIVEM-----------LTGEAEPPHLPFEFSPSPPSNFP 595 (603)
Q Consensus 557 ~~dP~~Rp-----t~~evl~~-----------l~~~~~~~~~~~~~~~~~~~~~~ 595 (603)
+.||.+|+ |+.||++. .++..+||..|-...+...+||.
T Consensus 274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s~~~ 328 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC
T ss_pred hhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhhhcC
Confidence 99999995 89999862 34566788888777788888874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-48 Score=401.72 Aligned_cols=149 Identities=28% Similarity=0.395 Sum_probs=134.5
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.++++++||||+++++++.+. +.+|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC--Ceeee
Confidence 56999999999999999999999999999999996531 122346789999999999999999999999987 89999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||||++|+|..++..... +++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 82 vmE~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeeecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999998876543 78899999999999999999999 9999999999999999999999999999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=388.91 Aligned_cols=148 Identities=26% Similarity=0.433 Sum_probs=133.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
++|++.++||+|+||+||+|+++ +++.||||+++... ...+.|.+|+.++++++||||++++|+|.+. +.+++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEE
Confidence 68999999999999999999984 78899999998643 3456899999999999999999999999886 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||+++|+|..++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 79 Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp ECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred EccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheecc
Confidence 9999999999976654 3388999999999999999999999 99999999999999999999999999997643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-48 Score=400.15 Aligned_cols=149 Identities=28% Similarity=0.384 Sum_probs=133.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~L 156 (603)
..|+.++.||+|+||+||+|++..+++.||||++...... ...+.+.+|+.+|++++|||||++++++.+. +.+|+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEEE
Confidence 3589999999999999999999999999999999764332 3346789999999999999999999999986 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||||.+|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|...
T Consensus 93 v~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccccccc
Confidence 999999999877665443 489999999999999999999999 9999999999999999999999999998643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-47 Score=402.53 Aligned_cols=151 Identities=26% Similarity=0.406 Sum_probs=135.9
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++++.||+|+||.||+|+++.+++.||||+++.. .......+.+|+.+|++++|||||++++++.+. ..+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEE
Confidence 35799999999999999999999999999999999763 334556788999999999999999999999986 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc--CCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD--GDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld--~~~~vKL~DFGlA~~~ 235 (603)
||||++|+|.+++.... ..+++.+++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+|...
T Consensus 105 mE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 105 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence 99999999998875543 3489999999999999999999999 999999999999997 6789999999999765
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 180 ~ 180 (352)
T d1koba_ 180 N 180 (352)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-47 Score=402.51 Aligned_cols=151 Identities=26% Similarity=0.414 Sum_probs=136.1
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.+|++++|||||++++++.+. +.+|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEE
Confidence 45899999999999999999999999999999999763 344567899999999999999999999999986 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc--CCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD--GDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld--~~~~vKL~DFGlA~~~ 235 (603)
||||++|+|.+++.... ..+++..+..++.||+.||.|||++ +||||||||+|||++ .++.+||+|||+|+..
T Consensus 102 mE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999999999986543 3489999999999999999999999 999999999999996 4678999999999765
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 177 ~ 177 (350)
T d1koaa2 177 D 177 (350)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=392.89 Aligned_cols=143 Identities=29% Similarity=0.471 Sum_probs=124.4
Q ss_pred ceeeccCceEEEEEEEc--CCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEcc
Q 046097 85 NRLGHGGFGSVYKAVVP--SSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYELM 161 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~--~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy~ 161 (603)
++||+|+||+||+|.++ .+++.||||+++... .....+.|.+|+.+|++++|||||+++++|.+ +..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 46999999999999864 355789999997543 23345679999999999999999999999975 4578999999
Q ss_pred CCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 162 ENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 162 ~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 90 ~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 90 ELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp TTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcc
Confidence 9999999987654 389999999999999999999999 99999999999999999999999999998654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-48 Score=396.56 Aligned_cols=160 Identities=28% Similarity=0.457 Sum_probs=140.3
Q ss_pred HHHHHhhcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEE
Q 046097 72 NLIRRATASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFA 146 (603)
Q Consensus 72 ~~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~ 146 (603)
.+++...++|++.+.||+|+||+||+|+++. +++.||||+++........++|.+|+.+|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3455567889999999999999999999753 56789999998766666678899999999999999999999999
Q ss_pred ecCCCCeEEEEEEccCCCCHHHHHhhccc---------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 046097 147 SDRRGRRLVLIYELMENRSLQDALLDRKC---------------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPP 205 (603)
Q Consensus 147 ~~~~~~~~~LVmEy~~~gsL~~~L~~~~~---------------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~g 205 (603)
.+. ...++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +
T Consensus 86 ~~~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ 160 (301)
T d1lufa_ 86 AVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 160 (301)
T ss_dssp CSS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ccC--CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence 886 788999999999999999965321 12378999999999999999999999 9
Q ss_pred eEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 206 VIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 206 IVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
||||||||+|||++.++.+||+|||+|+...
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~ 191 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIY 191 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred eEeeEEcccceEECCCCcEEEccchhheecc
Confidence 9999999999999999999999999997553
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-46 Score=397.02 Aligned_cols=149 Identities=34% Similarity=0.431 Sum_probs=130.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--hhHHHH---HHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--QGEREF---HNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--~~~~~~---~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
++|++.+.||+|+||.||+|+++.+|+.||||++...... .....+ ..++.+++.++|||||++++++.+. +.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--CE
Confidence 6799999999999999999999999999999998542111 111223 3457788889999999999999987 88
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+|+|||||++|+|.+++.... .+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999997653 388999999999999999999999 99999999999999999999999999997
Q ss_pred ec
Q 046097 234 LK 235 (603)
Q Consensus 234 ~~ 235 (603)
..
T Consensus 156 ~~ 157 (364)
T d1omwa3 156 DF 157 (364)
T ss_dssp EC
T ss_pred ec
Confidence 54
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=398.83 Aligned_cols=149 Identities=25% Similarity=0.364 Sum_probs=131.3
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC--ChhhHHHHHHHHHHhc-cCCCCceeEEEeEEecCCCCeEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG--SLQGEREFHNELSLAS-SLDCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~-~l~HpNIV~l~g~~~~~~~~~~~ 155 (603)
++|++.+.||+|+||+||+|+++.+++.||||++++.. .....+.+..|..++. .++||||+++++++.+. +.+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence 57899999999999999999999999999999996531 1122345667777665 68999999999999987 8899
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 80 ivmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999999997654 389999999999999999999999 9999999999999999999999999999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=392.77 Aligned_cols=149 Identities=27% Similarity=0.460 Sum_probs=130.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|+++. ++.||||+++... ...+.|.+|+.++++++|||||+++++|.+ +..++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEEE
Confidence 3579999999999999999999965 4679999997543 345679999999999999999999999865 457899
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||+++|+|..++..... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+|+...
T Consensus 90 ~Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp ECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhcc
Confidence 999999999998876543 3489999999999999999999999 99999999999999999999999999997653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=395.45 Aligned_cols=150 Identities=32% Similarity=0.525 Sum_probs=129.5
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCc----eEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQ----PLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.+|+++++||+|+||+||+|.+..+++ +||+|.++........+.+.+|+.++++++|||||+++|+|.+ ...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCe
Confidence 469999999999999999999987775 5889988765555567889999999999999999999999987 457
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+++|||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence 88999999999999887653 3489999999999999999999999 999999999999999999999999999976
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 161 ~~ 162 (317)
T d1xkka_ 161 LG 162 (317)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=387.04 Aligned_cols=151 Identities=27% Similarity=0.410 Sum_probs=127.1
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCC---ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSS---QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRL 154 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg---~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~ 154 (603)
.++|++.+.||+|+||.||+|++..++ ..||||.++........+.+.+|+.++++++||||+++++++.+ +.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeE
Confidence 467899999999999999999986543 46899998765566666789999999999999999999999965 568
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999999876543 3489999999999999999999999 999999999999999999999999999976
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 158 ~~ 159 (273)
T d1mp8a_ 158 ME 159 (273)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.1e-46 Score=378.07 Aligned_cols=153 Identities=25% Similarity=0.389 Sum_probs=135.8
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC--hhhHHHHHHHHHHhccCCCCceeEEEeEEecCC--CCe
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS--LQGEREFHNELSLASSLDCPHIVSLLGFASDRR--GRR 153 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~--~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~--~~~ 153 (603)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ......+.+|+.+++.++||||+++++++.... +..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999999999999999999976432 334567999999999999999999999987642 245
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
+|+||||+++++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 899999999999999886653 389999999999999999999999 99999999999999999999999999886
Q ss_pred ecc
Q 046097 234 LKT 236 (603)
Q Consensus 234 ~~~ 236 (603)
...
T Consensus 160 ~~~ 162 (277)
T d1o6ya_ 160 AIA 162 (277)
T ss_dssp ECC
T ss_pred hhc
Confidence 543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=388.12 Aligned_cols=149 Identities=26% Similarity=0.427 Sum_probs=128.2
Q ss_pred hcCCCCCc-eeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecC--CCCe
Q 046097 78 TASFSPSN-RLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDR--RGRR 153 (603)
Q Consensus 78 t~~y~i~~-~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~--~~~~ 153 (603)
.++|.+.+ .||+|+||+||+|++..+++.||||+++. ...+.+|+.++.++ +|||||+++++|.+. ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 46788875 59999999999999999999999999964 23567899887654 799999999998752 2367
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC---CCcEEEEeec
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG---DFKAKIGDFG 230 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~---~~~vKL~DFG 230 (603)
+|+|||||++|+|.+++..... ..+++.++..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 8999999999999999976432 3489999999999999999999999 9999999999999985 5679999999
Q ss_pred cceecc
Q 046097 231 LARLKT 236 (603)
Q Consensus 231 lA~~~~ 236 (603)
+|+...
T Consensus 160 ~a~~~~ 165 (335)
T d2ozaa1 160 FAKETT 165 (335)
T ss_dssp TCEECC
T ss_pred eeeecc
Confidence 997653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.8e-46 Score=378.98 Aligned_cols=150 Identities=25% Similarity=0.414 Sum_probs=135.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh--------hhHHHHHHHHHHhccCC-CCceeEEEeEEecC
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL--------QGEREFHNELSLASSLD-CPHIVSLLGFASDR 149 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~--------~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~ 149 (603)
++|++.+.||+|+||+||+|+++.+++.||||+++..... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999999999999999999764321 12346889999999997 99999999999987
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEee
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDF 229 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DF 229 (603)
+.+|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 83 --~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 --TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred --cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence 89999999999999999997643 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecc
Q 046097 230 GLARLKT 236 (603)
Q Consensus 230 GlA~~~~ 236 (603)
|+++...
T Consensus 155 G~a~~~~ 161 (277)
T d1phka_ 155 GFSCQLD 161 (277)
T ss_dssp TTCEECC
T ss_pred hheeEcc
Confidence 9997654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=384.99 Aligned_cols=157 Identities=28% Similarity=0.430 Sum_probs=126.5
Q ss_pred HhhcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecC
Q 046097 76 RATASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDR 149 (603)
Q Consensus 76 ~~t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~ 149 (603)
...++|++.+.||+|+||.||+|++.. +++.||||+++........+.+.+|..++.++ +|+||+.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 345789999999999999999999754 45689999998766666667788888888877 589999999988765
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNI 216 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NI 216 (603)
+..+++|||||++|+|.+++..... ...+++..++.++.||+.||.|||++ +|+||||||+||
T Consensus 90 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI 165 (299)
T d1ywna1 90 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 165 (299)
T ss_dssp -TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred -CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence 3578999999999999999976432 23488999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEEeeccceecc
Q 046097 217 LLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~~~ 236 (603)
||+.++.+||+|||+|+...
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~ 185 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIY 185 (299)
T ss_dssp EECGGGCEEECC------CC
T ss_pred eECCCCcEEEccCcchhhcc
Confidence 99999999999999997643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=381.23 Aligned_cols=145 Identities=29% Similarity=0.425 Sum_probs=123.2
Q ss_pred CCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhh----HHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEE
Q 046097 83 PSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQG----EREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIY 158 (603)
Q Consensus 83 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~----~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVm 158 (603)
.+++||+|+||+||+|+++.+++.||||+++....... ...+.+|+.+|++++|||||++++++.+. +.+|+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC--Cceeehh
Confidence 35789999999999999999999999999965432211 24688999999999999999999999987 7899999
Q ss_pred EccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 159 ELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 159 Ey~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
||+.++++..+.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 80 E~~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp ECCSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred hhhcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcccccc
Confidence 999887766555332 3488899999999999999999999 9999999999999999999999999998654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=380.49 Aligned_cols=148 Identities=26% Similarity=0.435 Sum_probs=126.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|++ .+..||||+++.+ ...+.+.+|+.++++++||||++++|+|.+. .+.+++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEEE
Confidence 35678889999999999999998 4778999999753 3446799999999999999999999998654 2557999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+++|+|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp ECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceec
Confidence 999999999999976432 3489999999999999999999999 9999999999999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=386.91 Aligned_cols=152 Identities=31% Similarity=0.510 Sum_probs=131.2
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCce--EEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCCCCeEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQP--LAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~--VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~~~~~~ 155 (603)
++|++.++||+|+||+||+|+++.++.. ||||.++........+.+.+|+.+|.++ +|||||+++++|.+. +.++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--CeeE
Confidence 5788899999999999999999887764 6778876544445567899999999999 699999999999986 8899
Q ss_pred EEEEccCCCCHHHHHhhcc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC
Q 046097 156 LIYELMENRSLQDALLDRK-------------CEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF 222 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~-------------~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~ 222 (603)
+||||+++|+|.+++.... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence 9999999999999997542 234589999999999999999999999 999999999999999999
Q ss_pred cEEEEeeccceec
Q 046097 223 KAKIGDFGLARLK 235 (603)
Q Consensus 223 ~vKL~DFGlA~~~ 235 (603)
.+||+|||+|+..
T Consensus 165 ~~kl~DfG~a~~~ 177 (309)
T d1fvra_ 165 VAKIADFGLSRGQ 177 (309)
T ss_dssp CEEECCTTCEESS
T ss_pred ceEEccccccccc
Confidence 9999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=385.96 Aligned_cols=150 Identities=22% Similarity=0.311 Sum_probs=134.7
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||+||+|.++.+++.||||+++.. ......+.+|+.+|++++||||+++++++.+. +.+|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESM--EELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEE
Confidence 46899999999999999999999999999999999763 23445688999999999999999999999987 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC--CCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG--DFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~--~~~vKL~DFGlA~~~ 235 (603)
||||++|+|.+++.... ..+++.++..++.||+.||.|||++ +|+||||||+|||++. ...+||+|||++...
T Consensus 80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999996543 2489999999999999999999999 9999999999999985 458999999998765
Q ss_pred c
Q 046097 236 T 236 (603)
Q Consensus 236 ~ 236 (603)
.
T Consensus 155 ~ 155 (321)
T d1tkia_ 155 K 155 (321)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=378.70 Aligned_cols=148 Identities=24% Similarity=0.435 Sum_probs=129.1
Q ss_pred CceeeccCceEEEEEEEcCCC---ceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEEEEc
Q 046097 84 SNRLGHGGFGSVYKAVVPSSS---QPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLIYEL 160 (603)
Q Consensus 84 ~~~LG~G~fG~Vy~a~~~~tg---~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LVmEy 160 (603)
.++||+|+||+||+|++..++ ..||||.++........++|.+|+++|++++||||++++|++.+. .+..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEEEE
Confidence 368999999999999986543 368999997656666778899999999999999999999998764 2678999999
Q ss_pred cCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 161 MENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 161 ~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
|++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 111 ~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp CTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred eecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999999875443 367888999999999999999999 999999999999999999999999999986543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=382.71 Aligned_cols=155 Identities=29% Similarity=0.429 Sum_probs=131.7
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCC-------ceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSS-------QPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDR 149 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg-------~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~ 149 (603)
.++|++.+.||+|+||.||+|+...++ ..||||+++..........+.+|...+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 467889999999999999999976544 479999998866666678899999999888 799999999999986
Q ss_pred CCCeEEEEEEccCCCCHHHHHhhccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 046097 150 RGRRLVLIYELMENRSLQDALLDRKC-------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNI 216 (603)
Q Consensus 150 ~~~~~~LVmEy~~~gsL~~~L~~~~~-------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NI 216 (603)
..+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++ +||||||||+||
T Consensus 92 --~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 92 --GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp --SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred --CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 789999999999999999976532 23489999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEEeeccceeccc
Q 046097 217 LLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 217 Lld~~~~vKL~DFGlA~~~~~ 237 (603)
|++.++.+||+|||+++....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~ 187 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHH 187 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGG
T ss_pred eecCCCCeEeccchhhccccc
Confidence 999999999999999976543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=374.93 Aligned_cols=150 Identities=27% Similarity=0.432 Sum_probs=129.0
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++++.||+|+||+||+|++..+++.||||+++..... .....+.+|+.+|++++|||||++++++.+. ..+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--cceeEE
Confidence 5799999999999999999999999999999999654322 2346789999999999999999999999987 899999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceec
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLK 235 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~ 235 (603)
|||+.+ ++.+++.... ...+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 80 ~e~~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp EECCSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred EeecCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceec
Confidence 999975 4555544332 23489999999999999999999999 9999999999999999999999999998654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=380.03 Aligned_cols=151 Identities=26% Similarity=0.369 Sum_probs=125.5
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC--CeEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG--RRLVL 156 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~--~~~~L 156 (603)
.+|.+.+.||+|+||.||+|++ +|+.||||+++... ........|+..+.+++||||++++++|.+... ..+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567778999999999999997 68999999996531 222223445666678899999999999986532 36899
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHS-----CEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~-----~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
||||+++|+|.+++... .+++..++.++.|++.||+|||+. ...+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999764 289999999999999999999963 134999999999999999999999999999
Q ss_pred ceeccc
Q 046097 232 ARLKTE 237 (603)
Q Consensus 232 A~~~~~ 237 (603)
++....
T Consensus 155 ~~~~~~ 160 (303)
T d1vjya_ 155 AVRHDS 160 (303)
T ss_dssp CEEEET
T ss_pred cccccC
Confidence 987643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=382.77 Aligned_cols=156 Identities=33% Similarity=0.543 Sum_probs=136.5
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcC-----CCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPS-----SSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~ 151 (603)
..++|++.+.||+|+||+||+|.++. ++..||||+++..........+.+|+.++++++||||++++++|...
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-- 95 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 95 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC--
Confidence 34678888999999999999998852 35789999998766666667899999999999999999999999876
Q ss_pred CeEEEEEEccCCCCHHHHHhhccc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcE
Q 046097 152 RRLVLIYELMENRSLQDALLDRKC-------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKA 224 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~-------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~v 224 (603)
...++||||+++|+|.+++..... ...+++..+..++.|++.||.|||++ +|+||||||+|||+++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 778999999999999999875421 12368899999999999999999999 99999999999999999999
Q ss_pred EEEeeccceeccc
Q 046097 225 KIGDFGLARLKTE 237 (603)
Q Consensus 225 KL~DFGlA~~~~~ 237 (603)
||+|||+|+....
T Consensus 173 Kl~DFGla~~~~~ 185 (308)
T d1p4oa_ 173 KIGDFGMTRDIYE 185 (308)
T ss_dssp EECCTTCCCGGGG
T ss_pred EEeecccceeccC
Confidence 9999999976543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=380.54 Aligned_cols=155 Identities=30% Similarity=0.403 Sum_probs=137.1
Q ss_pred hhcCCCCCceeeccCceEEEEEEEc-----CCCceEEEEEecCCCChhhHHHHHHHHHHhccC-CCCceeEEEeEEecCC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVP-----SSSQPLAVKILDSSGSLQGEREFHNELSLASSL-DCPHIVSLLGFASDRR 150 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l-~HpNIV~l~g~~~~~~ 150 (603)
..++|++.++||+|+||.||+|++. .+++.||||+++..........+.+|+.++.++ +|||||+++++|.+.
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~- 99 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence 3468889999999999999999863 456789999998766666777899999999999 699999999999986
Q ss_pred CCeEEEEEEccCCCCHHHHHhhccc---------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKC---------------EELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSN 215 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~---------------~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~N 215 (603)
...++|||||++|+|.+++..... ...+++..++.++.||+.||+|||++ +++||||||+|
T Consensus 100 -~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 100 -GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred -CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 778999999999999999976431 22488999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEEeeccceecc
Q 046097 216 ILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 216 ILld~~~~vKL~DFGlA~~~~ 236 (603)
|+++.++.+||+|||+++...
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~ 196 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIK 196 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTT
T ss_pred ccccccCcccccccchheecc
Confidence 999999999999999987653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=373.83 Aligned_cols=151 Identities=28% Similarity=0.402 Sum_probs=123.7
Q ss_pred cCCCCCceeeccCceEEEEEEEcCC-C--ceEEEEEecCCC--ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSS-S--QPLAVKILDSSG--SLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRR 153 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~t-g--~~VAVK~l~~~~--~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~ 153 (603)
++|++.+.||+|+||.||+|++... + ..||||+++... .....+.|.+|+.+|++++||||++++|+|.+ ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cc
Confidence 5689999999999999999987533 2 368999987643 23345689999999999999999999999976 45
Q ss_pred EEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccce
Q 046097 154 LVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLAR 233 (603)
Q Consensus 154 ~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~ 233 (603)
.++||||+++|+|.+.+.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred hheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 689999999999999877643 3489999999999999999999999 99999999999999999999999999998
Q ss_pred eccc
Q 046097 234 LKTE 237 (603)
Q Consensus 234 ~~~~ 237 (603)
....
T Consensus 160 ~~~~ 163 (273)
T d1u46a_ 160 ALPQ 163 (273)
T ss_dssp ECCC
T ss_pred hccc
Confidence 7643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=375.11 Aligned_cols=150 Identities=27% Similarity=0.376 Sum_probs=129.3
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-----hhHHHHHHHHHHhccCC--CCceeEEEeEEecCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-----QGEREFHNELSLASSLD--CPHIVSLLGFASDRR 150 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-----~~~~~~~~Ev~iL~~l~--HpNIV~l~g~~~~~~ 150 (603)
.++|++.+.||+|+||+||+|++..+++.||||+++..... ....++.+|+.+|++++ ||||+++++++.+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~- 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence 46899999999999999999999999999999998653211 11234678999999886 89999999999987
Q ss_pred CCeEEEEEEccCC-CCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-CCcEEEEe
Q 046097 151 GRRLVLIYELMEN-RSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-DFKAKIGD 228 (603)
Q Consensus 151 ~~~~~LVmEy~~~-gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~-~~~vKL~D 228 (603)
+..++||||+.+ +++.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|
T Consensus 82 -~~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 82 -DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp -SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred -CeEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECc
Confidence 889999999976 57777776543 389999999999999999999999 9999999999999985 47999999
Q ss_pred eccceec
Q 046097 229 FGLARLK 235 (603)
Q Consensus 229 FGlA~~~ 235 (603)
||+|...
T Consensus 155 FG~a~~~ 161 (273)
T d1xwsa_ 155 FGSGALL 161 (273)
T ss_dssp CTTCEEC
T ss_pred cccceec
Confidence 9998754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=370.41 Aligned_cols=154 Identities=25% Similarity=0.394 Sum_probs=124.2
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCC-CceEEEEEecCCCCh-hhHHHHHHHHHHhccC---CCCceeEEEeEEecC--
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSS-SQPLAVKILDSSGSL-QGEREFHNELSLASSL---DCPHIVSLLGFASDR-- 149 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~t-g~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l---~HpNIV~l~g~~~~~-- 149 (603)
..++|++++.||+|+||+||+|++..+ ++.||||+++..... .....+.+|+.+|+.+ +||||++++++|...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 457899999999999999999999654 678999998653221 1223455677666554 899999999998642
Q ss_pred -CCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEe
Q 046097 150 -RGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGD 228 (603)
Q Consensus 150 -~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~D 228 (603)
....++++|||+.++.+....... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 235789999999887665444332 23489999999999999999999999 999999999999999999999999
Q ss_pred eccceec
Q 046097 229 FGLARLK 235 (603)
Q Consensus 229 FGlA~~~ 235 (603)
||++...
T Consensus 160 fg~~~~~ 166 (305)
T d1blxa_ 160 FGLARIY 166 (305)
T ss_dssp CCSCCCC
T ss_pred hhhhhhh
Confidence 9998654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=371.40 Aligned_cols=151 Identities=26% Similarity=0.375 Sum_probs=126.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC----C
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR----G 151 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~----~ 151 (603)
..++|++++.||+|+||+||+|.++.+++.||||+++... .....+.+.+|+.+|++++|||||+++++|.... .
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3578999999999999999999999999999999997643 3334567899999999999999999999998652 2
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
..+|+||||+ +.+|..++... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 3679999999 56777776542 389999999999999999999999 999999999999999999999999999
Q ss_pred ceec
Q 046097 232 ARLK 235 (603)
Q Consensus 232 A~~~ 235 (603)
|...
T Consensus 168 a~~~ 171 (346)
T d1cm8a_ 168 ARQA 171 (346)
T ss_dssp CEEC
T ss_pred eecc
Confidence 9754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=370.19 Aligned_cols=153 Identities=22% Similarity=0.328 Sum_probs=129.9
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCC--CeE
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRG--RRL 154 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~--~~~ 154 (603)
.+.+|++++.||+|+||+||+|+++.+++.||||++.........+.+.+|+.+|++++||||+++++++..... ...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346799999999999999999999999999999999775555566789999999999999999999999976421 123
Q ss_pred EEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecccee
Q 046097 155 VLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARL 234 (603)
Q Consensus 155 ~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~ 234 (603)
+++++|+.+|+|.+++... .+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|..
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4445566689999999653 389999999999999999999999 999999999999999999999999999976
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 159 ~~ 160 (345)
T d1pmea_ 159 AD 160 (345)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-43 Score=362.02 Aligned_cols=149 Identities=26% Similarity=0.401 Sum_probs=131.0
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-hhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-QGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++++.||+|+||+||+|+++ +++.||||+++..... ...+.+.+|+.+|++++||||+++++++.+. +..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--CceeEE
Confidence 57999999999999999999985 7899999999764322 2246799999999999999999999999987 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
|||+.++.+..+.... ..+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|....
T Consensus 79 ~e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp EECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred EEeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecc
Confidence 9999877666665433 3489999999999999999999999 99999999999999999999999999987643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=367.70 Aligned_cols=149 Identities=27% Similarity=0.344 Sum_probs=125.0
Q ss_pred CCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecC----CCCeEE
Q 046097 80 SFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDR----RGRRLV 155 (603)
Q Consensus 80 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~----~~~~~~ 155 (603)
+|+..++||+|+||+||+|+++.+++.||||++..... ...+|+.+|++++||||++++++|... ...+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 57888999999999999999999999999999976432 234799999999999999999998643 235689
Q ss_pred EEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC-cEEEEeecccee
Q 046097 156 LIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-KAKIGDFGLARL 234 (603)
Q Consensus 156 LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-~vKL~DFGlA~~ 234 (603)
+|||||+++.+..+.........+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999998764444443333344589999999999999999999999 999999999999999775 899999999876
Q ss_pred cc
Q 046097 235 KT 236 (603)
Q Consensus 235 ~~ 236 (603)
..
T Consensus 173 ~~ 174 (350)
T d1q5ka_ 173 LV 174 (350)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-43 Score=361.33 Aligned_cols=153 Identities=22% Similarity=0.324 Sum_probs=127.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCC------
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRR------ 150 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~------ 150 (603)
-++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+|+.+|++++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4789999999999999999999999999999999865432 233467889999999999999999999986531
Q ss_pred CCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeec
Q 046097 151 GRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFG 230 (603)
Q Consensus 151 ~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFG 230 (603)
...+++||||+.++.+...... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 2568999999987666544332 23488999999999999999999999 99999999999999999999999999
Q ss_pred cceecc
Q 046097 231 LARLKT 236 (603)
Q Consensus 231 lA~~~~ 236 (603)
++....
T Consensus 163 ~~~~~~ 168 (318)
T d3blha1 163 LARAFS 168 (318)
T ss_dssp TCEECC
T ss_pred eeeecc
Confidence 997654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=351.46 Aligned_cols=150 Identities=23% Similarity=0.351 Sum_probs=135.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCC-hhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGS-LQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~-~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|++++.||+|+||+||+|++..+++.||||+++.... .....++.+|+.+|+.++||||+++++++.+. ...++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc--cceeEE
Confidence 579999999999999999999999999999999976543 33457899999999999999999999999987 889999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
++++.+++|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|....
T Consensus 80 ~~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eeecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhccc
Confidence 99999988888776543 388999999999999999999999 99999999999999999999999999997654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-42 Score=358.72 Aligned_cols=145 Identities=24% Similarity=0.478 Sum_probs=129.3
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEEE
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~LV 157 (603)
++|+++++||+|+||+||+|+++.+++.||||+++.. ..+++.+|+.+|..+. ||||+++++++.......+++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 5799999999999999999999999999999999753 3457889999999996 9999999999987655789999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCC-cEEEEeeccceecc
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDF-KAKIGDFGLARLKT 236 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~-~vKL~DFGlA~~~~ 236 (603)
|||+.+++|..+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|....
T Consensus 111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999997653 2389999999999999999999999 999999999999998655 69999999997654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-42 Score=352.39 Aligned_cols=150 Identities=22% Similarity=0.359 Sum_probs=123.4
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCceeEEEeEEecCCCCeEEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHIVSLLGFASDRRGRRLVLI 157 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~~~~~~LV 157 (603)
.++|++.+.||+|+||.||+|++..+++.||||++..... ..++..|+++++.++|+|++..++.+... +...++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEE
Confidence 4679999999999999999999999999999999876422 23578899999999877766555554432 3788999
Q ss_pred EEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEc---CCCcEEEEeecccee
Q 046097 158 YELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLD---GDFKAKIGDFGLARL 234 (603)
Q Consensus 158 mEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld---~~~~vKL~DFGlA~~ 234 (603)
|||+ +++|...+.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.
T Consensus 82 me~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEc-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 9999 556766664432 3489999999999999999999999 999999999999986 355799999999987
Q ss_pred ccc
Q 046097 235 KTE 237 (603)
Q Consensus 235 ~~~ 237 (603)
...
T Consensus 156 ~~~ 158 (299)
T d1ckia_ 156 YRD 158 (299)
T ss_dssp CBC
T ss_pred ccc
Confidence 643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=362.15 Aligned_cols=150 Identities=25% Similarity=0.319 Sum_probs=132.0
Q ss_pred cCCCCCceeeccCceEEEEEEE---cCCCceEEEEEecCCC---ChhhHHHHHHHHHHhccCCC-CceeEEEeEEecCCC
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVV---PSSSQPLAVKILDSSG---SLQGEREFHNELSLASSLDC-PHIVSLLGFASDRRG 151 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~---~~tg~~VAVK~l~~~~---~~~~~~~~~~Ev~iL~~l~H-pNIV~l~g~~~~~~~ 151 (603)
++|++++.||+|+||+||+|.. +.+|+.||||+++... .....+.+.+|+.++++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 5699999999999999999987 4478999999986532 11234568899999999976 8999999999987
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeecc
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGL 231 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGl 231 (603)
..++++|||+.+|+|.+++..... +++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred CceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence 889999999999999999976543 78899999999999999999999 999999999999999999999999999
Q ss_pred ceecc
Q 046097 232 ARLKT 236 (603)
Q Consensus 232 A~~~~ 236 (603)
|+...
T Consensus 176 a~~~~ 180 (322)
T d1vzoa_ 176 SKEFV 180 (322)
T ss_dssp EEECC
T ss_pred hhhhc
Confidence 97654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-42 Score=360.16 Aligned_cols=149 Identities=27% Similarity=0.379 Sum_probs=125.0
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecC----CCC
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDR----RGR 152 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~----~~~ 152 (603)
.++|+++++||+|+||+||+|+++.+|+.||||++.... .......+.+|+.++++++||||++++++|... ...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999999999999999997643 234456789999999999999999999999754 237
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
.+|+|||||.++ +.+.+. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchH-HHHhhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 899999999765 444443 2379999999999999999999999 9999999999999999999999999987
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
+..
T Consensus 167 ~~~ 169 (355)
T d2b1pa1 167 RTA 169 (355)
T ss_dssp ---
T ss_pred hcc
Confidence 654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-42 Score=358.02 Aligned_cols=152 Identities=26% Similarity=0.384 Sum_probs=128.3
Q ss_pred hhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCC-ChhhHHHHHHHHHHhccCCCCceeEEEeEEecCC---CC
Q 046097 77 ATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSG-SLQGEREFHNELSLASSLDCPHIVSLLGFASDRR---GR 152 (603)
Q Consensus 77 ~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~-~~~~~~~~~~Ev~iL~~l~HpNIV~l~g~~~~~~---~~ 152 (603)
..++|++++.||+|+||+||+|++..+++.||||+++... .....+.+.+|+.+|++++||||+++++++.... ..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3578999999999999999999999999999999997643 3344567899999999999999999999986431 13
Q ss_pred eEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcEEEEeeccc
Q 046097 153 RLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKAKIGDFGLA 232 (603)
Q Consensus 153 ~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA 232 (603)
..+++|+|+.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 345667778899999998543 389999999999999999999999 9999999999999999999999999998
Q ss_pred eec
Q 046097 233 RLK 235 (603)
Q Consensus 233 ~~~ 235 (603)
...
T Consensus 169 ~~~ 171 (348)
T d2gfsa1 169 RHT 171 (348)
T ss_dssp -CC
T ss_pred ccc
Confidence 643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-41 Score=346.77 Aligned_cols=149 Identities=20% Similarity=0.315 Sum_probs=129.2
Q ss_pred hcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCC-CceeEEEeEEecCCCCeEEE
Q 046097 78 TASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC-PHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 78 t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~H-pNIV~l~g~~~~~~~~~~~L 156 (603)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|++.+..+.| +|++.+++++.+. ...++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecC--CccEE
Confidence 4689999999999999999999999999999999865332 2346778888888875 8999999999876 88999
Q ss_pred EEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcC-----CCcEEEEeecc
Q 046097 157 IYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDG-----DFKAKIGDFGL 231 (603)
Q Consensus 157 VmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~-----~~~vKL~DFGl 231 (603)
||||+ +++|.+++.... ..++...+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 79 vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 99999 689999886543 3489999999999999999999999 9999999999999974 57899999999
Q ss_pred ceeccc
Q 046097 232 ARLKTE 237 (603)
Q Consensus 232 A~~~~~ 237 (603)
|+....
T Consensus 153 a~~~~~ 158 (293)
T d1csna_ 153 VKFYRD 158 (293)
T ss_dssp CEESBC
T ss_pred eEEccc
Confidence 987654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-38 Score=334.90 Aligned_cols=152 Identities=24% Similarity=0.306 Sum_probs=123.6
Q ss_pred cCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-----------CCceeEEEeEEe
Q 046097 79 ASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-----------CPHIVSLLGFAS 147 (603)
Q Consensus 79 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-----------HpNIV~l~g~~~ 147 (603)
++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+++.+. |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 4699999999999999999999999999999999753 233466788888887764 578999999987
Q ss_pred cCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCC----
Q 046097 148 DRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDF---- 222 (603)
Q Consensus 148 ~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~---- 222 (603)
.......+++|+++..+..............+++..+..++.||+.||.|||+ . +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 65456778888877665544444444444558999999999999999999998 6 999999999999997654
Q ss_pred --cEEEEeeccceec
Q 046097 223 --KAKIGDFGLARLK 235 (603)
Q Consensus 223 --~vKL~DFGlA~~~ 235 (603)
.++|+|||.|...
T Consensus 168 ~~~~kl~dfg~s~~~ 182 (362)
T d1q8ya_ 168 LIQIKIADLGNACWY 182 (362)
T ss_dssp EEEEEECCCTTCEET
T ss_pred cceeeEeeccccccc
Confidence 3899999998653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=2e-20 Score=178.34 Aligned_cols=134 Identities=17% Similarity=0.222 Sum_probs=104.8
Q ss_pred CCCceeeccCceEEEEEEEcCCCceEEEEEecCCCCh-----------------hhHHHHHHHHHHhccCCCCceeEEEe
Q 046097 82 SPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSL-----------------QGEREFHNELSLASSLDCPHIVSLLG 144 (603)
Q Consensus 82 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~-----------------~~~~~~~~Ev~iL~~l~HpNIV~l~g 144 (603)
.+.++||+|+||+||+|++. +|+.||||+++..... ........|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45689999999999999984 6899999987542110 01233567888999999999998876
Q ss_pred EEecCCCCeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeEEcCCCcE
Q 046097 145 FASDRRGRRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSCEPPVIHGDIKPSNILLDGDFKA 224 (603)
Q Consensus 145 ~~~~~~~~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~~~gIVHrDLKp~NILld~~~~v 224 (603)
+.. . +++|||+++..+.. ++......++.|++.+|.|||++ +|+||||||+|||++++ .+
T Consensus 82 ~~~----~--~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 82 WEG----N--AVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EET----T--EEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EE
T ss_pred ecC----C--EEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CE
Confidence 532 2 69999998754432 34445567899999999999999 99999999999999965 48
Q ss_pred EEEeeccceecc
Q 046097 225 KIGDFGLARLKT 236 (603)
Q Consensus 225 KL~DFGlA~~~~ 236 (603)
+|+|||+|....
T Consensus 142 ~liDFG~a~~~~ 153 (191)
T d1zara2 142 WIIDFPQSVEVG 153 (191)
T ss_dssp EECCCTTCEETT
T ss_pred EEEECCCcccCC
Confidence 999999997654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.33 E-value=5.3e-07 Score=87.24 Aligned_cols=152 Identities=17% Similarity=0.143 Sum_probs=99.8
Q ss_pred HHHHhhcCCCCCceeeccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCC
Q 046097 73 LIRRATASFSPSNRLGHGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRG 151 (603)
Q Consensus 73 ~l~~~t~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~ 151 (603)
++.+....|+..+..+.++.+.||+... +++.++||+...... .....+.+|...+..+. +--+.+++.++.+.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-- 82 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-- 82 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecC--
Confidence 5556666777666655555678998764 566788898754321 12224566777766553 33356777777665
Q ss_pred CeEEEEEEccCCCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 046097 152 RRLVLIYELMENRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLHHSC----------------------------- 202 (603)
Q Consensus 152 ~~~~LVmEy~~~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLHs~~----------------------------- 202 (603)
+..++||+++++.++.+..... .....++.+++..+..||+..
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred CceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 7889999999998876544221 112224455566666666420
Q ss_pred ---------------------------CCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 203 ---------------------------EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 203 ---------------------------~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
...++|+|+.|.|||+++++.+-|+||+.+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g~~ 216 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADK 216 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEEH
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccCCH
Confidence 12389999999999999876677999999887543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.61 E-value=3.4e-05 Score=73.60 Aligned_cols=134 Identities=19% Similarity=0.168 Sum_probs=81.4
Q ss_pred eeeccCc-eEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCC--CCceeEEEeEEecCCCCeEEEEEEccC
Q 046097 86 RLGHGGF-GSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLD--CPHIVSLLGFASDRRGRRLVLIYELME 162 (603)
Q Consensus 86 ~LG~G~f-G~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~--HpNIV~l~g~~~~~~~~~~~LVmEy~~ 162 (603)
.+..|.. +.||+... .++..+++|....... ..+..|...++.+. .-.+.+++.+..+. +..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeee
Confidence 3444443 67898876 4566788898765322 23455666665543 23366777777765 67899999998
Q ss_pred CCCHHHHHhhcccccccCHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 046097 163 NRSLQDALLDRKCEELMEWNKRFEIAIDIAKGLEYLH------------------------------------------- 199 (603)
Q Consensus 163 ~gsL~~~L~~~~~~~~l~~~~~l~Ia~qIa~aL~yLH------------------------------------------- 199 (603)
|.++.+.. .... .++.++...|.-||
T Consensus 90 G~~~~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 90 GQDLLSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp SEETTTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cccccccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence 76543210 0000 01112222223333
Q ss_pred --------hCC----CCCeEeccCCCCCeEEcCCCcEEEEeeccceeccc
Q 046097 200 --------HSC----EPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKTE 237 (603)
Q Consensus 200 --------s~~----~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~~ 237 (603)
... ...++|+|+.|.|||++.+..+-|+||+.+.....
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g~~ 208 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADR 208 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEET
T ss_pred HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccCCH
Confidence 211 12489999999999999876678999999877543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00018 Score=74.05 Aligned_cols=77 Identities=12% Similarity=0.043 Sum_probs=46.5
Q ss_pred ceeeccCceEEEEEEEcCCCceEEEEEecCC------CChhhHHHHHHHHHHhccCC---CCceeEEEeEEecCCCCeEE
Q 046097 85 NRLGHGGFGSVYKAVVPSSSQPLAVKILDSS------GSLQGEREFHNELSLASSLD---CPHIVSLLGFASDRRGRRLV 155 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~l~~~------~~~~~~~~~~~Ev~iL~~l~---HpNIV~l~g~~~~~~~~~~~ 155 (603)
+.||.|....||+.....+++.++||.-... .-.....+...|.+.|..+. ...+.+++.+..+ ..+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~----~~~ 107 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE----MAV 107 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT----TTE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC----CCE
Confidence 4689999999999998777888999975321 11111233445666666542 2456666655433 347
Q ss_pred EEEEccCCCC
Q 046097 156 LIYELMENRS 165 (603)
Q Consensus 156 LVmEy~~~gs 165 (603)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 8999997644
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.26 E-value=0.0032 Score=64.13 Aligned_cols=73 Identities=15% Similarity=0.155 Sum_probs=49.5
Q ss_pred ceeeccCceEEEEEEEcC-------CCceEEEEEecCCCChhhHHHHHHHHHHhccCC-CCceeEEEeEEecCCCCeEEE
Q 046097 85 NRLGHGGFGSVYKAVVPS-------SSQPLAVKILDSSGSLQGEREFHNELSLASSLD-CPHIVSLLGFASDRRGRRLVL 156 (603)
Q Consensus 85 ~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~-HpNIV~l~g~~~~~~~~~~~L 156 (603)
+.|+.|-.-.+|++.... ..+.|++++..... ......+|..+++.+. +.-..++++++.+ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG------GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------ce
Confidence 568888889999998743 34568888875322 2234557888888775 4445577777753 48
Q ss_pred EEEccCCCCH
Q 046097 157 IYELMENRSL 166 (603)
Q Consensus 157 VmEy~~~gsL 166 (603)
|+||+++..|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 8999987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.81 E-value=0.045 Score=53.05 Aligned_cols=163 Identities=15% Similarity=0.083 Sum_probs=81.7
Q ss_pred ccHHHHHHhhcCCCCCceee-----ccCceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCC-----Cc
Q 046097 69 FSYNLIRRATASFSPSNRLG-----HGGFGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDC-----PH 138 (603)
Q Consensus 69 ~~~~~l~~~t~~y~i~~~LG-----~G~fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~H-----pN 138 (603)
.+.+++.....+|.+.+... .|---+.|+.... +..+++|++...... ..+..|+.++..+.. |.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCCCH---HHHHHHHHHHHhhhhccccccc
Confidence 45678888888998865443 5656788988763 345899998653222 233444555554421 11
Q ss_pred eeEEE-eEEecCCCCeEEEEEEccCCCCHH-----HH---------Hhhc--cc--c--c------------------cc
Q 046097 139 IVSLL-GFASDRRGRRLVLIYELMENRSLQ-----DA---------LLDR--KC--E--E------------------LM 179 (603)
Q Consensus 139 IV~l~-g~~~~~~~~~~~LVmEy~~~gsL~-----~~---------L~~~--~~--~--~------------------~l 179 (603)
.+... |............++.++.+.... .. ++.. .. . . ..
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 11110 000000124455666666543221 00 0000 00 0 0 00
Q ss_pred CHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 180 EWNKRFEIAIDIAKGLEYLHH-SCEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 180 ~~~~~l~Ia~qIa~aL~yLHs-~~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
........+..+...+.-.+. ....++||+|+.+.||+++.+...-|+||+.+....
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~~ 215 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACNDL 215 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccccch
Confidence 011111122222222332222 123489999999999999988777899999987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.47 E-value=0.02 Score=56.43 Aligned_cols=138 Identities=12% Similarity=0.112 Sum_probs=74.5
Q ss_pred ceEEEEEEEcCCCceEEEEEecCCCChhhHHHHHHHHHHhccCCCCce--eEEEe-----EEecCCCCeEEEEEEccCCC
Q 046097 92 FGSVYKAVVPSSSQPLAVKILDSSGSLQGEREFHNELSLASSLDCPHI--VSLLG-----FASDRRGRRLVLIYELMENR 164 (603)
Q Consensus 92 fG~Vy~a~~~~tg~~VAVK~l~~~~~~~~~~~~~~Ev~iL~~l~HpNI--V~l~g-----~~~~~~~~~~~LVmEy~~~g 164 (603)
--.||++.. .+|..|++|+.+... ....++..|...+..+....| +..+. .+.. ++..+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~--~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH--QGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE--TTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeee--eeEEEEEEeecCCc
Confidence 358999987 468889999997642 234567778777766532221 11111 1111 36778899998763
Q ss_pred CH-----HHHH---------hh----ccc--ccccC-------------------HH---HHHHHHHHHHHHHHHHH-hC
Q 046097 165 SL-----QDAL---------LD----RKC--EELME-------------------WN---KRFEIAIDIAKGLEYLH-HS 201 (603)
Q Consensus 165 sL-----~~~L---------~~----~~~--~~~l~-------------------~~---~~l~Ia~qIa~aL~yLH-s~ 201 (603)
.+ ..+. +. ... ...++ .. .....+.++...+.-+- ..
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 22 1110 00 000 00111 11 11122223332222221 11
Q ss_pred CCCCeEeccCCCCCeEEcCCCcEEEEeeccceecc
Q 046097 202 CEPPVIHGDIKPSNILLDGDFKAKIGDFGLARLKT 236 (603)
Q Consensus 202 ~~~gIVHrDLKp~NILld~~~~vKL~DFGlA~~~~ 236 (603)
...++||+|+.+.|||++++ ..++||+.+....
T Consensus 190 ~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g~ 222 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRDG--PMFVDLDDARNGP 222 (325)
T ss_dssp SCCEECCSSCSGGGEEESSS--EEECCCTTCCEEC
T ss_pred CCceeecCCCCcccEEEeCC--ceEEechhcccCc
Confidence 23479999999999999743 4589999887654
|